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SCIENCE IN MEDICAL PRACTICE

Robert W. Berliner, M.D.

The following article is based on a talk which Dean
Berliner gave to the Council of Academic Societies at the
annual meeting of the Association of American Medical
Colleges in November. The theme of the session was
“Basic Science Education as the Foundation for
Advanced Medical Practice.

There will be new things in the practice of medicine that
future physicians will need to cope with. It is important
that they have sufficient background in science to be able
to understand these and sufficient critical judgement to be
able to make reasonable decisions about what they will
read or hear.
So, what should our students be taught in their preclinical science curriculum to prepare them for this future?
The specifics of what they are taught are far less important
than the generalities. 1 doubt that any of us know what
specific areas are going to be the important ones of the
future. Our problem is to give students a background that
will make it possible for them to assimilate and utilize new
developments in any one of a number of fields of knowl¬
edge. What is needed for that is not a mass of details at the
edge of present knowledge, but a broad understanding of
basic principles upon which to build, along with develop¬
ment of the habit of and faculty for applying those princi¬
ples to problems. Students must learn early the importance
of independent study and self-education. That is what is
going to be required of them for the rest of their profes¬
sional lives. They must learn to examine what they read
critically so that they can reach reasonable decisons about
the value of new things that appear in the medical literature.
These are the principles which, at least in theory, guide
our present curricula. But, in practice, we are not very
successful in following them. In the basic sciences, and in
the clinical years as well, there is a tendency to load the
students with details. Each member of the faculty acts as if
every member of the class was going to spend the rest of
his life in the field in which the faculty member is expert.
Often the result is that the student is loaded with a confus¬
ing mass of information that he has great difficulty not only
in retaining, but in assembling into an orderly system upon
which he can draw conclusions when faced with a problem
that may not fall precisely in a form that has previously

been presented. The examinations to which students are
subjected too often depend on the recall of specific facts
rather than requiring the application of more basic princi¬
ples to the solution of new problems.
Our curricula generally do not prepare students ade¬
quately to evaluate the validity of new developments. It is
often the case that, in medical school, the student for the
first time encounters material whose interpretation is con¬
troversial and uncertain. In general, what students have
previously been exposed to in their earlier experience will
have been fairly well established. In medicine, they must
learn to live with uncertainty not only in the sense of
probabilities, but in the form of unsettled controversy as
well. At the same time, it is important that they learn to
question the certainty of others and to doubt, possibly for
the first time, the written word.
An important element in preparation for critical evalua¬
tion of new information is, of course, an adequate ground¬
ing in statistics. This does not mean simply to understand
tests of statistical significance, how to calculate a standard
deviation or a standard error. Probably more important is
the ability to seek out and find possible flaws in the design
of studies, which in modem days is such more often the
source of faulty conclusions than simply inadequate statis¬
tical analysis. The literature these days is full of tests of
statistical significance and p-values so that it is unusual
that differences that could be attributable to chance alone
are interpreted as meaningful. However, it is not uncom¬
mon that these tests have been misapplied, and even more
frequently there are problems in the study design that make
the differences found questionable of interpretation. It is
the latter problem that lies behind many of the most con¬
troversial issues in present day medical practice.
There is nothing that can make an individual more
aware of the problems of experimental design and the
interpretation of data than personal involvement in carry¬
ing out a significant research project. It is difficult to make
such experience a regular part of the undergraduate medi¬
cal curriculum. It is demanding upon resources and, if
adequately supervised, on faculty time and attention. Even
more of a problem, however, is the perception that stu¬
dents do not have time in their already crowded schedule to
take on additional activities. At Yale, a school that has for
some 50 years required of each medical student a thesis
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based on original research, we are continually faced with
complaints from our students that they do not have enough
time. Often, I'm afraid the complaint is justified, although
those students who make adequate plans early enough do
not have serious problems. But all of them must deal with
the wasteful clinical years of medical school.
The wastefulness of these years is fostered by a number
of factors — historical, parochial, and psychological. His¬
torically, medical schools turned out graduates fully
prepared to engage in the practice of medicine. As the need
for additional training and experience became recognized,
the post-graduate years have been added, and it is now
generally held that the medical school years are to be
looked upon as preparation for several years of supervised
experience in a residency. Little adjustment has been made
in the clinical years to take this change into account.
One of the reasons that change has been resisted is that
each department jealously protects its share of the availa¬
ble time: in part, in an attempt to attract students to a future
in its own discipline; in part, out of enthusiasm for its own
activities; and in part, simply to make sure that its own
importance does not appear diminished relative to that of
another. If what is needed, however, is a broad founda¬
tion. an understanding of fundamentals, and the ability to
draw upon this foundation for the solution of problems,
equal time is not the appropriate division. Some areas have
broader application than others. I may be accused of
parochialism given my own background in internal medi¬
cine, if I say that internal medicine — and here I mean
internal medicine generally and not the great detail of its
individual sub-specialties — provides a greater opportu¬
nity for solidifying the student's grasp of how to apply the
principles of science to the solution of individual problems
of health and disease than most of the other clinical disci¬
plines. Undergraduate medical education is not the place
to make the student into a surgeon, an obstetrician, or a
psychiatrist. Hours spent holding retractors in the operat¬
ing room may add glamour to the medical school years, but
they do not contribute much to the ability of students to
deal constructively with new problems — unless he or she
is going to be a surgeon, which only a fraction of the
students will be.
But departmental parochialism is not alone in its respon¬
sibility for this type of misspent time. The students them¬
selves, and the house staff, fall easily into the pattern.
Students are all too ready to do those things that make them
feel like they are behaving as doctors, and nothing gives
them that feeling more than being involved in carrying out
procedures. The introduction of hands-on clinical experi¬
ence even into the first year of medical school, — either at
the insistence of the students or to stimulate their interest,
- is a reflection of the urge of students for identification
with the routines of medical care. Unless they are guided
with a strong hand away from these activities, they will
follow this urge only too readily. But the strong hand is
seldom there, or rather, it is there and pushing the students
in the wrong direction. The faculty, happy to see the students

in their own image, and the house staff, happy to share
what they now recognize as drudgery, are quite ready to
allow the students to take on as much of the routine as they
are capable of and willing to do. The students become
heavily involved in doing those things that would be better
reserved until their own house staff years, and things that
they will be doing the rest of their professional lives, rather
than those for which the medical school years are a unique
time — to study in depth, to think problems, even to make
mistakes while there are presumably wiser heads around to
correct them.
Fortunately we don't hear as much about relevance as
we did five years ago. At that time, the question was
directed at the basic sciences. Were they really relevant to
clinical medicine? Does the subsidence of that wave of
questioning represent a recognition among our students of
the true relevance of the sciences basic to medicine? I'm
inclined to think the answer is more “no” than “yes”.
Rather, I believe it reflects the behavior of a less rebellious
cohort of students more willing, if necessary, to put up
with the ideas of their elders even if unconvinced of their
validity. I think it is time for us to raise the question of
relevance. Perhaps we are better qualified to identify what
is really relevant and what is not, having been exposed to
the full range of school, post-doctoral education, “and
more”, as they say in the advertisements. The “more” in
this case is what has happened in medicine in the last few
decades and what is likely to happen in the next few.
What is really irrelevant to the future is much of the
detail of what now goes on in clinical medicine. Many of
the diagnostic procedures now in use, the specific pharma¬
cological agents that are prescribed, the surgical opera¬
tions that are performed, will be supplanted by others —
better ones, we may hope. Many of the things that now
seem to our students to be most relevant, in which they
most eagerly involve themselves, will not be out of date,
discarded. What will remain the same is the patient and his

or her problems and the physiology and biochemistry and
the psychology that underlie them. What will remain
relevant is the science that provides the basis for under¬
standing those problems, for appreciating the reaction of
the patient to his situation, and the rationale of the means
for dealing with them. The important part of the teaching
in the clinical phase of medical school is to emphasize the
application of those sciences to clinical problems and to
habituate the students to thinking about them in an orderly
and logical fashion. That process will never be irrelevant.
Well, here I am in a session supposedly concerned with
the teaching of basic science, and if I've said anything, it
has been largely in criticism of the teaching in the clinical
years. I would not want to leave you with the impression
that I don’t think there is anything to criticize in the
preclinical curriculum. It is often too crowded, too much
directed at the acquisition of detailed factual information,
and insufficiently concerned with the assembly of those
facts into a coherent system so that they can be used for
thinking out new problems.
The most important message to the basic sciences is that
they need not, indeed should not concern themselves with
emphasizing what is relevant to today’s clinical practice,
because tomorrow's will be different. They also should
recognize how wasteful of the student’s time much of the
clinical curriculum is, and should not hesitate to suggest
that some of it might be better used by them. Why should
new courses — genetics, immunology and the like, be
jammed into the limited time devoted to the basic
sciences? Only if it can be shown that the time occupied by
clinical exercises is better spent than what would be dis¬
placed from, or further crowded in, the preclinical
curriculum.
You may rightly ask whether the Yale curriculum
reflects what I have been saying. Well, my father used to
tell me, “Do as I say, not as I do.”
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A MATTER OF TASTE

'

'Jack Sprat would eat no fat; his wife would eat no lean. Between them both, they licked the platter clean.' ’ When it comes

to food tastes, there are almost as many variabilities as there are people. Although there are many cliches on the subject,
psychophxsicists are beginning to uncover some of the basic chemical and genetic reasons for differences in taste
perception. Their findings have implications for discovering causes of taste and smell disorders as well as for the future of
the food industry'.

To some people, rich sweet desserts are the epitome of
gustatory delight. Others prefer a tart apple or sour cherry
pie. Ardent coffee drinkers relish cups of strong, bitter
black brew. Those less enthusiastic, dilute theirs half and
half with milk and add plenty of sugar. Millions of calorie
counters drink diet soda and notice little difference
between it and the non-diet drinks, yet others find the
after-taste of diet drinks bitter and extremely unpleasant.
Why? Research scientists in the field of taste sensation
have found that although learning and culture are factors,
food preference is also affected by complex chemical and
genetic influences. Their findings have implications for
discovering underlying causes of taste and smell disorders
and for the future of the food industry.
‘ ‘Taste” is generally thought of in hedonic terms — the
pleasure or displeasure of flavor, aroma, texture, color,
and whatever else that gives a particular food or drink its
unique quality. In fact, taste is the sweet, sour, bitter or
salty quality of a dissolved substance as it is perceived by
cell receptors concentrated on the edges and at the back of
the upper surface of the tongue. Flavor — chocolate,
vanilla, lemon, beef, chicken, and so forth — has three
components: taste, smell and texture-temperature. When a
food enters the mouth, these three sensory modalities are
all independently stimulated to produce a distinct flavor.
More than two million American adults suffer from loss
or impairment of gustatory or olfactory senses, according
to a recent report of the National Advisory Neurological
and Communicative Disorders and Stroke Council. The
condition itself is not life threatening, and in comparison to
loss or impairment of vision or hearing, it is not generally
considered to be a serious loss. Scientists are beginning to
realize, however, that the chemical senses have consider¬
able medical significance.
Taste and smell disorders not only prevent people from
enjoying eating and drinking — a deprivation of a certain
quality of life — they may also have potentially dangerous
consequences. For example, anosomic patients (those
with an olfactory disorder) are unable to detect escaping
gas and other dangerous fumes as well as fires; smell and
taste often provide the only means of detecting rotten or
rancid foods. Chemosensory defects can signal serious
conditions such as cerebral tumors, temporal lobe epilepsy
4

or endocrine disorders. They can also be related to indus¬
trial pollutants, viral infection, congenital anomalies,
nutritional deficiencies and diabetes.
Although many patients consider taste or smell dis¬
orders disabling and serious enough to seek help, the
medical profession, for the most part, has viewed the
conditions as a mere inconvenience, frequently going as
far as to describe them as “neurotic”. Furthermore, since
there is little known effective treatment for these prob¬
lems, physicians who do take these complaints seriously
often dismiss their patients to “live with” the problem. As
a result, many consult psychiatrists, and a few even con¬
sider suicide, according to Dr. Linda Bartoshuk, associate
professor of epidemiology and psychology at Yale, and an
associate fellow of the John B. Pierce Foundation
Laboratory.
Dr. Bartoshuk is also associate director and co-principal
investigator with Dr. Frank Catalanotto, of the Connect¬
icut Chemosensory Clinical Research Center, a collabora¬
tive endeavor of the University of Connecticut, Yale
School of Medicine, the Worcester Foundation for Experi¬
mental Biology and the Pierce Foundation Laboratory.
The Center, one of only four in the country specifically
directed toward understanding taste and smell disorders, is
funded by a three-year grant from the National Institute on
Neurological and Communicative Disorders and Stroke,
to study, diagnose and treat disorders of taste and smell. In
addition to clinical studies of chemosensory impairment
related to illnesses such as multiple sclerosis, kidney
failure, neurological disorders, diabetes, and problems
related to radiation therapy for cancer, the Center will be
involved in basic scientific research on the physiological
and psychological basis of taste and smell.
Dr. Bartoshuk’s research is aimed at describing taste
sensation. Why do substances taste sweet, sour, salty or
bitter? Why do some people have stronger sense than
others of a particular taste sensation? The answers to such
questions are fundamental to an understanding of chemo¬
sensory disorders.
One of the difficulties in determining taste perception is
that there may be significant differences even among
“normal” populations in taste ability. Recent research in
Dr. Bartoshuk’s laboratory and others have revealed a

genetic basis for some of these differences.
Taste researchers have noted that there is more variation
among individuals for sweet and bitter than for salty and
sour. Salty and sour substances produce relatively little
individual variation in taste because the chemical stimulus
for both — a tiny positively charged ion — is relatively
simple in structure. In contrast, sweet and bitter substances
are usually large and complex organic molecules that have
varying effects.
Not all bitter substances act on the same receptor mech¬
anisms on the surface of the tongue, but rather, we taste
“multiple” bitters, according to Dr. Bartoshuk. One bitter
substance, phenylthiocarbamide (PTC), is a hallmark of
sorts of genetic determination of taste. Family studies
indicate that the inability to taste PTC in foods is a simple
Mendelian recessive trait; individuals who carry two
recessive genes are relatively insensitive to PTC and are
called “nontasters”; while those who carry one or two
dominant genes are much more sensitive and are called
“tasters”.
About seventy percent of Americans are tasters, and
tend to experience a bitter taste from saccharin in diet
sodas and potassium chloride, the most common substitute
for salt. Thus, reactions to PTC provide a test for gauging
reactions to salt and sugar substitutes. This finding is
important for research leading to new and better substitutes
than are currently available for sugar and salt.

Early studies on the structure of PTC seemed to suggest
that a certain very specific part of the PTC molecule was
responsible for the variation in bitterness. The only other
molecules containing the same structure were not often
encountered, so the effect was of more interest then to
geneticists than it was to taste investigators.
However, in 1975, Dr. Bartoshuk and her colleagues
discovered that caffeine, a bitter substance which does not
have the required structure, tastes more bitter to tasters
than to nontasters. “Interestingly enough, the concentra¬
tion of caffeine in an average cup of freshly brewed coffee
is below or near threshold for most nontasters, but it is
above threshold for most tasters,” she observed. “As our
studies continued, we found that the perception of the
bitterness of the saccharin was also related to PTC status.
At the concentration of saccharin used in most diet sodas,
the average taster of PTC perceives two to three times as
much bitterness as the average nontaster.”
Dr. Bartoshuk and one of her students, Bathsheva
Rifkin, have extended this research to potassium chloride
and to sodium benzoate, a preservative often used in
canned foods. They now assume that further study will
turn up many more bitter compounds related to PTC. In
addition, although it has not yet been statistically con¬
firmed, the research indicates that PTC tasters may be
particularly sensitive to certain types of chemotherapy.
This may account for taste problems in leukemia patients
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undergoing therapy, for example.
Early in the 1970's a group of medical science writers
and public relations people attending a meeting to learn
more about taste research from Dr. Bartoshuk, were some¬
what astonished when she passed a perfectly cooked arti¬
choke and a glass of water to each of them. After they had
eaten the artichoke and drunk the water as instructed, she
asked, “How many of you found that the water tasted quite
sweet?” Several, mostly women, had. The “artichoke
effect”, she explained, is another example of the genetic
implications of taste. It may also be sex-linked, hence the
reason more women than men at the meeting experienced it.
She and her colleagues happened on the taste differ¬
ences in artichokes while working on a series of projects on
taste modifiers — substances, including detergents, the
Indian herb Gymnema sylvestre, the African berry known
as “miracle fruit”, and one’s own saliva, — which, when
applied to the tongue will change the basic taste of another
substance. For example, if you brush your teeth before
eating breakfast, you will notice that orange juice tastes
unpleasant. Some toothpaste, and some mouthwash, con¬
tain sodium laurel sulfate, a detergent which produces
temporary effects on the sense of taste.
“Understanding these effects is the foundation for the
rest of the work in taste research. We don't know, for
instance, if two groups that are behaving differently
towards a food, are in fact, having the same sensory
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experience,” Dr. Bartoshuk pointed out.
Laboratory studies have demonstrated that individuals
may be sensitive or insensitive to each of the four basic
tastes. Dr. Bartoshuk’s studies further suggest that sweet
and bitter substances can themselves be subdivided so that
a given individual may, for instance, be insensitive to a
particular bitter stimulus, and very sensitive to other kinds
of bitter stimuli. The same may prove true for sweet
substances. This permits a great deal of potential varia¬
bility in taste both among individuals and across species.
Artichokes, caffeine, miracle fruit, saccharin and the
like may seem rather frivolous research material to hard¬
line bench scientists, but they contribute to a thorough
understanding of the environmental and hereditary factors
necessary to distinguish normal reactions to taste percep¬
tion from those produced by illness. The Connecticut
Chemosensory Clinic is staffed by taste and smell experts
as well as physicians from the medical specialties associ¬
ated with sensory function. One purpose of the clinic is to
provide expert diagnosis of abnormal taste and/or smell
function by comparing patients' taste/smell abilities with
normal function established by laboratory research such as
Dr. Bartoshuk’s. “It is our hope that we will not only be
able eventually to help these patients but that we will also
learn valuable lessons about taste and nutrition from
patients with disordered taste function,” she explained.
M. B. Noyes

DAVID MUSTO: a man with a sense of history

“This brings back keen memories of a childhood fascination
with all the sciences,’’ Dr. David Musto commented when
he learned he had been invited to membership on the Council
of the Smithsonian Institution. He is the first physician ever to
serve on the council of prominent scholars and scientists who
advise the Secretary of the Institution about its programs.
For David Musto, the invitation to serve the nation’s
historical and cultural center was not only an honor and a
delight, it was also an affirmation of his scholarship on the
history of the development of the sciences and social policy in
the United States. His research is recognized as an important
contribution to the understanding of legislative decisions in
these areas. It has also resulted in several significant appoint¬
ments including Historian to the President’s Commission on
Mental Health, and Historical Advisor to the Chairman of the
United Nations Commission on Narcotic Drugs, as well as to
membership on the White House Strategy Council on Drug
Abuse Policy during President Carter’s administration. He
also served as a member of the National Academy of
Sciences' Panel on Abuse and Alcoholism, whose final
report was released last fall.
Dr. Musto is professor of psychiatry (Child Study Center)
and histoiy of medicine, as well as head of the Section of
History and Social Policy of the Bush Center in Child
Development and Social Policy. A glance at his curriculum
vitae confirms that this combination of science and the
humanities has been consistent throughout his academic and
professional careers.
After graduation form the University of Washington,
where he majored in classical languages, he entered medical
school there. When he had completed two years of medical
school, he came to Yale for a master's degree in the history of
science and medicine. He returned to the University of
Washington to complete his medical education and received
his M.D. degree in 1963.
Following internship at The Pennsylvania Hospital in
Philadelphia, and a psychiatric residency at Yale-New Haven
Hospital Medical Center, he served as special assistant to the
Director of the National Institute of Mental Health from 1967
to 1969, and at the same time, as visiting assistant professor
of history at Johns Hopkins University. He joined the Yale
faculty in 1969 as assistant professor of psychiatry (Child
Study Center) and of history.
In addition to his book. The American Disease: Origins of
Narcotic Control, which received high praise, Dr. Musto’s
extensive bibliography covers such diverse subjects as the
biochemical genetics of glucose-6-phosphate dehydrogenase
deficiency; the theory of hereditary disease of Luis Mercado
(1525-1611); the support of basic sciences in 19th century

America; and an historical perspective on the freedom of
inquiry and subjects’ rights. It also includes insights into the
lives of notables such as John Quincy Adams, Sigmund
Freud and Sherlock Holmes. His article in 1968 in the
Journal of the American Medical Association on Holmes’s
and Freud's involvement with cocaine provided a basis for
the novel and film “The Seven Percent Solution’’.
It was as special assistant to the Director of the NIMH
that Dr. Musto first became interested in the history of
public policy making. “One day, the director. Dr. Stanley
Yolles, called me into his office and asked if I would help
him with a ‘historical problem’. Apparently, every time
public health officials suggested providing heroin main¬
tenance programs for addicts, the opposition, which in this
case was the Federal Bureau of Narcotics, would point to a
decision by the American Medical Association in 1920,
completely opposing heroin maintenance. Dr. Yolles
wanted me to find out why, so the next time the subject
came up at a Congressional hearing he would have a better
response,” he explained.
In both the National Archives and the Library of
Congress he found masses of materials on the history of
drug abuse policy dating back to before World War I,
which essentially had never been consulted. “I became
intrigued with the history of narcotics policy in the United
States because it was so different from what I had absorbed
in medical school and during residency. It was more com¬
plicated, and in many ways, more interesting.’’
In researching the assignment from Dr. Yolles, he
became aware that social problem solvers in Washington
and elsewhere in the country, could refer to the history and
evolution of the problems they deal with more often than
they do. ‘ ‘There are many simple facts about the history of
some of our policies, such as that regarding drug abuse,
which if better understood, would provide a different per¬
spective on how to approach the problem, and on what
kind of goals might be set with the likelihood of some
success,’’ he said. “The same might be said about the
profession of psychiatry, which has been particularly
susceptible to the social mores of its times, and is liable to
expressing in rather more complicated medical language
what might otherwise be called simple biases of the
moment. One of the dangers of being in the psychiatric
profession is that one might think that it is invulnerable —
that you can securely take a stance that is extremely objec¬
tive and separate from the social context in which you
live,” he explained. “However, any profession that has to
have one foot in the real world, and one foot in research, is
very vulnerable to strong pressures from society. It is
7

important to look at history in order to be humble, to
realize that distortions can happen.”
To illustrate his point. Dr. Musto cited a few examples.
In the 19th century, “documented” claims by pro-slavery
polemicists of the inherent inferiority of blacks and the
dangers to them of emancipation were matched in the
north by psychiatrists’ studies of Irish immigrants who
were claimed to suffer from an ethnic “constitutional
inferiority.” These examples merely confirm the contem¬
porary social attitude of that time in history when the vast
numbers of immigrants to this country seemed to threaten
its moral, social and economic structure.
A more recent and professionally disturbing example
occurred during the McCarthy era of the 1950's. It
involved a serious encroachment on the very basis of
professional ethics — preserving patient confidentiality.
In an attempt to learn what attracts people to com¬
munism, an academic project called “Appeals of Com¬
munism Project”, based at Princeton with operations all
over the world, turned to psychotherapists for the answer.
Therapists were selected by reputation, position, or pub¬
lished papers in social science research. Although half of
them declined to reveal information about their left-wing,
communist, or ex-communist patients, 35 cases were pro¬
vided by those therapists who agreed to participate. The
purpose of the study was to determine the family constel¬
lation that bred communists and the defensive role of
communism in their lives, according to Dr. Musto. Each
patient’s history was studied intensively and in great
detail.
“It is doubtful that the patients had consented to the use
of their histories or were even aware of this sharing of
information, although the published checklist of informa¬
tion requested from their therapists includes categories that
would easily identify the patients to anyone knowledgeable
about their party careers or public accomplishments,” Dr.
Musto observed. “This is a good example of how history
can be important to the profession, and how any of us,
under stress, can be led to do things we might later deeply
regret.
“The nation appeared to be in great danger from Com¬
munism at that time, and this may have justified to the
therapists an apparent grave breach of patient confidential¬
ity, that at a later time might seem strange. Still, good
history doesn't encourage one to laugh at the mistakes of
the past, but rather to appreciate the humanity and frailty
we all share, past and present,” he cautioned. “If we take
this incident merely as another example of how we have
progressed, we conveniently ignore the humbling continu¬
ity we have with the past.”
Dr. Musto’s work in the history of drug policy also
reveals a national susceptibility to social pressures of the
time. “It seems to me that drug policy is like a cork
floating on an ocean. The forces that move it up and down
are social perceptions of deviant groups; our attitudes
toward foreign nations, and what they may be doing to us;
and our faith in international law and diplomacy,” he
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pointed out. “There are so many factors involved other
than the actual effect of drugs that it's hard to imagine a
field more plagued by being affected by attitudes about
many, many other topics and subjects.”
Although drug use in the United States today is a matter
of considerable concern, it has been a part of the American
scene from the earliest settlers who drank heavily, not just
for inebriation, but also, they believed, for personal
health. Crude opium was imported then, mainly for medi¬
cinal purposes; later in the 19th century, both morphine
and codeine were isolated from it — again, mostly for
medical use.
It was not until the last third of the 19th century that
narcotics use began to be widespread. A year after it
developed Aspirin, the Bayer Company successfully man¬
ufactured heroin from morphine and introduced it com¬
mercially as a cough suppressant, sold over the counter. At
about the same time, advances in technology made pure
cocaine more readily available, and soon its stimulating
and euphoric qualities were highly recommended for
athletes, workers and students. Bottlers of popular soda
drinks and over-the-counter “tonics” added cocaine to
their products. By the turn of the century, both heroin and
cocaine were as available as wine and liquor.
“We had a totally free economy in drugs in the United
States up until around World War I. There was no restric¬
tion other than an average tariff on the importation of crude
opium and coca leaves, and their products could be pur¬
chased at grocery stores, through mail order catalogs and
elsewhere. The result of a free market in drugs was that
people used more and more of them,” Dr. Musto said. “I
find that of interest today, when some advocate the elim¬
ination of drug laws and predict that then drug use would
decline because the public would not feel compelled to use
a forbidden product. ”
With the widespread use of drugs came a fear of the
consequences. Drugs were frequently associated with
specific groups which were seen as a locus of difficulty.
For instance, before World War I, hostility of southern
blacks to whites was linked in the public mind and in the
minds of legislators as well, with cocaine. “In fact, it was
thought that cocaine was an especially dangerous drug for
southern blacks, because, unlike alcohol which damaged
your aim if you were shooting someone, cocaine was
thought to enhance your aim,” Dr. Musto said. “The truth
is, Americans were using cocaine in the north and south —
both whites and blacks, but given the social climate of the
times, the focus was on southern blacks. As the drug era of
the 60’s and 70’s progressed, I became amused at modem
studies that indicated that cocaine was a ‘naturally’ white
drug, and that heroin was a ‘naturally’ black drug. Before
World War I, the opposite connections were asserted,
‘naturally’. We have cliches in the history of drug policy
which are simply unexamined, but have a powerful affect
on what we decide to do, what we are after, and who we
are after, in the process.”
Before World War I, as now, some segments of the
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population believed that drugs were the cause of violence
and social disintegration in society. “Drugs like heroin
and cocaine are not good for society, and 1 am not in favor
of their use. However, the cause and effect of those drugs
at times did get a little mixed up. Perceptions of the way
drugs seem to affect people can be influenced by social
climate, the context in which the drugs are taken, and what
consumers expect those drugs to do after they have taken
them.”
Coincidental to the increasingly widespread use of
drugs at the turn of the century was the rise of the Progres¬
sive era, closely associated with Theodore Roosevelt.
According to Dr. Musto, in many ways the reform move¬
ments that characterized the Progressive era have much in
common with activities in this country during the 1960’s
and 1970's.
“Many federal activities which seem modem — the
battle against water and air pollution, legislation for pure
foods and drugs, mine safety, meat inspection, etc., came
from the Progressive period, in which even the word
ecology became a byword of conservationists and health
reformers alike,” he explained.
By the close of the Progressive period, the effort to
improve public health had gone a long way toward control
of dangerous substances, including the prohibition of
alcohol. Eventually, not only “prohibition” but even the
term “temperance” acquired a bad name, suggesting
over-righteousness and excessive governmental interfer¬
ence in private life. The final rejection of Prohibition and
the image it achieved have spread beyond the details of the
18th Amendment to include wariness at almost any state¬
ment or proposal to fight alcohol's damage to society.
“Neo-prohibitionist” has become a convenient label to
discourage open debate about alcohol's role in contempo¬
rary America.
“The taint the anti-alcohol movement received from
Prohibition led to a disassociation between what we might
call broadly the ecology movement — campaigns against
carcinogens, atomic wastes, air pollution — and that con¬
cerning alcohol. From a progressive, informed and
responsible public stance, attracting in 1900 the kind of
concerned people now in the ecology movement, those
alarmed over the abuse of alcohol have slipped from
leadership to the, so to say, arriere-garde.”

“Yet, the two campaigns for reform are not that far
apart in fundamental concern about public health and
safety, a reliance on scientific research, and a desire to
improve the common environment. The perception of
what we might call the temperance movement may
change, just as there has occurred a revolution in our
attitude toward cigarette smoking as a social activity and
health hazard. If this does occur, there will be a powerful
re-association between old allies with undoubtedly strong
effects on our social mores and policies,” he reasoned.
“Not that prohibition would be reinstituted, but consider
how significant a change would have taken place if we —
and those around us — began viewing a drink the way we
have come to view cigarettes.”
M.B.N
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A REVIEW

A Sense of the Ending

BARRIE COLLINS

By a departing light
We see acuter, quite,
Than by a wick that stays.
There’s something in the flight
That clarifies the sight
And decks the rays.
Emily Dickinson

WILLI RUNK

William Guth, left, the director, confers with Dr. Howard Spiro and
Professor Richard Sewall on location in Bethany.

Mr. Guth and Philip Garvin, the photographer, prepare for a scene at a
patient’s bedside.
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“A Sense of the Ending” is a television production about
terminal illness as seen from the quite different perspec¬
tives of two women who had cancer. It was directed and
produced by William Guth, director of Media Communi¬
cations, Yale School of Medicine.
Richard Sewall, professor emeritus of English at Yale,
relates with compassion and poetry “the very remarkable
experience” of his wife Mathilde’s death. Mrs. Sewall, a
potter and weaver, was a woman whose spirit and sense of
humor remained until the day she died at their home in
Bethany, Connecticut.
“The countryside was beautiful: the October coloring
has never been matched. She was surrounded by friends
and family and all the conveniences we could assemble,”
Professor Sewall remembers. “It occurred to me, though,
that this is all too seldom true of such cases, and I won¬
dered about those people who have to go through such an
experience in the lonely hospital room in a big, crowded
city hospital.”
Charlotte Barnard spent the last six months of her life in
the hospital, conscious, — reading and "thinking about
things” — and attached to an intervenous, hyperelementation life care pump, with a tube out of her nose. She, too,
was a woman of tremendous courage and a sustaining
sense of humor. She had hoped to be able to die at home,
but circumstances of her death necessitated hospitalization.
During those six months, Mrs. Bernard did a great deal
of thinking about her situation and what she could do to
improve similar experiences of other patients. She agreed
to be interviewed for a short videotape prepared for a
seminar on medical ethics for Yale medical and law stu¬
dents. Her physician and friend. Dr. Howard Spiro, pro¬
fessor of medicine and well-known gastroenterologist,
conducted the provocative and moving interview.
“A Sense of the Ending” was conceived from the
response of the students to this interview, according to
William Guth. “The videotape of Mrs. Barnard's reac¬
tions to her situation focused on the issues in a way that the
written word cannot, or does not do. We were impressed
with the students’ responses to it, which ranged from
almost complete withdrawal or denial of her situation, to
feelings of great compassion for her. In the discussion
which followed that and subsequent presentations to other
groups of students and health professionals, we became

aware of the need for more of this kind of material.”
Parts of the interview are incorporated into the 40-minute
program produced by Guth. In various settings including a
ward in the V.A. Medical Center, the cardiac unit at
Yale-New Haven Hospital and the Sewall homesite. Dr.
Spiro seeks reactions to it from Patricia Neil, a nurse who
had cared for Mrs. Barnard; Dr. Harvey Berger, Class of
'77 and assistant professor of diagnostic radiology; and
Professor Sewall.
In the interview. Dr. Spiro asks Mrs. Barnard what she
sees the future as bringing her. "Well, obviously nothing
but death, but the big questions are when and how grace¬
fully, and how much can I be prepared and can my loved
ones and friends be prepared?” she responds. “I think if
more people were frank, we’d get a lot farther in the
treatment of fatal illness — just in the comforting side of it
to the patient, day by day. This experience has taught me
that the touch of a hand, holding hands, can be the most
comforting thing in the world,” she continues.
"Doctors and others in the hospital may not be as aware
of that as they should be,” Dr. Spiro notes.
"A pat on the way by, holding a finger for just ten
seconds, gives the patient something he can carry with him
when he’s thinking about the fact that he will never again
eat a peanut butter sandwich,” she tells Dr. Spiro.
To at least one viewer, this is the lesson of Guth’s
program. It is not whether one spends one’s last days at
home surrounded by family and friends or hooked up to a
life-support system in a large city hospital — often, there is
no choice. The feeling of love and caring expressed to the
patient not only by family and friends, but also by doctors
and nurses determines the difference between experienc¬
ing death as a part of living or experiencing death as a
lonely ending to life.
Perhaps the answer lies in an observation nurse Patricia
Neil makes. "We must remember that a dying individual is
a living individual.” Often, this is extremely difficult.
"When you come into a patient’s room, as I did into my
wife's, with a lump in your throat as big as an orange, it’s a
little hard to be constructive. It’s just too hard to keep the
tears back,” Professor Sewall remembers. "If I could do it
over again, I certainly would see to it that I made a good
deal more explicit than I did, my love for her, my feelings
for her.”
"Mrs. Barnard’s experiences are a lesson for all of us,”
according to Dr. Berger, a young physician specializing in
the high-tech of nuclear medicine. As he talks he is adjust¬
ing a huge machine which looms over an elderly patient,
who looks very small in comparison — and quite appre¬
hensive. "The coronary care unit is a particularly scary
environment. The burden falls on us as physicians, as
investigators, clinicians, to be the person behind the
machine. It’s very important that patients realize and are
confident that there is a physician, that there is a person
behind all the new technology . . . We’ve got to reach out,
touch them, become part of their lives.”
As a health professional, Patricia Neil clearly has
wrestled with the question of involvement — of becoming

a part of the patient’s life support system. "Sometimes
there is limited choice in that for us as well. What comes to
mind is the issue of involvement or abandonment. It's hard
to get that involved,” she admits. "Out of my experience
and exposures here I see death more as a part of life. There
is a journey towards death, a wandering, a waiting. We, as
health care givers, must not abandon the dying patient. We
must not avoid involvement for our own protection.”
Dr. Spiro expresses the same sentiment in another way
in a conversation with his son, Philip, a fourth-year medical
student. "I’m your father. I’m my father’s son. I’m a
doctor. I will someday be a patient. You will be a doctor,
and alas, someday a patient. I think one of the things that
does seem to happen is that doctors don't always see
themselves and their friends and relatives as patients. In
that sense, the sense of the ending, knowing what is yet to
come, ties it all together for me.”
“A Sense of the Ending”, produced in color, was
funded by a grant from the Connecticut Humanities
Council. The title was taken from an essay adapted from a
convocation address delivered by Professor Sewall at
Williams College, Williamstown, Massachusetts. The
production was taped by Philip Garvin, an independent
public television producer and film maker. It is being
prepared for distribution to medical centers and schools,
and there are plans for showing it on public television as
well.
Asked if it was produced specifically for medical stu¬
dents, producer William Guth responded, "It was pro¬
duced for people who have to deal with death — which is
everyone.”
M.B.N.
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One of Yale’s most distinguished graduates
offers a challenge
Dr. Leona Baumgartner (’32 Ph.D., '34 M.D.) is recognized worldwide as an authority on public
health. Among numerous achievements and honors, she has been New York City's Commissioner
of Health, an Assistant Secretary of State and a Professor at Harvard Medical School.
Already a major benefactor of the School of Medicine, Dr. Baumgartner is especially concerned
about the rising cost of becoming a Yale doctor — now $ 17,000 a year for tuition and living
costs. Therefore, in addition to her generous previous gifts, she has just offered to give $75,000 in
new money to the Student Revolving Loan Fund, provided that a further $ 150,000 in new money
is given by other medical and public health alumni.
Every dollar that you give to this year’s Alumni Fund above what you gave last year will be
matched one-for-two by Dr. Baumgartner. If you made no gift last year, she will match your entire
gift one-for-two.
Currently at least three out of four Yale medical and public health students need significant
amounts of financial aid. Although ninety-five percent of all loans are repaid on schedule, there are
still not enough funds to meet students’ needs. If Leona Baumgartner’s challenge is fully met,
funds for student loans will be significantly increased.
Dr. Baumgartner is ready to do her share. How about you.-'

MEDICAL SCHOOL
ALUMNI FUND
12

PUBLIC HEALTH
ALUMNI FUND

A MESSAGE FROM THE DEAN OF STUDENTS

Howard Levitin, M.D.
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Recent publicity has focused much
attention on the problem of financing
higher education As you are undoubt¬
edly aware, rising costs and decreasing
money for financial aid create serious
problems for medical students and for
those considering a career in medicine.
In spite of the large amount of money
involved, our students have been will¬
ing to assume responsibility for their
education, anticipate a large debt, and
fully expect to pay back the money bor¬
rowed. This is attested to by the excel¬
lent performance of Yale students in
repaying loans.
In order for a loan program to meet
students' needs, it should make money
available on terms that make repayment
compatible with income during post¬
graduate training and the early years of
professional practice. Therefore, in
addition to having the necessary
amount of money available for loans,
repayment must be at a reasonable
interest rate and have a deferment
option that postpones the burden of
repayment to a time when income will
be commensurate with the repayment
schedule. The immediate crisis facing
students in higher education today is
the decreasing availability of money
with these desirable characteristics.
It is fortunate for the Yale School of
Medicine that at this crucial time, Dr.
Leona Baumgartner has made a substan¬
tial gift to the Student Revolving Loan
Program, and that she did this in a way
which encourages others to join in the
support of our students. Adequate
financial aid is imperative so that we
can continue our current admission pol¬
icy based on scholastic achievement,
not on the ability to pay. It is also
important that our graduates be able to
choose the specialty and location of
practice uninfluenced by the magnitude
of their debts.
Over the years the Yale Medical
School Alumni Fund income has been
designated by the Dean to be used for
student financial aid. The current
Alumni Fund annual giving will be
added to our Student Revolving Loan
Funds. The Leona Baumgartner chal¬
lenge provides an exceptionally fine
way to support this effort. I can assure
you that the need is great.
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Dr. Lerner is Honored
Dr. Aaron B. Lerner, professor and chairman of the
Department of Dermatology since 1958, received the 1981
Lita Annenberg Hazen Award for outstanding contribu¬
tions to clinical research. Dr. Lerner is well known for his
research in pigment cell disorders.
The Award cited his important contributions to immu¬
nology, endocrinology and neurobiology. “Dr. Lemer's
research on pigment cells has advanced our understanding
of disorders that involve the color of skin and eyes and has
taken science closer to finding a treatment for patients with
melanoma," the announcement said. Melanoma, a fre¬
quently serious type of cancer, usually involves the
melanocytes, or pigment-forming cells in the skin.
Dr. Lerner has also been among the leaders in research
in the study of vitiligo, a disorder involving loss of pigment
cells. It may also be related to immunologic abnormalities
involving the eyes, thyroid, adrenal glands, blood and
sometimes, the development of cancer.
Dr. Lerner, who was bom in Minneapolis, received his
advanced education at the University of Minnesota, earn¬
ing a B.A. degree cum laude in 1941, and a Ph. D as well
as M.D. degree in 1945. Prior to joining the Yale medical
faculty in 1955, he had been assistant professor of derma¬
tology at the University of Michigan Medical School, and
associate professor of dermatology at the University of
Oregon Medical School. In 1961-62 he was a Common¬
wealth Fellow at the Laboratory of Molecular Biology,
England.
The Lita Annenberg Hazen Awards were established in
1979 to honor physicians whose “investigative studies
have changed the medical profession's knowledge and
consequent treatment of disease." Half of the $100,000
award is given to the scientist whose work is honored; the
remainder is subsequently given to the investigator’s insti¬
tution for support of a research fellow or fellows to be
chosen by the Award winner. The awards are administered
by the Mount Sinai School of Medicine.

14

The following was excerpted from an article written by Dr. Lerner
which appeared in the December 1981 issue of Clinical Research.

Our research in the pigment field has covered much
ground, yet our projects are carefully focused and oriented
toward well defined goals. One of my most recent con¬
cerns has been to obtain adequate funding to keep intact the
best group currently working on the biology of pigment
cells. This group is important because I have long felt that
the problem of melanomas can be solved and we all want
to help with the work that has to be done. Good support
from the American Cancer Society and the National Insti¬
tutes of Health has been and continues to be essential.
Much of our work was initially of real interest only to those
few people concerned with the biology and chemistry of
pigment cells. It was only after we used melanocytes in the
isolation and characterization of the melanocyte stimulat¬
ing hormones from the intermediate lobe of the pituitary
gland and melatonin from the pineal gland that numerous
investigators realized the great value of these cells for
research in neuroendocrinology. Pigment cells arise from
neural tissue and are responsive to factors from the inter¬
mediate lobe of the pituitary gland and the pineal gland. It
is remarkable that our work on pigment cells has provided
the handles that were so necessary for the study of these
elusive structures. There has been an explosion of useful
knowledge of both glands and in neuroendocrinology in
general. Melanocytes were also used by Sutherland,
Bitensky, Pastan, Hadley, ourselves and others to advance
the “second messenger" concept of hormone action.
A satisfactory treatment for melanomas may arise from
general advances in oncology or from an unexpected
source, but until that happens we shall continue on our own
long march. Our present efforts combine three approaches.

We are seeking a full understanding of the receptors for the
melanocyte stimulating hormone; the cytotoxicity of prod¬
ucts from reactions catalyzed by tyrosinase; and the
immunology of pigment cells. These projects may appear
overwhelming but I believe that the only important miss¬
ing link is a strain of mouse that develops vitiligo, to be
used for the immunologic work. While it was indeed
strange that melanocytes provided the leads for research
into the pituitary and pineal glands it is still more surprising
that knowledge of vitiligo may bring us to the solution of
melanomas. There is hardly a disorder that has attracted
less attention than vitiligo, and yet the association of
depigmentation with autoimmune disorders of the thyroid,
parathyroid, adrenal and thymus glands, as well as with
pernicious anemia and melanomas, appears to be the
Rosetta stone that holds the clues to a useful therapy for
patients with melanomas. Years of clinical and laboratory
experience have brought me to this conclusion.
Vitiligo occurs in dogs, cats, pigs, horses, elephants,
fish, chickens and other animals. All animals with pigment
cells should have the potential to develop vitiligo. Chick¬
ens of a certain genotype, a year after hatching, lose all
their pigment, become blind and develop thyroiditis.
Removal of the bursa, the source of B cells, decreases the
incidence and delays the onset of these changes. We need a
mouse model similar to the chicken. When we are able to
examine the growth of melanomas in mice that develop
vitiligo we may be in a position to understand the role of
immunologic surveillance in the spontaneous regression of
tumors. Combining this understanding with information
on the nature of receptors for MSH and the cytotoxic
intermediates formed during melanin biosynthesis, we
shall have all the basic knowledge required to develop a
useful treatment for patients with melanomas. The cost of
obtaining all this information is large but finite — between
two and three hundred million dollars, the cost of two
Awacs planes.

BARRIE-KENT
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Three members of the School of Medi¬
cine faculty have been appointed to
named professorships. Dr. Lawrence
S. Cohen has been appointed Ebenezer
K. Hunt Professor of Medicine; Dr.
Robert M. Donaldson, Jr. has been
appointed David Paige Smith Professor
of Medicine; and Dr. Paul Greengard
has been appointed Henry F. Bronson
Professor of Pharmacology.
The Ebenezer K. Hunt Professorship
was bequeathed to Yale by Mrs. Mary
Crosby Hunt in 1896 in memory of her
husband. Dr. Hunt, who was an alum¬
nus of Yale College Class of 1833, re¬
ceived his M.D. degree from Jefferson
Medical College. He practiced medi¬
cine in Hartford for many years and was
president of the Connecticut Medical
Society in 1863-64.
The David Paige Smith Professorship
was established in 1912. It honors Dr.
Smith w ho was professor of the Theory
and Practice of Medicine from 1873 to
1877, and professor of the Principles
and Practice of Surgery from 1877 until
his death in 1880.
Originally designated as a chair in
comparative anatomy, the Henry F.
Bronson Professorship was reassigned
to the Department of Pharmacology by
recent action of the Yale Corporation. It
was established in 1889 through a gift
of Dr. Bronson, a member of the Yale
medical class of 1827.
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Appointment of Three Faculty Mem¬
bers to Named Chairs Announced

Dr. Lawrence S. Cohen.
Ebenezer K. Hunt Professor of Medicine

Dr. Robert M. Donaldson, Jr.,
David Paige Smith Professor of Medicine

A noted cardiologist. Dr. Cohen has
been professor of medicine here since
1970, and was chief of cardiology from
1960 to 1970.
A graduate of Harvard College, he
received his M.D. degree from New
York University School of Medicine in
1958. He first came to New Haven as
an intern at Yale-New Haven Hospital,
where he also served his assistant resi¬
dency. From 1962 to 1964, he was a
research fellow in cardiology at The
Peter Bent Brigham Hospital in Boston,
and assistant in medicine at Harvard
Medical School. He was senior investi¬
gator and head of Clinical Service,
Cardiology Branch of the National
Heart Institute for three years prior to
his appointment in 1968 as chief of
clinical cardiology and professor of
medicine at the University of Texas
(Southwestern) Medical School at
Dallas.
Active for many years in the Ameri¬
can Heart Association. Dr. Cohen was
named "Man of the Year" in 1980 by
the South Central Connecticut Chapter.
He is a member of several professional
and honor societies and is a fellow of
the American College of Cardiology,
the American College of Physicians,
and the Council on Clinical Cardiology
of the American Heart Association. He
serves on the editorial boards of the
American Journal of Cardiology, Pri¬
mary
Cardiology,
Cardiovascular
Medicine, and American Heart Journal.

Dr. Donaldson, who is vice-chairman
of the Department of Internal Medicine
and chief of Medical Services at the
Veterans Administration Medical Cen¬
ter in West Haven, is a leader in the
field of gastroenterology. He came here
in 1973 from the Boston University
School of Medicine, where he had been
head of the Gastroenterology Section
and professor of medicine.
After receiving a B.S. degree with
high orations from Yale University, Dr.
Donaldson studied medicine at Boston
University School of Medicine, where
he received an M.D. degree, cum laude,
in 1952. He was an intern at Montreal
General Hospital and a resident in in¬
ternal medicine at Boston Veterans
Administration Hospital. From 1957 to
1959, he was United States Public
Health Service Fellow in gastro¬
enterology at Peter Bent Brigham Hos¬
pital and assistant in medicine at
Harvard Medical School. He was
appointed to the faculty of the Boston
University School of Medicine in 1959.
A member of a number of profes¬
sional societies. Dr. Donaldson served
as president and is a member of the
governing board of the American Gas¬
troenterology Association. The author
of numerous abstracts and papers on
gastroenterology, he served as editor of
Gastroenterology from 1970 to 1977,
and is a member of the editorial com¬
mittee of the Journal of Clinical
Investigation.

Research, London, and the National
Institutes of Health, Bethesda, Maryland.
Dr. Greengard is a member of a
number of professional societies in¬
cluding the American Society for Bio¬
logical Chemists, the American Society
for Pharmacology and Experimental
Therapeutics, and the American College
of Neuropsychopharmacology. He is
on the editorial board of several journals
including The Journal of Biological
Chemistry; Drug and Alcohol Abuse
Research; and Current Topics in Mem¬
branes and Transport, and is the
founder and series editor of Advances
in Cyclic Nucleotide Research.

Two New Lectureships Established
by Alumni

Dr. Paul Greengard,
Henry F. Bronson Professor of
Pharmacology
Dr. Greengard, a leading authority on
the pharmacology and biochemistry of
the nervous system was appointed to
the Yale faculty in 1968. Prior to his
appointment to the Bronson Professor¬
ship, he had been professor of phar¬
macology and psychiatry.
A pioneer in the field of cyclic nu¬
cleotide research. Dr. Greengard is
well known for his investigations on the
phosphorylation of membrane proteins
and its potential role in nerve transmis¬
sion. His work has been recognized by
numerous awards and honors, includ¬
ing election to the National Academy of
Science, as well as to the American
Academy of Arts and Sciences in 1978.
In 1980, he received the New York
Academy of Sciences’ Award in Bio¬
logical and Medical Sciences, and last
year he was appointed an Andrew D.
White Professor - at - Large, one of the
most
distinguished
professorships
offered by Cornell University.
Prior to his appointment at Yale, Dr.
Greengard has been director of the
Department of Biochemistry at Geigy
Research Laboratories in Ardsley, New
York. A graduate of Hamilton College,
Clinton, New York, he received a Ph.
D. degree in neurophysiology from The
Johns Hopkins University. In addition,
he did research at the Institute of Psy¬
chiatry, University of London; the
Molteno Institute, Cambridge Univer¬
sity; the National Institute for Medical

Through a gift of an alumnus, a series
of annual Sanfurd G. Bluestein Lec¬
tures in Diagnostic Radiology was
inaugurated at the School on February
1 I. Dr. M. Paul Capp, professor and
chairman of the Department of Radi¬
ology at the University of Arizona
College of Medicine, spoke on “Medi¬
cal Imagery- 1990”.
The lecture series was established
through a contribution to The Cam¬
paign For Yale by Dr. Bluestein, a
member of the Class of 1946. A pioneer
in the field of radiology, he was one of
the first physicians in the United States
to use cobalt in the treatment of malig¬
nant disease. In the 1950’s, he pio¬
neered in the use of radioisotopes as a
diagnostic procedure.
Dr. Bluestein, who is attending radi¬
ologist at Chilton Memorial Hospital
and Bamert Memorial Hopspital in
New Jersey, is assistant professor of
radiology at Mt. Sinai Medical School.
A former member of the Hospital Plan¬
ning Council for Northern New Jersey,
he is a member of the Board of Direc¬
tors and of the Executive Committee of
the New York City Opera.
A lectureship honoring Dr. Jack R.
Cooper has been established in the
Department of Pharmacology through a
gift of Dr. Mohandas M. Kini. The first
annual lecture was given on February
19 by Dr. Jon Lindstrom of the Salk
Institute in San Diego.
Dr. Cooper, who is professor of
pharmacology, is well known for his
research in the field of neurochemistry,
and especially for his contributions to
new knowledge of the neurotransmit¬
ter, acetylcholine, and of the role of

thiamine in nervous tissue. He became
a member of the Yale medical faculty in
1956, and has been a Special Fellow of
the U.S. Public Health Service in
London, England (1965-66), and
visiting professor at Hebrew Univer¬
sity, Israel (1973).
A graduate of Queens University,
Kingston, Ontario, he received both his
M.A. and Ph.D. degrees in biochemis¬
try from George Washington Univer¬
sity. From 1952 to 1954, he was Smith,
Kline and French Research Fellow of
the National Heart Institute. He is a
member of the Advisory Board of the
USA-Israel Binational Science Founda¬
tion. The co-author of Biochemical
Basis of Neuropharmacology, now in
its fourth printing. Dr. Cooper serves
on the editorial boards of Biochemical
Pharmacology, Neurochemical Re¬
search, and the Journal of NeuroNeurochemistry.
Dr. Kini, who received his Ph.D.
degree from McGill University in 1960
and M.D. degree from Yale University
in 1965, is chief of Retina Services at
Boston University Medical Center, and
assistant professor of ophthalmology at
Boston University School of Medicine.
He did research in Dr. Cooper’s labor¬
atory while he was a postgraduate stu¬
dent at Yale.

Dr. Brieger Delivers
Fulton Memorial Lecture
The fourth annual John F. Fulton
Memorial Lecture was given on Octo¬
ber 30 by Dr. Gert Brieger, professor
and chairman of the Department of the
History of Health Sciences, University
of California, San Francisco. The lec¬
ture was entitled “Early Ambulation: A
Case Study in the History of Surgery”.
Dr. Brieger received his M.D. degree
from U.C.L.A., his M.P.H. degree
from the Harvard School of Public
Health, and his Ph.D. degree in history
from Johns Hopkins University. He is
president of the American Association
for the History of Medicine.
The lecture is named for the late John
F. Fulton, Sterling Professor of the His¬
tory of Medicine at Yale, and is funded
by a gift from Dr. Bern Dibner, Direc¬
tor of the Bumdy Library, Norwalk,
Connecticut. A committee of the
Beaumont Medical Club selects a
Fulton Fellow annually.
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Faculty Notes
The 1981 C.E.-A. Winslow Award
was presented to Dr. Robert W.
McCollum, who is recognized interna¬
tionally for his research on hepatitis.
The award, which is presented annually
by the Connecticut Public Health
Association, is given to an outstanding
professional in the field of public
health. It was established to honor the
memory of the founder of the Depart¬
ment of Public Health at Yale. Dr.
McCollum retired as Susan Dwight
Bliss Professor and chairman of the
Department of Epidemiology and
Public Health on January 1, to become
dean of the Dartmouth Medical School.
The National Academy of Sciences
presented the 1982 U.S. Steel Founda¬
tion Award in Molecular Biology to
Dr. Joan A. Steitz, professor of mo¬
lecular biophysics and biochemistry.
Established in 1961 to recognize nota¬
ble discoveries by young scientists in
the field of molecular biology, the
award cites Dr. Steitz's contribution to
the understanding of how RNA mo¬
lecules are recognized and synthesized
by enzymes, and discovering the roles
played by small ribonucleoprotein mo¬
lecules in RNA processing.
Among the first delegation of the
American Psychiatric Association to
visit China, were Dr. Donald J.
Cohen, professor of pediatrics, psy¬
chiatry and psychology, and Dr. Boris
Astrachan, professor of psychiatry
and director of the Connecticut Mental
Health Center. In addition to visiting
major psychiatric centers in the People’s
Republic of China, they presented
papers at the first Chinese symposium
on schizophrenia. It was their impres¬
sion that ideas about psychiatric dis¬
orders in China generally are similar to
those held by psychiatrists in the United
States.
The 1982 Kappa Delta Award for out¬
standing research in orthopedic surgery
was presented to Dr. Gary E.
Friedlaender, associate professor of
surgery (orthopedic). The awards are
given annually by a joint committee of
the American Academy of Orthopaedic
Surgeons and the Orthopaedic Research
Society. Dr. Friedlaender was recog¬
nized for his development of guidelines
for the safe and effective banking of
musculoskeletal tissues and for concepts
for clinical application of bone allografts
following traumatic, degenerative or
neoplastic diseases of the skeleton.
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Seven members of the faculty were
named American Association for the
Advancement of Science Fellows at the
Association’s annual meeting held in
January. They are Dr. Alvan R.
Feinstein, professor of medicine and
epidemiology; Dr. Robert E.
Handschumacher, professor of phar¬
macology; Dr. Kenneth K. Kidd,
associate professor of human genetics;
Dr. Frederic M. Richards, the Henry
Ford II Professor of Molecular Bio¬
physics and Biochemistry; Dr. Leon
E. Rosenberg, professor and chaimian
of the Department of Human Genetics;
and Dr. Sherman M. Weissman, pro¬
fessor of human genetics, medicine,
and molecular biophysics and bio¬
chemistry. A fellow of the AAAS is “a
member whose efforts on behalf of the
advancement of science or its applica¬
tions are scientifically or socially
distinguished.”

Dr. John A. Kirchner, professor of
otolaryngology, delivered the Semon
Lecture at the Royal Society of Medi¬
cine in London in November. Sir Felix
Semon was well known for his work in
laryngology, and in 1881, “Semon’s
Law” of laryngeal paralysis was pub¬
lished. In his lecture. Dr. Kirchner
examined this disorder as seen a cen¬
tury later.

Dr. James L. Boyer, professor of
medicine and director of the Liver Study
Unit, and Dr. Joyce D. Gryboski.
professor of pediatrics, have been
appointed to the National Digestive
Diseases Advisory Board. Dr. Boyer
was also named vice-chairman of the
Board, which was established in 1980
to recommend to Congress and the Se¬
cretary of Health and Human Services
ways to combat digestive diseases, a
leading cause of death and disability in
the United States.

New Books by Faculty

The 1981 Macomber Lecture at Harvard
Medical School was delivered by Dr.
Philip M. Sarrel, associate professor
of obstetrics and gynecology and psy¬
chiatry. His topic was “The Psycho¬
sexuality of the Menopause”. The
Macomber Lecture was established to
provide lectures by guest speakers to
undergraduate students on subjects of
sexuality in the field of human repro¬
duction and reproductive biology.
Dr. Gilbert H. Glaser, professor and
chairman of the Department of Neurol¬
ogy, has returned from a fall term leave
of absence spent mainly conducting
research as a visiting professor at The
Park Hospital, Oxford, England, the
National Centre for Children with
Epilepsy in Great Britain. He also was
designated a Fulbright Distinguished
Professor during the month of October
in Yugoslavia, where he gave a series
of lectures and conferences in the
University Departments of Neurology
and Neurosciences in Zagreb and Rijeka.

Dr. George A. Silver, professor of
public health and Institution for Social
and Policy Studies, has been elected a
senior member of the Institute of Medi¬
cine. Chartered in 1970 by the National
Academy of Sciences, the Institute of
Medicine enlists distinguished mem¬
bers of medical and other professions
for the examination of policy matters
pertaining to public health.

“Skin Signs of Systemic Disease”.
Second edition. By Irw in M. Braverman, M.D., professor of dermatology.
W.B. Saunders (Philadelphia) 1981.
“Clinical Psychiatric Medicine".
Julian Lieb, M.B.B.Ch., associate
clinical professor of psychiatry;
Andrew Slaby, M.D., PhD.; and
Lawrence Tancredi. M.D., J.D.
Harper and Row (New York) 1981.

Yale Medical Historians Contribute
to Classics of Medicine Library
An English translation of “The Etiology,
the Concept and the Prophylaxis of
Childbed Fever” by Ignac Semmelweis has recently been privately printed
for the members of The Classics of
Medicine Library. The elegantly bound
volume also contains translations of the
Semmelweis “Open Letters” prepared
by Dr. Sherwin Nuland, assistant clini¬
cal professor of surgery, and Ferenc
Gyorgyey, medical historical librarian
at the Yale Medical Library. Dr.
Nuland's article, “The Enigma of
Semmelweis — an Interpretation”,
from the Journal of the History of
Medicine and Allied Sciences is also
included. The Classics of Medicine
Library is a division of Gryphon Edi¬
tions, Ltd., Birmingham, Alabama.

FACULTY OBITUARIES
Robert Holt Green, M.D.
Dr. Robert H Green, clinical professor
of medicine and formerly professor of
pathology and medicine, died at his
home in Madison, Connecticut on
December 25. He was 70 years old.
A native of Charleston, South
Carolina, he received his B.A. degree
from the University of the South in
1933 and graduated from the Johns
Hopkins University School of Medi¬
cine in 1938. Following an internship at
Strong Memorial Hospital in Rochester,
New York, and post graduate training
in internal medicine at Western Reserve
University Hospital in Cleveland, he
was appointed a National Research
Council Fellow in the medical sciences
at the Rockefeller Institute. Dr. Green
served four years in the U.S. Navy dur¬
ing World War II and was discharged in
1946 with the rank of lieutenant com¬
mander. He returned to the Rockefeller
Institute for a year prior to joining the
Yale faculty in 1947 as an assistant pro¬
fessor of medicine. He was promoted to
associate professor in 1950.
In the ntid-1950’s Dr.Green was
engaged in practice of internal medi¬
cine in Madison; however, he returned
to the full-time faculty at Yale in 1957
as an associate professor of preventive
medicine working with Dr. John R.
Paul. From 1960 to 1967 he served as
associate professor and professor at
New York University School of Medi¬
cine. During this period he was asso¬
ciate scientific director of the Health
Research Council of the City of New
York and later chief of the medical ser¬
vice at the Manhattan Veterans Admin¬
istration Hospital. He returned to
Connecticut in 1967 as associate chief
of staff for research at the West Haven
Veterans Adminstration Hospital and
professor of medicine at Yale.
Then in 1969 Dr. Green responded to
a call from his homeland and served as
dean and professor of medicine at the
Medical University of South Carolina
until 1970. When he came back to Yale,
he was appointed professor of pathol¬
ogy and medicine and resumed his posi¬
tion at the Veterans Administration
Hospital. In 1974 he joined the staff of
the Middlesex Memorial Hospital in
Middletown, Connecticut as chairman
of the Department of Medicine and
continued his association with Yale as a
clinical professor of medicine.

During his career as a medical scien¬
tist, Dr. Green did extensive research
on the epidemiological and clinical
aspects of a variety of virus diseases,
especially rubella and intluenza. He
also studied the effects of virus infec¬
tions on persons suffering from bron¬
chitis and emphysema. He was a mem¬
ber of the American Association of
Immunologists, the American Society
for Clinical Investigation, the Infec¬
tious Diseases Society of America and
various other professional organizations.
In speaking of Dr. Green’s service as
chief of medicine since 1974, the
Middlesex Memorial Hospital presi¬
dent said, “Dr. Green was one of the
most outstanding physicians this insti¬
tution has known in terms of his contri¬
butions to the quality of patient care
here ... He worked in quiet, effective
ways, offering unique and special con¬
tributions
too
extensive
to
be
innumerated.
Dr. Green is survived by his wife,
Audrey Johnston, two sons and a
daughter.

Theodore Sehlosser Evans, M.I).
Dr. Theodore S. Evans, clinical pro¬
fessor emeritus of medicine, died on
Januray 25, 1982 at the age of 86 fol¬
lowing a long illness.
A graduate of Phillips Exeter Acad¬
emy, Dr. Evans received his B.A.
degree from Yale College in 1917 and a
B.S. Degree in 1919 from Columbia
University. In 1921 he received his
M.D. from the Columbia University
College of Physicians and Surgeons.
He interned at the House of Mercy
Hospital in Pittsfield, Massachusetts
and then served as a resident physician
at Roosevelt Hospital in New York City
from 1922 to 1924, when he located in
New Haven.
He joined the Yale School of Medi¬
cine faculty in 1933 as a clinical
instructor of medicine. He was pro¬
moted to assistant clinical professor
and subsequently to associate clinical
professor. In 1952 he was promoted to
the rank of clinical professor. He was
given an emeritus title when he retired
from the active faculty in 1964; how¬
ever, he continued to be active profes¬
sionally until 1976.
Dr. Evans was one of the first physi¬
cians in this area to specialize in hema¬
tology, and he won wide acclaim in that
field. For many years he was chief of

the medical service at the Grace Unit of
Grace-New Haven Hospital and director
of the Hematology Clinic. He also had
been chief of medical services at the
Hospital of St. Raphael in New Haven
and the Griffin Hospital in Derby. He
was a fellow of the American College
of Physicians, a member of the Internatinal Society of Hemotology, and
had served as president of the New
Haven Medical Association.
Throughout his medical career in
New Haven, Dr. Evans was a dedi¬
cated teacher of medical students and
house staff. On his retirement from the
active faculty. Dean Vernon Lippard
wrote as follows: “Your loyalty and
support of the highest ideals in medical
education and medical care have been
demonstrated on many occasions, and
the position you have held in the medi¬
cal community has made your support
effective.”
Cyrus Robert Friedman, M.I).
On November 27, 1981, Dr. Cyrus R.
Friedman, associate clinical professor
of pyschiatry, died suddenly following
a brief illness.
Dr. Friedman was bom in New York
City in December 1923. After receiv¬
ing his B.A. from Cornell University
and his M.D. in 1946 from Cornell
Medical College, he interned at the
Sinai Hospital in Baltimore, Maryland
and then served for two years in the
Army Medical Corps.
He began his residency in pyschiatry
in 1950 at the Winter Veterans Admin¬
istration Hospital in Topeka, Kansas
and was simultaneously a fellow at the
Menninger School of Psychiatry. In
1952 he moved to the Austen Riggs
Center in Stockbndge, Massachusetts
to complete his training. From 1955 to
1959 he was a member of the staff at the
Austen Riggs Center and had a private
practice in Pittsfield, Massachusetts.
In 1959 Dr. Friedman was appointed
chief of the Department of Psychiatry at
Mount Zion Hospital in San Francisco,
a post which he held until he came to
New Haven in 1961 to engage in the
private practice of psychiatry and psy¬
choanalysis. He was appointed to the
part-time faculty at Yale in 1963 as an
assistant clinical professor and was
promoted to associate clinical professor
in 1971. He was also an attending pyschiatrist at the Yale-New Haven Hospital.
continued, next page
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A graduate of the Western New
England Institute for Psychoanalysis
and a fellow of the American Psychiat¬
ric Association, Dr. Friedman was a
highly respected member of the New
Haven psychiatric community. He was
regarded by his colleagues to be a very
competent clinician and a challenging
and effective teacher.
Dr. Friedman is survived by his
wife, Carolyn Jaffe Freidman, and their
daughter, Margaret, and son, David.

Anil N. Jayawardena, Ph.I).
Dr. Anil N. Jayawardena, a research
associate in epidemiology and public
health, died suddenly, apparently of a
cardiac arrest, on December 20, 1981
at the age of 35.
Dr. Jayawardena came to Yale in
1975 as a postdoctoral associate in the
Department of Pathology. Born in Sri
Fanka, he attended the University of
Ceylon and graduated with the B.Sc.
degree with honors in Zoology in 1969.
He then went to England and received
his Ph.D. in 1975 from the University
of Fondon, where he had served as a
Commonwealth Scholar. Prior to com¬
ing to the United States, he worked as a
postdoctoral research fellow in the
Department of Immunology at Middle¬
sex Hospital Medical School in Fondon,
From 1976 to 1978, Dr. Jayawardena
held a James Hudson Brown Memorial
Fellowship in pathology at Yale and
worked with Dr. Byron H. Waksman
on the role of suppressor T-cells in an
animal model of trypanosomiasis. In
1978 he was appointed as a research
associate in pathology, and in 1980 his
appointment was in epidemiology and
public health. Throughout this period
he continued his immunologic research
in experimental trypanosomiasis and
received support from the National
Institutes of Health and the Rockefeller
Foundation.
Dr. Jayawardena was considered by
his colleagues to be an exceptional
individual and a profoundly competent
investigator. The sudden unexpected
death of this extremely promising
young scientist was a great shock to all
those who knew him.
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The intenor of the Hope Building, when the central area on the first
floor was used as a waiting room for the clinic — circa 1925-30.

Sitting squarely on the comer of
Congress Avenue and Cedar Street, the
dark red brick and rough stone building
is the oldest structure on the medical
school campus. Built in 1902 as the
clinic for the School it was considered
at the time to be one of the largest and
most thoroughly equipped clinical
buildings in the country. The Jane Ellen
Hope Building is of historical as well as
architectural significance to Yale and to
the surrounding neighborhood.
While its exterior is important as a
landmark, it is not exceptional architec¬
turally. The original interior of the
Hope Building, however, was a
masterpiece of architectural space and
detailing,
typical
of the times.
Designed around a central interior
court, three stories high, surrounded by
galleries leading to small rooms, with a
monumental stairway to the second
floor, it was crowned with a magnifi¬
cent skylight which filtered sunlight
throughout the central space. Tucked
behind, were a small lecture hall, and
perhaps the building's greatest treas¬
ure, an amphitheater.
Beneath the dismal hodgepodge of
subsequent clumsy and ill-conceived
partitioning and other intrusions on the
space, many of the elegant architectural
details survived, including the stairway

I
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and its balustrade, terrazzo from the
first floor, wood detailing and brackets,
and marble slab counters. Some of
these, as well as the lecture hall and the
amphitheater, are incorporated into the
renovation plans.
By the late 1960’s, it was evident
that the building, as it was originally
designed, was impractical for modem
use in a medical school where space is,
to put it mildly, at a premium. Further,
the open design, however appealing
esthetically, did not meet contempo¬
rary building fire and safety codes.
Fortunately, suggestions for demo¬
lition of the Flope Building were
rejected in favor of renovation to create
much needed new teaching space. The
final design by architect Alexander
Purves reflects a fine sensitivity both to
the historical and architectural qualities
of the building in a design that is a well
executed adaptation of the interior to
more practical use as an educational
center.
When work is completed sometime
this summer, two new auditoriums, one
on the first floor, the other directly
above, each with a capacity for 150
people; ten seminar rooms and the
existing small lecture hall will be avail¬
able for use by medical classes, as well
as for conferences and convocations.

Exhibition galleries, lounges, a snack
canteen and a catering kitchen to serve
day-long events, will add much needed
amenities to the facilities at the School
of Medicine.
There are also plans, temporarily
shelved for a lack of funding, to reno¬
vate the amphitheater. These plans are
described here by Mr. Purves.
The historic amphitheater is both the
symbolic and the architectural heart of
the Hope Building. It is the oldest surving teaching space at the School of
Medicine, and it forms the core of the
renovated building. Over time, as the
room ceased to be used for its original
purpose as a surgical amphitheater, it
fell on sad days. Previous renovations
to other areas began to encroach on the
space, and mechanical ducts were run
through it as they would be through any
other unused abandoned space.
The amphitheater, with its steeply
rising curved tiers of seats — like a
small Greek theater — was the most
unusual and architecturally striking
space in the old building. The current
renovations will retain the unique char¬
acter of the room and will restore it to
its appropriate place as a vital teaching
space at the center of the building. Cer¬
tain minor modifications to the original

room will be made to make it safer,
more easily accessible, and more ser¬
viceable as a teaching space. A new
entrance at each side will lead directly
from the first floor to the lowest tier of
seats. The floor of the pit will be
slightly raised so that it will suitable for
lectures. A chalk board will be inserted
within the old window frame on the
front wall, and the original skylight,
which had been partially destroyed,
will be replaced by a new one in the
same location. Enough of the original
seats survived so that they may be
reconditioned and reinstalled.
The room itself is of such a strong
architectural character and creates such
a dramatic ambience that it is likely that
a greater variety of uses will be found
for it in addition to that of a lecture
room. It would incidentally, be ideally
suited to small stage productions or
chamber music performances. But the
intention of the renovation is to modify
the room only as necessary to make it
serve as a teaching space while retain¬
ing its unique architectural character as
well as its unique place in the history of
the Yale School of Medicine.
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Class Notes
1930
The third edition of “Hand Surgery”
by J. Edward Flynn has recently been
published by Williams & Wilkins. Dr.
Flynn is clinical professor of surgery
emeritus at Tufts University School of
Medicine and chief. Hand Surgical Ser¬
vice at the Veterans Administration
Hospital in Boston.

The Alumni in Medicine Column
Notes from the President

Nicholas P. R. Spinelli, M.D.
Welcome to a new column. We intend
in future issues to present subjects for
discussion which are of interest to you,
ones which hopefully many of you have
suggested.
Our purpose is communication,
among ourselves and for ourselves. A
first and pertinent question is who
“ourselves” may be — Who are the
Yale alumni/alumnae in medicine in
1982? Across the span from our oldest
graduates from the Class of 1906 to
those of 1982, there is great profes¬
sional, geographic, and ethnic variety.
Our alumni ranks began with physi¬
cians, but with the growth of our organ¬
ization we have added to the roster public health professionals, house staff and
fellows, and recently the physician
associates.
Lastly, but so importantly, the cur¬
rent Yale medical student deserves
attention, and perhaps some orienta¬
tion, in this context. We are students so
briefly, and alumni forever thereafter.
Students should be viewed as the em¬
bryo alumni they are, and we probably
owe them an orientation to the sense of
responsibilities and opportunities which
the alumni status provides. Of particu¬
lar interest to all of us would be the
portrait of the Yale medical student in
1982. Does their experience parallel
those of the generations of graduates
who remember the Yale system of med¬
ical education so unique and so extra¬
ordinary? A future column or article
should be devoted to them so that they
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can present their self-portrait.
Most of the many graduates who
elected to remain active in alumni
affairs are involved in the fund-raising
process which addresses various needs
of our School and especially those of
our current students. Who are these
dedicated people and what gratification
do they derive from their effort? Ros
Gallagher (’30), for example, has for
the many years since its inception
chaired, in a low-key way, our Medical
School Alumni Fund’s Bequest and
Endowment program. Aided by Sam
Kushlan (’35), why did he last year
pursue this effort in a more high-keyed
way? What are the implications of such
activities concerning the future of
American medical education? In a
forthcoming column, we shall have you
meet Ros and Sam and let them state
their case.
We visualize communication in this
column as a dialogue. Since a dialogue
does not flow in one direction, we shall
need your suggestions, reactions, and
volunteered expertise to make this
enterprise successful. The chair may be
yours.

Crawford Campbell wrote recently:
“We have semiretired, although I spend
five months a year at the Mass. Gen.
Hospital in the Department of Ortho¬
paedics working in the field of patho¬
physiology of the bones and joints, and
another three months in other universi¬
ties teaching in the same field. Our ma¬
jor home is on Squam Lake in New
Hampshire and we have a condominium
on Commonwealth Avenue in Boston.''

1941
Robert Areson has been appointed full¬
time corporate medical director of Un¬
ion Camp Corporation in New Jersey, a
position he has held on a part-time basis
since 1969.
Dr. Areson will develop company
health policies and coordinate the activi¬
ties of other company physicians, while
continuing to provide medical services
at the Wayne (N.J.) headquarters. He
will also serve as the company's repre¬
sentative on industry health committees.
Dr. Areson has published several arti¬
cles on diabetes and serves as chairman
and president of the Camp Nejeda Foun¬
dation, which operates a camp for dia¬
betic children in Stillwater, New Jersey.
Among his professional honors are cita¬
tions from the New Jersey Diabetes
Association and from the Board of Trus¬
tees and medical staff of Mountainside
Hospital, Montclair, for his service as
president of the medical staff. He resides
in Little Falls, New Jersey.

1944
Laurence Roth, in private practice in
Batavia, New York, has been elected to
a three-year term as chairman of District
II (New York State) of the American
College of Obstetricians and Gynecolo¬
gists. From 1976 to 1978, he was a
member of its Committee on Patient
Education; in 1979, he served on its
Committee on Nominations; and from
1978 to 1981 was secretary of District II.
Dr. Roth is assistant clinical professor

at State University of New York at
Buffalo School of Medicine and clinical
instructor at University of Rochester
School of Medicine and Dentistry. In
addition, he is affiliated with Genesee
Memorial Hospital in Batavia.
Dr. Roth is also a Fellow of the Amer¬
ican College of Surgeons and a member
and past president of the Buffalo Gyne¬
cologic and Obstetric Society.

B. Day, comments further: “. . . Few
surgical scholars are so well fitted as
Karel Absolon to undertake the trans¬
lation of so much original background
information, or to evaluate and appre¬
ciate the life of Theodor Billroth as
evident in the work of Professor
Absolon. This Life is a magnificent
endeavour, and it is convincing.’’

1950

Donnell Etzwiler. pediatrician at St.
Louis Park Medical Center and director
of the Diabetes Education Center in
Minneapolis, has been honored by
election to membership in the National
Academy of Sciences, institute of
Medicine. Dr. Etzwiler is also a past
president of the American Diabetes
Association and is currently a vice pres¬
ident of the International Diabetes
Federation.

1953
John Strauss, professor and head of the
Department of Dermatology at Univer¬
sity of Iowa College of Medicine has
been selected as president-elect of the
American Academy of Dermatology. In
addition to having held many positions
in the Academy during the past 25 years,
he is also an assistant editor of the
Journal of the American Academy of
Dermatology and has served on the edi¬
torial board for the Journal of Investiga¬
tive Dermatology.
Dr. Strauss' activities extend into
many aspects of medical education and
health care. He is on the Committee on
Continuing Medical Education for the
Council of Medical Specialty Societies
and the Accreditation Review Commit¬
tee for the Accreditation Council for
Continuing Medical Education. He is
also an associate director of the Com¬
mission on Cutaneous Diseases for the
Defense Department and a consultant
to the Surgeon General of the United
States.

1952
Karel Absolon’s recently published
book, “The Surgeon’s Surgeon: Theodor
Billroth (1829-1894). Volume II (The
Middle Years, 1867- 1879)’’ is now
available in addition to Volume I. Vol¬
ume III is in preparation. The publisher
is Coronado Press in Lawrence, Kansas.
In a review of this work it was noted
that “it is important to recognize that
Professor Absolon was himself an edu¬
cator and busy surgeon during this
writing ... He uses facts, anecdotes,
epigrams, conversations, and docu¬
ments of historic importance, some of
which are reaching the outside world
tor the first time, in a singularly precise
way, delivering essentially Billroth the
person and surgeon first, and then with
less priority, the broad sweep of history.
. . . The sterling quality of Professor
Absolon’s Surgeon’s Surgeon is that
his subject was, and is, first and fore¬
most a human being
The reviewer of this work. Dr. Stacey

Jose Ramirez Rivera, Director of the
Western Consortium of Medical Edu¬
cation and professor of Medicine at the
University of Puerto Rico has received
an award as ‘'the highest value in Medi¬
cal Education” for 1981 from the West¬
ern District of the Puerto Rico Medical
Association. Dr. Ramirez is Chairman
of the Department of Medicine of the
Mayaguez Medical Center and Director
of the Rincon Rural Health Initiative
Project.

1954
The Uniformed Services University of
the Health Sciences has established a
Section on Medical History in the
University's School of Medicine, and
Robert Joy has been appointed the first
chairman and professor of medical his¬
tory. Dr. Joy, until his retirement from
the Army in October 1981, had served
27 years in the Medical Corps. He held
the rank of colonel and had most recent¬
ly served as Commandant of Students
at the School as well as chairing its
Department of Military Medicine and
History.
A lively and vivid lecturer. Dr. Joy
in 1980 received the first William P.
Clements Award which is given annu¬
ally at the University, as it is at the
service academies, to the uniformed
faculty member considered by the stud¬
ents to be their best teacher.
At a retirement ceremony on October
30, Dr. Jay Sanford, Dean of the
School of Medicine, referred to Dr.
Joy’s retirement as a “transition” rather
than a goodbye. Then, as Dr. Joy’s

mother, wife, and daughter looked on
Dean Sanford presented him with the
Army's Distinguished Service Medal,
the highest award that an active duty
military officer can receive in a non¬
combat role.

1956
William Hindle wrote recently from
Honolulu. He has been elected for a
third term as treasurer of the Hawaii
Medical Association.

1960
John Davis, state director of research
for the Illinois Department of Mental
Health and director of research at the
Illinois State Psychiatric Institute in
Chicago, has been appointed the first
Gilman Professor in the College of
Medicine, University of Illinois at the
Medical Center, Chicago. He has also
been named a research professor in the
College’s Department of Psychiatry.
Internationally known for his work
in the fields of psychopharmacology
and psychiatric depression, he has
served as consultant to the Food and
Drug Administration, the National
Academy of Science, National Institute
for Mental Health, the President’s
Commission on Mental Health, and the
National Commission on Marijuana
and Drug Abuse.

1964
An impressive health care system is
being developed in Bogota, Colombia,
South America by the Fundacion Santa
Fe de Bogota (F. S. F. B.). Of the six
founders of this Colombian Institution,
two are Yale medical school alumni;
Alfonso Esguerra and Jose Felix
Patino, (’52). Dr. Esguerra is the gen¬
eral director of F.S.F.B. Dr. Patino is
the chairman of the Department of
Surgery at the medical center being
developed by F.S.F.B.
The medical center will open in mid1982. Its 200-bed hospital will provide
a full range of in- and outpatient ser¬
vices. All full-time physicians and
those clinical physicians actively par¬
ticipating in the teaching programs of
the medical center will have academic
appointments at the University of the
Andes.

1965
William Grossman, formerly director
of the cardiac catheterization labora¬
tory at Brigham and Women's Hospital
in Boston, has been appointed director
23

of the cardiovascular divison at Boston’s
Beth Israel Hospital and promoted to
professor of medicine at Harvard Medi¬
cal School. He is particularly interested
in new developments in the treatment
of patients with acute myocardial in¬
farction. Dr. Grossman is the author of
the textbook, “Cardiac Catheterization
and Angiography" which is now in its
second edition and is the standard of
reference in his field.

1966
Arne Youngberg, an attending radio¬
logist at Waterbury (Conn.) Hospital is
vice chairman for the Medical Staff
Division of the Waterbury Hospital's
1982 Annual Appeal. The Annual
Appeal seeks support each year in
Waterbury and surrounding towns to
help fund the purchase of new and re¬
placement medical equipment.

1970
Daniel Dedrick is an assistant profes¬
sor of anesthesia at The Pennsylvania
State University College of Medicine at
The Milton S. Hershey Medical Center
in Hershey. Pennsylvania. His wife,
Dr. Carolyn Dedrick, a former member
of the class of 1973, is an assistant
professor of radiology at The Pennsyl
vania State University College of
Medicine.

1972
John Foster is now practicing diagnos¬
tic radiology at the Westerly Hospital in
Westerly, Rhode Island. He and his wife,
Barbara, are living just across the border
in Mystic, Connecticut with their two
children, Ainslie and Jonathan.
John Fulkerson is assistant professor
of orthopedic surgery and director of
the Sports Injury and Knee Clinic at the
University of Connecticut School of
Medicine in Farmington.
In January, Fred Hyde participated in a
two-day seminar in Washington, D.C.
on “Capital Financings and Refinanc¬
ings for Health Care Facilities” spon¬
sored by The National Health Lawyers
Association. Dr. Hyde spoke on “The
Future of the Capital Markets and How
to Survive it’ ’. Dr. Hyde is vice presiden
and National Health Care Manager at
Smith Barney, Harris Upham & Com¬
pany Incorporated in New York City.
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1973

1979

In a letter received from Richard
Boland in May, he mentioned that he
has “recently run into several former
classmates in the past few months, and
upon comparing notes, it appears that a
very large segment of our class has
stayed on (at least this far) in academic
medicine.”
He notes that he is now assistant pro¬
fessor of medicine at the University of
California, San Francisco, where he
has been funded to study glycoprotein
biochemistry in gastrointestinal cancer;
that John Stratton is doing research in
cardiology at the University of Wash¬
ington where he was recently appointed
assistant professor of medicine; and
that Richard Young became assistant
professor of pediatrics at Hershey
Medical School (The Pennsylvania
State University College of Medicine) a
year ago and is doing research in pedi¬
atric neurology.
Dr. Boland listed twenty-four other
classmates who, “as far as can be as¬
certained, currently hold academic
appointments and are actively involved
in research. This list (compiled from
the softest of data bases — rumor and
recollection) is in excess of one-third of
all those we could recall. It may be
somewhat overinclusive, and some
others may have been overlooked.”
He’d be interested in having corrobo¬
rating information about this.

Lisa Rosenfeld is now the director of
planning for the Jewish Hospital of St.
Louis (Mo.) which is one of three hos¬
pitals comprising Washington Univer¬
sity Medical Center. Her husband,
Steve, is an ophthalmology resident at
Barnes Hospital.

1974
Richard Pasternak, director of the
Coronary Care Unit at Pacific Medical
Center and clinical instructor in medi¬
cine at the University of California in
San Francisco has been elected to Fel¬
lowship in The American College of
Cardiology.

1980
Steve Rosenfeld writes that he and Lisa
are enjoying life in St. Louis, Missouri,
and that he is pleased with his ophthal¬
mology residency at Barnes Hospital.

Public Health
1965
Elliot Segal, staff director of the Over¬
sight Subcommittee of the House
Commerce Committee is leaving Capi¬
tol Hill to become manager of health
care cost containment programs for the
William Mercer subsidiary of Marsh
and McLennan, insurance brokers.

House Staff
1960
Richard Norton has been promoted to
professor of medicine at Tufts Univer¬
sity School of Medicine. He is in the
Section of Gastroenterology and is
located at the New England Medical
Center Hospital in Boston.

1976
Louis Wang announces his association
with Drs. Howard Smith and David
Roberts as a member of the Connecticut
Ear, Nose and Throat and Facial Plastic
Surgery Associates for the practice of
otolaryngology, facial plastic surgery
and head and neck surgery, with offices
in Middletown and Essex.

IN MEMORIAM
OscarS. Proctor, M. D.
August 12, 1981
Barnett Greenhouse
October 24, 1981
Herbert C. Soule, Jr.
July 22, 1981
Chester E. Hurwitz
May 15, 1981
Dexter M. Bullard, M. D.
October 5, 1981

ex med ’19

M. D '21

HS ’21

M. D. ’22

ex med '23

Spafford Ackerly
September 24, 1981

M. D. '25

Felix F. Tomaino
August 28. 1981

M. D. ’29

Dana L. Blanchard
December 29, 1981

M. D. '31

Morris F. Heller
October 11, 1981

M. D. '31

Charles E. Trihble
August 10, 1981

M. D. '31

John James Head
(date unknown)

M. D. '39

Arthur N. Springall
October 4, 1981

M. P. H. '50

MEDICAL SCHOOL ALUMNI WEEKEND PROGRAM
FRIDAY, June 4, 1982
Alumni Registration
Rotunda, Sterling Hall of Medicine
8:00-4:00

Yale School of Nursing Annual Alumnae/i College
"Tomorrow’s Issues Today in Nursing"
Registration, 855 Howard Avenue

8:30-4:30

Yale Alumni in Ophthalmology 1982 Annual Meeting
"Current Concepts in Glaucoma”
Registration, Brady Auditorium, 310 Cedar Street

10:15-11:00
11 :(H»-11:45

Department of Epidemiology and Public Health Symposia
I. "The Impact of Management and Labor on the Health Care System in the Eighties"
II. "Nuclear Warfare: The Role of the Medical Profession”
Winslow Auditorium, LEPH

1:55-3:00

Department of Epidemiology and Public Health Seminars
I. "Do We Really Need Infectious Disease Epidemiology?”
II. ‘ ‘The Statistical Needs of the Biomedical Researcher: Some Observations and Suggestions from
Director of a University Biostatistics Consulting Center”
III. "Problems in Conducting Epidemiologic Research”
IV. "Yale Graduates Look at Occupational Health”
(Locations to be announced)

3:15-4:30

Department of Epidemiology and Public Health Lecture
(To be announced.)

2:00-5:00

Guided Tours — New facilities of the Yale-New Haven Hospital

5:00

Dean’s Reception
Beaumont Room, Sterling Hall of Medicine

SATURDAY, June 5, 1982
Alumni Registration
Rotunda, Sterling Hall of Medicine
9:00-11:00

9:15-9:45

Coffee Service
Beaumont Room, Sterling Hall of Medicine
Special Alumni Symposium
"Yale Today”
A. Bartlett Giamatti, President, Yale University
Historical Library, Sterling Hall of Medicine

10:00-11:45

Seminars
I. "Gene Splicing in Biomedical Research”
II. "Efforts at Yale in Caring for the Elderly”
III. "The Graying of America: Implications for Health Care”
IV. "From the Bench to the Clinic: New Treatments for Depression and Opiate Withdrawal”
(Locations to be announced.)

10:00-12:00

Guided Tours — Yale Center for British Art; Historic Section of New Haven

11:45-12:30

Meeting of the Association of Yale Alumni in Public Health
Winslow Auditorium, LEPH

12:00-12:30

Annual Meeting of the Association of Yale Alumni in Medicine
Harkness Auditorium

12:30-2:00

2:00

Sherry and Buffet Luncheon
Harkness Lounge and Dining Hall
Guided Tours — New Facilities of the Yale-New Haven Hospital

3:00-4:15

Guided Tours — Yale Center for British Art; Historic Section of New Haven

4:30-6:00

Social Hour
Beaumont Room, Sterling Hall of Medicine
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Immunology at Yale

The following articles were coordinated and edited for
Yale Medicine by Dr. John Dwyer.

The Human Immune System:
A Very Personal Survival Kit for the 1980’s
and Beyond

By John M. Dwyer, M.D., Ph.D.
Human beings are, among many other things, efficient but
complex compilations of biological machinery. As with all
mechanisms that substitute intricacies for simplicity,
increasing sophistication is associated with increased
fragility and vulnerability. As is true of many human
endeavors, the biological systems of most individuals do
well in isolation; delicately poised mechanisms, allowed
the luxury of total introspection, perform with singleminded efficiency. Trouble comes, however, when these
biological systems must contend with a hostile environ¬
ment. While all of the above generalities are true at a
psychological level, we are here concerned with aggres¬
sion that is very definitely at the physical level and most
frequently posed by man’s most ancient and constant
enemy — microbes. Virus, fungi, bacteria and parasites
abound in our environment, and were it not for a very
active protective (immune) system, we humans, despite
our superb intellects, ingratiating sociability and advanced
knowledge of how our body works, would be extinct.
Our protective or immune system has been subjected to
intensive basic and clinical research in the past two
decades. What has been learned is of the greatest practical
importance as it allows physicians, among other things, to
make better vaccines, transplant organs, improve the cure
rate for cancer, understand and better manage allergies,
and, for the first time, approach scientifically many of the
chronic diseases of mankind. Altogether apart from its
practical importance, however, the details of the evolution
of a protective system that can handle the microbial enemy
and the manner in which it does so makes a fascinating
story for anyone remotely interested in biology.
Let’s approach the requirements for an adequate
immune system by analogy. Imagine that you are hiring
night watchmen for the world’s largest and most sophisti¬
cated computer operation, programmed to support systems
involved in life and death decision making. Going through
Dr. Dwyer is associate professor of medicine and pediatrics and chief of the
Section of Clinical Immunology

a checklist of the essential attributes for candidates you
may hire to guard this vital establishment, you would be
certain to include the following. Firstly, your night watch¬
man must be sufficiently educated so that he identifies with
complete accuracy a true problem when it arises. An
intruder into his complex must be distinguished from, for
example, other watchmen who superficially may look
very similar to the unauthorized entrant. What a tragedy if
our watchman made a mistake and shot a fellow guard.
Yes, the first attribute sought would be maturity and
education sufficient for accuracy in problem identification
(recognition).
The second desirable, even essential, attribute for our
candidate would be the ability to learn on the job. If the
domain under his protection was attacked and our watch¬
man prevailed only after a considerable struggle, we
would wish that the memory of his “close encounter of the
first kind” would lead to the development of expanded
mechanisms capable of more efficiently handling the same
invaders should they be foolish enough to attack again.
Memory of the inadequacies of the first response would
lead to a more efficient secondary response.
Our watchman is of no use to his employers if he cannot
respond decisively to any threat to the computer complex.
He must be armed so that he can repel the danger. The
weapons at his disposal, however, must be used judi¬
ciously. The appropriateness of his response will distin¬
guish the really well programmed watchman. No use firing
off lots of bullets in all directions. Even if he hits the
enemy, the damage to innocent bystander computer
mechanisms might be horrendous. Certainly if you were to
find a watchman whose every action was appropriate and
reliable, you would be likely to make him a supervisor of
less well trained individuals. His job would then be one of
supervision or regulation of armed but relatively inexperi¬
enced (and therefore potentially dangerous) recruits.
The human immune system, of necessity, specializes in
accurately recognizing the enemy (antigen), attacking him
powerfully but appropriately and using a highly developed
memory system that will insure that adequate preparations
are made for more efficiently handling second encounters.
As the inflammation that can be initiated by the immune
response is so powerful, such a weapon system is very
tightly controlled by all important regulatory mechanisms.
The cast of characters that provide us with our immune
system is large, but the stars are small white blood cells
known as lymphocytes. There are two major classes of
lymphocytes; B lymphocytes, so called because they are
educated in the bone marrow and T lymphocytes which
mature in the microenvironment of a remarkable gland,
the thymus, that lies in the chest over those great vessels
that enter and leave the heart. Apparently the evolutionary
pressures exerted by microorganisms on lower species
aspiring to evolve into higher species was of sufficient
magnitude and complexity to require the development of
two cooperative but distinct weapon systems. It is the job
of one to fight bacteria (the B cell system) while the other’s
function is to fight viral, fungal and parasitic infections

(the T cell system).
Humans are armed with about 400 billion of these little
“pac-men-like” lymphocytes. Some lymphocytes con¬
stantly patrol around the body seeking antigens that may
have entered our environment. Others remain stationed in
lymph nodes and the spleen, waiting for antigens to be
delivered to them in the lymphatic fluid that runs in the
specialized lymph vessels that travel throughout the body
with our arteries and veins.
The antigen recognition capacity of lymphocytes is
individually programmed. Unlike our night watchman
who should be able to recognize any and all intruders, any
individual lymphocyte is capable of recognizing only one
antigen. Cells that can recognize streptococci can't recog¬
nize staphylococci. By the time we are bom we already
have enough lymphocytes to recognize upwards of a
million different potential invaders. Like our watchman,
these B and T cells are “armed”. When a B cell binds
antigen to a surface receptor that is designed like an
expensive lock that will accept only one very specific key,
to bind one specific antigen, it responds by manufacturing
and secreting remarkable chemical molecules known as
immunoglobulins or antibodies. These molecules can bind
to antigens, whereupon they indicate the destruction and
removal of this material by harnessing a number of
inflammation producing mechanisms that rely heavily on
the properties of a none too specific scavenger cell known
as a polymorphonuclear cell. T cells work similarly,
although the chemicals they secrete are not antibodies but
rather lymphokines; reagents that harness another non¬
specific cell (the monocyte or macrophage) to attack
antigens bound by the T cell. Unlike B cells, T cells are
themselves pretty good at directly killing many antigens.
Since at any given moment we have to be able to
recognize any one of a million different enemies and we
are not composed of huge masses of lymphocytes, we do
not have many cells that can recognize any one of these
antigens. As a result the primary immune response is slow
to develop. During the primary encounter with an antigen,
however, those cells that do recognize the antigen will
divide many times to expand geometrically the population
or clone of cells capable of recognizing that particular
antigen. The result is a disproportionate accumulation of
cells that have been involved (sensitized) in a particular
battle. The expanded recognition capacity represents
immunological memory and insures a much more potent
and rapid secondary response to antigen.
One of nature's biggest immunological mistakes was to
program humans with lymphocytes possessing the capacity
to recognize their own body constituents as antigens.
Thus, apart from having lymphocytes that carry receptors
for nonself, we also have both B and T lymphocytes that
carry receptors for those structures that represent our own
constituent antigens. For most of us this never presents a
serious problem because of the presence of supervisory
cells that continuously regulate the immune response.
There are cells that develop in the thymus, but instead of
producing an inflammatory response on encounter with

antigens, they control effector cells. They act as an
immunological thermostat, constantly insuring the
appropriateness of all that is done by the cells that can
produce inflammation. Among the chief responsibilities of
these immunoregulators is the maintenance of a state of
nonreactivity amongst those lymphocytes capable of react¬
ing with us. Usually these cells work quietly and efficiently,
but occasionally (disturbed by drugs or viral infections or
because they were not so well educated in the first place —
second rate genetic information) they fail to control these
potential attackers of self, and autoimmune disease results.
Rheumatoid arthritis, systemic lupus erythematosus,
thyroid disease, multiple sclerosis, pernicious anemia and
myasthenia gravis are but a few of the diseases that can
result.
Lymphocytes are rapidly giving up their secrets to
scientists, and the results are being felt in everyday medi¬
cine. There is, however, still much to be learned about
these “night watchmen” and the supporting players with
whom they have to interact. It seems reasonable to predict
that the explosion of interest in immunology will continue
to be a profitable one if as much progress is made in the
next 20 years as in the previous two decades. Many scien¬
tists and clinicians believe that it will be improvement in
our understanding of the immune system and the applica¬
tion of this knowledge that will provide us with our best
chance for the next great advance in improving both the
quality and quantity of human life. For improvement in the
latter, one further major disadvantage of our immune
system will have to be overcome. Individual T lymphocytes
live for upwards of 60 years and then slowly fade away. As
the thymus works for only a few years of post-natal life, we
have within the immune system nature’s classic example
of inbuilt obsolescence. Most people reading this will have
their biological T cell clock fully wound and ticking nicely
but definitely finitely. The eternal elixir of life (when
eventually we find it) is certain to contain a good measure
of extract of young T cells.
The more one learns about immunology the more
fascinated you are likely to become with this subject, and
more articles on this subject follow. But apart from
intellectual satisfaction, the future of immunology may
relate very personally to your own future. After all, the one
inescapable disease we all suffer from is aging. You would
do well to keep an eye on scientific efforts to unravel the
mechanistic prowess of Methuselah’s T cells.

Transplantation Antigens:
Markers of Individuality, Love and Disease

By Robert E. Cone, M.D.
In the early 1900’s, tumor biologists were surprised to find
that tumors developing in some laboratory mice would not
grow when transplanted in other mice. This was quite
puzzling. Why should some mice be resistant to the tumor
while others were not? Did some mice have the ability to
recognize the malignant nature of cancer cells and destroy
them, while others lacked this capability? If so, under¬
standing this phenomenon would be an important clue to
understanding cancer in humans.
It was subsequently found that resistance to the growth
of the transplanted tumor is due not to recognition that the
cells are malignant, but rather, to recognition that the cells
come from another mouse and are “foreign”. (Studies
have shown, in fact, that tumors transplanted from one
genetically indentical mouse will grow). Animals dis¬
criminate “self’ from “non-self” or foreigners by
examining antigens on the surface of the transplanted cells
known as histocompatibility antigens. Over the years,
these have been shown to be defined by an area on the 17th
chromosome, known as the Major Histocompatibility
Complex.
As a result of several events in the last thirty years, the
study of histocompatibility in mice and humans has
become an important area of research in many laboratories
around the world. For instance, when human organ trans¬
plantation became feasible, surgeons in the field experi¬
enced some of the same frustration felt by the early mouse
tumor transplantation biologists: the immune system of
recipients of organ transplants defended itself against the
foreign intruder. In 1958, the French immunologist, Jean
Dausset, discovered antibodies which detected a human
leucocyte antigen (HLA). It was then found that disparities
in HLA antigens correlated with rejection of organ trans¬
plants and the science of histocompatibility testing in
humans began.
HLA antigens have now been studied and defined in
many ethnic and racial groups throughout the world. An
example of the quality and spirit of cooperation in the
world-wide scientific community can be found in the
degree of information sharing between laboratories work¬
ing in this field.
Eighty-two different HLA antigens have been defined
so that their position on chromosome 6 in humans can be
mapped. The genes which determine these antigens can be
grouped into at least four positions on the chromosome and
the maximum number of combinations of these genes

Dr. Cone is associate professor of pathology and surgery
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approaches seven billion. With this many possible com¬
binations, it is easier to draw a royal flush in poker than it is
to find two unrelated individuals with identical HLA
genes!
For this reason, the immunological problems in organ
transplants are considerable. That some individuals who
receive an organ transplant from unrelated donors retain
the organs for one or many years can be attributed to “the
luck of the draw” in histocompatibility matching; or more
likely, it can be attributed to the steady improvements in
therapeutic modalities which suppress immune rejection
of the organ. While the immune response to the graft must
be suppressed for successful organ transplantation, there is
also great danger of infection if the immune system is
completely suppressed. The problem will be solved when
methods are refined to suppress only the response to HLA
antigens on the transplanted tissue. Research to develop
such immunosuppressive “smart bomb” treatments is
being done in many laboratories.
The discovery and elucidation of the complexity of
HLA antigens has important applications other than those
of providing jobs for transplantation immunologists, and
frustrations for the transplant surgeon. As a marker for
human biologic individuality, histocompatibility testing
has important genetic and even legal application. HLA
typing of racial and ethnic groups worldwide is of great
value to anthropologists. Inclusion of HLA-typing has also
been extremely useful in settling legal paternity suits.
In addition to their importance to organ transplantation
as well as for markers of human biologic individuality,
HLA antigens are also crucial to human well-being. An
integral relationship for Major Histocompatibility Com¬
plex genes to the immune system was demonstrated first in
studies with inbred mouse strains. It was found that certain
mouse strains would make a strong immune response to
synthetic amino acid polymers while others would not.
Genetic studies demonstrated that the relative immune
response of mice to these polymers was determined by
genes which were “mapped” to the Major Histo¬
compatibility Complex (MHC). These regulatory genes
were termed “immune response” (Ir) genes. Moreover,
the ability of immune cells to kill cells infected by viruses
appears to be restricted by other gene products of MHC. In
extrapolating these results with mice to humans, it appears
that genes of the MHC can determine how strongly the
immune system responds to infectious organisms and,
once it responds, how effectively it deals with the foreign
invader.
Is such extrapolation warranted? The susceptibility to a
number of diseases appears to be associated with MHC
genes. The prototype example of this HLA-disease
association is the rheumatoid disease, anklylosing
spondylitis. Almost 100 percent of patients with this
disease possess the HLA antigen B27, although only about
25 percent of the total population carry this antigen. This
does not imply that B27 positive individuals are destined to
be affected by anklylosing spondylitis, but they are
certainly more prone to the disease than B27 negative
4

individuals.
Other diseases demonstrating an HLA-susceptibility
association include hayfever, asthma, multiple sclerosis,
coeliac disease, and juvenile diabetes, to name a few.
Every month new associations, or non-associations, are
reported. Many of the diseases showing an association
with HLA antigens have in common an inflammatory
and/or immune basis. In many, and perhaps all, the actual
cause of the disease is unknown.
What are our HLA genes telling us? If the extrapolation
of mouse studies to humans mentioned earlier is valid, it
may be that the HLA-disease associations are due to an
improper response and/or lack of response to our immune
system to infectious agents. At least, it is clear that there is
a genetic basis for susceptibility to many, and perhaps all
disease processes. Understanding the genetic basis for
HLA-disease association could help clarify the nature of
the complex diseases linked to these genes so that more
appropriate therapies can be developed. As the list of
HLA-disease susceptibility associations grows, it seems
possible there might come a time when the population
would be typed for MHC genes. There would then be a list
of diseases to be on the alert for and preventive steps could
be taken.
Finally, one very recent observation, again made in
mice, should be mentioned here. Inbred strains of mice
exhibit a preference for strains to which they will mate.
This mating preference has been found to be determined
by genes mapping to the MHC. It is suspected that females
present an odor, possibly a pheromone, which excites, or
turns off a male.
In this way, nature uses histocompatibility antigens to
help insure the best continuing association of new genetic
formulae. For instance, it is much more difficult to pro¬
pagate animals by inbreeding than it is by outbreeding,
because implantation of a fertilized egg is greatly facilitated
if the histocompatibility antigens associated with the
seminal fluid are very different from those of the motherto-be. She will make an immune response to these antigens
that will cause inflammation in the fallopian tubes or
uterus, thus providing a hospitable environment for
implantation.
The possibility that human MHC genes may decide
whether or not a blind date will succeed has yet to be
determined. Perhaps it shouldn’t be. Somehow ensuring
“love at first sight” by genetics and/or chemistry would
take all of the fun and mystique from one of the most
basic of human responses. Is nothing sacred anymore?
Clearly, the romance (forgive the word) with histo¬
compatibility genes is not over. New traits governed by
these genes are still being described. The demonstration of
precisely how these genes work, and perhaps ultimately,
the isolation of the genes will further the understanding of
how the immune system works, and how it can be
modulated to our advantage. Perhaps genetic engineering
may someday be used as a method of prevention for certain
diseases.

The Helper T Cells^
By Charles A. Janeway, M.D.
The initiation of the complex cellular cascade known as the
immune response involves recognition of foreign materials,
called antigens, by lymphocytes. The principal cells
involved in the initiation of these responses are known as
helper or inducer T cells. Our research involves an exten¬
sive characterization of these cells, presently at the single
cell level, using T cells grown from a single progenitor
cell, or T cell clone.
Antibody responses can be characterized either quanti¬
tatively or qualitatively; that is, the amount of antibody
produced can be measured but so too can the class of
antibody be determined. Antibodies come in eight distinct
forms, each with a different effect or function. We have
found that there are two classes of helper T cells, one of
which is principally involved in increasing the quantity of
antibody produced, while the other modulates the quality
of the antibody produced. These cells differ in other prop¬
erties, and these differences allow us to separate them and
to study them as independent entities.
We have focused on three different aspects of recogni¬
tion by helper T cells; recognition of specific foreign
antigens; recognition of antigens encoded on the major
histocompatibility complex, the genes that control anti¬
gens on tissue cells that serve as the targets recognized by
lymphocyte causing rejection of foreign tissue grafts; and
recognition of determinants found on antibody molecules.
Our studies of the precision of foreign antigen recogni¬
tion by T cells demonstrated that individual T lymphocytes
are uniquely specific for a particular antigenic determinant.
Such cells readily discern very minor changes in antigen
structure.
We next turned to a consideration of the role of the major
histocompatibility complex (MHC) in antigen recognition
by T cells. The MHC consists of a cluster of genetic
information that produces not only cell surface antigens
that determine our immunological identity, and supply the
targets for recognition in the transplant situation, but also
produces many influences that regulate immune response.
For example, we found that helper T cells are influenced
by a region of the major histocompatibility complex that
also controls the magnitude of antibody responses, the
so-called immune response or Ir genes. These genes have
now been shown by our laboratory to encode cell surface
antigens expressed in B cells. The helper T cells recognize
not just the foreign antigen we inject into the animal but
their own Ir gene products as well.
Since only B cells express these Irgene products, only B
cells bear antigen in a form that is recognizable by the
helper T cells, and thus T cell help is directed exclusively
to such cells. This mechanism is very important in con¬
trolling the quantity of antibody produced. Interestingly,

genes that encode transplantation antigens recognized as
non-self in graft rejection, also encode self recognition
markers that are critical to communication between cells in
the immune system. The mechanism by which antigen
associates with the Ir gene product to control immune
responses is now a central focus of our research.
In performing functional assays of helper T cells in
mice, we discovered that there are two helper T cell
populations that act synergistically. Subsequent studies
have shown that one of these is antigen-specific and
recognizes antigen on B cells in association with self Ir
gene products, but the second cell, while also specific for
the foreign protein antigen, is specific for self immuno¬
globulin or antibody determinants. This cell does not
develop in mice deprived of B cells experimentally, and
we have therefore termed such cells immunoglobulin
dependent helper T cells. It would appear that such cells
play a critical role in the regulation of antibody quality,
such as the type of antibody produced (e.g. allergic
antibody versus neutralizing antibody). Thus, the helper T
cell system can be divided into those that recognize Irgene
products and those that recognize immunoglobulins. Only
the former also respond to non-self transplantation
antigens encoded by the Ir genes.
By preparing cloned helper T cells, it has been possible
to show that a single T cell can be specific for a foreign
antigen recognized in the context of self Ir gene products as
well as for non-self Ir gene products. This finding, which
has been made in several systems, provides a potential
explanation for the intensity of graft rejection reactions
directed at antigens encoded in the major histocompatibility
complex. T cells specific for any antigen would also be
specific for some non-self transplantation antigen; thus, all
antigenic contacts also immunize an animal against major
histocompatibility complex encoded antigens of the species.
Hence, an animal is immunized for graft rejection by
encounter with conventional environmental antigens,
presented to T cells on the surfaces of self cells.
In summary, our studies have shown that helper T cells
are highly specific for foreign antigens. These antigens are
recognized on self cell surfaces in the context of self major
histocompatibility complex encoded antigens, and the
same cell can also recognize non-self transplantation
antigens encoded by allelic variants of these same
polymorphic genes. There is a second set of helper T cells
that do not recognize major histocompatibility complex
encoded antigens at all, but rather recognize self antibody
molecules. The precise chemical nature of the recognition
process, and the relationship of these cells to regulatory T
cells that in turn control the activity of helper T cells forms
the focus of our current research effort.

Dr. Janeway is assistant professor of pathology
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Immortalization of the Thymus Derived
Lymphocyte
By Nancy H. Ruddle, Ph.D.
The body’s defense against foreign invaders is accom¬
plished in part by substances produced by many different
kinds of cells. These substances include antibodies or
immunoglobulins produced by members of the bone
marrow derived lymphocyte (B cell) family and lymphokines produced by members of the thymus derived
lymphocyte (T cell) clan.
B cells recognize foreign invaders called antigens, such
as viruses and bacteria, by means of their surface antibody
and the chemical nature of this class of molecules is well
understood. The T cell’s mechanism for recognizing anti¬
gen is much less clear, as is the biochemical nature of the
factors they produce.
These problems have entertained and frustrated
immunologists for many years and will probably continue
to do so for some time to come. It is important to under¬
stand T cells intimately in order that we may direct them in
their already well-known roles in defense against viral and
fungal infections and against malignancy, through their
direct killing of tumor cells and mobilization of other
defense systems by means of factors called lymphokines.
One impediment to our understanding of T cells is the
plethora of different subsets which can be categorized
according to their functions. T cells can act as regulatory
cells. They help B cells to differentiate into antibody
secreting cells called plasma cells. Suppressor T cells
inhibit the differentiation of B cells into plasma cells and
inhibit effector functions of other T cells as well. Other T
cells act as effector cells killing virus producing cells of
manufacturing lymphokines which in most cases act on
other "nonT” cells. These factors, to name a few, include
migration inhibitory factors (MIF), immune interferon
(IFN-Y), lymphotoxin (LT), macrophage activating factor
(MAF), osteoclast activating factor (OAF), T cell growth
factor (TCGF, also called interluken 2) and B cell growth
factor (BCGF).
Because it is difficult to obtain enough T cells of one
particular subset with the ability to recognize a particular
antigen, a major goal of my laboratory has been to isolate
individual T cells and then transform the normally non¬
dividing T cell into a continually proliferating line which
can be grown and cloned in tissue culture. When this is
accomplished, the progeny of an individual T cell repre¬
sentative of a particular subset can be isolated and studied
providing basic information at the single cell level.
Because T cells do not normally grow in culture for
extended periods of time, we have to trick them so they
grow, divide, and maintain their function in tissue culture.

Dr. Ruddle is associate professor of epidemiology
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One method we have used to prepare continual cell lines
is to isolate T cells from antigen immunized mice and
culture them in the presence of growth factors, specific
antigen, and irradiated spleen cells from mice of the same
strain. Spleen cells act as feeder cells and antigen present¬
ing cells for the T cells. Many lines derived in this way do
grow and divide in the presence of specific antigen and
produce lymphotoxin (LT) and immune interferon (IFNG). Some lines can be stimulated to produce factors at
concentrations 500 times higher than those produced by
cells immediately after removal from the animal. These
cell lines are already providing quantities of lymphokines
sufficient for biochemical analysis and use in biological
experiments.
The marvelous technique of cell hybridization can also
be used to immortalize T cells. The antigen specific T cell
is taken from the animal and fused with a proliferating T
cell tumor called a lymphoma. This fusion is accomplished'
by means of an agent such as sendai virus or polyethylene
glycol, which perturbs the two cell membranes in such a
way that holes are formed and repaired when the two cells
stick together. Information from both parents is con¬
tributed to the resultant hybrid.
The tumor cell, with its capacity for unlimited growth,
rescues the antigen specific properties of the T cell and
provides the proper environment for that cell to flourish
and proliferate. The result is a clone of hybrid cells with
the antigen specificity and lymphokine producing capacity
of the T cell and the unrestricted growth and replicative
properties of a tumor. Even in the face of occasional
instability, we have been able to detect expression of many
functions in T cell hybrids which are characteristic of both
individual parents. These include expression of particular
surface antigens characteristic of T cells and traits typical
of individual T cell subsets.
Thus, when we used as parents a T lymphoma and
suppressor T cells enriched by their adherence to antigen
coated plates, we have obtained hybrids which bind anti¬
gen when it is presented on a cell and produce suppressor
factors. Other hybrids have been prepared from T cells or
T cell lines (described above) which produce lymphokines.
Many such hybrids express LT, and we are presently
screening for one that expresses IFN-V.
The dissociation of LT and IFN in some hybrids
suggests that they are separate molecules and demonstrates
an important use for hybrids in allowing us to distinguish
between molecules which can only be monitored by
biological assays. We are also using hybrids to isolate
individual cells which interact in complex immunological
phenomena. The perpetuation of particular subsets which
may make a profound contribution to a reaction, but which
comprise only a very small segment of the population, is
also affected through the preparation of T cell hybrids.
In recent experiments we have analyzed the nucleic
acids of T cell hybrids and tumors and have made the
startling observation that mouse T cells can excise frag¬
ments of DNA from a segment of chromosome 12 that

codes for immunoglobulin heavy chain. By analogy with
information concerning the generation of diversity in B
cells which produce antibodies, it appears that a similiar
mechanism is operative in T cells and may be involved in
generating the specificity of the T cell antigen receptors.
Now that cloned T cell lines and hybrids that produce
lymphokines have been developed, it is possible to isolate
messenger RNA and by recombinant DNA techniques,
clone the genes for the lymphokines. This will permit the
production of vast quantities of homogenous T cell
products such as LT and IFN-Y which are of such pro¬
found immunotherapeutic potential in tumors and viral
diseases, particularly in the compromised host.
Immunology at Yale has kept pace with recent develop¬
ments in molecular biology and genetics. The tools of
these disciplines are being applied to ever more clearly
defined questions that have always plagued the
immunologist. With these approaches, T cell immunology
has emerged as a serious but still intriguing discipline.
Students of T cells can move beyond phenomenology and
descriptive studies and begin to understand mechanisms.
By applying technical advances of molecular biology to
cultures of cloned T cell populations, it is finally possible
to study T cells at the most basic levels which ultimately
elucidate the most complicated interactions at the level of
the whole animal.

Immunology: An Approach to Health
Problems of the Third World
By Frank F. Richards, M.D.
About 80 to 90 percent of the research into disease cure and
prevention in the world is carried out in the United States.
This research is largely directed against diseases such as
cancer and cardiovascular disease which are serious
threats to only about 10 or 20 percent of the world’s
population; yet most of the population does not have the
luxury of worrying much about the diseases of advancing
years. The old enemies of poverty, malnutrition, infection
and insect-borne diseases take their toll in youth and the
middle years. In many parts of Africa, for instance, old
age is revered because it is still a difficult and rare
accomplishment.
Some of the most formidable diseases which face man
in the tropics, and sometimes outside the tropics, are the
parasitic diseases. Both animals and people can become
infected and infested with a wide range of other animals
which range from microscopic single-celled creatures
such as amoeba or trypanosomes, to large many-celled
creatures such as tape worms. In the West, we are used to
making clear distinctions between animal and human
diseases, but often in the third world, these distinctions are
either blurred or lost. For instance, where protein malnu¬
trition is the most important human disease, parasitic
infections of domestic animals are in fact a serious cause of
human sickness.
There is nothing new in the process whereby one animal
makes its home within another for at least a portion of its
life cycle. This arrangement has gone on since the dawn of
life, and it was certainly well established before our primi¬
tive ancestors left the sea to crawl on land. It has to be
recognized that while another animal’s body is a friendly
environment, rich in food and protected from the ele¬
ments, in another sense it is hostile, since most vertebrates
have developed chemical and cellular systems of
immunity designed to rid themselves of unwanted
parasites.
To become established in a hostile world of antibodies
and cells designed to engulf and kill invaders, the parasites
have developed an audacious array of dirty tricks to fool
the body’s defenses. Some may cover themselves in
sheep’s clothing of host proteins, so that the body’s
defenses cannot distinguish the parasite from its host.
Others, such as trypanosomes, cover themselves in an
easily recognized protein coat, but as soon as the body
produces antibodies to that coat, the parasite changes coats
and assumes one which is not recognized by the first
antibody. In fact, a single trypanosome has been shown to
produce more than 100 different coats.

Dr. Richards is professor of medicine
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These parasites seem to have explored very thoroughly
the working of the immune system in man as well as
animals. They appear to have learned stratagems which
can interfere in the complicated body cell interactions
which constitute the immune system. It was shown in
studies at Yale that an African trypanosome, a close rela¬
tive of the organism that causes sleeping sickness, can turn
on cells which suppress the body’s immune responses.
The implications of such a discovery are profound,
because on reflection, one can see the difficulties that such
biological phenomena may have in the development of
vaccine. In recent years, a number of antigens associated
with parasites have been grown in tissue culture. Usually,
not long after we learn to culture an organism we can
prepare a vaccine by extracting harmless antigens from
such material. However, if the parasite has learned to
stimulate the immune system in such a way that immune
responses are turned off rather than on, as in the case of
trypanosomes, it is possible to give an extract of dead
antigen to millions of people with good intentions of
preventing parasitic disease, only to have the vaccine turn
off their immune response, rather than turn it on. For this
reason, it is extremely important that we understand how it
is that organisms such as the trypanosome and the parasites
that cause malaria are able to activate suppressor mecha¬
nisms that supply these parasites.
As the study of parasites develops, it becomes clear that
their survival devices are based on some novel and
interesting genetic and biochemical mechanisms. It is this
flamboyant biology which continues to attract skilled
young molecular biologists, immunologists and chemists.
There is also the added attraction of the very real potential
for making discoveries which can be applied directly to
human welfare.
Immunology has a great deal to offer third world
countries because of the nature of their problems. It is very
important that we train physicians willing to look to these
problems. Ninety million people in the world suffer from
malaria, which causes untold suffering. Malaria, as well
as protein malnutrition and parasitic diseases clearly are
major factors in preventing the third world from entering
modem society.
To this end Yale has begun to develop a Parasitology and
Tropical Medicine Program which spans many depart¬
ments in the School of Medicine. A clinical program is
being designed to enable Yale physicians to be trained in
Africa, Central America and in the Caribbean. In turn, the
School will enable physicians working in the field to come
here for further training and research. Further plans being
discussed include a Ph.D. program in parasitology and the
possibility of a Center for the Study of Parasitology and
Tropical Medicine.
No longer can we isolate ourselves from the troubles of
the world. We have learned that drug-resistant malaria
acquired in the Far East is not uncommon among New
Haven veterans who served in Vietnam. Refugee popula¬
tions from Indochina have brought exotic diseases to
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regions where such diseases were never seen before. Many
United States industries have operations in Africa,
Indonesia, South America and increasingly, in jungles and
inaccessible regions. These industries are faced with
combating tropical diseases, yet few American physicians
are trained in their management. Yale is learning to
collaborate with industry in the solution of such problems
and the community of interests created, may provide a real
industry-academia bridge for the future.
All of the research on parasitology now under way in
laboratories here or planned for the future, is based on the
solid understanding of the immune response of the human
body. It is now almost a hundred years since the science
and art of immunology was bom. We are beginning to
apply it to some of the world's most urgent problems.

Medical Illustration: a picture is worth more

The woman at the front desk was conferring with a wellknown scientist about illustrations for a book he is prepar¬
ing. People came and went in steady procession to deliver
or pick up projects. In an adjacent room, five technical
artists worked diligently at their drafting boards, while in
the darkroom beyond, a photographer processed prints for
delivery later that day. An illustrator was putting finishing
touches on a beautifully articulated anatomical drawing.
The phones rang with frenetic insistence.
It was a typical morning in the Office of Medical
Illustration. “Spring is our busiest time of the year, but in
fact, it is always pretty hectic here,” Virginia Simon, the
director, acknowledged with a wan smile as she answered
requests from a faculty member in need of a last minute
illustration, conferred with her staff, and politely granted
an interview, almost simultaneously.
She has been director of the Office for almost twenty
years, and the activity of the place is a tribute to her skills
not only as an illustrator, but as an administrator as well.
“It was a one-person office in 1963, when I succeeded
Armin Hemberger, a very fine artist who had been medical
illustrator here for many years. But as the demand increased
for the charts, graphs, drawings and photographs necessary
to illustrate research being done in the School, the staff
grew. There are three medical illustrators, three photog¬
raphers and five technical illustrators, and several more on
call for times such as this, when the workload is more than
we can handle,” she reported.
According to Arlene Resnick, who was the first person
to join the staff, and is now senior administrative assistant,
the Office serves more than 250 faculty, research staff and
students, and produces an average of 500 to 600 projects
each month. The variety of illustrative style and media is
as impressive as the volume of work. Perfunctory charts
and graphs, typical of textbook and lecture illustrations,
are of course a part of the work, but the Office also
produces fine four-color and black and white slides and
prints as well as drawings of exquisite detail and artistic
merit. The Office also designs and produces exhibits and
posters. Orders range from a simple chart or graph to
detailed anatomical drawings and photographs to illustrate
an entire textbook.

Illustration by David Bo! insky of the horizontal section of a head, looking down
on the tongue, a rear molar, and tonsils. It was drawn as a reference.
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An illustration by Linda Seigneur
depicting the successive stages and
core of the nursing program at Yale.

Diagram for Dr. P Barash of the Department ofAnesthesiology, was drawn by
Suzanne Kendall.

The placenta of the first twin monkeys known to be born in
captivity was photographed by Mildred Satterfor
the late Dr. van Wagenen

Cartoon for a slide presentation about
anesthesiology drawn by Anita Mullin.

Medical illustration and medical photography were
originally handled in two separate offices, but after
Howard Reynolds, the photographer retired, the work was
gradually assumed by Virginia Simon’s staff. In fact,
photography has become an important factor in the pro¬
duction of much of the work that comes from the office,
and photographers on the staff frequently work closely
with the artists and illustrators on projects.
As medical illustrators from Vesalius down through
history have recognized, nowhere is the old proverb, “a
picture is worth a thousand words”, more true than it is in
medicine. Description of a complex new research finding
or an intricate surgical procedure would be almost
impossible without some kind of graphic assistance. In
addition to traditional methods of illustration, modem
technology has made possible a fantastic array of tech¬
niques to capture on film or paper tiny organisms or remote
and hitherto inaccessible sections of anatomy.
With these sophisticated methods for precise replication
available, isn’t the age-old art of medical illustration
passe?” Not at all,” Mrs. Simon replied. “There are many
instances when a drawing is preferable. For instance, in

Beverly Pope illustrated for Dr. D. Cuono the design of a new skin flap
procedure to resurface rhomboid skin defects produced by removal of skin
tumors.
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Photograph of a pleridium rhizome, enlarged many times, was made by Thomas
Coughlan.

describing a surgical procedure, a camera might capture
too much detail. The artist, on the other hand, can ‘peel
away’ unnecessary elements and concentrate only on the
most significant parts, so that the drawing is much easier to
read than a photograph would be,” she replied.
There is more to medical illustration than merely artistic
ability. ‘ ‘It requires as much knowledge of anatomy to be a
good medical illustrator as it does to be a medical anatomist
who is also a doctor. It also requires very particular kinds
of drawing skills and great precision,” Mrs. Simon
explained. In addition to constant reference to anatomical
texts, the medical illustrators on the staff sometimes find
themselves in the operating room alongside surgeons,
nurses and anesthesiologists, watching the procedure
closely, and taking many rolls of film for reference.
Recently two members of the staff took turns recording
step by step a very delicate surgical procedure which took
almost twenty hours.
Some members of the faculty are more experienced than
others in their knowledge of graphic representation and
know precisely what methods will reflect best the content
of their work. Usually these same people have very real

Photograph of functional neck dissection performed by Dr. Clarence Sasaki by
Randall A. Smith.

Drawing by Wendolyn Hill of superior venacava common pulmonary artery
shunts, executed for Dr. William Glenn.
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Virginia Simon

Schematic rendering by Virginia Simon of seven vertebrate nephrons drawn to a
single scale adapted from references to illustrate an article by S. Long and G.
Giebisch, which appeared in the Yale Journal of Biology and Medicine

esthetic judgement, and as a result, are a real pleasure to
work with, according to Mrs. Simon. “Others bring in
work without realizing the problems of translating their
pen or pencil scratches into a finished product. We are
frequently faced with the problem of presenting vast
amounts of information in a very small space,” she said.
Still other members of the faculty and some students are
“first timers”, and require considerable counsel and
advice. “Actually, this may be my favorite part of this job.
I really enjoy sharing the experience we have gained in this
office with them. The exchange of knowledge between the
client and members of the staff about presenting scientific
information has been one of the most rewarding aspects of
working here,” Mrs. Simon said.
A former student of the Art Students League in New
York, Virginia Simon started her career as a painter and an
architectural and technical draftsperson. She first worked
as a medical illustrator for Yale on a free-lance basis from
her home in Rhode Island. One of her most frequent clients
then was the late Dr. Nicholas Giarman, professor of
pharmacology.
When Armin Hemberger announced his intention to
retire in 1962, she applied for the job and was accepted.
The question then, she said with a laugh, was, “is there
enough work to keep her busy full time?” In no time at all
she was indeed very busy. “I was so excited about the job
— I still am.”

OGCE at
YALE
“This is a superior program. The School’s support for
continuing medical education, the productive relationship
between clinical departments and the Continuing Medical
Education Office, the substantial formalized on-going
community hospital interaction, all lead to the expectation
of continued growth in providing superior educational
activities.” These words of praise were included in a letter
from the Accreditation Council for Continuing Medical
Education, announcing that the School of Medicine’s pro¬
gram for continuing education had received accreditation
for a new term of six years. A standard interval of accred¬
itation is four years; one of six years is given only to
exceptionally stable and meritorious programs, according
to the Council.
Established in 1975, the Office of Graduate and Con¬
tinuing Education extended programs of the School’s
former Office of Regional Activities. They were based on
the federal Regional Medical Programs legislation (PL
89-239) of 1966, which expired in the mid-70’s. It
expressed Congressional concern about the translation of
federally funded basic medical research to the improve¬
ment of patient care in the community, and provided funds
to accomplish this goal.
Dr. James D. Kenney was appointed associate dean for
graduate and continuing education in the fall of 1978.
There hasn’t been a dull moment in the Office since.
In spite of a busy private practice in rheumatology and
internal medicine in New Haven, Dr. Kenney’s interest in
continuing medical education runs deep. On being
appointed associate dean, he literally rolled up his sleeves
and began applying his incredible energy and creativity to
its operation.
“When the regional medical program began, 1 as a
devout practicing private physician had an interest in
Yale’s relationship to the private medical community,” he
explained. “As such, I was invited to sit on some of the
committees involved in setting up the regional activities
program here.” As time went on, he also helped to
develop the four Professional Standards Review Organiza¬
tions in Connecticut, and for about ten years, he has
headed the Internal Medicine Review Course.
“I had one foot in the region and one foot in continuing
education, and I had watched the OGCE grow from its
early days as an Office for Regional Activities through the
development of an associate deanship for graduate and
continuing education. I was very interested in becoming a
part of it.”
Under the federal regional medical legislation, the
Connecticut Regional Medical Program established a
system of affiliation of community hospitals either with
the Yale School of Medicine or the University of
Connecticut School of Medicine. Yale already had long¬
standing relationships with several community hospitals.

With the new regional medical program, these ties were
formalized, coordinated and gradually expanded.
A major undertaking since Dr. Kenney’s appointment
has been the review and renegotiation of five-year agree¬
ments with each of the regional hospitals in Yale’s
program. (Hospital of St. Raphael in New Haven;
Bridgeport and St. Vincent’s Hospital; Danbury Hospital;
Greenwich Hospital; Griffin Hospital in Derby; Lawrence
and Memorial Hospitals in New London; Norwalk Hospital;
and St. Mary’s and Waterbury Hospitals). The general
objectives of the affiliations include continuing education
of medical staff, graduate medical education of house
staff, undergraduate medical education, recruitment of
faculty and medical staff, and multi-hospital research
programs and referral networks.
After moving cautiously at first, the Yale affiliated hos¬
pitals program is proving attractive to all parties. “The
chiefs of services and others in the hospitals who interact
with our faculty have become increasingly prudent plan¬
ners, so that the teaching provided by Yale to the regional
hospitals is not simply a matter of talking heads, but
instead, includes bedside rounds, special conferences,
grand rounds, clinic review — whatever the chief at the
hospital feels will be best for a program that is underway
there,” according to Dr. Kenney.
The OGCE staff has given a great deal of attention to the
organization and standardization of the mass of informa¬
tion involved in the agreements with each individual
hospital, in an effort to facilitate access and review by
outside agencies such as the Accreditation Council for
Continuing Medical Education. In addition, they keep a
census of continuing medical education events in the
various hospitals. “This is essential,” Dr. Kenney pointed
out, “so that Yale, as an institution, does not appear to be a
landlord who signs an agreement, and as he leaves says,
‘Call me if anything interesting happens.’ We specifically
solicit and keep records of most, if not all, of the CME
programs that take place in each hospital. ”
One of the most innovative programs Dr. Kenney has
brought to the office provides physicians the opportunity to
acquire 26 Category 1 CME credits a year without ever
leaving home. It consists of objective open-book examina¬
tions given twice a year, based on the contents of THE
MEDICAL LETTER in the preceding six months. THE
MEDICAL LETTER, published by a non-profit organiza¬
tion, is a widely circulated and well-known source of
information about drugs and therapeutics.
Developed in the latter part of 1979, the examination
program took off like a rocket, and there are now about
10,000 subscribers. “Extremely valuable. Researching
the answers constitutes a most valuable review.” “It is
excellent. Taking the exam compels me to study THE
MEDICAL LETTER. This improves my expertise in
‘medicine’ which helps me as an orthopedic surgeon and
professor.” “It’s the most attractive of the good quality
CME correspondent courses in terms of cost per CME
credit unit.” “Excellent. Would like to see more like it.
Every physician should participate,” have been some of
13

The OGCE Staff
Janice Gore, front row center, is assistant to the associate dean for
graduate and continuing education. According to Dr. Kenney, she
manages the Office, doing everything from balancing the budget to
making arrangements for the many conferences sponsored by the
Office, and administering the postdoctoral fellow program — and she
does it with easy grace.
Helen Kosack, front row right, is the Office secretary. In addition, she
does all of the administrative work involved in the production of THE
MEDICAL LETTER EXAM, including the test scoring, analysis,
reporting of results, and awarding of certificates. ‘ ‘An absolute marvel
with detail, she is the perfect person for the job, ’' Dr. Kenney said.
Patricia Soderberg, front row left, is the liaison between the Office and
the affiliated hospitals, arranging for lecturers and the like.
Mary Ellen Levy, in the back row with Dr. Kenney, produces the
Medical Center Weekly Schedule of Events, one of the Office’s many
subsidiary projects.
Dr. Kenney, a professor of clinical medicine, has been the associate
dean for graduate and continuing education since 1978. “One of the
unique privileges of practicing medicine at Yale-New Haven Hospital is
to be part of the most unusual organization here, in which we have
people of basic scientific expertise, people who are straight-forward
practitioners, and all shades in between. There are lots of vigorous
minds and an extraordinarily good house staff. It’s a nice vigorous
climate in which to work. ’ ’

the many favorable comments from participants.
The program was developed to permit physicians, and
when possible others who subscribe to THE MEDICAL
LETTER, to acquire the CME credits conveniently and at
a very low cost of $15 per year. The examinations are
written by a committee of Yale physicians, including
senior and junior faculty with skills in teaching, research
and clinical practice. They prepare examinations made up
of multiple choice, true/false and matching questions not
only with scholarly intent, but with a touch of wit as well.
One participant noted, “Excellent education excercise,”
and added “I enjoyed the humorous aspects of several
anecdotal ‘cases’. The exam was a pleasure to take.”
In addition to the affiliated hospital programs and THE
MEDICAL LETTER exam, the OGCE makes all of the
arrangements for continuing education workshops,
seminars and conferences held throughout the year and
attended by physicians and other health professionals from
all over the state. Generally sponsored by a department or
section in the School of Medicine, these programs reflect
the interests of faculty here, and as such augment activities
at the Medical Center. According to Dr. Kenney, “In all
of its endeavors, the Office tries to operate in such a way
that it can be seen as an extension of the scholarly life
proper to the Medical Center.”
In response to a question of whether a medical school
was the proper agent for graduate and continuing educa¬
tion, Dr. Kenney left little doubt about his feelings about
the subject. “To provide continuing medical education is,
as 1 see it, a proper endeavor of the university. Whether or
14

not there are laws mandating CME, and whether or not
there might be a conflict, either for legal reasons or
psycho-social reasons with state medical societies, it is
still the proper business of the university.”
This philosophy is evident in the direction of activities
the OGCE has taken over the past few years. “My own
instincts are those of a practicing physician with some
minor scholarly pretensions. I am not an educator or an
educationist. I lament the entry into this field of those
educationists who are long on the quantification of what
there is to be learned, or how much time it takes to leam it,
or how great was one’s satisfaction with what had been
learned and how that was expressed in one's life. I don’t
think the business of becoming cultured in any way —
whether in medicine, the arts, or hard science — is pro¬
perly dealt with that way,” he explained. “After all, the
population of people with whom we deal is bright, and the
approach to measuring what has been achieved by them
has to be more general. ”
For that reason, he sees the Office of Graduate and
Continuing Education as a mediator between the people
who make demands for quantitative reportage on the one
hand, and the people in the School of Medicine, who are of
professional merit. “Our job is to interpret and make easy
a transference between the vigorous, difficult-to-define
life of a university, and the bureaucratic mind, which seeks
principally a report of what was done. We stand between,
trying to make things satisfactory for the critic, and easily
presented by the person of skill.”

Letters to the Editor

A View From The Other Side of the Retractor
I read with interest the article entitled “Science in Medical
Practice” which appeared in the last issue of Yale Medicine.
Who could disagree that an important part of under¬
graduate medical education should be the teaching and
development of critical thinking? What intellectual skill
more surely defines the excellence of both investigator and
clinician than the ability to critically evaluate new
information? However, isn’t our mission as medical
educators broader than this ? We are here not only to nurture
inquiring minds; we are here also to train the next genera¬
tion of health care professionals — men and women who
will be responsible for the lives of the infirm and insecure.
Where in the curriculum are we to breed and evaluate the
integrity and empathy that will insure against abuse of this
responsibility — and the humility and humor to carry this
responsibility gracefully? Where in the curriculum are we
to assess the students’ ability to respond to stress with
equanimity and effectiveness? Where and how are we to
teach these students about priorities and decision-making?
Where are we to evaluate how maturely and sensitively
they are able to work with others? Where are we to teach
and assess their ability to take initiative when it is indicated
— and to ask for help when it is needed? My guess is that
most of these qualities are fostered and refined during
those “wasteful clinical years of medical school” to which
the article referred. And unless this interface with the
clinical faculty remains good and meaningful we will have
abdicated one of our most important academic roles:
career development and counseling. This is not
“parochialism”; it is helping future physicians decide
what to do with their lives.
I believe that a relevant, integrated medical school
curriculum requires an environment which values inquiry
and emphasizes the need to utilize basic science instincts
and insights in approaching and solving clinical problems.
We are teaching students who have come to a professional
school, not a graduate school. We are here to provide
guidance in approaching both problems and patients —
and to help our students acquire the skills and stimulation
necessary for continuing self-education. Our role, it seems
to me, is to clarify the relevance of the basic sciences to the
clinical sciences, to require the same intellectual rigor in
both, and to expect that these intellectual skills be balanced
by maturity and compassion.
I believe that there are some specific ways in which
surgery (as compared to other clinical disciplines) is
particularly relevant to the development of these problem¬
solving skills, whether or not the student has any interest in
surgery as a career: surgical problems tend to be betterdefined (with a clear-cut beginning and end) and usually
evolve over a shorter time-line; decision-making and

intervention are central to altering the course of these
problems (and intervention decisions cannot be made
without a consideration of priorities); the consequence of
the intervention is usually clear (as is the feedback as to its
effectiveness). Clinical problem-solving implies both an
evaluation of the problem and a plan for treatment.
Surgical problems not only require an early decisive
assessment but also are more likely to result in a clear and
tangible solution. The surgeon who is called to see a
patient who is septic with an acute abdomen or hypo¬
tensive following an automobile accident or exsanguinat¬
ing from a gastric hemorrhage must be calm,
compassionate, thorough, and decisive. The student who
is there in the operating room when the perforated colon is
resected, the lacerated liver is repaired, or the bleeding
ulcer is oversewn, is seeing the impact of anatomy,
pathology, and physiology on the solution of a clinical
problem. The student who participates in this process is
learning about problem-solving skills that are fundamental
to his future.
This is a case not for “departmental parochialism” but
for medical education.
Richard J. Gusberg, M. D., Assistant Professor
of Surgery, Director of Medical Students,
Department of Surgery

This letter from Dr. Gusberg is the only correspondence received
by Yale Medicine in response to the article ‘ ‘Science in Medical
Practice’ ’; however, Dr. Berliner has received several personal
letters from alumni, all but one of which enthusiastically supported
his views on curriculum as expressed in that article. Editor.

Erratum:

An error in Dean Berliner’s article
“Science
in
Medical
Practice”
published in the Winter 1982 issue has
come to our attention.
In the first column on page 3, the
word “not” was erroneously included
in the next to last line. The sentence
should read: “Many of the things that
now seem to our students to be most
relevant, in which they most eagerly
involve themselves, will be out of date,
discarded”.
We apologize for this error.

Letters to the Editor continued on next page.
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Letters to the Editor, continued
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Associates of the Yale
Medical Library

Two on Faculty Elected to National
Academy of Sciences

In 1948, a small group of senior mem¬
bers of the faculty joined together to
form the Associates of the Yale Medical
Library, an organization of people who
are devoted to developing not only the
quality, but also the accessibility of the
great collection of books found here.
Since that time, members of the
Associates, by their dues or contribu¬
tions, as well as, in many cases, by
their active participation have been
instrumental in maintaining the high
standards of scholarship which the
Library makes possible.
Each year in the spring, the Library’s
outstanding event is the annual meeting
of the Associates, at which a distin¬
guished visiting scholar or public figure
speaks on a topic of bibliophilic
interest. This year's speaker was Dr.
Lawrence K. Altman, Science Editor
of the New York Times, who spoke on
the topic “Medicine and the PressA Historical Overview”.
At the time of the annual meeting, a
special exhibit is arranged in the
Cushing Rotunda for our members and,
as a souvenir of the occasion, each is
given a facsimile of a manuscript which
has had an important place in medical
history. A reception follows the lecture
to allow members the opportunity to
meet the speaker and greet one another.
It is my pleasure to invite all Yale
Medical Alumni to membership in the
Associates. This can be yet another
way of identifying with the goals and
aspirations of Medical School and
Hospital, encouraging the Library, and
helping to define its philosophy and
direction. Become an even closer
friend of your medical alma mater —
we need all the help you can give.

Two members of the faculty have been
elected to the National Academy of
Sciences. Dr. Charles F. Stevens,
professor of physiology, has been
elected a member; and Dr. Tsuneo
Tomita, senior research scientist and
professor emeritus of ophthalmology
and visual sciences, has been elected a
foreign associate of the Academy.
Election to the National Academy of
Sciences is considered one of the
highest honors that can be accorded to a
scientist or engineer in this country.
Dr. Stevens is well known for his
research on the molecular basis for
nervous system function, and in parti¬
cular, for his studies on the role of pro¬
teins in transmission of information
between nerve endings and the nerve
impulse. A graduate of Harvard
University, he received an M.D.
degree from Yale in 1960 and a Ph.D.
degree from Rockefeller University in
1964. Prior to his appointment to the
Yale medical faculty in 1975, Dr.
Stevens had been professor of
physiology and biophysics at the
University of Washington School of
Medicine in Seattle, where he had been
a member of the faculty since 1963. In
1969-1970, he was guest investigator
at Lorentz Institute for Theoretical
Physics, Leiden University, The
Netherlands. He received the W. Alden
Spencer Award
from Columbia
University College of Physicians and
Surgeons in 1979, and was the Grass
Lecturer for the Society of Neuro¬
science in 1981.
Dr. Tomita made a major contribu¬
tion to the understanding of the visual
process when he first described the
electrical signals produced in the

Sherwin B. Nuland, M.D., ’55
Chairman, Board of Trustees,
Associates of the Yale Medical Library
Note:
Membership dues are $25 for contribu¬
ting member, $100 for sustaining
member, and $1000for life member.
Checks payable to Yale University
should be sent to the Associates of the
Yale Medical Library, 333 Cedar
Street, New Haven, Connecticut, 06510.
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photoreceptor cells of the eye. Further,
with his colleagues, he has been able to
describe the way in which the nerve
cells of the retina process these photo¬
receptor signals. Formerly professor of
physiology and dean of the Keio
University School of Medicine, he has
been associated with the Department of
Ophthalmology and Visual Sciences at
Yale since 1971. He received both an
M.D. degree and a Ph.D. degree from
Keio University, where he was a mem¬
ber of the faculty for thirty-five years.
Dr. Tomita is the recipient of a number
of honors including the Purple Ribbon
Medal of the Japanese government, the
Proctor Award of the Association for
Research in Vision and Ophthalmology,
and the Japan Academy Award.

Two Professors Retire

Two distinguished professors at the
School of Medicine will retire at the
end of this academic year.
Dr. Dorothy M. Horstmann, John
Rodman Paul Professor of Epi¬
demiology and Professor of Pediatrics,
and a member of the faculty for 39
years, is recognized throughout the
world for her research on poliomyelitis
and rubella. She received her B.A. and
M.D. degrees from the University of
California at Berkeley, and first came
to Yale as an instructor in preventive
medicine in 1942. In 1969, she became
the first woman ever to hold an
endowed chair at Yale, when she was
promoted to the Paul professorship.
She is a member of American Academy
of Sciences, and a Fellow of the
American College of Physicians.
Dr. Joseph S. Fruton, Eugene S.
Higgins Professor of Biochemistry and
Professor of the History of Medicine, is
one of the nation’s leading scientists in
the field of the biochemistry of
proteins. He received a B.A. degree
and Ph.D. degree from Columbia
University, and after ten years on the
staff of The Rockefeller Institute for
Medical Research, came to Yale in
1945 as an associate professor.

Pharmaceutical Firm Establishes
Visiting Professorship in
Pharmacology
The School of Medicine has received a
grant of $50,000 from Sterling Drug
Incorporated to establish a Sterling
Drug Visiting Professorship in the
Department of Pharmacology. The
grant was made in honor of Dr. Alfred
Gilman, a distinguished research
scientist and educator in the field of
pharmacology.
The Sterling Drug Visiting Profes¬
sorship is intended to promote the
interchange of knowledge in pharma¬
cology between colleges and universi¬
ties. Visiting professors will deliver a
major lecture to faculty and students, in
addition to participating in seminars
and workshops.
Dr. Gilman, who has been a lecturer
in pharmacology at Yale since 1973, is
co-author with Dr. Louis S. Goodman
of “Pharmacological Basis of Thera¬
peutics”. The book, published by
MacMillan & Company and now in its
8th edition, is considered one of the
most important texts in the field of
pharmacology.
Before
coming
to
Yale,
Dr.
Goodman had been professor and
chairman of the Department of
Pharmacology at Albert Einstein
College of Medicine since 1956. He is a
graduate of Yale College and received
his Ph.D. degree in biochemistry here
as well. In addition to being elected to
membership of the National Academy
of Sciences, he is a fellow of both the
American Academy of Arts and
Sciences and the American Association
for the Advancement of Science, and a
member of a number of other pro¬
fessional societies.
In
1979, he
received an honorary Doctor of Science
degree from Dartmouth College.
The endowment to establish the
Sterling Drug Visiting Professorship in
honor of Dr. Gilman was presented to
Dr. Alan C. Sartorelli, professor and
chairman of the Department of
Pharmacology, by Dr. W. Clarke
Wescoe, chairman of the board and
chief executive officer, and Dr.
Monroe E. Trout, senior vice-president
for medical and scientific affairs of
Sterling Drug Inc., in a brief ceremony
on March 24.

Leading Geneticist was Fifth
Caldwell B. Esselstyn Fellow
Dr. Charles R. Scriver, one of
Canada’s most distinguished medical
geneticists and educators, delivered the
Caldwell B. Esselstyn Lecture on
Monday, April 26, at the Yale School
of Medicine. The title of his lecture was
“Genetics and Medicine: an Evolving
Relationship.”
Named
the
Fifth
Caldwell B. Esselstyn Fellow of the
Department of Epidemiology and
Public Health, Dr. Scriver also held
informal meetings and participated in
seminars with faculty and students.
The organizer and leader of the
genetic screening and health services
program in Montreal, Canada, con¬
sidered to be one of the most outstand¬
ing in the world. Dr. Scriver is also
widely recognized for his research on
the role of amino acids and phosphate
transport in inborn errors of metabo¬
lism. He is a professor of medicine,
biology, and human genetics at McGill
University,
Montreal,
where
he
received a B.A. degree, cum laude, in
1951 and M.D.C.M. degree, cum
laude, in 1955. A Fellow of the Royal
College of Physicians and Surgeons
(Canada), as well as of the Royal
Society of Canada and the Canadian
College of Medical Geneticists, he is
the recipient of numerous honors and
awards including the Queen’s Jubilee
Medal (1977), the Gairdner Interna¬
tional
Award
(1979),
and
the
McLaughlin Medal of the Royal
Society of Canada (1981).
The Caldwell D. Esselstyn Fellow¬
ship was established by the Esselstyn
Foundation in 1978 in honor of the late
Dr. Esselstyn, Class of 1925, to bring
to the Yale community the opportunity
for dialogue on social and ethical issues
as they affect health and the quality of
life. Fellows are selected from among
those whose work has influenced
present public debate on health care
policies, whether or not they are
directly concerned with the delivery of
health care services.

AWARDS 1982
The Francis Gilman Blake Award is
presented annually by the graduating
medical school class to the outstanding
teacher of the medical sciences. The
award this year was presented to Dr.
Edwin C. Cadman, associate pro¬
fessor of medicine and pharmacology.
Dr. Caroline Ryan, an intern in medi¬
cine, and Dr. David Podell, a secondyear resident in medicine, received the
Samuel D. Kushlan Awards. Estab¬
lished in 1969, the awards recognize
the intern and second-year resident who
have contributed the most to patient
care during rotation through the
Memorial Unit Medical Service. Selec¬
tion of recipients is made in consulta¬
tion with the clinical faculty and the
nursing service.
The Benedict R. Harris Award, estab¬
lished in 1967, was presented to Dr.
Samuel D. Kushlan, clinical professor
of medicine and associate chief of
medicine at the Yale-New Haven Hos¬
pital. The award is made annually to the
private physician who has contributed
the most to the teaching of the house
staff. Selection is made by first-year
assistant residents.
The Betsy Winters House Staff Award
is presented annually to the member of
the house staff of the Yale-New Haven
Hospital who made the most significant
contribution toward the education of
medical students. The selection is made
by the senior class, who this year
presented the award to Dr. David
Braun, resident in pediatrics.
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“THE MOVE” into New Patient
Care Facility: fanfare, flowers and
festivity
The first patients moved into the YaleNew Haven Hospital's new seven-story
patient-care facility on April 21,
culminating nearly 20 years of planning
and three years of construction. The
enormous task of moving patients, staff
and equipment from the outmoded New
Haven Unit and parts of the Memorial
Unit was launched amid balloons,
flowers and a spirit of festivity in the
pristine, attractive new facility.
Each patient moved received a
commemorative coffee mug marking
the occasion, and every patient in the
Hospital was given a red carnation as a
token of the event. Patient moves are
expected to be completed by June 10.
“This is an exciting, landmark day in
the history of Yale-New Haven Hos¬
pital,” noted President C. Thomas
Smith, who presided over a brief
ceremony before the first bed was
wheeled onto the fifth floor. “It marks
a major advance in our ability to deliver
the best possible patient care.”
The $73 million project replaces
outdated facilities located across the
street in the New Haven Unit with a
modem, comfortable and integrated
patient care area. The project also
includes renovation of the childbirth
facilities in the Memorial Unit.
The building has enabled the
Hospital to consolidate the departments
of radiology, pediatrics, the operating
rooms, admitting and discharge offices
and the cafeterias. The new emergency
room located on the first floor has
doubled in size. Patient rooms on floors
five through seven have been designed
with privacy and comfort in mind.

Fulton Award Presented to
Jed Gorlin
Jed Gorlin, a fourth-year medical
student, was awarded the John F. Fulton
Memorial Award in the History of
Medicine. The award was established
in 1966 by a group of Dr. Fulton’s
former students and alumni of the
Nathan Smith Club, an organization of
students interested in medical history.
The award, which perpetuates Dr.
Fulton’s work of fostering student
interest and enjoyment in research in
medical history, is given annually to
the student who submits the best
manuscript of a talk presented before
the Nathan Smith Club.
Mr. Gorlin’s paper entitled “The
Doctrine of Difficult Dentition” is based
upon his study of medical concepts
concerning teething in childhood.

Dr. William H. Prusoff received the
1982 AS PET Award from the American
Society for Pharmacology and Experi¬
mental Therapeutics. Dr. Prusoff, who
is professor of pharmacology, is recog¬
nized for his work in the development
of nucleotide analogs as potential anti¬
viral and anticancer agents.

Faculty Notes
At a ceremony on May 20, the Univer¬
sity of Wisconsin Medical Alumni
Association
presented
Dr.
Leon
Rosenberg with the Distinguished
Alumni Citation Award, the highest
award conferred by the Association. In
February, Dr. Rosenberg, who is pro¬
fessor of human genetics and pediatrics,
and chairman of the Department of
Human Genetics, was the UCLA
Annual Lecturer, and in April, he was
Pfizer Lecturer at the University of
Minnesota.
The National Board of Medical
Examiners has appointed Dr. Philip
Felig, professor of medicine, as chair¬
man of the National Board’s Part II
Medicine Test Committee. The distin¬
guished corps of examiners of the
Board, which includes individuals
selected from among the most promi¬
nent members of medical faculties
throughout the United States and
Canada, has the responsibility for the
development of National Board exami¬
nations and for assuring the quality and
integrity of the overall evaluation
system of the National Board of Medi¬
cal Examiners.
Dr. Donald Cohen, professor of
pediatrics and psychiatry in the Child
Study Center, has been elected a
member of the Board of Trustees of
Brandeis University.
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The John Simon Guggenheim Memorial
Foundation has awarded fellowships to
two members of the faculty. Dr. Arthur
Broadus, associate professor of medi¬
cine received the award for his work on
isolation of the factor responsible for
the hypercalcemia of malignancy; and
Dr. Frederick Naftolin, professor and
chairman of the Department of
Obstetrics
and Gynecology,
was
recognized for his research on the struc¬
ture-function relationship in neuro¬
endocrinology. They were among 277
scholars, scientists and artists chosen
from 3,200 applicants in the Founda¬
tion’s 58th annual competition.

Two members of the faculty were
recently honored by the American
College of Physicians. Dr. Howard
Spiro, professor of medicine and wellknown gastroenterologist, has been
made a Master of ACP. The Richard
and Hinda Rosenthal Foundation
Award “to that scientist or scientific
group whose recent innovative work is
making a notable contribution to
improve clinical care in the field of
internal medicine” was presented to
Dr. Alvan R. Feinstein, professor of
medicine, and epidemiology.
In addition to being elected president of
the American Association of Patholo¬
gists, Dr. Vincent Marchesi has also
been named editor-in-chief of the
American Journal of Pathology, the
official publication of the Association.
Dr. Marchesi is Anthony N. Brady
Professor and chairman of the Depart¬
ment of Pathology.
The Greater New Haven Chapter of the
University of Connecticut Alumni
Association honored Dr. Robert B.
Hurowitz with
its Distinguished
Alumni Award at the Association's
annual award reception in June. Dr.
Hurowitz is assistant clinical professor
of pediatrics.

Dr. Mary Swigar, associate professor
of psychiatry, has been named “Distin¬
guished Alumnus’’ by Muhlenberg
College, in Allentown, Pennsylvania.
She is one of four women ever to receive
this award, which is given annually by
the college.
Dr. Ira V. Hiscock, Anna M R.
Lauder Professor Emeritus of Public
Health, celebrated his 90th birthday on
May 7. Among greetings he received
was this telegram from Hector Acuna
(’51 MPH), director of the Pan-American
Health Organization: “Please receive
my heartiest congratulations on the
occasion of your ninetieth birthday. As
a former student of yours, I would like
to express once more my deep affection
not only for your thoughtful lectures,
but especially for your warm and wise
guidance that you have provided to
myself and hundreds of others to better
serve the cause of public health. On
behalf of the Pan American Organization
Regional Office for the Americas of the
World Health Organization and myself,
we feel pleased to honor you in this
way.’’ Dr. Hiscock resides at the Pine
Run Community in Doylestown,
Pennsylvania.
Richard Schweiker, Secretary of Health
and Human Services has invited Dr.
Adrian Ostfeld to join the National
Advisory Council on Aging. The
council is the senior advisory group on
aging research and training in the
National Institutes of Health. Dr.
Ostfeld is Anna M R. Lauder Professor
of Epidemiology and Public Health.
Dr. Gary Schwartz, professor of
psychology and psychiatry, has been
busy on the lecture circuit this spring.
On March 2, he delivered the second
annual Kate Ellen Polachek Memorial
Lecture on Behavioral Medicine at the
University of Wisconsin Medical
School; and the next day he gave an
invited workshop on research in
psychophysiology at a meeting of the
Society of Behavioral Medicine. He
recently gave an invited series of lec¬
tures at the Skinner Institute on Bio¬
feedback and Behavioral Medicine in
Rome.

The 22nd Annual Herman Beerman
Award was presented to Dr. Frank
Ruddle, professor of biology and
human genetics, by the Society for
Investigative Dermatology. The award
is presented to a scientist outside the
specialty of dermatology for significant
contributions in developing a new
biomedical technology with applica¬
tions in dermatology. Dr. Ruddle
delivered the Beerman Lecture entitled
“Reverse Genetics: A New Approach
to Human Genetic Analysis.’’

David Andrew Balia, Ph.D.
Dr. David A. Balia, associate professor
of psychology in the Child Study
Center,- died on February 16, 1982 at
the age of 42.
A native of Pittsburgh, Pennsylvania,
Dr. Balia received his B.A. degree
from DePauw University in 1961 and
the M.S. and PhD. degrees in
Psychology from Yale University in
1965 and 1966. He was appointed a
Research Staff Psychologist in the Yale
Department of Psychology in 1967 and
in 1970 was promoted to Research
Associate in the Department of
Psychology and the Child Study
Center. In 1977 he was appointed to the
rank of Associate Professor in the Child
Study Center.
Dr. Balia made major contributions
in
the
fields
of developmental
psychology, mental retardation, and
juvenile delinquency. He was an
associate editor for Applied Research in
Mental Retardation and a consulting
editor for the American Journal of
Mental
Deficiency
and
Clinical
Psychology Today. Dr. Balia was also
the author of more than 60 scientific
publications including both journal
articles and books.
In addition to his wife and parents,
he is survived by three daughters, a
son, and a brother. S.S.S.

On March 31, Dr. Bernard Gee, pro¬
fessor of medicine, gave the Dr. Owen
Clarke Memorial Lecture at the
University
of
Western
Ontario,
London, Ontario, with the title of
“Sarcoidosis: Current Concepts in
Pathogenesis, Diagnosis and Manage¬
ment.” Dr. Gee was also an organizer
and director of the International Con¬
ference on Occupational Lung Disease
sponsored by the American College of
Chest Physicians and held in Chicago
in March.
Dr. Frederic L. Holmes has been
appointed Master of Jonathan Edwards
College for a five year term. Dr.
Holmes is professor of the history of
medicine.

New Book by Faculty
“Narcotic Analgesics in Anesthe¬
siology”. Edited by L.M. Kitahata,
professor and chairman of the
Department of Anesthesiology and
J.G. Collins, assistant professor of
anesthesiology and pharmacology.
Williams & Williams (Baltimore)
1982.

I
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Special Lectures
The following endowed lectures were given at the School of Medicine during the academic year 1981-1982:
The Paul B. Beeson Memorial
Lecture

Dr. Anthony S. Fauci, National Institutes of Health, “Human B Lymphocyte
Function: Activation and Immunoregulation in Normal and Disease States.” January 27.

Sanfurd G. Bluestein Lecture

Dr. H. Paul Capp, University of Arizona College of Medicine. “Medical
Imaging-1990.”-February 11.

Phyllis T. Bodel Memorial Lecture

Dr. Margery W. Shaw, University of Texas Health Center. “Prenatal Medi¬
cine and Selective Abortion: Legal Issues Confronting Physicians.” November 11.

Philip K. Bondy Lecture

Dr. David J. Weatherall, John Radcliffe Hospital, “The Clinical and Molecular
Diversity of the Thalassaemias: A Model for Genetic Disease in Man. ” — April
4.

The Jack R. Cooper Lecture

Dr. Jon Lindstrom, The Salk Institute, “Use of Monoclonal Antibodies to
Study Acetylcholine Receptors and the Autoimmune Response to Receptors in
Myasthenia Gravis. ” — February 18.

Clyde L. Deming Memorial Lecture

Dr. Vincent O’Connor, Jr., Northwestern Memorial Hospital, “Experience
with Vesicovaginal Fistula Repair.” - November 30.

Caldwell B. Esselstyn Lecture

Dr. Charles R. Scriver, McGill University, “Genetics and Medicine: An
Evolving Relationship.” - April 26.

Harold Fink Memorial Lecture

Dr. Ernest Beutler, Scripps Clinic and Research Foundation, “Bone Marrow
Transplantation in the Therapy of Acute Leukemia.” - May 12

John P. Flynn Memorial Lecture

Dr. Eric R. Kandel, Columbia University College of Physicians and Surgeons,
“Cell Biological Approaches to the Study of Anxiety in Simple Animal
Models.” - March 5.

John F. Fulton Memorial Lecture

Dr. Gert Brieger, University of California “Cooperation Between Medical
Historians and Clinicians.” - October 28.
“Some Aspects of the History of Therapeutics” -October 29.
“Early Ambulation - A Case Study in the History of Surgery.” — October 30.

Samuel Clark Harvey Lecture Series

Dr. Howard A. Pearson. “History of Pediatrics in New Haven. “-February 8.
Dr. Franklin C. Wagner “Spinal Cord Injury from Imhotep to Present.” February 15.
Dr. MarkM. Ravitch, University of Pittsburgh, “Development of the
Resection of Chest Wall Tumors.” - March 8.

William Barriss McAllister Jr.
Memorial Lecture

Dr. Steven Silverburg, George Washington University Medical Center,
“Hormones and Endometrial Cancer.” - March 24.

John Meyer Visiting Professor
Lecture

Dr. Andrew W. Bruce, University of Montreal, “Prostatic Acid Phosphate Current Status.” - March 8.

Louis H. Nahum Memorial Lecture

Dr. B. Sakmann, Max Planck Institute, “Measurement of Single Channel
Currents Activated by Putative Transmitters in Muscle, Spinal Cord Neurons
and Heart.” - April 28.

Leon E. Sample Lecture

Dr. William R. Drucker. University of Rochester Medical Center, “Metabolic
Basis for Defense of Homeostasis During Shock.” - March 20.

Henry E. Sigerist Lecture

Dr. James H. Cassedy, National Institutes of Health, “A Medical Calculus of
America’s Foreign Mission Enterprise 1830-1860. ’ ’ - February 26.

Arnold D. Welch Lecture

Dr. Frank M. Huennekens, Scripps Clinic Foundation, “Three Roads to
Tetrahydrofolate - Implications for Chemotherapy.” - April 16.

Dr. Samuel and Kathryn Yochelson
Lecture

Alan M. Dershowitz, Hazard Law School, “The Cage, the Couch, and the Cat
of Nine Tail: The Roles of Psychiatry in the Justice Department.” - March 1 1.
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alumni
news

Why a Gift to “Endowment”?

The Alumni in Medicine Column

Introduction by Nicholas
Spinelli, President

P.

R.

Among many alumni, working for the
School with constancy but quietly and
with low profile, has been Ros
Gallagher (’30 Med). He has been
Chairman of our Medical School
Bequest and Endowment Program
since its inception in 1960. In these
times when private educational institu¬
tions
are
experiencing financial
hardship, remembering our alma
mater among our heirs, in some
fashion, has become a more urgent
necessity. This effort has been most
successful in the Yale College Alumni
Fund as well as other Yale graduate
schools, most conspicuously the Law
School. In recent years, Ros has been
ably assisted by Sam Kushlan (’35
Med) in this task. Following is their
description of what B and E are all
about.

“. . . Kissing your hand may make you
feel very good but a diamond . . . lasts
forever.” So, too, does a gift to the
Yale Medical School Alumni Fund
Endowment. “Endowment” to many
of us spells permanence, “a gift in
perpetuity”, “a gift that keeps on giv¬
ing” — those are what a gift to
“Endowment” is all about.
It is the permanence of a gift to
Endowment that appeals to so many of
those whose circumstances permit
them to consider making a substantial
gift. Unlike the Parisian’s kiss, it is not
for the moment. Year after year after
year the income it generates will help to
maintain the School’s quality.
The “giving” also has permanence.
Like “The Brook” of Alfred Lord
Tennyson, it will ‘‘go on forever’ ’. The
total amount of a donor’s gift to
Endowment is credited in his or her
name and class in the year it is received
and its income will be similarly credited
each year thereafter. It is impossible to
know how much this way of recogniz¬
ing a donor’s gift to Endowment may
influence the donor’s decision to make
a contribution. But is it not true that
there is more than a little of “. . . this
pleasing hope, this fond desire, this
Other donors like the variety of ways
a major gift can be made to Endowment.
For one, a Life Income gift best fits his
or her circumstances; for another a
Deferred Annuity gift, a Bequest, a
Capital gift or a gift of a Life Insurance
policy whose protection is no longer
required will
be appealing and
appropriate.
The fact that the gift’s capital is
managed so as to compensate for
attrition by inflation must impress
every prospective donor; no one likes
the thought that a gift’s real value will
gradually (these days rapidly) diminish.
To counteract this the Fund adds a
fraction of each year’s income to the
capital amount of the original gift.
These brief speculations of why
alumnae and alumni choose to make
gifts to Endowment suggest another
fundamental question: why does a
graduate desire to make a substantial
gift? Like many basic ones — there is
no single, definitive answer.
You, no doubt, have thought of more
than one reason. There are many:
“divers dive for diverse reasons” —
and so do people who give. Some of the
reasons are homely, familiar; others.

equally valid, may be obscure. It’s a
wise donor who knows his own motives.
Warm feelings, fostered by happy
memories of his or her own School
experiences, or of one or more teacher’s
encouragement, inspiration or friendli¬
ness, must be high on everyone’s list of
reasons. An uncomplicated, simple
feeling of obligation to repay the
School for at least the difference
between the tuition paid and the amount
his or her education cost the School is
another. Or a mix of empathy with
succeeding generations of students and
the memory of one’s own struggle may
serve to breed a desire to make these
younger people’s journey as beneficial
as — and less grueling than — the
donor’s.
Then there are the complex, more
intimate reasons: the need further to
feed a still hungry ego, or to bolster a
still less than solid identity. Not all the
processes of adolescence reach their
destinations before the thirties!
And, often intertwined with one or
more of those, is a reason that might
better have been mentioned first; the
fact that many donors previously had
learned that giving is a rewarding
experience, that it is “ . . . more blessed
to give than to receive”, and frequently
more satisfying.
Ros Gallagher, Chairman
Sam Kushlan, Co-Chairman
Yale Medical School
Bequest and Endowment Program

Class Notes
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Myron Wegman
has been elected
president of the American Association
for World Health for the biennium
1982-83. From 1952 to 1961 Dr.
Wegman served with the Pan American
Health Organization, first as chief of
the organization’s Training and Educa¬
tion Division, later as secretary
general. He was dean of the University
of Michigan School of Public Health
from 1961 until his retirement in 1974.
The AAWH is a private non-govemmental health agency whose function it
is to carry out programs of public
education relating to the objectives and
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programs of the World Health Organi¬
zation and to encourage citizen support
for WHO in the United States.
In addition, Dr. Wegman was the
recipient of the first Distinguished
Alumnus Award for Outstanding
Service in Public Health from the Johns
Hopkins University School of Hygiene
and Public Health. The selection was
based on a recent alumni survey in
which 50 were nominated for the
honor. Dr. Wegman received his mas¬
ter’s degree in public health in 1938
from Johns Hopkins University.

Secretary, Donald G. Johnson
Box 116
Bar Mills, Maine 04004

other, in Dallas after a residency there
in medicine.
A letter also to Jim Ferguson from
Crawford Campbell outlined plans
for a six week lecture tour in March and
April of this year to Japan, Thailand,
South Africa, and finally to Rome
where Kay will join him for three
weeks in Florence. We are all glad to
learn Kay has recovered from her
Spring 1981 illness. Crawford and
Kay’s younger son has decided to make
a fantastic change from ballet to medi¬
cine. I wish him well in his new career.
Communication
from
Champ
Taylor mentions a recent trip to France
for a month last fall. His son, Reid, is in
his third year of medical school and is
interested in surgery.

Dear Classmates,
It would be inaccurate to categorize my
secretarial efforts as productive. In
fact. I’ve had nothing about which to
write since nothing has been brought to
my attention. You will be pleased
perhaps to learn that I do now have
something to report, most of which is
through Jim Ferguson.
Bill Oakes writes from Los Alamos,
N.M. that he is now truly retired and
has been travelling about the Southwest
in his recently acquired trailer, visiting
parks and thoroughly enjoying it.
AI Merendino has written to Jim
Ferguson to say he has left the Univer¬
sity of Washington and is now back in
Riyadh, Saudi Arabia as director of the
Cancer Therapy Institute and acting
director of operations of King Faisal
Medical City. Al’s “new career’’
sounds challenging. More power to
him.
Mirabile dictu!! a letter to Jim dated
last November from Joe Sokol. Joe’s
career has taken him from medical
school to training in medicine in New
Haven before and after W.W. 2 with
interim Army service in the Pacific.
Then back to New Haven on the faculty
at Yale, military service again 1950-52
in Europe, then back to New Haven.
Joe went to Roswell Park in Buffalo in
1955 and became research professor of
medicine at State University of New
York. He left Buffalo in 1979 for Duke
University and is a full professor
“without responsibilities, less teach¬
ing’’, but with time for research pro¬
jects dealing with chronic myeloid
leukemia. Joe is married to a native
Floridian, and has two sons both of
whom are M.D.’s; one of his sons is
now in Upper Volta, Africa and the

Both Jim and I received letters from
Jack Blaisdell. Jack went into ortho¬
pedics, and following discharge from
the Army in 1947, he went into practice
in Santa Ana, California where he
remained until 1975. It appears Jack
truly got involved in organized medi¬
cine through participation in numerous
medical societies. He has received on
two occasions the A.M.A.’s Physician
Recognition Award in Continuing
Medical Education. Having “tired of
the rat race” in California, Jack and his
wife, Famie, moved to Northern Idaho,
still practicing, but in a relaxed manner
and in the pleasant surroundings of
Lake Pend Oreille in Sandpoint, Idaho.
On Saturday, March 20, 1982 Jack
Wells had a group of us 1940ers at his
home in Wethersfield, Conn. Present
were Eddie Martin and wife Marty;
Eddie is still practicing in New Britain
and believe me, he doesn’t look his
age. Jim and Izzy Ferguson, now
retired, are enjoying tennis and life in
general. Jack and Eunie Wells are still
up to their necks in civic activities.
Jack’s current practice is limited by his
own choice to former old patients. Ron
and Betty Beckett, with whom I stayed
for the week-end, were there. Ron is
“retired” but still works in the
Hartford Hospital in pathology and is
involved in his nomenclature and
computers. And who showed up?? Bill
Lee, whom we all consider a classmate
even though he didn't graduate with us.
Bill now works in the Employees
Health
Department
at
Hartford
Hospital, having given up practice after
a brush with vascular problems. He
plays tennis actively and frequently.
Your secretary completed the group at
Jack’s soiree. I am still retired in

1940

Maine, not engaged in any way in prac¬
tice , but working in a vague sort of way
with the Red Cross Blood Services,
Northeast
Region
(Maine
and
Massachusetts). The party was a great
success and I hope many of you had
burning ears from our reminiscences.
If you welcome this column for the
next issue of Alumni news, I would be
delighted to do it again with support
from those long since silent.
Best wishes to all.

1943
Announcement has been received that
Robert Furman, vice president for
corporate medical affairs at Eli Lilly
and Company, has been named to the
Union College Board of Trustees at
Schenectady, New York. Before join¬
ing Eli Lilly and Company in 1970, Dr.
Furman held a teaching position at
Vanderbilt University and a research
position at the University of Oklahoma
School of Medicine. He has been pro¬
fessor of medicine at the Indiana
University School of Medicine since
1970. He is the author or co-author of
more than 170 scientific papers in the
fields of endocrine, cardiovascular and
metabolic disorders and has served on
the board of editors of several scientific
publications in addition to being a
member of numerous professional
organizations. Dr. Furman is also a
very active alumnus of Union College.

1951
Robert Hamburger, professor of
pediatrics and head of the Immunology
and Allergy Division at the University
of California at San Diego, was elected
in January to a three-year term as a
member of the Board of Regents of the
American College of Allergists.

1956
Announcement was recently received
that Captain William Narva, MC,
USN, has been appointed by the Presi¬
dent to the position of vice president of
the Uniformed Services University of
the Health Sciences, and that upon
Senate confirmation, he was promoted
to the rank of rear admiral. Since 1978,
Dr. Narva has served as professor and
acting chairman of the Department of
Dermatology at the Uniformed Services
University School of Medicine, a posi¬
tion which he will retain with his new
assignment. Also since 1978, he has
served as special assistant for reserve

affairs in the Bureau of Medicine and
Surgery, and from 1970 Dr. Narva has
been staff officer to the chief of Naval
Operations.

1958
Robert Neuwirth has been named
director of obstetrics and gynecology at
St. Luke’s-Roosevelt Hospital Center
in New York City. His appointment
marked the merger of Ob/Gyn patient
care, teaching and research activities
into a single department in the Hospital
Center’s three divisions: St. Luke’s,
Roosevelt and Woman’s Hospitals. Dr.
Neuwirth, noted for his research in
non-surgical techniques for female
sterilization, has coordinated numerous
such projects internationally and has
consulted on many in emerging and
Third World nations. He pioneered the
use of laparoscopy and is widely
recognized
as
an
authority
on
hysteroscopy.

1959
Mark Bitensky has resigned his pro¬
fessorship at Yale to join the Los Alamos
National Laboratory in New Mexico,
where he is Division Leader of the Life
Sciences Division. He recently wrote to
say that the demands of his new posi¬
tion are awesome. The functions of the
division include toxicology testing of
shale and other synfuels, mutagenicity
and carcinogenicity testing, genetics
and cytogenetics research, environ¬
mental science and waste management,
flow cytometry, experimental pathol¬
ogy, and radiobiology.

1970
Daniel Dedriek is an assistant profes¬
sor of anesthesia at The Pennsylvania
State University College of Medicine at
The Milton S. Hershey Medical Center
in Hershey, Pennsylvania. His wife.
Dr. Carolyn Dedriek, a former member
of the class of 1973, has been named
assistant professor of radiology at The
Pennsylvania State University College
of Medicine.
Bruce Reitz wrote recently that he is
leaving Stanford University School of
Medicine where he has been associate
professor of cardiovascular surgery to
become professor and head of the
Division of Cardiac Surgery at Johns
Hopkins University School of Medi¬
cine, a position which "has been held
for the last 18 years by another Yale

medical school
Gott, (’53).”

graduate,

Vincent

House Staff

1971

1946

Steven Moffic has recently been pro¬
moted to associate professor of
psychiatry at Baylor College of Medi¬
cine and has edited the book "A
Clinician’s Manual on Mental Health
Care: A Multidisciplinary Approach”,
(Addison-Wesley, 1982).

The Houston Academy of MedicineTexas Medical Center Library has
honored John P. McGovern in naming
the library’s history of medicine collec¬
tion for him. At a reception in April, a
portrait of Dr. McGovern and a bronze
plaque commemorating The John P.
McGovern History of Medicine Collec¬
tion were presented to the library.

1973
A letter received from Richard Boland
in May 1981 was unfortunately omitted
from the previous issue. He mentioned
that he had "recently” run into several
former classmates in the past few
months, and upon comparing notes, it
appears that a very large segment of our
class has stayed on (at least this far) in
academic medicine.”
He notes that he is now assistant pro¬
fessor of medicine at the University of
California, San Francisco, where he
has been funded to study glycoprotein
biochemistry in gastrointestinal cancer;
that John Stratton is doing research in
cardiology at the University of
Washington where he was recently
appointed assistant professor of medi¬
cine; and that Richard Young became
assistant professor of pediatrics at
Hershey Medical School (The Pennsyl¬
vania State University College of
Medicine) a year ago and is doing
research in pediatric neurology.
Dr. Boland listed twenty-four other
classmates who, "as far as can be
ascertained, currently hold academic
appointments and are actively involved
in research. This list (compiled from
the softest of data bases — rumor and
recollection) is in excess of one third of
all those we could recall. It may be
somewhat overinclusive, and some
others may have been overlooked.”
He’d be interested in having corrobo¬
rating information about this.

1974
Richard Pasternak, director of the
Coronary Care Unit at Pacific Medical
Center and clinical instructor in medi¬
cine at the University of California in
San Francisco, has been elected to
Fellowship in The American College of
Cardiology.

1969
Michael Rosner wrote in April: "I was
recently elected chief of medicine at
Holyoke
Hospital
in
Holyoke,
Massachusetts. I continue in private
practice in Holyoke with three other
associates including Robert Seaver
who was a Gastroenterology fellow
(’71) at Yale.”

IN MEMORIAM
Matthew Griswold
March 7, 1982

M. D. '25

Moses Cooperstock
January 30, 1982

M. D. ’26

Richard M. Starr
(date unknown)

M. D. ’26

Harold A. Flynn
January 30, 1982

M. D. ’27

J. Merriman Lynch
February 20, 1982

M. D. ’30

Dana L. Blanchard
December 29, 1981

M. D. ’31

Frederick A. Wies
January 19, 1982

M. D. ’33

Charles W. Cashman, Jr.
February 8, 1981

M. D. ’41

Gabriel A. Saviano
December 15, 1981

M. D. ’48

Allen R. Traurig
February 12, 1982
Ronald M. Holloway,
M. D.
December 20, 1981

HS ’66

M. P. H. ’67

Class of 1982
First-Year Postgraduate Appointments
Arizona

Iowa

University of Arizona Affiliated Hospitals,
Tucson
David Goldstein — Medicine

University of Iowa Hospitals, Iowa City
Muriel Cyrus — Medicine

California

Johns Hopkins Hospital, Baltimore
Rise Chait — Psychiatry

Maryland
Cedars-Sinai Medical Center, Los Angeles
Albert Ungricht — Surgery
Kaiser Foundation, San Francisco
Eric Wells — Pediatrics
Stanford University Affiliated Hospitals,
Stanford
Mary vander Velde — Pediatrics
University of California Hospitals,
San Francisco
Cathleen Belden — Obstetrics & Gynecology
Gabriel Escobar — Pediatrics
Howard Jaffe — Medicine
Kathleen Nolan — Pediatrics
University of California/Irvine, Irvine
Louise Connolly — Obstetrics <£ Gynecology
Gary Garshfield — Pathology
University of California/Los Angeles
Keith Gladstien — Pediatrics

Colorado
St. Joseph Hospital, Denver
Jonathan Amow — Surgery
University of Colorado Affiliated Hospitals,
Denver
Kenneth Huttner— Pediatrics

Connecticut
Norwalk Hospital
Alfred Harrington — Medicine
University of Connecticut Hospital,
Farmington
Stuart Gardner — Pediatrics
Waterbury Hospital
Carol Pilbeam — Medicine
Yale-New Haven Medical Center
Deborah Blair — Medicine
Paula Braverman — Pediatrics
Thomas Brennan — Obstetrics & Gynecology
Fred Drennan — Medicine
Laune Katz — Pathology
Teresa Massagli — Pediatrics
Christopher Otis — Pathology
Mark Piccinllo — Radiology
Carrie Redlich — Surgery
Robert Rohrbaugh — Psychiatry
Stephanie Rosenblum — Medicine
Philip Sager — Medicine
Paul Sylvan — Medicine
Lynn Tanoue — Medicine
Patrick Toth — Surgery
Laurence Turka — Medicine
Ronald Voit — Obstetrics & Gynecology

Georgia
Grady Memorial Hospital, Atlanta
Craig Lewis— Medicine

Illinois
Rush-Presbyterian-St. Luke’s Medical
Center, Chicago
Juan Larach — Medicine

Sinai Hospital of Baltimore
Henry Jampel — Medicine

Massachusetts
Beth Israel Hospital, Boston
Sylvia Beck — Medicine
Boston City Hospital
Don Stromquist — Medicine
Brigham & Women’s Hospital, Boston
Michele Masi — Medicine
Donald Regula — Pathology
Robert Rizzo — Surgery
Cary' Sennett — Medicine
Cambridge Hospital
Alan Brown — Flexible
Children's Hospital Medical Center, Boston
Jed Gorlin — Pediatrics
Lewis Rubin — Pediatrics
Massachusetts General Hospital, Boston
Joyce O'Shaughnessy — Medicine
New England Medical Center, Boston
Paula Schlesinger — Pediatrics

Michigan
University Hospital, Ann Arbor
Seyms Cartwright — Medicine

Minnesota
Mayo Graduate School of Medicine, Rochester
George Gaunt — Pathology

Missouri
Barnes Hospital, St. Louis
Jeffrey Gimble — Medicine
Michael Katz — Radiology
Peter Namnum — Medicine

New York
Bronx Municipal Hospital
Charles D Wright — Psychiatry
Brookdale Hospital Center, New York City
Kamu Kokayi — Family Practice
Harlem Hospital, New York City
Carola Greengard — Medicine
Highland Hospital, Rochester
Beth Connors — Family Practice
Montefiore Hospital Center, New York City
Dan Odenheimer — Surgery
Henry Stem — Surgery
Ellen Tattelman — Family Practice
New York University Medical Center-Bellevue Hospital, New York City
Jerrold Levine — Medicine
Presbyterian Hospital, New York City
Daphne Hsu — Pediatrics
St. Vincent's Hospital, New York City
Liba Goldblum — Flexible
The New York Hospital, New York City
Jeffrey Tepler — Medicine
University of Rochester Hospitals, Rochester
Evangeline Franklin — Medicine

24

New Zealand
Dunedin Hospital, Dunedin

David Menkes — Flexible

Pennsylvania
Hospitals of University Health Center, Pittsburgh

Michael Carty — Medicine
Richard Doan — Psychiatry
William Sikov — Medicine
Hospital of the University of Pennsylvania, Philadelphia

Lisa Crossley — Medicine
Andrew Fox — Surgery
James Michelson — Surgery
James Reinprecht — Medicine
David Wright — Psychiatry
St. Christopher’s Hospital, Philadelphia

Jane Cross — Pediatrics
Temple University Hospitals, Philadelphia

Ratal in Roth — Medicine

Rhode Island
Miriam Hospital, Providence

Lila Inouye — Medicine
Rhode Island Hospital, Providence

Christopher Roberts — Medicine

Vermont
Medical Center Hospital of Vermont, Burlington

David Fassler— Psychiatry
Robert Pierattini — Psychiatry

Washington
University of Washington Hospitals, Seattle

Ethan Lemer — Medicine
Steven Resnick — Pediatrics
David White — Medicine
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TO LIFE
Leon E. Rosenberg. M.D., C.N.H. Long Professor
and Chairman , Department of Human Genetics.
Commencement

Address:

Yale

School

University

of Medicine

May 24, 1982

This is an auspicious day. We are here to celebrate the
conferring of the Doctor of Medicine degree on 28 women
and 56 men who constitute the class of 1982 of the Yale
University School of Medicine. I congratulate each of you,
confident that I speak for everyone in attendance and for
family, friends, and teachers who are not. Your achieve¬
ment testifies that young (and a few not so young) people
in our society can still set their own goals and have the
discipline, dedication, and patience to reach those goals.
At a time of national doubt and introspection, this is
reassuring. Your presence here signifies, too, that the
unconditional love which your parents have for you, their
children, and the sacrifices they have gladly made in
expressing that love are rewarded. That is beautiful. More¬
over, this commencement ceremony proclaims that this
venerable institution of learning, whose architecture can
most charitably be described as eclectic, whose educa¬
tional trappings run the gamut from outmoded to antique,
and whose faculty structure most closely resembles that of
an anthill, can manage to pull itself together for your
benefit. That is amazing.
This is a day, too, of thanksgiving: of children thanking
their parents for the tangible and intangible support essen¬
tial to reaching this milestone; of parents thanking their
children for taking a large step toward independent, selfsufficient lives; of teachers and students thanking each
other for shared experiences conferring mutual stimulation
and sustenance. I wish to add my personal thanks to the
class of 1982 for selecting me to speak here today. To be
recognized by one’s students is always a special reward for
a teacher. To be recognized by you at this unique moment
in your professional lives is a singular honor, and one, I
can confidently say, that I (the recipient) will remember
far longer than you (the bestower). I say this because it is
precisely 25 years since I received my M.D. degree on a
day and at a place something like this, and listened to a
commencement address. Sadly. 1 must confess to remem¬

Dr Dorothy M. Horstmann, John Rodman Paid Professor Emeritus of
Epidemiology and Pediatrics, left, was Senior Marshal at commencement
ceremonies on the Old Campus last May. Not shown in the photo is another
member of the School of Medicine faculty. Dr Joseph S. Fruton, Eugene
Higgins Professor Emeritus of Molecular Biophysics and Biochemistry, who
was Corporation Marshal-

bering nothing of the message delivered on that occasion.
Sadder still, I cannot even recall who uttered those
unmemorable words. Fortunately, however, I do remem¬
ber quite a lot about what ensued in the years subsequent to
that blotted out ceremony and it is those reflections I will
use in trying to say something that someone of you may
remember sometime.
I suspect there are two things on your mind today. One is
the hope that this ceremony will be mercifully brief so you
can clutch your diploma, kiss your spouses and parents.
I

hug your classmates, and have a glass of wine. Fear not for

candor, it was the thing to do. Remember, those were the

I have taken my cue from Muriel Humphrey who liked to

halcyon years of biomedical research in this country and

remind her loquacious husband. Hubert, that for a speech

NIH was Mecca. My experience there began disastrously.

to be immortal it need not be eternal.
The other matter, only slightly less immediate, concerns

I found myself participating in metabolic balance studies
aimed at understanding the cachexia of terminal malig¬

your internship, now called many things but still meaning

nancy. Caring for a large number of patients dying of
cancer was difficult enough. Trying to do detailed met¬

the same thing. When you leave here today some of you
will stay in New Haven, others w ill scatter to every comer
of the United States and one of you w ill go as far away as

abolic investigations on these debilitated, uncomfortable
people was excruciating.

Dunedin. New Zealand. For most of you choosing an

There was, however, one child on the service with a

internship has been the major occupation and preoccupa¬
tion of the past year. Among the rationales given for the

puzzling syndrome characterized clinically by progressive

enormous amount of time and energy devoted to this

skeletal muscle wasting and chemically by a markedly
exaggerated excretion of amino acids in urine. He was a

process, two stand out.
The first contends that internship marks the rite of

pleasant, bright lad, and caring for him was a welcome

passage from student to physician, and with that status
change a quantum jump in responsibility and independ¬

being studied because someone believed that his muscle
wasting might, in some way. be likened to that observed in

ence. That assessment is correct. I believe. Being an intern

patients with cancer. That idea, for which there was no

respite from my otherwise depressing chores. He was

is not like being anything else. It is an idiosyncratic year in

logical foundation and from which nothing materialized,

which extremes become the norm: greater exuberance
from medicine than many of you will ever again expe¬

did not catch my attention. What did fascinate me was the
fact that two of this boy's brothers had an identical clinical

rience coupled with greater fatigue; an absolute commit¬

and biochemical picture. Each of these boys died of

ment to your work which pushes nearly all other commit¬

respiratory muscle failure, without definition of the
mechanism for muscle wasting or the renal tubular defect.

ments to the background; a time of triumph and of being
sorely tested. It is a year for which I envy you. knowing
full well interning should not be done more than once.

What did not die was the interest that these children's
illness ignited in me concerning the biochemical and

The second rationale for all the angst associated with

genetic basis of disease. Months later, this spark of interest

internship selection derives from the belief that this
choice, more than any other, sets in motion a elear,
orderly, even inexorable chain of career events. My expe¬

exploded into a dazzling sense of well being when I carried

rience says otherwise. I chose an internship in internal

out some related laboratory experiments which gave
interpretable, but by no means, earth-shaking results.
Thus, I literally caromed into the emerging field of

medicine blithely convinced that I wanted a career largely

medical genetics, and have resided there happily ever

devoted to clinical practice with some time, perhaps, for
teaching. Research was not a serious consideration;

since.

specialization in medical genetics was not even imagined

occurrences, and serendipities which redirected my pro¬

since the specialty didn't exist. If anyone had suggested to

fessional aspirations are not unusual, and feel certain that

me at my medical school commencement that laboratory
research and teaching in medical genetics would, in fact,

many of you w ill be surprised by the unexpected turns your
careers will take, and by your inability to anticipate

be the major pursuit of my next 25 years, or that I would

currently what lies ahead. So be open to the year-long
happening your internship will be. View it as a rocket

one day become board-certified in internal medicine only
to devote the vast majority of my limited clinical effort to
the care of young children with

inherited metabolic

diseases I would have been incredulous.
Let me explain how this total career flip-flop came
about. My internship experience was rewarding and
important because I was exposed to teachers who believed
that scientific rigor and humane understanding were
equally important ingredients for sound medical practice.
But my exposure to fellow house officers with quite
different career orientations may have been even more
important. Most of my colleagues were headed for
research fellowships at the National Institutes of Health,
because they were embued with the notion that the rapid
progress being made in biochemistry, pharmacology, and
physiology would have a great impact on medical practice,
and they wished to participate in this surge. So 1 tagged
along, in part because I was vaguely curious about my
interest in and ability for research, but more because, in

I am convinced that the series of accidents, chance

carrying you to uncharted space, not as a bow designed to
propel you straight toward a target.
Whereas some of your careers will be nudged and
deflected by chance, all of your careers will be revolu¬
tionized by change. Here again. I will use my past to
project your future.
It is impossible to overstate the magnitude of the change
the field
Entirely
genetics
solution

of medicine has undergone since my graduation.
new biomedical sciences such as molecular
and cell biology have appeared, and with them the
of such fundamental problems as the structure of

chromosomes, the nature of the genetic code, and the
significance of subcellular organelles. Clinical diagnostic
capability has been transformed by such techniques as
cardiac catheterization, radioimmunoassay, and comput¬
erized axial tomographic scanning. No less dramatic are
the therapeutic advances made by the cardiovascular
surgeon toward the correction of certain congenital and

acquired heart defects, by the oncologist and radiother¬
apist in the treatment of certain forms of Hodgkin’s

sufferer.
Nor is your good fortune diminished by the increasingly

Disease and leukemia, and by the pediatrician in the
prevention of mental retardation caused by phenylketo¬

large shadow that health concerns and health expenditures
cast on our world. Rather your opportunity to serve is

nuria. Major diseases such as poliomyelitis, diphtheria,
and small pox have literally or virtually disappeared
through population-based immunization and surveillance

enhanced because you will have even more ways to
express your individual talents and beliefs. For example,

programs.
This too abbreviated synopsis of the march of progress,
sometimes beginning at the bedside and other times in the

doctors of medicine will be found in increasing numbers as
elected legislators and appointed executives where they
will act as spokesmen and women on public issues whose
understanding, even resolution, will depend on the physi¬

laboratory, sometimes initiated by clinicians and other

cian's critical perspective. This will be good, I believe, for

times by basic scientists, is part of the medical fabric for
you the class of 1982. I refer to it neither to make you. the

both society and medicine. We do have a unique perspec¬
tive which is as important to the public dialogue on matters

physicians of the future , feel puffed up by the tools at your
disposal nor to make us, the preceding generation of

like occupational safety and reproductive options as our
responsibility for expressing that perspective is large.

scholars, smug in our accomplishments. Rather I mention
what has happened in slightly more than two decades to
remind you of what is certain to happen in the next two.

Let me close by drawing on my ethnic rather than my
medical roots. At celebrations like this one, Jews say two
things. We say “Mazeltov” which means good luck, and

The power of recombinant DNA technology, of mono¬
clonal antibody synthesis, of in vitro fertilization, of

you will need luck in the years ahead as much as any of the
technology or compassion in your possession. Perhaps

nuclear magnetic resonance spectroscopy, and of other,

more to the point, Jews toast celebrants with the word

yet undiscovered modalities will be directed toward
patient care. You will very likely witness the eradication of
malaria, the cure of sickle cell anemia, the understanding
of oncogenesis, and even the elucidation of some of the

“l’chaim” which means to life. It is, after all, to life that
your formal medical education has been directed and to

fundamental rules governing nervous system develop¬
ment. You will see more than new medical science with
which to embellish your clinical art. You will see radically
different systems of computerized medical communica¬
tion and of preventive services. Lest you fear that these

which your careers will ever be devoted. And so, to each
member of Yale Medical School's Class of 1982 I say
“l’chaim” — to your lives, to the lives of your loved ones,
to the lives of the people who will be entrusted to your
care, and to the lives of all humankind poised so fragilely
on this vulnerable, little star.

changes will fall on you like an avalanche, let me empha¬
size that they will occur gradually and that you will
participate in and preside over them. They will be part of
the natural evolution of your careers provided you develop
the critical judgment to distinguish what is truly novel
from that which is merely new, the flexibility to embrace
rather than recoil from change, the wisdom to discard
deeply ingrained but faulty dicta, and the courage to
grapple with uncertainty and controversy.
By now, you have probably guessed that I consider you
most fortunate to have chosen a career in medicine. Your
profession is not constrained by geography or national
boundaries. It speaks a worldwide language. Your profes¬
sion has a continuum which runs from the laboratory bench
to the bedside, from hard science to compassionate
humanism, from the broad arenas of international and
public health to the intimacy of private practice, and from
the classroom of the school to the board room of industry.
Moreover, you alone are free to determine where along
this spectrum you stake your claim and when you see fit to
move from one vantage to another. Physicians are
rewarded by our society with a degree of economic
security unknown to virtually any other group, and with
societal approbation that remains unusually strong, despite
some selfish and arrogant stances on our part which seem,
at times, intent on diminishing our collective esteem. This
societal embrace is a token of mankind’s commitment to
health and of humanity's thanks to those who comfort the
3

THE GREYING OF AMERICA! problems; research; care
By Marjorie B. Noyes

campaign to keep Americans forever young, the hard fact

While Madison Avenue is waging its multi-million dollar

been assumed for centuries, the consequence of the natural
process of aging: nor is it due, as was once thought, to

is that in spite of cosmetics guaranteed to melt away

hardening of the arteries. The cause remains a mystery.

wrinkles, dozens of books with instructions on how to
have a fit and youthful body and $ 100 designer sweat suits

Dr. Elias E. Manuelidis, professor of neuropathology
and neurology, and his colleagues. Dr. Laura K.

to wear while doing so, a large portion of the population is
getting old. The over-75 year old group is now the fastest

Manuelidis. associate professor of neuropathology, and
Dr. Jung H. Kim. assistant professor of neuropathology,

growing

million

are among a small group of scientists working on the

Americans are 65 years and over; the population 85 and

segment

in

the

nation.

Twenty-six

hypothesis that Alzheimer's disease is caused by a slow-

over is 2.4 million. Census Bureau projections indicate

virus of the type recovered from brain tissues of victims of
the fatal but rare form of dementia, Creutzfeldt-Jakob
disease.

these figures w ill nearly double by the year 2025.
There are implications in these statistics for students of
health care. While some elderly people are truly enjoying
the Golden Years, others are in poor health and many are

to the study of dementias, and was the first to transmit

disabled by severe arthritis and skeletal disorders, chronic

Creutzfeldt-Jakob virus to small laboratory animals such

obstructive

as guinea pigs, hamsters and mice. Because it has not been
possible so far to transmit Alzheimer's disease to labora¬
tory animals, he and his research team use these animal

pulmonary

disease,

diabetes,

peripheral

vascular disease, congestive heart failure and other dis¬
orders associated with old age.

Dr. Manuelidis has devoted most of the last seven years

models for their slow-virus research.
THE WORST OF ALL DISEASES

The slow-virus hypothesis is based on a few significant

By far the most pervasive and debilitating problem of

similarities observed between Creutzfeldt-Jakob (C-J)

aging is senility or senile dementia. An estimated 2.5

disease and Alzheimer's disease. Although C-J patients

million American adults suffer some sort of dementia.

usually lapse into a deep coma shortly after the onset of the

The most prevalent form. Alzheimer’s disease, affects

disorder, and die within a year or two. while Alzheimer's

over a million people. They occupy over half of the 1.2
million nursing home beds in the country at a cost now

patients can live for quite some time, patients of both
experience the dramatic personality change, memory loss

exceeding $10 billion and expected to increase to $40
billion or more within a few years.

characterized by degeneration of nerve cells in the brain

Dr. Lewis Thomas, former Dean of the $chool of
Medicine, now Chancellor at Memorial Sloan-Kettering
Cancer Center, has described Alzheimer's disease as the
"worst of all diseases, not just for what it does to the
victim, but for its devastating effects on families and
friends. It begins with the loss of learned skills, arithmetic
and typing, for instance, and progresses inexorably to a

and dementia noted by Dr. Thomas. The two diseases are
and an increase of supporting cells called glia cells, and
there is a marked deficiency in choline acetyltransferase
enzyme in the cortex.
According to Dr.

Manuelidis,

lesions in the brain

characteristic of Alzheimer’s disease, have been found in
up to ten percent of patients who died of C-J virus; while
spongy areas in the nerve cells characteristic of C-J virus,

total shutting down of the mind." he wrote. "It is, un¬
mercifully, not lethal; patients go on and on living, essen¬

have been found in the brain of persons w ho have died of

tially brainless but otherwise healthy, into advanced age,
unless lucky enough to be saved by pneumonia."

members of the same family have had C-J disease while
others have had Alzheimer's disease. The symptoms were

Changes most commonly associated with Alzheimer's

so similar that only post-mortem examination could clarify

disease occur in the protein of nerve cells in the cerebral
cortex, causing accumulation of abnormal fibers, which
when viewed under a microscope, appear as a tangle of
filaments. Scattered throughout the cortex, groups of
nerve endings degenerate and disrupt the passage of
electro-chemical signals between the cells. These areas are
called plaques. The larger the number of plaques and
tangles, the greater the disturbance in intellectual function
and memory. Research has also revealed that Alzheimer's
patients have a reduction, often as much as 90 percent, of
the brain enzyme choline acetyltransferase. which is in¬
volved in the passage of nerve signals and is crucial to
memory function.
What causes this devastating condition? It is not, as has
4

Alzheimer's

disease.

The

literature

notes

that some

which member had C-J disease and which had Alzheimer's
disease.
Dr. Manuelidis and his colleagues will study the
mechanisms and progress of C-J disease in laboratory
animals and compare them with symptoms observed in
patients with Alzheimer’s disease. The ultimate goal is to
learn about the structure and function of the enigmatic
slow-virus and to apply this knowledge to a better under¬
standing of Alzheimer's disease.
This fall, two significant grants underscored the impor¬
tance of the research. The Commonwealth Fund awarded a
grant of $225,000 in support of a full-time investigator in
the study, for five years. The National Institutes on Aging
awarded the School of Medicine over $1.3 million in

support of Dr. Manuelidis’ research for a period of five
years.
This type of long-term support is extremely valuable to
this research. Studies of slow-viruses take a long time and
are painstaking. When injected into susceptible laboratory
rodents, the virus produces no evidence of the disease for
eighteen months or longer, after which there is rapid
destruction of the brain. To begin with, it requires an
enormous amount of funding just to maintain a colony of
laboratory animals in good health for a year and a half or
two, but that is not the only reason.
Scientists working on slow-viruses, are essentially
working in the dark. Unlike other viruses, slow-virus does
not seem to consist of particles visible by electron micro¬
scope or detectable by chemical methods; and although it
multiplies itself thousands of times over in the affected
brain, no one has discovered nucleic acid in slow virus. It

Dr Andrea Schaffner and Dr. Leo Cooney pause during morning rounds to give
an encouraging word to a patient in the Continuing Care Unit.

may well be that it is self-replicating with its own DNA or
RNA, or it may be similar to a class of very small viruses
found in plants. There is not even the slightest knowledge
of how it functions.

THOSE WHO CARE
As her husband watched, a woman in her early sixties
shuffled aimlessly around the garden, talking incoherently
to herself. “It's so hard to believe," he said sadly. “She’s
a Phi Beta Kappa graduate with a Ph D. degree in chemis¬
try. Not only did she have a brilliant career, she also
managed our household — we used to give wonderful
dinner parties. Then she began losing hold. We noticed it
first when she became more and more illogical over even
the smallest matters,” he noted. “Then, gradually, she
became like a little child, unable to take care of herself.
Incontinence is a big problem.”
Like many families of Alzheimer’s patients and patients
with other dementias, this man is reluctant to put his wife
in a nursing home while he is able to care for her, but the
mental and physical burden of coping becomes over¬

Dr Elias Manuelidis

whelming. “Why me?” a daughter designated by her
family as caretaker of an elderly mother asked. “I love my
mother, but sometimes I get so frustrated and lonely taking
care of her that I come close to putting her in a home. Then

As Dr. Thomas noted, the work requires more time and
more money than most biomedical scientists believe they
have at their disposal these days. “If you were planning to
inject samples of a suspect virus into an array of experi¬
mental animals, the thought of an interval of a year-and-a
half or two years before you could reasonably expect even

I suffer terrible guilt for weeks. It doesn’t help. ”
A year ago, the Geriatric Assessment Clinic was
established in Yale-New Haven Hospital to offer support to
families such as these. The program was over-subscribed
almost from the day it started. It was developed by Dr.
Andrea Schaffner, assistant professor of medicine, who
believes that in geriatric medicine it is extremely important

a preliminary, tentative answer would stay your hand . . .
By the time you finished your first experiment you would
be near the end of your first grant, most likely with nothing
to show for it.”

to treat the whole person instead of merely symptoms. This
includes consideration of the patient's home environment.
"Taking care of an elderly parent can put severe stress
on even the best family relationships,” Dr. Schaffner

These obstacles have not discouraged Dr. Manuelidis,
who continues his research with enthusiasm and optimism.
“There are two reasons," he stated simply. “First and
foremost, there is the possibility for finding the cause and
maybe a way to treat the most terrible disease in humans.

explained. “Social contacts often are greatly curtailed
because families are embarrassed to entertain in their
homes when an elderly person with problems symptomatic
of dementia are around, and at the same time, they cannot

Then there is the tremendous challenge to unravel the
mystery of this incredible virus, which so far has eluded all
attempts by the most sophisticated scientific investigation. ’7

go out as often as they once did because they can't leave
the patient alone, and it's difficult and expensive to have
someone in to take care of them. These people feel isolated
and frustrated. They need almost as much help and support
5

as the patients themselves.”
The Clinic helps patients and their families deal with

our clinical judgement and form the basis for much of our

chronic

general

altered in the very old patient. The standard "work-up”

psycho-social problems that leave elderly patients unable
to care for themselves. A majority of the patients have

reserve ot the elderly person. A simple contrast gastro¬

disorders,

long-term

disabilities

and

Alzheimer’s disease. Thorough physical examination by
Dr. Schaffner, and if necessary, a psychiatric examination
by Dr. Frances Baker, assistant professor of psychiatry, is
given each patient. The staff, including Nan Scholhamer,
a social worker, then meet with the family to discuss
treatment of physical and/or mental problems and to assist
in making arrangements with various community-based

clinical strategies .

. . Clinical strategies must often be

must be altered in view of the often fragile physiologic
intestinal work-up can have significant side effects in the
elderly, in that the patient can become quite dehydrated
and debilitated from the preparation and completion of
these studies. Blind adherence to normal serum levels and
rote work-ups of abnormal
disastrous consequences.

findings can often

have

services to provide home care or arrange for

"There is much research to be done to answer many of
these strategy questions,” he continued. "What is the

institutional placement if it becomes obvious that the
family can no longer cope.

value versus the morbidity of various diagnostic evalua¬
tions in the elderly? Should the elderly patient with a

Records are kept of each patient and follow-up is a part
of the program. Through this, the staff is attempting to

myocardial infarction be moved from a skilled nursing
facility to an acute coronary care unit? What are the

determine which medical, mental, environmental and

‘normal’ serum drug levels in the elderly?”

social factors best predict a patient’s ability to remain in his
or her own home. In addition, they are undertaking studies

“Physicians are extremely important individuals in
their patient's long-term care decisions,” he told the

on

treating

audience. "Families and patients turn to physicians for

Alzheimer’s disease and other organic mental conditions.
Although the Clinic has been in operation for only a year, it

given. In addition, physicians must certify most types of

social

the

effectiveness

of

various

drugs

for

is becoming a model for multi-disciplinary care for the
elderly.
Today's medical students are mostly interested in the
more challenging aspects of the profession. In contrast to

advice regarding the site and type of care that will be
institutional and home care. This role must be recognized
and the young physician must be prepared to assess the
functional needs of the patient and to help organize the

specialties such as cardiology, immunology or cardiology,

provision of resources to fill these needs. The student must
be taught simple methods of assessing a patient’s ability to

geriatrics

Andrea

care for himself and to recognize that the ability to get out

Schaffner disagrees. "There is something quite challeng¬
ing and rewarding about trying to improve a person’s final

of bed and walk to the toilet may be much more important
to the elderly patient than the level of the serum calcium.''
In conclusion, he emphasized, "Substantial progress in

might

seem

pretty

low-key.

Dr.

years,” she said.
A graduate of Columbia University’s College of
Physicians and Surgeons, Dr. Schaffner came to YaleNew Haven Hospital as an intern in internal medicine. In

the care given to the dependent elderly patient requires a
strong geriatric force at each medical school and center.
Full-time faculty physicians must have as their major focus

1981, she was awarded a fellowship in geriatrics, working

research, service, and teaching in care of the elderly. The

with Dr. Leo M. Cooney, associate professor of medicine
and director of the Continuing Care Unit, and this year she

scholarly efforts of these physicians must be supported and

was appointed assistant professor of medicine, as well as
medical director of a local nursing home.
The Geriatric Assessment Clinic is an outgrowth of the
Continuing Care Unit, which is dedicated to returning to
their homes as soon as possible, elderly patients hospital¬
ized with acute problems such as amputation, cardiothoracic surgery, rheumatoid arthritis, and hip fracture.
Many of these patients would otherwise be at risk for
long-term placement in nursing homes. The 13-bed Unit,
where the average patient stay is about two weeks, is as
well, an educational resource for residents and medical,
nursing and physical therapy students.
Dr. Cooney and Dr. Schaffner are very interested in
improving education in the care of the elderly, and have
developed electives in geriatrics for house staff as well as
medical students. They treat the subject not as an extension
of internal medicine, but as a sub-specialty in itself.
Speaking at the 1982 Gerontological Society's annual
scientific meeting. Dr. Cooney said, "The clinical years in
medical school and throughout house staff training mold
6

their research efforts nurtured if geriatric medicine is to be
well taught to students in their clinical years.”

WOMEN IN MEDICINE

the centuries to an accurate understanding of female
anatomy.
Equally engrossing and well documented are early
perceptions of women's contributions to reproduction.
This section traces the evolution of Aristotelian and
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ing in their faithful reiterations in treatises of the 16th
century. It also contains drawings by Andreas Vesalius
and the 17th century physician, Jan Swammerdam, who
successfully challenged these early theories.
For women practicing and studying medicine, however,
the most important section of the small exhibition may
well be that part describing early women healers using
texts from Biblical acknowledgment of midwifery (The
Book of Exodus) to post-Renaissance obstetrical treatises
written by women. "Legends abound of famous female
healers, whose identities are not sufficiently supported by
historical evidence," according to the introductory narra¬
tive. "These legends are important not only for the
historical figures they name, but also for the attitudes
towards women healers they reveal."
Legend tells of Agnodice, a young Greek woman of the
4th century B .C., who, in order to study medicine, dressed
in male clothing. She attended the lectures of Herophilius
of Chalcedon (Alexandria), and learned to tend and teach
other women. Rival physicians, jealous of her skills,
dragged her before an Athenian council, where she
revealed her true identity. The wives of the councilmen
defended her good offices, according to the tale. The
councilmen heeded their appeals, and Agnodice was
allowed to continue her practice.
Most of the information about women healers in ancient

This illustration and the one on the following page are from Ein Schon Lustig
Trostbuchle by Jacob Reuff f 1554), courtesy Yale Medical Historical Library.

An Exhibition Portrays the History of Women in Medicine

times is based on treatises, according to Dr. Puklin, but
these represent only a small portion of women involved in
the healing arts. "They were a conglomerate of different
types and of different training,” she explained. "Those
writing texts presumably had monastic or university edu¬
cations. Beyond that, there were women who took their
place among those trained in the craft — just as the glass
blowers or the weavers did — and learned to do their
healing procedures through experience and apprenticeship.”
In Italy in the fifteenth century, for example, women

Women have practiced the healing arts since the earliest
times, according to a concise exhibition of “Images of
Women in Medicine" on view in the Cushing Rotunda of
the Yale Medical Library through December. Prepared by
Dr. Diane Puklin, a medical historian, with Susan Alon,
secretary to the Medical Historical Library, it traces the
perceptions of female anatomy and concepts of women's
contributions to reproduction as well as the role of women

practiced surgery. It was a craft passed from fathers to
their children. If he had no son, the father would teach his
daughter rather than a nephew or the son of a neighbor.
They obeyed very rigid codes of entry into practice. Other
women practiced midwifery or were herbalists — and
there were some empiric physicians as well.

as healers, from Biblical times through the 18th century —
a period not often dealt with in women's studies.
Unusual anatomical engravings made three dimensional
with layers of lifting paper shutters; an exquisite ivory
mannequin, probably 17th century German, with the
abdomen open revealing a finely carved fetus, and other
beautiful illustrations show the slow progression through

to these strictly female conditions had recognized profi¬
ciency. Called midwives or sage-femmes, they included
women of wealth and social standing as well as women
whose livelihood depended on their practice. They

Maternal care and delivery historically were tasks
performed by healing women. The women who attended

assisted at the birth of emperor and commoner alike and
often were
services.

honored

and

lavishly

awarded

for their
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In his tales of the Knights of the Round Table, the 15th
century author. Sir Thomas Malory describes such
women. Morgan Le Fay, Queen Isolde and Maiden
Lynette are but a few of the women who "serched his
wounds, and stynted his blood. ” In the exhibit, “La Beale
Isoud, who was a noble surgeon” illustrates women in the
duties of both leech and surgeon throughout Arthurian
legends.
Most healing then was done with herbs. Since women
tended the gardens it was natural that they also mixed the
herbs. "What we are learning through intensive studies of
herbal medicine today is that a number of these medicines
were exceptionally specific and could not have been
derived by happenstance,” Dr. Puklin stated. “They were
applied by women of the past who, avoiding philosophical
constraints of the time, used the same techniques of
observation and reason and drawing conclusions that
Hippocrates emphasized over and over again as the basis
for all medical remedies.”
“From this particular aspect of the exhibition we were
trying to imply the sense of importance of the woman as
healer in the societies from Biblical times until the 18th
century,” she continued. “Then in the late 18th and early
19th centuries, when medical knowledge rapidly increased
simultaneously with the rise of “capitalism” in the middle
classes, medicine became professionalized. In the past
people in medicine had struggled to become professional
without success. Therefore we see some of the polemics
against women in medicine beginning then. For instance,
in the late 18th century, male midwives challenged female
mid wives, and began to encroach on women's longrecognized field,” she explained. “Put the midwifery

One such woman was Justine Dittriehin Siegmundin

movement today in this perspective and you can see the
origins of some of the resistance to it. The diminution of
women’s influence in obstetrical care really began to

(1650- 1705), whose influence persisted well into the 18th
century. Recognizing her obstetric skill, Frederick III

gather momentum in early 19th century.”
Although “Images of Women in Medicine” is a small

appointed her court midwife to Brandenburg, and later in

exhibition constrained by a lack of space and some
materials, it is beautifully documented. One could wish for
more illustrations in each of the three categories covered,

1701, court midwife in Prussia. In 1690, she published Die
Chur-Brandenburgische Hoff-Wehe-Mutter, an authorita¬
tive text in the form of a dialogue.
Some midwives, especially those in Italy during the
16th and 17th centuries, studied at universities and pub¬
lished on gynecological matters. Isabella Contese, for
example, flourished as a student and midwife during the
Italian Renaissance. She wrote on female disorders and on
cosmetics, a relatively obscure area of healing arts dating
to antiquity, which was widely practiced by women of her
era. Most midwives, however, learned their trade at the
bedside and rendered prenatal counseling, delivery, and
infant care without recording for history their experiences.
The importance of the woman healer was predicated not
only on certain knowledge they possessed, but also
because of their proximity to the sick. Women were the
heads of the estates or manors, and therefore were respon¬
sible for taking care not only of their families, but also the
serfs and their families. It was a logical extension of their
nurturing role.
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but as it is, it evokes interest and curiosity about the
subject.
By Marjorie Noyes, based on an
interview with Diane Puklin, Ph.D.

Office for Women in Medicine

opportunity for women physicians of diverse backgrounds

Today, many women are pursuing careers once considered
for men only — law, religion, architecture, medicine — to
name a few. For some, entry into these male-dominated

Co-sponsored by the Connecticut branch of the American
Medical Women’s Association, the event was highly

bastions has been smooth, while other women have found

Baidack put a tremendous effort into the presentation of a
two-day conference on “The Crisis of Battering: Profes¬

and disciplines to meet with women medical students.

that old prejudices die hard.
About a third of the medical students at Yale are women,
and there are increasing numbers of women postdoctoral
fellows and faculty. More than a few have discovered that
being involved in medicine in a traditionally male institu¬
tion can be rough going.
In 1975, with support of Dean Robert Berliner and
Deputy Dean Arthur Ebbert, Jr., on recommendation of
the late Dr. Phyllis Bodel, the Office for Women in
Medicine was founded. It has come a long way in seven
years from the humble basement office with an indomi¬
table part-time student administrator, to its present com¬
fortably furnished quarters, with a staff of two dedicated,
extremely busy women. Kay D. Codish, director, and Ann

successful. A few months later, Ms. Codish and Ms.

sional Response.” Co-sponsored by the Victimology
Program of Yale-New Haven Hospital, it attracted a large
audience of health care professionals, educators and
service providers, including law enforcement officers.
Social isolation is one of the most pervasive problems of
women in medicine, according to Ms. Codish. This is
especially true in the case of postdoctoral students, who
often work odd hours in the laboratories and have little
opportunity to meet other students. An overstuffed brown
velvet couch, a caned rocking chair, lots of books and
magazines on

women’s concerns provide

a friendly

atmosphere in the office where women can meet and chat

Baidack, assistant to the director, produce an extraordi¬
nary number of programs and workshops, in addition to

— or just relax from the rigors of study and work. Potluck
suppers, especially the annual one held at the home of
Dean and Mrs. Berliner, are another popular means of

publishing a newsletter and offering support services to

bringing together women faculty and students.

women students and faculty.
One of the few organizations of its kind in the country,
the Office for Women in Medicine (OWM) is “committed
to advancing the professional standing and personal lives
of women in medicine and the medical sciences, helping
them counter the prejudices and discrimination, sex-role
stereotyping and compromise of personal life common to
women in twentieth century medicine,” according to a
brochure distributed by the Office. A part of the School of
Medicine administration, the OWM is concerned with
advocacy, program development, counseling, research

One of the more important aspects of OWM is providing
access to various support groups for women faculty and
students, spouses of interns and medical students, and
single mothers. It also offers an opportunity for discussing
personal and academic problems on an individual basis,
and can, on request, provide an annotated list of local
therapists and counselors.
As a part of the University’s equal

opportunity/

affirmative action program, the OWM collects statistics on
women and minority faculty members, housestaff and
postdoctoral trainees. This mechanism for complying with

and referral. The issues they are concerned with are
specific to women in medicine throughout the country' —
limitations in medical school admissions, discrimination
in hiring and promotion policies, lack of visible role

affirmative action guidelines, monitoring accountability
and achieving goals is being developed into a computer¬

models, salary inequities, and limited access to the tradi¬

same time, a log of sexist comments and incidents is
maintained by the office to record incidents of sexist
behavior and harrassment at the School of Medicine. The
OWM encourages women to report such incidents, to

tionally “male” specialties.
Combining an interest in medical science and a strong
commitment to women’s rights with her background in the
theater, Kay Codish orchestrates the many activities of
OWM in much the way a theater director would a stage
production. The approach is effective.
A lively speaker series brings notable women in medi¬
cine to the School for discussions of relevant issues. Last
year, for instance, the series included such topics as tenure
at Yale; dual career marriages; alpha-fetoprotein screen¬
ing; pro-choice abortion tactics; reproductive health
hazards for women; medical attitudes towards death and
dying; minority women in today's medical system; nurse/
doctor relationships; and substance abuse among medical
professionals. A number of lectures are offered on stress
management, and budgeting and financial management
for professional women.
Last year, the OWM sponsored a day-long workshop
“Women Meeting Women in Medicine,” offering an

ized system to store and evaluate on an ongoing basis
information regarding salary, rank and promotions. At the

discuss their complaints and to use grievance procedures to
file complaints when treated unfairly or treated in an
offensive manner.
Although some

of these

activities are

necessarily

defensive, OWM is concerned not only with fostering and
promoting activities, policies and strategies favorable to
women in medicine, but also with demonstrating the
enormous contribution women make and have always
made to the medical and scientific professions. To this end
it is planning to document the varied involvement of
women affiliated with Yale medicine and science from
1916, when women were first admitted to the School of
Medicine, to the present. There has yet to be a woman
chairman of a department or a woman dean, but Yale's
women medical graduates and faculty have made many
very significant contributions to the profession.
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The First Yale Women Medical Graduates
There were three women and thirty-two men in the Class
of 1920 — the first class after the Yale Corporation voted
in 1916 to accept women students in the School of Medi¬
cine.

They were Louise Whitman Famam, who had

received a Ph.D. degree in physiological chemistry from
Yale; Helen May Scoville, a graduate of Wellesley
College; and Lillian Lydia Nye, who had received B.A.

Agreement with Bristol-Myers for

and M.A. degrees from the University of Minnesota.

Development of Anticancer Drugs

Lillian Nye dropped out of the class to finish her medical
studies at Johns Hopkins University, but Helen Scoville
received her M.D. degree, cum laude, as did Louise
Famam, who was also awarded the Campbell Gold Medal,
given the student with the highest rank in exams upon
graduation.
Dr. Scoville, one of the first women other than secre¬
taries, librarians and nurses, to be hired by the School of
Medicine, became an instructor in pathology and bacteri¬
ology. In 1936, she left Yale to attend at the House of
Mercy Hospital in Pittsfield, Massachusetts.
After

graduating

from

Yale,

Dr.

Famam

studied

obstetrics at Johns Hopkins, following which she spent six
months as an intern in pediatrics at Bellevue Hospital in
New York. Then she was on her way to Changsha, China,
where she was one of the first doctors in the Yale-in-China
Association’s Yali Medical School. As a doctor in China
she was called on to do much more than her specialty of
pediatrics — and during the revolution she spent more time
treating war injuries than treating pediatric patients. In the
summer of 1930, when Mao's army stormed Changsha,
the hospital personnel fled. Dr. Famam was the last to
leave and the first to return. “I hated to go off and leave
a man with a bullet in his chest liable to have pneumonia,
with no doctor on board. So I stayed.” she wrote.
Dr. Famam was married to Hugh Brian Wilson, an
English businessman in
England,

1931, and in 1933 moved to

where she continued to practice medicine.

During World War II, she replaced home medical service
doctors who were called into war service, for which she
received commendation from the British government.
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Yale Enters A Cooperative Research

Bristol-Myers Company and Yale
University have entered into a $3 million
cooperative research agreement to
facilitate the production and availability
of new anticancer drugs.
The agreement brings the investiga¬
tive talents of Yale medical scientists,
who are recognized leaders in cancer
chemotherapy research, together with
the
research
and
developmental
resources of Bristol-Myers Company, a
major producer and distributor world¬
wide of anticancer agents. Through on¬
going technical and scientific interac¬
tion, they will seek to employ the
unique resources and skills of universityand industry-based approaches to
development and production of new
effective and safe drugs for the diagnosis
and treatment of neoplastic diseases.
President A. Bartlett Giamatti of Yale
stated that he was extremely pleased
with this major step forward in cooper¬
ative research. “The agreement with
Bristol-Myers is testament to the
opportunity for the University and
industry to collaborate in areas of
mutual research interest under condi¬
tions which don’t infringe our underly¬
ing principles of openness and free
dissemination of ideas,” he said. “It is
particularly rewarding to combine the
skills of Yale's scientists with those of
their industrial colleagues and to apply
these in true cooperative fashion to the
solution of major health problems such
as cancer. The results of such collabo¬
ration serve the interests of the Univer¬
sity, industry and of the public.”
Richard L. Gelb, Chairman of
Bristol-Myers Company, said, “We
are pleased to join in this collaboration
with Yale. We believe this program can
make an important contribution in the
development of significant advances in
cancer therapy.”
Yale is one of very few research insti¬
tutions in the world where scientists
involved in the development of a new
anticancer drug work together from the
first experiments at the laboratory
bench through to treating patients in the

clinic. They have played a leading role
in the development of several important
drugs, and in addition, they have been
conducting research to increase the
effectiveness and reduce the toxic side
effects of a number of drugs which have
been used with some success, by revis¬
ing the scheduling of their administra¬
tion, and by utilizing them in
combination.
Bristol-Myers Company will provide
support in the amount of $600,000 a
year for five years to the Yale School of
Medicine for research in oncology. The
Company has the option to license
cancer chemotherapy drugs discovered
by participating faculty during the
agreement period.
Unlike cardiovascular, antimicrobial,
and anti-inflammatory drugs, where
investment to produce them can be
readily recovered a few years after they
enter the market, the probability of
producing a major anticancer drug
capable of returning the exceedingly
large investment required to produce,
test, and market it, is very low. For this
reason, according to Dr. Alan C.
Sartorelli, chairman of the Department
of Pharmacology and head of the Sec¬
tion of Developmental Therapeutics of
the Comprehensive Cancer Center at
Yale, many drugs of possible use in the
treatment of cancer discovered in
university laboratories do not become
patented and developed, and remain
merely laboratory curiosities.
“Although universities with support
from government and private sources
have the intellectual capability and
resources to identify the new drugs with
the potential for treating cancer, the
resources of industry are required to
conduct toxicology tests for safety
essential for their production and
distribution throughout the world. This
collaborative venture could result in the
movement of more agents with unique
mechanisms of action to clinical trial
and eventually, to public use,’’ he said.
“It is with these goals in mind that Yale
University and Bristol-Myers Company
enter this collaborative scientific
program.”

Dr. Stolwijk, a Noted Environmental
Physiologist Appointed Chairman of
Epidemiology and Public Health
Dr. Jan A.J. Stolwijk, a leading author¬
ity on the effects of the environment on
human health, has been appointed
Susan Dwight Bliss Professor and
chairman of the Department of Epi¬
demiology and Public Health. A pro¬
fessor of epidemiology (environmental
health) and a faculty member of the
Institution of Social and Policy Studies
at Yale since 1975, Dr. Stolwijk is also
a fellow and associate director of the
John B. Pierce Foundation Laboratory
in New Haven.
Highly regarded as a teacher and
lecturer. Dr. Stolwijk is known through¬
out the world for his research on the
effects of climate on the human thermo¬
regulatory system, as well as for his
studies on health problems related to air
pollution. During the 1950’s and 60’s
he was involved in the development
and evaluation of life support systems
for the NASA space program.
His current research interests include
the public perception of technological
risk, as well as the development of a
scientific basis for victim compensa¬
tion. He is a member of the World
Health Organization Committee on the
Health Implications Related to Indoor
Air Quality, and of the Committee on
Indoor Air Pollutants, National Re¬
search Council of the National Acad¬
emy of Sciences.
The Department of Epidemiology
and Public Health is unique in that it is
also an accredited school of public
health, one of only twenty in the United
States. With almost 200 full- and parttime faculty and 250 enrolled degree
candidates, it is based both in the
School of Medicine and the Graduate
School. Many of its over 1200 alumni
have achieved wide recognition as
health administrators, researchers, and
policy makers in private and govern¬
ment health agencies. As chairman.
Dr. Stolwijk succeeds Dr. Robert W.
McCollum, who resigned last Decem¬
ber to become dean of the Dartmouth
Medical School.
Bom in Amsterdam, Netherlands,
Dr.Stolwijk attended Wageningen Uni¬
versity, Holland, where he received a
B.S. degree in 1948, an M.S. degree in
engineering with honors in 1951, and a
Ph.D. degree in 1955. Following grad¬
uation, he was appointed Senior Sci-

Dr. Stolwijk

entific Officer at Large with the Dutch
government. He came to the United
States in 1955 as Maria Moors Cabot
Research Fellow at Harvard Univer¬
sity, and in 1957, was appointed to the
research staff of the John B. Pierce
Foundation Laboratory, which is affil¬
iated with Yale University.
Dr. Stolwijk joined the Yale School
of Medicine faculty in 1962 as an
instructor in physiology, and was pro¬
moted to assistant professor in 1964. In
1968, he was appointed assistant pro¬
fessor of epidemiology (environmental
physiology), and the following year he
became an associate professor with a
joint appointment in the Institution for
Social and Policy Studies. He was
promoted to professor in 1975.
In addition to serving on the execu¬
tive board of the International Biometeorological Society. Dr. Stolwijk is a
member of a number of professional
societies including the American Phys¬
iological Society, Biophysical Society,
Aerospace Medical Society, American
Public Health Association and the
Society for Occupational and Environ¬
mental Health.

A New Chairman Appointed for the

Dr. Evans Appointed John Rodman

Department of Molecular Biophysics

Paul Professor of Epidemiology

and Biochemistry

Dr. Dieter G. Soli, a leading scientist
in the field of transfer ribonucleic acid,
has been appointed chairman of the
Department of Molecular Biophysics
and Biochemistry. Dr. Soil has been
professor in the department since 1976.
Born in Stuttgart, Germany, Dr.
Soil received a Diplom Chemiker in
1960 and a Ph.D. degree in chemistry,
summa cum laude in 1962, both from
Thechnische Hochschule in Stuttgart.
He came to the United States in 1962 as
a postdoctoral fellow at the University
of Wisconsin's Institute for Enzyme
Research, and from 1965 to 1967, he
was assistant professor there. He was
appointed
associate
professor of
molecular biophysics and biochemistry
at Yale University in 1967. He was
Visiting Professor of the Japan Society
for the Promotion of Science in 1972,
the same year he was awarded a
Guggenheim Fellowship.
The author of numerous scientific
papers, abstracts and reviews. Dr.
Soli has been executive editor of
Nucleic Acids Research since 1974,
and serves on the editorial boards of the
Journal of Bacteriology and the
Journal of Biological Chemistry as
well. He was co-chairman of the
Gordon
Research Conference on
Nucleic Acids in 1973; of the Banff
Conference on the Genetics and Bio¬
chemistry of Suppression in 1975; and
the Cold Spring Harbor Meeting on
Transfer RNA, 1978. He is a member
of the American Society of Biological
Chemists,
American
Chemical
Society, and the American Society for
Microbiology.
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Dr. Alfred S. Evans, a distinguished
scientist in the field of preventive med¬
icine, has been named John Rodman
Paul Professor of Epidemiology. Dr.
Evans has been professor of epidemi¬
ology and director of the Section of
International Epidemiology and the
WHO Serum Reference Bank at Yale
since 1966.
The professorship honors a worldrenowned member of the Yale faculty
from 1928 to 1961, who developed the
science of clinical epidemiology, and
whose research was instrumental in
determining the causes of rheumatic
fever, infectious hepatitis and infec¬
tious mononucleosis. Dr. Paul, who
died in 1971, is especially noted for his
studies on poliomyelitis, which were
significant contributions to the under¬
standing of the disease, and ultimately, to
the successful immunization programs.
Dr. Evans is a well-known authority
on infectious diseases and especially on
infectious hepatitis, mononucleosis
and diseases of the lower respiratory
tract. A graduate of the University of
Michigan, he received his M.D. degree
from the University of Buffalo, and his
M.P.H. degree from the University of
Michigan School of Public Health.
Following military service as a medical
officer with the U.S. Army in Japan,
Dr. Evans joined the School of Med¬
icine faculty in 1946 as instructor and
then assistant professor in the Section
of Preventive Medicine.
From 1950 to 1952, he was recalled
to active duty with the Army and served
as chief of the Hepatitis Research
Laboratory, 98th General Hospital, in
Munich, Germany. In 1952, he was
appointed associate professor of pre¬
ventive medicine and microbiology at
the University of Wisconsin School of
Medicine. He served as professor and
chairman of the Department of Preven¬
tive Medicine there and as director
of the Wisconsin State Laboratory of
Hygiene from 1959 to 1966, when he
returned to the Yale School of Med¬
icine. Dr. Evans is the author of numer¬
ous publications, including Viral Infec¬
tions of Humans, published by Plenum
Press, for which he received the
American Medical Writers Award for
the best book written for physicians in
1977. He was awarded the Thomas
Parran Lectureship and Medal by the
University of Pittsburgh in 1978. A

Dr. Evans

fellow and member of the Board of
Directors of the American College of
Epidemiology, he is a member of a
number of other professional societies
as well, including the American Asso¬
ciation of the History of Medicine;
American Epidemiological Society;
American Medical Writers Associa¬
tion; and the American Society for
Tropical Medicine. Dr. Evans has
served as a Consultant in Epidemiology
to the Surgeon General, U.S. Army,
and was president of the Society of
Medical Consultants to the Armed
Forces in 1980-81.

!

Dr Jekel

Dr. Kantor Named Paul B. Beeson

C.-E. A. Winslow Professor of

Professor of Medicine

Public Health Named

Dr. Fred S. Kantor has been appointed
Paul B.Beeson Professor of Medicine.
A professor of medicine since 1973, he
is well known for his research on the
immune responses in man.
The Paul B. Beeson Professorship
honors a former member of the Yale
medical faculty who served as chair¬
man of the Department of Internal
Medicine from 1952 to 1965. This out¬
standing medical scientist and distin¬
guished teacher is now retired and
living in Seattle. As a Helen Hay
Whitney Fellow at Yale, Dr. Kantor
studied under Dr. Beeson in 1960-61.
A graduate of Union College, Dr.
Kantor received his M.D. degree from
New York University School of Med¬
icine in 1956. The following year he
was an intern at Barnes Hospital in St.
Louis, Missouri, and from 1957 to
1959, he was research associate at the
National Institute of Allergy and Infec¬
tious Disease, National Institutes of
Health.
Dr. Kantor came to the Yale-New
Haven Medical Center in 1959 as
assistant resident in medicine, and in
1962 he was appointed to the faculty as
instructor in medicine. He was pro¬
moted to assistant professor the follow¬
ing year, and to associate professor in
1967.
In addition to his appointments at
Yale, Dr. Kantor has been honorary
research associate in the Department of
Zoology (Tumor Immunology) at Uni¬
versity College in London (1975-76),
and a visiting professor of medicine at
Pahlavi University, Shiraz, Iran, and at
Hebrew University, Hadassah Medical
Center, Jerusalem. He is a member of
the American Association of Immunol¬
ogists, American Board of Internal
Medicine, American Academy of
Allergy, American Society for Clinical
Investigation, and the Council on the
American Heart Association.

Dr. James F. Jekel, an expert in health
programs
evaluation,
has
been
appointed C.-E. A. Winslow Professor
of Public Health. He has been a pro¬
fessor in the Department of Epidemi¬
ology and Public Health since 1980.
The professorship was established in
1958 in memory of Charles-Edward
Amory Winslow, one of the nation’s
most prominent public health teachers
and leaders. Dr. Winslow organized
the Yale Department of Public Health
and from 1914 until 1945 served as its
first chairman. Many of the Depart¬
ment’s current programs reflect C.-E.
A. Winslow's interests, some of which
are only now emerging as nationwide
public health issues.
Dr. Jekel is an authority on programs
for pregnant adolescents. In 1975, he
was awarded the first annual research
award of the National Alliance Con¬
cerned with School Age Parents.
Dr. Jekel came to Yale in 1967 from
the Center for Disease Control, where
he had been a commissioned member
of the U.S. Public Health Service since
1962. A graduate of Weslyan Univer¬
sity, Middletown, Connecticut, where
he was elected to Phi Beta Kappa
Honor Society, he received his M.D.
degree from Washington University
School of Medicine in St. Louis, and an
M.P.H. degree from Yale University.
Dr. Jekel was an intern and an assistant
resident at Hartford Hospital.
He is a member of the study section
on social sciences and population of the
National Institutes of Health, and of the
maternal and child health section
council of the American Public Health
Association. In addition he is a fellow
of the American College of Preventive
Medicine and of the American Scien¬
tific Affiliation, as well as a member of
the Association of Teachers of Mater¬
nal and Child Health, of which he was
president from 1978 to 1980.
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Challenging Questions Addressed in
Symposium on Ethical Issues in
Health Care
In celebration of the dedication of its
new patient care facility, the YaleNew Haven Hospital presented a
symposium on “Ethical Issues in
Health Care.” Four distinguished
speakers and a panel probed some of
the most sensitive issues currently fac¬
ing the medical profession.
The speakers were: Paul B. Beeson,
M.D., former chairman of the Depart¬
ment of Internal Medicine at Yale, now
professor of medicine emeritus. Uni¬
versity of Washington; Lawrence G.
Crowley, M.D., vice-president for
medical affairs, Stanford University
Medical Center; Albert R. Jonsen,
Ph D., professor of ethics in medicine.
Institute for Health Policy Studies,
University of California at San
Francisco; and Joseph B. Warshaw,
M.D., former professor of pediatrics
and obstetrics and gynecology at the
School of Medicine and director of the
Newborn Special Care Unit, Yale-New
Haven Hospital.
Setting the tone of the symposium,
Dr. Jonsen cited three of the most
challenging health care issues: medical
research using human subjects, limited
access to lifesaving technologies, and
the appropriate use of life support. New
medical technologies raise highly tech¬
nical and legal questions, yet beyond
the jargon and legal arguing lie some of
the oldest questions of society — what
are the basic rights of the individual;
who shall receive preferred treatment;
and when does life lose its value?
“The message of bioethics consists
not in making definitions about resus¬
citation or informed consent, not in
issuing regulations about research,” he
stated. “It announces that the forms of
care provided to preserve and restore
human health must reflect the deepest
moral beliefs of our culture.”
Following Dr. Jonsen, Dr. Beeson
stressed that health care must be appro¬
priate for those being cared for, and
illustrated how right — and how wrong
- extraordinary measures can be in
prolonging the lives of the elderly.
He told of an elderly patient who had
suffered multiple serious injuries in an
automobile
accident.
Wheelchairbound and in great pain for months, the
man passed through so many medical
crises that his survival was termed a
14

“miracle.” On the way to see his
patient in the hospital. Dr. Beeson had
to drive by a very poor school with few
recreational facilities. “I must admit I
sometimes thought that the tremendous
sum spent on that man's care could
have been better spent on the school,”
he said. However, the man lived for
some years, enjoying life, pleased to be
with his family, and glad to have
received care.
On the other hand. Dr. Beeson spoke
of a friend, who was suffering with
cirrhosis and who did not have such
good fortune. No longer able to respond
to medication, he underwent emergency
surgery. “For the next five days until
he died, he hung on in the intensive care
unit. Because of all his tubes and lines,
he couldn't speak to his wife or touch
her. But he winked at her." Dr. Beeson
told the audience. “I kept going in and
out of there and I thought to myself —
what have we done to give this man
such a horrible way to die?”
Dr. Beeson then turned to the diffi¬
cult decisions created by the very high
cost of caring for the elderly, citing
passive mercy killing methods such as
cutting back on antibiotics, withhold¬
ing fluids, and issuing orders not to
resuscitate the patient. “We must never
lose sight of the risk that these practices
can put us on a slippery slope leading to
inhumane practices,” he cautioned.
Dr. Crowley told the audience while
the percentage of industry-supported
research in universities has generally
declined over the last 30 years, the new
field of genetic engineering has aroused
mutual interest between industry and
campuses as never before. The reasons:
genetic engineering possesses great
profit potential; most of the scientists
with expertise in the field are in the
universities, while industry has most of
the money.
“The problem is that industry and
universities work in different ways
towards different ends. Universities
seek to create and freely spread new
knowledge for human betterment. By
contrast, industrial concerns control
and withhold knowledge so that their
products command a commercial
edge,” he explained. Yet there is much
to be gained by cooperative research,
according to Dr. Crowley. “The key is
for universities to keep their basic
values foremost so as to protect their
essential value to society.”
Towards that goal, he suggested full
public disclosure, in advance of all

university/industry agreements; “no
strings attached” industrial investment
in university research; new patent and
licensing agreements to reward the ini¬
tiative of faculty members; and gen¬
erous faculty leaves of absence so that
professors can explore industrial jobs
without creating conflicts of interest.
Twenty years ago, as neonatology
began to emerge as a sophisticated
medical discipline, Yale-New Haven
Hospital established the first newborn
special care unit in the nation. Since
then, enormous progress has been
made in caring for infants at risk. For
example, when the Yale Newborn
Special Care Unit began less than half
of infants weighing two- to three-and-a
half pounds survived. Those who did
often suffered severe, permanent dam¬
age from the inexact therapy of the day.
Today, more than 90 percent of these
infants survive, most in remarkably
good health.
“Judging from these advances, we
have had great success,” said Dr.
Warshaw, who has been director of the
Unit for the last seven years. “How¬
ever, we now face major questions as
we search for an appropriate balance
between technology, humanity and
expectation.”
Beyond question, the staff of the
Newborn Special Care Unit can do
remarkable things on behalf of the
almost 1,200 sick infants seen there
each year and their families. What to
do, however, and whether to do it are
often difficult issues for families and
Unit staff to decide.
Recent negative publicity and result¬
ant investigations have focused public
debate and legislative pressure on
physicians. The cruel irony of the sit¬
uation is that care givers have been
criticized both for over-using and
hesitating to use life-supporting tech¬
nology. “There are no simple rules,”
Dr. Warshaw said. “Each case is dif¬
ferent. What is a good decision for one
family may be inappropriate for
another. We must listen to families as
well as to our own most informed med¬
ical judgements.
“Those of us who work in newborn
medicine are experts in understanding
medical processes,” he continued.
“We are experts in applying the very
technologies which have created many
of the ethical questions in newborn
medicine. Hopefully, we are sensitive,
compassionate, and will never lose our
capacity to empathize with those who

suffer. However, in areas of social
judgement and ethical concern, we are
no better or no worse than any indi¬
vidual in our population. We have no
purchase on the truth. We are conduits
for the ethical wisdom and current
values of our society. ’ ’

Hospital Dedicates its New Patient
Care Facility

It poured rain on every important occa¬
sion here this spring, and the dedication
ceremony on June 13 for Yale-New
Haven Hospital’s new patient care
facility was no exception. When it
became obvious that the relentless
downpour was not about to let up, the
gala affair planned for the Harkness
lawn was hurriedly moved indoors by a
troop of dedicated staff members. The
U.S. Coast Guard Band, stranded with
bus problems, was replaced at the last
minute by the gallant Pressenda String
Quartet; balloons meant to Boat aloft
under blue skies were secured to the
auditorium
bannisters,
and
most
impressive of all, the 700-pound
cornerstone was hauled from the tent to
the auditorium stage — all in time.
In his welcoming address to the large
audience, C. Newton Schenck, chairman
of the Board of Trustees of the Hospital,
praised his predecessor, Richard H.
Bowerman. “This extraordinary man
orchestrated for the Board the develop¬
ment of the new building, in its plan¬
ning, financing, and the crucial certifi¬
cate of need.”
The $73 million project, the result of
years of planning and three years of
construction, replaces outdated facili¬
ties of the New Haven Unit with inte¬
grated patient care facilities. The new
seven-story building which includes an
emergency room twice the size of the
one in the New Haven Unit, consoli¬
dates the departments of radiology and
pediatrics, the operating rooms, admit¬
ting and discharge offices, and two
cafeterias.
“In planning and financing the
building, we have had the opportunity
to bring together all segments of the
community to create something for the
benefit of all,” said Mr. Bowerman,
who observed that the Hospital had
always been “nourished by two
streams: University and Community
physicians.”
Following remarks by C. Thomas

Smith, president of the Hospital, and
Paul H. Johnson, chairman of the
Hospital Campaign, United States
Senator from Connecticut Christopher
J. Dodd, delivered the dedication
address. “This building is a good
example of what Americans can do
when the public and private sectors join
hands in a common cause,” he said.
“It’s clearly a tribute to the community
and I’m proud to represent such
people.”
The dedication ceremony was the
culmination of a weekend of activities
planned in celebration of the new
building, including a symposium on
ethical issues in medicine. On June 12,
nearly 500 employees, staff and friends
dined and danced to big band music at
the Dedication Dance, sponsored by
the
Community
Associates
of
Yale-New Haven Hospital.

ment of Epidemiology and Public
Health moved its graduation cere¬
monies across town to the Yale Reper¬
tory Theater. Eighty candidates received
M.P.H. degrees, and seven were
awarded
Ph.D.
degrees.
Denise
Heinemann received a Doctor of Public
Health degree. Their diplomas were
presented by Dr. Robert C. Wallis, pro¬
fessor of epidemiology (entomology),
following which Dr. Arthur J. Viseltear,
associate professor of the history of
medicine and public health presented
the annual E. Richard Weinerman
Fellowship to second year students
Cecilia Zapata and Gerald Tracy. The
Richard H. Schlesinger Fellowship
was awarded to Rory Cohen, and Terry
O’Connor received the Kay Howe
Scholarship.
The
commencement
address was delivered by Dr. Colin
White, Ira Vaughan Hiscock Professor
of Public Health and acting chairman of
the Department.

CONGRATULATIONS!
The Class of 1982

Physicians Associate Students

Medical Students
For the first time in many years, rain
fell on commencement day this May
24. Even though gloomy skies persisted
throughout the day, the scene around
Sterling Hall of Medicine was one of
pride and joy, as balloons Boated aloft
and cameras clicked everywhere.
Families and friends of the eightyeight recipients of the M.D. degree
gathered in the Harkness Auditorium
where they were welcomed by Dr.
Howard Levitin, dean of students.
Following the presentation of degrees
by Dean Berliner, Dr. Leon E.
Rosenberg, C.N.H. Long Professor of
Human
Genetics,
delivered
the
commencement address, appearing on
page 1 of this issue.
Five students received the joint
M.D./Ph.D.
degree;
Jeffrey
M.
Gimble; Kenneth M. Huttner; Ethan A.
Lemer; David B. Menkes, and Lewis
P. Rubin. Evangeline R.H. Franklin
received a joint M.D./M.P.H. degree.
Following the ceremony, a reception
was held in Edward S. Harkness Lounge
for the new graduates and their guests.

On the 16th of August, 18 students
were graduated from the Physicians
Associate Program. The speaker for
this 11th commencement was Dr.
Alfred N. Sadler, Jr., the Program’s
first director. Following his address,
Linford Stillson, a member of the
graduating class and president of the
Jack Cole Society, presented the
Didactic Instructor Award to Parker
Bailey, who has served as coordinator
and instructor in the animal surgery
course in the program since 1972; and
the Clinical Instruction Award to Dr.
Kathleen H. Lyons, who accepted the
award in behalf of Waterbury Hospital,
whose Department of Emergency
Medicine has been a training site for the
P.A. students since 1973. The Jack W.
Cole Society Award was presented to
Elaine E. Grant, executive director of
the Program. Following the conferring
of certificates by Dean Robert Berliner,
Dr. Howard Levitin, dean of students
and medical director of the Physicians
Associate
Program
closed
the
ceremony.

Epidemiology and Public Health
Students
With their building and grounds still in
disarray from construction, the Depart¬
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Yale Medical Faculty Give Virology

Promotions to Professor

Workshop in China
At the invitation of the Ministry of
Health of the People's Republic of
China, Dr. Gueh-Djen Hsiung, profes¬
sor of laboratory medicine, organized
and directed an advanced course in
virology in Wuhan, People's Republic
of China. The two-week course was
held in October at Hubei Medical Col¬
lege, which was co-sponsor of the
course with Hunan Medical College
(formerly
Yale-in-China
Medical
School), Yale-China Association and
the Yale School of Medicine.
Two-Hundred
English-speaking
Chinese scientists, selected by the
sponsors in China, participated in the
training workshop of lectures and
laboratory exercises prepared by Dr.
Hsiung and co-director of the course.
Dr. William C. Summers, professor of
therapeutic radiology, molecular bio¬
physics and biochemistry and human
genetics. Altogether, nine scientists
from institutions in the U.S. (including
four from Yale) and Canada took part in
the program, which resulted from a
visit to China in 1980 by the Medical
Committee of the Yale-China Associa¬
tion.
During the visit, faculty of the
School of Medicine observed medical
practice and biomedical research of
several of China's leading medical
centers. At the conclusion, they and
scientists from the host institutions
agreed to sponsor a training workshop
in medical and experimental virology
to provide Chinese scientists with prac¬
tical experience and the most recent
information on virological research.
Since virology has emerged as an
important clinical and research disci¬
pline only in the last twenty years,
during the cultural revolution in China,
scientists there have not had access to
recent developments in the field. The
intensive training workshop organized
by Drs. Hsiung and Summers will pro¬
vide new information and techniques in
virology to a nucleus of teachers and
research scientists, who in turn, will
provide expertise and leadership within
the medical institutions of China.
In addition to Dr. Hsiung and Dr.
Summers, Yale participants in the
course included Dr. Frank J. Bia,
assistant professor of internal medicine
and laboratory medicine, and Wilma P.
Summers, senior research associate in
therapeutic radiology.
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Digestive Diseases Division
Established

The following members of the medical
faculty were promoted to the rank of
professor effective July 1982: Philip
W. Askenase, M.D., professor of
medicine; Paul G. Barash. M.D.,
professor of anesthesiology; Paul D.
Doolan, M.D., clinical professor of
medicine; Maurice J. Mahoney, M.D.,
professor of human genetics, pediat¬
rics, and obstetrics and gynecology;
Paul L. McCarthy. M.D., professor of
pediatrics; Bruce M. McDonald, clin¬
ical professor of pediatrics; Sreedhar
Nair, M.D., clinical professor of medi¬
cine; James J. Nordlund, M.D.. pro¬
fessor of dermatology; Donald M.
Quinlan. Ph.D., professor of psychol¬
ogy in psychiatry; Clarence T. Sasaki.
M.D.. professor of surgery (otolaryn¬
gology); Norman J. Siegel, M.D..
professor of pediatrics; Howard W.
Smith, M.D., D.M.D., clinical pro¬
fessor of surgery (otolaryngology);
Yung H. Son, M.D., professor of
therapeutic radiology; Kay Tanaka,
M.D., professor of human genetics;
David C. Ward. Ph.D., professor of
human genetics; Fred S. Wright.
M.D., professor of medicine and
physiology; Barry F. Zaret. M.D..
professor of medicine.
In addition to the above promotions,
Mary G.M. Cumen. M.D., Dr. P.H..
was appointed clinical professor of
epidemiology and pediatrics as of July
1982. Dr. Cumen has been a member
of the faculty of the Columbia Univer¬
sity School of Public Health since
1973; at Yale she will serve as director
of the Connecticut Cancer Epidem¬
iology Unit and will be medical director
of the Connecticut Tumor Registry, a
unit of the State Health Department.

Joshua Schor Receives 1982
Marguerite Rush Lerner Award
In 1981 Dr. Aaron Femer and family
established the Marguerite Rush Femer
Award to be awarded each year to a
medical student who demonstrates
outstanding skill in writing and/or
performance in a non-scientific vein.
Fast year the award went to Peter Blier.
Feonard Saltz, and Henry Weiner for
their delightful skit in the Second Year
Show called Dr. Seuss. This year
Joshua Schor, class of 1984, was
awarded the prize for his poem titled
“The Proof of Rain.''

After 27 years as chief of the Gastro¬
enterology Section of the Department
of Internal Medicine, Dr. Howard M.
Spiro has chosen to set aside his
administrative duties and is taking a
well-deserved sabbatical leave. The
Gastroenterology Section and the Liver
Study Unit have now been combined
into a single Digestive Diseases Divi¬
sion with Dr. James L. Boyer as chief.
Given the distinguished history of both
components of the Division. Dr. Boyer
plans to have them maintain independ¬
ent academic identities. Combining the
sections, however, will permit a more
efficient use of resources and facilities
as well as a greater ease of developing
new programs.
Faculty Notes
Dr. I. George Miller, whose research
on Epstein Barr virus has attracted
international recognition, received the
1982 Squibb Award of the Infectious
Disease Society. The award, given
annually to an investigator 45 years old
or younger who has made outstanding
contributions to the field, was pre¬
sented to Dr. Miller by Dr. Dorothy
Horstmann. John Rodman Paul Pro¬
fessor Emeritus of Epidemiology and
Pediatrics. Dr. Miller was the first to
successfully transfect cultured cells
with complete EBV-DNA.
Most
recently he has been able to transfect
mouse cells with cloned fragments of
the EBV-genome, an approach which
has paved the way to mapping several
genome functions and opens up the
possibility for defining the molecular
mechanism of viral transformation and
oncogenesis. Dr. Miller is John F.
Enders Professor of Pediatric Infec¬
tious Disease and Epidemiology.
The College of Physicians and Sur¬
geons of Columbia University pre¬
sented the 1982 W. Alden Spencer
Award to Dr. Patricia GoldmanRakic. professor of neuroscience. The
award, given annually for outstanding
contributions to neuroscience, cites her
contributions to the understanding of
the morphological, biochemical and
functional organization of the primate
association cortex — that part of the
brain essential for memory and cogni¬
tion. Working with nonhuman pri¬
mates,
Dr.
Goldman-Rakic
has

pioneered in analyzing the develop¬
ment of the prefrontal cortex.
At its annual meeting in April, the
American Physiological Society pre¬
sented Dean Robert W. Berliner the
Ray G. Daggs Award. The honor is
presented annually in recognition of
distinguished service to the Society and
to the science of physiology.
Dr. Leon E. Rosenberg, C.N.H.
Long Professor and Chairman of the
Department of Human Genetics has
been elected to the Institute of Medi¬
cine. The recipient of numerous honors
for his contributions to research in
human genetics. Dr. Rosenberg is also
recognized as a distinguished clinician
and teacher. Election to the Institute of
Medicine is both an honor and a work¬
ing assignment. On appointment,
members make a commitment to
devote a significant amount of time to
serve on committees involved in a
broad range of health policy issues.
The 80th Christian A. Herter Lecture
was delivered by
Dr.
Charles
Radding in May at New York Univer¬
sity School of Medicine. Dr. Radding,
professor of human genetics and
molecular biophysics and biochem¬
istry, spoke on “The Recombinase
Activity of E.coli recA Protein:
Synapsis and Strand Transfer.”
The Federation of American Societies
for Experimental Biology and The
Burroughs Wellcome Fund awarded
Dr. Gerhard H. Giebisch a Wellcome
Visiting Professorship for the academic
year 1982/83. The visiting professor¬
ships are offered annually to stimulate
interest in the basic sciences and to
recognize eminent scientists in physiol¬
ogy, biological chemistry, pharmacol¬
ogy, pathology, nutrition and immu¬
nology. Dr. Giebisch, who is Sterling
Professor of Physiology, will deliver a
Burroughs Wellcome lecture as well as
participate in seminars and classroom
discussions with faculty and students at
the University of Alabama.
Nine members of the School of Med¬
icine faculty and research staff will
share a $175,000 award from the
Swebilius Trust Fund to support
research on the causes, therapy and
prevention of cancer. They are Drs.
Christopher C. Benz, assistant pro¬
fessor of medicine; Robert Gillies,
research associate in molecular bio¬

physics and biochemistry; Edward
Hawrot,
assistant
professor
of
pharmacology; Ann Korner, research
associate in dermatology; R. Michael
Liskay,
assistant
professor
of
therapeutic radiology; Mark Marsh,
research associate in cell biology; Ira
S. Mellman, assistant professor of cell
biology; Judith White, research
associate in cell biology, and Stephen
Zuckerman, research associate in
human genetics.
Dr. Joan A. Steitz was elected a fellow
of the American Academy of Arts and
Sciences at the Academy’s 202nd
meeting
held
in
Cambridge,
Massachusetts in May. Dr. Steitz who
is professor of molecular biophysics
and
biochemistry,
has
received
numerous awards and honors for her
research on RNA processing.
Dr. James F. Lecknian is one of two
scientists to receive fellowships estab¬
lished by The John Merck Fund to
encourage research related to certain
problems of children and to advance the
careers of promising young profes¬
sionals in the field of child psychiatry.
Dr. Leckman is assistant professor of
psychiatry and pediatrics. Child Study
Center, and associate director of the
Children’s Clinical Research Center.
His research is directed toward deter¬
mining the biological and environ¬
mental factors involved in the trans¬
mission and expression of major
developmental and psychiatric dis¬
orders in children and adults, as well as
the behavioral and developmental
correlates of brain metabolism.
Dr. Myron Genel has been awarded a
Robert Wood Johnson Health Policy
Fellowship for a year of study and
congressional work assignment in
Washington, D.C. during 1982-83.
The fellowships were established in
1974 by the Institute of Medicine with a
grant from the Robert Wood Johnson
Foundation. The program, conducted
in cooperation with the American
Political
Science
Association,
is
designed to provide a better under¬
standing of major issues in health
policy, and a knowledge of how federal
health programs are established. The
recipients, who are chosen on a
competitive basis, are outstanding mid¬
career
professionals
working
in
academic health settings. Dr. Genel,
who is professor of pediatrics and
program director of the Children's

Clinical Research Center, is the third
member of the medical school faculty
to be selected; in 1974, Dr. Arthur
Viseltear, associate professor of the
history of medicine and public health
was one of the inaugural Robert Wood
Johnson Health Policy Fellows; and in
1976 Samuel Korper, former assistant
dean for regional activities was selected
as a fellow.
At the annual meeting held in Montreal,
Quebec in November, Susan Addiss
was elected president of the American
Public Health Association. A lecturer
in the Department of Epidemiology and
Public Health, Ms. Addiss chief of the
Connecticut Bureau of Health Planning
and Resource Allocation, and is
responsible for conducting the state’s
health planning activities, including
implementing the state health plan.
It was a busy fall for Dr. William F.
Collins, Jr., who in September was
Norman M. Dott Memorial Lecturer at
the University of Edinburgh, Scotland,
where Dr. Dott was the first professor
of neurosurgery. In October, Dr.
Collins, who is Harvey and Kate
Cushing Professor of Surgery, was the
honored guest of the Japan Neuro¬
logical Society at their 41st annual
meeting in Tokyo, following which he
was visiting professor at the Hokkaido
University School of Medicine in
Sapporo, and at the Tohoku Medical
School in Sendai, Japan.
At the annual meeting of the New
England Surgical Society in October,
Dr. William W.L. Glenn was elected
president of the Society. Dr. Glenn,
who is Charles W. Ohse Professor of
Surgery, is well-known for his contri¬
butions to cardiothoracic surgery.
In September, Dr. Marvin Sears,
professor and chairman of the Depart¬
ment of Ophthalmology and Visual
Science, joined the ranks of Yale
School of Medicine faculty visitors to
China. He spent several weeks lectur¬
ing at the Peking Medical Association,
Shanghai Medical Association, the
Peking Capital Hospital of the Chinese
Academy of Medical Sciences, and the
Nanking Hospital. His lectures covered
new findings from automated peri¬
metry, medical therapy, and techniques
of surgical and laser treatment in
glaucoma, and the pitfalls of medical
and surgical treatment.
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I)r. Joseph Bertino, professor of
medicine and pharmacology, has been
named the first editor of the Journal of
Clinical Oncology, the official publica¬
tion of the American Society of Clinical
Oncology. Dr. John Marsh, professor
of medicine, is an associate editor of
the Journal.
The American Medical Writers Asso¬
ciation awarded an honorable mention
in the “Physicians Category" of the
1982 AMWA Medical Book Awards
competition to Endocrinology and
Metabolism. The book was co¬
authored by Dr. Philip Felig, professor
of
medicine,
and
Dr.
Arthur
Broadus, associate professor of med¬
icine, with Dr. John Baxter and Dr.
Lawrence Frohman.
The 1982 Seymour L. Lustman Prize
for research during the psychiatry
residency was presented to Dr. Alan
Breier. At the award presentation. Dr.
Breier delivered a lecture entitled
“Self-Control in Psychotic Disorders."

Books by Faculty
“The Biochemical Basis of Neuro¬
pharmacology," 4th edition. By Jack
R. Cooper, professor of pharmacology,
F. E. Bloom, and R.H. Roth, professor
of pharmacology and psychiatry.
Oxford University Press (Oxford,
England) 1982.
“Diagnostic Virology,” 3rd edition.
G. D. Hsiung, professor of laboratory
medicine,
in
collaboration
with
Caroline K.Y. Fong, senior research
associate in laboratory medicine. Yale
University Press (New Haven) 1982.
“Cancer Therapy.” By John C.
Marsh, professor of medicine, and
David S. Fischer, clinical professor of
medicine. G.K. Hall (Boston) 1982.
“Letters to a Young Doctor." By
Richard Selzer, assistant clinical
professor of surgery. Simon and
Schuster (New York) 1982.
“Total Child Care — a Contemporary,
Prepared Approach to Parenthood from
Birth to Age Five.” By Lorisa
DeLorenzo and Robert J. DeLorenzo,
associate professor of neurology.
Doubleday and Company (Garden
City, N.Y.) 1982.
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Ira Stovin Goldenberg, M.D.
Di. Ira S. Goldenberg, professor of
surgery, died suddenly on July 31,
1982 at the age of 57.
Dr. Goldenberg was born in Bridge¬
port, Connecticut. He graduated from
the University of Michigan in 1947 and
received his M.D. degree from Boston
University in 1951, where he was a
member of AOA Medical Honor
Society.
Dr. Goldenberg served his internship
and residency at Yale-New Haven Hos¬
pital and was a research fellow in the
Department of Surgery during 1952—
53. He was appointed a member of the
Yale faculty in 1957 and became pro¬
fessor of surgery in 1968. He was an
attending surgeon at Yale-New Haven
Hospital and a surgical consultant at the
West Haven Veterans Hospital and
other Connecticut hospitals.
A veteran of World War II. he was a
member of numerous professional
societies and organizations, including
the American College of Surgeons and
the American Association of Univer¬
sity Surgeons.
Dr. Goldenberg was a leader in the
field of breast surgery with a national
reputation in treatment of breast
cancer. He was a consultant to the
National Cancer Institute, serving on
the Breast Cancer Task Force. He was
one of the pioneering supporters of the
Hospice movement in this country,
helping to found Connecticut Hospice
and serving on its board of directors.
A resident of Orange, his widespread
interests included long term service to
that town as an influential member of
its Library Board and as its Police
Department surgeon. Dr. Goldenberg
was a noted antique collector and
authority, and had attained the pres¬
idency of the Connecticut Antique
Dealers Association for 1981-82.
Ira Goldenberg was a unique physi¬
cian and human being. His early
interest in breast cancer came at a time
when medical science had little to offer
in the way of cure or palliation for
unfortunate victims of advanced dis¬
ease. His compassion, empathy, and
skill enabled him to bring comfort to
thousands of women and endeared him
to them and their families. More than a
consultant, he was always available
when his patients needed him most. His
sudden, tragic death has left a void that
cannot be easily filled. S.S.M.

John Black Goetsch, M.D.
John Black Goetsch, assistant clinical
professor of surgery (urology), was
born in Oak Park, Illinois, on April 30,
1914. He died after a happy day of
salmon fishing on the Matapedia River
in New Brunswick, Canada, on August
8, 1982.
After attending public schools in
Oak Park, he earned his B. A. and M.D.
degrees at the University of Rochester.
He served as a house officer on the
surgical and urological services at the
Strong Memorial Hospital in Rochester
and took a year of training in surgical
pathology at the same institution. After
World War II service in the 40th Army
General Hospital in the European the¬
ater, he took his urological residency
under Dr. Clyde Deming at the YaleNew Haven Hospital. On completion
of that residency, he devoted two years
to research at the Yale School of
Medicine under the auspices of the Jane
Coffin Childs Fund and was awarded
membership in Sigma Xi. He was certi¬
fied by the American Board of Urology
in 1948.
Dr. Goetsch entered the private
practice of urology in New Haven in
1949 and was continuously actively
engaged in it until the time of his death.
His interest in research and pathology
never dwindled and resulted in the
publication of a number of papers both
in basic science and clinical expe¬
rience. He gave generously of his time
to the teaching of medical students and
house officers and was a faithful attend¬
ant at the Yale Urological tumor clinic
for many years. His patients became his
friends and were as devoted to him as
he was to them.
Those of us who linger briefly
behind will never forget his kind,
gentle nature and his warm, friendly
smile. We are all diminished by this
loss. R.R.B.

Elmer V. Newton
Elmer V. Newton, who had worked at
the School of Medicine for 26 years and
was well known to the students during
this period, died on June 5, 1982.
After having worked for many years
for the New Haven Railroad, Mr.
Newton was employed by Yale in 1956
as an assistant in research in the Depart-

ment of Anatomy. Generations of
students will remember him in the
anatomical laboratories. In 1971 he
became a technical specialist for the
Office of Student Affairs and as such
continued to be a well known figure and
friend to the medical students.
He is survived by his wife, Winifred
Goodrich Newton, and a brother,
Kenneth, both of Branford, Con¬
necticut.

Errata
Your editor was very much embar¬
rassed by the number of errors which
appeared in our last issue, spring/
summer 1982. As one keen alumnus
wrote: “Most times I accept what I read
in Yale Medicine as gospel truth. But
this time I think you guys goofed, as
noted on the enclosed pages. ’ ’
It may have been gremlins at work;
however, the editor has to accept the
blame. Our apologies to those who
were misrepresented or misquoted and
to our readers.
Corrections are noted below.
In the article on “Medical Illustration
. . .”, the caption for the drawing on
page 9 should have read: Illustration by
Patrick Lynch of a horizontal section of
a head looking up on the palate, molar
teeth, and the base of the skull. It was
drawn as a reference.
On page 17, two errors appear in the
item in the first column concerning the
visiting professorship honoring Dr.
Alfred Gilman. The textbook “Phar¬
macological Basis of Therapeutics” is
now in its 6th edition, not the 8th
edition. The first sentence of the fourth
paragraph should read: Before coming
to Yale, Dr. Gilman had been professor
and chairman of the Department of
Pharmacology at Albert Einstein Col¬
lege of Medicine since 1956. Our
apologies to Dr. Gilman.
A major omission marred the column
entitled, “Why a Gift to Endowment?”
by Drs. Gallagher and Kushlan in the
Alumni News section on page 21. Their
entire fourth paragraph and part of the
final sentence in the third paragraph
were left out in our production. There¬
fore, the column is being reprinted in its
entirety on this page.

Why a Gift to “Endowment”?
“. . . Kissing your hand may make you
feel very good but a diamond . . . lasts
forever.” So, too, does a gift to the
Yale Medical School Alumni Fund
Endowment. “Endowment” to many
of us spells permanence, “a gift in
perpetuity”, “a gift that keeps on giv¬
ing” — those are what a gift to
“Endowment” is all about.
It is the permanence of a gift to
Endowment that appeals to so many of
those whose circumstances permit
them to consider making a substantial
gift. Unlike the Parisian’s kiss, it is not
tor the moment. Year after year after
year the income it generates will help to
maintain the School’s quality.
The “giving” also has permanence.
Like “The Brook” of Alfred Lord
Tennyson, it will “go on forever”. The
total amount of a donor’s gift to
Endowment is credited in his or her
name and class in the year it is received
and its income will be similarly credited
each year thereafter. It is impossible to
know how much this way of recogniz¬
ing a donor’s gift to Endowment may
influence the donor’s decision to make
a contribution. But is it not true that
there is more than a little of “. . . this
pleasing hope, this fond desire, this
longing after immortality” deep in
many of us?
To consider permanence a major
reason for a decision to make a gift to
Endowment would seem to be a
justifiable conjecture, but there are
usually — probably always — other
telling reasons. For example, the fact
that the allocation of the income from
the gift will be reconsidered annually
appeals to many donors. Each year the
Dean and his advisors assign the
income from
the Alumni
Fund
Endowment to that area they believe
deserves the highest priority. In recent
years, because of the rapid, extensive
rise in tuition (it will be $8,750 next
year!) it has gone into scholarship aid.
Other donors like the variety of ways
a major gift can be made to Endowment.
For one, a Life Income gift best fits his
or her circumstances; for another a
Deferred Annuity gift, a Bequest, a
Capital gift or a gift of a Life Insurance
policy whose protection is no longer
required will
be appealing and
appropriate.
The fact that the gift’s capital is
managed so as to compensate for
attrition by inflation must impress

every prospective donor; no one likes
the thought that a gift’s real value will
gradually (these days rapidly) diminish.
To counteract this the Fund adds a
fraction of each year’s income to the
capital amount of the original gift.
These brief speculations of why
alumnae and alumni choose to make
gifts to Endowment suggest another
fundamental question: why does a
graduate desire to make a substantial
gift? Like many basic ones — there is
no single, definitive answer.
You, no doubt, have thought of more
than one reason. There are many:
“divers dive for diverse reasons” —
and so do people who give. Some of the
reasons are homely, familiar; others,
equally valid, may be obscure. It’s a
wise donor who knows his own motives.
Warm feelings, fostered by happy
memories of his or her own School
experiences, or of one or more teacher’s
encouragement, inspiration or friendli¬
ness, must be high on everyone’s list of
reasons. An uncomplicated, simple
feeling of obligation to repay the
School for at least the difference
between the tuition paid and the amount
his or her education cost the School is
another. Or a mix of empathy with
succeeding generations of students and
the memory of one’s own struggle may
serve to breed a desire to make these
younger people’s journey as beneficial
as — and less grueling than — the
donor’s.
Then there are the complex, more
intimate reasons: the need further to
feed a still hungry ego, or to bolster a
still less than solid identity. Not all the
processes of adolescence reach their
destinations before the thirties!
And, often intertwined with one or
more of those, is a reason that might
better have been mentioned first; the
fact that many donors previously had
learned that giving is a rewarding
experience, that it is “. . . more blessed
to give than to receive”, and frequently
more satisfying.
Ros Gallagher, Chairman
Sam Kushlan, Co-Chairman
Yale Medical School
Bequest and Endowment Program
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alumni
news
The Alumni in Medicine Column
Notes from the President
Nicholas P.R. Spinelli, M.D.
A strange and unprecedented monsoon
drenched the festivities at the Yale
Medical Alumni Day this past June 5th.
Fourteen inches of rain, a record, fell
on reunion Saturday. This did not
discourage a banner number of attend¬
ees from assembling to register in the
Cedar Street rotunda that morning.
With the muffled hum of the downpour
as background, the dripping forms of
the drenched arrivals, umbrellas use¬
less, entered the loud and animated
murmur of a happy, warm crowd. A
tum-away audience heard an upbeat
address by our dynamic University
President
Giamatti
on
Saturday
morning.
The adverse performance of the
elements seemed to kindle a particular
and undeniable enthusiasm for all
components of the day's program
(dampened attractions of the Yale golf
course or the trip to the British Museum
undoubtedly contributed.) The unani¬
mous consensus was that this had been one
of the finest reunions within memory.
Everyone seemed to get to know and
converse with the spirited and spir¬
itually youthful members of the 50th
reunion class at the several common
social events. It was especially pleasing
to see this group communicating the
fascinating history and details of their
distinguished medical careers of a half
century with a group of young Yale
medical students. Many among the
50th reunion group enjoyed this dia¬
logue, (i.e.
Farr. Clarke, Lam,
Wegman, Humphreys et al). Less vis¬
ible because they were cloistered in
their own special 25th reunion year
program was the group led by Jack
Levin and Gil Hogan, '57. They felt
that every quarter century reunion class
should do a similar type of program.
The 10th year class, '72, under the
energetic direction of Harry Malech
assembled an enthusiastic group of
returners. These “college kids of the
late sixties" displayed no visible scars
of their supposedly stressful academic
times.
The voices of the alumni body this
past June could be heard with a seeming
common enthusiasm: “more pro¬
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grammed. structured reunions . . .”
Levin, '57; “more attention to senior
class reunion entertainment . . . ”
Ogilvie '34/Pickett '44; “how can we
get to know Yale medical alumni in the
real world?" Gwin '84/Fish '85; “are
there ways the many Yale Med/EPH
grads in Washington. D. C. area could
be gotten together?’’ Muriel Wolf '59.
In these times when a process of
societal alienation is described by the
sociologists, perhaps we are returning
to the traditional doorways of commu¬
nication which school reunions pro¬
vide. Reunion year 1982 was. in an
interesting and declarative sense, a
communication, reconnection, com¬
munion event if the feedback can be
interpreted. Perhaps it wasn't the rain
alone that nurtured the roots of the
group's return to its past. Achieving the
social intimacy among generations
which we realized during this past
reunion is always subconsciously a
sought after goal. The challenge in
future programming will be to structure
events attractive enough to lure us to
participate, in the absence of rain. In
any event, the purpose of this reminis¬
cence is to convey the consequent stir¬
rings at alumni headquarters this
summer and to report:
Len Kemler, '42, volunteered to be
chairman of the Program Committee
again, for 1983, and assembled a core
group this summer to begin planning.
Jack Ogilvie and Larry Pickett co-chair
a committee to plan a special program
of entertainment and activities for the
50th reunion group in 1983.
Plans are underway for publication
of a Yale Medical Alumni Directory. In
responding to requests for information
for this endeavor, we hope you all will
participate enthusiastically in an effort
which may provide you with useful
information. Whether there are alumni
who would be interested in a preceptor
role for the rare Yale student interested
in a tutorial experience, in the New
Haven or Connecticut area or in distant
hometown cities (“an orthopod in
Chicago? ...
a cardiologist
in
Denver?’’), is a question which a direc¬
tory would help answer. With such a
resource the possibilities for those so
inclined to achieve regional linkages
within the Yale context are clear.
The alumni/ae organization — a
many-headed organism — can demon¬
strate dynamism, like any organism.
We hope that this year's energy endures
and flourishes and that next year’s

reunion will bring even more pleasure
to returning alumni/ae than did this
year’s. It was in every way a model
experience worth repetition.

Alumni Weekend
Soaked but Successful
From the middle of May through the
first two weeks of June, New Haven
experienced an uninterrupted series of
rainy weekends; however, the worst by
far, was the torrential downpour on
Saturday of the Medical Alumni
Weekend. Heavy rains which began in
the early morning hours continued
throughout the day. By mid-afternoon,
streets in West Haven. Hamden, and
other neighboring towns were flooded,
and many major highways were
impassable. It was one of the worst
rainstorms to visit the area in many
years.
In spite of the weather, the Medical
Alumni Weekend was very successful,
and the attendance set a new record.
Although the official registration was
336. it is estimated that about 400
attended the events on Friday and
Saturday. In addition, some of the fiveyear reunion class members who were
unable to attend the events at the School
were present at the class dinners on
Saturday evening.
An innovation this year was the
Dean's reception on Friday afternoon.
Held in the Beaumont Room, it
provided a pleasant setting for friends
and former classmates to meet, and the
presence of several faculty and some
medical students enabled returning
alumni to hear about current events at
the School. It was apparent that many
of the alumni present at the reception
were especially pleased to have an
opportunity to chat with some of the
medical students.
The alumni were honored to hear
President Giamatti speak on “Yale
Today.’’ His talk given in the Histor¬
ical Library on Saturday morning drew
an extremely large crowd; it was stand¬
ing room only, and several people were
barely able to squeeze into the back of
the room. The seminars which fol¬
lowed on Saturday also attracted con¬
siderable interest.
As always, the buffet luncheon at

Edward S. Harkness Hall was a pieasant
occasion and attracted a large turnout.
Many who were present at the Medical
Alumni Weekend commented: "It was
the best yet!”

Association of Yale Alumni in
Medicine
Annual Business Meeting on
June 5, 1982
The meeting held in Mary S. Harkness
Auditorium was chaired by Dr. Nicholas
Spinelli, president. Returning alumni
were welcomed by Dean Berliner, and
special greetings were extended to the
reunion classes. Members of the class
of 1932 celebrating their 50th reunion
were introduced by Dr. Spinelli. He
also introduced those present who had
graduated prior to 1932: Helen Langner
(’22), Myron Sailick (’24), Max Alpert
(’28), Russell Scobie (’29), James Hart
(’30), and Paul Lavietes (’30).
On recommendation of the Nomi¬
nating Committee, the following were
elected to serve on the Association’s
Executive Committee, each for a term
of two years: Gilbert Hogan (’57), R.
Leonard Kemler (’43), Richard Norton
('60 HS), O’Dell Owens (’76),
Rebecca Solomon (’39).
Alumni elected to serve as represent¬
atives to the Association of Yale
Alumni (AYA) were: A. Frederick
North (’56), Daniel Passeri (’75),
Muriel Wolf (’59).
Following the elections. Dr. Spinelli
congratulated those newly elected and
expressed appreciation to the two out¬
going members of the Executive
Committee, Sarah Auchincloss (’76)
and William Waskowitz (’57), both
having loyally served for two-year
terms. He also expressed appreciation
to those who had completed terms as
medical and public health representa¬
tives to the AYA, Victor Crown (MPH
’69) and Harris Pastides (Ph.D. ’80).
The next item of business was the
report of the chairman of the Medical
School Alumni Fund, Dr. Lowell
Goodman. He noted that the total raised
by the 1981 -82 campaign was expected
to exceed $225,000 and would establish
a new record in annual giving. The
important influence of Dr. Leona
Baumgartner's challenge gift of match¬
ing funds was noted. Following Dr.

Goodman’s
report,
the
following
motion from the audience was voted
unanimously: "In recognition of her
extreme generosity, the Association of
Yale Alumni in Medicine, at their
Annual Meeting, express, record and
communicate their sincere appreciation
to Leona Baumgartner."
Mrs. Kathleen Howe reported on the
Public Health Alumni Fund, which also
established a new record in the total
amount of annual gifts. Mrs. Howe said
that this year all Public Health Alumni
contributions will be used to establish
the Robert W. McCollum Fund for
Student Aid, to honor the former
chairman of Epidemiology and Public
Health.
There being no other business. Dr.
Spinelli adjourned the meeting after
announcing that the dates of the 1983
Alumni Weekend would be June 3 and 4.

REUNIONS
1932 —

Fiftieth

By
Clement Clarke and Myron Wegman
The 50th reunion of Yale Med '32 was
marred by what is said to have been the
worst rainstorm in the history of New
Haven, with resulting serious floods.
Cushing, coming up from New York
was almost three hours getting from
Bridgeport to New Haven and to the
Graduates Club. Wehger, coming
from Bridgeport had to go by a very
roundabout route taking an hour longer
than usual. Clarke, who had organized
the dinner, never made it all because his
car got into the water on the way in. He
and his wife had to be rescued and spent
most of the night in Peppino’s Clam
Bar before being taken home about five
in the morning by a high-rise Coast
Guard truck equipped with inflatable
lifeboat and outboard just in case. After
the dinner Wegman took the watery
Whalley Avenue route to Southbury,
swamped his rental car, waded to the
rescue car of a female police officer and
spent the night in the National Guard
Armory on Goffe Street.
The warmth of the meeting and the
fellowship among the eight persons,
four wives and one son who did get to
the dinner, made up to some extent for
the difficulties. Those who attended
were: Bob and Robin Cushing, Frank

and Shirley Carroll, Joe and Monica
Donnelly,
Lee
Farr,
Storer
Humphries, Connie Lam, Dutch
Wehger and his son, Roland, and
Myron Wegman.

1937 —

Forty-fifth

By Wilbur Johnston
The class of 1937 did not have a formal
reunion this year. Two letters were sent
out by Wilbur Johnston to have a gettogether, but there was no positive
response from our members.
Several messages and phone calls
were received. Dennie Pratt called
from Mt. Pleasant, South Carolina to
report all was well. Also heard from
were Al Spicer from Weekapaug,
Rhode Island; Crosby Greene, from
Baltimore,
Maryland;
Morgan
Sargent, Quincy, Massachusetts; and
Lucille Wiepert of Avon, Connecticut.
All expressed a desire to wait for the
tiltieth and hoped tor fewer weddings
and other competitive reunions.
Of course the ten inches of rain on
Saturday, June 5th, established a record
and was not helpful for those alumni
attending the several arranged functions.

1942 Med.
No report received.

1947

— Thirty-fifth

By Philip Phi I bin
Fifteen members of the class of 1947,
about one-fourth, made it to the 35th
for a most pleasant reunion.
Despite record rains, there was little
that dampened the pleasure of seeing
familiar faces after so many years and
hearing brief sketches of their activities.
There were many laughs, some poign¬
ant memories, all enjoyable. There was
correspondence from Barnes and
Bowers which added to the evening.
Blansfleld,
Cannon,
Chase,
Colwell, Collins, Breg, Epstein,
Friedlander,
Kerin,
Mache,
Maniatis,
McClelland,
Newton,
Tamm, and myself made it to our
reunion headquarters at the New Haven
Medical Society Building despite the
downpour, where we had drinks and a
delightful dinner. This was the climax

to a very busy and educational day at
the school and was arranged with due
appreciation by Drs. Maniatis and
Newton.
The only disappointment was that of
noting the absence of many of the class,
all just a few hours from New Haven,
particularly after seeing the large
number traveling many miles to make
it.
Let’s do it better in 1987, our 40th.

George Barnes, Jr., in honor of his
special contributions to the medical
profession, selected for fellowship in
the American College of Radiology,
received his award at its annual meeting
in September. Dr. Barnes resides in
Gig Harbor, Washington and is affili¬
ated with St. Joseph and Tacoma
General Hospitals in Tacoma.

1952 — Thirtieth
By Harvey Young
Sterling Characters Have Great 30th!
With another issue of the class news¬
letter and photographs of reunions past,
six members of the class of ’52 and
their guests enjoyed a fine evening of
reminiscing and dinner at the Graduate
Club on June 5th.
Mo Bogdonoff provided a most
entertaining and truly enjoyable review
of thirty years and a peek into the
future. Ray Duff, although unable to
attend, was present in that he arranged
the evening’s location and the excellent
meal.
Those attending the reunion were:
Mo Bogdonoff, Bob and Maggie
Gerety, Art and Katie Hustead, Bill
Klatchko, Don and Judy Schultz,
Hilda and Harvey Young.
Several were unable to attend
because of conflicts with graduations of
their offspring, and Jose Patino wrote
that he was traveling and unable to put
New Haven on his itinerary.

1957 — Twenty-Fifth
By Jack Levin
Undaunted by the seven inches of rain
which fell on New Haven on the
Saturday of Reunion Weekend, 34
members of our class (most of them
accompanied by their wives) celebrated
our 25th Reunion. Amazingly, the
n

same number of our class (43%)
attended the 20th Reunion. Those who
travelled
the
farthest
were
Al
Chun-Hoon (from Honolulu), Jack
Levin (from San Francisco), and Dave
Martin (from Wabasha, Minnesota).
Following the program presented by
the School of Medicine on Saturday
morning and lunch, 1957 Medicine
held a Non-Scientific Mini-Symposium.
The speakers and topics were: Cliff
Reifler (Going to College and Letting
Go: Problems of Transition); Stan
Kilty (From Private Practice to
Organized Health Service Delivery);
Howie Minners (Man in Space); and
Tom
Danaher
(Experiences
in
Afghanistan). Then it was through the
storm and down flooded roads to the
shore and the Pine Orchard home of the
family of Gil and Carol Hogan (This
was not the first time that Carol’s
mother, Mrs. Donovan, had offered the
hospitality of her home to members of
our class). The unending rain did not
prevent us from enjoying cocktails,
dinner, and much good conversation.
Fortunately, the weather did not deter
members of the Connecticut contingent
from arriving as the evening progressed.
Some of our Connecticut classmates
stopped the dinner party from turning
into a pajama party by guiding car
caravans out of Pine Orchard onto
relatively clear roads.
Members of the class who attended
the reunion were: Vince and Doria
Andriole, Cal and Phyllis Bigler,
Jack and Barbara Blechner, Harry
and Joann Briggs, Jack and Ann
Carey, AI and Myrna Chun-Hoon,
Lou and Matty Cooper, Tom and
Nancy Danaher, Joe Demis, Jim and
Colleen Dorr, Ed Eyerman, Hal and
Jo Fallon, Bob Fishbein, Ron and
Estelle Fishbein, Tony and Mary
Fons, Elizabeth and Ben Forsyth,
Joyce and Bill Gryboski, Gil and
Carol Hogan, Stan and Carol Kilty,
Bill and Priscilla Kissick, Willard and
Bea Krehl, Ed and Naomi Levin, Jack
Levin, David Martin, Howie and
Gretchen Minners, Hugh Moffet,
Herb and Ann Newman, Joe and
Nancy Pagano, Ray Phillips, Cliff
and Barbara Reifler, Don and Amy
Stahl, Arthur and Sheila Taub, and
Bill and Barbara Waskowitz. Joe
Amenta was suitably represented by
his wife, Madilon.
The reunion was organized by Jack
Levin, Gil and Carol Hogan, Ron
Fishbein, Howie Minners, and Bill

Waskowitz. Particular thanks go to Gil
and Carol for hosting the class dinner
and to Howie for the enormous effort
required for the preparation of the
superb collection of biographic infor¬
mation. Bob Fishbein enjoyed himself
sufficiently to be inspired to compose
“The Anatomy of Alumni Day.”
Finally and importantly, due in large
part to the efforts of our recent Class
Agent, Bill Waskowitz, 78% of our
class have contributed over $9,000 to
the Medical School Alumni Fund during
our 25th reunion year. This is the
highest level of participation and the
greatest amount of money donated in
the history of our class. I think we
should attempt to achieve 100% partici¬
pation on the occasion of our 30th
reunion.

Editor’s note:
The following by Robert Fishbein is
being included at his special request. In
a recent letter he noted that this “is not
a poem, but a rambling essay" and
explained its origin as follows: “The
idea was conceived as we all sat in the
Anatomy Lecture Room after class¬
mates Howie Minners, Cliff Reifler,
Stan Kilty, and Tom Danaher had
presented interesting experiences in
their quartered century since we were
ordained medical ministers. Gil Hogan
proceeded to explain . . . with chalk
drawn map . . . directions to the
evening dinner at Mrs. Donovan's
house
. . and his rapid delivery (as
everybody was taking notes) took me
back — in a flash — to the labyrinth of
anatomical quick sand when it was only
the reassurance of Drs. Forbes, Crelin,
and Gardner that I would survive in that
jungle of knowledge . . . .”

1962 — Twentieth

The Anatomy of Alumni Day
“A Prosector's Prose . . . ForThe Archives Of Posterity"
It Was The Day Of Assault As We All
Aluminumized To Recall And Recollect
From The Point Of Our M . Deed . .
A
Quarter Of A Century Ago ....
With Casted Characters And Characteristics
We Gathered . . . Having Been Scattered Hither
And Yonder . . . The Magnet Of Tradition
Brought From As West As Hawaii, As South
As Carolina, As North As Vermont, And
Ironed The Filings In Between. Haven We
Came. So Did The Rain . . . .
Gil, Not To Be Confused With The Breathing
Apparatus Of Fish, Helped Us Snorkel To The
Donovan. . . Under Trestles And Over Puddles . . .
Hydrofoil Style. We Were Hogan's Heroes,
Sandwiched Between The Rain Drops.
The Lord Had Taken An Overdose Of Diuretics.
Clouds Were Emptying Their Bladders. Was
This A Eulogy To Urology? Did The
Almighty Need A New Plumber? Heaven Only
Knows ....
The Road Map From Cedar Street Took Me
Back To The Labyrinth Of The Brachial Plexus . . .
With All Its Turns And Twists . . . As Gil Said
“Cervical One Across The Oak Street Connector
From Behind C2 Getting On To The Ulnar
Branch Going Distal To The Dorsum Of The
Quinnipiac Bridge . . . Take The Left Fork
In The Artery Under The Railroad Trestle
Down Frontage Supine . . . This Is Sort Of Like
An Elbow Joint. Past This Antecubital Fossa
Follow The Flexor Muscles Along The Brachial
Vein. . . This Route Is Won! Now Over The
Branford Hill And Under The Carpal Tunnel . . .
The Right Fork Is Meta To The Carpal And
146 Degrees In Flexion To The Position Of
Function. Get A Good Grip On The Steering
Wheel And Keep Making Right Turns On
Those Radial Tires Till You See An Arm . . . Or . . . Ry
Of Pines In An Orchard. At The Intersection
Of The Recurrent Branch Of The Radial Nerve
And The Thenar Eminence Is Lake Place. This
Arbitrary Tributary Runs Into The Sesamoid
Known As Bony Island View Avenue.
The Reunion Is At The Third Digit Of
The Palm. That Is The Donovan."
“Good Turtle-ing,” Said Gil Taking A Deep Breath
Before Submerging.
We Broke Ranks, Embarked, Drived, Derived,
And Arrived. We Had Swum Under The
Flood.

By Michael Alderman
The class of 1962, at graduation some
75 strong, met in 20th reunion this past
June. Consistent with the high spirit,
the sense of camaraderie and the strong
commitment to the Yale Medical
School that has always characterized
this group, attendance was high.
Indeed, at the climactic weekend event
— dinner at Mory’s on Saturday night
— a record 21 class members were on
hand. They came from literally all over
the country, with Paul Ackerman
from Southern California taking the
distance traveled award. Bill Miller
from Savannah, Georgia was not too
far behind. Mickey Alderman, Ollie
Dann, Dick Collins, Arnie Eisenfeld,
Bruce Elfenbein, Joe Ferrone, John
German,
John
Godley,
John
Hageman, Frank Hartman, Gary
Jacobson, Dave Knoop, Carter
Marshall, Malcolm Martin, Stan
Matyszewski, Dave McConnell, Dick
Pschirrer, Dave Seil, and Jim
Spencer completed the group. The
actual number of celebrants was
swelled to 34 by the presence of 12
spouses and one McConnell son. Word
was also received from Walt Karney
from the Walter Reed Medical Center
in Bethesda where he is Chief of
Nephrology.
Following an extended cocktail
hour, and satisfying dinner, some
semi-serious time was devoted to
recounting recent past and present
activities, as well as conjectures upon
the future and observations about
medicine and life in general. Many
seem to have followed a sometimes
unexpected, but nevertheless interesting
and exciting path so far. Perhaps not
unexpectedly, the practitioners (a
majority) view those in full time situa¬
tions with some envy — and vice
versa. There was little apparent desire,
however, on the part of either group to
switch. Before venturing out onto New
Haven streets, awash after torrential
rains, all agreed it had been a memorable
evening, thanks to arrangements by the
Pschirrers, that should be repeated — if
possible before the 25th and with even a
larger turnout.

This Was A Breeze, Compared To National Boards.
From The Reign
Of Aqua Haven
On
YALE ALUMNI DAY

Manuel Lipson, executive director of
Massachusetts Rehabilitation Hospital
in Boston and assistant clinical profes¬
sor of medicine at Harvard, has been
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appointed an institutional member of
the
Interhospital
Coordinating
Committee on Rehabilitation at Harvard
Medical School. The Committee,
charged with formulating institutional
arrangements for support of programs,
development of resources, and plan¬
ning the governance of a Harvard
Medical School system initiative in
rehabilitation medicine, will also work
to assemble the Division of Rehabilita¬
tion Medicine as an academic adminis¬
trative unit of the Faculty of Medicine.

1967 — Fifteenth
By Robert Kirkw ood
Our fifteenth reunion began with a
relaxed evening of cocktails and dinner
at the country “estate” of Martin and
Karen Wand in Avon, Connecticut.
While little Wands ran around keeping
us well served, Mary Williams Clark
showed slides of the old Yale days,
including our senior play, “Iatrogenic.”
We could recognize most people as we
relived Larry Henry playing the
“hyper-tern”; Korobkin acting as the
appropriately suave and tactful surgeon
explaining cancer to Rigney, the
emaciated patient; Hart, pipe in
mouth, playing Dr. Freedman; and the
Barber Shop quartet of Strohl,
Crumley, Rosser and Kirkwood. We
found most of us have not changed
much in appearance through the
fifteen-year turbulent passage and the
decade of the seventies, although in
many cases our lives surely have.
The weekend of June 4th brought
record rainfall to southern New
England, and many of our classmates
were unable to attend the celebration.
The outdoor party at #1 South Street
was cancelled. The dormitory looked
much the same, although locks and TV
surveillance cameras spoke of new
times. The Medical Center was burst¬
ing with construction of tall and
imposing
laboratories,
and
the
neogothic Catholic church had given
way to the change. A large parking lot
now covers the still
unfinished
connector. Yale is still vital and
growing.
Many of us did make it through the
fender-deep water to Guilford and the
Sachem House for dinner. We heard
about each other’s lives, and talked and
laughed about the Friday night parties
we used to have with Manuel, followed
by the next morning brain cuttings that
24

cleared the sinuses. We remembered
Liebow's honed lectures with slides
deftly, and sometimes not so deftly,
handled by the terrified pathology
resident. We remembered the aura
around the farewell talk of Paul
Beeson, and felt proud to be from Yale.
It felt good to be filled with the warmth
of our renewed friendships. We missed
those who could not be with us, and we
paused in silence to remember our
deceased
colleagues,
Barry
MacAnally, Mike Lindsley, Alan
Circle and Larry Henry.
Our classmates who attended were
Mary
Williams
Clark,
Jim
Dowaliby, John Drews, Dick Hart,
Peter Herbert, Bob Kirkwood, Mel
Korobkin, Tony Lovell,
Laura
Manuelidis, John Pastore, Brian
Rigney, Joe Sabbatino, Helen Smits,
Martin Wand, Bob Young, and Pete
Zeman.
Space in this journal is limited, and I
will send a more lengthy newsletter
soon that shares news that I received
this year.

1972— Tenth
By Harry Malech
The Yale University School of Medi¬
cine class of 1972 celebrated its 10year reunion with a dinner at The Chart
House restaurant on Saturday, June 5,
1982. The Chart House is on the water¬
front and the deluge of rain on the
windows and over the water added to
the effect of being on a boat in the
harbor. Though it wasn't apparent until
the next day, this rainstorm resulted in
some of the worst flooding in Connect¬
icut in several decades. I assume that all
the dinner attendees got home ok.
The group was large enough that we
were able to discuss the current activi¬
ties of all members of our class except
for a very few individuals. Several
people brought their children, and most
came with spouses which I think added
greatly to the feeling that this was a
comfortable gathering of old friends.
Members of our class who attended
were: Bruce Haak, John Foster,
Peter Panzarino, Thomas Horn,
John Fulkerson, Felix Freshwater,
Robert DeBlasi, Jesse Jupiter, Philip
Lebowitz, Philip Rothfeld, Michael
Charney, Daniel Begel, Gary Strauss,
Paul Lucky, and Harry Malech.

1977 —Fifth
No report received.

IN MEMORIAM
Walter C. Tilden
May 7, 1982

M.D. ’12

William Y. Sayad
March 16, 1982

M.D. ’21

Hyman W. Weinstein
April 14, 1982

M.D. ’23

Edward M. Gould
July 16, 1982

M.D. ’24

Jacques D. Soifer
September 2, 1982

M.D. '24

William H. Hahn
June 3, 1982

M.D. ’26

Edith N. Stainsby
March, 1979

M.D. ’26

William H. Veale
July 17, 1982

ex med '26

Mary B. Harris Michal
February 28, 1979

M.D. ’28

Harry C. Oard
March 12, 1982

M.D. ’28

Benjamin Castleman
June 29, 1982

M.D. ’31

DeWitt Dominick
May 20, 1982

M.D. ’34

Daniel M. Killoran
May 30, 1980

M.D. ’34

Marguerite Booth
March 28. 1979

M.D. ’35

Paul H. Twaddle
February 14, 1982

M.D. ’35

Maurice A. de Hame,
M.D.
August 24, 1982

ex med '35

Hannibal Hamlin
June 28, 1982

M.D. ’36

Chester H. Tidings
October 12, 1981

ex ph ’39

Jackson H. Stuckey
September 16, 1982

M.D. '42

Mrs. Alice L. Edwards
Spillane
(Date Unknown)
B. Allen Richardson
December 30, 1981
Lillian Welch
February 13, 1982

M.P.H. '42

M.D. ’43

M.P.H. ’66

1981-1982

Medical School Alumni Fund Campaign

Message from the Medical School
Alumni Fund Chairman

A Message from the Dean

I am delighted to report that the 1981-82 Medical School
Alumni Fund surpassed its previous record-breaking year by
39%, with a grand total of $296,729!
Leona Baumgartner '32 PhD., '34 M.D. provided the School
and the Department of Epidemiology and Public Health with a
$75,000 challenge award for new and increased gifts which
enabled the Fund to raise additional money for student financial
aid. This welcomed incentive from one of our own graduates
could very well be the start of an important precedent.
I want to thank all the alumni, former House Staff, parents
and friends who responded so thoughtfully to our campaign;
sincere thanks also to the volunteers who continue to provide the
momentum that keeps our Fund growing at such a superb rate;
and a very special acknowledgment to those volunteers who
assisted the reunion Class Agents. This special effort contributed
significantly to our excellent giving record during the past year.
My first year as Chairman has been particularly interesting
and very gratifying. I want to share with you several paragraphs
written by one of our Class Agents that best describes my own
feelings about Yale and fund raising:
“The job of a fund raiser is at times rewarding; at other
times almost fun, but most of the time extremely
frustrating. 1 am impressed with the apathy toward the
Medical School and its efforts to provide a quality of
education to those who need funds. The Yale Medical
School Alumni Fund really should be one of the top
priorities on the list of my classmates. I learned many,
many years ago when I graduated from high school,
when in the commencement address, it was noted that
‘With privilege goes responsibility.' I am afraid that
there are too many of us, who forget this — like it or
not. It is a privilege to be a physician; it is not a right.
For all of the complaining and moaning that we physi¬
cians do at times, I think that the bottom line is that
most of us are happy in our work, doing what we want
to do, are respected in our profession and financially
rewarded more than is adequate.
I personally feel that giving financial help to the
Medical School Alumni Fund is a small way of
showing that we care, are grateful.’’
I appreciate your past support to look forward to another
successful year.
Lowell I. Goodman ’51
Chairman

This past year the Medical School Alumni Fund established a
remarkable new record with contributions totalling $296,729.
This surpasses the previous year — also a record breaker — by
39%. Such manifestation of loyalty and support is extremely
encouraging.
As in previous years, your Medical School Alumni Fund
contributions will be used to provide additional student loans.
Money for student financial aid continues to be one of the
School’s greatest needs. This need was recognized by Leona
Baumgartner in establishing her $75,000 challenge grant to
match new and increased gifts. We are especially grateful to her
for providing this incentive.
In addition to thanking those who have contributed to the
Fund, I want to congratulate Lowell Goodman and all of those
who worked with him to achieve these impressive results. Your
continued support is greatly appreciated.
Robert W. Berliner

Message to Public Health Graduates
The incentive of the Leona Baumgartner Challenge Fund; the
honoring of retiring Chairman Robert W. McCollum by
committing the proceeds of the 1981 -82 drive to a fund bearing
his name and the efforts and generosity of many people, all
combined to make this a banner year for Epidemiology and
Public Health. A new record was established when 139% of the
goal was achieved and a total of $48,799 raised to be used for
student revolving loans.
This level of giving reflects an awareness of and sensitivity to
the tremendous financial demands on the student of today and
presents the alumni/ae with the further challenge of maintaining it.
Colin White
Kathleen Howe
Samuel B. Webb, Jr.

Fund Officers 1981-82
Medical School Alumni Fund
Lowell I. Goodman '51, Chairman
Malvin F. White '39, Vice Chairman
William K. McClelland '47, Vice Chairman
John L. Cieply '71, Vice Chairman
J. Roswell Gallagher '30, Bequest & Endowment Co-Chairman
Samuel D. Kushlan '35, Bequest & Endowment Co-Chairman
Epidemiology and Public Health Alumni Fund
Kathleen H. Howe '56, Co-Chairman
Samuel B. Webb, Jr. '63, Co-Chairman
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Medical School Alumni Fund Class Participation

Year

1980-81

1980-81

1981-82

1981-82

Total

% Part.

Total

% Part.

Agent
$

1908-21
1922

Edward T. Wakeman

1923

288

$ 7,758

275

45%

285

56%

William Cohen

5,625

60%

760

71%

1924

Myron A. Sallick

2,943

75%

2,195

63%

1925

Alice A. S. Whittier

975

68%

945

73%

1926

Maxwell Bogin

1,523

42%

521

58%

1927

Henry Irwin Fineberg

1,161

42%

1,104

53%

1928

Max Alpert

2,441

62%

2,297

68%

1929

Paul F. McAlenney

2,022

84%

1,828

79%

1930

J Edward Flynn

10,738

69%

5,343

58%

1931

Michael D'Amico

2,075

54%

1,687

68%

1932

Storer P Humphreys

1,024

55%
*4,384

64%

1933

Frederick Wies

4,198

55%
2,133

57%

2,211

64%

2,333

72%

2,977

52%

Henry Brill
Franklin M Foote
1934

DeWitt Dominick

1935

James Q Haralambie

1.620

54%

1936

Hannibal Hamlin

3.319

43%
2,671

44%

1937

David Dolowitz

1,767

49%

*1.622

50%

1938

Nelson Ordway

1,986

60%

1,095

52%

1939

Robert Ernst

1,855

38%
1.795

53%

1940

James F. Ferguson

5,355

64%

2,555

64%

1941

Charles B Cheney

1,785

61%

2,260

100%

George A. Hahn

Rebecca Z. Solomon

1942

Walter J. Burdette

11,679

53%

*16,672

55%

1943A

Jonathan Lanman

2,030

54%

2,070

54%

S Brownlee Brinkley

1,242

43%

2,027

52%

Nicholas P R Spinel11

4,188

55%

4,615

65%

3,260

69%

3,359

64%

*8,830

66%

6,542

49%

B
1944
1945

Richard W Breck

1946

Julian A. Sachs

1947

William Roy Breg

3,165

54%

*6,142

68%

1948

Paul Koehler

3,480

60%

3,905

62%

1949

Daniel Elliott

2,945

48%

5.516

56%

1950

David Frucht

1,661

32%

2,813

56%

1951

Lowell I. Goodman

*4,520

100%

5,275

52%

1952

Harvey L. Young

3,102

38%

*4.873

49%

1953

Vincent Lynn Gott

3,445

49%

3,908

47%

1954

John K Rose

2,616

45%

5,267

68%

1955

Robert A Kramer

3,740

62%

4.443

52%

1956

John H. Gardner III

*14,930

63%

4,070

33%

1957

William J Waskowitz

5,300

64%

*9,291

79%

1958

Charles A. Hall. Jr

3,890

43%

5,370

59%

1959

Asa Barnes, Jr.

5,600

57%

6.665

62%

1960

Thomas P. Kugelman

40%

1961

Jon D. Dorman

1962

A. Richard Pschirrer

1963
1964

4,235

49%

3.495

*3.681

50%

2,580

35%

4,296

51%

*11,849

65%

Craig H Llewellyn

3,085

37%

4,990

52%

William J Houghton

5,556

58%

4,390

60%

4.569

49%

4,425

49%

*3,642

54%

2,923

52%

James Dowaliby

3.960

59%

*9,170

70%

Frank E Lucente

4,145

54%

2,760

46%

1969

Lee Merrill Jampol

4,736

63%

6.888

67%

1970

James R Missett

1.771

39%

2,001

36%

1971

John L. Cieply

*5.771

59%

4,046

47%

1972

Paul A Lucky

1,619

46%

*3,709

54%

1973

David Bailey

1,189

34%

2,273

44%
26%

1965

David A Hill

1966

Mary Alice Houghton

1967
1968

1974

Peter J Buchin

505

22%

710

1975

Daniel Passeri

605

20%

701

24%

1976

Robert F. Taylor

*987

21%

872

27%

1977

David Kreis

555

22%

*1,575

30%

1978

Duke Cameron

521

14%

1,467

23%

1979

Barbara Peters

165

6%

640

20%

1980A

Eduardo Alfonso

100

12%

225

15%

Mark Bernhardt

235

19%

317

18%

365

15%

B
1981

26

Anthony Urbano

$194,905

45%

$224,432

48%

Former House Staff

6,498

18%

6,863

21%

Parents and Friends

5,439

Miscellaneous

6,422

13,393

—

42,183

Medical Alumni

Baumgartner Match

Medical School Alumni Fund Total

$213,264

9,858

38%

$296,729

42%
^Reunion

Public Health Alumni Fund Class Participation
1980-81

1980-81

1981-82

1981-82

Total

% Part.

Total

% Part.

$ 1,960

43%

$ 4,258

56%

320

43%

430

50%

Eric W Mood

310

21%

450

50%

Eric W, Mood

130

44%

345

44%

1945-1949

Kathleen Howe

995

26%

4,035

40%

1950

Elizabeth D. Robinton

290

42%

905

61%

1951

Leonard F. Menczer

255

23%

455

35%

1952

Yolande F. Lyon

515

42%

700

39%

1953

Milton H. Sisselman

535

38%

615

40%

1954

Ruth M. Taber

160

18%

110

24%

1955

Frances R Ogasawara

230

36%

305

33%

1956

Henry M. Parrish

735

32%

710

21%

1957

Edward R. DeLouise

212

25%

602

43%

1958

Thomas T Flynn

445

21%

300

14%

1959

Dorothy M Wilson

415

31%

915

39%

Year(s)

Agent

1923-1941

Kathleen Howe

1942

Eric W. Mood

1943
1944

1960

Hannah Clark Russell

220

29%

400

33%

1961

Gordon R. Beem

488

30%

665

59%

1962

A. Kay Keiser

35

14%

105

31%

1963

David Dolins

430

33%

550

43%

1964

Estelle Siker

520

38%

1,310

54%

1965

Michael E. Kove

305

30%

430

38%

1966

Allen Cohen

245

23%

470

34%

1967

James M. Malloy

770

33%

790

26%

1968

Arnold R Saslow

560

28%

1,300

32%

1969

Samuel P Korper

495

17%

940

26%

1970

Susan W Balter

410

10%

1,125

31%

1971

William P. Ferretti

1,622

34%

John Bihldorff

1,360

49%

1972

Daphne DeJ Gemmill

405

28%

715

36%

1973

Judith G Beatrice

770

27%

600

19%

1974(A)

Rose Salisbury Beer

270

31%
290

32%

455

35%
315

39%

Linda K. Broker

556

26%

1,321

41%

1976

Elaine P. Anderson

380

25%

1,297

43%

1977

Carroll Schilling Neisloss

575

24%

1,223

33%

1978

Richard C. Poole

655

26%

1,073

33%

1979

Ralph Tartaglione, Jr

575

26%

1.315

39%

1980

Christina P. Quinn

543

27%

880

34%

1981(A)

Diane E. Goren

435

31%

1981(B)

Jill Goldwater

105

15%

$34,149

37%

Elizabeth Helming
1974(B)

Roberta Lawrence
Abigail L Smith

1975

Alumni

$18,790

28%

EPH Associates

—

Miscellaneous

—

2,039

Baumgartner Match

—

10,667

Public Health Alumni Fund Total

$18,790

1,945

28%

$48,800

37%
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Contributors to the 1981/82 Fund
1903
ROBERT ROWLEY*
1906
CHARLES MITCHELL*
1908
MICHAELPARLATO*
1912
WALTER TILDAN*
1913
RALPH TAYLOR*
1919
WILLYS MONROE*
1920
OSCAR BRENNER*
1921
ELLA WCALHOUN
JOSEPH T EAGAN
1922
BENEDICT R HARRIS
CHESTER HURWITZ
HELEN PLANGNER
REGINALD T LOMBARD
MAURICE F O’CONNELL
EDWARD T WAKEMAN
1923
WILLIAM COHEN
JOSEPH EPSTEIN
JOSEPH A JOHNSTON
JACOB MELLION
1924
JOHN J BATCHELOR
DAVID M RASKIND
MYRONASALLICK
JACQUES D SOIFER
HAROLD T VOGEL
1925
DORENCE S COWLES
EDWARD A CRAMTON
WALDO F DESMOND
HENRY W FERRIS
MATTHEW GRISWOLD
DAVIS H PARDOLL
SAMUEL REBACK
WELLES A STANDISH
ALICEAS WHITTIER
GONSALVO C WILLIAMS JR
HOWARD A WOOD
1926
STANTON T ALLISON
MAXWELL BOGIN
JOSEPH HETZEL*
MORRIS HINENBURG
BEN KLOTZ
MILTON MALEV
ALEXANDER E ROSENBERG
WILLIAM H VEALE
1927
WALLACE BOSTW1CK*
HYMAN COHEN
HENRY IRWIN FINEBERG
JOHN FREIHEIT*
MEYER FRIEDENSON
HERMAN H GOLDSTEIN
ALBERTJABLONSKY
NATHAN LEVY
WILLIAM C MEREDITH
MOSES ROTHBERG
M DAWSON TYSON
GEROGE H ZINN
1928
MAX ALPERT
CLEMENT FBATELLI
BERTHOLD R COMEAU
SHELDON A JACOBSON
EDWARD PJ KEARNEY
RALPH E KNUTTI
FERDINAND G KOJIS

28

* Deceased

R HAROLD LOCKHART
EDWARD LUDWIG*
HARRY COARD
NATHAN E ROSS
ROBERT I RUBINSTEIN
JOHN RUSSELL*
ALVIN ASCHAYE
LEWIS ASCHEUER
1929
JAMES RAE ARNEIEL JR
FRANK H D’ANDREA
CHARLES J EPSTEIN
ROBERT A FRISCH
OLIVE GATES
GEORGES GOLDMAN
ALEXANDER HAFF*
JOHN A HANGEN
HAROLD J HARRIS
GEORGE P JACKSON
VERNON W LIPPARD
PAUL F MC ALENNEY
TONY LIEBMAN RAKIETEN
WILLIAM FROTH JR
RUSSELL BSCOBIE
BENJAMIN SPOCK
ROBERTTENNANT
RAYMOND WASHBURN*
MABEL WILSON
FUMIKO YAMAGUCHI-AMANO
HERMAN YANNET
1930
DANIEL BEERS*
FREDERICK FITZHERBERT BOYCE
CHARLES BRECK*
ROBERT D M CUNNINGHAM
VINCENT A DOROSZKA
KNOX H FINLEY
J EDWARD FLYNN
J ROSWELL GALLAGHER
LEONARD GREENBURG
JAMES C HART
EDMUND L KITZMEYER
PAUL H LAVIETES
MOSES D LISC'HNER
JAMES LYNCH*
JOHN C MENDILLO
PAUL WATSON
AMY H WILSON
CHARLES L WOOD
1931
DANA L BLANCHARD
HENRY H BRIGGS JR
BENJAMIN CASTLEMAN
MICHAEL D'AMICO
RICHARD L FRANK
HELEN R GILMORE
PAUL A HARPER
HAROL.DE HARRISON
MORRIS HELLER*
THOMAS CJALESKI
A PHILIP L.AFRANCE
RHODA M MICKEY
NELSON NEWMARK
SHELDON PAYNE
MORRIS L RAKIETEN
ABRAHAM J SCHECHTF.R
JAMES ASTRINGHAM
1932
LOUIS K ALPERT
REGINALD V BERRY
HENRY BRILL
FRANK CARROLL
CLEMENT C CLARKE
HESTER B CURTIS
JOSEPH P DONNELLY
LEWIS F FOSTER
CONRAD R LAM

MARIO LPALMIERI
ARTHUR J PRESENT
ELIZABETH M RAMSEY
BENJAMIN N TAGER
RUDOLPH E VANDEVEER
MYRON E WEGMAN
CARL HENDRICKS WIES
FRANK B WISNER
EDMUND A ZYBULEWSKI
1933
MYRON ADAMS*
LEE E FARR
FRANKLIN M FOOTE
JACK GREENBERG
DANIEL F HARVEY
GEORGE K HIRST
ROBERT W HUNTINGTON JR
JOHN G MARTIN
JOSEPH MIGNONE
RAYMOND E MILLER
ASHLEY POND III
LESTER Q STEWART
SIDNEY STRINGER*
FREDERICK A WIES
FRANCIS M WOODS
1934
FREDERICK BECK
JAMES F BLADES
JOSEPH BUDNITZ
DEWITT DOMINICK*
DERICK A JANUARY
KNOWLES B LAWRENCE
THEODORE P MERRICK
HERBERTC MILLER
EDWARD T O'DONNELL
JOHN B OGILVIE
LUCIEN M PASCUCCI
HARRY SHERMAN
WILLIAM R WILLARD
GEORGE ZALKAN*
1935
GEORGE A CARDEN JR
SAWNIER GASTON
H HOFFMAN GROSKLOSS
JAMES QUINTIN HARALAMBIE
W HOWARD HORNER
SAMUEL DKUSHLAN
NORMAN E PEATFIELD
NORMAN PRINDGE
MILTON ROSE
CLARK PSEARLE
JACK C SLEATH
WALTER A L THOMPSON
SAMUEL ZELMAN
1936
GEORGE HENDERSON BROWN
LESTER WBURKET
ALBERT W DIDDLE
FRANKLIN F FERGUSON
MARGARET C LGIEDEA
GEORGE D GROSS
GEORGE A HAHN
LOUISE G HUTCHINS
E ROBBINS KIMBALL
PHILIP M LECOMPTE
FREDERICK A POST
MARGARET SOMMERS
ROBERT H STEVENS
MORRIS TAGER
EDGAR W WARREN
1937
EDMUND R BLOWER
DAVID A DOLOWITZ
D CROSBY GREENE
WILBUR D JOHNSTON
ALFRED E KING
DUNHAM KIRKHAM
* Deceased

JAMES PMORRIEE
CHARLES W NEUHARDT
WINSTON J ROWE
MORGAN SARGENT
EDWARD J SHAW
ALBERT D SPICER
JOHN M THOMAS
JEAN WELLS
LUCILLE R WIEPERT
LORANDE M WOODRUFF
1938
ROY N BARNETT
HENRY LCARIDEO
ROBERTA CRUTCHER
JOHN A DILLON
S CHARLES KASDON
BENJAMIN E LYONS
EDWARD NICHOLS
NELSON K ORDWAY
EDWARD W PINKHAM JR
JAMES RADCLIFFE JR
GEORGE E ROBERGE
LESTER J WALLMAN
J RICHARD ZAHN
1939
NORMAN LC'RESSY
WILLIAM H DRUCKEMILLER
JOHN P FERGUSON JR
S JEROME GREENFIELD
NATHANIEL KENIGSBERG
MARGARET A LENNOX
WARD J MC FARLAND
JAMES PETER MURPHY
RUSSELL NAHIGIAN
ERNEST LSARASON
BRADFORD SIMMONS
REBECCA Z SOLOMON
STUART S STEVENSON
JOHN D TOBIN
ARTHUR S TUCKER
DARRELL G VOORHEES
DOUGLASS W WALKER
JOHN H WENTWORTH
MALVINF WHITE
1940
THEODORE E ALLEN
IOSEPH V BALDWIN
RONALD S BECKETT
JACKS BLAISDELL
PHILIPS BREZINA
CRAWFORD J CAMPBELL
DAVID CROCKER
THADDEUS S DANOWSKI
WYNANT DEAN
ROBERTM DUNLAP
JAMES F FERGUSON JR
EUGENE J FITZPATRICK JR
JOHN C HALEY
H STUART IRONS JR
DONALD G JOHNSON
PAUL D MAC LEAN
EDWARD MARTIN
WILLIAM R OAKES
LEE S SANNELLA
W NORMAN SEARS
JOSEPH ESOKAL
J CHAMPNEYSTAYLOR
PATRICIA E WANNING
JOHN B WELLS
HELEN H WOODS
1941
LOUIS CACQUA
ROBERT H ALWAY
ROBERT H ARESON
PAUL H BARBOUR JR
WRANDAL BELL
KNUTE E BERGER

MARVIN BLUM
HUGH H BUTLER
WILLIAM A CAREY
JOSEPH P CARSON JR
CHARLES W CASHMAN JR
CHARLES BCHENEY
HERBERT W DIEFENDORF
ROBERT F DINE
PETER A DUNCAN
JOHN E FENTON
LLOYD D FLINT
JOHN FRANKLIN
ROBERT L GILBERT
FREDERICK PGLIKE
STANLEY T GRZEBIEN
THOMAS S HARVEY
EDWARD R HARVEY JR
WILLIAM EDMUND KENNEY
SIDNEY L LASELL
WILLIAM LEE
BJORN LIH
F EUGENE MARTIN
JOHN R MC DERMOTT
WILLYS M MONROE
G HENRY MUNDT
MALCOLM CMURFITT
JEAN E NEIGHBOR
EDWARD B O'CONNELL
ROBERT WOLLAYOS
GIOACCHINOS PARRELLA
DAVID V PECORA
EDWIN D ROGERS
LESLIE SIMMONDS
JANET H VAN ORDEN
IRVING WALTMAN
1942
WILLIAM E BLOOMER
JAMES M BUNCE
WALTER J BURDETTE
ROBERT E CARROLL
DONALDS CHILDS JR
NICHOLAS DEAN*
HENDRIK DEKRUIF
DAVITT FELDER
ELIHU FRIEDMANN
ALLAN V N GOODYER
CHARLES R HARMS
WILLIAM HARRISON JR
LEO KELLERMAN
JOHN R LINCOLN
PATRICKS MULLINS
CHARLES F SCHOLHAMER
RICHMOND W SMITH JR
JACKSON H STUCKEY
EDGAR B TAFT
MAURICE TULIN
FRANCIS P VOSE
IRVING NORMAN WOLFSON
1943

RICHARD N ABBOTT
JOHN R ALMKLOV
JAMES L BRADLEY
ROBERT F BRADLEY JR
S BROWNLEE BRINKLEY
HENRY B BRUYN JR
THOMAS L BUCKY
JANEBCADBURY
PHILIP B CHASE
HUNTER H COMLY
RONALD W COOKE
LYCURGUS M DAVEY
JEAN P DAVIS
JOSEPH I EPSTEIN
R M FASANELLA
C THOMAS FLYNN JR
GERARD FOUNTAIN
ROBERT H FURMAN

HENRY H JONES
R LEONARD KEMLER
JONATHAN T LANMAN
HENRY E MARKLEY
SAWYER EMEDBURY
HOYT B MILES JR
RUSSELL A MOR1SSETTE
WALTER J J NERO
DOROTHEA R PECK
EDWARD FRABE
IRA A RASHKOFF
EARLJ RHOADES
HENRY A RIEDEL
BERNARD R ROWEN
MARCUS ESANFORD
DONALD WSELDIN
EDWARD FIERSEY SOULE
FRANCIS A SPELLMAN
SOPHIE TRENT STEVENS
OLIVER G STONINGTON
ROBERT LEE TAYLOR
FREDERICK A WALDRON
C WESLEY WATSON
JOHN J WEBER
ROBERT H WYATT
1944
CARLE ANDREWS
EDWARD J CONWAY
JOHN C COOLIDGE
FRANK W COUNTRYMAN
LAWRENCE S CRISPELL
CHARLES H CROTHERS
LAWRENCE G CROWLEY
DONAL L DUNPHY
ROBERT W FRELICK
CAROL GOLDENTHAL
CHARLES A HALL
HOWARD B HAMILTON
ROBERT 1 HINKLEY
W RAYMOND JAMES
WARDS JENKINS
EDITH M JURKA
FREDERICK F KRAUSKOPF
ELLEN P MAC KENZIE
KATHARINE HAWLEY MARTIN
JOSEPH MASSARO
A REESE MATTESON
LAWRENCE K PICKETT
LAURENCE G ROTH
HAYNES W SHEPPARD
SARAH PSHERWOOD
NICHOLAS PR SPINELLI
PRISCILLA DIENES TAFT
ANTHONY VARJABEDIAN
CALVIN W WOODRUFF
REUBEN ZUCKER
1945
GEORGE HOWARD ALLISON
A JOHN ANLYAN
ALBERT S ATWOOD
FREDERIC M BLODGETT
RICHARD W BRECK
CARLETON J BROWN
LOUISE H BURR
ALICE SHEPARD CARY
JAY B COHN
THOMAS P COTTER
EDWARD M DANIELS
RICHARD R DYER
ROBERTS EASTON
SIDNEYS FEUERSTEIN
ALICE DERSHIMER FRIEDMAN
RAYMOND A GAGLIARDI
PHILIPS GOOD
GOVE HAMBIDGE JR
HERBERTS HARNED JR
PAUL W HOFFERT

O ROGER HOLLAN
HANS R HUESSY
LELANDW JONES
RAYMOND E LESSER
MARK MC D LINDSEY
CHARLES E MC LEAN
LAWRENCE J MORIN
GEORGE W NAUMBURG JR
FITZHUGH C PANNILL
RAYMOND E PARKS
RICHARD M PETERS
CHARLES E SHERWOOD
KENNETH C STEELE
LEROY S WOLFE
1946
AARON T BECK
FRANKLIN C BEHRLE
SANFURD G BLUESTEIN
LINUS W CAVE
THOMAS J COLEMAN
THOMAS A DOE
H LAMBERT FILER JR
GREGORY E FLYNN
MARTIN E GORDON
CHARLESS JUDD JR
HAROLD KING
BENJAMIN F KITCHEN JR
VINCENT J LONGO
RICHARD H MANN
THOMAS J MATHIEU
HUGH J MC LANE
JOHN H MORTON
FRANCIS REILLY*
DAVID H RIEGE
JULIAN A SACHS
DONALD PSHEDD
RICHARD G SISSON
COLBY S STEARNS
ROBERT R WAGNER
WILLIAM P WALSH
WILLIAM J WEDEMEYER JR
ELIHU SWING JR
1947
GEORGE R BARNES JR
HENRY N BLANSFIELD
ALBERT W BOSTROM JR
JOHN E BOWERS
WILLIAM ROY BREG JR
RICHARD G BRITTON
JOHN L. CANNON
M RICHARD CARLIN
BETTY PRICE CARLIN
CHARLES R CAVANAGHJR
ROBERT A CHASE
AMOZICHERNOFF
WILLIAM F COLLINS JR
ROBERT PDARROW
ARCHIE L DEAN JR
JEAN H DOUGHERTY
OWEN W DOYLE
FRANKLIN HAROLD EPSTEIN
RICHARD K FRIEDLANDER
FRANK L GOLBRANSON
FRANK H HORTON
ROBERT J KERIN
DON F KIMMERLING
RICHARD P LEVY
BROCK LYNCH
VICTOR A MACHCINSKI
CHARLES L MACHE JR
WILLIAM K MC CLELLAND
ROBERT F NEWTON
MYRON KNOBIL
LAWRENCE C PERRY
PHILIP H PHILBIN
EDGAR B PHILLIPS 2D
OLIVE E PITKIN

IRVING RUDMAN
ALVIN SOMBERG
IGOR TAMM
PATRICIA B TUDBURY
ELLIS J VAN SLYCK
M HENRY WILLIAMS JR
1948
RUSSELL J BARRNETT
EDITH M BECK
ALLYNG BRIDGE
LEE BUCKINGHAM BROWN
ARTHUR L COLEMAN JR
RUTH ECORTELL
G ROBERT DOWNIE
MARIE C DUNCAN
BOY FRAME
EMIL FREI 3D
JULIAN FRIEDEN
ALLAN GREEN
B HEROLD GRIFFITH
SYLVIA PRESTON GRIFFITHS
BEATRIX A HAMBURG
RICHARD M HANNAH
W RAYNERJOHNSON
PAUL B KOEHLER
ROBERT ELEMPKE
JOHN P MORRIS
JOHN B MORRISON
DAVID E MORTON
GERALD RNOWLIS
JESSIE E PARKINSON
GEORGE P ROSTEL
LEWIS P ROWLAND
BENJAMIN F RUSH JR
GABRIEL SAVIANO*
JEROME H SHAPIRO
ANNE GST GOAR
WALLACEWTURNER
PAUL WOODBURY WELD
1949
ALFRED E BACON JR
RICHARD LBARACH
WILLIAM DBEVIS
JONATHANS BISHOP
THOMAS L CHIFFELE
MARY PUCCI COUCHMAN
PHILLIP GCOUCHMAN
PETER R CUNNINGHAM
N JOELEHRENKRANZ
DANIEL W ELLIOTT
GUNNAROENG
ALBERT A FISK
PAULS GOLDSTEIN
FREDERICK W GRAY
JACKSON HARRIS
ROBERT C HOWARD
GORDON D JENSEN
BENJAMIN A JOHNSON
FRANK D LAW
ORVAL I MC KAY
TIMOTHY F NOLAN JR
RICHARD D OTIS
JULIAN I PICHEL
EDMUND L PIPER
CHARLES L RENNELL JR
DANIEL RUDMAN
CARL M RUSSELL
WILLIAM II SEWELL
RAYMOND D SUDARSKY
1950

RUSSELL N ANDERSON
LYALD ASAY
JOHN E BOROWY
KENT ELLIS
THOMAS J FERRARO JR
DAVID A FRUCHT
CARL A GAGLIARDI
29

ARCHIE J GOLDEN
CHESTERFIELD G GUNN JR
WALLACE M KEMP JR
MARILYN M KRITCHMAN
SIDNEY S LEE
JANUS C LINDNER
MARGARETS LYMAN
HAROLD MARCH
JOHN H MEYERS
ORLANDO J MILLER
CYN1A B SHIMM
JANEBSHUMWAY
JOHNS STRAUSS
1951

KAREL BEDRICH ABSOLON
GOFFREDO ACCETTA
W ROBERT ADAMS
FRANK R ALLEN
THOMAS T AMATRUDA JR
ELEANOR CLAY
JOHN J EGAN
DANIEL X FREEDMAN
LAWRENCE R FREEDMAN
SIDNEY S FURST
LOWELL I GOODMAN
JOHN T GROEL
ROBERT N HAMBURGER
WILLIAM KIEKHOFER
ROBERT D KING
JOCELYN S MALKIN
FRANCIS L MERRITT
PAULDMILLIKIN
WALTER S MORGAN
ALBERT R MOWLEM
RICHARD S MUNFORD
CHARLES A NUGENT JR
JOSE FELIX PATINO
ARTHUR A PAVA
MAJIC S POTSAID
WILLIAM F STEPHENSON
WILLIAM TAYLOR*
HERBERT PUNGRICHT
JAMES WALKER
1952

JOHNWARNOLD
FRANK R COUGHLIN JR
PHILIP GARDNER DEANE
RAYMOND S DUFF
JAMES R DURHAM
RICHARD D FLOYD
ROBERT PGERETY
WILLIAM JOSEPH JOHNSON
THOMAS S KELLY
WILLIAM W KLATCHKO
WILLIAM R LETSCH
JAMES KENT LUCE
N KARLE MOTTET
SIDNEY NATHAN PALY
ROBERT G PETERSDORF
LEON A PHILLIPS
JOHN MACKLIN ROBERTS
LEONARD RUSH
MARY WHEATLAND SCHLEY
DONALD H SCHULTZ
ROBERT B SCHULTZ
VIRGINIA LEE SWANSON
JOHN H WAGNER JR
JOHN L. WOLFF
HARVEY L YOUNG
ROBERT ZEPPA
1953
CLAUDE BLOCH
HAROLD D BORNSTE1N JR
WILLIAM R CHAFFEE
ALLEN CHETRICK
REX BCONN
LOUIS R M DEL GUERCIO
30

JAMES P DUNN
DONNELL DENCIL ETZWILER
A DANIEL HAUSER
GEORGE L HOFFMANN
DAVID PURDY HOLMAN
ALVIN JOSEPH KEROACK
RICHARD ROBERT KNOWLES 3D
H1LDEGARD MUELLER LESLIE
JOHN DUTCH LORD
ROBERT N MELNICK
WARWICK POTTER JR
PAUL G QUIE
JOSERAMIREZ-RIVERA
BARBARA F ROSENBERG
IRWIN K ROSENBERG
VIRGINIA CSAFT
RICHARD ANDREW SINNOTT JR
LYNN CORTLAND STOKER
MATTHEW ANDREW TANDYSH
WILLIAM JUNIOR VANDERVORT
WILLIAM AUGUST WILSON JR
JAMES FREDERIC YOUNG

PAULGONICK
DICRAN GOULIAN JR
ION GRESSER
JOHN H HODGE
D FRANKLIN JOHNSON JR
HARRY O KENDALL
DAVID R KESSLER
ROBERT A KRAMER
WILLIAM E LATTANZI
GILBERT MPLEIB
JOSEPH S MCGUIRE JR
ROBERT C NODINE
SHERWIN B NULAND
GLORIA CONQUE
JOHN C PACE JR
ROBERT H PETERS JR
GREGORY PETERSON JR
ROBERTA REICH
PHILLIP W SMITH
ALAN A STONE
ALEXANDER ZUCKERBRAUN

1954

ALVIN D BENJAMIN
LEVON Z BOYAJIAN
THOMAS M BROWN
ROSALIE A BURNS
JOSEPH CCERNY
JAMES CCOLLIAS
DONALD J DALESSIO
CHANDLER DAWSON
GILBERT M EISNER
GEORGE E GREEN
ALAN RGURWITT
JOHN HERD HART
WILLIAM H HINDLE
WILLIAM V LEWIT
LEO LUTWAK
PRESTON C MANNING
NORMAN F MOON
DONALDJ NALEBUFF
JAMES SCHEUER
EDWARD CSENAY
BENJAMIN A SHAVER JR
DANIEL RSILBERT
DONALD R SPERLING

W DEAN ASHWORTH
FRANK P BERG
RICHARD J BOUCHARD
GEORGE N BOWERS JR
RALPH K CAMPBELL
JOHN R COLE
ALAN H COVEY
ARTHUR C CROVATTO
DONALD D DAVIS
WALTER J FREEMAN
JOHN AGARIEPY
EDWARD J GERETY
FRANK LGRUSKAY
NICHOLAS A HALASZ
ROBERT P HATCH
WALKER R HEAP JR
LELAND E HILBURG
HERBERTS HURWITZ
ROBERT F HUSTEAD
ROBERTJTJOY
RICHARD LAMB
EVA HENRIKSEN MAC LEAN
PAUL N NEUFELD
LOWELL E OLSON
WILLIAM J PAULE
ANTHONY V PICCIRILLO
RICHARD D PULLEN
JACQUES M QUEN
EDWIN R RANZENHOFER
JOHN KEITH ROSE
ELIHU M SCHIMMEL
LEONARD M SILVERMAN
ROBERT L STEIN
JOHN W VOSSKUHLER
1955

JOHN B ATWATER
JOHN C BAILAR 111
GEORGE E BECKER JR
E EDWARD BITTAR
DOUGLAS G BOYDEN
IRWIN M BRAVERMAN
EDWARD NOEL BRENNAN
PADRAIC BURNS
NICHOLAS A COASSIN
EDWARD COPPOLA*
PASQUALE JAMES COSTA
JOHN G DALEY
FRED WENDELL DOYLE
WILLIAM O EDWARD
LEROY ENGEL.
F ROBERT FEKETYJR
MAHLON V R FREEMAN
BARBARA W GIBSON
RUDOLPHJGOERKE3D
Deceased

1956

1957

DONALD AGOSTINELLI
JOSEPH S AMENTA
LOUIS V AVIOLI
F CALVIN BIGLER
JACK NORMAN BLECHNER
RICHARD I BREUER
HARRY C BRIGGS
CARL A BRINKMAN
JOHN P CAREY
ALBERT K CHUN HOON
LOUIS Z COOPER
HAROLD DICK CROSS
JOHN D'AGOSTINO JR
THOMAS H DANAHER
F JOSEPH DANNEMILLER
D JOSEPH DEMIS
JAMES R DORR
EDWARD LOUIS EYERMAN JR
SALVATORE FALBO
HAROLDJFALLON JR
ROBERT E FISHBEIN
RONALD H FISHBEIN
JAMES R FITZGERALD
ANTHONY L FONS 3D
ELIZABETH H FORSYTH
EDWARD O FOX
ROBERT H GLASS
ANNE H GOOD
JACK PETER GREEN
GILBERT F HOGAN
WARREN R JOHNSON

RICHARD LEE KAHLER
ROBERT LINCOLN KAISER
STANLEY E KILTY
WILLIAM LKISSICK
WILLARD A KREHL
EDGAR H LEVIN
JACK LEVIN
MARK D MARSHALL
DAVID E MARTIN III
HOWARD A MINNERS
ROBERT K MODLIN
HUGH LAMSON MOFFET
GEORGE ALBERT NELSON JR
HERBERT A NEWMAN
THOMAS FRANCIS O'BRIEN JR
JOSEPH S PAGANO
RAYMOND E PHILLIPS
CLIFFORD B REIFLER
LATHROP E ROBERTS
MELVILLE P ROBERTS JR
JESSE G RUBIN
ARNOLD A SCHOOLMAN
STANLEY SIMBONIS
KENNETH A SIMON
CHARLES A SLANETZ JR
GILBERT B SOLITARE
ROBERT W SOUTHWORTH
DONALDCSTAHL
ARTHUR TAUB
ROMEO VIDONE
WILLIAM J WASKOWITZ
JAMES G ZIMMER
1958

GEORGE K AGHAJANIAN
JOSEPH E ANGELO
JOHN P ARNOT
GERARD N BURROW
BENJAMIN BURSTEN
DAVID A CARLSON
JOHN A CARLSTON
ROBERT V DISERENS
LAWRENCE DUBIN
DONALD A DUNCAN
JOELCEBERLIN
MICHAEL E FISHMAN
RAYMOND A GAITO
JOHN C GALLAGHER
MARCIA KRAFT GOIN
WILLIAM M GOULD
JAMES GREENWALD
STANLEY HARRIS
ERNEST L HARTMANN
MICHAEL KASHGARIAN
HASKINS K KASHIMA
JAY WARD KISLAK
THEODORE W LIEBERMAN
MYRON LOTZ
THOMAS JMAURO JR
MICHAEL JMC CABE
ANDREW JOSEPH MC GOWAN JR
RICHARD CHARLES MILLER
ROBERT S NEUWIRTH
CAROL F PHILLIPS
DAVID M PUGH
WILLIAM B RADCLIFFE
PAUL A RUDNICK
WILLIAM W SCHLAEPFER
THOMAS R SHEA
BRUCE H SKLAREW
EDWARD LLOYD SOCOLOW
RAYMOND W TURNER
MARGARET SMITH WENZEL
1959

SCOTT INGRAM ALLEN
CAROL J AM1CK
ROBERT MAMICK
ASA BARNES JR

FRANCIS A BEER
JACK F BOWERS
WILLIAM C BUTTERFIELD
EDWARD CALL JR
SIDNEY M COHEN
MARTIN COLODZIN
LYALLSCRARY JR
RONALD C DE CONTI
WILLIAM L DONEGAN
GERALD FENICHEL
ROBERT L FISHER
ROBERT JGONYEA
GERALD B GORDON
W KEITH HADLEY
WILLIAM H HEYDORN
C RICHARD HINCKLEY
LEONARD INKER
JOHN J JASAITIS
EDVARDAS KAMINSKAS
DAVID W KINGSBURY
MYRON SS LEE
KATHRYN HUXTABLE LEWIS
JAMES A O’NEILL JR
ROBERT H OSTBERG
NICHOLAS M PASSARELLI
CHARLES A PHILLIPS
LINCOLN T POTTER
JAMES D PROKOP
JAMES R RALPH
DAVID PARDEE REED
JOSEPH DOUGLASS ROBINSON JR
JOSEPH D SACCIO
CONSTANTINE J SAKLES
MARC D SCHWARTZ
OWEN A SHTEIR
DAVID B SKINNER
SANFORD P SOLOMON
JAMES J STAGNONE
LISA A STEINER
JOHN S STRAUSS
LEO H VON EULER
ROBERT B WHITNEY JR
MURIEL D WOLF
1960

VICTOR ALTSHUL
ALAN W AMES
STUART PBOWNE
DONALD P BUEBENDORF
STANLEY M K CHUNG
NEIL R COOPER
CALDWELL B ESSELSTYN JR
PAUL JAY FRIEDMAN
EUGENE C GAENSLEN JR
JAMES I GILMAN
ROLAND H INGRAM JR
WILLIAMS KADEN
ERIC P KINDWALL
SUSAN TKLEEMAN
THOMAS P KUGELMAN
EDWARD R LANG
THOMAS L LINCOLN
EUGENE G MC CARTHY JR
DONALD L MILLER
RICHARD G MORRILL
ALLAN W NEWCOMB
FRED PALACE
NANCY ROLICK POWELL
ALBERT MATTHEW ROSS
JOHN J SCHROGIE
FRED STARGARDTER
ROBERT CWALLACH
MAY YUNG-FUN WOO WANG
RONALD A YANKEE
1961

KENNETH A ARNDT
EARL L BAKER
ALBERT A BECHTOLDT JR

PAUL DAVID DEITER
RALPH J DEPONTE
T WAYNE DOWNEY
JOHN EFENN
NORBERT FLEISIG
JAMES MGIFFIN
EDWARD C GILBERT
LOUIS D HUNT
RICHARD L KEEFE
ROBERT ISAAC LEVY
JOSEPH RICHARD LUSBY
JOHN A MCCORMACK
RICHARD ALLEN MOORE
NORMAN I MOSS
ROLAND DPAEGLE
ROY E RONKE JR
STANLEY G SCHADE
HUGH C THOMPSON III
FRANKLIN H TOP JR
WARREN DWIDMANN
JOHN R WOODWARD
1962

DAVID L ADAMS
MICHAEL H ALDERMAN
CHARLES B ANDERSON
FREDERIC P ANDERSON
ANN BRACE BARNES
SPENCER J BRODY
DEAN E BURGETJR
FREDERIC K CANTOR
RAY ALLEN CARLSEN
RICHARD N COLLINS
OLIVER TOWNSEND DANN
ARNOLD JOEL EISENFELD
I BRUCE ELFENBEIN
JOSEPH DFERRONE JR
JOHN W FOREMAN
LEROY A FORSTROM
STEPHEN JOHN FRICKER
ROGER P FRIEDENTHAL
JOHN A GODLEY
DAVID HGROTH
RODERICK CHAFF
JOHN T HARRINGTON
FRANK R HARTMAN
PATRICIA CHASSAKIS
J DALE HOWE
VICTOR W HURST III
GARY JACOBSON
GLENN L KELLY
DAVID E KNOOP
JOHN P LYNCH
CARTER L MARSHALL
ALLAN L MATTERN
STANLEY E MATYSZEWSKI
DAVID J MCCONNELL
WILLIAM G MEFFERT
GEORGE STUART MILLER
WILLIAM A MILLER
DAVID D NICHOLAS
A RICHARD PSCHIRRER
JOSEPH ROSS
DAVID SEIL
JAMES A E SPENCER
NANCY ANN STALEY
LARRY LEE STEWART
H OLIVER STOUTLAND
SETH THALER
SHERWOOD WALDRON JR
WILLIAM FARNSWORTH WEBER
STEWART R WRIGHT
1963

ARTHUR HOWARD ACKERMAN
BARBARA ROSENTHAL ALMOND
RICHARD J ALMOND
MIGUEL R ALONSO
V RICHARD BACK

CHARLESWCARL JR
THEODOREJCHU
GORDON S COHEN
JOHN E CONTE JR
DAVID F CROSS
ANDREW EDIN
JOHN PELIOPOULOS
B ALLEN FLAXMAN
WILLIAM T FRIEDEWALD
DAVID H FULMER
ALEXANDER R GAUDIO
F JOHN GENNARI
VINCENT F GEREMIA JR
LEE D GOLDBERG
PETER B GREGORY
GEORGE H HOLSTEN III
HAROLD P KAPLAN
EDWARD C LARKIN
WILLIAM B LEHMANN
CRAIG H LLEWELLYN MC
EDWARD G LUND JR
ROBERT H MARGULIS
HERBERT MELTZER
ROBERT E MUELLER
JAY M POMERANTZ
GENER PROFANT
JOSEPH BUDD STEVENS
PETER V TISHLER
LAWRENCE TREMONTI
HELEN N WALSH
PETER G WEINER
ALFRED J WISE
1964

MILLARD JAMDUR
BERTON W ASHMAN
LELAND S BERGER
PHILIP BLUME
ANTHONY J BRAVO
ROBERT M BRIGGS
THOMAS A CARDELLA
JOSEPH FJCURI
MARY V DIGANGI
ANTHONY FERRANTE
NORMAN C FOST
PETER A GROSS
JOHN FB HANEY
GENE I HIGASHI
LAWRENCE HORWITZ
WILLIAM J HOUGHTON
WILLIAM E KNIGHT
LEWIS LANDSBERG
THOMAS L LENTZ
JAMES S LEVINE
PAUL R LIGHTFOOT JR
RICHARD MURRAY LINBURG
ROBERT W LYONS
WILLIAM F MATCHETT
THOMAS OMC CANN
ROBERTL MITCHELL
ALAN H MORRIS
JAMES J MURPHY
DONALD AO’KIEFFEJR
HOWARD C POMEROY
WILLIAM B PRATT
STANLEY J ROSENBERG
NORMAN SCHER
ROBERT L SHELTON
TADASHI SHIMADA
A THOMAS SNOKE
LYALL C STILP II
SIGRID L TISHLER
STEPHEN WALTMAN
1965

SUSAN A AOKI
THOMAS TAOKI
JOHN H M AUSTIN
PAUL BALTER

VICTOR J BURNER
THOMAS B CALDWELL III
DAVID G CAMPBELL
MICHAEL J CUMMINGS
DAVID S FEDSON
ROBERT I FINKEL
RICHARD I FRANKEL
FRANKJGRADY
GARY LAWRENCE GROSS
ROBERT ANDRE GRYBOSKI
JAMES KGUDE
REID R HEFFNER JR
DAVID A HILL
EDGAR W HULL
RONALD J KARPICK
ROBERT H KOEHL
RICHARD J KOZERA
DAVID J KUPFER
SANDRA CHOOK LEVINE
MARK W LISCHNER
ROBERT R MC MEEKIN JR
WALTER W NOLL
A LAWRENCE OSSIAS
JOHN A PARRISH
ROBERT L PICKENS
ALAN N RACHLEFF
WILLIAM A RENERT
GENE A ROBINSON
JOHN H SEASHORE
MARGRETTA ANN REED SEASHORE
CHARLES J SEMONSKY
DAVID M SHAMES
DAVID P SIMMONS
HARLAN SPITZ
E JAMES STANLEY
BERT YUAN-SHU WONG
1966

BENJAMIN FBALME
JOHN D BAXTER
FRANK C BELL
JAMES EDWARD BROWN
EUGENE PATRICK CASSIDY
DONALDJCOHEN
THOBURN AARON DADISMAN JR
JOSEPH A DONADIO
ROBERT E DRAGON
MARVIN A EISENGART
JARED M EMERY
ROBERT N FRANK
PETER D GIBBONS
JEFFREY B GLUCKMAN
STANLEY I GREENSPAN
J MCLEOD GRIFFISS
ROBERT A GUNN
JAYG HAYDEN
MARY ALICE HOUGHTON
RICHARD J HOWARD
BRUCE W JACKSON
NEAL KOSS
STUART M KOTLER
WILBUR LKUKES
LYNNE L LEVITSKY
HENRY B MANN
HAROLD MELLIN
ELI H NEWBERGER
JAMES DSLAVIN JR
MARK SNIDER
GARY L TOWNSEND
LEE VAN LENTEN
JOAN T WAYLAND
JOHN W WICKENDEN
WILLIAM B YEAGLEY
ARNES YOUNGBERG
RICHARD B YULES
1967

DANIEL L ARONS
ARTHUR L BEAUDET
31

RICHARD S BOCKMAN
DANIEL J BOOSER
GARYC BURGET
MARY WILLIAMS CLARK
CYNTHIA RAPP CURRY
MARIAN C DAVIDSON
JAMES LUCIUS DAVIS III
JAMES J DINEEN
TIMOTHY J DONDERO JR
ALEXANDER FDORA
JAMES M DOWALIBY II
JOHN A DREWS
DENNIS GRANT EGNATZ
HERBERT W FELSENFELD
MELVIN VICTOR GOLDBLAT
RICHARD J HART
RICHARD L HEPPNER
PETER N HERBERT
GEORGE P HERR
DAVID L INGRAM
J ROBERT KIRKWOOD
MELVYN KOROBK1N
ANTHONY P LOVELL
HALBERT BAYLESS MILLER
STEPHEN W MILLER
WILLIAM J MITCHELL
JOSEPH L MORRIS
JENNIFER ROBINSON NIEBYL
JOHNOPASTORE
WILLIAM E PERKINS
BRIAN F RIGNEY
ROBERT I ROY
JONATHAN LSAVELL
ALFRED QSCHEUER
STEPHEN CSCHIMPFF
SIDNEY C SMITH JR
HELEN LSMITS
ROBERT S STEINBERG
RICHARD B SWETT
M DAVID TILSON III
KAREN HTOKER
GEORGETYLER
ROBERT A VOGEL
ROBERT A VOLLERO
JOSEPH F WALTER
MARTIN WAND
ROBERTS K YOUNG
PETER M ZEMAN
196S
JOSEPH F ANDREWS JR
PHILIP L BARRY
DANIEL I BECKER
STUART J BRILL
DONALD RCOUSTAN
RUTLEDGE W CURRIE
BARBARA MAYER EGBERT
ALAN G F1NESILVER
RICHARD A GETNICK
MARK GILBERT GRAND
LEONARD GRAUER
JOHN R HILL 11
HARRY S HOLCOMB III
DANIEL EKEIM
JEFFREY S LEE
MARCELIPPMAN
FRANK E LUCENTE
RODRIGO MARTINEZ
HARMON MICHELSON
DAVID PM1LLETT
JAMES B MORRIS
JOHN A OGDEN
JACKSON B E PICKETT III
CHARLES T POST JR
RALPH JEROME RAUCH
ALFRED QSCHEUER
JACOB JSCHLESINGER
BRUCE STUART SCHOENBERG
32

ELIZABETH M SHORT
HOWARD W SIEGEL
GERALD L SPRINGER
LEE H STROHL
PER HENRIK WICKSTROM
ROBERT J WINER
1969
BRIAN D ALTMAN
CHARLES S ANGELL
DAVID G ANSEL
DAVID W BARRY
ROBERT E BELLIVEAU
JOSEPH P CLEARY
N ROGER COOKE
RICHARD J DALY
CHARLES A DINARELLO
DOUGLASS T DOMOTO
DANIEL M EICHENBAUM
RALPH J FALKENSTEIN
GARYSFARNHAM
STEVEN A FRANKEL
WILLIAM H FRAZIER
ANNAS GAIL
DAVID A GEER
STEVEN M HERZBERG
THOMAS C HOWARD
LEE M JAMPOL
JOEL MARK KAUFMAN
JOHN J KELLY JR
ROZELLA S KNOX
ROWENA KOROBKIN
STEPHEN KRANT
LYNN G LAGERQUIST JR
MICHAEL R LIEBOWITZ
C ELONG III
PAUL A MARKEY
ARNOLD F MAZUR
ELLEN B MILSTONE
THOMAS FMINEHAN
BRUCE K NAGLE
LIONEL M NELSON
NANCY OLMSTED
RICHARD PPOLLIS
DEBORAH A PUTNAM
N BURGESS RECORD JR
JOSEPH D ROBINSON
JOSEPH M ROCHFORD
DENNIS J RUDZINSKI
DAVID JSAHN
LUTZ H SCHLICKE
ADRIAN MSCHNALL
DAVID J SCHULAK
GERALD J SMALLBERG
ROBERTJ WALAT
STEVEN C WHITE
1970
ELISSA B ARONS
HENRY C’HESSIN
MICHAEL JCHUSID
ANNE MCB CURTIS
MICHAEL D DANZIG
JAMES EDE LANOJR
JONATHAN ECKER
BRUCE A FABRIC
THOMAS H GOUGE
PAULC HESSLER
JAY H HOOFNAGLE
ROBERTLJANCO
JONATHAN I) KATZ
MARK A KORSTEN
THOMAS L LEWIS
ANNE W LUCKY
JAY W MARKS
JAMES R MISSETT
WILLIAM K MUELLER
ROBERTM ROSA
JOEL F RUBINSTEIN

DENNIS E SHIELD
STUARTSSHORR
PHILIP ESTEEVES
RAY W TRIPP III
C BRUCE WENGER
JOELLEN WERNE
DANIEL WUENSCH
1971
JUDITH L BADER
MARIAN H BLOCK
WILLARD CATES JR
FREDERICK L COHN
DAVID COSSMAN
EDWARD C COTTLE
MICHAEL CYNAMON
JOHNSEBERSOLE
LEONARD I EISENFELD
THOMAS ETKIN
HARVEY FERNBACH
FRED FINKELMAN
JEROLD ALAN HABER
KENNETH L HARKAVY
WILLIAM W HAY JR
WILLIAM S HOFFMAN
ARTHUR FJONES
RICHARD E KAUFMAN
BARBARA K KINDER
WILLIAM L KRINSKY
LAURENCE W LEVINGER
SHERRY W H LOO
SAMUELS MASTERS
JOHN C MILLS
PATRICK TMINIHAN
STEVEN H MOFFIC
RICHARD ALBERT MOGGIO
MARTIN PARIS
JOHN A PATTI
STUART B PHILLIPS
ANTHONY V PROTO JR
IRVING G RAPHAEL
LAURIE JANE ROSENTHAL
DOUGLAS R SCHMIDT
JAMES PSOUTHWICK
JONATHAN W STEWART
RICHARD D TRAVERS
YVONNE EVAUCHER
PAULA VIGNOLA
ALBERT CARL WE1HL
1972
ROBERT D ARBEIT
MICHAEL A CATALANO
MICHAEL LCHARNEY
ALANJCLARK
PHILIP L COHEN
ROBERT FDEBLASI
FRANCES DEGRAAFF*
NORMAN M DINERMAN
WILLIAM H DRUCKEMILLER
MARC S FELLER
JOHN W FOSTER JR
M FELIX FRESHWATER
DOROTHY M GOHDES
ANDREW H GREENHILL
THOMASLHORN
VERNON H HUMBERT JR
ANTHONY H JACKSON
DONALD L KENT
DAVID LKNEAPLER
PHILIP W LEBOWITZ
THEODORE M LEVIN
PAUL A LUCKY
HARRY LMALECH
JEFFREY S MENKES
JEROME H MEYER
JORGE A MOTTA
DAVID B MOYER JR
JOHN P O'GRADY
Deceased

THOMAS H OGDEN
EDWARD JOLINGER
PETER J PANZARINO JR
JOHN N POSCH
DAVID HROMOND
PHILIP M ROTHFELD
JOHNSSMOLOWE
LAWRENCE PTEMKIN
PHILIP J WEYMAN
BROOKE S WOLF
JOHN D WRIGHT JR
MICHAEL W YOGMAN
STEVEN M ZELDIS
1973
DAVID A ADLER
DAVID NELSON BAILEY
MICHAEL L BRAMLEY
MARY ANN BRUNSTETTER—SHAFER
MARVIN MCHASSIN
CHRISTOPHER M DORAN
JOSEPH W EICHENBAUM
JANE H FERGUSON
RICHARD J FINGEROTH
GEORGE I FRANK
LEE GOLDMAN
GARY V GORDON
NEAL HANDEL
DAVID C JOHNSON
ANDREW G KADAR
SAULLANDE
GEORGE LISTER JR
MARK G F MC CORMICK
JOHN F MC QUADE III
JOHN F NEIL
CLAES M NILSSON
DAVID E PEACH
DAVID PICKAR
CHARLES F REYNOLDS III
JAMES S ROBERTSON
JERROLD F ROSENBAUM
ROBERT A SIROTA
MICHAEL ESOLIN
JOHN R STRA TTON
JAMES F SULLIVAN
THOMAS F SWEENEY
ROBERTJ URSANO
CHRISTINE A WALSH
MARC A WEINBERG
RICHARDS K YOUNG
1974
IRVING M ASHER
DOUGLAS A BERV
NEIL BLUMBERG
PETER J BUCHIN
PAUL DAVID
VINCENT A D1 MARIA
IRLLEXTEIN
REGINALD K FRANKLIN
ALLAN B FRIEDLAND
MICHAEL A GERBER
EDWARD L MARUT
RICHARD C PASTERNAK
ANDREW LRIES
DAVID ZRITVO
DANIEL I ROSENTHAL
HARRY SHAMOON
CAROL CTEITZ
JOHN JONES THOMPSON
JASON S ZIELONKA
1975
RALPH E BINDER
NEIL BLUMBERG
YVONNE E LOMAX BURNETT
BRENDAN CLIFFORD
PAUL A JOHNSON
CAROLLKANDALL
RICHARD J LOEWENSTEIN

EPIDEMIOLOGY AND PUBLIC HEALTH
ROBERT FMALACOFF
HYMAN JM1LSTEIN
MARY JANE MINKIN
ANDREW B NEWMAN
EDWIN G OLSON
DANIEL J PASSERI
VIVIAN REZNIK
PHILIP J RICH
ROBERTS SANDLER
STEVEN A SCHWARTZ
BARBARAJSTOLL
MARK F WHEELER
HENRY SWILLNER
DOUGLAS R ZUSMAN
1976

SARAH S AUCHINCLOSS
ALAN B BLOCH
SHARON L BONNEY
RANDALL DCEBUL
RICHARDS CHILDS JR
JOHN D CLEMENS
VINCENT C DICOLA
JOHN A ELEFTERIADES
GEOFFREY ETHERINGTON
ALICIA GONZALEZ
GLENN AGORLITSKY
RANDALLS HAWKINS
AVIJ HETTENA
NORMAN V KOHN
WILLIAM K LEVY
GEORGE W LUEDKE
LARRY MARKOWITZ
JON S MORROW
PAUL R RAMIREZ
JAMES L ROSENZWEIG
BONITA F STANTON
ROBERT FTAYLOR
PETER M TING
JOHN C WILES
1977

GEORGE BOLEN
JOHN J BORONOW
MARGERY BUCK BRENNER
CHRISTOPHER S CLARK
SYBIL EDUCHIN
ANNE H FLITCRAFT
JAMES A FOX
JULIA B FRANK
ROBERT W HAND
EDWIN K HUANG
BRUCE L INNIS
KAREN G KELLY
DAVID J KREIS JR
MARGARET S MC KENNA
ROBERTJ MITCHELL
R ANDREW PACKARD
ALAN S PENZINER
LAWRENCE E SAMELSON
STEVEN J SCHEINMAN
RICKY M SCHNEIDER
SIMEON A SCHWARTZ
MARKS SMITH
GAIL M SULLIVAN
RONALDJ VENDER
DIANA RWASSERMAN
I DOUGLAS WHITE
1978

MICHAEL J ANDERSON
PATRICIA BELL
DUKE E CAMERON
JESSE MCEDARBAUM
HOWARD M CHASE
MARY-MARGARET CHREN
EMILY A FINE
MARK LFINKLESTEIN
EUGENEGLENN FONG
STUART M FORMAN

ARTHUR M GERSHKOFF
LINDA J HALL
ALEXANDRA N HELPER
ROBERT HERSHFIELD
KENDRICK E LEE
SETH M POWSNER
ROBERT M ROTHBART
NEAL D RYAN
DONALD C SIMONSON
CAROLINE R TAYLOR
MARCIA J WADE
SHARON R WEINSTEIN
1979

NANCY BERLINER
JOANN N BODURTHA
DAVID A BRENNER
STUART L BURSTEN
MICHAEL M CHANG
ORLANDO FERNANDEZ
JOEL I FRANCK
JOHN JAY GARGUS
DAVID E GOLAN
BRUCE HALPERIN
EDWARD C HALPERIN
ARTHUR C JOHNSON III
DAVID E NESS
JEAN ROSENTHAL
GARY LSCHAER
CYNTHIA ANNE SHERMAN
THOMAS JOSEPH SMITH
MARK JAY YEAGER

1923

ISIDORES FALK
LEONARD GREENBURG
1927

ALICES BALDWIN
MARION H DOUGLAS
1929

GERTRUDES BOYLE
1930

RUTH E GROUT
KATHERINE MARDEN
1931

HERBERT FHIRSCHE
1932

LEONA BAUMGARTNER
1933

EDWARD B BOSWORTH
MIRIAM M CAMPBELL
EVELYN H HALPIN
STANLEY B LINDLEY
ELIZABETH MURPHY
EUNICE NICKERSON TYLER
1934

IVAL A MERCHANT
IWAOM MORIYAMA
AMY H WILSON
1935

FRANKLIN M FOOTE
ALMEDA KING
1936

M ALLEN POND

1980

1937

DAVID EADELBERG
SETH LEO ALPER
DAVID ALLEN AUGUST
PATRICIA CHURCH BROWN
MICHAEL W CHAMPEAU
CLAUDIA DINAN
FORREST JOHN DOUD
TODD J GARVIN
DAVID M DKASS
MARY C KORNEI
CESAR R MOLINA
STEVEN IRA ROSENFELD
JEFFREY M SHAPIRO
JEFFREY N SIEGEL
LESLIE WSOJKA
MARCIA R TAYLOR
MARIA L WHITE-GREENWALD

LIDIE V DYER
HOWARD WEST
WILLIAM R WILLARD
1938

WILLARD H BOYNTON
RICHARD KC LEE
KATHERINE HAWLEY MARTIN
LUCY S MORGAN
JEAN H NELBACH
1939

CARL I COHEN
JAMES CHART
FRANCES S MILLER
1940

GEORGE FELDMAN
ELIZABETH H PITNEY
MEYER J PLISHNER

1981

1941

CYNTHIA B ATEN
PATRICIA A BURKE
LOUIS ESSANDOH
JUDY E GARBER
PHILIP D GOLDSTEIN
LAURIE J GORDON
NEIL D GROSS
ANNETTE D GUIDO
SCOTT A HUNDAHL
AIZIZ O LAWOYIN
BARTON N MILESTONE
ROBERT M MILSTEIN
DAVID A PALY
BARBARA A ROACH
ANTHONY M URBANO
JOHN C WONG

ELEANOR H KERBY
ROSLYN LMAC NISH
MILTON ROSE
NINA TOLL
ALEXANDER WITKOW
1942

LEONARD PARENTE
CLAIRE B REINHARDT
CHARLES D SPANGLER
1943

RICHARD F CLAPP
CAROLYN S KOFFLER
ERIC W MOOD
HENRIETTA N PAINE
MIRIAM H ROHDE
ADELEPSCHLOSSER
JANE L WHITE
1944

MASSIMO CALABRESI
JEAN F HESTON
LILY BERMAN MOSTYN
JANE Y PARKER

JOE B GRABER
LOIS M JUND
JOHN C POTKAY
1946

D PATRICIA NELSON
1947

CLARA E COUNCELL
ANNE E FULTON
LILLIAN L KONICK
LEAH LEHRER
JOSEPHINES LEWIS
EDNA MILLER
JEAN M PINDER
CECIL GSHEPS
SAMUEL ZIBIT
1948

MARY L ELLIS
MARY MARGARET FITZGERALD
SAMUELS HERMAN
BARBARA L HOLMAN
RICHARD E JOHNSON
DOROTHEA S LABELLE
DOROTHY FSCHOBER
HIRAM SIBLEY
1949

EDGAR LGEIBEL
ERNEST M GRUENBERG
DOROTHY Y HALL
ELEANOR P KOSTANT
HILDA H KROEGER
CHRISTINE ROWRE
WILLIAM B PARSONS
1950

WYNTHA T BOOTHE
HENRY G BRICKMAN
IDA M BUCHER
HILDA B CARR
AUSTIN J EVANS
JEROME M CLASSMAN
DOROTHY R GRANOFF
EUGENE K HARRIS
MARTHA P JAYNE
EVERETTE D REESE
FRANCES K REYNOLDS
ELIZABETH D ROBINTON
NATHAN M SIMON
JOHN D THOMPSON
1951

HECTOR R ACUNA
CLARISSA E BOYD
CLARENCE WILLIAM BUSHNELL
NORTON G CHAUCER
GEORGE KRAUS
LEONARD FMENCZER
EMITANABEOGI
ANGELICA ZSYSESKY
ELIZABETH ULRICH THROM
VIRGINIA E TORRES
JAMES M A WEISS
1952

CAHID H CORBACIOGLU
HOWARD DUNPHY
VIRGINIA M GOOD
JOANNA ADELE HENRY
MALCOLM C HOPE
ERLEEN FRANCES JAMISON
CHARLES HOLWAY LAWRANCE
SIDNEYS LEE
HELEN KARDYS LORIA
YOLANDEFLYON
ANNE BARLOW RAMSAY
BRENA B WOLFF

1945

1953

ROSLYN R BILFORD
MARY B DALE
NAOMI BARER GOLDEN

JEANETTE AVERILL
HAROLD ROBERT BERNSHOCK
ABRAHAM CUTCHER
33

CECILIA FRANCES Dl CICCO
GRAYDON DORSCH
WILLIAM H HERMANN
BARBARA J LEE
LAURENCE K RAINSFORD
MILTON H SISSELMAN
CONSTANCE B THOMAS

K BERRIDGESOHLER
HAROLD W WICKS
1962

1969

1973

SUSANS ADDISS
VICTOR CROWN
EBELLE EVANS
GERALD R HARPEL
SYLVIA N HOLTZBERG
SAMUEL PKORPER
JUDITH B NICHIPOR
LOREN K OLSON
SAMUEL D ROWLEY
MARVASEROTKIN
GERT M K WALLACH
ROBERT L YOUNG

EVA DANIELSSON COHEN
BERNICE E COLEMAN
ROBERT OIOTT
CHANG S LAO
DENNIS P MAY
GARY DEAN SAX
JANET B SCHOENBERG
ALICES STARK
IRENE TROWELL-HARRIS
BONNIE CYANKASKAS
CARL J ZACK

1970

I WILLARD ABRAHAMS
ROSE SALISBURY BEER
GREGORY BELOK
THOMAS A BENOIT
IAN B BERGER
ELIZABETH M HELMING
STANLEY E KILTY
ALANS KRIMSLEY
ARTHUR L LANCKTON
ROBERTA LAWRENCE
KAREN K LINDFORS
EVELYN B MOSTOW
NILS R RICHARDSON
SHELLEY SSHANOK
ABIGAIL L SMITH
MYRNA M WEISSMAN
BIENVENIDOG YANGCO

1954

1963

DOROTHY WEICHERT BROCKWA\
DAVID DOLINS
C DU VE FLOREY
FRANK M ISBELL
EDWARD M KENNEY
JEAN M MAYNARD
GEORGE EDDY PARKER
RONALD VOGLESONG
SAMUEL B WEBB JR

1955

1956

DAVID D BOYD
KATHLEEN H HOWE
PAULC KAUFMAN
HENRY M PARRISH
1957

LEE DE CADY JR
WILLIAM A CLERMONT
EDWARD R DELOUISE
LILLIAN E JENKINS
PETER PIERDINOCK
JEROME RSAPOLSKY
SHIRLEY TSTEIDEL
PAUL W STERNLOF
SYLVIA RTALBOT
PATRICIA A VISCOSI
1958

HELEN H DAVENPORT
E FIELD HORINEJR
J PHILIP KEEVE
EDWARD H NOROIAN
THOMAS P WEIL

1964

MARIAS BAISIER
ELIZABETH C BELLIS
BARTLEY H CALDER
JAMES JCULHANE
KATHERINE MARIA DETRE
CARTER L MARSHALL
NEALL MASLAN
CAROLE S PROFANT
ALBERT E ROBINSON
THEODORE ROSENBERG
ESTELLESIKER
MONROE W SPERO
CLAUDEWELL SIDNEY THOMAS
1965

ROBERT M EDWARDS
H PATTERSON HARRIS JR
JAMES FJEKEL
MICHAEL EKOVE
CHARLOTTE MILLER
ELLIOT A SEGAL
VIOLA J SPINELLI
ALICE JTUREK
SARAH L TURNER
DAVIDS WEINER

1959

1966

CESAR A ALEMAN
O WADE AVANTJR
CONSTANCE AZZI
RITA DINGMAN
BENNETT I ENOWITCH
JOHN T FOSTER
FOLLY HOFER
WILLIAM L KISSICK
MARVIN A LAVENHAR
LEE J PODOLIN
ELLWYNDSPIKER
KENNETH J WILLIAMS
DOROTHY M WILSON

BARBARA L BRODY
ALLEN COHEN
AMALIA PCRAGO
DOROTHY NOYES EVANS
DIANA B FISCHER
JENNIFER L KELSEY
ROBERT CLOWRIE JR
BIRCH H MILLIKEN
RAIF E NASSIF
NANCYAPERSILY
1967

KATHRYN L D'AMICO
WOUTER EKKER
ROSE AIANNOTTA
KATHARINE ANNA KEPPEL
LOWELL STERN LEVIN
R JOHN C PEARSON
HANNAH CLARK RUSSELL
ELSE NIEBUHR SCHULZE

PETER T ELLIOT-WOTI ON
RICHARD W GERRY
STEVEN JONAS
JOSEPH F KUKLA
PATRICIA D MAIL
JAMES M MALLOY
MICHAEL C QUADLAND
BRUCE JSTEINHARDT
BETH M WHELAN
IRMA WILLNER
ROBERT L WOODWARD

1961

1968

NICHOLAS G ALEXIOU
GORDON R BEEM
MARY S BLACKBURN
MARTIN DONABED1AN
ALFRED E FLETCHER
GEOFFREY M JEFFERY
HELEN M O'CONNELL
MARGARET R PARKER
HERBERT RUBINSTEIN
ANGELA M RUSSO
WILLIAM R SLIVKA

GLENDA DAVIS ANDERSON
SONIA M COLON
JOSEPH L DORSEY
ROBERT R EVERETT
CARL R FISCHER
HAROLD C LOVELY
JEAN C MAC CORISON
RICHARD L PETRELLI
ARNOLD R SASLOW
DOREEN PSHARABATI
SHEILA W WELLINGTON

196(1

34

FREDERICK A VAGO
JOYCE R WAKSMAN

THOMAS A BLUMENTHAL
A KAY KEISER
CHARLES A MAC INTOSH
THOMAS R MAYHUGH

DONALD R COWAN
CALVIN PHATCHER
WILLIAM A MARKEY
RUTH MTABER
CONSTANCE T BEEMER
AMYL CAWLEY
ISRAEL GITLITZ
MORRIS LONDON
MARY MCCMOGAN
FRANCES R OGASAWARA
GERALD ROSENBLATT

ELIZABETH C WRIGHT
BARBARA LYETKA

FREDERICK G ADAMS
SUSAN W BALTER
ROBERT T BEEMAN
MICHAEL B BRACKEN
HAMILTON B BROWN JR
SHAN CRETIN
FORREST G DRESSLER JR
ROBERT SGUREASKO
J KEVIN KINSELLA
PETER ORRIS
DAVID A PEARSON
NANCY NORTON REITZ
CHARLOETTE F SCHWARTZ
STEPHEN SKORCZ
CAROL B VON STEIN
JOSEPH A ZACCAGNINO
1971

JOHN BIHLDORFF
EVELYN J BROMET
WILLIAM F CAREY JR
WILLARD CATES JR
THOMAS W CHAPMAN
KATRINA H CLARK
DALE A CULP
HARVEY FERNBACH
WILLIAM PFERRETTI
ANNE-MARIE A FOLTZ
BILLIES HAMBLIN
SARA P HARTMAN
WANDAJ HATMAKER
MOHAMED ISMAIL JOHNSON
WILLIAM PKOUGHAN
BERNARD G KOVAL
CATHERINE S LINDENBERG
MARK J MAGENHEIM
JOAN L MARTINEZ
EUGENES MAYER
JOSEPH S MC MANUS
LLOYD FNOVICK
WAN HINOOI
CAROLLPAUL
MARCIA RUSSELL
JANE SILVER
WALTER O SPITZER
VICTOR J TUCCI
JUDITH WHITCOMB
1972

STEPHEN B BARUCH
MICHAEL L BENJAMIN
FRANCES L BUSHNELL
C GENE CA YTEN
CATHERINE A CONNOLLY
PAULFINLAYSON
DAPHNE DEJ GEMMILL
DOROTHY N LEWIS
STEVEN M LIPSIUS
GERALD MILLER
SERGIO RUSCHEL
JO ANN K SILVERSTEIN
RAYMOND LSPHAR JR
LAURENCE A TANNER

1974

1975

CLAYTON A AJELLO
CHRISTINE PANTAYA
EDITH N BAUM
RALPH E BINDER
LINDA K BROKER
ANN C CUNNINGHAM
GEORGE R CURRY
HILLARY DEMBY
JACK A EIFERMAN
MARY FRANCES FLYNN
DONNA BROWN GROSSMAN
ANNE H HALL
KENNETH G HILL
ELIZABETH T HUNTER
SUSAN M KAETZ
JAMES EKNOBEN
KATHY S KOHN
NANCY J KREIGER
STUART L LEFKOWICH
ANGELA R MC LEMORE
LAURENCE F MC MAHON JR
LOIS S MICHAELS
EILEEN MO'GARA
MARY W PALSHAW
WILLIAM P QUINN
DALE P SANDLER
EDWARD V SARGENT
NANCY E STROUP
THOMAS J TRUDELL
AUDREYS WEINER
MARION LEE WU
1976

PETER B AARONSON
ELAINE P ANDERSON
WILLIAM FAPPICELLI
ROCHELLE ARCUS-TING
CHERYL FAUSTEIN
CATHERINE M BOYLE
KATHLEEN KEENAN BUCHOLZ
CYNTHIA D BUTLER
DARRYL EUGENE CROMPTON
FRANCES L DE PEYSTER
AGUEDA N DEANS
PAUL H ETKIND

BERTON D FREEDMAN
ANNETTE B GAROFALO
PHILIP D GOLDSTEIN
KAREN A GORDON
DAVID M CUTE
JANET HEINRICH
FRANCES ANNE KANACH
ROBERT A KNAUF
JANINALEVY
GINOANALLI
RUTH FITCH QUAH
JAMES B ROKOS
ROBERT RISDON SCHWARZ
MARY JO SHEPARD
ROBERT SILTEN
MARCIA A TESTA
THOMAS S WINGARDNER JR
1977

RICHARD B BURFORD JR
PATRICK FCARONE
STEVEN R COHEN
BRUCE D CUMMINGS
MARSHA E DUNN
MARY K EICHELMAN
GERARD J FOLEY
PAULA YANEY GAMBILL
DEBRA J GROSSMAN
ELLEN DJASLOW
RHONA KANTOR KERSHNAR
ROBERT WALTER MAKUCH
EDWARD MORGAN
SHARON A MULGREW
CARROLL SCHILLING NEISLOSS
JAMES M O'CONNOR
KRISTIN K O’CONNOR
VERONICA C OESTREICHER
HARRIS PASTIDES
LINDA MENDELSOHN POTTERN
DOROTHY A RICE
WILLIAM T RICHARDS
DEBORAH ROSE
ABBY ROTHSCHILD
ANTHONY V SARDINAS
BARBARA G SMITH
THOMAS H ULFELDER
LEON F VINCI
MARIA W WILLARD
1978

DAVIDS ABERNETHY
KATHLEEN M BERMAN
WILLIAM HARVEY BLITZ
ALAN B BLOCH
ROBERTJ FENSTERHEIM
ROBERT H FRAZIER
ANN T FREEDMAN
NANCY G HILDRETH
STEPHEN W HILDRETH
DAVID W HOUCK
WILLIAM A HOWARD
JEAN CRUM JONES
MARGARET LONG KARIS
ROSLYN I LISS
MAURA ANN LOUGHLIN
MARGUERITE NELLIGAN
ELIZABETH L PANTELICK
TRUDEE PARENTEAU
PATRICIA LYNN PERRY
ELLEN J REIFLER
ELLEN D ROTHBERG
GEORGE C ROUSH
KAREN C SCHNEIDER
MICHELLE D SCHOENBERGER
ROBERT E SCHWARTZ
ROBERTA JO SHAPIRO
ROBERTA NANCY SILBERT
ALAN J SINISCALCHI
MARIE STOECKEL

BERNADETTE S VISSAN1
LUCY ELLEN WEIGER
1979

BRUCES ANDERSON
MARIANNE BERWICK
RHONDA S BESUNDER
RUSSELL J BRAMLAGE
MARIA A BUATTI
JAMES FCONSEDINE II
RICHARD D'AQUILA
SUSAN DE RENZO
FRANCES DWYER
TERRY EDELSTEIN
LYNN FIELDEN-SMITH
JUDITH B GANCHER
LUCINDA H GERSON
BRUCE H HECKMAN
SHELLEY HELFER
KAREN G HELLENBRAND
KAREN KMETZO
PAUL ANTHONY KOWALSKI
RENEES LEARY
JEAN-FERN LIAN
BENNETT MYLES LOCKE
MARY ELISABETH LORENZI
ELISABETH LEE LUTTGENS
OSVALDO MARRERO
WILLIAM MC CUNEIV
PATRICIA J MOORE-PASTIDES
LAUREC NICHOLS
ANNA M REAGER
MARCIA C RICHARDSON
LISA K ROSENFELD
AUDREY PSILVEY
RALPH TARTAGLIONE JR
ELIZABETH TEDDER
MARY JANEATETA
ILENEB WACHS
LOUISE WISE
1980

GARYJ ABOFF
ANNE C BRESCIA
CURTIS S BRESLIN
ANTOINETTE M BROOKE
DEBORAHJCARR
SHELIA LCONNEEN
DIANE L DENIS
CHANTAL C DOTOLI
PHYLLIS F DOWER
AUDREY L FETTER
BETH M FINKELSTEIN
BARBARA H GRANGER
SUSAN BGREENBERG
ELLEN B GREIF
SAMUEL S HAMILTON
VIRGINIAS HUMPHREY
HELEN E KELLY
YEE-LEAN LEE
ROBERT V LEVINE
KATHLEEN A LEWIS
PAUL A LOCKE
ANNE MORRISON MC NALLY
SUSAN W MOORE
STEVEN MORROW
JANE UNGATE O'CONNOR
KRISTINA MARIE OBOM
SHARON IORT
MARGARET G PHILLIPS
ANN L PRESTIPINO
JANE T SIEGAL
RICHARD GERALD STRACQUALURSI
FELICIA TENCZA
W DOUGLAS THOMPSON
THOMAS A TOBIN
GARY F VELAT
RHONA WEISS
MARIE LZANOTTI

1981

NANCY J ANGOFF
CHRISTOPHER J BEVAN
HEIDI BOERSTLER
ANGELO J DE VITA
KRISTEN H FORREST
RICHARD TFORSLEY
ROBERT FOX
BARBARA A GAUGLER
MARIE FGAVULA
JILL GOLDWATER
ROSLYN HAMILTON
SUSAN A HART
JILLLLAPIDES
BLACKFORD MIDDLETON
MARLEE D MOONEY
CHARLES W NELSON
HOWARD J NEWMAN
MARY E PAPKE
MAUREEN T POWER
GERALD W ROBINSON JR
ELIZABETH N SHAPIRO
KARIN SWANSON
JOAN H URQUHART
KATHLEEN R YAGER

HOUSE STAFF
ROBERT A ACHTEL
FREDERICK W ACKROYD
N ERICK ALBERT
JOHN L ALBRIGO
NEILS ALEX
FREDERICK M ANDERSON
ADEL H AYOUB
ROBERT G BACHAND
RONALD J BAILEY
DAVID B BALDWIN
ARNOLD M BASKIN
GREGORY KENT BERGEY
KENNETH BERV
MARY C BIBRO
RALPH DANIEL BIEN
A ROGER BOBOWICK
HENRY M BOWERS
ALAN L BREED
MARVIN B BROOKS
FREDERICK S BRUCKMAN
DENNIS J CARD
WHEIC CHANG
RICHARD ALLEN CHASE
CHANG SONG CHOI
MICHAEL CHUN
JAMES C COBEY
JAMES P COMER
DAVID L COPEN
ALAN R COTE
F MITCHELL CUMMINS
HARVEY DAVIS
MARTIN THOMAS DAVIS
MIECRYLOW DEREN
RICHARD K DONABEDIAN
WILLIAM R DRUCKER
MARLENE R ECKSTEIN
STEPHEN A EDELSTEIN
LAWRENCE B EISENBERG
MALCOLM MITCHELL ELLISON
GERARD A ENGH
ALVAN R FEINSTEIN
ROBERT A FELDMAN
RICHARD WEBSTER FINNER
MORRIS A FLAUM
BRUCE T FLETCHER
DANIEL J FRIEDENSON
GARY E FRIEDLAENDER
NORMAN HGAHM

GEORGE OGELINAS JR
VICTOR P CLASSMAN
BARRY GOLDBERG
ALDO GONZALEZ-SERVA
ISSAC GOODRICH
LAWRENCE GOULD
BARRYNGREENBERG
WILLIAM H GREENE
WILLARD F GREENWALD
JOSEPH GUARALDO
WILLIAM R HAAS
SEYMOUR HABER
HEDDA ANN LITOWITZ HANING
JUAN HERNANDEZ
HUBERT B HOLSINGER
MELVIN HORWITZ
DAVID SMITH HUBBELL
ERIC A HYSON
ROBERT ORVILLE JENSEN
WAYNE JULIAN
BERNARD L KAYE
MICHAEL W KEITH
STEPHEN KING
E LARRY KNIGHT
RICHARD KNOBELMAN
EUGENEKUCHNER
JOELCLABOW
JOHN T LATHAM JR
PAUL JULIUS LAUBE
DOUGLAS M LEVIN
STANLEY B LEVINE
ARTHUR L LEVY
JOHN D LEWIS
JOSEPH W LEWIS JR
STEVEN MACHT
CARMI Z MARGOLIS
RAYMOND C MATTEUCCI
RICHARD J MAUNDER
JOHN PMC GOVERN
PATRICK E MORIARTY
HANS C MUECHLER
RUTH EIKOODA
JOSEPH MANUEL ORTIZ
RAYMOND L OSBORNE JR
ROBERT L PALTZIK
ELAINE BEGUIN PANITZ
PRADIP M PATHARE
EDWARD L RACEK
DONALD C RANKIN
GILBERT A RATCLIFF
RANJITRATH
STEPHEN RAWE
HAROLD E REAVES
PHILIP J RETTIG
CLAUDEROGE
ALLEN ROSSMAN
WILLIAM T ROWE
MARK RUBENSTEIN
JONATHON L SAMBURG
ANTON SCHITTEK
CARL ISCHOENBERGER
LOUIS N SCOTTI
S WILLIAM SEIDMAN
LEONARD M SELSKY
RICHARD ALAN SELZER
THOMAS E SHAFFER
VERNON H SHARP
FREDERICK N SILVERMAN
EARL J SIMBURG
ETHAN A H SIMS
RICHARD I STAIMAN
JOHN G STECIW
ELSA L STONE
FRED LESLIE STRICKER
HERBERT TABOR
IMADFTABRY
JARED R TINKLENBERG
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THEODORETYBERG
DANIEL W VANHEECKEREN
ROMULOL VILLAR
THOMAS A WARTHIN
ALAN WEINBERG
SSU I WENG
HERBERT ALLAN WENNER
GEORGE WHARTON
ROBERT R WHITE 3D
ROBERT J WILLIAMSON
ElJI YANAGISAWA
ROBERT C YOUNG
MARVIN PAUL ZIMMERMAN
RICHARD WALTER ZIMMERMAN
LAWRENCE H ZINGESSER
LOUIS ZINTERHOFER

PARENTS AND FRIENDS
ALAN L AARON
ROBERT AUGUST
STANLEY AUGUST
JOHN & MARIE BABICH
W BAISIER
SUZANNE BERMAN
J BRADLEY
ORMONDEL BROWN
MINNIE R CARTWRIGHT
ABECAZEN
RICHARDS CHILDS
EVIS J CODA
SIDNEY J COHEN
DCONKLE
RALPH DICKER
KENNETH T DORAN
WILLIAM C DRENNAN
J EYMARD
ERNEST J EWASCHUK
MAX FINKELMAN
PETER I FRIED
LGALVEZ
JOSE M GARCIA-MADRID
ROGER W GILBERT
ALLAN GREEN
MYRON GREENGOLD
JAMES GREENWALD
BARBARA J GUILLETTE
KENNETH H GUTNER
EARL HELLERSTEIN
ROBERT EHERZSTEIN
GLORIA F HOLMES
MR & MRS DANIEL KAPLAN
HAROLD KATZ
BORIS KLIOT
RAYMOND W LEE
SANFORD M LEFT
SHIZUO MATSUI

J MEIGS
ETHEL T MERCHANT
JULIUS NESS
HERBERT ANESTLER
WILLIAM G O'DONNELL
RICHARD D OTIS
FLORENCEL PACKOFF
ADOLPH PAOLA
SAMUEL PERLMAN
MARINO PIERATTINI
LEONARD PORTNEY
HOWARD I RATAIN
BARRY D REZNIK
B ROBINSON
IRVING ROSENBERG
JOEL G ROTH
FRED J RUBENS
KLAUS G RUCKER
JACK SALTZ
RICHARD SAYRE
JOSEPH SCHLES1NGER
MELVIN L SCHWARTZ
ARTHUR A SHACHNER
JACKSHANA
SEYMOUR A SIKOV
NORMA F SIMONSON
ANTONIO SIU
ALLEN SOSIN
PHILIP SOSKIS
HOWARD M SPIRO
PAULINE E SWAN-FERM
G TANGOREN
LEO TEITZ
ANTONIO URBANO
BENJAMIN WAGSHAL
U WEIL
HAROLD WEINBERG
MILTON WEINBERG
IRENE GARROW WERNE
TONY Y WONG
ROSALYN YARMUSH

Epidemiology & Public
Health Associates
Thomas H. G. Aitken
Robert E. Brubaker
Edward M. Cohart
George B. Darling
Wilbur C. Downs
Alfred S. Evans
Adolf Pharo Gagge
John Goldman
John W. Meigs
John A. Nelson
Edward M. Opton
Colin White
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MEDICAL CARE OF THE AGED
Paul B. Beeson, M.D.
Dr. Paul B. Beeson, a professor of medicine emeritus, University of Washing¬
ton, Seattle, is editor-in-chief of the Journal of the American Geriatrics Society.
He was one of four distinguished speakers at a symposium on ' 'Ethical Issues in
Health Care" which was a part of the Yale-New Haven Hospital dedication
ceremonies in June 1982. Dr Beeson has given Yale Medicine permission to
publish this unedited transcript of the talk which he gave on that occasion. We
believe that his comments on this topic will be of interest to our readers.

With regard to the topie of ethical issues in the care of the
elderly. I'd better begin by pointing out the limitation of
my perspective. I am not an ethicist or a philosopher. I’ll
be talking mainly on the basis of personal experience with
individual cases, in a setting of academic medicine, in a
tertiary care type of hospital. The patients there, often
elderly, are referred for short-term stays, for diagnostic
procedures or therapy. We have very little opportunity to
observe their lives and progress outside the hospital as in
other types of institutions.
The issues I am going to be talking about have become
much more insistent and much more troubling in the last
thirty years because of developments in science and tech¬
nology of medical care and, particularly, because of the
development of life support systems such as dialysis or
assisted respiration, cardiopulmonary resuscitation, and
so on. One of the ways which ethical issues intrude on
these considerations has already been referred to: the
matter of cost to society, inasmuch as health care amounts
to almost 10% of the gross national product. We are
obliged, I think, to consider the impact of what we do
because we all pay these bills, through our taxes, thirdparty insurance, and so on. One statistic that impressed me
greatly was to hear Dr. Sanders, the former head of the
Massachusetts General Hospital, say that in the decade
between 1965 and 1975, they employed 1,000 additional
people, much of it because of the creation of 10 intensive
care units. Of course, this is one of the reasons why cost is
becoming so important. The elderly are a special case in
point, because, although only 11% of our population is
beyond the age of 65 years, that segment uses up about
30% of the nation’s health bill. So problems of cost in the
care of the dependent elderly are growing, and the problem
is going to get worse because of the demography. More
and more people are living into the age of retirement, long
past the age of child-rearing. Families are becoming
smaller, so that the earning proportion of our population is
shrinking. Certainly after the year 2000, when the effects
of the post World War II baby boom begin to bring that large
chunk of the population into the age of retirement, the care
of the elderly is going to become an even more serious
problem. Another factor in addition to the ones that I've
mentioned is malpractice litigation. There is, of course, a
great increase in the amount of this.
Now, we have entered an area of public discussions
about the matter of sustaining life in patients who have
suffered apparently irreversible brain damage. Our medi¬
cal journals are carrying editorials and general articles
discussing such things as the care of the elderly, the ethical
and societal issues involved. Some new phrases are heard
on the wards nowadays such as “quality of life” and
“death with dignity”. These are tossed about in a some¬
what careless way, without too much definition.
Let me get into this by citing examples of problems that
have made a great impression on me as an internist practic¬
ing in tertiary care hospitals. The first type is one that I saw
soon after I moved to Seattle. I was walking down the
corridor with one of the residents and we came to an old
1

man in a wheelchair. He (the resident) said, “I’ve got to
show you our star patient.” The story was that several
months before, this man had been struck by an automobile
and had suffered multiple fractures of his extremities and
also of his ribs so that he had a flail chest. He was rushed to
the hospital and in the emergency room it was obvious he
could not survive without assisted respiration. This was
begun and still had to be carried out for some hours each
night when I saw him, months later. In the immediate
post-injury period, he suffered a renal shutdown and had
been on dialysis for a while. He also had acute respiratory
syndrome with a '’white lung", which eventually was taken
care of. He had pneumonia and had been brought through
that. He had any number of transfusions. He developed
disseminated intravascular coagulopathy, which eventually
subsided with platelet transfusions and other kinds of care.
They could not do much for the fractures in his extremities
because of these pressing problems, so the fractures were
more or less allowed to heal in whatever positions the
bones were in. This had left him with a good deal of pain.
Two months after the injury, he developed mesenteric
infarction and had to have a bowl resection. This had been
successful, but he was by then a very frail man. I listened
to this story and thought a great deal about it. I could guess
at the expense involved in taking that man through all those
kinds of treatments. Certainly in a hospital where bills are
rendered to the patient's insurance company, the bill
would have been in the tens of thousands of dollars —
perhaps more than an average citizen could hope to save
over a lifetime. I remember, too, that in driving back and
forth to the hospital, I used to pass a public school in a
low-income area of Seattle. The schoolyard had no recrea¬
tional facilities. Paint was peeling from the school build¬
ing, and many windows had broken panes. I kept thinking:
my goodness, what could be done for that school for the
amount of money that was spent in keeping that old man
alive, to suffer a great deal of pain? My own inclination
was that it has been unfortunate that our modem life¬
saving technology had been available. But there is an
important follow-up: I saw that man three or four years
later, when he was admitted to the ward on which I was
attending physician. He was better; he was enjoying life,
and was glad that all of those things had been done for him
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At the other end of this spectrum of dilemmas is a more
common kind of problem. A patient is transferred into the
acute care hospital from a nursing home because he has
fever. On examination it is quickly recognized that the
fever is due to pneumonia. Bacteriologic studies are
carried out, the appropriate antibiotic therapy is given, and
the patient is supported in the intensive care unit for a few
days. But then it is found that the patient is severely
demented, and unresponsive, and no one has come to visit
him. The resident in charge calls the nursing home and
says, "Your patient's fever is gone, his pneumonia is
clearing, but he seems to have become so demented that
we can't communicate with him.” The reply, "Well, he’s
been that way for months. We simply felt we had to
transfer him to you for the treatment of whatever was
causing his fever, but he has been abandoned by his
family. He sits here apparently unaware of events taking
place around him.” Then the question comes up whether
we had performed a worthwhile service by prolonging that
kind of life. I must qualify a bit here, because in the world
outside of academic institutions that kind of surprise
doesn't present itself as frequently, because there is likely
to be a doctor who knows the background and is in much
better position to exercise options about aggressive treat¬
ment than the resident who happens to be on duty in the
emergency room when such a patient comes in, unaccom¬
panied by information about the background.
The matter of expense is one of the most troubling things
in modem medicine. Should we recognize a duty to society
and to our national welfare when we commit the expendi¬
ture of vast sums of money to the care of individual
patients? This is a distasteful thing to have intruding on
one’s clinical thinking — whether one should even give
thought to expense, or whether the entire effort should be
guided by the sanctity of human life and saving of human
life? Those people who champion the view that there
should be no other thought except the duty to prolong life
to the very last possible moment have an easy way of
getting out of this dilemma. Dr. Eugene Stead of Duke,- a
person I have known well for a long time and for whom I
have the highest regard, has written an editorial in the
Journal that I edit. The Journal of the American Geriatrics
Society, April, 1982, entitled "Ethical Issues in the Care
of the Elderly”. He quite courageously, I think, takes up
the subject of the cost of prolonging life and gives very
thoughtful consideration of it. Stead is known for an ability
to see things clearly, without regard to the opinions of
those around him. He speaks of the fact that our society
does countenance some inequities; as examples, he points
to conditions that prevail in many of our institutions for
care of mentally retarded people, the conditions in our
prisons, the conditions in many of our nursing homes, the
conditions of life in some of our inner cities, and he
emphasizes that society is aware of these. Then he
addresses the question whether we are justified in spending
a great deal of money on a patient who cannot be expected
to live more than another three months, or whether that

amount of money ought to go into education of dis¬
advantaged children. He says, “I would lean toward the
latter.” As editor of the journal, I am already beginning to
get some “static” on that statement, likening it to the
attitudes of the Nazi experimentalists.
Let me say just a word or two about the elderly as a
group and our attitudes toward them, whether they’re sick
or well. I've already mentioned that they are increasing in
numbers. More people are living into seventies and
eighties than ever before. There is no question that our
culture tends to have a feeling toward the changes of old
age that can almost be described as abhorrence. The dis¬
tortions of the body and of the mind make us appear
unattractive, and contrast with our enchantment about
youthfulness, and the way we try to look and act youthful.
All one needs to do to get an indication of this is to leaf
through a magazine or to sit and watch advertising on
television. One gets the impression that all of the people
who use toothpaste or deodorant, or who take pleasure
cruises, are good-looking young people. We don’t see very
much about what some people would like to feel are the
beauties of aging. Why do we feel this way? Some psy¬
chologists say it is because we realize subconsciously what
lies ahead for all of us, that we see in those older people the
changes we hate to envision for ourselves. For many
years, I noted an example of this sort of emotion when I
used to take morning report with the housestaff. They
identified with the people in their own age group, and
spoke of their illnesses as “tragic”, but could comment
objectively about the same illnesses in people forty years
older. Then there are the unpalatable bits of hospital lingo
that we hear about the older patients — for example, the
term “gomer”. And articles are being written about the
“hateful patient”. “Gomers” and “hateful patients”
always seem to be older people. This gives us some idea of
the way young health professionals tend to think of the
elderly. And from there we move easily into that much
used phrase, “quality of life”. They are asking them¬
selves: what is the quality of this patient's life? Is it really
life with quality? They’re certainly not using it in the sense
of “the quality of mercy”. They are not talking about high
quality of life. Discussion of the quality of life begins
when considering a person who is really only marginally
existing, in a condition that none of us would ever like to
think of for ourselves. Sometimes the word “quality”
seems to be confused with the word “quantity”. Do we
want to preserve this patient’s life for a few more days or
weeks or months? The difficulty is: can we decide what
quality of life means to that person? It is particularly hard
for young people to decide issues of that kind in the case of
elderly patients. One of the young physicians in Seattle,
who is much interested in ethical issues in medicine, said
recently, “For me, one of the features that makes for
quality of life is the ability to love, but for an elderly,
partially demented women in a nursing home, it may be
represented by the ability to go on crocheting”. This is
worth keeping in mind when we’re thinking about whether

a given patient has a possibility of life of quality. It was
remarked two centuries ago that a person who begins to
take it on himself to decide about the value of someone
else’s life can become the most dangerous person in the
state.
Let’s turn to what is sometimes referred to as passive
euthanasia. That is, for example, withholding antibiotics
when the elderly, dependent patient who seems to have
nothing to live for, develops pneumonia. Or, cutting down
on the intake of fluids; or failing to apply modem therapy
with as much zest and force as we would in a younger
individual. This business of passive euthanasia leads right
into a sort of slippery slope toward inhumane treatment,
and we have got to be awfully careful about the considera¬
tion of withholding antibiotics for the patient with
pneumonia, as in the second example that I presented
when I began.
One of the things that comes up in modem hospitals now
is the question of deciding in advance whether an attempt
will be made to resuscitate a patient who has just died.
Most hospitals now have their own private code which will
summon the emergency team. In the hospital I’ve been
working in, the term simply was “no code”. Perhaps a
more widely used expression is “do not resuscitate”.
There ought to be very careful safeguards in any institution
as to who has authority to write such an order, and what
persons will have to concur in it. Certainly the chief
resident and the attending physician ought to concur. And
the mere fact that that order is in the record should not
necessarily interfere with taking every measure to help that
patient to survive some acute episode, if it appears that
there is a possibility of helping the patient. Ideally, that
kind of decision ought to be taken in consultation with the
patient at a time when the patient is competent to make
such a decision. If not, we have the more difficult problem
of discussing it with the patient’s family. I have always
found a lot of difficulty here because I have a feeling that
making a family help me with that kind of decision may
lead them subsequently to have a feeling of remorse
because they didn’t say, “No. Go for it. Try to keep him
(or her) going”. I don’t have firm answers for this. I do
think that discussing it with the patient well in advance is
something that should be done more often: that patients
will appreciate, and that it can do some good. One system
for handling it is with the so-called “living will”. This
doesn’t have true legal standing, but nevertheless it has a
considerable value for the doctor in charge. The living will
is simply a letter the patient addresses to the doctor at a
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time when the patient is fully able to think things out. It
usually says something to this effect: “If I should become
severely disabled and mentally incompetent, I would pre¬
fer that if after a given period of time — say, two weeks of
care — it appears that I am not showing any improvement,
I would prefer that extraordinary measures not be used to
sustain life". This is designed to help the doctor make that
kind of decision and also to help the family. I have written
such a letter to the doctor in whose care I am at the present
time. I have talked to him about it and he said, “Just what
do you mean?” My reply: “In the simplest terms, I just
don't want to die in an intensive care unit”. If you look
around in an intensive care unit, great as it is, and
marvelous as some of its achievements are, you don't see
any patient there who is having a good time. The patients
are usually supine with things attached to all four extremi¬
ties. If unable to breathe properly, they’re intubated so that
they can't speak. They may be able to write. They never
seem to be turned from side to side but are always on their
backs. This doesn't make a very suitable way to die,
particularly because of all the hustle and bustle of healthy
young strangers going and coming, talking across the
patient about ‘the numbers’ and things of this kind. If you
watch, you rarely see one of them even place a hand on a
patient or engage the patient’s eyes with their own eyes.
It’s a discussion across and above the patient as if he were
not even there.
My worst experience of this kind was with a colleague in
Oxford, a distinguished scientist whom I had known for
some years. We had attended many faculty meetings and
some social engagements together. At the time of his
terminal illness, he had cirrhosis of the liver and had begun
to bleed massively from esophageal varices. We did all the
usual things, but he did not stop bleeding. Finally, in
consultation with the surgeons, it was decided to try an
emergency shunt. He was operated on — a long five hour
procedure — during which he had been intubated, so that
when he regained full consciousness he was unable to
speak. I was in and out of that intensive care unit frequently
during the succeeding five or six days until he died. He
continued to bleed. His wife sat in a little alcove outside.
She would come in to see him now and then. He couldn’t
speak to her. He couldn't even reach out and touch her.
But he would wink at her, and I’ll never forget the sight of
that brave little gesture. I kept asking myself, “What have
we done to give this man such an awful way to die?”
Well, I’m near the end of this. In the last few years in a
veteran’s hospital in Seattle, I have had the experience
many times of having a ward team of residents and stu¬
dents come in to see me about a patient: about this same
question of sustaining life. I think they came to me because
they knew I was old enough to be able to identify with the
patient, and that I had been through this many times
before. I didn't very often say, “Cut off his fluids, or his
assisted respiration”. I usually counseled that we try not to
make a decision about further supportive care for a few
more days, because there was a good possibility the issue
would be decided for us. But I admit that a time or two.
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when a patient we had known for a long time, who
appeared to have widespread malignant disease and he
then developed pneumonia, 1 was willing to say, “I don't
think you have to”. And they would be relieved at this
kind of advice. Whether it’s “right” I am certainly not
going to try to say.
We heard a little about the Hippocratic Oath this
morning. To me the code that has seemed a good deal more
applicable to day-by-day medicine is the few phrases on
the tombstone of Edward Trudeau, a great American
physician of the turn of the century who founded the
Saranac Lake Sanitarium. Trudeau used to paraphrase an
old French saying, “The doctor can cure now and then,
can help often, and comfort always”. It is that last phrase
that appears to be the most helpful one in these dilemmas
— “comfort always” — and “comfort” applies to the
family as well as to the patient.
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THE STUDY OF EVENT- RELATED BRAIN POTENTIALS

By William R. Goff, Ph.D. and Truett Allison, Ph.D.

Drs. Goff and Allison have been co-principal
investigators of the Neurophysiology Laboratory
for twenty-three years. Under their direction,
with the support of Dr. Gilbert H. Glaser, chair¬
man of the Department of Neurology at Yale, and
Dr. Jacob Levine, chief of Psychology Service,
West Haven Veterans Administration Medical
Center, the Laboratory has become one of the
largest of its kind in the world, and has achieved
international recognition for its many research
and clinical contributions.

The dramatic increase in the use of computers and com¬
puter techniques in medical research and application to
health care comes as no surprise to scientists in the
Neuropsychology Laboratory. For over twenty years, the
Laboratory, which is affiliated with the School of Medi¬
cine's Department of Neurology and located at the West
Haven Veterans Administration Medical Center, has been
using computers to study how the nervous system pro¬
cesses sensory input.
Computers are crucial to the non-invasive recording of
the minute electrical potentials generated by the nervous
system in the course of sensory processing. Computer
processing of the electroencephalogram (EEG) permits the
systematic study of these potentials by allowing them to be
recorded from the scalp of humans. Based originally on
animal research in which recording directly from the
exposed brain was possible, it has long been known that
brain cells continuously generate electrical potentials as a
result of electrochemical (ionic) changes which are con¬
stantly ocurring within and between them. Although we
now know that the pattern of these potentials changes
depending on whether the subject is alert or drowsy, awake
or asleep, sick or well, in general the pattern of activity
bears no necessary relationship to external sensory events.

Thus, it is frequently referred to as “spontaneous”
activity.
The discovery of a second type of electrical brain
activity, which is similarly related to sensory input, is attri¬
buted to Richard Caton while he was working at the Royal
Infirmary School of Medicine in Liverpool in 1875. While
recording from the exposed brains of rabbits, Caton found
electrical potentials related to sensory stimulation which
were superimposed on the spontaneous potential oscilla¬
tions. He immediately realized the implications of these
stimulus-related potentials for cerebral localization
studies.
Although reported to the International Medical Con¬
gress held in Washington, D.C. that year, Caton’s work
received little attention. Systematic study of brain electri¬
cal activity directly in humans became possible about 65
years later with the report by Hans Berger, who in 1929
repeated and confirmed Caton’s work, and extended the
work to man by showing that the use of electronic tech¬
nology for amplification and visualization of very small
electrical signals made it possible to record the spon¬
taneous potentials from electrodes placed on the scalp.
This discovery laid the foundation of modem clinical
electroencephalography (EEG).
The type of stimulus-related potentials observed by
Caton, now called “evoked potentials” (EPs), are
generally of lower voltage than the EEG and, therefore,
were poorly resolved by standard EEG techniques. This
adverse ”signal-to-noise” ratio initially limited human EP
research to components large enough to be distinguished in
EEG traces or recorded from the brain during neurosurgi¬
cal operations. Systematic investigation of EPs in man
became more feasible with the demonstration in 1951 by
G.D. Dawson, an Englishman working at National Hos¬
pital in London, that the technique of “signal averaging”
could be used to extract evoked brain potentials from
background EEG noise in human scalp recordings.
In the late 1950's, Dr. Burton S. Rosner, then at the
Yale School of Medicine and the founder of the Neuro¬
physiology Laboratory, became interested in recording
EPs. A psychologist educated in psychophysics and
physiological psychology. Dr. Rosner was interested in
relating subjective sensory experience as measured
psychophysically
to underlying neurophysiological
events.
Since psychophysical determinations require human
subjects who can follow instructions and report sensations,
human EP recording offered the opportunity to study
associated brain activity in the same subjects. Computers
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of any type were a relatively recent development and their
size and cost precluded the dedicated laboratory use
required to apply signal averaging of the EEG to EP
recording. Thus, no instrumentation for such an applica¬
tion was available.
At about the time, Truett Allison came to Yale as a
doctoral candidate in psychology. Since his undergraduate
training was in electrical engineering. Dr. Rosner inter¬
ested him in helping to design and build an averaging
device. In 1959, Dr. William Goff joined the laboratory,
and participated in the later stages of development of what
was basically an analog computer using a continuous-loop
magnetic tape recorder as its “memory.” This twochannel averaging device was a pioneering application of
electronic technology to the recording of EPs from the
scalp of humans.
The Laboratory 's averager was capable of recording a
much longer period after stimulus delivery (averaging
epoch) than Dawson's device, and the scientific staff was
able to observe complex SEP activity lasting as long as 350
to 400 milliseconds post-stimulus. In the 1960's, their
research focused on describing the morphology and scalp
distribution of SEPs, its parcellation into segments by the
demonstration of their different neurophysiological
properties, description of their characteristics under
barbituate anesthesia, which permitted their comparison to
a considerable body of comparable animal literature, and
changes in EP characteristics in various stages of sleep. A
complementary program of animal research was con¬
ducted, oriented primarily to discovering the neuroanatomical origins of human SEPs. Research was also
expanded into the examination of EPs in the visual, audi¬
tory, and olfactory modalities.
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The first EEG averaging device based on digital com¬
puter technology became commercially available in the
early 1960's as well, resulting in a rapid expansion of EP
research throughout the world. Many clinical applications
were attempted, but were not particularly successful,
probably because there was still too little known about the
neuroanatomical substrates of EPs.
The Neurophysiological Laboratory’s (NPL) shift to
more directly clinical research began in 1970 with a study,
conducted by Dr. Peter Williamson, a Yale neurologist.
It was designed both to determine the effect of strokes
affecting the sensorimotor area, and to explore hypotheses
based on animal research about the nature of SEP projection
pathways to the brain. Clinically, a positive relationship
was found between the degree of sensory deficit resulting
from the stroke and alterations in the SEP. The results also
indicated that the sensory projection pathways found in
lower animals, such as the cat, were different from those
of man. This finding, together with the observation that
lower animals have less complex EPs than humans, indi¬
cated that, in general, case development of animal models
of human EPs would require the use of primates.
Both basic and clinical research has expanded rapidly,
and has led to numerous clinical diagnostic and prognostic
applications. The basic advantage of EP analysis for clini¬
cal use derives from the fact that it is an objective, benign,
non-invasive test of the integrity of the somatic, auditory,
and visual sensory systems and associated brain function
which does not require patient cooperation, or even that
the patient be conscious. It therefore has its most valuable
use in conditions where routine neurological examination
is undependable or impossible.
NPL and similar laboratories are currently engaged in
the development of human EP recordings to assist in the
evaluation of neurological disorders. Since some EPs can
be recorded without active participation by the patient (for
example, while the patient is asleep or comatose), they are
valuable in assessing the neurological status of patients
who cannot communicate with the physician. For
example, in collaboration with Drs. Bennett Shaywitz
associate professor of pediatrics and neurology and Peter
Rothstein at Yale, Drs. W.R. and G.D. Goff have been
using somatosensory EPs (evoked by stimulation of the
median nerve at the wrist) to evaluate the neurological
status of children with Reyes Syndrome, a serious, often
fatal disease afflicting young children. Physicians at YaleNew Haven Hospital have had considerable success in
reducing the mortality rate from Reyes Syndrome by using
deep sedation, muscle relaxation, and artificial ventilation
to reduce the abnormally high pressure on the brain and
other effects of the disease. However, this treatment has
the undesirable side effect of preventing the physician
from communicating with the child and from carrying out
neurological examinations. EP recordings from Reyes
Syndrome patients have demonstrated that the degree of
abnormality in EPs relative to those of normal children
provides a useful index of brain function during the course
of treatment, and may predict which children are likely to

have later neurological or behavioral impairment. The use
of EPs to assess the degree of brain damage in other types
of coma and following traumatic head injury is also being
actively investigated.
Another important clinical application of human EP
recordings is to help detect and localize lesions and other
neurological abnormalities located in or near the sensory
pathways. It has become clear over the last ten years that
such lesions can produce definite EP abnormalities even in
patients who report no noticeable symptoms. The detec¬
tion of such clinically “silent” lesions is proving valuable
in the early detection of demyelinating lesions of the type
which later develop into multiple sclerosis, in the early
detection of brain tumors, and in detection of lesions of
several types of hereditary neurological disease in persons
who have affected family members but who have not yet
reported symptoms themselves. Some of these abnormali¬
ties may also be detectable by radiological techniques such
as the CT scan, but some produce little or no structural
abnormality (at least in the early stages of the disease) and
may be missed in radiological studies.
Dr. Allison currently employs a battery of EP tests to
search for such clinically silent lesions and to help verify
the location of lesions whose existence is suggested by
clinical findings or radiological studies. VA patients are
tested at NPL and patients in Yale-New Haven Hospital are
tested in a similar laboratory established by NPL and the
Department of Neurology, and directed by Dr. Ann Hume
research associate in neurology. The EP test battery con¬
sists of stimulating each of the three major sensory
systems - the visual, auditory, and somatosensory systems.
The visual test uses a checkerboard pattern stimulus which
is rapidly moved twice each second so that the positions of

the light and dark checks appear to reverse. This stimulus
produces a barrage of nerve impulses traveling from the
retina through the optic nerve to the thalamus and visual
cortex. Activation of visual cortex produces a characteris¬
tic EP component approximately 100 milliseconds follow¬
ing the checkerboard reversal. As human EPs go, this
potential is relatively large (about five millionths of a volt)
and quite stable in latency in neurologically normal sub¬
jects. Abnormally long visual EP latencies indicate the
presence of a lesion somewhere along the visual pathway.
This technique is currently one of the most sensitive means
of detecting demyelinating lesions in the optic nerve, a
common precursor of multiple sclerosis. During the acute
phase of the disease, patients may experience blurring of
vision or other visual symptoms, but these often disappear
after several weeks. However, recent work suggests that
the demyelination is still present and produces the char¬
acteristic EP abnormality. Thus, a useful feature of this
test is that it allows verification of optic nerve lesions
which may have occurred years earlier and either produced
no visual symptoms at the time or produced symptoms
which disappeared before the person became concerned
enough to see a physician.
The auditory and somatosensory systems are tested with
EPs in a similar manner, using acoustic clicks and brief
shocks to a peripheral nerve, respectively. The auditory
and somatosensory EPs that have been most clinically
useful are those known to be generated by particular
structures along the afferent pathway in each modality. By
determining which potentials are abolished or altered, it is
possible to infer the location of abnormalities in the peri¬
pheral nerve, brainstem, or midbrain. The auditory and
somatosensory EPs are both extremely small (less than a

The photograph illustrates recording of electrical activity from the surface of the brain to locate the sensormotor
cortex during surgical removal of a tumor.
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millionth of a volt) and between 500 and 1000 stimulus
repetitions are usually necessary to resolve them
adequately. Fortunately, such EPs can be recorded at
stimulation rates of 5 - 10 per second, so that the tests can
be carried out in a few minutes. Auditory EPs have been
useful in the early detection of acoustic neuromas,
demyelinating lesions of the brainstem or midbrain, and
other types of neurological disease that affect those brain
regions. Somatosensory EPs have also been useful in
detecting demyelinating lesions, as well as other spinal
cord, brainstem, and midbrain abnormalities.
The pathophysiological mechanisms underlying some
of the EP abnormalities in neurological disorders are rela¬
tively well understood. For example, the abnormally late
visual, auditory, and somatosensory EPs associated with
multiple sclerosis result from demyelinization of nerve
fibers which slow their conduction velocity. The patho¬
physiological mechanisms responsible for other common
EP abnormalities, such as the abolition of certain auditory
and somatosensory EPs, are not yet understood.
EP recordings are also clinically useful in neurosurgery.
When abnormal tissue must be removed from the brain, it
is important to spare cruicial areas such as sensorimotor
cortex and the areas devoted to speech. In collaboration
with Drs. Peter D. Williamson and Dennis B. Spencer of
the Departments of Neurology and Neurosurgery, an NPL
group headed by Dr. Charles C. Wood has developed a
new technique based on cortical surface EP recordings for
use in localizing sensorimotor cortex during neurosurgery.
The traditional localization procedure was developed by
Penfield and colleagues at the Montreal Neurological
Institute in the 1930s and 1940s. It involves stimulation of
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the cortical surface with minute electrical currents.
Stimulation of sensorimotor cortex produces sensations or
movements in parts of the body corresponding to the
cortical area stimulated. Careful mapping of the sensory or
motor responses to stimulation of a number of different
cortical sites allows the location and extent of sensori¬
motor cortex to be estimated. A disadvantage of the proce¬
dure for patients is that the surgery must be performed
under local anesthesia so that they can be awake, coopera¬
tive, and able to report sensations and movements elicited
by the cortical stimulation.
The NPL procedure involves stimulation of the median
nerve at the wrist as in the somatosensory EP recordings
from the scalp described above, and recording from an
array of sterilized electrodes placed directly on the
exposed cortex. The median nerve stimulus produces EPs
which have a characteristic spatial distribution on the
cortical surface. The location of sensorimotor cortex can
be reliably inferred from the form of that spatial distribu¬
tion. The NPL procedure is at least as reliable as the
traditional electrical stimulation procedure, it is faster, and
it does not require the patient's cooperation; hence it can be
used with general anesthesia.
A major value of EPs used in neurological test (para¬
graphs) derives in part from their insensitivity to subjective
states; if the sensory pathways are intact, these EPs will be
present. However, the signal averaging technique has also
been used to study other potentials which are elicited only
when a stimulus has meaning or significance within
information processing tasks which the subject is perform¬
ing. Since such potentials are not, strictly speaking,
“evoked," they have been termed "event-related poten-

Dr. Allison

tials” (ERPs). For example, if subjects are required to
categorize each of a series of tones into two groups (for
example, high versus low frequency tones), ERPs timelocked to those tones will include a group of potentials not
present to the same stimuli delivered without a task. The
timing of those potentials is proportional to the time
required for the categorization: if the task is to categorize
high and low frequency tones, these potentials will occur
about 350 milliseconds after the tone onset, whereas if the
task is more difficult, for example to categorize words into
groups based on their meaning, the potentials will occur
some 200-300 milliseconds later. Such ERPs are thought
to represent activity of brain systems involved in elemen¬
tary cognitive processes.
Dr. Gregory McCarthy of NPL and Dr. Shlomo Bentin,
a visiting scientist from Israel, have been conducting
research concerned with potentials sensitive to psycholo¬
gical task manipulations. There are two goals of this
research: to attempt to characterize the psychological
processes associated with these potentials, and to deter¬
mine what brain systems and structures are responsible for
their generation. In employing this approach, NPL scien¬
tists hope to gain a better understanding of the neurological
basis of certain cognitive processes.
The value and utility of these neurophysiological tech¬
niques depends upon two types of knowledge: the statisti¬
cal limits of normality for potentials recorded from normal
human subjects, and the knowledge of the anatomical
structures which generate scalp potentials. NPL is engaged
in research on both problems. They recently completed
normative studies of some of the EPs used in neurological

testing and have for many years conducted studies on the
anatomical sources of scalp potentials. The latter include
recordings from the exposed cortical surface of the human
brain during neurosurgery and from chronically implanted
electrodes in epileptic patients (see the companion article),
experiments in primates and other nonhuman species
under conditions comparable to those of the human record¬
ings and, together with Dr. Terrance Darcey of NPL, the
development of mathematical models of electrical sources
in the brain.
In summary, the work of NPL has helped to establish EP
and ERP recordings as a noninvasive means of studying
electrical activity of the human nervous system. Such
recordings are valuable as neurological tests for assessing
the functional integrity of the sensory afferent pathways
and related brain structures, and as a means of investigat¬
ing the neural structures involved in human cognitive
processes. Because EP and ERP recordings provide a
measure of some aspects of brain function, they are com¬
plementary to the CT scan and other radiological tech¬
niques for assessing brain structure. Together, such tech¬
niques have in the last decade vastly improved our ability
to “see” deep within the brain from the outside.
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PROGRESS IN TREATING INTRACTABLE EPILEPSY
The Yale epilepsy surgery program is among the
foremost in the world. Its success is due in part to
intensive ongoing research in pre-surgical evalua¬
tion conducted at the West Haven Veterans
Administration Medical Center, as well as to the
development of new surgical procedures at the
Yale School of Medicine. It is also the result of
close collaboration between neurologists and a
surgeon.

Tom Regan met with interviewers in his room in the Yale
Epilepsy Center at the West Haven Veterans Administra¬
tion Medical Center early in April. A handsome and
articulate man in his early thirties, he had come there that
morning from Utica, New York for psychological and
neurological tests, and his head was crowned with a dozen
or so scalp electrodes. A year ago, Mr. Regan had under¬
gone brain surgery to remove the site of epileptic seizures
that had affected him for several years.
An estimated 2 million Americans are epileptic. As a
result of centuries of myths and misunderstanding about
the disorder, a major problem for many of them is not only
their seizures, but the psychological, social and economic
problems the disorder causes.
Derived from the Greek word, epilepsia, meaning ‘"to
seize," epilepsy does not refer to a simple syndrome of
similar symptoms, but rather, to a number of very different
types of seizures that vary widely in severity, appearance,
cause and consequence. Advances in pharmacology have
led to the synthesizing of large numbers of anticonvulsant
agents and today, epilepsy can be partly or fully controlled
in at least three-fourths of all patients. There is new hope as
well for at least some of those patients for whom drug
therapy has not been successful.
In addition to developing new technology and drugs to
control epileptic seizures, the Department of Neurology at
Yale has designed a comprehensive treatment program
which includes psycho-therapy and socio-economic guid¬
ance. The Epilepsy Center at the V. A. Medical Center is a
major part of this program. Designated by the Veterans
Administration as its Northeastern United States Center
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for Epilepsy, it is one of the most highly developed such
facilities in the country.
Dr. Richard H. Mattson, clinical profesor of neurology,
is director of the Center, where twenty-four hour a day
intensive closed circuit TV/EEG monitoring enables more
accurate diagnosis of seizures, as well as related problems.
Its epilepsy surgery program is among the foremost in the
world.
The success of the Yale Epilepsy Surgery Unit is due in
part to intensive on-going research in pre-surgical evalua¬
tion, as well as to the development of new surgical proce¬
dures. It is also the result of collaboration among the
three neurologists of the Unit, Dr. Mattson, Dr. Susan
Spencer, assistant professor of neurology, and Dr. Peter
Williamson, associate professor of neurology, who work
closely with Dr. Dennis D. Spencer, associate professor of
surgery (neurosurgery), who is known world-wide for his
work in epilepsy surgery.
Patients are referred to the Epilepsy Center for surgery
from medical centers throughout the Northeast United
States when medication has failed to control their seizures,
and there is no evidence of other illness or disorders, such
as brain tumors. Criteria for selection include the patient's
age (between ten and fifty years); the possible surgical
accessibility of the disease site; the patient’s interest in and
willingness to comply with the extensive pre-surgical
evaluation; and whether the seizures significantly interfere
with the patient's life.
"We would probably not operate on a patient who, in
addition to his epilepsy, was profoundly retarded and it
was clear that the operation would not greatly improve his
ability to function”, explained Dr. Williamson. Similarly,
the Unit is sometimes referred patients for epilepsy surgery
whose seizures are a problem, but whose psychiatric diffi¬
culties are an even greater problem. They are not con¬
sidered good candidates. “We don’t perform surgery to
alleviate psychiatric problems — we do it for epilepsy. In
fact, we consider major psychiatric problems a contra¬
indication for surgery.”
Ninety percent of all epileptic patients experience their
first seizures before they are twenty years old. Tom Regan
is one of the exceptions. An Army veteran and college
graduate employed as a construction manager of a large
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Depth electrode recording shows the onset of a seizure located deep within the right temporal lobe. Precise localization of such seizure sites, which is not
possible with scalp electrodes, enables Dr Dennis Spencer to successfully remove diseased areas without causing significant compromise to brain function.

firm, he was in his twenties when his seizures began. They
were mild at first but, as they increased in frequency and
severity, he became profoundly depressed and his behav¬
ior became increasingly aggressive. Finally, he had to
resign his job, and could no longer drive his car. When it
became evident that medications and other therapies
would not control his seizures, and in fact his epilepsy was
becoming increasingly more severe, his doctors in upstate
New York referred him to the Epilepsy Center in West
Haven.
Candidates for epilepsy surgery go through a battery of
tests before the decision is made whether or not to operate.
Detailed neuropsychological evaluation includes measure¬
ment of verbal and performance I.Q., verbal and visual/
spatial memory, language and motor function, and sensory
perception. In addition, CT scans and scalp electro¬
encephalograms are made of each patient.
The first human electroencephalogram from the scalp
was recorded in 1929 by Hans Berger, a German psychia¬
trist. His observations that epileptic seizures were
accompanied by major electrical disturbances of the brain
as recorded on the EEG’s, paved the way for subsequent
advances in characterization of epileptic seizures.
Since then, new audio visual and medical technology
have contributed to the development of highly sophisti¬
cated specialized seizure monitoring systems. The Epi¬
lepsy Center, under the leadership of Dr. Mattson, Dr.
Gilbert H. Glaser, chairman of the Department of Neuro¬
logy, Dr. Lewis L. Levy, clinical professor of Neurology
and others at Yale pioneered many of these advances. The
monitoring is done by a highly experienced and motivated
staff of nurses, EEG technicians and other paramedical
professionals.
The display can be tape recorded for repeated examina¬
tion by the staff, which facilitates more precise characteri¬
zation of seizures during sleeping as well as waking hours.
"This information is of great value, not only for the
diagnosis of specific seizure types, but also for the locali¬
zation of the onset of the attack," explained Dr. Mattson.
A patient is considered an appropriate candidate for
continuing evaluation if his or her seizures are consistent
and appear to be coming from a part of the brain where
surgery would not greatly impair vision, speech, motor

control or memory.
Next, electrodes are implanted deep within the brain for
a more accurate localization and description of the sei¬
zures. It is a procedure that involves some initial pain,
since implantation is done with only local anesthesia, and
requires considerable patience on the part of the patient,
who must be restrained in bed for the duration of from
seven to ten days. Although not widely used, the staff at
the West Haven V.A. Medical Center considers depth
electrode recording essential in certain types of epilepsy,
where seizures are likely to be located deep within the
brain on the inside of the temporal or frontal lobe — areas
not readily sampled by scalp electrodes.
Up to four electrodes are inserted on both sides of the
brain. Each electrode has eighteen contacts on it giving a
potential for 144 recording points within the brain. After
they have been implanted, they are hooked up to a moni¬
toring program similar to the one used for scalp electrodes.
The Surgery Unit has developed a sophisticated 64-channel
computerized monitoring system, which is currently under
construction. For the time being, a prototype model is used
which automatically detects and records seizures on
magnetic tape. Patients are closely monitored until a
sufficient number of seizures — at least three — are
recorded, for final decision making about the viability of
surgery.
Although depth electrodes have been used for epilepsy
since the 1950’s, the technique developed by Dr.
Williamson and his colleagues at the Center is unique, and
information derived from it is yielding important new
insights into seizures. "The other two major centers using
depth electrodes insert them from the side of the brain; we
put them in from closer to the mid-line, and one through
the base of the occipital lobe, which penetrates deep into
the posterior lobe,” explained Dr. Susan Spencer. The
electrodes are longer than ones used by other institutions
and therefore, sample a greater area.
The use of the posterior electrode is perhaps the most
critical. “It certainly gives us the most information about
temporal lobe epilepsy," said Dr. Williamson. "We have
learned that occipital lobe onset seizures can look exactly
like temporal lobe seizures. We have also found that many
temporal lobe seizures come from much farther back in
11
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Diagram illustrates typical placement of depth electrodes

that lobe than was previously thought. As a result. Dr.
Dennis Spencer has developed a new technique for remov¬
ing temporal lobe seizures which seems very promising.”
The procedure designed by Dr. Spencer involves
removing part of the hippocampus as well as areas farther
back in the temporal lobe and allows a more complete
removal of the diseased area than previous surgical pro¬
cedures, without significantly compromising vision,
speech, memory and motor function. Through her exhaus¬
tive review of world literature and her experience at Yale,
Dr. Susan Spencer and her colleagues can now predict
that, when seizures are precisely located. Dr. Spencer’s
procedure has a 90 percent chance of curing the epilepsy.
Since the hippocampus is important to memory, a
simple test involving anesthetizing the part of the brain to
be operated on is made. While that side has no sensation,
the patient is presented with various pictures, words and
objects. When the medication wears off, he is asked if he
can remember what he had been shown. ‘‘This tells us how
competent the temporal lobe that will not be operated on is
in terms of memory, and if it’s not, we will not proceed
with the operation,” Dr. Susan Spencer said.
Operations are performed at Yale-New Haven Hospital
by Dr. Dennis Spencer. He operated on Tom Regan last
April. The procedure involved removal of the left tip of the
left temporal lobe — “way down under,” according to
Mr. Regan. It took about six hours and there was some
pain, he remembers. “But that was a minor investment for
a major improvement,” he said with a smile.
For the first six months following the operation, he had
trouble with memory and speech, but that as well as his
attitude improved. “I began to approach things in a con¬
structive rather than destructive way. Now when things go
wrong, I can laugh at them. It’s a great feeling.”
Patients return to the Yale Epilepsy Center for follow-up
testing every three months the year following surgery, then
12

every six months the next year, and annually thereafter.
Although Mr. Regan is still on medication as a pre¬
cautionary measure, some patients have been taken off
anticonvulsant therapy with no adverse affects.
What about patients whose seizures come from multiple
sites or from areas in the brain that cannot be removed
without creating serious deficits? In some, this problem
can be approached by a sectioning of the corpus callosum —
a technique known as “split-brain,” in which the two
halves of the brain are physically separated. The corpus
callosum is a large band of connective neural tissues
resembling a large, multi-cable telephone line, that allows
the two halves of the brain to communicate, and thus
coordinate both sides of the body. Previously done in the
1940's, the procedure fell into disfavor and was discontinued until early in the 1970's when it was revived and
improved by neurologists and surgeons at Dartmouth
Medical School. The Yale team began doing the proce¬
dure, modified by Dr. Dennis Spencer, a few years later.
They are the two leading institutions in the country doing
this type of surgery.
Only patients with extremely severe epilepsy are con¬
sidered — patients whose seizures spread so quickly that
they black out, fall down and suffer many injuries as a
result. Some are so severely impaired they must live in a
padded environment. When the operation is successful, it
establishes better control and reduces the severity of the
seizures. A decrease in abnormal behavior is frequently a
very important side benefit.
Contrary to what has been written in the popular press,
the split-brain operation is not devastating. According to
Dr. Williamson, coordination of the two sides of the body is
a problem at first, but usually improves or the patient
learns how to deal with it. There are admittedly problems
with memory, types of motivation and several intellectual
processes that, in the long run, may make it difficult for the
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patient. “On the other hand, we see incredible gains in
other functions that overshadow these problems. The
seizures are much less frequent and definitely less severe;
the patients no longer fall down or black out with the risk of
terrible injury. “
Three-fourths of the patients who have undergone splitbrain operations during the past decade, either at Dart¬
mouth or at Yale, have had good to excellent results. If
this, and the temporal lobe procedure designed by Dr.
Spencer, have proven so successful, why not opt for
surgery over drug therapy in ail epilepsy?
“That is a good question. The reason is the risks, which
are such that we can only recommend surgery for people
who have no alternative, and for those who we know will
benefit from surgery.” Dr. Susan Spencer replied. “We
know that some patients — those who have never worked
or socialized or done anything productive or functional —
will never achieve functional capacity even if they are
cured of their epilepsy. We play God a little bit sometimes
in making these decisions. But when you consider the
tremendous amount of time and energy involved on the
part of the staff, not to mention the incredible involvement
on the part of the patient and the family, it doesn’t seem

fair to spend all of this to get rid of seizures, when the
family will still have someone they have to take complete
care of anyway,” she added. “On the other hand, we can
take people who have been completely devastated by the
illness and absolutely cure them. It doesn't always work
out the way you hoped it would, but when it does, it is
tremendously rewarding.”
Since epilepsy made it impractical for him to continue
construction management, Tom Regan has learned a new
profession and is now a traffic planner in Oneida County.
He is eagerly awaiting the green light to drive again, and
plans to buy a motorcycle as well. “I feel elated just
looking forward to all of the things I can do again. ”
By Marjorie B. Noyes

The highly experienced and motivated staff of nurses, EEG technicians, and other paramedical professionals allow the Epilepsy Surgery Unit to function at a
high level twenty-four hours a day. They play a critical role in the success of its operation, according to Dr. Mattson.
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DR. COHEN IS APPOINTED
DIRECTOR OF THE CHILD
STUDY CENTER
The Yale Corporation has appointed
Dr. Donald J. Cohen, professor of
pediatrics, psychiatry and psychology,
director of the Yale Child Study Center.
Dr. Cohen is a well-known authority on
mental illnesses in childhood. His
appointment is effective July 1.
In his new position. Dr. Cohen will
succeed Dr. Albert J. Solnit, a distin¬
guished child psychiatrist and author on
the mental health of children, who has
been director of the Child Study Center
since 1966. Dr. Solnit, Sterling Profes¬
sor of Pediatrics and Psychiatry, will
continue his research, patient care and
teaching responsibilities.
Dr. Cohen is also associate director
of the Children’s Clinical Research
Center at Yale-New Haven Hospital,
and co-director of the Yale Mental
Health Research Center. He is inter¬
nationally recognized for his investiga¬
tions in the neurochemical dysfunction,
as well as the cognitive and learning
disabilities of children with disorders
such as autism, childhood psychosis,
aphasia and Tourette’s syndrome.
Applying methods of developmental
psycholinguistics, he and his colleagues
at the Child Study Center have studied
language patterns in autistic and
aphasiac children. In collaborative
studies with teachers and parents, often
involving hours of observation at home
and in schools, they have delineated the
relations between cognitive difficulties
and social competence in these children.
“The detailed description of chil¬
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dren’s underlying competence often
provides a framework for designing
educational interventions for autistic
children.’’ he observed. “While
formal testing may underestimate a
child's true competence, many hours of
careful
observation
can
reveal
remarkable underlying abilities which
can be capitalized on in specially struc¬
tured educational settings.”
Dr. Cohen, who was graduated
summa cum laude from Brandeis
University in 1961, was a Fulbright
Scholar in philosophy and psychology
at Trinity College, Cambridge Uni¬
versity, England for a year before he
attended Yale School of Medicine. He
received the Miriam Kathleen Dasey
Award and his M.D. degree cum laude
in 1966.
During the following two years he
was a research and teaching fellow in
psychiatry at Harvard Medical School
as well as assistant in medicine at Chil¬
dren's Hospital Medical Center,
Boston. From 1970 to 1972, he was a
clinical associate at the National Insti¬
tute of Mental Health, Adult Psychiatry
Branch, as well as special assistant to
the Director of the Office of Child
Development, Department of Health
Education and Welfare.

Dr. Cohen

Dr. Cohen came to Yale in 1972 as
associate professor of pediatrics, psy¬
chiatry and psychology, and was
appointed professor in 1979. He has
received a Woodrow Wilson Fellow¬
ship in Psychiatry (1961); Falk Fellow¬
ship of the American Psychiatric
Association (1970-71); Annual Public
Service Award, National Society for
Autistic Children (1972); Special
Recognition, Hofheimer Prize Board,
American
Psychiatric Association
(1977); and the Ittleson Award. Ameri¬
can Psychiatric Association (1981). He
is a member of the Board of Trustees of
Brandeis University.
The author of numerous publications
and articles on mental illness in child¬
hood, he serves on the editorial boards
of the Journal of the American
Academy of Child Psychiatry, and The
Journal of Child Psychology and Psy¬
chiatry. A fellow of the American

Academy of Child Psychiatry and of
the American Pediatric Society, he is
also a member of the Western New
England Psychoanalytic Society, the
American Psychoanalytic Society, and
the
International
Psychoanalytic
Society.

SECTION OF CELL BIOLOGY
BECOMES A DEPARTMENT:
DR. JAMIESON IS APPOINTED
THE NEW CHAIRMAN
The Yale Corporation has established
the Section of Cell Biology, and has
appointed Dr. James D. Jamieson
chairman of the Department, effective
July 1.
Dr. Jamieson will succeed Dr.
George Palade, who has been chairman
since 1973, when the Section of Cell
Biology was established in the School
of Medicine with a grant from the
Commonwealth Fund. Dr. Palade, who
received the Nobel Prize for Physiol¬
ogy and Medicine in 1974, will assume
his new appointment as Special
Advisor to the Dean of the School of
Medicine on July 1.
Dr. Jamieson, well known for his
research in the structural and functional
correlates of membrane components in
epithelial tissues, is an outstanding
teacher as well. He came to Yale in
1973 from The Rockefeller University,
where he was an associate professor in
the Laboratory of Cell Biology, of
which Dr. Palade was the head.
Bom in British Columbia, Canada,
he attended the University of British
Columbia in Vancouver, where he
received his M.D. degree in 1960. He
was awarded the Eric W. Hamber Gold
Medal for the highest ranking member
in the graduating class, as well as
the Homer Gold Medal in Internal
Medicine.
In 1966, he received his Ph.D.
degree from The Rockefeller Univer¬
sity and was a member of the faculty of
the Laboratory of Cell Biology there
until his appointment as associate pro¬
fessor of cell biology at the Yale School
of Medicine in 1973. He was promoted
to professor in 1975, and was also
appointed professor in the Department
of Biology, Yale University in 1979.
Dr. Jamieson has been director of the
Yale Medical Scientist Training Pro¬
gram since 1975.

Dr. Jamieson

A member of the American Society
for Cell Biology, of which he was
1982-83 president. Dr. Jamieson is
also a member of the Harvey Society,
the American Society of Biological
Chemists, and the American Pancreatic
Association. He is a member of the
editorial boards of Membrane Bio¬
chemistry; Blood Vessels; and the
Journal of Cell Biology.

Dr. Barash

NEW CHAIRMAN OF THE
DEPARTMENT OF
ANESTHESIOLOGY
Dr. Paul G. Barash, professor of anes¬
thesiology, has been appointed chair¬
man of the Department of Anesthesiol¬
ogy. He succeeds Dr. Luke M. Kitahata,
who will resume his research and teach¬
ing activities in the Department.
Dr. Barash’s research interests are
directed at cardiovascular and respira¬
tory physiology as well as critical care
medicine. He has been director of the
Surgical Intensive Care Unit at YaleNew Haven Hospital since 1974.
A graduate of City College of New
York, he received his M.D. degree in
1967 from the University of Kentucky
College of Medicine. Following intern¬
ship at Kings County Medical Center in
Brooklyn, he was a resident in anes¬
thesiology at Yale-New Haven Hospital
from 1970 until 1973, when he was
appointed assistant professor. He was
associate professor from 1978 to 1982,
when he was promoted to professor and
appointed acting chairman of the
Department of Anesthesiology.
Dr. Barash is a member of a number
of professional societies including the
International Anesthesia Research
Society; American College of Chest
Physicians; American College of Anes¬
thesiology; American Society of
Anesthesiologists; Society of Critical
Care Medicine, and the Society of
Cardiovascular Anesthesiologists.
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A NEW CHAPLAIN IS APPOINTED
Dr. Alan C. Mermann, clinical profes¬
sor of pediatrics and a distinguished
pediatrician in the New Haven area for
twenty-five years, has been appointed
chaplain of the School of Medicine. Dr.
Mermann, who is an ordained Protes¬
tant minister, has been actively
involved for many years in ethical
issues both locally and nationally.
The Office of the Chaplain was
established at the School of Medicine in
1967 to support the humanistic needs
and interests of medical students. In
addition to offering counseling to stu¬
dents, the chaplain also conducts
courses on medical ethics. “I hope to
bring certain values to the job,” Dr.
Mermann said. ”1 will approach it as
both a physician and a pastor from a
spiritual and behavioral viewpoint.”
A specialist in pediatric hematology
and oncology. Dr. Mermann received
his B.A. degree from Lehigh Univer¬
sity in 1943, and his M.D. degree from
Johns Hopkins University School of
Medicine in 1947. He was an intern
both at Bellevue Hospital in New York
City and at Johns Hopkins Hospital,
and completed his residency at
Memorial Hospital in New York.
Follow ing military service in Japan as a
lieutenant in the medical corps, U.S.
Naval Reserve, he was a research
fellow at Sloan-Kettering Institute and
was ordained a minister in the Con¬
gregational Church.
Dr. Mermann has been a partner in
private pediatrics practice in Guilford
since 1954. Active in civil rights and
peace efforts throughout his career, he
was a volunteer physician for the Medi¬
cal Committee for Human Rights.
Based on his involvement and observa¬
tions of the health problems of school
children and migrant workers in
Alabama, Tennessee and Florida, he
was one of a team of physicians who
testified before the U.S. Senate on
hunger and deprivation among poor
children of the South.
He was appointed to the Yale faculty
in 1954 as a clinical instructor in
pediatrics, and was appointed clinical
professor of pediatrics in 1979, the year
he received a Master of Divinity degree
from the Yale Divinity School.
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Y-NNH APPOINTS DR. FENN
CHIEF OF STAFF
Dr. John E. Fenn has been appointed
chief of staff at Yale-New Haven Hos¬
pital, effective March 1. He succeeds
Dr. Lawrence K. Pickett, William H.
Carmalt Professor of Surgery, who
resigned as chief of staff, but will con¬
tinue as associate dean for clinical
affairs at the School.
In announcing the appointment, C.
Thomas Smith, president of the Hos¬
pital said, “Dr. Fenn's breadth of
experience and intimate knowledge of
the institution, in conjunction with his
commitment to the Hospital, his
demonstrated skill and integrity, augur
well for Yale-New Haven Hospital. I
am
very
pleased
with
this
appointment.”
Bom in New Haven, Dr. Fenn is a
graduate of Hopkins Grammar School,
Dartmouth College and the Yale School
of Medicine. He received post-graduate
training in surgery at Yale-New Haven
Hospital.
Dr. Fenn's specialty is vascular
surgery. He has been associate chief of
surgery as well as medical director of
the operating room at Yale-New Haven
Hospital prior to his appointment. A
Fellow of the American College of
Surgeons, he is a member of the
American Medical Association, the
Connecticut Medical Society, Connect¬
icut Society of American Board Sur¬
geons, the New England Society for
Vascular Surgery and the Pan-American
Medical Association.

Dr. Mermann

Dr. Fenn

Dr Steitz

Dr. Weissman

TWO FACULTY ELECTED TO NAS

NEW FACULTY

The National Academy of Sciences has
announced the election of Dr. Joan A.
Steitz and Dr. Sherman M. Weissman
as two of its 60 new members in recog¬
nition of their distinguished and con¬
tinuing achievements in original
research. Election to membership in the
Academy is considered to be one of the
highest honors that can be accorded an
American scientist or engineer.
Dr. Steitz is professor of molecular
biophysics and biochemistry. Her
research is directed toward understand¬
ing molecular mechanisms of gene
expression in both bacterial and
mammalian cells. The work is focused
on RNA molecules, their structures and
how they function in processes that
result in information stored in genes
being expressed in the form of proteins.
Recently her investigations have
involved the use of auto-antibodies from
persons with systemic lupus erythe¬
matosus, a rheumatic disease where
patients make antibodies against their
own cellular constituents.
Dr. Weissman’s research has been in
the molecular genetics of SV40 (a
virus), the human hemoglobin genes
and the genes of the major histocom¬
patibility complex. The work has been
concerned with the relation between
gene structure and the regulation of
expression of genes, both in normal and
in diseased states. Dr. Weissman is
professor of human genetics, medicine
and
molecular
biophysics
and
biochemistry.

Ali A. Khodadoust, M.D., was ap¬
pointed professor of ophthalmology,
effective
September
1982.
Dr.
Khodadoust received his M.D. degree
from the Shiraz University School of
Medicine in Iran in 1962. Following
residency training in ophthalmology at
the Johns Hopkins Hospital, he was a
member of the faculty at the Wilmer
Institute prior to returning to Iran. From
1968 to 1980, when he returned to the
Wilmer Institute, he was professor and
chief of the Department of Ophthal¬
mology at the Shiraz University School
of Medicine. He is internationally
recognized for his clinical work and
research on corneal transplantation.
Ellen R. Gordon, Ph.D., has joined
the Liver Study Unit as a senior
research scientist in medicine as of
December 1982. Dr. Gordon, a bio¬
chemist, is internationally known for
her studies of bilirubin metabolism and
the effects of ethanol on intermediary
metabolism in the liver. From 1966 to
1978 she was on the faculty at McGill
University in the Department of
Experimental Medicine and since 1978
she has been research associate and
professor of medicine at the Mount
Sinai School of Medicine in New York
City. She has also served since 1980 as
scientific director of the Alcohol
Research Center at the Veterans
Administration Medical Center, Bronx,
New York.
Effective February 1983, M. Wayne
Flye, M.D., Ph.D., joined the faculty
as associate professor of surgery and
will be responsible for developing a
transplant program. He was previously
on the faculties of Duke University and
the University of Texas Medical
Branch in Galveston. Also as of Febru¬
ary, John F. Tallman, Ph.D., was
appointed as associate professor of
psychiatry. He will direct a research
program in the brain biochemistry of
major mental illness. He has been at the
National Institutes of Health since 1972
and since 1975 in the Section of Bio¬
chemistry and Pharmacology, Biologi¬
cal Psychiatry Branch, National
Institute of Mental Health, where he
was chief prior to coming to Yale.
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SEARCH FOR NEW DEAN
Since Dean Berliner will be retiring in
June 1984, President A. Bartlett
Giamatti has recently appointed a
Search Committee which the President
himself will chair. The Committee is
looking for a nationally recognized
leader in medicine or biomedical
science with proven ability as a scholar
and administrator. It would welcome
suggestions from alumni or others of
any
individuals
who
would
be
considered strong candidates for this
position.
Nominations and applications should
be submitted prior to September 1,
1983. Curriculum and bibliography
should be sent to:
Search Committee for
Dean of the School of Medicine
Yale University
Woodbridge Hall
105 Wall Street
New Haven, Connecticut 06520

YALE STUDENT ELECTED
PRESIDENT OF AMSA
_
Valerie Stone, a fourth year medical
student, is the newly elected 34th
National President of the American
Medical Student Association (AMSA).
She is the fourth woman ever to hold
this position, and is AMSA's first black
president. Prior to this position, Ms.
Stone was the National Coordinator of
Minority Affairs, and also a member of
AMSA’s Board of Trustees in 1981 and
1982.
Ms. Stone will take a year’s leave of
absence to fill the full-time position of
president. She will return to Yale in the
spring of 1984 to graduate. She plans to
specialize in primary care with a major
concentration in pediatric and ado¬
lescent medicine, and is committed to
improving health care policy.

NOTE: The article on The First Yale
Women Medical Graduates on page 10
of the Fall/Winter 1982 issue of Yale
Medicine, was based on an article in the
Yale Journal of Biology and Medicine
(1980), written by Susan Baserga, a
third year medical student.
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UNIVERSITY COUNCIL
COMMITTEE ON
MEDICAL AFFAIRS
Two
new
members
have
been
appointed by President Giamatti to the
Committee on Medical Affairs of the
University Council. The primary func¬
tion of this Council is to study the major
educational programs and activities of
the University and to offer recom¬
mendations for their improvement.
This work is carried out by the Coun¬
cil’s various committees, each of which
has as chairman, a Council member
appointed by the President of the Uni¬
versity. Committee members are not
necessarily Yale alumni — many come
from outside the Yale alumni body,
often from outside the academic world:
but they are all individuals who have
particular expertise in the committee’s
area of responsibility.
The Committee of Medical Affairs
has as its responsibility the School of
Medicine,
including programs in
Epidemiology and Public Health, and
the School of Nursing. It is chaired by
Dr. William L. Kissick.
Other members of the committee are
Mr. Jack R. Aron (B.A. ’28), president
of the J. Aron Charitable Foundation;
Dr. George A. Carden, Jr., (B.A. '31,
M.D. ’35), clinical profesor of internal
medicine at Columbia University
College of Physicians and Surgeons;
Dr. June Osborn, professor of medical
microbiology and pediatrics and asso¬
ciate dean of biological sciences at the
University of Wisconsin; and Dr.
Rozella M. Schlotfeldt, professor of
nursing and former dean of the School
of Nursing, Case-Western Reserve
University.
New members are Dr. Herman N.
Eisen, who is professor of immunology
at the Massachusetts Institute of
Technology, and Dr. Arnold S.
Reiman, editor of The New England
Journal of Medicine.
The Committee held its most recent
semi-annual meeting in New Haven on
April 14 and 15.

SCHOOL'S BUILDING PROJECTS
EARN RECOGNITION
Two recent School of Medicine building
projects have received awards. The
New Haven Preservation Trust pre¬
sented a Merit Award to the School for
its sensitive rehabilitation and creative
reuse of the historic Jane Ellen Hope
Building. The oldest building on the
School’s campus, the red brick and
rough stone building was built in 1902
as a clinic building. Renovations by
architects Alexander Purves and Allan
Dehar Associates for its use as a teach¬
ing facility were completed last fall.
First prize for excellence in consult¬
ing engineering in the category of
mechanical and electrical design was
awarded the School by the New York
Association of Consulting Engineers
for fostering excellence in engineering
of its new chilled water thermal storage
system. The firm of Meyer, Strong and
Jones, P C. were mechanical and elec¬
trical engineers for the facility which
was built to increase the capacity of the
Sterling Power Plant in order to provide
air conditioning for the Yale-New
Haven Medical Center.
Augustus G. Kellogg, director of
facilities planning for the School, was
responsible for organization and plan¬
ning of both projects.

THE YALE JOURNAL OF
BIOLOGY AND MEDICINE TO
PUBLISH THE PROCEEDINGS
OF THE INTERNATIONAL
ORGANIZATION FOR
MYCOPLASMOLOGY
The Yale Journal of Biology and Medi¬
cine w ill publish the Proceedings of the
Fourth International Organization for
Mycoplasmology, which took place in
Tokyo, September 1-7, 1982. The
Proceedings will include approximately
60 papers from scientists in Europe,
Asia, Africa, Australia and North and
South America, concerned with the
clinical, epidemiological, taxonomic,
molecular biological, evolutionary and
immunological characteristics of these
microorganisms and the diseases they
produce. In addition, about 100
abstracts of posters and brief presenta¬
tions will be included

AS ESSELSTYN FELLOW, NEJM
EDITOR VOICES CONCERN
ABOUT DEVELOPING MEDICAL/
INDUSTRIAL COMPLEX
“The issue is whether health care is
going to become simply a commodity
like automobiles or shoes or tomatoes,
and whether we are going to treat it as a
business and allow the market place to
determine the distribution and the cost
of health care," Dr. Arnold S. Reiman
told a group of reporters at a press con¬
ference prior to delivering the 1983
Caldwell B. Esselstyn Lecture on
“Health Care as Commerce, Medicine
as Business: What does Profes¬
sionalism Mean?” The well-known
educator and editor of the New England
Journal of Medicine was on campus
from March 21 to 23 as the Sixth
Caldwell B. Esselstyn Fellow of the
Department of Epidemiology and
Public Health.
Throughout his visit, in informal
meetings and seminars with faculty and
students, and in his lecture, he expressed
concern, first voiced in a controversial
article published in the NEJM in
October 1980, about the major trend
toward the development of a medicalindustrial complex in the United States.
“The personal commitment of the
doctor to his patient, one on one, and
collectively, of physicians to the health
and welfare of society, has been
weakened or strained by the growing
specialization and sophistication of the
means of health care, ” he said.
“Furthermore, the change in the
financing of health care with the third
party reimbursement system has vastly
increased the amount of money being
put into the system and the amount of
money doctors can earn. These two
changes, specialization and third party
reimbursement system, have encour¬
aged a kind of commercialism — an
entrepreneuralism in medicine we have
never seen before. Companies have
gone into the health care business
because the third party reimbursement
system guarantees them a profit and the
more special services they provide, the
more money they make,” he told the
reporters. “It is an irresistible oppor¬
tunity for entrepreneurial capitalism.”
In response to a question from a
reporter whether he thinks things are
better or worse than when he wrote the
article. Dr. Reiman said flatly, “I think
it’s worse. The involvement of the
medical profession in the commer¬

cialism has increased considerably, and
there is a third development — a
change of attitude on the part of
government. As the cost of health care
has increased, and as the federal
government has reduced its commit¬
ment to health care, it is encouraging a
medical market place, by treating
health care as a commodity as a way of
controlling its cost.”
In conclusion the NEJM editor told
reporters, “We don't know what
influence the profit imperative is hav¬
ing on the delivery of health care.
Ideally, I would like to see the medical
profession take more responsibility for
this question. I would advocate that
doctors separate themselves totally
from any financial interest in the health
care industry and accept the principle
that they should only gain financially
from their own personal services and
from overseeing the services of
others ... I advocate that the medical
professionals regulate themselves. It is
imperative that there be careful studies
of the effect of for-profit health care on
the rest of the health care system. ”
The Caldwell B. Esselstyn Fellow¬
ship was established in 1978 to bring to
the Yale community an opportunity for
dialogue on social and ethical issues as
they affect health and the quality of life.
It is the gift of the Esselstyn Foundation
to the Department of Epidemiology and
Public Health in honor of the late Dr.
Esselstyn, Yale Class of 1925, who was
a distinguished physician and humani¬
tarian. Previous Fellows have included
Dr. Lewis Thomas, Dr. Benjamin
Spock, Dr. Edmund Pellegrino, Dr.
Charles Scriver and the late Dr. Rene
DuBois.

A VIDEOTAPE SERIES ABOUT
THE HUMAN VOCAL TRACT

speech therapy and singing.
Although they are a part of a series,
each of the five tapes is designed to
present a separate subject: the adult
vocal tract; structural development;
functional development; structural
evolution; and functional evolution.
Narrated by the author, they include not
only drawings and models but also as
much live action as possible.
To simplify descriptions of how they
function Dr. Crelin made rubber copies
of the vocal tracts. One, using a plastic
larynx and air under pressure, is the
first copy ever made that produces
vowel sounds by the same process used
in living adults.
In the tape on structural evolution,
replicas are shown of nearly all of the
fossil skulls of human ancestors from
5,000,000 to 30,000 years ago. Dr.
Crelin demonstrates how he used skull
base anatomy to reconstruct the vocal
tracts of human ancestors and trace
their lineage to present day humans. It
is noted that the development of the
human vocal tract between three and
six years of age is a synopsis of what
occurred during human evolution
between 1,000,000 and 50,000 years
ago.
Through the use of reconstructed
functional vocal tracts and fossil skull
replicas, the tape on functional evolu¬
tion demonstrates that the evolution of
the vocal tract is related to the develop¬
ment of the frontal lobe in the human
brain. In this tape Dr. Crelin offers the
hypothesis that speech sounds first
became language, which in turn led to
abstract thought.
Further information about the tapes,
which run approximately 30 minutes
and cost $200.00 each, may be
obtained from Videoplay Systems,
Inc., Tolland Industrial Park, P.O. Box
800, Rockville, CT 06066; phone:
(203)875-5211.

With a series of five videotapes. Dr.
Edmund S. Crelin has developed a
creative and comprehensive approach
to tracing the evolution and describing
the anatomy, function and develop¬
ment of the human vocal tract. Pub¬
lished as original research data by Dr.
Crelin, who is professor and head of the
Section of Anatomy, the series is also
intended as teaching material for high
school and college biology courses. In
addition, it should be of interest to
graduate students and professionals in
diverse fields such as anatomy,
embryology, anthropology, linguistics.
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FRY COLLECTION ON VIEW
IN LIBRARY
Works by Peter Breughel. Rembrandt
van Rijn, and Charles Addams are
among those featured in “A NEW
LOOK
FOR
OLD
MEDICAL
PRINTS,” an exhibit currently on view
at the Yale Medical Library. The
exhibit,
subtitled
"Conservation,
Microphotography, and Microcom¬
puters in the Clements C. Fry Collec¬
tion,” was organized to introduce and
explain a new system, developed at the
Library to facilitate and enhance the
cataloging, preservation, and accessi¬
bility of special museum collections.
Combining the technologies of micro¬
image photography with microcom¬
puters, the system is the first of its kind
to be applied in a library or museum
environment. Its development and
application was made possible through
a gift from Hoffman-La Roche,
Incorporated.
The Clements C. Fry Collection,
bequeathed to the Medical Library in
1955, is one of the great collections of
art related to medicine. Its 2000 prints
and drawings present artists’ views of
the practice of medicine over four cen¬
turies. "For many years, the collection
has not been easily accessible to schol¬
ars, and its preservation has been a
serious concern,” said Susan Wheeler,
director of the project and preparer of
the exhibit. "Our purpose was to
develop a practical, low-cost method
for creating full access to the collec¬
tion, while at the same time, preserving
it and maintaining its security. The
project represents a successful collabo¬
ration among specialists in diverse
areas, some of whom have never applied
their expertise to museum or library
problems.”
To facilitate the cataloging and con¬
solidation of records in the Fry Collec¬
tion, Dr. David Stagg, Director of the
Biomedical Computing Unit, developed
and wrote a flexible database manage¬
ment system, which makes available
for the low-cost microcomputer some
of the features of sophisticated pro¬
gramming which have previously only
been available for larger computer sys¬
tems. The program provides for 43
categories of information to be recorded
for each item in the collection, together
with retrieval of a print or drawing by
any category.
A method of visual access to the
collection was devised by William
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Guth, Director of Communications
Media in the School of Medicine. Color
microimages of each item in the collec¬
tion now permit scholars to view
rapidly all, or a portion of the collection
without compromising the security or
preservation of the fragile originals.
Conservation was a major part of the
two-year project. Time, exposure to
sunlight and air pollution, and chemical
interaction of various papers and
mounts had caused a number of the
prints to be on the verge of destruction.
Jane Greenfield, Conservator of the
University Library, supervised the
preservation and restoration of several
hundred of the prints, examples of
which are on view.
The exhibition is designed to demon¬
strate some of the problems of main¬
taining small collections, together with
practical solutions to those problems. It
also reintroduces an important resource
to the community. "Historical research,
using art as a source, is dependent upon
collections such as the Fry Collection.
From historical graphic representations,
it is possible to learn about the customs
and practice of the past,” Ms. Wheeler
noted.

FESTSCHRIFT HONORING
DR. HORSTMANN PUBLISHED
BY THE YALE JOURNAL
Dr. Dorothy M. Horstmann, John
Rodman Paul Professor Emeritus of
Epidemiology and Pediatrics, was
honored at a party in June 1982, given
by her many friends and students;
manuscripts of a group of papers writ¬
ten in her honor were presented to her
on that occasion. These papers have
now been published in a special 230
page issue of The Yale Journal of
Biology and Medicine (Volume 55,
No. 3-4). The distinguished author¬
ship, which reflects the high regard in
which Dr. Horstmann is held through¬
out the world, includes 35 papers con¬
cerned with virology, ranging in scope
from epidemiology to molecular biol¬
ogy. Additional copies are available at
$24.95. These can be ordered from The
Yale Journal of Biology and Medicine,
333 Cedar Street, New Haven, CT
06510.

FACULTY NEWS
At its annual meeting on April 26, the
Greater New Haven Chamber of Com¬
merce presented its Community
Leadership Award for 1983 to Dr.
James C. Comer, Maurice Falk Pro¬
fessor of Psychiatry, Child Study
Center and associate dean of the School
of Medicine. In announcing the award
the Chamber stated, "Dr. Comer’s
contributions to this area have been
most significant. He has been directing
a project for the Yale Child Study
Center in cooperation with the New
Haven Public School systems; he has
been a consultant to other school
systems in the area. The results of the
project he has led have constituted a
success story now being copied in
many other cities.”
Dr. XandraO. Break efield received
a McKnight Neuroscience Develop¬
ment Award in support of her research
on "The Biochemical Component of
Memory: Locating the Gene Responsi¬
ble for Familial Alzheimer’s Disease.”
The Foundation established the awards
to advance research in neuroscience
especially as it pertains to memory and
to a better understanding of disorders
affecting memory and its biological
substrates.
Dr. Joseph S. Fruton and Dr. Robert
Jay Lifton are among 292 scholars,

scientists and artists awarded John
Simon Guggenheim Fellowships for
1983. Dr. Fruton, who is the Eugene
Higgins Professor Emeritus of Molecu¬
lar Biophysics and Biochemistry, will
work on studies in the history of bio¬
chemical sciences; Dr. Lifton, the
Foundations Fund for Research in
Psychiatry Professor of Psychiatry,
will continue research for a book on the
Nazi holocaust and nuclear threat.
The American Society for Microbiology
presented the 1983 Becton-Dickinson
and Company Award in Clinical
Microbiology to Dr. Gueh-Djen Edith
Hsiung for her outstanding contri¬
butions to the field of diagnostic
virology. The award honors a distin¬
guished microbiologist whose research
accomplishments have led to important
clinical microbiology applications. Dr.
Hsiung is professor of laboratory medi¬
cine and chief of the Virology Labora¬
tory at the Veterans Administration
Medical Center, West Haven.

Three School of Medicine scientists
have received research grants from the
American Cancer Society. They are:
Dr. George Miller, the John F. Enders
Professor of Pediatric Infectious Disease
and Epidemiology, who received a
grant in support of his research in the
molecular mechanism of viral transfor¬
mation and oncogenesis; Dr. Ravinder
Nath, associate professor of therapeutic
radiology, who has been awarded a
grant to compare the effectiveness of
americium-241
gamma rays with
radium-226 gamma rays in the treat¬
ment of gynecological cancers; and Dr.
Richard Peschel, assistant professor
of therapeutic radiology, whose grant
will support his study of the underlying
radiobiology which occurs in tumors
treated with continuous low dose rate of
irradiation.
Dr. Mark Cullen has been selected as
a Henry J. Kaiser Family Foundation
Faculty Scholar in Internal Medicine.
Dr. Cullen is director of the Yale
Occupational Medicine Program and of
the General Occupational Health Clinic,
and co-director of the Occupational
Lung Disease Clinic at Yale-New
Haven Hospital.
The Professional Division of the
American Association of Publishers
has awarded the 1982 prize for the most
outstanding book in the behavioral
sciences to Father and Child, edited
by Dr. Alan Gurwitt, associate clini¬
cal professor of psychiatry. Child
Study Center, Dr. Stanley Cath, and
Dr. John Ross. The award was based on
contribution to the field and design of
the book, which was published by
Little, Brown and Company.
In Washington, D.C. on May 24, Dr.
James L. Boyer and Dr. Harold O.
Conn, participated in "Meet the
Researchers Day,” sponsored by the
American Liver Foundation to famil¬
iarize the general public with progress
in research in the treatment of liver
diseases. Dr. Boyer, professor of medi¬
cine, is director of the Liver Study Unit
at the School of Medicine, and Dr.
Conn, also a professor of medicine, is
chief of the Liver Unit at the Veterans
Administration Medical Center in West
Haven.
Dr. Peter Jatlow, professor of labora¬
tory medicine and psychiatry, has been
elected president of the Academy of
Clinical Laboratory Physicians and
Scientists (ACLPS) for 1983-1984.

ACPLS is primarily concerned with
teaching and research in laboratory
medicine. Dr. Jatlow has also been
appointed to the Clinical Chemistry
Test Committee of the American Board
of Pathology.
The Academy of Laboratory Physi¬
cians and Scientists awarded the Gerard
T. Evans Prize to Dr. Joseph Bove,
professor of laboratory medicine, for
"his outstanding contributions to the
science and clinical discipline of
laboratory medicine, and with gratitude
of the many academicians in laboratory
science whose careers were initiated
and enriched by his guidance.” Dr.
Bove is internationally recognized as
an expert on the scientific and clinical
aspects of blood transfusion, and is co¬
author of one of the major textbooks on
this topic.
The School of Medicine has been
selected as one of five institutions to
participate in the third Mental Health
Research Network on Risk and Protec¬
tive Factors in the Major Mental Dis¬
orders. The network which is sponsored
by the John D. and Catherine T.
MacArthur Foundation brings together
internationally recognized investiga¬
tors from the fields of psychiatry, psy¬
chology,
biology,
genetics,
epi¬
demiology and sociology to examine
risk and protective factors in patients
with schizophrenia, antisocial per¬
sonality disorders, and affective dis¬
orders such as depression and manicdepressive illness. Dr. Myrna M.
Weissman, professor of psychiatry,
and Dr. Donald J. Cohen, professor of
pediatrics, psychiatry and psychology
have been named to lead research pro¬
jects for the network at Yale.
Raymond
Yesner,
professor of
pathology, delivered the WHO Lecture
at the 72nd annual meeting of the Inter¬
national Academy of Pathology on
March 1. His topic was classification of
lung tumors. He also addressed the
Arthur Purdy Stout Society of Surgical
Pathologists on small cell tumors of the
lung.

BOOKS BY FACULTY
"Working with Disadvantaged Parents
and Their Children.”
By Sally
Provence, professor of pediatrics,
Child Study Center; and Audrey
Naylor, assistant clinical professor of
social work. Child Study Center. Yale
University Press (New Haven) 1983.
192 pp.
"Indefensible Weapons: The Political
and
Psychological
Case
Against
Nuclearism”. By Robert Jay Lifton,
professor of psychiatry; and Richard
Falk. Basic Books (New York) 1982.
"Thoracic and Cardiovascular Sur¬
gery”, 4th edition. Edited by William
W. Glenn, M.D., Charles W. Ohse
Professor of Surgery.
AppletonCentury-Crofts (Norwalk) 1983.
"Examine Your Doctor, A Patient’s
Guide to Avoiding Medical Mishaps”.
By Siegfried J. Kra, M.D ., associate
clinical professor of medicine. Ticknor
and Fields (New Haven) 1982.
Basic M-Mode Echocardiography”.
By Siegfried J. Kra, M.D. Medical
Examination Publishing Co. (New
Hyde Park, New York) 1982.
"Deductive Echocardiography: Case
Studies”. By Siegfried J. Kra, M.D.;
and Kenneth Schwartz, M.D., assist¬
ant clinical professor of medicine.
Medical Examination Publishing Co.
(New Hyde Park, New York) 1982.
"Strabismus and Ocular Motility”. By
Caleb Gonzalez, M.D., professor of
ophthalmology. Williams and Wilkins
(Baltimore) 1983.
“Basic Neuroradiology”. By Mohammad
Sarwar, M.D., associate professor of
radiology; Behrooz Azar-kia, M.D.;
and Solomon Batnitzky, M.D., Warren
H. Green Inc. (St. Louis) 1982.

Dr. George Palade received an award
from the Yale Science and Engineering
Association. The award was presented
to the distinguished professor and
chairman of cell biology at the Associ¬
ation’s annual meeting on April 6.
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EDWARD H. STORER. M.D.
Edward Hammond Storer, professor of
surgery and associate dean, died on
February 21st, while cutting firewood
on his wood lot in Guilford. A subdural
hemorrhage led to his sudden and
untimely death.
Ed was a gentle man in every sense
of the word. Bom in Rockland, Maine,
in 1921, he embodied all of the fine
qualities that have long been associated
with the descendants of his staunch
New England forebears.
Hardworking, honest and forthright
in his dealings with associates and
friends — compassionate with those in
need, and a keen sense of duty to the
many who relied on him in so many
different ways.
Ed was a man of very few words but
penetrating thoughts — preferring to
express his views and values by the way
he conducted his personal life — a life
lived with integrity, generosity and
devotion to his family.
He received his undergraduate
education at the University of Chicago
where he held an Honor Scholarship
and remained there to complete his
medical studies in 1945.
Perhaps the one phase of Ed's pro¬
fessional life of which he was most
proud were the years spent in the
laboratory of the great Lester Dragstedt
at the University of Chicago Clinics
from 1943 to 1950. It was during this
time that his strong interest in scientific
research was awakened and played a
significant
role
throughout
the
remainder of his life.
There at Chicago, in collaboration
with Dr. Dragstedt, the pioneering
work on the role of the vagus nerve in
gastric secretion was carried out and led
to a totally new concept in the surgical
management of peptic ulcer disease,
which remains predominant today.
These were "heady” times for this
young academic surgeon, in more ways
than one. For it was there that he wooed
and wed Dorothy — his wife of thirtyeight years.
On leaving Chicago in 1952, the
Storers moved to Seattle and the Uni¬
versity of Washington, where they fell
in love with the Great Northwest. Their
stay in Washington, was cut short
however, by an invitation from another
distinguished surgeon. Dr. Harwell
Wilson, to join the faculty of the Uni¬
versity of Tennessee in Memphis, as an
assistant professor of surgery and direc¬
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tor of the Surgical Research Labora¬
tories in 1955.
His research productivity continued
unabated while at Tennessee, publish¬
ing 19 scientific papers and a textbook
of surgery during the following ten
years. His many contributions earned
him a full professorship in surgery and
a joint appointment in the Department
of Physiology and Biophysics.
Yale was fortunate, in 1959, when
Ed accepted our invitation to join the
faculty as a professor of surgery and
serve as chief of surgical services at the
West Haven Veterans Administration
Hospital,
where
he subsequently
assumed the additional roles of chief of
staff and associate dean. Even in the
face of these adminstrative burdens, he
continued to make fundamental contri¬
butions to our knowledge of gastro¬
intestinal physiology through his many
publications. Since 1969, Ed was
editor of the textbook. Principles of
Surgery — probably the leading text¬
book of surgery in the world and cur¬
rently in its 4th printing.
While Ed enjoyed his professional
work immensely, he was a man of
many and varied interests. His fine bass
singing voice, which so few of us were
privileged to hear, was put to good use
from time to time in singing madrigals
and was a reflection of his abiding love
of good music.
His skills with tools of all kinds and
flair for woodworking enabled him,
with Dorothy's careful supervision, to
convert the old Post Office in Sachem's
Head to a charming home where guests
were treated to the Storer’s warm and
gracious hospitality.
High on his list of pleasures was a
good round of golf on the Yale Course,
where he achieved a respectable handi¬
cap and was known to occasionally
pick up a tournament prize.
One of his most remarkable achieve¬
ments, at least to his contemporaries, is
one he shared with Dorothy when they
both passed the qualifying tests in
scuba diving, and as recently as four
weeks ago he and Dorothy were explor¬
ing the mysteries of the Caribbean Sea
at a depth of 150 feet off Bimini Island.
There is much, much more that one
could say about Ed, but he of all
people, would want this to be brief.
I must say we'll miss Ed and his
bright bow ties so lovingly designed by
Dorothy and we are all grateful for the
way this fine man enriched our lives.
J.W.C.

SUSAN C. ALTSHUL, M S N.
Susan Cleveland Altshul. assistant
clinical professor of nursing and psy¬
chiatry. died April 1, 1983 after a long
illness. Mrs. Altshul was bom May 9,
1941 in Norwood, Massachusetts and
attended elementary and high schools
in the Boston area. She graduated from
Skidmore College with a B.S. degree in
nursing in 1963 and worked for two
years as a nurse and an instructor of
nursing as a Peace Corps Volunteer in
Turkey. Upon her return from Turkey,
Mrs. Altshul worked for the Visiting
Nurse Association of Boston for two
years.
She came to Yale in 1967 and in 1969
received a M.S.N. degree from the
School of Nursing. From June 1969
until her death Mrs. Altshul was a cli¬
nical specialist (in psychiatric nursing)
on the staff of the Mental Hygiene Cli¬
nic at the West Haven Veterans
Administration Medical Center. She
established and directed the Continuing
Care Division of the Clinic and
assumed responsibility for the coordi¬
nation of the treatment provided
patients with chronic, disabling psy¬
chiatric difficulties. To this work Mrs.
Altshul brought energy, true caring, an
inquiring mind, and an interest in
teaching others how to do what is easily
seen as unrewarding treatment. She
participated actively in a variety of
research projects and presented at a
number of professional conferences. In
addition to her contributions to the
Mental Hygiene Clinic, she was a
valued member of the Nursing Service
at the Veterans Administration Medical
Center, and was involved in consulta¬
tive and teaching activities throughout
the Medical Center.
Mrs. Altshul is survived by her hus¬
band, Victor Altshul, an associate
clinical professor of psychiatry, and by
two children, Jonathan and Katherine.
Contributions in her memory may be
made to the Susan C. Altshul Fund (by
check payable to "Veterans Admini¬
stration Medical Center,” sent c/o Paul
Errera,
M.D.,
Chief,
Psychiatry
Service, VAMC, West Haven, Con¬
necticut 06516). G.S.G.

The foregoing tribute was presented by
Dr. Jack W. Cole at a Memorial Ser¬
vice for Dr. Storer in Dwight Chapel on
February 24, 1983.

alumni
news
NEW CHALLENGE GIFT FOR THE ALUMNI FUND
In the spring of 1982, announcement was made of Dr.
Leona Baumgartner’s challenge gift to encourage new and
increased contributions to the Medical School Alumni
Fund and the Public Health Alumni Fund for student loans.
Dr. Baumgartner pledged $75,000 for the Student Revolv¬
ing Loan Fund, provided that a further $150,000 in new
money was given by medical and public health alumni and
friends of the School — a one-for-two match. The re¬
sponse was impressive, and as of December 1982 the
$150,000 in new money had been raised to qualify for Dr.
Baumgartner’s $75,000 gift.
Dr. Baumgartner has now offered a new challenge gift

THE ALUMNI IN
MEDICINE COLUMN
Notes from the President
Nicholas P.R. Spinelli, M.D.
Alumni Directories/Alumni Directions
The process is in progress. At this writ¬
ing 4,210 questionnaires have been
mailed to graduates of the Yale School
of Medicine; 1,955 to graduates of
Epidemiology and Public Health;
1,446 to members of Grace-New
Haven and Yale-New Haven Hospital
house staff; 477 to post doctoral fel¬
lows; and 147 to the relative new¬
comers among Yale graduates in the
medical disciplines, the physician asso¬
ciates. The primary message of this
communication (like that accom¬
panying the questionnaire) is: Please
complete and return it promptly,
preferably on receipt.
For those delinquent, one repeat
mailing will be forthcoming. It is frus¬
trating to be presented a deficient direc¬
tory or an inaccurate one; yet a satisfac¬
tory conclusion is contingent on every¬
one's cooperation and performance.
Enough said, almost.
The occasion does provoke rumina¬
tion and questions: inquiry into the
mission, the purpose of our alumni
organization; questions of purposes to
be served by our planned directory.
Will it serve as a tool to guide us to new
or possible future directions? Does it
pose “possibilities” otherwise unseen ?
The inquiry, of course, illuminates
the fragile structural nature of the

of $50,000 for the Student Revolving Loan Fund provided
that an additional $150,000 in new money is contributed.
Thus every dollar that you give to the Medical School or
Public Health Alumni Fund above what you gave the
previous year will now be matched one-for-three. If you
made no gift last year, your contribution this year will be
matched one dollar for every three.
If Dr. Baumgartner’s new challenge is met, the much
needed funds for additional student loans will be signifi¬
cantly increased. We hope that all of our medical and
public health graduates will respond to this magnificent
appeal.

Association of Yale Alumni in Medi¬
cine. The heart of its purpose remains
the quinquennial return to New Haven
for reunion, that tribal and ritual tradi¬
tion whereby we nourish a need to
replenish our energies at their remem¬
bered source. The Executive Commit¬
tee of our Association functions largely
to provide contact and definition for our
reunion weekends each year. It is a
focus as well for the review and tallying
of our fund raising activities. In recent
years these have grown from token
gestures to more passionate statements
of affirmative support for increasingly
needy students. This response has been
a touching and impressive one, and
revealing two of our organization’s
spiritual structure. About half of our
graduates include their school in these
concerns; perhaps the other half
address similar concerns of other insti¬
tutions. Those addressing Yale Medical
and Public Health Alumni Funds have
been increasingly generous.
Our Directory shall, of course, be a
geographic guidepost for professional
reference and consultation. But in a
time when we stand on the threshold of
great change in health care delivery, the
fragmentation of Yale-degree profes¬
sionals to be traced makes our reference
source more diverse and challenging.
Our graduates with M.D., Ph.D., and
Public Health degrees will answer three
different questionnaires. Our trip
through the directory maze of the future
may be more complex and multipurposed than that of the past. In
answering the question of who your

Yale neighbors are, our Directory poses
the challenge of regional organizational
development. The provinces have been
heard from, those interested in such
endeavors are there. The potential for
their flourishing must be allowed to
materialize. Should these ventures take
root, the strength and breadth of our
organization will have broadened struc¬
turally to a meaningful degree in the
decades ahead. Education in medicine,
as in all fields, faces financial stress so
clearly defined in the future. For the
50% who have manifested their con¬
cern for the survival of quality private
education (as was provided them),
access to a regionally structured alumni
group would render the School's cur¬
rent
activities
more
immediate,
available, and involving. With a
broadening of alumni organizational
structure in this manner, the opportu¬
nity for addressing these supportive
acts, be they financial or intellectual,
which are the essence of positive
alumni involvement, would be greatly
enhanced. It would also provide the
faculty and School administration an
opportunity for continuity of a rela¬
tionship equally meaningful to them.
Possibilities for maintaining continuing
education bonds exist. Political, eco¬
nomic, social spin-off come readily to
mind. There are so many possibilities.
May the Directory be a way for the
Yale student in medicine to seek
counsel and direction? To those alumni
close to New Haven and fortunate
enough to have the opportunity to meet
continued on the next page
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Notes from the President — continued

1923

the student of the 80's, one must rank
this as a “possible direction.” Their
responsiveness to even superficial
attention is disarming and provocative.
To know them, however briefly, is to
know that they are the best and the
brightest. Their “Yale espirit” in the
past few years is outstanding in my
remembered time. Class spirit is
achieving renaissance and is so evi¬
dently
psychologically
sustaining.
However superficial the opportunity
for an alumnus to interact with today's
student, one is quick to realize the
universality in time of the student
experience: the inevitable evolution of
role-models among faculty; the vital
cohort-bonding which produces such a
necessary psychologic support system,
never more important in these times of
more intense student stress. Sharing
with them the remembered student
anxieties of whatever era in time is so
immensely reassuring to them and of
value. An interface between student
and alumnus is difficult to achieve
because of time constraints bilaterally,
but it can be productive. To observe
them is to remember ourselves, to
recognize the beginnings of our own
professional matrix. It is to this con¬
stant,
renourishing
environmental
source which we return then, quinquennially, in our Spring.
So again we ask you to respond to the
Directory mission; for our organiza¬
tion, present and future; for its
directions; for its possibilities.

The 1982 Maxwell Bogin Lectures were
held on October 20. The series of lec¬
tures held each fall, deals with current
topics in pediatrics and is structured to
appeal to a wide audience interested in
child healthcare. They were established
in 1978 by the Pediatrics Department of
Bridgeport (Connecticut) Hospital and
sponsored by the friends and former
patients of Maxwell Bogin who was
chief of Pediatrics at Bridgeport Hospi¬
tal from 1949 to 1966. He was co¬
founder of the Children’s Medical
Group from which he has since retired
and is former president of the Hezekiah
Beardsley Pediatric Society and former
state chairman of the Connecticut
Chapter of the Academy of Pediatrics.

CLASS NOTES

1922
In June 1982, on the occasion of her
90th birthday, Helen Langner was
guest of honor at the Milford (Connect¬
icut) Medical Society meeting held at
the Milford Yacht Club. An active
member of the Milford Hospital Medi
cal Staff, Dr. Langner was recognized
for her 60 years of practice in the field
of psychiatry both in Milford and for
many years in New York City.
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1927
News received last fall, but too late to
appear in the fall/winter issue of Yale
Medicine, was that Albert Jablonsky,
having retired in June 1982 after more
than a half-century of private practice
in
Jeannette,
Pennsylvania,
was
honored in a very special way by the
city which he had served for so many
years.
Dr. Jablonsky not only served the
health needs of the people of Jeannette
but was active in community affairs.
Shortly after World War II, he was
among a group of community leaders
who foresaw a need for a community
hospital in Jeannette. In 1947 he was
elected to the first executive board that
directed the organization of planning
and fund-raising for the proposed hos¬
pital which was to be erected as a
“living memorial” to veterans of all
wars. Having had an engineering as
well as a medical degree. Dr. Jablonsky
drew up the original plans for the 99bed hospital and later served as
chairman of the building committee.
When the new Jeannette District
Memorial Hospital opened in 1959
under the operation of the Sisters of
Charity, Dr. Jablonsky was elected the
first president of the medical staff.
Although now retired from practice, he
still holds staff positions at both West¬
moreland
Hospital and Jeannette
District Memorial Hospital.
In an official mayor's proclamation
which cited Dr. Jablonsky’s “unselfish
dedication and humanism toward his
fellow man” during his 54 years of
medical practice, November 5, 1982
was designated as “Dr. Jablonsky

Day” and a testimonial dinner was
attended by his many friends, former
patients, co-workers, hospital associ¬
ates and civic leaders. In addition to
numerous proclamations, resolutions,
and plaques presented in tribute to Dr.
Jablonsky and his work, he and Mrs.
Jablonsky received a special gift of ap¬
preciation—a promise of a trip for two
“anywhere they want to go, at any time
they want to take it.”

1929
A note from Paul McAlenney reported
that Frank D’Andrea had spent several
months in Papua, New Guinea on a
volunteer medical service program. He
noted that Frank has retired from anes¬
thesiology in Stamford, Connecticut to
his Strawberry Hill Farm in Shoreham,
Vermont, but that each year he contrib¬
utes his services as an instructor and
anesthesiologist at some remote area
hospital.
Russell Scobie of Newburgh, New
York, who retired after 50 years of
active practice of pediatrics on June 20,
1982, has received a number of new
honors during the past year. A procla¬
mation by the Mayor of the City of
Newburgh on February 19, 1982 noted,
in part; “The City of Newburgh is
proud of Dr. Russel B. Scobie, who has
not only distinguished himself as an
outstanding pediatrician, but has posi¬
tively affected the health of our entire
community and been an ambassador of
good will for our region. Dr. Scobie's
dedication and commitment have
become hallmarks of quality and ser¬
vice and we are pleased that his alma
mater has honored Dr. Scobie with the
Yale Medal; that he has received the
Joseph B. Goldberger Award in Clini¬
cal Nutrition from the American Medi¬
cal Association; that our regional New
York State Public Health Association
has recognized him with its Distin¬
guished Service Award . . . .”
In October 1982, the American
Academy of Pediatrics selected Dr.
Scobie for a special recognition award
“for his pioneering and sustained ef¬
forts in promoting community water
fluoridation throughout the world.”
Having been instrumental in initiating
the first mass fluoridation system, the
now
famous
Newburgh-Kingston
Water Fluoridation Study in 1945, he
subsequently gained an international
reputation in connection with the use of
fluoride to reduce dental cavities. The

award was made at a luncheon meeting
attended by about 1000 people in New
York City.
Most recently Dr. Scobie received
the 1983 Newburgh Jaycees Distin¬
guished Service Award at a dinner on
March 5 attended by 200 friends and
neighbors. The local newspaper quoted
Russ Scobie as follows: “I think that if
I had to write about myself. I'd title the
book after the old T.V. series 'I Led
Three Lives.' The three lives I would
chronicle deal with my work in pediat¬
rics as a physician, my work for the
Yale Alumni Association, and my pet
project, educating others as to the
importance of water fluoridation. ”

1932
Myron Wegman, dean emeritus of the
School of Public Health at University
of Michigan, gave a principal address
on the occasion of The Pan American
Health Organization’s 80th anniversary
in Washington in December.

1935
Samuel Kushlan retired in June 1982
as associate physician-in-chief, YaleNew Haven Hospital, a position which
he held for 15 years. A most rewarding
aspect of those years was his close
contact with the resident staff who
impressed him not only as very bright,
but also compassionate, intelligent,
and thoughtful. Although hesitant to
admit it, Sam feels that there must be a
great many other such fine young men
and women all over the country and
throughout most of the world, giving
him much more hope about the future
than the media would lead one to
believe.
Sam is continuing his association
with Yale-New Haven Hospital as a
consultant to the chief of staff, a posi¬
tion in which he hopes his accumulated
experience of 51 years in and around
Yale-New Haven Medical Center will
be useful and productive.
He will continue to hold his faculty
appointment as clinical professor of
medicine. Among his other activities,
he continues as co-chairman of the Yale
Medical School Bequest and Endow¬
ment Program and welcomes your
input and support in this crucially
important area. Sam is also a member
of the Advisory Committee on Investor
Responsibility, a committee of the Yale
Corporation.

1936
George Hahn wrote: "After practicing
and teaching for almost forty years in
the Philadelphia area, I decided to
migrate to the Eastern Shore of Mary¬
land.” He now resides in Royal Oak,
Maryland and is serving as tumor con¬
sultant at the Peninsula General Hos¬
pital, a 450-bed institution with a newly
dedicated radiation therapy unit, which
includes an 18 million volt electron
beam machine and a 6 million volt
(photon) machine and a versatile simu¬
lator. He has also been appointed con¬
sultant in gynecology, oncology at the
240-bed Memorial Hospital in Easton.
Dr. Hahn has been a director of the
Yugoslavia-United
States
Medical
Association since its inception about
six years ago, and at the time of his
writing, was planning to go to Sarajevo,
Yugoslavia to attend the Third Scien¬
tific Meeting of the Association where,
in conjunction with a gynecologist
from Yugoslavia he was to moderate a
session on neonatology.
Dr. Hahn also noted: “I am enjoying
serving as class agent since it enables
me to renew contacts with my medical
school classmates. I have heard from
AI Diddle on a number of occasions; he
is in the process of retiring from his
practice in Knoxville.”

1938
Roy Barnett was honored on the occa¬
sion of his retirement on June 30, 1982
after thirty-five years of service as
chairman of the Department of Pathol¬
ogy at Norwalk (Conn.) Hospital. Over
the years, he has earned the affection
and respect of all who know him. At a
dinner in his honor, he was given
recognition for his many accomplish¬
ments during his distinguished service
to the hospital, and it was noted that
under his energetic and untiring leader¬
ship, the department has grown to a
team of more than ninety professionals
in seven laboratories conducting a
multiplicity of tests — half a million a
year — to help identify and arrest
disease.
Among his many innovations are his
intiation of Norwalk Hospital’s first
educational scientific conferences for
the medical staff; his inauguration of
the hospital’s first residency program
providing post graduate specialty train¬
ing for physicians; his establishment of
a school of medical technology; and his
introduction of computer processing to

speed access to patients’ laboratory
data.
Dr. Barnett, a resident of Westport,
has also retired from his position as
clinical professor of pathology at Yale.

1939
Arthur Tucker writes that he has
retired as professor of radiology at the
University of Michigan and has moved
to Colorado. He is still active, how¬
ever, in practice and teaching at the
Fitzsimons Army Medical Center,
where he is pediatric radiologist. He
and his wife. Gale, live at 12339 E.
LaSalle Place, Aurora, Colorado
80014.

1940
It’s high time to sharpen progressively
dulling wits and my pencil to see what
can be accomplished by this attempt to
put a newsworthy column together. My
thanks to Jim Ferguson for making it
possible. I did receive a letter from
Crawford Campbell dated (I shudder)
September 21, 1982, telling me of his
current hormone therapy for a prostatic
malignancy, diagnosed last spring.
There has been a good response to
therapy; Christmas card contact in
mid-December was lacking in further
information. Crawford had seen Jim
Flett’s sister, Mary, sometime back;
she was hoping to set up a scholarship
in Jim’s name, but plans had not as yet
been completed. A letter from Champ
Taylor in August indicates his retire¬
ment as of July 1st last. He spent July
and August at his retreat near Hot
Springs, Virginia, enjoying the “easy
life”. Two later letters from Champ
state that he had open heart (by-pass)
surgery in April 1981 and continues to
do well. Another letter reported that
Jack Haley’s second daughter had died
from a rapidly fulminating unusual
form of malignancy. I would like to
express sincere sympathy to Jack and
his family in the name of 1940ers. A
word about Jim Ferguson who keeps
me informed about some of you, but he
too is in the dark about many of our
class who have chosen to remain silent.
He and Iz were about to depart for
South America (he didn’t say where or
why; maybe to jog in the Andes, or
perhaps because it’s summer down
there). He reports favorably on his
brush with prostatic mitotic activity
(his
euphemism).
Helen
Haury
Woods has written Jim from Texas with
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news of her husband, Dick, and his
problem
with
chronic
hepatitis,
requiring a shunt. Follow-up letters in
November were encouraging. Helen
writes so enthusiastically about "their
island" and the plethora of birds, some
unidentifiable. Sounds idyllic. Her four
children are in the East — one at State
University of N.Y., one at Mt. Sinai in
the Pediatrics O.P.D., and one at
University of Massachusetts. Her son is
in Chicago working on a "fuel-cell
project." A note from Jack Blaisdell
states that he now has given up surgery
and hospital work, confining his
medical activities to "minor trauma,
office orthopedics, consultations, and
second opinions". He has eight grand¬
children "with no end in sight". Maury
Ross has retired, but still lives in Saco,
Maine. (I'm ashamed to say he lives
very close to me, but I never get to Saco
and hence haven't seen him since our
40th.) He has become involved with
community services, such as child
abuse programs, mental health, and
Physicians for Social Responsibility.
He says he is doing well though being
treated for chronic lymphatic leukemia.
He and Ellen were planning to go to
Florida for the months of February and
March. Joe Sokal is still at Duke, and
enjoying North Carolina and his current
project, "an international cooperative
study of chronic myeloid leuke¬
mia". This project has involved travel
to Bologna, Barcelona, Lyon, etc. Joe
reports that #1 son is at the C.D.C. in
Atlanta; #2 son has one more year to go
with the U.S.P.H.S., operating the
only Indian medical clinic in Texas.
Norm Sears sent a long letter to Jim
from Napa, California; he says he feels
"pretty young" most of the time,
except for some hypertension and reti¬
nal problems. He and other family
members had large salmon catches out
on the Campbell River in British
Columbia late last summer. Norm
reports the "class baby," his first son.
is now 46 and very successful. His
second son, Jim, is at Univ. of Massa¬
chusetts in Marine Botany. His third
son lives in Beverly, Mass., and has a
fascinating life involving music —
composing
and
manufacturing
flutes. Norm and his wife, Ty, may
soon be returning to the Palo Alto
area.Wy Dean and Biddy took a trip to
Italy in July, returning to familiar
stomping grounds. Wy reports the
sudden onset of a neurological problem
of vascular origin involving the right
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frontal lobe. Check-up at the Mayo
Clinic produced a "clean bill of
health". He was about to leave for
Sanibel Island in Florida as of early
January. Hank Humphrey is still
actively practicing in Ithaca, and for the
first time is talking about retiring "in a
year or two". (I'll believe it when I see
it!) Hank sent a fascinating review of a
case he handled—a schizophrenic who
performed a Caesarean section on her¬
self with a pen-knife. She sutured
the incision, walked down town with
the premature infant strapped to her
back, and was then picked up by a
police officer who took her to the local
hospital. Needless to say she was sub¬
sequently transferred to a psychiatric
institution. I hope this doesn't start a
new trend in obstetrics! If allotted
sufficient space I would send to all
1940ers the article from the Hartford
Hospital entitled "A Roast for Ronny"
on the occasion of Ron Beckett's
retirement from the Department of
Pathology at Hartford. The "roast"
was given by one of his former resi¬
dents. It is a glorious but side-splitting
tribute to Ron. a delightful characteri¬
zation. I honestly doubt Ron has really
retired; he is so engrossed in his nomen¬
clature project. Jim Ferguson had a
communication from Lee Sannella
regarding "his interest in clarifying
energetic states active in people
today". My background in mundane
things like child-bearing precludes
comprehension of many facets of Lee's
activities. He is also one of the directors
of the Aesop Institute in Sebastopol,
California, concerned with research in
energy.
Such
widely
diversified
endeavors boggle the mind, at least my
mind. Your class secretary's life in
Maine goes on in an uneventful, non¬
medical sort of way. Thus far the winter
has seemed like autumn with unseason¬
ably warm days. It makes one feel like
ordering seeds, roto-tilling the garden,
and doing other such like things. But
never fear—the white stuff will come
and 1 can once again dust off the cross¬
country skis. I continue my volunteer
efforts with the Red Cross Blood
Services, Northeast Region, exercise
my Anglophilic propensities, occasion¬
ally discussing George Ill's affliction
with porphyria. Not a very exciting life
by some standards, but I do not regret
my decision to retire early. Once again
I extend a sincere invitation to any
1940ers who wander this way.
Class Secretary’, Donald G. Johnson
Box / IS Bar Mills. Maine 04004

1941
Gioacchino Parrella was elected pres¬
ident of the Connecticut State Medical
Society for 1982-83. He is a former
president of the New Haven County
Medical Association and practices
general surgery in Milford.

1942
William Fleeson. the first associate
dean for student affairs in the school of
Medicine at the University of Connect¬
icut Health Center, retired on October
1st. Dr. Fleeson. who was appointed to
the faculty at the University of Con¬
necticut in 1963, was one of the six
original members who took part in the
detailed planning of the medical and
dental schools and the Health Center's
programs and facilities. Dr. Fleeson
established admissions procedures for
the School of Medicine, and in 1968,
the first medical students were admitted,
graduating in 1972. In 1974 he resigned
his position as associate dean to
concentrate on teaching as a professor
of psychiatry.

1944
At last writing, Robert Frelich had
assumed the role of program director of
the Division of Resources, Centers and
Community Activities of the National
Cancer Institute in Washington while
taking a sabbatical from his active
oncology practice in Wilmington,
Delaware. He wrote that he now has his
pilot's license and "would happily fly
to tell any of you about his activities".
He had also completed a year as pres¬
ident of the Wilmington Medical
Society.
"I'm being repotted, not retired” is
the way Lawrence Pickett explained
his decision to relinquish the position of
chief of staff of Yale-New Haven Hos¬
pital. Although he resigned from this
post as of February 28, he will continue
to serve as a member of the School of
Medicine faculty as the William H.
Carmalt Professor of Surgery and as
associate dean for clinical affairs. He is
currently enjoying a six-month sabbat¬
ical leave of absence.
On his retirement as chief of staff.
Dr. Pickett was honored at a gala recep¬
tion given by the Medical Staff of the
Hospital on February 25. On that occa¬
sion Dr. Steven Wolfson, president,
announced that the Medical Staff had
established the Lawrence K. Pickett
Lectureship to be given annually at
Yale-New Haven Hospital.

1945
In honor of his contributions to college
and university health, Isao Hirata, Jr.
received the Edward Hitchcock Award
at the 60th meeting of the American
College
Health
Association.
An
authority on sports medicine. Dr.
Hirata had been a member of the faculty
at Yale until 1972, when he joined the
staff of the University of South Carolina
as director of Student Health Services.

1946
Aaron Beck received the honorary
degree. Doctor of Medical Science
(D.M.S.), at Brown University's 214th
Commencement last May. Dr. Beck, a
psychiatrist, supports a psychiatric dis¬
cipline which he calls cognitive therapy
— a theory which for many years was
met with resistance of others in his
field, but which is now being used by
many mental health professionals.
Cognitive therapy begins by treating
what had been considered more a
symptom than an underlying problem
— a patient's unrealistically negative
views of himself. As the patient grad¬
ually accomplishes a range of tasks
which have been set up by the psychia¬
trist for him to do, he is made aware of
his distorted, negative self-views.
Dr. Beck, an alumnus of Brown
having received his A.B. in 1942, now
resides in Wynnewood, Pennsylvania.

1949
Richard Barach was elected to fellow¬
ship in the American College of Radio¬
logy at its annual meeting in Sep¬
tember.
Dr.
Barach
resides
in
Princeton, New Jersey and is affiliated
with the Medical Center at Princeton
and the Carrier Foundation in Belle
Mead, New Jersey.

1950
Norman Loux, in 1955, together with
other physicians and citizens commit¬
ted to the development of psychiatric
and mental health services for their
immediate area, founded the Penn
Foundation for Mental Health, Inc. in
Sellersville, Pennsylvania. Dr. Foux is
senior psychiatrist at the Foundation
which received the Good Neighbor
Award from the Pennridge Chamber of
Commerce. In presenting the award,
the Chamber of Commerce expressed
its appreciation to the Foundation and
noted that "the excellent service of
Penn Foundation for Mental Health has
enriched the mental health of the entire
community.’’

1951
Daniel Freedman, chairman of the
Department of Psychiatry at University
of Chicago, was awarded the honorary
Doctor of Science degree by Indiana
University in May 1982. Dr. Freedman
is an internationally acclaimed leader in
psychiatric medicine and research. In
the 1950’s he was involved in the
development of new areas in pyschopharmacology and in the 1960's he
discovered the link between hallucino¬
gens and the metabolism and disposi¬
tion of serotonin in the brain. He has
made important advances in the inte¬
gration of basic and clinical disciplines
in psychiatry and has brought the
resources of psychiatry and medicine to
bear on the public health issues and
problems of drug abuse. He has had
significant influence in legislative and
policy issues affecting the use and
abuse of psychotropic drugs.
Dr. Freedman served as the 110th
president of the American Psychiatric
Association during 1981-82. His
presidential address, "Science in the
Service of the Ill’’ was published in the
September 1982 issue of the American
Journal of Psychiatry.

1952
The American College of Surgeons has
elected Jose Felix Patino of Bogota,
Colombia an honorary fellow; the
award was conferred in October. It is
distinctly unusual, and may be unique,
that a surgeon who is already a fellow
of the College, has received in addition,
an honorary fellowship.
The citation stated in part: "The
American College of Surgeons, more¬
over, is greatly in debt to Dr. Patino
for his numerous services.
His
long-standing membership on the Inter¬
national Relations Committee, his deep
concern over the selection of Interna¬
tional Guest Scholars, and his current
role as ACS governor for Columbia are
all evidence of his great interest in
College affairs.” It further noted that
"Dr. Patino is a tireless worker, a
superb surgeon, a concerned husband
and father, and truly a gentleman. He
stands as a stellar example of the signif¬
icant role of physicians in improving
international relations.”

1956
William Hindie wrote from Honolulu
that he has been appointed chairman of
the National Task Force on Studies on
Techniques for Assessment of Clinical
Competence. This task force of the
American College of Obstetricians and
Gynecologists is to evaluate ongoing
quality assurance both of individual
physicians and departments of Ob-Gyn
in the hospital setting. Dr. Hindle also
serves on the National Health Care
Commission, Committee on Gynecol¬
ogic Practice of the American College
of Obstetricians and Gynecologists.

1957
A letter from Howard Minners gave
news about his recent activities and also
those of classmate, Robert Kaiser,
who has received two national awards
for his work in disease prevention and
public health.
Dr. Kaiser, who is director of
U.S.P.H.S. Centers for Disease Con¬
trol's Division of Parasitic Diseases,
received the 1982 William Crawford
Gorgas Medal which is presented
annually by the Association of Military
Surgeons for the United States for
"distinguished work in preventive
medicine” in honor of Major General
Gorgas, whose work in preventive
medicine made possible the construc¬
tion of the Panama Canal.
An alumnus of the Fondon School of
Hygiene and Tropical Medicine from
which he received a diploma in Tropi¬
cal Medicine and Hygiene in 1963, Dr.
Kaiser was awarded the 1982 Ademola
Medal which is presented by the
School’s Council to past and present
students who have made the greatest
contributions to the promotion of health
in developing countries. The medal
honors Dr. G. A. Ademola, a key figure
in the development of health and
welfare services in Nigeria.
Since 1964, Dr. Kaiser has been
extensively involved in the Global
Malaria Eradication Program, and
particularly with malaria control in
Central America and with health
research in Egypt, the Caribbean, Cen¬
tral America, and Mexico.
About his own activities. Dr.
Minners wrote that he had traveled in
September to Manila where he was
head of the United States delegation to
the World Health Organization West¬
ern
Pacific
Regional
Committee
Meeting. Following the sessions in
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Manila, he visited research organiza¬
tions in Rangoon and Colombo, con¬
cluding his travels around the world
with a short stop in Geneva with the
World Health Organization.

1958
Gerard Burrow visited Yale in April
to deliver The Philip K. Bondy Lec¬
ture, which honors the former chairman
of the Department of Internal Medi¬
cine. Dr. Burrow is the Sir John and
Lady Eaton Professor and chairman of
the Department of Medicine at the
University of Toronto. He spoke on
thyroid disease in pregnancy.

1959
Gerald Fenichel spoke to the Yale
Neurological Study Unit on September
28; his topic was "The Neurological
Complications of Immunization." Dr.
Fenichel is professor and chairman of
the Department of Neurology at Van¬
derbilt University School of Medicine.
Leonard Inker, who resides in
Wellesley Hills, Massachusetts and is
affiliated with Framingham Union
Hospital in Framingham, Massachu¬
setts, was awarded a fellowship in the
American College of Radiology at its
annual meeting in September.

1960
Announcement was made last fall by
the regional medical director of the
Kaiser-Permanente Medical Care Pro¬
gram and president of Northwest Permanente, P.C., Physicians and Sur¬
geons in Portland, Oregon, that Stuart
Bowne had been appointed Kaiser
Sunnyside medical director and vice
president of operations. He is respon¬
sible for medical services of the Kaiser
Sunnyside Medical Center and KaiserPermanente Medical Offices in south¬
east metropolitan Portland.
Dr. Bowne, physician in charge at
Kaiser Foundation Hospital at El
Cajon, California since 1979, previ¬
ously held positions with the Southern
California Permanente Medical Group
at San Diego. In 1967, he was appointed
as a general and vascular surgeon; in
1968, he became chief of surgery and in
1978, assistant to the associate medical
director.
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Northwest Permanente, P.C. Physi¬
cians and Surgeons is a group of 264
physicians affiliated with KaiserPermanente Medical Care Program
providing health care services to
approximately 250,000 prepaid group
practice Health Plan members in
Oregon’s Portland, Vancouver and
Salem areas.

1961
John Fenn was appointed chief of staff
of Yale-New Haven Hospital, effective
March 1. A life-long resident of the
New Haven area. Dr. Fenn has been
involved in many community activities
and within the Hospital has served as
associate chief of surgery, medical
director of the operating rooms, presi¬
dent of the medical staff and in many
other assignments.
Another book on family therapy has
been published by John Pearce.
Ethnicity and Family Therapy, 600
pp., edited by Monica McGoldrick,
John Pearce and Joseph Giordano from
the Guilford Press (New York City),
came out last fall. This book, which
should be very useful as a textbook,
describes ways of doing therapy with
18 different USA ethnic groups. Dr.
Pearce reports that he is now starting a
new book on cross-cultural marriage.

1963
In July 1982 Craig Llewellyn became
professor and chairman of the Depart¬
ment of Military Medicine and Com¬
mandant of Students at the Uniformed
Services University of the Health
Sciences in Bethesda, Maryland.
During the previous year he was a
student at the Industrial College of the
Armed Forces where he wrote a prize¬
winning research study on strategic
aeromedical evacuation.
This
past
November
Colonel
Llewellyn was installed as president of
the International Health Society at the
American Public Health Association
meeting in Montreal.

1964
Remo Fabbri participated as a lecturer
and member of a faculty of 17 at the
annual workshop, "Application of
Hypnosis in Therapy," of The New
England Society of Clinical Hypnosis
in Boston in April. Dr. Fabbri, a fellow
of The American Society of Clinical
Hypnosis and chairman of that Soci¬
ety's education committee, is also a
fellow of the Academy of Psychoso¬
matic Medicine.
Dr. Fabbri, specializing in the use of
hynotic techniques in the treatment of
psychosomatic and sexual disorders,
practices in New Haven and is an
associate psychiatrist at Yale-New
Haven Hospital.

1965
Victor Burner, who has practiced in
La Canada, California for over ten
years, is the author of a book entitled
"The Noblest Form," released by the
Great Western Publishing Co., Glen¬
dale in 1981. The narrative, which
closely follows the Biblical account,
tells the story of David and Jonathan.
Its form is operatic libretto so it may
one day achieve musical expression.
Dr. Burner is also a devoted musi¬
cian. He is a member of the American
Guild of Organists and a trustee of the
Southern California Conservatory of
Music. He has played in Italy with the
Rome Festival Orchestra, and in France
with Les Jeunesses Musicales Francaises, and on tours with the Los
Angeles Doctors Symphony Orchestra.
Ronald Karpick has been elected to
fellowship in the American College of
Physicians and was so honored at the
College's annual session in San Fran¬
cisco in April. Dr. Karpick, who resides
in Falls Church. Virginia, is on the staff
of the Alexandria Hospital, Northern
Virginia Doctors Hospital, Fairfax,
Circle Terrace and Jefferson Memorial
Hospitals.

1966
At the 1982 American Psychiatric
Association meeting in Montreal, it
was announced that Stanley Green¬
span was selected to receive the 1982
Edward A. Strecker Award for out¬
standing research contributions to child
psychiatry.

1968
Grace Jordison Boxer is now associ¬
ate chief of staff for education at the
Ann Arbor Veterans Administra¬
tion Medical Center. In this position
Dr. Boxer has responsibility to coordi¬
nate training for most of the medical
center’s 950 employees and establish
affiliation agreements with colleges
and universities that bring as many as
1,000 trainees to the medical center
annually in areas such as medicine,
surgery,
pharmacy
and
physical
therapy. She also oversees support
services such as medical photography
and illustration, the medical center
library, and the patient education
program.
Before assuming her new position
last year. Dr. Boxer served for three
years as chief of the Hematology
Section of the Indianapolis VA Medical
Center and was from 1977 to 1982
assistant professor of medicine at the
Indiana
University
School
of
Medicine.
She and her husband, Lawrence
Boxer (HS ’68), have a six-year old
son, David.

1969
Charles Dinarello has been promoted
to physician in the experimental medi¬
cine division of the New England
Medical Center Department of Med¬
icine. He also is an associate professor
Qf medicine at Tufts University School
of Medicine. Dr. Dinarello came to
NEMC and Tufts in 1977 from
Bethesda, Maryland, where he was a
senior investigator for the Laboratory
of Clinical Investigation of the National
Institute of Allergy and Infectious
Diseases, National Institutes of Health.
John Kelly wrote in March that after
two years of internal medicine at Yale
and after having been a consultant in
neurology at the Mayo Clinic, he is
now an associate professor of neurol¬
ogy at Tufts Medical School and Tufts
New England Medical Center in
Boston where he is director of the
Electromyography Laboratory.

1972
Announcement was made recently that
Philip Cohen has been elected to
fellowship in the American College of
Physicians and he was so honored at the
annual session of the College in San
Francisco in April Dr. Cohen, who
specializes in rheumatology, has been a
resident of Chapel Hill, North Carolina
for three years and is on the faculty of
the University of North Carolina
School of Medicine.
Roy Kaplan, a resident of Leucadia,
California, is specializing in rheuma¬
tology and is on the staff of the Mercy,
Sharp Memorial, and University Hos¬
pitals in San Diego and the Arthritis
Foundation, San Diego Chapter. He
has been elected to fellowship in the
American College of Physicians and
was among the group to be so honored
at the College’s annual session in San
Francisco in April.

1973
David Adler has been appointed
assistant chief of the Division of Adult
Psychiatry in the Department of Psy¬
chiatry at the New England Medical
Center in Boston. Dr. Adler, following
residency at the Massachusetts Mental
Health Center, joined the staff of the
New England Medical Center in 1976.
Thomas
Romano
and James
Sullivan have been elected to fellow¬
ship in the American College of Physi¬
cians. Dr. Romano, a specialist in rheu
matology, is on the staff at Los Altos
Hospital in Long Beach, California.
Dr.Sullivan, who resides in Quaker
Hill in Connecticut, is on the staff of the
Lawrence and Memorial Hospitals in
New London and is an assistant clinical
professor of medicine at Yale.

1975
Sydney Spiesel is now engaged in the
private practice of pediatrics and ado¬
lescent medicine at 19 Edwards Street
in New Haven. He will continue to
serve on the Yale faculty as assistant
clinical professor of pediatrics.
Stephen Vlay, director of the Uni¬
versity Hospital Coronary Care Unit at
State University of New York at Stony
Brook has been elected to fellowship in
the American College of Cardiology.

1976
Q’dell Owens is now at the University
of Cincinnati Medical Center where he
is assistant professor of obstetrics and
gynecology and director of the Division
of Reproductive Endocrinology and
Infertility. Prior to this appointment.
Dr. Owens had been working in this
field at Harvard.

1978
John Ogland is now instructor and
chief resident in the Department of
Psychiatry at the Connecticut Mental
Health Center at Yale.

HOUSE STAFF
1946
The Coalition of National Health
Organizations has acknowledged John
McGovern’s tireless efforts in the
promotion of health and a better quality
of life for the people of the United
States by presenting him with its
Distinguished Service Award which
cites Dr. McGovern for his significant
contributions to health education and
medicine. In addition to currently
holding eleven university faculty posi¬
tions, eight of which are in Texas, Dr.
McGovern remains director of the
clinic that bears his name and which he
organized. He is the chairman of the
boards of the Texas Allergy Research
Foundation and the John P. McGovern
Foundation. A member of numerous
honorary and professional societies in
medicine, science and health educat¬
ion, Dr. McGovern continues to be an
active consultant to the Board of
Regents of the National Library of
Medicine to which he received a Presi¬
dential appointment and which he
chaired in 1973-74.

1968
Lawrence Boxer is director of Pediat¬
ric Hematology-Oncology at Mott
Children’s Hospital in Ann Arbor and
professor of pediatrics at the University
of Michigan School of Medicine.
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1975
Regarding Herman Kamenetz’ latest
publication, “Dictionary of Rehabili¬
tation Medicine", the publisher's
(Springer Publishing Company, New
York) catalog states: “This superb
resource book offers in a single volume
a look into the multidisciplinary world
of medical rehabilitation in its broadest
aspect . . . . It is a uniquely valuable
reference source for teachers and stu¬
dents in medicine, physical, occupa¬
tional, and other therapies, nursing,
psychology,
prosthetics,
physical
education, speech pathology and other
fields
close
to
rehabilitation
medicine. “
Dr. Kamenetz is chief of rehabilita¬
tion medicine at the Veterans Admini¬
stration Medical Center in Washington,
DC.

EPIDEMIOLOGY AND
PUBLIC HEALTH

unit in Lima, Peru, for tropical diseases
research. There are customarily several
U.S. Navy officers from NMRI on
detached assignment to the Yale
Arbovirus Research Unit.

1977
A letter from John Zil states: “I have
been promoted to associate professor of
psychiatry and medicine at University
of California, San Francisco effective
July 1, 1982. I remain on as chief of
psychiatry and neurology at the Vet¬
erans Administration Medical Center in
Fresno (a UCSF teaching hospital),
where I am continuing two research
projects
on
sleep-deprivation and
cholinergic-driven effects on REM
parameters."

IN MEMORIAM
Joseph Weiner, M. D.
January 13, 1983

ex mec1 '20

Maurice F. O'Connell
January 1, 1983

M . D. ’22

Joseph A. Johnston
December 25, 1982

M D. '23

David Freeman
December 25, 1982

M. D. '24

Thomas Cottiero
December 14, 1982

M. D '26

Hyman Cohen
August 10, 1982

M. D. '27

Marion H. Douglas
April. 1982

M. P. H. '27

A brief note from James Malloy states
that he is now director of University of
Illinois Hospital in Chicago.

Er-Chang Ping
October 24, 1982

M. D. '28

1972

Alvin A. Schaye
February 25, 1983

M. D. '28

Yale D. Koskoff
March 9, 1983

M. D. '31

Roberta Crutcher
January 31,1983

M. D. '38

Philip E. Nelbach
January 31, 1983

M. P. H. '38

1951
In December, on the occasion of the
80th anniversary of The Pan American
Health Organization, welcoming re¬
marks were presented by the Organiza¬
tion's director Hector Acuna. Dr.
Acuna noted in a recent letter that he
has held this position for two four-year
terms and that following the end of his
second term in January 1983, he would
be serving for six months in an advisory
capacity with the director-general of the
World
Health
Organization,
Dr.
Halfdan Mahler.
After June 1983, he will be with the
Area II Office of the Pan American Sani¬
tary Bureau in Mexico City.

1967

Raymond Sphar, M.D. assumed
command in January, 1983, of the Naval
Medical Research Institute (NMRI),
Bethesda,
Maryland.
Now
in
its 41st year of conducting basic and
applied biomedical research, the Insti¬
tute has programs in casualty care,
environmental stress, hyperbaric medi¬
cine, and infectious diseases. In addi¬
tion to the main laboratory complex at
Bethesda, NMRI operates a detach¬
ment for toxicology research at
Dayton, Ohio, and a newly-established
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Robert G. Ernst
February 18, 1983

M. D. ’39

Rev. Sydney S. Byrne
(date unknown)

ex med1 '40

Charles W. Cashman. Jr.
(date unknown)

M. D. '41

William F. Hillier, Jr.
May 25. 1982

M. D. '43

CarletonJ. Brown
December 7, 1981

M. D. '45

Nelson F. Evans
(date unknown)

M. P. H. '49

Eunice R. Pellow
(date unknown)

M. P. H. '53

Allan W. Ames
(date unknown)

M. D. '60

David Paul Dunn
December 17, 1982

M. D. '60

Class of 1983
First-Year Postgraduate Appointments
Arizona
University of Arizona Affiliated Programs,
Tucson
Augusta Roth — Family Practice

Yale University Graduate School
Richard Chaillet — Physiology
Waterbury Hospital
Joan von Arras — Medicine

California
Kaiser Foundation Hospital, Los Angeles
Mathew Clark — Family Practice
Kaiser Foundation Hospital, Oakland
Julie Faisst — Medicine
Letterman Army Medical Center, San Francisco
Richard Morales — Surgery
Los Angeles County — University of
California Medical Center, Los Angeles
Miguel Martinez — Surgery
John Neal — Neurosurgery
San Diego Naval Hospital, San Diego
Maria Schmidt — Surgery
Stanford University Hospital, Stanford
Richard Cawthon — Psychiatry
Scott Lambert — Medicine
University of California Affiliated Hospitals,
San Diego
David Easter — Surgery
Elizabeth Nolan — Surgery
University of California (Davis) Medical Center,
Sacramento
Frederic Martin — Medicine
University of California Hospitals, San Francisco
Stephen Cook — Medicine
Jessica Herzstein — Medicine
David Norton — Pediatrics
David Schwartz — Medicine
Yuen So — Medicine
University of California Los Angeles
Hospital and Clinics, Los Angeles
Patricia Warkus- Daaboul — Psychiatry
Bruce Yager — Pediatrics
University of California Los Angeles
Neuropsychiatric Institute
George Bartzokis — Psychiatry

Canada
Toronto Western Hospital, Toronto
James Deutsch — Flexible

Connecticut
Griffin Hospital, Derby
Laurie Margolies — Flexible
Hartford Hospital
Gabino Lomeli — Transitional
Norwalk Hospital
Gem Goodman — Medicine
Yale-New Haven Medical Center
Amos Bodner — Medicine
Elena Citkowitz — Medicine
Nancy Czarkowski — Pediatrics
Sean Dowling — Medicine
Dianne Edgar — Surgery
James Grober — Medicine
Robert Johnson — Obstetrics & Gynecology
Marshal Mandelkem — Psychiatry
Lois Morton — Psychiatry
Nancy Terrell — Medicine
Michael Tom — Surgery
Eric Winer — Medicine
Tina Young — Pediatrics

District of Columbia
Children’s Hospital, Washington
Stephen Pearson — Pediatrics
Walter Reed Army Medical Center,
Washington
Charles Lim — Radiology

Hawaii
Queens Medical Center, Honolulu
Victor Perez — Psychiatry

Illinois
University of Chicago Clinics
Daniel Sosin — Medicine

Maryland
Johns Hopkins Hospital, Baltimore
Pamela Zeitlin — Pediatrics
University of Maryland Hospital, Baltimore
Barbara Brandt— Family Practice

Massachusetts
Beth Israel Hospital, Boston
Brian D'Angona — Surgery
Tammy Harris — Obstetrics & Gynecology
Susan O'Donnell — Medicine
Boston City Hospital, Boston
David August — Medicine
Elaine Daniels — Medicine
Adam Lemer — Medicine
Cambridge Hospital, Cambridge
Eliot Gelwan — Transitional
Massachusetts General Hospital, Boston
Donald Johns — Medicine
Harlan Pinto — Medicine
Susan Skea — Psychiatry
McLean Hospital, Mt. Auburn
Eric Nestler — Psychiatry
New England Deaconess Hospital, Boston
William Kadish — Medicine
University Hospital, Boston
Judith Melin — Medicine

Minnesota
Mayo Graduate School of Medicine, Rochester
April Chang — Medicine
University of Minnesota Hospitals, Minneapolis
David Lindgren — Orthopedic Surgery
Jon Younger — Medicine

Missouri
Barnes Hospital, St. Louis
Jerry Tobler — Diagnostic Radiology

New Jersey
University of Medicine and Dentistry of
New Jersey — Rutgers Medical School,
New Brunswick
Laura Schafer — Psychiatry
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Class of 1983
First-Year Postgraduate Appointments — continued

New York

Oregon

Bronx Municipal Hospital Center

Providence Hospital, Portland

Daniel Sabbeth — Psychiatry

Mary Johnson — Medicine

Lenox Hill Hospital, New York City

University Hospital, Portland

Brian Arenare — Surgery

Barbara Keene — Pediatrics
David Lichter— Family Practice

Montefiore Hospital, New York City

Anil DeSilva — Surgery

Pennsylvania

Mount Sinai Hospital, New York City

Graduate Hospital. Philadelphia

Alan Reznik — Surgery

Alan Bloom — Medicine

New York University Medical Center,

Hospital of the University of

New York City

Pennsylvania, Philadelphia

Edouard Martin — Medicine
Michael Silverberg — Medicine

Mark Boytim — Orthopedic Surgery
Thomas Brockmeyer — Orthopedic Surgery
Michael Choti — Surgery
James Lucarini — Surgery

Presbyterian Hospital, New York City

George Daniel — Obstetrics & Gynecology
Jose Guillem — Surgery
Ana Lamas — Medicine
St. Luke's Hospital, New York City

Janis Cutler — Flexible
St. Luke’s-Roosevelt Hospital Center,

Temple University Hospitals, Philadelphia

Robert Kotloff — Medicine
Abby Van Voorhees — Medicine
Henry Weiner — Medicine

Vermont

New York City

Medical Center Hospital of Vermont, Burlington

Randle Ware — Medicine

Colin Lee — Medicine

The New York Hospital, New York City

David Helfgott — Medicine
Robert Kenet — Medicine
Moshe Rubin — Medicine
Leonard Saltz — Medicine

North Carolina

Washington
University of Washington Affiliated Hospitals,
Seattle

Emily Altman — Medicine
Nancy Kraemer— Pediatrics
Dwight Stapleton — Medicine

North Carolina Memorial Hospital, Chapel Hill

Philip Spiro — Surgery

Wisconsin

Ohio

Clinics, Madison

Case Western Reserve University Hospital,

Brent Tetri — Medicine

University of Wisconsin Hospital and

Cleveland

Patricia Kellner— Family Practice
Cincinnati General Hospital

James Glower— Emergency Medicine

32

ATTENTION!
ALUMNI/AE IN MEDICINE AND
PUBLIC HEALTH
The most useful and interesting Alumni
Directory is the one which is the most
complete and up-to-date. Have you
done your part for the new Yale School
of Medicine Alumni/ae Directory? If
yes, thank you. If no, this is an urgent
reminder to return your questionnaire
TODAY! For additional information
call (203) 785-4674 (Medicine) or
(203) 785-4845 (Public Health).

Yale Medicine
333 Cedar Street
New Haven, Connecticut 06510

NON-PROFIT ORG.
U5 POSTAGE
PAID
New Haven, Conn,
Permn No 470

Medical Library - 4 copies
SHM

Alumni Bulletin f the School of Medicine: Summer 1983

mmmeMimm

■«*

'^IS#

YALE MEDICINE:

Alumni Bulletin of the School of Medicine

Yale Medicine is distributed to members of the
Association of Yale Alumni in Medicine,
students, and others interested in the
School of Medicine. Communications may be
addressed to the Editor. 333 Cedar Street,
New Haven, Connecticut 06510

Summer 1983 Vol. 18, No. 2

1983 Commencement Address
Surviving the Third Year
Survival: Is That Our Real Goal?
New Views
Here and About
Alumni News

2
5
7
9
12
19

Editorial Staff
Editor: Arthur Ebbert, Jr., M.D.
Managing Editor: Marjorie Blake Noyes
and design
Assistant Editor: Guldane K. Mahakian

Cover: Resemblance to the tunnel to Wonderland is purely coinciden¬
tal. The new pedestrian walkway provides protected access between
the new parking garage and the hospital. For more new views of
the Yale-New Haven Medical Center, see pages 9-11 (Photo by
M. Noyes)

Association of Yale Alumni in Medicine
President: Nicholas P. R. Spinelli, M.D., '44
Vice President: Dwight F. Miller, M.D., ’56
Secretary: Richard W. Breck, M.D., '45
Past-President: William L. Kissick, M.D., ’57;
M.P.H., ’59; Dr. P.H., '61
Executive Committee
Susan S. Addiss, M.P.H., '69
J. Roswell Gallagher, M.D., ’30
Gilbert F. Hogan, M.D., ’57
R. Leonard Kemler, M.D., ’43
Thomas P. Kugelman, M.D., ’60
Richard A. Norton, M.D., ’60 HS

1984 ALUMNI WEEKEND
JUNE 7, 8 & 9
PLAN NOW TO ATTEND!

Richard D. Otis, M.D., '49
O’dell M. Owens, M.D., ’76 M.P.H.
Rebecca Solomon, M.D., ’39
Muriel D. Wolf, M.D., ’59
Lowell I. Goodman, M.D., ’51,
Chairman, Medical School Alumni Fund
1

excerpts from the

1983 COMMENCEMENT ADDRESS
By Robert H. Gifford, M.D.

NI31SN3TO OIAVQ

I would like to welcome all of the smiling parents,
grandparents, relatives, and friends who have come to
New Haven for this happy occasion. You have every
right to be proud of these men and women graduates. 1
can attest to that, for many have come to be my very
close friends during the past four years and 1 am in awe
of their collective and individual abilities.
In a few short weeks, most of you will find yourselves
as interns, scattered across the land. It will be a memora¬
ble year. I’m certain that many of you have looked at
graduation as the light at the end of the tunnel.but I
caution you to remember that the light at the end of the
tunnel could well be a train coming the other way.
Although that train could represent the rigors of in¬
ternship, it might also be symbolic of the public's grow¬
ing unhappiness with us as a medical profession. Despite
remarkable advances in our ability to diagnose and treat
human disease, something is wrong with our image.
How can things be wrong, you ask, w hen our physicians
are more able than ever?; when people are living longer
than ever?; when our hospitals are bulging with sophisti¬
cated equipment?; and when physicians are plentiful and
moving into every nook and cranny of the country? How
can the public possibly be disgruntled with all of that?
Although the answers to these questions are complex,
there is no doubt that the traditional doctor/patient
relationship has become tarnished. Today, 1 want to
examine five possible reasons relating to some of the
public’s unhappiness. These five factors are important to
consider here because they need attention and you soon

highly trained, well paid, generalist who has the skills to

will be in positions to do something about them.

ferred to subspecialists. This primary physician must be

The first important factor contributing to the public’s
dissatisfaction with American medicine has been our

able to practice in a stimulating group environment, and

failure to provide a strong primary care system. In the
past twenty-five years, we have encouraged our brightest

organized in such a way as to provide opportunities to
get away from it from time to time, for continuing

doctors to become subspecialists and they are now' trip¬
ping over one another, competing for access to the same

physician should he the backbone of our medical care

pool of patients. Specialists now account for fifty to sixty
percent of all physicians. Any system of health care that

be willing to tackle any complaint. The practice must be

education, for a meaningful private life. The primary
system. Since it requires the most comprehensive knowl¬

encourages patients to see several different specialists,

edge and sensitivity, this role should be reserved for our
most exceptional doctors and w'e must find ways to lure

just for health maintenance, is bound to be expensive

some of them away from the attractions of subspecialty

and inefficient. Furthermore, it does not guarantee good

practice. It is important to accept the notion that this
primary physician is not just for trivial illness as the

care. It is certain to annoy patients who don’t know
w hich specialist to call when they simply feel sick all over
and can’t identify a specific organ that is malfunctioning.
Patients followed by several doctors may not only re¬
ceive several bills, but conflicting messages about their
diagnoses and therapy.
There must be a primary physician in charge, and, in
my opinion, it is appropriate for that person to be a

Dr. G iff ore! is professor of medicine, and chief of Medical Services at
the Veterans Administration Medical Center in West Haven.
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handle a great many of the medical problems now re¬

public has come to perceive. I know that it is possible to
find outstanding generalists who can deal competently
with most medical conditions. My current chief resident
is one, and if he could just be cloned, I believe that we
could do away with half of the medical subspecialists
in the country. I would trust him to care for almost any
non-surgical illness that 1 could have. His knowledge
and clinical abilities are remarkable. He might need a
specialist from time to time as a consultant, but certainly
not to provide continuing care. One partial answer to the

problem has been for subspecialists also to serve as
primary physicians, but the extent and effectiveness of
this practice may have been overstated in the recent
literature. 1 would prefer to see committed generalists
who have been trained for just that kind of practice.
The real solution to this problem of encouraging gen¬
eralists to enter practice will probably have to be eco¬
nomic. Unfortunately, invasive maneuvers done to pa¬
tients continue to be reimbursed at a much higher rate
than the good old-fashioned use of the brain alone. It is
time to restore some balance to the system. Complex
medical intensive care management should at least be
the monetary equivalent of a simple surgical procedure.
When insurance carriers reduce their support of expen¬
sive (and possibly unnecessary) procedures, and increase
their support of general medical care, our best doctors
may be more inclined to consider general medicine,
general pediatrics or general psychiatry.
In addition, medical educators must restore prestige
to the general practice of medicine. Academia continues
to foster the glory of subspecialization because most of
the faculty are subspecialists. We must find ways to
reverse the trend and retain outstanding general physi¬
cians on medical faculties, as well as to encourage our
most capable young clinicians to consider general medi¬
cine as a way of life. I am hopeful that some of you will
follow that course.
A second reason that the public is displeased with us is
related to the rapid pace of modern medicine and, as a
result, poor communication with doctors. Doctors, un¬
fortunately, seem to be too busy to spend much time
with patients as medicine has become more complicated.
The hospital, too, has become a bustling place.
Being a patient, it turns out, is an intensely personal
affair, charged with worry and prone to misunderstand¬
ings. Every physician as well as everyone who works in a
hospital must never forget that. We tend to become so
accustomed to the hospital environment and to illness,
that it is easy to forget how significant every little thing
becomes for a patient. There must be a quiet respect for
the special needs of the sick and ample time reserved by
us to sit and talk with our patients.
A third significant factor troubling the public is the
enormous cost of medical care. They cannot understand
why the total annual cost has finally reached ten percent
of our gross national product. Is there any limit to the
continued rise? The public grumbles that physician’s fees
are too high even though they represent only twenty
percent of the total cost of medical care; that insurance
premiums are outrageous; that the costs of medicine,
laboratory tests and procedures are shamefully inflated;
and that the cost of a day in the hospital, to say nothing
of the intensive care unit, is beyond that which any
ordinary person can afford. I urge you to look at the bills
of some of your hospitalized patients. It was shocking to
me to see the cost of tests which I had ordered in sort of a
casual way. A single day at Yale-New Haven Hospital,
not including the physician’s fee, diagnostic tests, or
drugs, currently costs $285.00 for a private room. If you

are unfortunate enough to be in the intensive care unit, it
will cost you about $700 dollars a day, double that of
only two years ago. 1 bought my first car for less than
that. A chest x-ray costs $41; a simple blood count, $5.50
and $8.00 more if you want a differential count. Electro¬
lytes cost $25, enough to pay for a sumptuous dinner. A
Swan-Ganz catheter costs $91 but a staggering $721
hospital charge for its insertion in the procedure room,
on top of a $350 professional fee, for a total cost of over
$1000 for this commonly used procedure. And so it goes.
It is important to realize that the hospital is not out to
gouge the public. It is a non-profit organization. It is
simply trying to stay solvent; to pay for its buildings, its
work force, its equipment, and all the other things that
we order. It is an enormously expensive business and we
are, in part, responsible for the generation of much of it.
What, if anything, can we do to stem the tide? The
public wants sophisticated comprehensive care and is
apparently willing to pay a large amount of money for it,
but the increases are rapidly reaching a point where
limits will be necessary. You can help. You will have to
help.
Consider the very real possibility that everything that
we do to patients may not be absolutely necessary for
quality care. Could home care be strengthened? Does
every inpatient need a fancy hospital? Could a hotel or
motel attached to a hospital substitute fora hospital bed
in some cases? Do we, as physicians, think carefully
about the cost effectiveness of tests ordered; of proce¬
dures done; and of therapies given? Are we aware of the
relative cost of drugs and that one drug may be much
cheaper than another with just about the same spectrum
of action? For the most part, physicians are not well
acquainted with what many of these things cost. We
haven’t been used to thinking in these terms, but it will be
essential to do so in the days ahead. I believe that it
would be possible for us to reduce the current costs of
medical care ten or twenty percent without compromis¬
ing the scope or quality of that care, simply by education
and reminders to physicians about the costs of what they
are generating.
In addition, physician’s fees must be more realistic and
balanced. Insurance carriers must stop rewarding high
cost procedures and provide more financial incentives to
curtail tests and to encourage comprehensive primary
care. We must, as a group, support the inevitable
changes in the current reimbursement program. We
should, at the very least, acquaint ourselves with the
details of our reimbursement systems, including medi¬
care, medicaid, and the new system coming in October,
known as DRG, or diagnosis related groups, whereby a
set amount will be prospectively paid to the hospital for a
certain condition regardless of the actual cost. It is a
subject too important to leave for others.
A fourth reason for the public’s complaint with us has
been our failure to accept death as a natural part of
living. We still look at death as a failure of medical
science. Sometimes it is just that, but our zeal to support
life at all cost has not always been well received. The

majority of our intensive care beds are occupied by
patients whose life expectancy is only a few months.
Respirators and other sophisticated monitoring equip¬
ment which do save many lives, also allow us to prolong
the life of many with a terminal illness. We are all uneasy
about the problem because it has always been difficult
for physicians to discuss the option of no treatment with
patients. For terminally ill patients, the Hospice move¬
ment represents a way to face death in a positive rather
than a negative way. Hospice is a remarkable concept
and its powerful message warns us not to neglect the
dying. On rounds, do not pass by the room of a dying
patient without stopping. A brief visit, soft words, a
tender touch, and reassurance about pain control will
bring comfort and peace to one’s final hours.
Lastly, the public is unhappy because they have un¬
realistic expectations about what medical science can do
for them. The media is partly to blame with its emphasis
on spectacular medical experiments covered widely in
the press, such as heart and liver transplants. Is it any
wonder that the public tends to look at their bodies like
an automobile? Bring it in for new parts and when it
doesn’t work, blame the mechanic. We have not done a
good job in educating the public to the limitations of our
therapies. They Hock to emergency rooms expecting
quick cures for the common cold. Americans have been
gradually abandoning personal responsibility for their
own health and insidiously transferring that responsibil¬
ity to us. We must provide vigorous leadership in in¬
forming the public that preventive medicine is still the
best treatment. Alterations in personal behavior could
profoundly reduce a number of major disease processes.
We must become politically active and lobby on behalf
of those causes which play such an adverse role on the
health of this nation and world.
Cigarette smoking kills tens of thousands of patients
each year. As physicians, we have been a weak and
ineffectual force in combating tobacco lobbies to reduce
this terrible health problem. The complications of alco¬
hol continue to fill our hospital wards. We cannot sit
back passively and watch the slaughter. We must help
society find better ways to control this awful problem.
Environmental pollution threatens us all; and worse, the
unbridled proliferation of nuclear weapons poses a
health threat with which we simply cannot cope. We
must also decry the fact that the projected increase in the
defense budget is more than the entire NIH budget for
medical research.
Physicians must be heard on these issues. We have a
responsibility to our collective patients to speak out, to
educate, and to become a political action group on
behalf of health. I am counting on you to carry the torch.

4

SURVIVING THE THIRD YEAR
By Laird D. Madison
At a recent symposium for new clinical clerks. Dr. Thom¬

unavoidable aspects of learning, but speaking out about

as Duffy noted a most striking aspect of the third year is
“the extraordinary advancement that people make be¬
tween June of one year and June of the following. It is

difficult problems helps students to recognize them as
problems, to recognize the feelings of helplessness as
such, and to begin to identify solutions.

very important at the present time,... when you feel you

Two years ago a group of Yale medical students con¬

are being tossed into a frenzy and really don’t know

ceived the idea of developing an educational program

which way to turn, to simply know where you are in
relation to what it is that’s being asked of you.”

for third year clinical clerks that would supplement the
traditional clerkship schedule. The idea grew out of the

Medical education and medical providers have been

belief that this formative period was often unnecessarily

under increasing attack from the public because of per¬
ceived deficits in the training of physicians and in provid¬

troubling to students because of a lack of orientation to
their new environment, and that as a result they were

ing medical care in a humane fashion. Criticism of medi¬

often unaware of the consequences of their actions on

cal curriculum and medical practice have come from The

others and themselves. Last year, Patty Kellner (’83)
organized a one-day symposium entitled, “Surviving the

New York Times, The New England Journal of Medi¬
cine, The American Medical Student Association, and
The Association of American Medical Colleges, to name
a few. As students undergoing the training in question,
we felt that, perhaps better than the faculty, we could

Third Year: The Well-Being of the Patient and the Med¬
ical Student.” Largely because of the success of that
symposium, we organized and recently held the first of

understand some of the processes and experiences in the

two planned symposia for third year students. The sym¬
posium held during the second week of the clerkship

training of physicians which lead to this widespread
criticism. Certainly, the internship year is a formative

tation to the experiences the students were beginning. It

one for the physician, but as important is the third year
of medical school when students encounter patients,
patients’ families, doctors, nurses, and their fellow stu¬
dents in the environment in which they will function for
the rest of their careers. No amount of attention in the
first and second years of medical school can prepare
students for the issues encountered in the third year.
They can only be addressed and understood in the envir¬
onment in which they are relevant.
Many changes occur in the behavior and thought
processes of physicians as they are trained. We are not
so cynical as to think that all of these changes are bad, or
so naive as to think that those that are bad are entirely
preventable. We do believe, however, that encouraging
students to become aware of their environment and their
role in that environment, to be more aware of the conse¬
quences of their actions on patients and on their own
lives, would increase the likelihood of training a more
humane physician with less damaging consequences
throughout their careers to their patients, society, and
themselves. Many students begin their third year with
“good” values, but they have a hard time maintaining
their beliefs during the onslaught of learning clinical
medicine. They feel helpless, and they fail. . . repeatedly
at what they are learning. The consequences of these
failures are often detrimental to the treatment of patients
and to the personal well-being of the student. The diffi¬
culties, the failures, and the helplessness are probably

Laird D. Madison, a M.D.j Pli.D. Student, was largely responsible
for the organization of the 1983 Clinical Clerkship Orientation Sym¬
posium. This article is based, in part, on a report he gave to the
Medical School Council.

period in July was intended to provide a practical orien¬
was organized by fourth and fifth year students through
the office of Dr. Alan Mermann, Chaplain of the School
of Medicine.
Speakers from throughout the medical center gave
short talks on subjects of interest to the new clinical
clerks. Dr. Robert Lang and Dr. Alan Kliger, associate
professors of medicine noted that, “the academic back¬
ground we all get preparing us for medicine leaves a huge
gap when you start your third year.” They described
their seminar for third year students in the medicine
clerkship, “Issues in Medicine,” which tries “to work
with students so they can discover from their experience,
what it takes to feel good, to do it well, and to fit in the
right place . . . No one pays very close attention to what
we are feeling when we are with patients.” The impor¬
tance of trying to understand these feelings during the
third year was underscored by noting that the “patterns
that you set for yourself this year are likely the patterns
you are going to use for the rest of your life.”
Angela Holder, medicolegal counsel for the School
and Hospital discussed common legal questions raised
by students. She assured students that her office was
eager to hear from students early about potential legal
problems but observed that “the majority of students
who come to her with what they think is a problem did
not understand the situation . . . Part of your education
may be finding out that what appears to be to an outsider
like a certain clear and compelling screw-up ... is not.”
She reminded students that “patients do not waive their
right of privacy because they are in a teaching hospital
. . . but that there are very few patients who don’t want
to become involved with medical students ... They think
you are kind, considerate and spend much more time
5

with them than other people do.”
Dr. James Nocks, associate clinical professor of psy¬
chiatry. spoke about dealing with the alcoholic patient
and noted that “somewhere along the line in medical
school, a fair amount of negative learning takes place
about alcoholism.” Following his talk. Dr. Leonard
Grauer, associate clinical professor of medicine, encour¬
aged medical students to engage with the private attend¬
ing early in the care of private patients.
Dr. Duffy, professor of medicine, noted that the ad¬
mission of medical students to the ward for learning “is
not something that has gone on for a very long period of
time.” He advised the students, “you must become the
master of your physical examination . . . The problem
that exists is that you will run away from what is the
excitement of the initial encounter to be looking at your
scans, to be looking at whatever it is that takes you down
the corrider from where the most information can be
generated . . . the patient.”
“I think that (as students) you bring to you what
amounts to a certain burden in the whole process of the
doctor-patient relationship. The burden is a certain laidback, mellow quality where you may substitute friend¬
ship for w'hat is the absolute need for detached
concern where you are concerned about another hu¬
man being, but not to the point where you are so anxious
that you’re making the wrong decisions,” Dr. Duffy told
the students. “And. friendship oftentimes gets in the way
of the necessary detachment w'hich doesn't move all the
way to aloofness. You have to learn how to-walk a very
tight rope, in terms of the tension, where you can use
your professional knowJedge to help another human
being, but not be overwhelmed by the suffering that it
allows and demands your access to.”
He cautioned the students to be aw'are of their role and
to respect the difference between their role and that of
the interns and residents. The urge of the student to be in
charge overlooks “the greatest luxury that you have as
medical students—to have access to an intensity of med¬
ical problems without having to go home at night and
worry whether or not you helped somebody or hastened
somebody’s death.”
A very important element of the day consisted of small
discussion groups of third year students led by fourth
year students. In these sessions they discussed the real
“work” of clinical clerks: work-ups, write-ups, and oral
presentations. They discussed strategies for succeeding
in various clerkships, common problems, and ways of
trying to avoid them. Most importantly, they provided
reassurance to each other that not only would they
“survive” the third year, but that they could expect to
triumph in their new skills and responsibilities by the
time the year was through.
The participation of most of the third-year class,
many interested fourth-year students, as well as a
number of concerned faculty, demonstrate that there is a
body of knowledge and skills in the clinical years that
spans all clinical disciplines that can and should be ad¬
dressed independent of ward and clinical experience.
6

The current curriculum of the third and fourth years of
medical school does not address these broader issues
affecting our delivery of medical care. Since this period is
one in which students first begin to form their clinical
“styles” and attitudes it is important to reconsider what is
to be accomplished in the second half of medical school.
In an ideal situation the clinical attendings would ad¬
dress these broader issues as they become relevant in
their dealings with students, thereby lending the support
and wisdom of their broad clinical experience to those
just entering the profession. The reality of the situation,
however, is that the attendings are busy with many other
activities, and clinical clerks end up learning and pattern¬
ing their behavior after the interns, people only two years
more advanced in their training themselves. The interns
are not necessarily concerned with their influence as
teachers, and many aren’t displaying the best attitudes
and behaviors because of their own stressful situation.
Our activities in organizing symposia for third year
students is a modest beginning in an effort to enrich the
experience of the clerkship period. It is hoped that with
the support of the faculty this effort could be continued
and enlarged in the future.

Dr. Mermarm led members of the Class of 1983 in the taking of the
Hippocratic Oath at Commencement.

SURVIVAL: IS THAT OUR REAL GOAL?
By Alan C. Mermann, M.D.

“In the final analysis, to succeed is to survive relatively
unscathed.”1 This statement from a “survival manual”

It is against this background of an uneasy paradox
incredible scientific progress and rampant social

written recently for medical students beginning clinical
training bothers me. 1 am quick to grant that there is a
measure of humor and exaggerated self-pity in the use of

decay- that the concerns of the medical student for
survival must be examined. There are mixed messages

the word “survival” in reference to the rigorous life of the

of health services. On the one hand the universities, no

medical student today. But we are enjoined to take
language seriously. Even in such diverse genres as

less than the high-tech corporations, are in a race to
exploit new methods for uncovering Nature’s long-held

humor, essays, innuendo, faux pas and prayer, we do say

secrets of DNA replication, leukocyte function or hor¬

what we mean. So, when the second year class bequeaths
a Survival Kit to the entering class and the fourth year
students are easily recruited for a seminar for third year
students designed to help them survive “going on the
wards”, I think we should pay attention.
Medicine is evolving rapidly. The remarkable applica¬

being transmitted to the students and to the consumers

mone production. Toward these ends, impressive fund¬
ing is committed. On the other hand, students come to
medical school, for the most part, to learn to become
physicians responsible for the medical and psychological
care of their fellow human beings. The teaching of the

tion of high technology to laboratory methods, surgical

skills of interaction with patients, colleagues, adminis¬
trators, public health officials and lawyers is left, pretty

and investigative procedures and life-saving apparatus

much, to observing busy house officers and attending

has so altered hospital practice as to make it awesome, if
not incomprehensible, to older physicians. The expo¬

physicians. The role of the doctor in issues of allocation,
public policy toward the poor and the goals of research is

nential growth of scientific knowledge has made “keep¬
ing up” with medicine-in-general impossible for the of¬

rarely discussed.

fice practitioner, and has pressed the physician and

student is the explosion of information in basic science
taught in the first two years of medical school. Many

surgeon in an academic setting further into specializa¬
tion to maintain leadership, pursue research, and ad¬

The product of these decisions in the education of the

students are hard pressed by the avalanche of facts which

vance scholarship.
These scientific and technologic advances have pro¬

they are expected to process without any clues as to what
is important for them in preparation for the clinical

duced some unexpected results. The rise in patient ex¬

years. Tittle help is forthcoming from those teachers who
have devoted their professional lives to research in the

pectations for cure of illness and repair of injury is
paralleled by an impressive increase in malpractice suits.

“pure” sciences. The intense competitiveness which be¬

Our capacity to maintain biologic existence by mechani¬
cal means, to change species by genetic engineering, to

gan in the undergraduate years continues, even in medi¬
cal schools which downplay examinations and grading.

alter behavior by drugs, and to study and treat the
human fetus has created a new discipline- biomedical

Perhaps the absence of formal examinations and non¬
grading creates more anxiety and confusion than we
might like to believe.

ethics—which attempts to clarify some of the dilemmas
we have produced and assist in the search for answers to
confounding questions never anticipated.
The most serious questions of all for medicine are

The most perplexing issues revolve around the impact
of the role of the doctor on the personal life of the
student. The model for medical students— the physician-

raised by the necessity to allocate scarce resources. The
social costs of developing an artificial heart, of dialysis of

teacher in medical school and hospital, and the practi¬
tioner in the community—again sends mixed messages

end-stage renal disease in the elderly patient, of organ
transplantation, and of exquisitely designed and exe¬

to the student. The place of the physician in our culture
has been one of prestige, power and wealth. Despite

cuted experiments in immunology are real and painfully
apparent. A stroll -or perhaps safer, a drive- through

many current criticisms of the profession and ambiva¬
lent feelings toward them, physicians still maintain posi¬
tions of respect and prominence in society. This elevated
status seems often in conflict with professed altruism of

the neighborhoods of most university medical centers
will demonstrate, in a graphic way, the needs of our
people. The relationship of our wealthy universities to
the desperate, the poor, and the illiterate persons who
live, both literally and figuratively, in their shadows,
needs immediate definition and explanation.

Dr. Mermann, clinical professor of pediatrics and chaplain of the
School of Medicine, has practiced pediatrics in the New Haven area
for twenty-five years.

the medical profession. The effects of this conflict have
been carefully outlined and discussed recently in an arti¬
cle in The New England Journal of Medicine.2 The
increased incidences of suicide, drug and alcohol abuse
and marital problems among physicians are disconcert¬
ing signs of personal unhappiness and lack of fulfillment
in a profession held in high esteem. Techniques for
surviving medical school may not function well over an
7

The implication of survival is that the present is a

become intimately involved in the lives of others. When
the physician is free enough to acknowledge limitations

difficult or painful period to be gotten through in antici¬

usually all too apparent to the patient, then the rich and

extended period of time of stress.

pation of better times; that the immediate is neither

powerful experience of accompanying other human be¬

desirable nor rewarding. One of the reasons the clinical
years are something to be survived is that many students

ings on a journey can be undertaken. It is willingness to
open our hearts and minds to the pain and suffering of

and house staff have yet to develop an inner life capable

others that deepens us and allows more and more insight

of incorporating those painful and difficult parts of
training which demand so much of us physically, emo¬

empowering us to do even more. Walking the extra mile

tionally, and intellectually. Conflict with other profes¬

can be an exercise in self-fulfillment and enlightenment.

sionals on the health care team; confrontation with pain,

Reaching out can provide a positive and a hopeful pos¬
ture for living. I have found the hoary dictum, “First, do

suffering and death; fatigue; a growing understanding of

into our own needs and feelings, strengthening us and

the devastating effects of illness; and an awareness of the

no harm,” to be a depressing and negative foundation

futility of much of medical, surgical, and psychiatric

for life, both as a physician and as a person.

practice, all combine to place serious stresses on the
young student and house officer.
When we look to the goals for which we are willing to

the humanities have a grade-school level understanding

survive those student years, we face again the physician:

If we can teach the latest developments in nuclear mag¬

Many of us with advanced degrees in the sciences and
of values, meanings and relationships between persons.

or

netic resonance, we can also teach ancient skills in seek¬

university—and often desperate and unhappy. Success

ing self-knowledge, recognition of the inter-relatedness

may be a mirage, an illusion which fades as we approach
its realization. Success becomes failure because the goal

of all life, and the transient values of treasures kept
where “moth and rust doth corrupt.”

wealthy,

prestigious,

powerful

in

community

is not worthy of our best endeavors: in fact, did not even
engage our selves.
It is that engagement of the self in the care of the

Physicians devote considerable time and energy to
persons who are frightened and exposed to mortal
danger. The attitudes we display toward our patients—

patient which can convert a survivor into a committed,

the way patients see us

even joyful, physician. One wonders what witticism
would be forthcoming from the Osiers and Cushings of

health professions as a template for their behavior. Shal¬

Medicine if “survival” was touted as a mark of the

are accepted by students in the

lowness of spirit, unexamined values, inability to iden¬
tify with the feelings of the patient, and an exaggerated

successful doctor. Studies have demonstrated that phy¬

idea of the importance of the doctor

sicians spend less and less time visiting patients as they
become sicker with terminal illnesses. The more difficult

only limited success is possible for those who survive the
clinical years.

all these teach that

the patient, the more obscure or untreatable the disease,
the less personal is the care provided by the doctor. It has

If medical students now think of clinical training and
education as a time calling for survival, it is an attitude

been said that physicians visit dying patients less because

we have taught them. Practitioners, professors and re¬

“death is seen as failure - as the enemy.” 1 think that is a

search scientists—all need to search the depths of their

romantic excuse for an inability of physicians to face,
accept, and deal with the fact of death. So many of us are

personal and professional lives, examine their belief sys¬
tems and show forth, in a courageous and compassion¬

bothered, not by the fact that the patient died because we

ate fashion, what it means to care for other persons.

could do no more, but rather because death is a part of

It is a temptation to reduce problems to the least
common denominator, and this is often spoken of as
oversimplification of complex problems. But we do have

life which few of us handle well. This is true of pain,
loneliness, anxiety, and telling the truth to others. The
difficulties lie with the physician, not with the patient.

it on good authority that simplicity and deliberate search

Denial and avoidance are strange but frequent ways of
dealing with reality.

for the essentials of living are necessary.3 Survival is not
enough. If we are to avoid despair we must take the risks

It has been noted that terminally ill persons are fear¬
ful, not of death, but of abandonment as they die. At the

implied in involving our lives with those of our col¬
leagues, our students and our patients. To live, not
having loved, is desperation. To die, not having lived, is

very moments in our lives when we need companionship,
compassion and close contact with those we know and

the ultimate tragedy.

trust
when we are critically ill or dying
cians absent themselves.

Footnotes

many physi¬

1 think that inhumane aspects of medical care result
from the lack of careful and deliberate instruction during
medical training which builds the resources for coping
with trials which lie ahead. We need to learn, not only to
withstand the devastating crises in medical practice, but
to incorporate those experiences into and everdeepening and satisfying psychological life. One of the
greatest gifts which life has for us is the opportunity to

1. Gusky, M.D., Jeff, Medical Student Ward Survival Manual,
Medical Students Publishers, Dallas, 1982, p. 9.
see also. Survival Manual: A Guide to the Classical Years, AMSA.
1983
2. Jonsen, Ph.D., Albert R., “Sounding Board: Watching the Doc¬
tor,” NEJM, vol. 308, no. 25, June 23, 1983, p. 1531.
3. Thoreau, H.D., Walden, pp. 16, 17.

NOYES

NEW VIEWS
New signs of brightly colored plastic,
lighted at night, guide visitors who come to
the Medical Center. The green, red, gold
and white seal of the School of Medicine,
on afield of blue, stands in front of Ster¬
ling Hall of Medicine. In addition to signs
in front of major buildings, there are direc¬
tional signs and comprehensive maps of
the Medical Center on several strategic
<^j street corners in the area.

The lawn in front of Hark ness dormitory is
a favorite spot for lunch on balmy spring
and summer days. In the background—the
new park in front of the recent addition to
the Hunter Radiation Therapy Center,
and the bridge connecting the New Haven
Unit and the new hospital.

The major construction and reno¬
vation projects at the Medical Cen¬
ter are, for the most part, com¬
pleted. For more than two years,
great craters and mounds of earth,
attended by gigantic machines re¬
sembling prehistoric monsters,
created near havoc in the area.
( Yale Medicine, Fall 1979) From
all of this has arisen a new parking
garage, six levels high and two
blocks long; a new hospital build¬
ing to replace the aged and out¬
dated New Haven Unit; and en¬
larged and improved facilities for
therapeutic radiology research and
patient care. And, three bridges
have been added to the streetscape

two to facilitate interac¬

tion between basic scientists and
physicians at the bedside; one to
protect users of the garage from
traffic and the weather. The vener¬
able Hope Building has been given
a new lease on life ( Yale Medicine,
Winter 1982), and projects are un¬
derway to renovate still others
of its vintage. All in all, the views
here and about
considerably.

have

changed

9

NEW VIEWS

NOYES

A
A park has been created at the intersection
of Cedar Street and Davenport Avenue.
Across Davenport A venue, the new hospi¬
tal building is connected with the Memo¬
rial Unit.

<1
The 250-foot covered walkway between
the parking garage and the main entrance
to the hospital is intended to provide safety
and security for the faculty, staff, students
and visitors who park there. Open twentyfour hours a day, the garage with space for
2400 cars, greatly alleviates dire parking
conditions in the area. York Street passes
under the garage.

10
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Entrance to the new emergency room is on
Davenport Avenue, almost at the corner
of Howard Avenue.
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HERE
AND ABOUT

Dr. Stevens

Dr. Zaret
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A SECTION OF MOLECULAR
NEUROBIOLOGY IS
ESTABLISHED WITH
DR. STEVENS AS CHAIRMAN

SCHOOL DESIGNATED A
CENTER FOR MAJOR N1H
STUDY OF NEW TREATMENT
FOR HEART ATTACK

President A. Bartlett Giamatti has an¬
nounced the formation of a new Sec¬
tion of Molecular Neurobiology, and
the appointment of Dr. Charles F.
Stevens as the chairman, both for a
term of five years, effective July 1. “I
am confident the future of neuro¬
science at Yale will be strengthened by
the establishment of this new Section,”
President Giamatti said.
Dr. Stevens, professor of physiol¬
ogy at Yale since 1975, is well known
for his research on the molecular basis
for nervous system function, and in
particular, for his studies on the role of
proteins in transmission of informa¬
tion over nerves and from one nerve
cell to another in the brain. “During
the past five years, there has been a
very rapid and striking development
of the molecular approach to practi¬
cally all areas of medical science, in¬
cluding the study of the human brain,”
he said.
The new Section of Molecular Neu¬
robiology will bring together six
scientists of various disciplines, whose
primary appointments will be in the
Section, and who will interact with
scientists from other departments in
the University to apply molecular ap¬
proaches to traditional problems in
neurobiology. In addition, Dr. Stev¬
ens will assume responsibility for or¬
ganizing a graduate program in the
neurosciences, as well as continue his
teaching of medical students.
Elected to the National Academy of
Sciences in 1982, Dr. Stevens is a
graduate of Harvard College, and re¬
ceived his M.D. degree from Yale in
1960, and a Ph.D. degree from Rocke¬
feller University in 1964. Prior to his
appointment at Yale in 1975, he had
been professor of physiology and bio¬
physics at the University of Washing¬
ton School of Medicine in Seattle,
where he had been a member of the
faculty since 1963.
During the academic year 1969-70,
Dr. Stevens was guest lecturer at Lorentz Institute for Theoretical Physics,
Leiden University, The Netherlands.
In 1979, Columbia University College
of Physicians and Surgeons presented
him the W. Alden Spencer Award for
outstanding contribution to neuro¬
science, and in 1981, he was the Grass
Lecturer for the Society of Neuro¬
science.

The National Institutes of Health have
awarded more than S1.5 million to
Yale University to establish one of
three core laboratories and a clinical
unit for collaborative clinical trials of
a new treatment by thrombolysis of
acute heart attack. Dr. Barry Zaret,
professor of medicine and diagnostic
radiology, is director of the labora¬
tory, and Dr. Charles K. Francis, as¬
sociate professor of medicine, is prin¬
cipal investigator of the clinical unit of
Yale’s portion of the study, which in¬
volves radioisotope aspects of throm¬
bolysis in myocardial infarction
(TIMI).
“The concept of thrombolysis has
been an exciting major step in cardiol¬
ogy,” according to Dr. Zaret. “The
NIH study seeks to evaluate its effec¬
tiveness in preventing morbidity and
mortality of heart attacks.”
Studies based on initial observa¬
tions in Germany have shown that not
only are heart attacks caused by a
blood clot formed in the area of one of
the vessels supplying blood to the
heart, but also that the clot can be
dissolved by aggressive therapy in¬
volving infusion of an anticoagulant
either through a catheter at the sight of
the clot, or intravenously. If throm¬
bolysis is administered in the early
stages, blood flow is returned to the
affected area, the heart attack may be
aborted, and significant heart muscle
damage may be prevented.
The NIH sponsored T1M1 study
will address two major questions. Is
thrombolysis as beneficial as prelimi¬
nary studies indicate? Which method
of thrombolysis—by catheter or by
infusion—is the safest and most
efficient?
Approximately 1200 heart attack
patients will be studied during the
three-year investigation by major
medical centers in the United States.
Data generated from patients seen in
the 12 clinical centers designated by
the NIH will be analyzed and pro¬
cessed in the core laboratories at Yale,
Maryland Medical Research Institute,
and the University of Washington.
The Yale portion of the study will
assess the efficacy of intravenous in¬
jection of anticoagulants as opposed
to lysis through a catheter. They will
measure the overall benefits of throm-

Scientists at the School of Medicine
have isolated for the first time a newly
recognized spirochete from the blood,
skin or cerebrospinal fluid of patients
with Lyme disease. “The recovery of
this organism from patients provides
important evidence that the I. clammini spirochete is the causative agent
of Lyme disease,” according to Dr.
Allen C. Steere, principal investigator
of the research.
Previously the spirochete had been
isolated only from Ixodes dammini,
the tick identified as the probable
transmitter of the disease. The new
finding has implications for better di¬
agnosis and treatment of the illness,
and may help in the understanding of
some other immune-mediated dis¬
eases such as rheumatoid arthritis.
Lyme disease, first recognized in
1975 by Yale medical scientists includ¬
ing Dr. Steere and Dr. Stephen E. Malawista, professor of medicine and
head of the Section of Rheumatology,
has affected hundreds of people along
the Atlantic coast and in some midand far-western states. It typically be¬
gins in summer with a unique skin
lesion, erythema chronicum migrans
(ECM), which sometimes expands to
a diameter of five inches or more, and
may be accompanied by flu-like symp¬
toms. Weeks to months later, some
patients develop neurologic or heart
symptoms, and still later, may develop
intermittent attacks of arthritis, which
may become chronic.
The later stages of Lyme disease
often mimic several serious immunemediated disorders including juvenile
rheumatoid arthritis, rheumatoid ar¬
thritis, rheumatic fever, the GuillainBarre syndrome and multiple sclero¬

Dr. Steere

T, CHARLES ERICKSON

MYSTERY OF LYME DISEASE
A STEP CLOSER TO BEING
SOLVED

sis. The fact that the Yale scientists
recovered the I-dammini spirochete
not only from the skin and blood of
patients, but also from the cerebrospi¬
nal fluid of those with neurologic
symptoms ten weeks after the onset of
the illness, suggests that the organism
may first invade the skin or blood via
the tick bite, and eventually migrate to
the nervous system. The course of the
organism thereafter is still unclear.
Dr. Steere and his colleagues are
continuing their research to determine
whether the spirochete is present dur¬
ing the late, arthritis manifestations of
the disease, and if so, where it is lo¬
cated and what role it plays. “The
question of a persistent infectious
agent being necessary for continued
disease activity, as opposed to trigger¬
ing by such an agent, followed by au¬
to-immunity, is of central importance
in a number of immune-mediated dis¬
eases,” they reported. The first clue
that Lyme disease was caused by an
infectious agent was the fact that sev¬
eral children with typical symptoms
lived in the same neighborhood in
Lyme, Connecticut. The rural setting
of the area, plus identification of ECM
as a distinguishing characteristic
of the illness, suggested that it might
be transmitted by an arthropod. Sub¬
sequent investigation by the Yale team
provided strong evidence that a re¬
cently identified tick, Ixodes dammini,
was the victor.
In 1979, Dr. Steere and his col¬
leagues found that penicillin or tetra¬
cycline given early in the illness,
shortens the duration of ECM and can
sometimes prevent more serious
symptoms. This suggested that the
causative agent was a penicillinsensitive bacterium such as a spiro¬
chete. In 1982, a previously unrecog¬
nized spirochete was isolated by
scientists at the Rocky Mountain Lab¬
oratory in Hamilton, Montana, from
an Ixodes dammini tick collected on
Shelter Island, New York, where a
number of cases of Lyme disease have
been reported.

T. CHARLES ERICKSON

bolysis using radioisotopic techniques
perfected by Dr. Zaret and his col¬
leagues, to measure heart function.
In addition to Drs. Zaret and Fran¬
cis, participants in the Yale portion of
the study will include Dr. Lawrence S.
Cohen, Ebenezer K. Hunt Professor
of Medicine, Dr. William P. Batsford,
associate professor of medicine, and
Dr. Harvey J. Berger, associate pro¬
fessor of diagnostic radiology and
medicine.

Dr. Malawista
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The University’s 282nd Commence¬
ment was held on the Old Campus,
between rain showers, on May 23rd.
In contrast to the previous few years,
when anti-war and social protests
were evident, this year’s commence¬
ment was marked by a note of gentle
humor amidst the traditional pomp
and circumstance. Forestry graduates
decorated their mortar boards with
leaves, and Divinity School graduates
stuck pipecleaner halos on theirs,
while a small cast from the Drama
School wore Groucho Marx masks.
School of Medicine graduates re¬
mained relatively staid, with only an
occasional happy-faced balloon rising
from their ranks as they marched to
their places beneath the elms.
In addition to 1,189 bachelor’s de¬
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grees awarded to graduating seniors,
Yale presented 1,824 graduate and
professional degrees, including 99
M.D. degrees, and 74 M.P.H. degrees.
Professor Dame Sheila Sherlock, who
had been a guest lecturer at the School
of Medicine a few days before, was
one of nine distinguished men and
women of the arts and science to re¬
ceive an honorary degree. Chairman
and professor of medicine at the Uni¬
versity of London, she is an interna¬
tionally reknowned scientist, clinician,
author and editor.
Following the ceremony on the Old
Campus, medical graduates returned
to the School where, under a blue and
white striped tent in the courtyard of
Harkness Hall, Dean of Students
Howard Levitin welcomed them and

their families and friends. Dr. James
P. Comer, associate dean, awarded
more than 20 prizes and honors to
graduates who had excelled during
their four years as students.
The ninety-nine members of the
Class of 1983 then filed to the podium
to receive their diplomas and congrat¬
ulations from Dean Robert W. Ber¬
liner. Six were awarded the M.D./
Ph.D. degree: Richard M. Cawthon,
John R. Chaillet, Robert O. Kenet,
Marshal Mandelkern, Eric J. Nestler,
and Pamela L.. Zeitlin. In addition,
Jose Gaston Guillem received a joint
M. D. / M. P. H. degree.
Following the presentation of de¬
grees, the new doctors took the Hip¬
pocratic Oath, led by Dr. Alan C.
Mermann, chaplain of the School. Dr.
Robert H. Gifford, professor of medi¬
cine, delivered the commencement
address, excerpts from which appear
on the preceding pages. A gala buffet
luncheon served on the terrace of
Harkness Hall concluded an occasion
both solemn and joyous.
For the second year, the Depart¬
ment of Epidemiology and Public
Health abandoned its traditional blue
and white tent, and held commence¬
ment exercises in the more weather¬
proof Yale Repertory Theater.
Chairman Jan A.J. Stolwijk wel¬
comed the graduates and their guests,
and Dr. Kyle Grazier, assistant pro¬
fessor of public health, presented the
diplomas.
The commencement address was
given by Dr. Colin White, Ira
Vaughan Hiscock Professor of Public
Health. Announcement of the E.
Richard Weinernran Fellowships was
made by Dr. Arthur J. Viseltear, asso¬
ciate professor of history of medicine
and public health, and Dr. Diana B.
Fischer, senior research associate and
lecturer in public health, announced
the Richard H. Schlesinger Fellow¬
ship and the Kathleen Hara Howe
Scholarship. Dr. James F. Jekel pre¬
sented the award of certificate, preven¬
tive medicine residency program.
In addition to the 74graduates who
received M.P.H. degrees, four E.P.H.
students received Ph.D. degrees,
awarded at the Graduate School.
They were: Susan E. Brown. Priscilla
F. Canny, Gretchen S. Dieck, and
Rebecca T. Zagraniski.
Following the ceremony, the grad¬
uates and their guests were feted at a
buffet luncheon party.

SECOND YEAR STUDENT
AWARDED ALF STUDENT
RESEARCH FELLOWSHIP
Michael L. Grossbard, a second year
student, has been awarded a Student
Research Fellowship from the Ameri¬
can Liver Foundation. Mr. Grossbard
is studying the biochemistry of blood
following liver damage in the labora¬
tory of Dr. James L. Boyer, professor
of medicine and director of the Liver
Study Unit.
A national voluntary organization,
the American Liver Foundation pro¬
vides facts about liver disease, the
fourth leading cause of death to age
65. The Foundation is currently plan¬
ning a national campaign to increase
public support for liver research.

YALE STUDENT RECEIVES
AOAAWARD
Matthew R. Moore, Class of 1986,
was one of five students to receive the
first annual Alpha Omega Alpha Stu¬
dent Research Fellowship Awards.
The Awards were established last year
to make available up to five $1,000
prizes annually in support of student
research. The 1983 award winning re¬
search projects were considered the
“most promising” of 33 proposals of
impressive quality received, according
to the AOA award committee. In ad¬
dition to Mr. Moore, recipients were
from Case Western Reserve Univer¬
sity, the University of Pennsylvania,
University of California, San Fran¬
cisco, and Mount Sinai School of
Medicine.

RECEPTION FOR CLASS
OF 1983
The Association of Yale Alumni in
Medicine held a reception on April 22
for members of the medical class of
1983. It was well attended by students
in the graduating class and by a
number of local alumni. Dr. Nicholas
Spinelli extended greetings on behalf
of the Alumni Association. It is
planned to make such a reception hon¬
oring the graduates an annual event.

AW A R PS AND HONO RS 1983
Each year, members of the faculty and
house staff are honored by colleagues
and students for their various contri¬
butions to the medical profession. The
1983 awards reflect the continuing re¬
gard at the Yale-New Haven Medical
Center for excellence in patient care as
well as for teaching and research
accomplishments.
Ihe Betsy Winters House Staff
Award is presented annually to the
member of the house staff of YaleNew H aven Hospital who has made
the most significant contribution to¬
ward the education of medical stu¬
dents. The selection is made by the 4th
year class, who this year presented the
award to Bernard Shen, Class of 1981,
who is a second-year resident in
medicine.
Dr. John Mellors, assistant profes¬
sor of medicine, received the Benedict
R. Harris Award. Established in 1967,
the award is made annually to the at¬
tending physician who has contrib¬
uted the most to the teaching of the
house staff.
The Samuel D. Kushlan Awards
were established in 1969 to recognize
the intern and second-year resident
who have contributed the most to pa¬
tient care during rotation through the
Memoral Unit Medical Service. Selec¬
tion of recipients is made in consulta¬
tion with the clinical faculty and the
nursing service. The 1983 awards were
presented to Dr. Lynn Tanoue, Class
of 1982, an intern in the Department
of Medicine, and Dr. Stewart Greisman. Class of 1981, a junior assistant
resident in medicine.
The Francis Gilman Blake Award is
presented annually by the graduating
medical school class to the outstand¬
ing teacher of medical sciences. Dr.
Frank .1. Bia, assistant professor of
medicine and laboratory medicine,
was so honored this year.
The Department of Psychiatry each
year presents the Seymour L. Fustman, M.D. Research Awards for re¬
search accomplishments during resi¬
dency. This year, a first place award
was presented to Dr. Robert B. lnnis,
and second place awards were pre¬
sented to Dr. Alan Breier and Dr. Jef¬
frey Satinover.

FIVE ON FACULTY BECOME
PROFESSOR EMERITUS
Five professors in the School of Medi¬
cine retired from the faculty on July 1.
Dr. Stephen Fleck, professor of
psychiatry and public health, and for
many years, psychiatrist-in-chief of
the Yale Psychiatric Institute, is well
known for his studies on schizophre¬
nia. A member of the faculty for thirty
years. Dr. Fleck received his M.D. de¬
gree from Harvard University follow¬
ing studies at the University of Frank¬
furt and the University of Amsterdam.
As a leader in the application of
clinical psychology to pediatric re¬
search, Dr. Ethelyn H. Klatskin has
been a pioneer in developing roomingin and other models of care for moth¬
ers and newborn children. A professor
of psychology in pediatrics at the
Child Study Center, Dr. Klatskin re¬
ceived her B.A. degree from the Uni¬
versity of Mississippi and her Ph.D.
degree from Yale University. She has
been a member of the School of Medi¬
cine faculty for almost 37 years.
Dr. Robert M. Lowman, professor
of diagnostic radiology, is former di¬
rector of the Memorial Unit radiology
service at Yale-New Haven Hospital.
He is well known by students, house
staff, and attendings as an enthusiastic
teacher. A member of the faculty for
31 years, he is a graduate of Harvard
College, and the University of Mary¬
land School of Medicine.
Chairman of the Section of Cell Bi¬
ology since it was established on 1973,
Dr. George E. Palade was co-winner
of the 1974 Nobel Prize for Physiology
and Medicine for his discoveries on
structural and functional organization
of cells. Dr. Palade, who is Sterling
Professor of Cell Biology, will con¬
tinue his association with the School
as Special Advisor to the Dean and a
senior research scientist in Cell
Biology.
The chairman of the Department of
Microbiology from 1950 to 1961, Dr.
Henry P. Treffers, professor of pa¬
thology, has been on the faculty for 38
years. An authority on the chemical
aspects of immunity and of microbial
resistance to chemotherapeutic
agents, he received his B.A. and his
Ph.D. degrees from Columbia
University.
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MENTAL HEALTH, MENTAL
ILLNESS, AND THE FAMILY
The Department of Psychiatry spon¬
sored a conference in June on key as¬
pects of the family in health and illness
to honor Dr. Stephen Fleck, professor
of psychiatry and public health and
deputy chairman of the department.
Dr. Fleck’s pioneering research at Yale
spans the areas of family studies and
schizophrenia as well as treatment and
preventive strategies.
The program held on June 10 and
I 1 was introduced with opening re¬
marks by President A. Bartlett Giamatti and Deputy Dean Arthur Ebbert, Jr., who spoke on behalf of Dean
Berliner. The keynote address was
given by Dr. Daniel X. Freedman,
chairman of the Department of Psy¬
chiatry at the University of Chicago.
Speakers on the scientific program in¬
cluded Dr. Theodore Lidz, Sterling
Professor Emeritus of Psychiatry,
who was responsible for bringing Dr.
Fleck to Yale in 1953.
A banquet for Dr. Fleck held on
Saturday evening, June 1 I, at the Park
Plaza Hotel was attended by those
who had participated in the confer¬
ence and about three hundred guests.
A number of Dr. Fleck’s colleagues
and former students paid tribute to
him in a series of after dinner talks.
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DR. SOLNIT FETED

DR. KLATSKIN IS HONORED

Dr. Albert J. Solnit, Sterling Profes¬
sor of Pediatrics and Psychiatry, was
honored at a gala reception held in the
University Commons Woolsey Hall
on Sunday, May 15. Jhe occasion,
which was attended by several
hundred representing both town and
gown, celebrated Dr. Solnit’s seven¬
teen years as director of the Yale Child
Study Center and his appointment as
Freud Memorial Professor at Univer¬
sity College, London for the the year
1983-84.
Having served as director of the
Child Study Center since 1966, Dr.
Solnit has relinquished this position to
devote his full attention to research,
patient care, and teaching. Following
a sabbatical yearat University College
London, he will return to Yale in 1984.

Former fellows of the Liver Study
Unit convened on June 2 and 3 for a
scientific program honoring Dr. Ger¬
ald Klatskin on the fifth year of his
retirement. The program of 16 scien¬
tific presentations, covering a broad
range of topics related to liver function
and disease, effectively demonstrated
the significant contribution Dr. Klats¬
kin has made to the field of
hepatology.
Dr. Klatskin, who is David Paige
Smith Professor Emeritus of Medi¬
cine, came to Yale in 1933 as an intern
in medicine. He has since earned rec¬
ognition not only as a leader in liver
research, but also as an outstanding
teacher. In May, the American Gas¬
troenterological Association honored
him with its highest award, the Julius
Friedenwald Award, for his distin¬
guished contribution to the field of
gastroenterology. It was presented to
him by Dr. James L. Boyer, w ho suc¬
ceeded him as director of the Yale
Liver Study Unit.
J he Gerald Klatskin Yale Liver Li¬
brary is being established to provide
permanent archives for Dr. Klatskin’s
collection of over 50,000 color slides
from 10,000 liver biopsy specimens.
Alumni and friends are invited to con¬
tribute to the fund in care of Dr.
Boyer, Yale Liver Study Unit, 333
Cedar Street, New Haven, CJ 06510.

PROMOTIONS TO PROFESSOR
The following members of the medical
faculty were promoted to professor¬
ships effective July 1983: lan M. Armitage, Ph.D., professor (adjunct) of
research in molecular biophysics and
biochemistry; Edward Dunn, M.D.,
clinical professor of surgery; John E.
Fenn, M.D., clinical professor of
surgery; Lawrence P. Fielding,
M.B.B.S., clinical professor of
surgery; Angela R. Holder, LL.M.,
clinical professor of pediatrics (law);
Sidney Hurwitz, M.D., clinical pro¬
fessor of pediatrics; Charles A. Jane¬
way, Jr., M.D., professor of path¬
ology; Arthur T. Rosenfield, M.D.,
professor of diagnostic radiology;
John H. Seashore, M.D., professor of
surgery and pediatrics; Clifford L.
Slayman, Ph.D., professor of physi¬
ology; Eiji Yanagisawa, M.D., clinical
professor of surgery (otolaryngology);
Robert K.-J. Yu, Ph.D. professor (ad¬
junct) of research in neurology.

NEW CLINIC ASSISTS
TRAVELERS TO THE TROPICS
Connecticut area vacationers, schol¬
ars, businesspeople and other travelers
abroad will be interested to learn that
a Tropical Medicine and International
Travelers Clinic has been established
by the Department of Internal Medi¬
cine. Located in Yale-New Haven
Hospital, the Clinic’s staff are special¬
ists in the prevention, diagnosis and
treatment of tropical diseases and
other medical problems encountered
in foreign travel.
“Each year, many business and va¬
cation travelers leave the United
States without adequate medical in¬
formation or preparation for their trip
abroad,” according to Dr. Michele
Barry, who with Dr. Frank J. Bia,
directs the Clinic. “Lack of proper
vaccinations, failure to take precau¬
tions against malaria and other tropi¬
cal diseases, and a poor understanding
of how infectious diseases are com¬
municated can often result in needless
illness.”

FACULTY NOTES
Dr. Barry and Dr. Bia, who are as¬
sistant professors of medicine, have
had extensive experience in evaluating
and treating medical problems of the
tropics at the Hospital Albert
Schweitzer in Haiti, and in Southeast
Asia. Dr. Barry is director of the
Southeast Asian Refugee Clinic at
Yale-New Haven Hospital, whose ser¬
vice not only to refugees, but to travel¬
ers to that area as well, prompted the
development of the Tropical Medicine
and International Travelers Clinic. In
addition, another member of the med¬
ical staff, Dr. David Melchinger, asso¬
ciate clinical professor of medicine,
was involved in the smallpox irradication program in West Africa.
The Clinic offers a unique service to
residents and businesses in Connecti¬
cut and surrounding areas, according
to Dr. Bia. “Most medical training in
this country does not include very ex¬
tensive study of tropical diseases, so
few physicians and other medical pro¬
fessionals are able to offer the kind of
service and experience that are avail¬
able in the Clinic.”
In addition to familiarizing travel¬
ers with the international vaccination
requirements for diseases such as
cholera, yellow fever, and smallpox,
and initiating or updating immuniza¬
tion for polio, tetanus, typhoid and
cholera the Clinic provides an effective
regimen for malaria prevention, par¬
ticularly for travelers to areas where
drug resistant strains of the disease are
likely to be encountered. They will
screen patients for previous tuberculo¬
sis exposure, as well as for immunity
to hepatitis, and will administer
gamma globulin when required. Phy¬
sician referral when abroad is pro¬
vided, and individuals with medical
problems will be advised if their cur¬
rent therapy needs specific revision for
the trip.
On return, travelers may be
screened for recent exposure to tuber¬
culosis; tested for the presence of intes¬
tinal parasites or pathogenic bacteria;
and given a course of therapy to pre¬
vent delayed attacks of malaria. The
Clinic strongly recommends that trav¬
elers visit there, when possible, at least
four to six weeks prior to departure.

Mt. Holyoke College conferred an
honorary Doctor of Science degree on
one of its distinguished alumnae. Dr.
Ruth Whittemore, clinical professor
of pediatrics. The citation read in part,
“Through your clinical proficiency
and sensitive concern for children, to¬
gether with your intense dedication to
medical education, you provide a role
model that has influenced thousands
of nurses and physicians to follow in
your footsteps. Your career is proof
positive that the successful practice of
medicine is more art than science; few
physicians can present such an envi¬
able record of achievement.”
Dr. Paul G. Barash, chairman of the
Department of Anesthesiology, was
named president-elect of the Society
of Cardiovascular Anesthesiologists.
The Society is an international organ¬
ization of specialists in the field of
anesthesia for cardiac, vascular and
thoracic surgery. Dr. Barash had pre¬
viously served as chairman of the Re¬
search and Education Committee, and
most recently, as chairman of the Pro¬
gram Committee.
The American Psychiatric Associa¬
tion presented the 1983 Samuel G.
Hibbs Award to Dr. John Strauss,
professor of psychiatry, for his work
on understanding of psychiatric dis¬
orders. The prize is awarded annually
to honor contributions to clinical re¬
search in psychiatry.
The American Association for the
Advancement of Science elected Dr.
Lawrence Marks, associate professor
of epidemiology and psychology, a fel¬
low of the association. Dr. Marks,
who is also a member of the scientific
staff of the John B. Pierce Foundation
Laboratory, is well known for his re¬
search in psychophysics.
Dr. Eleanor Adair, another member
of the Pierce scientific staff, was also
elected a fellow of the AAAS.
The 42nd Annual Chapin Medal of
the Rhode Island Medical Society was
presented to Dr. Alvan R. Feinstein,
professor of medicine and epidemiol¬
ogy. At the presentation ceremony,
continued on next page
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held on June 7, Dr. Feinstein delivered
a talk on “Clinical Epidemiology: An
Additional Basic Science for Clinical
Medicine.”The medal commemorates
Charles V. Chapin, an internationally
known public health authority. Pre¬
vious faculty to receive this honor
were Drs. Francis G. Blake, Stanhope
Bayne-Jones, and John Rodman
Paul. Dr. Leona Baumgartner, Class
of 1934, also received this medal.
The Federation of American Societies
for Experimental Biology and The
Burroughs Wellcome Fund have
awarded Dr. Flenry J. Binder, profes¬
sor of medicine, a 1983-84 Wellcome
Visiting Professorship in the Basic
Medical Sciences. Dr. Binder who is
well known for his research in gas¬
troenterology, will spend several days
teaching and participating in seminars
with students and faculty at the Uni¬
versity of Nevada School of Medicine,
and deliver a Wellcome Lecture in the
Basic Medical Sciences. The awards
were established to stimulate interest
in the basic sciences and to recognize
eminent scientists.
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RICHARD K. GERSHON, M.D.
Dr. Richard Keve Gershon, professor
of pathology and biology, died at
home on July 11, 1983, after a long
struggle with lung cancer.
He was born in New York City on
December 24. 1932. A cum laude
graduate of Harvard College, he en¬
tered the Yale University School of
Medicine in 1954. After interrupting
medical school for a year of research
training in Paris, he received his M.D.
degree from Yale in 1959. He received
his training in Pathology at Yale, and
became acting chief of the Viral and
Rickettsial Diseases Medical General
Laboratory of the United States Army
in Japan. He joined the faculty of the
Yale Pathology Department in 1964.
He became interested in immunology
as part of his research on the factors
regulating tumor growth, and in 1967
he spent a year furthering this interest
as a visiting professor at the Chester
Beatty Research Institute in London.
After his return to Yale he became
chief of the Division of Immunology
in 1976, and was appointed director of
the Laboratory of Cellular Immunol¬
ogy of the Howard Hughes Medical
Institute at Yale in 1977. He was
elected a member of the National
Academy of Sciences in 1980.
His research in immunology led to
the discovery of subsets of Tlymphocytes, and in particular to
identification of the suppressor Tlymphocyte. These discoveries dem¬
onstrated that immunity is not merely
the result of an induction of a response
but rather a highly controlled se¬
quence of events. He identified an
immunoregulatory circuit which con¬
sists of inducer cells, precursor/ampli¬
fier cells, and effector cells, which may
either induce or suppress the immune
response. In his own colorful way he
described this sytem as “an immuno¬
logic orchestra” which could play a
variety of symphonies known as im¬
mune responses. It was his discoveries
that allow us to further explore the
mechanisms of the immune response
to foreign invaders; and, perhaps most
important of all, the reaction of the
body to atypical proliferation, or
cancer.
He was widely recognized for his
achievements, and just this year he re¬
ceived the George Thorn Award for
outstanding medical research, and the
Gairdner Foundation International
Award for outstanding discoveries in

medical science.
To his classmates and friends he will
be remembered for more than his
scientific achievements. A connoisseur
of wine and food, an enthusiastic
sports fan, a world traveller, and a
friend with a memorable sense of
humor, he shared his joy in life with all
around him. Whether as scientist,
teacher, classmate or friend, he left a
legacy to all of us.
Dr. Gershon is survived by his wife,
the former Robyn Mione, a daughter,
Alexandra, his parents, and a brother.
Dr. Michael Gershon, chairman of the
Department of Anatomy at Columbia
University. M.K.

KAJ HARINE C. ANGELL
Katharine Cramer Angell, the widow
of James Rowland Angell, president
of the University from 1921 to 1937,
died on July 22, 1983, at the age of 93.
She was a long-time friend and sup¬
porter of the School of Medicine.
Contributions in Mrs. Angell’s mem¬
ory may be made to the Katharine C.
Angell Medical Student Loan Fund,
which was established in her honor on
the occasion of her ninetieth birthday.

ALUMNI NEWS
ALUMNI WEEKEND 1983
Alumni weekend gets better each year.
The varied and interesting programs
offered a neat balance of intellectual
stimulation, sociability, and nostalgia—
has been attracting alumni back to the
Sterling Hall of Medicine in increasing
numbers, and, the more, the merrier.
This year, several events which were
planned to coincide, added further
dimension to Alumni Weekend, which
began unofficially on Thursday, June
2, with a scientific program honoring
Dr. Gerald Klatskin, the former direc¬
tor of the Liver Study Unit. The next
day, the program assumed a festive
air, with interesting feature events and
superb side shows as well.
The Yale Alumni in Ophthalmology
held its annual day-long meeting with
symposia on the “Treatment of Hy¬
phema” and “Diagnosis and Treat¬
ment of Congenital Leukokoria) Syn¬
dromes Including Pars Plicata Surgery”.
Dr. Morton F. Goldberg, professor
and chairman of the Department of
Ophthalmology at the University of
Illinois, was the guest speaker.
That morning, a symposium mark¬
ing the 60th anniversary of the School
of Nursing, “Toward Humane TwoTier Health Care”, attracted a large
audience. Uwe Reinhardt, professor
of economics and public affairs,
Woodrow Wilson School of Public
Health and International Affairs at
Princeton, interspersed his talk with
hard facts and pithy humor.
At the same time, the Association of
Yale Alumni in Public Health
(AYAPH) and the Yale University
Hospital Administration Alumni As¬
sociation (YUHAA) held their annual
workshops and jointly sponsored a
symposium on “The Administration’s
View of the Federal Government’s
Role in Medical Care and Public
Health”. Keynote speaker. Dr. Robert
J. Rubin, assistant secretary for plan¬
ning and evaluation, U.S. Department
of Health and Human Services, gave
the Reagan Administration “A” for
effort in improving the nation’s health
care system.
In the afternoon, in an AYAPH
seminar, “The Federal Government’s
Role in Public Health: Another
View”, Susan Addiss took issue with
Dr. Rubin’s assessment in a hard hit¬
ting criticism of the Administration’s

social and health policies. Ms. Addiss,
(’69 EPH), is chief of the Bureau of
Health Planning and Resource Allo¬
cation, Connecticut Department of
Health Services, and president-elect of
the American Public Association.
Following her talk. Dr. Jan Stolwijk, chairman of the Department of
Epidemiology and Public Health, de¬
scribed research he and his colleagues
are conducting on the effects of indoor
air pollution, and new methodology
they are developing for assessing such
information. Dr. Stolwijk has been a
strong advocate of federal environ¬
mental regulations based on more and
better scientific information.
As expected, the YUHAAA’s an¬
nual workshop addressed “Prospec¬
tive Payment and Diagnostic Related
Groups”, with a talk by John D.
Thompson (’50), professor of public
health and nursing administration,
who was one of principal authors of
the controversial plan. He also spoke
the next day in an Alumni Day sem¬
inar on the same subject.
The EPH alumni program attracted
one of the largest alumni audiences
ever. Over 100 attended the reception
and dinner held on Friday night in the
Presidents Room at Woolsey Hall.
On Saturday morning, still more
alumni arrived at the Rotunda for a
day beginning with remarks by Presi¬
dent A. Bartlett Giamatti, followed by
four extraordinarily interesting and
timely seminars. Dr. Edward Adelberg was moderator for “Introduction
to Genetic Engineering”, which in¬
cluded talks by Dr. William Summers
on “Genetic Engineering in Research
on Gene Structure and Organization”,
and Dr. Michael Kamarack on “Ge¬
netic Research on Gene Expression”.
Dr. John Dwyer held an enthusias¬
tic audience overtime with his talk on
“The Immunological Twilight Zone:
Evidence for the Mind’s Ability to
Manipulate Immune Defense Mecha¬
nisms”. The promises and problems of
DRGs were again explored by Profes¬
sor Thompson, joined in this seminar
by Dr. Joanne Finley, who was Com¬
missioner of Public Health of New
Jersey when that state was the first to
use the system. The fourth seminar
was given by Dr. Leo Cooney and Dr.
Andrea Schaffner, who discussed the
increasingly important topic of “Phy¬
sicians and the Aging Society”.
The remainder of the day was di¬
vided between business and enter¬
tainment, with the annual meeting of

the Association of Yale Alumni in
Medicine followed by the traditional
sherry hour and buffet lunch, and at
4:30, a Social Hour was held in the
Hope Building. Reunion classes held
their individual class dinners that
evening.
Throughout the weekend, many
alumni were overheard praising Louis
Kaplan, associate dean for commu¬
nity and governmental relations and
alumni affairs, and Constance Tol¬
liver, his senior administrator, for
their very competent and creative
planning and implementation of the
Alumni Weekends.

REUNIONS
1928
Fifty-fifth

No Report Received
1933
Fiftieth

Yale Medical School’s class of 1933
was represented by four graduates at
their 50th reunion June 3 and 4, but
they agreed that what was lacking in
numbers was made up in fun and en¬
thusiasm. Of the 38 who graduated in
1933, only 21 are known to survive.
The events of Friday, June 3 and
Saturday, June 4, described elsewhere
in this issue, provided us with some
interesting choices. There were also
social hours each afternoon.
Saturday evening the Yale Medical
Alumni Association hosted a great
dinner at the Graduates Club for the
class of 1933. Present from our class
were thoracic surgeon Francis Woods
of Jaffrey, New Hampshire (who came
3 days early for an Alumni College
seminar on computers), internist Ray
Miller of Trenton, New Jersey, path¬
ologist Robert Huntington of Cam¬
bria, California and public healther
Franklin Foote of Wethersfield,
Connecticut—the latter three were ac¬
companied by their wives. Present
were officers of the association, also
acting dean Art Ebbert, associate dean
Lou Kaplan, former dean Vernon
Lippard (’29) who was an intern in
pediatrics when we were in school, and
Harry Zimmerman (’27) who taught
us pathology.
Messages came from some class¬
mates: Jack Wolfe of Naples, Florida
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reported having enjoyed 13 years in
India and China and having learned
that pitching bales of hay over a fence
can produce disc problems; Joe Mignone of North Haven has arthritis
which kept him home; Ashley Pond of
Taos, New Mexico found that a cervi¬
cal laminectomy last year put a stop to
skiing, at least for now; Dan Harvey is
in a skilled nursing facility in Hanover,
New Hampshire; Paul Saffo of Rol¬
ling Hills, California, has a daughter
who is professor of biology at
Swarthmore and a son who is an at¬
torney; Ed Seelve of Berkeley, Cali¬
fornia, who practiced surgery in
Worcester, Massachusetts lost his wife
in 1978 but has remarried the widow
of his roommate at Amherst.
The big news is that our class did
nobly in supporting the Medical
School Alumni Fund in our reunion
year to provide student loan funds.
We had the highest per cent of
contributors—67%—of all medical
school alumni, and the highest aver¬
age gift of$375. Congratulations to all
who helped us go over the top!
Franklin Foote
1938
Forty-fifth
The far-flung Class of 1938 DID have
a reunion dinner, thanks to the efforts
of Charlie Petrillo, who made the ar¬
rangements. It was held at the Race
Brook Country Club. Medical School
days were re-lived in the company of
Charlie and Ann Petrillo (New
Haven), Ben and Blanche Lyons
(Westport), Joe and Virginia Rey¬
nolds (Havertown, Pennsylvania) and
I.es and Elizabeth Wallman (Burling¬
ton, Vermont). Jack Dillon u'rote
from California saying that he is in
good health and doing “good busi¬
ness”. Joe Criscuolo sent his best re¬
gards to all his classmates.
Summers in Mattapoisett, Massa¬
chusetts; winters in Seminole, Florida
are enjoyed by Jim Radcliffe and his
wife. Jim’s nephew-in-law took over
Jim’s practice in 1981. Still licensed,
Jim keeps himself available for volun¬
teer work and keeps up with CME.
Between whiles he enjoys tennis de¬
spite a triple-bypass operation. The
Roy Barnetts, visiting Japan as guests
of a Japanese Society, were not able to
attend the dinner.
Your secretary, now in her sixth
year of retirement from anesthesiol¬
ogy at the V.A., accompanied a class¬
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mate from high school days to our
55th reunion held in Toronto, having
graduated from a University of
Toronto-sponsored school for mis¬
sionary children in Japan. Between
domestic crises she works with the
State Probation Department, and as a
guardian ad litem for the local court
and surrogate auntie for a “Boys’
Home”.
Located just across the Connecticut
River from Dartmouth and around
the corner from the Norwich Inn, my
house is the fourth on the right; the
latchstring is always out on football
weekends. Agnes V. Bartlett
1943 (March)
Fortieth
The fortieth reunion was, indeed, out¬
standing and most deserving of super¬
latives. The attendance was the best
ever, with 20 classmates and 16
spouses. We invited the three who had
to drop behind when attacked by the
“red raider” and two of them
attended Priscilla Dienes Taft (with
her husband, Edgar) and Donal
Dunphy. It was the first reunion for
approximately five people. As for do¬
nations to the Medical School Alumni
Fund, our class ranked first of all
classes this year both for total amount
contributed and for percentage of
class contributing, as of June 4.
Those present w'ere: Ralph Alley
(Jane), Bill Davey (Artemis), Chuck
Dowling, Rocky Fasanella (Marion),
Tom Flynn, Gerry Fountain (Polly),
Stu Joslin (Dorothy), Een Kemler
(Joan), Doug Lindsey, Henry Markley (Mary). Dee Peck (Hugh Dwyer),
Ed Rabe (Emily), Mark Sanford
(Mildred), Ted Soule(Florence). Hilly
Spitz (Norma). Sophie Trent Stevens,
Bob Taylor (Chris), Fred Waldron
(Polly), John Weber (Clare), Morris
Wessel (Irmgard).
Many of us attended the Dean’s Re¬
ception Friday, continuing Saturday
morning with the lectures which viv¬
idly showed aspects of the changes in
the bio-sciences in the past 40 years. In
the afternoon several classmates
toured the recently completed modern
hospital and other buildings of the
Yale-New' Haven Medical Center,
which is such a spectacular contrast to
the old New' Haven Hospital w'e ea¬
gerly wandered through 40 years ago.
We concluded w ith dinner for 39 at the
Graduates Club (where 40 years ago
women could not enter through the

front door and could dine in one side
room only).
Ralph Alley an outstanding and
lively master of ceremonies, recalled
many unusual and amusing incidents
of our student days. He also reminded
us, with some help from Dr. Fulton's
diary, of the stress, worry, tragedy and
tension of our last sixteen months at
Yale due to our entrance into World
War IF He recalled our dignified and
impressive graduation in the Histori¬
cal Library the first of the waraccelerated classes.
Bob Taylor regaled us with one of
his dead-pan down-east Maine stories
about a postman’s trials with a cas¬
trated dog. Deedee Joslin recalled her
apprehension about an encounter of
her boss, Dean Bayne-Jones with an
unknown (to her) character named
Winternitz.
Don Dunphy claims the most as¬
tonishing recent achievement- he has
a two-year-old-baby! He also wins
first prize for having the youngest
child in the class. Hilly Spitz has two
sons who are physicians.
Doug Lindsey travelled the farthest
(from Arizona) to come to Reunion.
Five of those present have retired
completely, although still carrying on
medically related administrative or
consulting activities. Three are work¬
ing shorter or fewer days. The other
thirteen are still hard at it full time. A
more detailed account of the careers of
the entire class will be mailed to each
member of the class soon.
Overall, it was a highly successful
and enjoyable weekend. We hope to
see many more of the class at the fortyfifth reunion. Dorothea R. Peck
1943 (Dec.)
Fortieth
Our 40th class reunion went beauti¬
fully, although we missed those of you
who couldn't make it.
It began at the Dean’s Reception
Friday afternoon when I found Bob
Bradley and his w'ife Betty, who had
come down from Boston, along with
Hoyt Miles and his wife Fuana from
Reno and Bob Furman and his wife
Mary Frances from Indianapolis. The
Dean’s Reception was delightful and
went on long after the dinner hour.
You might be interested in learning
that the fortuitous circumstance which
graduated two classes in 1943 (ours
and the one ahead of us) causes both
classes to have reunions the same year.

For this reason we get to see and renew
acquaintances with a number of those
from the class just ahead of us. A
number of these people were at the
Dean’s Reception and we saw them
elsewhere during the weekend.
The following morning we had the
opportunity to attend one of several
seminars, while some of those attend¬
ing the reunion went on a tour of the
new Museum of British Art at the
main Yale Campus.
Saturday morning Ronnie Cook
and his wife Fran from Hartford
joined us, and John Almklov and his
wife Dorothy arrived from Bakersville, California. A beautiful open-air
tent luncheon was served on the
greensward in front of the residential
hall. At the sherry hour preceding the
luncheon Fred Haddad from Ansonia
joined our reunion group.
Saturday evening we had a delight¬
ful reunion dinner at Tom Bucky's
house in Weston, near Bridgeport.
Tom and his most gracious wife Doris
put on a beautiful meal for us. We
were pleasantly surprised on arrival to
find Ira Rashkoff and his wife Gladys
awaiting us there, having driven up
from White Plains. Joe Epstein had
indicated that he would get over to the
dinner from Middletown but was un¬
able to make it. Fred Haddad also was
unable to get there although he had
hoped to.
1 am going to write you all a long
detailed letter later this summer. The
Alumni Office will send this out for us,
so don’t throw a letter from the
Alumni Office away unopened on the
assumption that it is just another mass
mailing! Jim Bradley (and Ann)
1948

__

Thirty-fifth
Some of the members of the Class of
’48 began their reunion festivities by
meeting at Gail and Rus Barrnetts
home on Friday evening. It was a very
informative get-to-gether because we
inspected the brand new Barrnett kit¬
chen and learned that Rus has
gourmet cooking skills and the neces¬
sary accessories. (Perhaps, this will be
the site of our next class reunion
dinner. Just joking, Rus.)
Dinner at Mory’s on Saturday,
June 4, 1983, was preceded by a mo¬
ment of silence in memory of departed
classmates Bob Maurer, Bob Lawson, Gabe Saviano and Jim Leslie.
Those attending dinner were: Edith

Beck, Gail and Rus Barrnett, Cecilia
and Art Coleman, Amy and Jerry
Shapiro, Nan(Godley)and Walter St.
Goar, Sylvia (Preston) Griffiths and
Ray, Betty and Paul Goldstein, Nora
and Ben Rush, Gerry and John Mor¬
rison and Lorraine (formerly. Dr.
Gardner’s technician) and yours truly.
There was no formal program, but
each class member had an opportunity
to talk about their own achievements
or families. Rus Barrnett provided his
usual update on activities at the medi¬
cal school and the current student
body.
A lot of class members sent their
regrets about missing the 35th reunion
dinner: Jeanne and Hal Griffith had to
cancel out 3 days before the reunion!
Marty and Bob Downie had pre¬
viously scheduled, and paid for, a trip
down the Colorado River. Bernie
Naab couldn't attend because he had
just lost his partner. Bud Rowland was
in Europe. Ruth Cortell sent news
about herself and her family. Jerry
Nowlis, Howie Simon, Paul Talalay,
Jane Andrews Rivers, Al Blaustein,
Betty (McCleary) Hamburg, Vic Drill,
Ray Johnson, Dick Peterson, Al
Bridge, Dick Hannah and Al Green
expressed regrets in not being able to
attend. Probably, I've missed others,
too.
In closing, the class of ’48 placed
third in total monies collected for
reunion year classes. Thirty-one
classmates contributed $6,571, an av¬
erage of $212 per gift. This, too, placed
us third again, behind the classes of
1933 and 1943 (March). My sincere
thanks are conveyed to Nan (Godley)
St. Goar, Sylvia Preston Griffiths, Hal
Griffith, and John Morrison who so
kindly helped me with the “Phonathon,” which made all this happen.
Thanks, too, to all the faithful con¬
tributors to the Yale Medical School
Alumni Fund, whose monies are used
for loans to medical students. Paul
Koehler
1953
Thirtieth
Our class reunion began on an auspi¬
cious note Friday afternoon with a
Symposium presented by 1953 gradu¬
ates and co-sponsored by the Depart¬
ment of Surgery, Dr. Arthur E. Baue,
chairman. The participants were: Lou
DelGuercio, Don Etzwiler, Vince
Gott, and Bill Whalen.
As we did five years ago, Maureen

and I hosted dinner at our North
Haven home Friday evening. While
we were only fourteen around the din¬
ing table in 1978, this time we totaled
twenty-five! Attending were: Jeanne
and Remi Cadoret from their Iowa
farm; Paula and Lou DelGuercio
from Westchester; Doe and Jim Dunn
of New Jersey; Marion and Don Etz¬
wiler from Minneapolis; Betty and
Tom Gentsch of Miami; Iveagh and
Vince Gott from Baltimore; Bob
Hamlisch and his new wife, Robin,
from Ithaca; New Yorkers Carol and
Fred Lane; Ora and Howie Smith of
New Haven; Betty and Lynn Stoker
from Albert Lea, Minnesota; Bill
Whalen of Willimantic, without Nina,
who had become ill; and Martha and
Bill Wilson f rom Storrs, Connecticut.
Conversation was animated as we rem¬
inisced and updated.
On Saturday evening twenty-three
of us gathered in the elegant Board of
Governors Room of the Quinnipiack
Club for a delicious dinner. Unable to
remain from the Friday gathering
were the Gotts, Lanes, Wilsons, and
Bill Whalen. However, the following
were able to join us: New Haveners
Joan and Al Chetrick; Hyla and Bob
Melnick from Larchmont; Harvey
Peck of Mahwah, New Jersey; and, all
the way from San Juan, Leila and Jose
Ramirez-Rivera. Following dinner,
each of us had an opportunity to share
personal and professional activities.
Although each graduate present
tried to update those assembled on the
whereabouts and whatabouts of the
absent brethren, it would be great to
hear from each of you.
Look forward to seeing you at our
thirty-fifth in 1988! Harold D.
Bornstein, Jr.
1958
Twenty-fifth
The twenty-fifth reunion of the class
of 1958 got off to an impressive start
with our meeting in the Beaumont
Room of the Sterling Hall of Medi¬
cine. Surrounded by the portraits of
our elegant professional ancestors,
Mike Kashgarian had put together a
stimulating introductory program,
which was entitled “The Maturation
of the Class of 1958.” Emeritus Dean
Tom Forbes recalled some of our finer
moments, and then Paul Rudnick, Lee
Phillips, and Gerry Burrow each
spoke for a few minutes about their
professional lives and how their expe21

riences at Yale had affected them.
Deputy Dean Art Ebbert made a pre¬
sentation to Dick “The Gooch” Gershon's wife and family honoring
Gooch's tremendous scientific contri¬
butions in the field of immunology.
Because of Gooch's illness, he was un¬
able to attend, but we were all deeply
touched with the warmth of the
presentation.
Friday evening, large numbers of
the group enjoyed an outdoor concert
by the New Haven Symphony, which
fortunately was not rained out. The
next morning, we were pleased to hear
President Giamatti address the visit¬
ing alumni on the problems of the
medical school and, particularly, in
choosing a new dean since Dr. Ber¬
liner will be retiring this coming year.
We then had the opportunity to listen
to stimulating programs varying from
the practical aspects of the DRG’s to
molecular biology, and then a pleas¬
ant luncheon was held in the Harkness
dining room. That evening, the crown¬
ing achievement of our resident reun¬
ion arranger, Mike Kashgarian, was
presented. Whether or not the Quinnipiack Club will ever allow members
of the class of '58 through its doors
again is purely speculative at this
point. At any rate, Mike saw to it that
the kitchens and the wine cellars pre¬
pared a feast which was truly elegant.
After a few moments of pleasantries,
the toasting began. Everyone rose and
said a few well-chosen words about
classmates and their experiences.
M uch of it, of course, is unprintable. It
was a superb evening, and it culmi¬
nated in more good fellowship at the
top of the Park Plaza Hotel. All those
who attended had a marvelous time,
and I think are all looking forward to
returning to New Haven in another
few years to renew old friendships
once again.
The California contingent was im¬
pressive in its numbers and included
Rudnick, McClanahan, and Tom
Mauro. Gene Spector and John Arnot
came from St. Eouis, Gerry Burrow
from Toronto, Dave Pugh from Kan¬
sas City. George Aghajanian, Dave
Carlson, Mike Kashgarian, Ray Gaito
and John Creatura were the Connecti¬
cut representatives. Dave O'Keefe, Jay
Kislak, Andy McGowan, Ed Socolow, Joe Cillo, Ted Lieberman all
came from the New York/ New Jersey
area. Bill Schlaepfer was our lone
Pennsylvanian. John Carlston came
from Virginia Beach, Virginia, and
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Pat McKegnev and Al and Lee Phil¬
lips traveled from Vermont. The irre¬
pressible Bob Donohue regaled us
with stories of impossibly difficult cat¬
aracts, and we aptly dubbed him “The
King of Holyoke.” Ray and Maria
Turner came from Washington, D.C.,
as did Capt. Pete Flynn, and Jack and
Pauli Wood from Rhode Island. The
ever-smiling Jim Ralph and Dick
Hinckley came from Amherst, Mas¬
sachusetts. Those dignified, proper
Bostonians who attended included the
Al Muggias, Ernie Hartman, and Leo
McCallum.
We owe many thanks to Mike
Kashgarian for arranging everything
and to the Yale School of Medicine for
giving us all a good start and permit¬
ting us to have made such warm
friendships, which began nearly 30
years ago. Those of us present at the
reunion certainly missed seeing the
other classmates, and do hope that we
will hear from them via the Alumni
News and certainly at our next reun¬
ion in five years.
Just as this report was going to
press, we heard the sad news that Dick
Gershon died at home on June 11,
1983. Paul A. Rudnick and Michael
Kashgarian
P.S. For those of you who deny the
allegations regarding the Quinnipiack
Banquet, I (Paul) have pictures in liv¬
ing color to support my contentions,
and they are available for review upon
request.
1963
Twentieth
Twelve members of the Class of '63,
ten of whom were accompanied by
their spouses, met for our twentieth
reunion dinner at the Graduates Club
on Elm Street. Peter Gregory, who
toils in academia in sunny California,
won the prize for coming from the
most distant location. Peter’s daugh¬
ter, when she enters Yale as a freshman
in September, will join the Dalsimer,
Edin, Gaudio, Kaplan and Meltzer
families in making regular tuition
payments to Yale. Of that group of
proud parents, Jim and Adele Dalsi¬
mer sent regrets (Jim is now in private
psychiatric practice in Boston, and
Adele is assoc, prof, of English at Bos¬
ton College.) The Edins, Gaudios and
Kaplans were all in attendance. Andy
and Becky Edin were runners-up to

Peter for the travel award (Winona,
Minnesota). The Edins enjoyed the
hospitality of Jon and Jean Fessel, in
Guilford, during theirstay in Connect¬
icut. Jon refuses to accept the distinc¬
tion of “only grandfather” in the class
(son Michael, 27, has two sons, Nick,
age 5, and Tony, age 3), until we hear
from Gary Van Galder. At the other
end of the spectrum. Dudley Danoff,
w ho was unable to attend, writes, “My
two kids (by my first and only mar¬
riage) are 22 months and 3lA years
respectfully . . .” Dudley also writes
that he had spoken with John Conte,
who lives in San Francisco, and who
apparently is the proud father of a
brand new baby girl, as of April 1983
(child #1, wife#!, duly reported.) Herb
Meltzer, who is now professor of psy¬
chiatry at the University of Chicago,
and director of a research unit at the
Illinois State Psychiatric Institute, was
unable to join us. Our thanks to Judy
Davis, who practices psychiatry in
Chicago, and whose husband directs a
similar unit, for passing on the gossip.
Rounding out the group for dinner,
were the Peter Tishlers (Peter is doing
research in human genetics and run¬
ning a house staff training program
in medicine at the Brockton,
Mass. VA), the George Holstens
(George is a pathologist in Springfield,
Massachusetts), Jay Pomerantz, who
is practicing psychiatry in Longmeadow, Massachusetts, with his
wife, Farida; Craig and Gail Llewellyn
(Colonel Llewellyn is professor and
chairman. Department of Military
Medicine, at the Uniformed Services
University School of Medicine, in
Bethesda) and the Bill Lehmanns. Bill
is practicing ENT in Hartford. Also
practicing in Hartford, in pulmonary
disease. Bob Mueller reported that his
daughter Sarah w ill be a freshman at
Wellesley, while his wife Marnie, who
is a vice-president at Connecticut
Mutual Life Insurance supports him
through his mid-life crisis. Completing
the Massachusetts contingent were Al
and Suzanne Wise, making the trip
from Williamstown.
Among those who were unable to
come to New Haven, but sent new'sy
letters which we all shared at dinner,
were Ric and Barbara Almond, who
confessed that their oldest son, David,
just completed his freshman year at
Harvard; Dorothy Otnow Lewis, w ho
is professor of psychiatry at NYU;
Dave Holden, who is directing a fam¬
ily practice residency program in Wich-

ita; Gordy Cohen, who has given up
medicine, and is now the prosperous
president of Jeneric Industries, Inc. in
Wallingford, Connecticut; Chuck
Wilson, who is a diagnostic radiologist
in Costa Mesa, California; John Gennari, who is chief of nephrology at U.
of Vermont; and Alan Shapiro, who
after 6 years in Puerto Rico, now prac¬
tices urology in Los Angeles.
Everyone who was able to attend,
really enjoyed the evening. We look
forward to a big attendance for our
25th. Plan now for that first week of
June 1988, to be with us in New Hav¬
en. Hal Kaplan
1968
Fifteenth
The class of '68 held its fifteenth year
reunion dinner at Mory’s. Joe and
Carol Andrews came in from Nor¬
walk, Connecticut where Joe is prac¬
ticing internal medicine. Don Coustan
stopped in from Providence, Rhode
Island where he is practicing obstetrics
and gynecology. Bill Flynn, a peri¬
pheral vascular surgeon, and his wife
came down from Boston. Dick and
Paula Getnick joined us from Waterbury, Connecticut where Dick practi¬
ces as an ophthalmologist. Kevin
Hennessey and his wife came up from
Kensington, Maryland where Kevin
practices neurology. Jerry Springer,
who practices emergency medicine in
Waterford, Connecticut, also made it
to the dinner as did Bruce Wenger.
Peter Jokl, who is in New Haven prac¬
ticing orthopedics with a subspecialty
interest in sports medicine, and who
helped arrange the dinner, was unfor¬
tunately unable to attend. I also have
stayed in New Haven to practice in¬
ternal medicine and cardiology and
gerve as co-director of the Coronary
Care Unit at Yale-New Haven Hospi¬
tal. We were all impressed with how
little anyone had changed over the
past fifteen years and all hope to be
back for the 20th year reunion. We
look forward to seeing many more of
our classmates at that time. Leonard
Grauer
1973
Tenth
The tenth reunion was an occasion for
a range of activities. A preliminary
gathering of the local class of 1973 was

sponsored by the Office of Alumni in
April, as was a telethon to accessible
members of the class from David Baggish, John Kirkwood, George Lister
and Thomas Sweeney. Vintage 73
mustered a capacity crowd of 30 for a
first-night dinner at Mory's on June
3rd. The grounds of the Association of
Yale Alumni was our home base for an
all-afternoon gathering on June 4th
(these sites won out over the Old Lyme
Yale outdoor facility, several local
country clubs, and a variety of more
formal campus settings, in the hopes
that those in the class with children
would feel free to bring them to the
reunion). Dinner on June 3rd was a
time for catching up on the past de¬
cade, a bit of which I may recapitulate
for those unable to attend.
Jim Neviackas and his wife arrived
from the reaches of Illinois, where he
is an active nephrologist, while An¬
drew Kadar returned from vacation in
Greece en route to Los Angeles (where
he is an anesthesiologist). Rick and
Harriet Fingeroth took time from a
busy orthopedic practice and several
children in Springfield to attend the
dinner, as did Rob and Karen Sirota,
who arrived from Philadelphia where
Rob is a nephrologist at the Albion
Hospital. Sessions Cole arrived from
Boston, a lone representative of that
northern contingent. It was rumored
that Randy Zusman is unable to find
his way out of his new mansion in
Newton, Massachusetts and that Joe
Simeone, Jerry Rosenbaum and Dave
Adler remain alive and well in the
same city. Lee Goldman is doing well,
recently having joined the administra¬
tion of the Department of Medicine at
the Brigham. Bennett and Helene
Blitzer have recently moved to Cin¬
cinnati, Ohio and Michael Bramley
sends his regards from North Caro¬
lina, where his pediatric practice was
too hectic to allow a jaunt North for
our siesta. Word from Mary Ann
Brunstetter-Shafer has fulfilled her
fourth year class show role in her sub¬
specialty of adolescent VD. Joe Con¬
nors has entered medical oncology in
Vancouver while Claes Nilsson (in
San Francisco), Paul Abrams (at
Frederick, Maryland), Bob Polackwich (in Tampa, Florida) as well as
your reunion secretary have all
reached the same subspecialty by a
variety of routes. John McQuade, III
is doing well in cardiology in North
Carolina. Chris (Kull) Walsh and her
husband arrived from Little Neck,

Long Island to bring us good cheer
from the Big Apple; Marc Weinberg,
Jerry Nagler and others from there
were unable to make the festivities.
The syndicate continues to gather for
intermittent outings, vague details of
which filter back to assure us that
Dave Peach, Dave Coulter, James
Robertson, Chris Reynolds and Joe
Connors continue with their previous
fraternity. We missed Midge Tripp,
who has moved from Morgantown,
West Virginia to Michigan and Danny
Moros, who was detained in the city
with his wife Anne, who has just ful¬
filled Danny’s ambitions in psychiatry
and together had their first child,
Elizabeth.
On the afternoon of the 4th, follow¬
ing the lectures and formal activities of
the reunion celebration, a stout bunch
of holdovers from the preceding eve¬
ning were joined by Gary Gordon, his
wife and children from Philadelphia,
and a pleasant cookout was held in the
courtyard of the AY A House, ar¬
ranged by George Lister. We all owe
George a vote of thanks. John M.
Kirkwood
1978
Fifth
No Report Received

CLASS NOTES
1931
At the 1983 meeting of The American
Pediatric Society, the John Howland
Award “for distinguished service in
pediatrics” was given to Drs. Helen
and Harold Harrison. In his presenta¬
tion speech. Dr. Laurence Finberg be¬
gan as follows:
“Three special features characterize
the thirty-second awarding of The
Howland Medal. The first is unique in
that the award is to a team of pediatric
investigators; a married couple, Helen
C., and Harold E. Harrison. Sec¬
ondly, more than in most years of
honoring the distinguished men and
women of pediatrics, this one clearly
illuminates the strong generational
ties and continuity in American pedi¬
atrics during the seventy-eight years
since John Howland became a
member of The American Pediatric
Society. Finally, this year’s award rec¬
ognizes excellence across the whole
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spectrum of pediatrics specified in
our constitution; advancement of
knowledge, education, clinical treat¬
ment and prevention of children’s dis¬
eases, and also humanitarian child
advocacy.”
He then traced the careers and ac¬
complishments of the Harrisons when
they were at Yale and subsequently at
the New York Hospital and then at
Johns Hopkins and the Baltimore
City Hospital. In conclusion, he ob¬
served: “They have carried the torch of
American pediatrics from those fol¬
lowing the founding generation to our
contemporary one. They have given us
an impressive, even awesome, exam¬
ple and challenge.” This presentation
speech will be published in its entirety
in Pediatric Research at a later date.
1960
Alan Ames wrote recently in regard to
theerroneous report of his death in the
spring issue of Yale Medicine: “Dear
Classmates: I am happy to inform you
that the report of my death was pre¬
mature. My health remains excellent,
and 1 am enjoying the practice of car¬
diology, and life in general, out here in
Oregon.”
1961
Robert Levy has been appointed vice
president for health sciences at Co¬
lumbia University, effective July 1.
Dr. Levy will have primary responsi¬
bility for the health sciences at Co¬
lumbia as the senior university officer
on the Washington Heights campus.
He will oversee the activities on that
campus and supervise the deans of the
Schools of Medicine, Dental and Oral
Surgery, Nursing and Public Health
while providing overall direction and
coordination to Columbia’s health
sciences programs.
Since 1981 Dr. Levy has held the
positions of vice president for health
sciences at Tufts University and pro¬
fessor of medicine and Dean of the
School of Medicine. He was pre¬
viously associated with the National
Heart, Lung and Blood Institute for
18 years, and served as director from
1975 to 1981.
1967
An Artificial Heart Training Program
is being planned at Pensacola, Flori¬
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da’s West Florida Hospital under a
preliminary agreement signed in April
by Hospital Corporation of America,
of which West Florida Hospital is an
affiliate, and Kolff Medical, Inc., man¬
ufacturer of the JARVIK-7 Artificial
Heart. The agreement was to be sub¬
ject to the approval of the University
of Utah where an intensive two-year
training program is to be held with the
goal of qualifying in the use of the
JARVIK-7 Artificial Heart.
David Conkleand two other cardio¬
vascular surgeons from Medical Cen¬
ter Clinic and West Florida Hospital
will spend about two years studying
and performing total artificial heart
surgery research in Utah. The team
will cooperate with the University of
Utah and four to six other institutions
in a multi-center series of experimen¬
tal human artificial heart trials, and it
is projected that after approximately
two years, it will be prepared to make
application for approval to proceed
with the highly specialized surgical
technique.

HOUSE STAFF
1957-1958
A very successful twenty-fifth reunion
of medical house staff (1957-58) was
held at the School of Medicine on
Saturday, May 21. A morning scien¬
tific program was followed by lunch¬
eon and a tour of the new Yale-New
Haven Hospital building. In the eve¬
ning, a reception at the home of Dr.
Howard Levitin, Dean of Students,
was attended by Dean and Mrs. Rob¬
ert Berliner. The reunion dinner at
Mory’s was the occasion for reminis¬
cences of house staff days and deeds
under the leadership of the chief resi¬
dent. Robert Petersdorf.
Those members of the medical
house staff who attended the reunion
included David Bernanke, Rubin
Bressler, Alexander Deutsch, Fritz
Fenster, Ben Forsyth, Jay Goodkind,
Donald Harter, Marie-Louise John¬
son, Willard Krehl, Edgar Levin,
Herbert Lubs, Jr., Richard Norton,
Robert Petersdorf, Robert Rentz,
Robert Shope. Most were accompa¬
nied by spouses. The reunion was
planned by Drs. Forsyth and Harter
with the cooperation of the Associa¬
tion of Yale Alumni in Medicine and
the School’s Alumni Office.

IN MEMORIAM
Inglis F. Frost
April 7, 1983

M. D. T2

Francis M. Dooley
(date unknown)

M. D. ’22

Prof. Edward Tolstoi, M. D.
May 22, 1983
ex med '22
C. Eugene Woodruff
April 5, 1983

M. D. ’26

George H. Zinn
June 1, 1983

M. D. ’27

Norman E. Gissler
(date unknown)

M. D. '28

Arthur J. Gavigan
(date unknown)

M. D. ’31

Crawford J. Campbell
June 24, 1983

M. D. ’40

Marvin Blum
April 16, 1983

M. D. '41

Ross Lionel Wilson
(date unknown)

M. D. ’43
(Dec.)

Lawrence J. Morin
May 12, 1983

M. D. '45

Col. F. Joseph Dannemiller. MC
April 30, 1983
M. D.'57
Leslie Plonsky
May 6, 1983

M. D. ’79

Lathrop E. Roberts
July 3, 1983

M. D. ’57

Martin L. Stein
June 5, 1983

M. D. ’30

Paul Watson
May 29, 1983

M. D. ’30

Edward A. Cramton
July 13, 1983

M. D. ’25

Erratum: In the Spring 1983 issue In
Memoriam, Allan W. Ames, M. D.
’60, was listed in error based upon a
report from the Alumni Records Of¬
fice. We subsequently learned that the
deceased Allan W. Ames was a 1918
graduate of Yale College.

“HELLO, I’M CALLING FROM NEW HAVEN
AND WE NEED YOUR HELP.”

That’s what students at the Yale School of Medicine
were saying this past spring as they spent several eve¬
nings calling medical alumni across the country to ask
for their support of the 1982-83 Medical School Alumni
Fund.
That phonathon the first in Medical School Alumni
Fund history—proved to be an enjoyable and worth¬
while experience for callers and alumni alike. It offered a
unique opportunity for alumni and students to engage in
enthusiastic conversation, sharing impressions and con¬
cerns, refreshing memories, learning about one another.
It also offered more tangible results:
*significant increases in pledge amounts for the
Fund, which earned additional dollars from the
Baumgartner Challenge
*a substantial number of new contributors to the
Fund
*important new dollars for the Student Revolving
Loan Fund, which is helping to ease the financial
burden of so many Yale medical students
Medical education at Yale can continue to maintain its
excellence only with the support of those who have
benefited from the School’s tradition of excellence. We
need your continuing and generous support.
YALE MEDICAL SCHOOL ALUMNI FUND
P.O. Box 1890
155 Whitney Avenue
New Haven, Connecticut 06508
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HOW DO WAYS OF LIVING AFFECT HEALTH?
By Lisa F. Berkman and Lester Breslow

The purpose of this study is to explore the
relationship between certain behaviors and
social connections of individuals — ways
of living and physical health status — and
mortality.

The idea that ways of living are related to health is not
new. In the Western World, the Greeks and Romans
recognized the importance of preventing illness through
living sensibly. Hygeia, the Greek goddess of health,
represented the view that “health is the natural order of
things, and a positive attribute to which men are
entitled if they govern their lives wisely.” Medicine’s
most important function, according to this viewpoint,
was to discover the natural laws by which human
beings were ensured “a healthy mind in a healthy
body.” The idea of host susceptibility to illness was
part of classical medical thought, and the philosophy
of maintaining health by living properly has roots not
only in Western, but also in Chinese, Middle Eastern,
and other ancient civilizations.
The purpose of this study is to explore the relationship
between certain behaviors and social connections of
individuals — ways of living and physical health status
and mortality. In our exploration of these relation¬
ships, we have been guided by two thoughts. The first is
that in most industrialized countries new living circum¬
stances are responsible for an increasingly large proportion
of the morbidity and mortality among middle-aged
and older adults. These disease determinants reside primarily
within the social environment and promote certain
distinctive behaviors. They have always been related to
health status in some way, but may previously have
been obscured by other causative factors including
exposure to virulent and infectious organisms.
The second thought concerns the precise role these
social and behavioral factors play in causing disease.

This article has been excerpted, with permission from

Health and Ways of Living by Lisa F. Berkman and
Lester Breslow, published by Oxford University Press,
October 1983. Dr. Berkman is associate professor of
epidemiology and public health.

Most epidemiologic investigations, and medical research
in general, focus on the relationship between specific
factors and specific diseases. It is becoming increasingly
apparent, however, that some factors are associated
with a wide range of diseases and may, in fact,
influence susceptibility to disease in general. Social
and behavioral factors appear to be particularly likely
to influence health status in this way. Thus our
investigation concentrates on sets of these factors that
may be associated with many diseases.

CONCEPTUAL FRAMEWORK
The significance of this work comes from the idea that
health and disease arise mainly from circumstances of
living. Within rather well-defined biologic limits, the
health, disease, and mortality pattern of any community
generally reflects the conditions of life in that communi¬
ty. Rural communities with poor sanitation, located in
areas heavily infested by parasites, mosquitoes, and
other disease agents and vectors are afflicted with one
pattern of health, disease and mortality. Urban commun¬
ities starting on the path of industrialization but
affected by crowding, inadequate food, and poor
sanitation have another pattern. Modern metropolitan
communities with advanced industrialization and rea¬
sonably good sanitation, but low physical demand
coupled with access to plenty of fatty foods, alcohol
and cigarettes, have still a third kind of health, disease,
and mortality pattern.
Ways of living in the latter kind of community, just
as in the others, underlie the typical health picture
found there. Hence, ascertaining specific ways of living
that are responsible for the health impairment and
premature deaths that occur (or, on the contrary, ways
of living that favor health and longevity) may lead to
advances in health care. Knowledge that exposure to
such disease agents as Anopheles mosquitoes and
malaria, snails and schistosomes, drags down the
health of a community, open the path to improvement
in such communities. Rudimentary industrialization
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with accompanying inadequate nutrition, exhaustion,
and overcrowding have usually brought misery and
premature death from tuberculosis and other diseases
and injuries to many people.Knowledge of these
relationships has led to social improvement and a
healthier life. Correspondingly, knowledge of the
precise features of living that harm health and preclude
enjoyment of life’s potential in the modern commun¬
ities of the United States and similar countries should
lead to further advances in health.
This thought stimulated development of the Health
Population Laboratory in Alameda County, California,
a community typical of the United States in the late
twentieth century. The first aim was to measure health
in the sense of the World Health Organization defini¬
tion, “physical, mental, and social well-being.” The
second was to examine ways of living in such a
community that might contribute to or detract from
the health of its people.
One set of ways of living to be studied consisted of
seven common habits, such as excessive use of alcohol
and cigarette smoking. Early investigations based on
the Alameda County data confirmed and extended
what was already known about the relationship of
obesity, cigarette smoking, excessive use of alcohol,
and other habits to health and mortality. A summary
health practices score, with one point for each of seven
favorable health practices, correlated highly both with
physical health status in 1965 and with longevity based
on mortality during the next five years. For example, a
man at age 45 who was observing six or seven of the
health practices had a life expectancy of about 11 years
more than that of a 45-vear old man with a health
practices score of three or less.
Another aspect of living
namely, the nature and
extent of a person’s social network — also attracted
attention as a possibly significant factor in health and
longevity. Earlier work by others had shown, for
example, that being married was more favorable to
health than being divorced, single or widowed. Moving
from one community to another, and thereby breaking
social ties, appeared adverse to health. Belonging to a
church seemed favorable. The original design of the
HPL had provided for study of these factors. Thus it
became possible to examine the relationship of social
networks to physical health and mortality.
According to the HPL concept, health consisted of
the three probably interrelated dimensions of well¬
being: physical, mental and social.Each of these three
could be regarded as a spectrum, so that an individual
could be located at certain points on all three spectra
and these points would represent that person’s degree
of health. Thus, for example, at age 25 a person would
likely fall toward one (the healthy) end of the Physical
Health Spectrum, and at age 85 toward the other.
Death means reaching the latter end of the spectrum. If
these concepts reflect reality, and if health practices
and social networks influence both physical health and
2

The HPL approach to health — that is, its
measurement, what influences it, and,
implicitly, how it may be improved
departs from the prevailing scientific focus
on understanding the biologic mechanisms
of disease as the way to advance health.

mortality, then health practices and social networks
should also influence one’s progress over time on the
Physical Health Spectrum. Persons selected at any one
time would, as a whole, be expected to move during the
ensuing decade toward the less healthy end. Would
that average movement toward poorer health and
ultimate death, however, be measurably retarded by
favorable health practices and strong social networks?
Would it be accelerated by poor health practices scores
and weak social networks? The HPL provided an
opportunity to examine the issue by making available
a questionnaire measure of people’s physical health
status in 1965, their mortality through 1974, and
another measure of health status for the same people
who survived to 1974 and completed a second ques¬
tionnaire.
The HPL approach to health — that is, its measure¬
ment, what influences it, and, implicitly, how it may be
improved
departs from the prevailing scientific
focus on understanding the biologic mechanisms of
disease as the way to advance health. Discovering the
precise mechanism by which cells become cancerous
might well open the path toward some means of
countering the development of cancer. The same
rationale applies generally to other diseases that
plague modern humanity. History demonstrates, how¬
ever, that interventions can be quite effectively planned
without completely understanding the biological mech¬
anisms involved. For example, it now appears that the
sanitary campaigns, social reforms, and nutrition
programs of the nineteenth and early twentieth century
had at least as much to do with overcoming tuberculo¬
sis, cholera, pellagra, and other infections and noninfectious diseases as did the discovery of the tubercle
bacillus and other pathogenic microorganisms, impor¬
tant as these discoveries were. These interventions
were frequently based on associations found between
contaminated water or dietary factors and disease
outcomes without the precise identification of the
causal agents involved.
One task for the health scientists, then, is to examine
as people generally do, but more systematically and
with scientific vigor
precisely what ways of living
preclude or enhance the possibility of maximum health
and longevity. Health and ways of living are natural
phenomena and as such they are subject to scientific

investigation. The crudeness of our definitions, con¬
cepts, and methods of measuring these phenomena
only makes the task more challenging, not less impor¬
tant. Advancing knowledge in this direction will, it is
hoped, help people who are seeking a healthful style of
living in modern, urban, industrialized communities.
Developing a knowledge base for guiding such action
broadly would carry us beyond such significant but
particular items as that cigarette smoking in the early
1980’s accounts for more than 300,000 premature
deaths in the United States each year, and that
excessive consumption of alcohol adds greatly to that
toll.
The usefulness of data from the HPL studies, as in
any scientific investigation, depends on the methods of
data collection. Because of the nature of the investiga¬
tions intended, the laboratory staff devoted the first
five years essentially to developing and testing such
methods. That preparatory work enabled them to
proceed with data collection that was economical,
represented accurately the adult population of Alameda
County, showed reliability and validity so far as these
could be ascertained, and provided information making
it possible to follow up the sample. All these points had
to be assured to the highest possible, and certainly to a
satisfactory degree, before starting on the main study
in 1965.
SUMMARY OF FINDINGS
Of the 2229 men aged 30 to 69 years constituting a 1965
sample of men that age in Alameda County, 9.5
percent died during the period from 1965 to 1974. On
the other hand, only 6.4 percent of the 2496 women 30
to 69 years of age in the sample died in that same time
period. That mortality picture is consistent with statis-

Health Practices
Analysis of the data revealed five common habits to be
strongly, and each one independently, associated with
mortality during the nine years of follow-up. These
habits, called high-risk health practices, were smoking
cigarettes, consuming excessive quantities of alcohol,
being physically inactive, being obese or underweight,
and sleeping fewer than seven or more than eight hours
a night.
Two additional habits, skipping breakfast and snack¬
ing rather than eating regular meals, had been shown
in an earlier analysis to be associated with mortality.
The earlier analysis covered five and a half years’experience
in the entire adult population sample, including those
under 30 and over 69 years of age. The analysis
reported here indicates that, for persons aged 30 to 69
years, not eating breakfast and snacking do not carry
as heavy a mortality risk as the other five health
practices.
To construct a simple Health Practices Index for
purposes of further analysis, each of the five favorable
health practices (ie.,not smoking cigarettes, drinking
alcohol moderately if at all, being physically active,
maintaining moderate weight, and sleeping seven to
eight hours per night) was given one point. These
points added to a score of 0 - 5 for each person. Thus,
people with a score of 0 - 2 can be considered as
following high-risk health practices; 4 - 5, low-risk, and
3, intermediate.
Persons following the various individual high-risk
health practices experienced death rate 25-115 percent
higher than persons who followed the corresponding
low-risk practices. Mortality, however, showed a strik-
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ingly higher gradient with the Health Practices Index
that summarized all five health practices for each
person. Thus, the death rate among men 30 - 49 years
of age with a health practices score of 0 - 2 was 840
percent (8.4 times) as high as that among men the same
age with a health practices score of 4.5 For men aged
50 - 59 and 60 - 69, the relative risks were 2.4 and 1.7,
respectively. As with practically all risk factor analyses
among men, the association was stronger tor younger
men. Among women, the corresponding relative risks
in the three age groups (30 - 49, 50 - 59, and 60 - 69)
were 2.9, 2.0, and 4.0 respectively.
These data confirm the strong relationship between
number of health practices followed and mortality
found in earlier analyses of the HPL data. Interpreta¬
tion of that association, however, is by no means
obvious. Persons who were seriously ill in 1965, and
thus likely to die in the ensuing few years, may already
have been unable to maintain normal weight, to
exercise, or to sleep regularly seven to eight hours a
night. A low health practices score, hence, might have
reflected poor health and the likelihood of early death,
rather than having preceded
and possibly been
causally related to — mortality. Do “poor health
practices” result in fatal illness or vice versa?
If profound and soon-to-be fatal illness in 1965 had
been largely responsible for the low health practices
scores in the sample, then the deaths associated with
those scores should have occurred mainly among
persons who were already disabled in 1965, persons so
sick as to be unable to exercise, or maintain normal
weight, and whose sleep was disturbed, and among
those who died in the first years of the follow-up
period.
In fact, the data do not support that hypothesis.
Among men, an even steeper mortality gradient pre¬
vailed among those with no health problems and those
with symptoms only, than among persons who reported
some chronic conditions and disability of varying
degrees. Also, during the period from 1965 to 1974, less
than one-seventh of the male deaths occurred among
the five percent who had any disability and a Health
Practices Index of 0 - 3 in 1965. Finally, only a small
minority of the deaths in that group occurred during
the first year and a half of the follow-up, when
seriously ill people would have been likely to die.
Though there was a slight concentration during the
early years, the deaths were distributed fairly evenly
over all nine years. Thus the striking association
between health practices and mortality cannot be
explained by pre-existing disease resulting in the “poor
health practices.”
Analysis of the data reveals, moreover, that the
health practices score predicts mortality independently
of socioeconomic status, race, and seven psychological
factors examined. Finally, the Health Practices Index
is related not only to total mortality, but strongly also
to death rates from each of four major categories of

disease: coronary heart disease, cerebrovascular and
other circulatory disease, cancer, and all other diseases.

Social Networks
Several items in the questionnaire were used as a
measure of the nature and extent of social connections
in the form of marriage, contacts with close friends and
relatives, church membership, and affiliation with
non-church groups. The HPL mortality rates showed a
gradient with each of the four components of the social
network. For example, the age-adjusted mortality
among unmarried men aged 30 to 69 years was 14.7
compared with 8.4 among married men. The corre¬
sponding rates among women were 7.6 and 5.8.
Mortality among men with few close friends and
relatives was 12.5, but only 7.4 among men with many
close friends and relatives; corresponding rates among
women were 11.2 and 4.6.
To investigate their cumulative relationship to mor¬
tality, the four types of social connections were used to
construct a Social Network Index. The latter divided
the study population into four groups: 1 (fewest
connections), II, III, and IV (most connections).
This Social Network Index showed a gradient with
mortality: group I had the highest death rate and group
IV the lowest. The mortality gradient with the Social
Network Index was just about as striking as with the
Health Practices Index. Men constituting the most
isolated group had an age-adjusted mortality rate 2.3
times higher than men with the strongest social
connections; among women the difference was 2.8.
Because a person’s social network is obviously
related to that individual’s position in the social
structure, we examined the social class, race, level of
urbanization, geographic mobility, and occupational
mobility as possibly confounding variables. All of
these had been shown by other investigators to be
associated both with social networks and with health.
Analysis was therefore directed toward ascertaining
the relationship between each of the sociostructural
elements (social class and others) and between social
networks; and assessing whether the Social Network

Index predicted mortality independently of the other
social factors.
Many studies show an association between socio¬
economic status, and health data from the HPL
confirm that association. The latter also reveal, how¬
ever, that throughout the socioeconomic spectrum
men and women with few social contacts had higher
mortality rates than those with many connections.
This finding supports the conclusion that the Social
Network Index predicts mortality independently of
socioeconomic status. Analysis also indicated that the
relationship between social isolation and mortality
risk could not be attributed to race, geographic
mobility, occupational mobility, or level of urbaniza¬
tion so far as these could be measured from the
questionnaires. The social network gradient in mor¬
tality likewise persisted through the varying levels of
preventive health care.
It is often suggested that psychological states may
either mediate the relationship between social networks
and mortality or affect the people’s network directly.
According to the first hypothesis, people without
social ties become lonely, depressed, or otherwise
psychologically disturbed and some such state induces
disease. According to the second hypothesis, people
who are psychologically disturbed find it difficult to
maintain social ties.

Thus, the findings indicate that the extent
to which people maintain social connections
is strongly associated with risk of mortality.
The relationship holds independently of
age, physical health status at baseline,
position in social structure including
socioeconomic status, level of preventive
health care and the seven psychological
factors that were examined.
In order to explore these issues, the psychological
characteristics ascertained in the 1965 survey were
analyzed. Seven of these factors, including personal
uncertainty, anomie, and life satisfaction were selected.
Of them, the one termed life satisfaction proved to be
most significant for predicting mortality, the relative
risk being almost 2 for men and 3 for women.
Nevertheless, the Social Network Index was associated
with mortality independently of life satisfaction, as
well as the other six psychological factors examined.
Thus, the findings indicate that the extent to which
people maintain social connections is strongly associ¬
ated with risk of mortality. The relationship holds
independently of age, physical health status at baseline,
position in social structure including socioec.onomic

status, level of preventive health care and the seven
psychological factors that were examined.
The association between health practices, social
networks, and mortality is clear. And it appears to be
independent of possibly confounding factors such as
age, sex, race, physical health status at baseline,
preventive health care, and socioeconomic status when
these factors are considered one at a time. The
possibility that, cumulatively, these factors might
account for the association was also examined, using
multiple logistic analysis. The latter method confirmed
the independence of the associations between mortality
and the health practices and social networks. When
considering all potential confounders (including both
social networks and health practices) simultaneously
in the logistic analysis, the approximate relative mor¬
tality risk for those with many high-risk health practices
was 2.4 for men and 2.2 for women. For those with
least social contacts, the risks were 2.2 and 2.4 for men
and women, respectively.
Both sets of factors were also found to be associated
in the expected direction, with changes in health status
occurring between 1965 and 1974. As anticipated,
physical health status for the sample population as a
whole declined over the nine-year period, consistent
with aging of the population. The decline was signifi¬
cantly greater, however, among those who were follow¬
ing high-risk health practices, had weak social networks
in 1965, or both; correspondingly, the decline was
significantly less among persons with low-risk health
practices and strong social networks. These associations
are independent not only of each other, but also of
socioeconomic status.
In summary, the data substantiate early findings of
the H PL that health is associated with certain common
habits called health practices, and with social networks.
The associations are strong and prevail not only with
regard to health status as originally determined in the
1965 survey, but also through nine years of mortality
experience, and through decline of physical health
status over the same time period. Persons with highrisk health practices and weak social networks die off
more rapidly and their physical health deteriorates
faster. The associations of these two sets of ways of
living persist in all four major categories of causes of
death, as well as in mortality as a whole. They are
independent of — that is, cannot be “explained by”
age, sex, socioeconomic status, baseline physical health,
and other potentially confounding factors examined.
These findings raise many issues that cannot be
directly answered by further analyses of these data.
Some of the questions have to do with social networks:
How are social networks related to health status? What
is it about social isolation that carries health conse¬
quences? What are the biologic mechanisms that lead
from social disconnection to disease and death? Other
similar questions concern the relationships between
health habits and morbidity and mortality, though we
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are closer to understanding how certain physical
aspects of living, such as exposure to cigarette smoke,
affect health.
What can be clearly perceived is the historical
relationship between ways of livingand the patterns of
health, disease, and mortality. During the early stages
of industrialization, the conditions of life among the
increasing numbers of people who were being drawn
into factory work obviously affected health and mortal¬
ity. Major determinants were the physical conditions
of life such as grossly poor sanitation, polluted water,
crowding, and impaired access to food. Later stages of
industrialization have brought relative affluence to
masses of people. This relative affluence has made rich
food, cigarettes, and alcohol widely available and
attractive; it has also reduced the physical demands of
life. In addition, advanced industrial civilization, espe¬
cially in the United States, has profoundly changed
family patterns and other social relationships.

forms of noninfectious respiratory disease. About
midway through the twentieth century when this
changed pattern was recognized, it seemed to many
that cancer and cardiovascular disease were occurring
as a “naturaL’concomitant of aging. Now it is becoming
evident that ways of living still determine the disease
picture, that premature deaths in our type of society
generally reflect, among other things, cigarette smoking,
excessive consumption of alcohol, and other common
habits termed health practices in this work; and by
what are here termed weak social networks. A perspec¬
tive in which chronic diseases are not viewed as an
inevitable part of the aging process invites efforts to
extend both the life span and years of life free from
disability. Such a view now seems justifiable; in fact,
evidence is mounting that many of the physiological
changes we commonly think of as part of the “natural
aging process” are to a large degree environmentally
determined.

The significance of this work comes from
the idea that health and disease arise
mainly from circumstances of living. Within
rather well-defined biologic limits, the
health, disease, and mortality pattern of
any community generally reflects the
conditions of life within that community.

It now appears that these alterations in ways of
living may be fundamentally responsible for the con¬
trasting patterns of disease in the two periods. In the
latter part of the nineteenth and early twentieth
centuries, tuberculosis and other respiratory infections,
as well as typhoid and other intestinal infections,
dominated the scene. In the latter part of the twentieth
century, their place has been taken by coronary and
other cardiovascular diseases, lung cancer, and other
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COMPUTERS IN MEDICINE

Last year, over 1.4 million computers were sold
worldwide; a million of them in the United States
alone. Sales may more than quadruple this year,
leaving little doubt that by the turn of the century,
computers will be as common in American homes as
television sets are today. In the meantime, they have
become so commonplace in industry, business and
education, that it is difficult to imagine the world
before computers.
Computer Unit is Installed at the School of Medicine

A Biomedical Computing Unit has been installed on
the third floor of the Sterling Hall of Medicine to meet
some of the special needs of the Medical Center
community. Its primary function is to provide scientific
investigators with collaboration at a sufficiently high
academic level to contribute to the design and imple¬
mentation of research projects using computers, accord¬
ing to Dr. David Stagg, the director.
The three-room unit includes a 32-bit virtual memory
machine which can support a wide variety of hardware
and software options. It can be used via terminals
located in a separate area within the unit, or via
telephone. The terminal room also houses a graphics
terminal with a hard copy option and a digital XY
plotter. A small single-user computer is also available
as is compatibility with other computer units.
The Unit’s staff are trained in biomedical research as
well as computer science. Their collaborations are
primarily in the basic sciences, particularly neuro¬
science, and research involving image processing tech¬
niques. They are also becoming increasingly involved
in clinical research and projects involving data manage¬
ment.
This fall, the Office of Graduate and Continuing
Education held a seminar for members of the Medical
Center community to demonstrate the varied uses of
computers currently being applied in basic science
investigation and clinical research here. They include a
video game for patient education in management of
childhood asthma; expert consultation systems;image
development and enhancement; and patient care
information systems. Examples of computer application
to clinical medicine, to basic medical research, and to
diagnostic imaging follow.

ways which appear to exhibit intelligence. AI tech¬
niques have been applied to many problems including
playing games such as chess, “understanding” written
or spoken language, recognizing objects in a visual
scene, and performing medical diagnosis.
A recent direction in AI research has been the
development of “expert systems” — problem solving
computer systems which contain knowledge about a
practical, real-world domain, such as medicine, com¬
puter system design, or geologic analysis. The system’s
knowledge is usually gathered from one or more
human experts with the goal of developing a system
which can make expert-level judgements and recom¬
mendations. Over the past decade, a number of expert
systems have been developed in medicine; most, how¬
ever, are still in the research stage.
Previously developed expert systems in medicine
have taken the approach of simulating a physician’s
decision-making process. They gather information as a
physician would, and then try to arrive at similar
conclusions. When applied to medical management,
such systems have the clinical effect of trying to tell a
physician what to do.
Dr. Miller’s systems are different. Instead of trying
to tell a physician how to practice medicine, the system
first asks how he or she proposes to manage the
patient. It then critiques the proposed plan, discussing
the risks and benefits of that plan as opposed to
alternatives which might be reasonable or preferred.
As a result, a critiquing system tells the physician,
“This is what I think of your management plan”,
whereas the traditional computer-advisor says,“This is
how I think you should manage your patient.”
There are several potential clinical advantages to the
critiquing approach. It accommodates the inherent
variation of medical practice. It leaves the primary
responsibility for formulating patient management
with the physicians, and allows the computer to play a
secondary role, providing feedback to help evaluate
and optimize their approach. It casts the computer in
the role of an ally, rather than a potential competitor.
Dr. Miller is applying the technique in several types
of medical management, one of which is described
here, along with excerpts from their output, illustrating
the critiquing nature of their advice.
HT-ATTENDING system for essential hypertension

Expert Computers in Clinical Medicine

Dr. Perry L. Miller, assistant professor of anesthe¬
siology, is developing “expert” computer systems in
several areas of medicine, using Artificial Intelligence
(AI) techniques to critique a physician’s plan. Artificial
Intelligence is the science of designing complete compu¬
ter systems to behave, respond or perform tasks in

HT-ATTENDING is designed to critique the pharma¬
cologic management of essential hypertension, and is
being developed in collaboration with Dr. Henry R.
Black, director of the Hypertension Clinic and associate
professor of medicine. In treating a hypertensive
patient with gout, a physician has proposed initiating
antihypertensive treatment with hydrochlorothiazide
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50 mg bid, a commonly used initial program.
The computer replied. In the United States, diuretics
are recommended by most authorities as initial or step
one therapy. Since the initiation of diuretic therapy
may precipitate a gouty attack, you may wish to start
prophylactic treatment when beginning a diuretic in a
patient with gout.
A thiazide diuretic or similar acting agent is the drug
of choice for most patients. Hydrochlorothiazide is a
commonly used thiazide diuretic. Chlorthalidone or
metolazone are alternative agents worth considering
since they are long-acting and can be given once a day.
We usually start treatment with a lower dose than the
dose you proposed. We now recommend treatment
with hydrochlorothiazide 25 mg qd or bid. Recent
work by Mater son* has shown that low doses or
diuretics may be as effective as higher doses yet cause
less hypokemia.The reference to Materson is
available on-line. After the system’s critique, the
physician may ask to see any such references and may
also ask for additional information about the various
issues discussed.
In treating hypertension, a physician usually starts
with one agent, and periodically either increases
dosages or adds further agents until blood pressure is
controlled. There is a bewildering, changing array of
drugs available, each with risks and benefits. As a
result, there is great latitude for practice variation. At
the same time, it is extremely difficult for a practicing
physician to keep current with all the various possible
options. The critiquing approach gives physicians
feedback as to how their approach fits in with current
thinking in the field and the current spectrum of agents
available.
The application of microcomputers in research
The use of computers in research laboratories is a
phenomenon which has grown with the rise of the
computer industry itself. Until the end of the I970’s,
medium-sized computers dominated the laboratory
environment, providing for the first time a computer
system which was fast, had large storage capacity, and
was, in comparison to its forerunners, relatively in¬
expensive.
Over the last four years, this domination has been
changing. Microcomputer systems are now finding
their way into the laboratory. Initially reserved for
word processingand simple mathematical applications,
microcomputers, whose speed and functional capa¬
bilities have been increasing as rapidly as their price
has been falling, are now serious contenders for the
data aquisition, display and analysis tasks of many
research laboratories.
Microcomputers are being used in every area of
laboratory experimentation, ranging from their in¬
clusion in complex equipment, where they are enhan¬
cing functionality and ease of use, to complete control
of entire experiments. Ideally suited to handling both
8

simple repetitive tasks as well as simplifying complex
ones, they are helping to speed up the often long
process of analysis and interpretation of experimental
results. Their inherent flexibility allows them to be
easily adapted to a wide variety of different situations
within the laboratory.
For instance. Dr. Brenda Ritchie’s laboratory in the
John B. Pierce Foundation Taboratory is investigating
problems of human neuromuscular fatigue and in
quantifying relationships between physiological vari¬
ables such as force, EMG, and the electrical activity
associated with single unit motoneurons. With Dr.
Simon Smith, associate research scientist with the
Biochemical Computing Unit, they have developed a
computer system based on a popular microprocessor
which has many of the features formerly seen in much
larger systems, but for considerably reduced cost.
This laboratory computer system actually contains
four separate microprocessors, each performing a
dedicated task. One acts as the “master” system, and
the other three are used to speed up the processing
required to handle special features.
To compliment this hardware, several software
packages have been developed. This integrated software
allows for data acquisition from the experimental
setup or from an FM tape recorder to the storage
device; preliminary data review and analysis using the
graphics display; and secondary data analysis — or
comparisons between different experiments.
This system is being used in the determination of the
relationships between fatigue, motorneurone activity,
and voluntary force generation in a variety of human
muscles, and is shedding new light on the role of
motoneuron activity in the generation of muscle force.
The more recent and highly successful introduction
of second generation microcomputer systems will help
to further the development of less expensive, more
powerful and highly functional laboratory computer
systems. The role of the microcomputer in modern
research can only continue to increase in the future.
Computers in medical imaging
Digital computers have wide application in medical
imaging, according to Dr. John Gore, associate pro¬
fessor of diagnostic radiology and director of NMR
imaging at Yale. An image is a recording of some signal
from different parts of an object which contains
features that convey information to an observer. The
“signal” may, for example, be the x-ray intensity
transmitted through the body, while the “features”
could be the shadows cast by bones and organs in the
body. Such images occur in several different guises in
medicine, but one of the most important areas that
directly affects patient care is diagnostic imaging,
which includes conventional radiography, ultrasound,
nuclear medicine, computed tomography, and now,
nuclear magnetic resonance (NMR) imaging. Digital
computers are used extensively to create, display, and

manipulate or process images, particularly in tomo¬
graphy and NMR imaging where usually the entire
imaging system is centered around a computer.
NMR imaging has developed in the last decade as a
powerful addition to the range of methods available
for creating images of the inside of the body. It uses the
properties of some atomic nuclei, notably the hydrogen
nucleus contained mainly in water and fat to absorb
and re-emit energy in characteristic amounts when
placed in a magnetic field. A radiofrequency transmitter
is first used to disturb the nuclei in atoms, and a tuned
coil connected to a sensitive radio receiver is used to
detect the response of the body nuclei as they recover
and emit a weak signal. Coils which produce magnetic
field gradients are driven by powerful audio amplifiers
to add further information about where the signals
come from. An NMR scanner, therefore, comprises
several complex electronic modules, but the heart and
brain of the system is a computer, which manages and
coordinates the various subunits, records and analyses
the signal information, and displays the resultant
image.
For example, the computer communicates through
a special interface to the radio frequency transmitter to
define the complex electrical waveforms that are fed to
the transmitter coil used to excite the nuclei. The
precise shapes and magnitudes of these excitations are
defined in software, and they are stored in computer
memory as arrays of numbers. Similarly, when the
appropriate NMR radio signal is induced in the
receiver coil, it is converted to digital form and the
numerical samples are stored in memory for processing.
In NMR, the nature of the image information is
strongly dependent on the shapes and timings of the
various pulse sequences used to procure a signal, and
these are controllable in a very flexible way by
computer software. The computer therefore controls
all aspects of data collection, and a crucial role is
played by the interface between the digital and ana¬
logue worlds.
Once data is acquired into memory, several numerical
computations usually take place. For example, in
NMR the signal may require filtering to remove
unwanted interference, smoothing to remove sharp
spikes, interpolation between samples and then Fourier
transformation. The latter is a complex mathematical
manipulation that can only practically be performed
by computer, and which is often the reason for
including an array processor that performs such
calculations very rapidly in the computing system.
In both CT and NMR, many different signals are
accumulated and then recombined to form an image,
and this image reconstruction is always performed by
computer. The image produced exists in computer
memory as a large two-(or three-) dimensional array of
numbers (typically 256 X 256) that correspond to the
measured image quantity from specific small volume
elements (voxels) of the object. This quantity may be

the x-ray absorption (in x-ray CT scanning), the
hydrogen nucleus NMR properties, the activity of a
radio nuclide, and so on. The array of numbers in
memory is used to control the intensity of a video
display so that the stored number value corresponds to
the image brightness in one Dicture element (pixel).
Many types of further image processing may occur
after the image is obtained. For example, whole images
may be added to improve the quality. One particularly
important type of such arithmetic is subtraction. Two
images taken at different times may be subtracted to
reveal only those regions that have changed. If, in the
interim, a contrast agent is introduced, the agent alone
will be visualized in the difference image. Such sub¬
traction methods are now widely used for x-ray
angiographic studies to observe blood vessels and
flow. A wide variety of techniques have been developed
to improve image quality, and these are readily
implemented using fast computer processing. Smooth¬
ing may be performed to reduce the mottle of an image,
and thereby improve the detection of low contrast
objects, while edge enhancement may be implemented
improve the ability to resolve fine details and increase
sharpness.
Computers may also be used to extract quantitative
information from images, which cannot be done bv the
human visual system alone. These may be simple
statistical quantities, such as the mean and variance
over a region of interest. Where the spatial pattern of
pixel values conveys information about the nature of
the object, texture analysis may be useful to discriminate
tissues, e.g. for analyzing ultrasonic speckle patterns.
Edge detection and boundary mapping may be auto¬
mated to allow accurate planimetry or volume estima¬
tions to be made such as in calculating heart chamber
volumes. The computer-generated result may be less
prone to illusion and artefact and more reproduceable
than that produced by a human observer.
There is currently much research in digital image
processing, manipulation and algorithm development,
and ideas and techniques may cross fertilize from one
area of imaging, such as satellite reconnaissance, to
another — such as in vivo medical diagnostic imaging.
The medical community can expect to see a greatly
increased involvement of digital computers in all types
of medical imaging.

Material for this article was provided bv Drs. Stagg,
Miller, Smith and Gore.
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A LOOK AT MEDICAL EDUCATION TODAY
— a case for the “Yale System”
The Association of American Medical Colleges
(AAMC) is undertaking a Project on the General
Professional Education of the Physician and College
Preparation for Medicine. During the first six months
of 1983, the Project Panel held four regional meetings
at which representatives from medical schools, under¬
graduate colleges, and various professional organiza¬
tions were invited to report. The following statement
was presented at the Northeastern Regional hearing in
May by Dr. Fred S. Wright on behalf of the Yale
School of Medicine. Dr. Wright, professor of medicine
and physiology, is chairman of the School's Curriculum
Committee.
My aim will be to provide testimony in line with the
goals of the AAMC Project: to tell about our approach
to medical education, about our course of instruction,
and about the philosophy on which it is based.
Among curriculum types, the outline of courses at
Yale would probably be viewed as traditional. The
four-year program is divided into preclinical and
clinical phases. The division is not absolute, but in
general outline, the first three semesters are devoted to
preclinical science courses and the third year is occupied
by clinical clerkship rotations. Between these segments,
an integrated program in the fourth semester provides
an Introduction to Clinical Medicine. In this semester,
students are offered, for the first time, formal instruc¬
tion in clinical assessment, diagnostic procedures, and
pathophysiology. Thus, during much of the first two
years, teaching is in a classroom situation. The formal
work in nearly all of these courses is approached by a
combination of lectures and small group discussions
(or in a few cases, laboratory sessions) that meet
regularly during the course.
This general plan has guided course scheduling with
only minor modifications for the past ten years. At the
end of the 1960’s, Yale experimented with a “new
curriculum” that introduced in the first semester,
clinical concerns such as history taking and physical
examination, and provided at the end of the first year,
an apprentice-like experience with a preceptor, usually
in community practice. Overall, this program was
intended to integrate basic science and clinical medicine
by presenting both throughout all of the four years.
Within a few years, however, it became clear that this
intention was not being realized. In particular it was
evident to many that the effort to enrich the program
of the last two years with further courses in the basic
sciences was not succeeding.
Having characterized Yale’s present curriculum as
being nearly classical in its resemblance to the formula
standardized early in this century, I must go on to say
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that the milieu in which this general structure exists
very likely differs from that in many other schools.
Despite periodic revisions of the schedule of courses,
the general policy governing implementation of the
schedule (referred to in New Haven as “the Yale
System)” has somehow persisted with little change
since it was adopted more than 50 years ago:
1. Primary responsibility for setting priorities
and for successfully completing their medical
studies is vested with students.
2. Advancement of individual students proceeds
at a rate best for each student.
3. A thesis is required of all students.
4. Examinations are not required during or at
the conclusion of individual courses.
5. Proficiency in pre-clinical subjects is dem¬
onstrated by successfully passing a compre¬
hensive examination. Originally, this examina¬
tion was a one-week session of written and
oral exercises offered twice a year; since the
1940’s, the requirement has been met by
passing the National Board Exam Part I.
Naturally, this rather idealistic approach, which
attempts to reduce competition in a competitive world,
is not without problems. It is not best for all students;
some would probably accomplish more in a more
rigidly structured program. Since attendance at classes
is not required, sometimes students and teachers do
not meet and this is not helpful. Faculty morale suffers
when students do not appear. In the present era,
however, these difficulties are not dominant and the
general level of participation and involvement on the
part of both students and faculty is high. Teaching in
this voluntary and non-punitive environment is a
pleasure. The importance of this approach, and its
benefits, struck me when I read David Roger’s descrip¬
tion, published in The Pharos last spring, of a visit with
medical students. He described “an outpouring of
frustration, disappointment, and real rage.” The stu¬
dents “felt they were being lectured to death.” They
complained of insufficient time for study and of
“dreary never-ending series of quizzes, tests, and other
bracings.”
We think that some of these difficulties have been
avoided at our school because of the basic policy I
referred to as the Yale system. In view of the apparent
viability of this 50-year-old experiment, we hope the
committee will recognize and affirm the advantages of
having each school set its own standards and course of
study. It would be a great service if the committee
report restated the important difference between indiv¬
idual academic programs leading to a degree, and the

process of certification qualifying graduates to practice
medicine. Certification ought to remain exclusively
with licensing boards. They should set their own
standards of competence for the practice of medicine
in their jurisdictions. Schools should develop their
own curricula and thus be able to innovate and to
respond to their own particular strengths. As this
committee reviews medical education throughout the
country, we think it is important to preserve the
possibility of individual innovations and approaches
and to avoid setting particular guidelines that could
well serve as ammunition for particular interest groups
who might want one specific course or another to be
taught in all schools. The curriculum should not be a
political issue open to coercion by such interest groups.
The features of medical education at Yale that I have
described briefly, the traditional course structure, and
the unusual (although now long-standing) approach to
requirements, are really technical matters. What it is
that we are trying to teach, and that this structure is
supposed to enable students to learn, remains the focus
of our continuing concern. We are engaged in a
continuing struggle to provide general education for
future physicians. One reason that this is a struggle is
the increasing specialization of both medical practice
and our own faculty. Both faculty and students tend to
deal in subspecialty interests, at the cost of missing
opportunities to involve themselves in a broad range of
more generally useful information. We are attempting
to develop and maintain a program that treats the
medical school years as preparation for further post¬
graduate training, not as preparation sufficient for
medical practice. We believe, therefore, that two
elements are essential: a secure grounding in the
sciences relevant to medical practice; and clinical
activities that develop habits of mind and behavior
that will outlast particular currently popular techniques
of diagnosis and treatment.
This does not mean that we demean or ignore the
facet of this project concerned with “qualities, values
and attitudes.“We must be equally concerned with the
ability of doctors to respond to patients’ needs in a
compassionate and understanding manner. The admis¬
sions committee must recruit students who possess,
and the medical school program must foster continuing
development of those qualities necessary in the wise
and caring physician. But we think it is very important
to recognize that concern for humane and compassion¬
ate medical care is not alternative to dedication to
scientific knowledge or clinical acumen. We are very
concerned that our program of instruction in basic
science remain strong. After describing his worries
about medical education, David Rogers went on to
state the two major objectives of medical school: to
inculcate personal habits of learning (to make the
physician a continuing learner throughout his or her
lifetime); and to lay down an appropriate scientific
base, to understand facts, think deductively and gain
experience in logical decision making. He seems to be

saying that medical education in the basic sciences
should not be viewed as a hurdle to get over, or as a
burden to bear, or as a destructive dehumanizing
ordeal, but rather that the information and the intellec¬
tual activity involved in dealing with it are a crucial
element in forming habits of mind that will serve
physicians in their future continuing education.
1 was also struck in reading Paul Starr’s new book.
The Social Transformation of American Medicine, by
the pervasive references to the importance of science to
the development of present day medicine. Starr argues
that medicine’s link to modern science is one of the
important factors underlying its very legitimacy. To
choose one such statement from this book:
“Modern medicine is one of those extraordinary works
of reason: an elaborate system of specialized knowledge,
technical procedures, and rules of behavior. By no
means are these all purely rational: our conceptions of
disease and responses to it unquestionably show the
imprint of our particular culture, especially its individu¬
alist and activist therapeutic mentality. Yet, whatever
its biases and probably because of them, modern
science has succeeded in liberating humanity from
much of the burden of disease. Few cultural relativists,
suffering from a bad fever or a broken arm, would go
so far to prove a point as to trade a modern physician
for a traditional healer. They recognize, in behavior if
not always in argument, that in medicine the dream of
reason has partially come true.”
There is a need for balance in the curriculum, for
vigilance to be sure that courses dealing with science
and courses concerned with patient care both provide
effective general education. However, we do not
believe that blame for whatever may be amiss today in
medical education should be laid at the door of basic
science. I think we all realize that effective medicine in
the future will be based in part on the pre-clinical
sciences we call “basic” and to a fearful extent on
science that we do not yet know but must be prepared
to understand and apply. At Yale we are looking for
ways to get more general education, including science,
into the curriculum.
Medical education should equip the student with a
scientific approach to medical problems, the skills
necessary to obtain clinical information, and the
ability to respond in a compassionate manner to the
problems of patients. Medical education should empha¬
size problem solving that is independent of a large
instantly recalled data base. Increasingly ,the ability to
master all of the information necessary to practice
medicine will become a more distant and unachievable
goal and the use of information retrieval systems will
become increasingly common. Therefore, it is important
for the medical student and the future physician to be
able to acquire necessary information from available
sources, to learn to use this information to solve
clinical problems, and to do this while retaining and
developing the capacity to offer understanding and
sympathy to fellow humans when they sorely need it.

HERE AND ABOUT
DR. BONDY APPOINTED
CHIEF OF STAFF, V.A. MEDICAF
CENTER IN WEST HAVEN

CHAIRMAN APPOINTED FOR
DEPARTMENT
OF
LABORATORY MEDICINE

The Veterans Administration has
appointed Dr. Philip K. Bondy chief
of staff at the Medical Center in West
Haven. Dr. Bondy, who is professor
of medicine, and is well knowm as an
outstanding teacher and endocrin¬
ologist, has also been appointed asso¬
ciate dean for the V.A. Medical Center.
A graduate of Columbia College
and Harvard Medical School, Dr. Bondy
first came to Yale in 1948 as Alexander
Brow ne Coxe Fellow' in Physiological
Chemistry. He became a member of
the School of Medicine faculty in
1952, when he was appointed
assistant professor of medicine. In
1965, he was named Ensign Professor
of Medicine, and the following year,
he was appointed C.N.H.Long Pro¬
fessor and chairman of the Depart¬
ment of Internal Medicine. He left
Yale in 1972 to become Cancer Re¬
search Campaign Visiting Professor
of Medicine at the Institute of Cancer
Research, and consultant in medicine
at the Ludwig Institute of Cancer
Research in London; appointments
he held until 1977, when he returned
to Yale as professorof medicine, and
as associate chief of staff for research
at the V.A. Medical Center.
Editor-in-chief of the Yale Journal
of Biology and Medicine, Dr. Bondy
is also editor of the Metabolism
Section of the Year Book of Medicine
and serves on the editorial boards of
Cancer Topics and Merck Manual.
Elected to Phi Beta Kappa, Sigma Xi
and Alpha Omega Alpha honor socie¬
ties, he is a fellow of the American
College .of Physicians, the American
Association for the Advancement of
Science, and the Royal College of
Physicians, and a member of a number
of professional societies including
the American Society for Clinical
Investigation, Association of Ameri¬
can Physicians, the American Feder¬
ation for Clinical Research, and the
Association of Physicians of Great
Britain and Ireland.

Dr. Peter I. Jatlow, an authority on
the clinical toxicology and pharma¬
cology of psychotropic drugs, has
been appointed chairman of the De¬
partment of Laboratory Medicine at
Yale, and director of clinical labora¬
tories at Yale-New Haven Hospital.
He succeeds Dr. David Seligson,
professorof laboratory medicine, who
has held these offices since 1972.
Dr. Jatlow, who is professor of
laboratory medicine and psychiatry,
is well known for his extensive clinical
studies of the effects of cocaine and
antidepressant drugs as well as drugs
used in the treatment of children with
attention deficit disorders. He was
the first to successfully measure the
level of cocaine in the blood of individ¬
uals taking the drug by various routes.
A graduate of Union College, Sche¬
nectady, he received his M.D. degree
from the State University of New
York, Downstate, and came to Yale
in 1962 as an intern in pathology at
Yale-New Haven Hospital. He was
appointed to the School of Medicine
faculty as an instructor in pathology
in 1964, and was promoted to assistant
professor four years later. In 1975, he
was named director of clinical chem¬
istry in Yale-New Haven Hospital,
and the following year, was appointed
professor of laboratory medicine. He
received a joint appointment as pro¬
fessor of psychiatry in 1978.
Dr. Jatlow serves on the editorial
boards of several professional journals
including Chemical Chemistry, Jour¬
nal of Analytic Toxicology, Titerapeutic Drug Monitoring, and Clinica
Chemic Acta. He is president of the
Academy of Clinical Laboratory
Physicians and Scientists and is a
member of numerous other national
advisory committees including the
National Institute on Drug Abuse
and the American Board of Pathology
Chemical Pathology Test Committee.

Dr. Bondy

Dr. Jatlow

Dr. Gagge
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PIERCE LABORATORY
CELEBRATES 30th ANNIVERSARY
The John B. Pierce Foundation Lab¬
oratory celebrated its 50th anniversary
on November 4th, and paid tribute to
Dr. A.Pharo Gagge, fellow emeritus.
Dr. Gagge has been a member of the
Laboratory’s scientific staff since it
was founded in 1933 to conduct
research and educational programs
“for the increase of knowledge to the
end that the general hygiene and
comfort of human beings and their
habitations may be advanced.”
Dr. C.E.-A. Winslow was appointed
the first director of the Laboratory
while he was chairman of the Yale
Department of Public Health, and he
retained both offices until his retire¬
ment in 1945. Under his leadership,
and that of subsequent directors, the Lab¬
oratory has gained worldwide recog¬
nition for its many significant contri¬
butions to the field of environmental
physiology. In recent years of energy
shortages and increasing pollution
production, their work has assumed
added importance as governments
seek a balance between energy conser¬
vation and a healthful environment.
The close relationship between the
Pierce Laboratory and the Depart¬
ment of Epidemiology and Public
Health has continued. A major por¬
tion of Yale’s program in environ¬
mental health is conducted in the
Pierce Laboratory, and in 1968, quali¬
fied graduate students and postdoc¬
toral fellows were admitted as majors
in environmental physiology in the
Department of Epidemiology and
Public Health.
Dr. Gagge, who is also professor
emeritus of epidemiology, is well
known in the scientific world for his
contributions to the field of thermo¬
physiology. In the 1930’s, he and his
colleagues developed the use of partitional calorimetry, a widely applied
method of measuring absorbed or
evolved heat, which is less compli¬
cated than the use of a full calorimeter.
In addition, his research led to the
development of the ET*Scale, a bio¬
physical index combining the physical
properties of the skin surface, to give
a single temperature index of the
environment. Based on a concept
similar to the weather reporter’s fam¬
iliar THI (Temperature Humidity
Index), ET* is a more scientific and
accurate assessment of the effect of
the environment on human comfort.
More recently, Dr. Gagge designed a
method for direct measurement of

thermal insulation of all types of
clothing as they are worn during
heavy exercise as well as during rest.
His research is of importance to
scientific programs, including those
of NASA, involved with the effects of
the environment on human health.
Dr. Jan A. Stolwijk, chairman of
the Department of Epidemiology and
Public Health and associate director
of the Laboratory, was chairman of
the anniversary program. Historical
events of the institution recounted by
Dr. Vernon Lippard, dean emeritus
of the School of Medicine, and mem¬
bers of the Laboratory were followed
by the reading of tributes to Dr.
Gagge from colleagues and friends
from around the world.

CMHC RESEARCH CENTER
NAMED IN HONOR
OF SENATOR R1BICOFF
On September 28, the research facili¬
ties of the Connecticut Mental Health
Center were dedicated as the Abraham
Ribicoff Research Facilities, in honor
of the former Governor of Connecti¬
cut. President A.Bartlett Giamatti
was joined by Governor William A.
O’Neill and Dr. Herbert Pardes, direc¬
tor of the National Institute of Mental
Health in a tribute to Senator Ribicoff
and his long support of mental health
programs as governor. Secretary of
Health, Education and Welfare, and
U.S. Senator.
During his terms as governor. Sen¬
ator Ribicoff was a strong proponent
of the Connecticut Mental Health
Center, which was established in 1966
as a cooperative endeavor of the
State of Connecticut Department of
Mental Health and Yale University.
Research conducted at the Center is
recognized internationally for its
many contributions to basic and clini¬
cal studies of mental disorders.

PHYSICIAN ASSOCIATES HOLD
TWELFTH COMMENCEMENT
On August 22, twenty-one students
received Certificates Of Physician
Associate in a ceremony in the Mary
S.Harkness Auditorium. They were
the twelfth class to graduate from the
program established in the School of
Medicine in 1973 under a grant from
the National Institutes of Health.
Elaine E. Grant, executive director

of the Program, and Dr. Howard
Levitin, dean of students and medical
director of the Program, officiated
during the commencement, which
included an address by Dr. Lowell
S. Levin, professsor of public health.
Gary Spinner, a student, presented
the Didactic Instructor Award to Dr.
David Coleman, a postdoctoral fellow
in the Department of Internal Medi¬
cine, for his exemplary efforts in the
education and training of physician
associates.
Clinical Rotation Site Awards were
presented to Danbury Hospital, Law¬
rence and Memorial Hospital, Nor¬
walk Hospital, Surgical Associates
ot New Haven, Waterbury Hospital,
Yale-New Haven Hospital, and the
West Haven Veterans Administration
Medical Center. Deputy Dean Arthur
Ebbert,Jr.,and Debbie Waldes, assis¬
tant director of the Program, awarded
the certificates, following which the
graduates and their families and
friends celebrated at a reception in
their honor in the adjoining courtyard.
The Yale Physician Associate Pro¬
gram is classified as Type A, offering
extensive training in general medical
theory and clinical practice. Graduates
are capable of examining patients,
taking a medical history, and assisting
physicians in performing diagnostic
and therapeutic procedures. They function
under the supervision and responsi¬
bility of the physician, and under
special circumstances, with defined
rules, may perform without the immedi¬
ate surveillance of the physician.

HOSPITAL DEDICATED
TO FORMER DEAN
The Bayne-Jones Army Community
Hospital located at Fort Polk, Louisi¬
ana was dedicated on August 12,1983.
The 169-bed hospital is named in
honor of Brigadier General Stanhope
Bayne-Jones, who joined the Yale
faculty in 1932 as professor of bacteri¬
ology and who served as dean of the
School of Medicine from 1935 to
1940. He was also master of Trumbull
College from 1932 to 1938.
At the outbreak of World War II,
Dr. Bayne-Jones resigned as dean in
order to enter military service. He
was called to active duty as a lieuten¬
ant colonel in 1942, and was soon
promoted to the rank of colonel and
in 1944, to brigadier general. When
Dr. Bayne-Jones died in 1970 at the
age of 82, he was buried with honors
in Arlington National Cemetery.
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THE ROYAL SOCIETY
HONORS DR DOUGLAS

DR.LEVY IS HONORED

A HEALTH GUIDE
GLOBAL TRAVELERS

Dr. Will iam W. Douglas, professor
of pharmacology, has been elected a
fellow of the Royal Society. In
honoring him, the British scientific
society cited Dr. Douglas’ research
on the physiology and pharmacology
of endocrine, exocrine and other
secretory cells, which has led to the
recognition of the involvement of
calcium in stimulus-secretion cou¬
pling. Chartered by King Charles II
in 1663 as the “Royal Society of
London for Improving Natural
Knowledge”, the society is one of the
oldest and most prestigious scientific
academies in the world.
A native of Glasgow, Scotland,
Dr. Douglas has been a member of
the School of Medicine faculty since
1968. Lollowing graduation from the
University of Glasgow, he did post¬
graduate work in physiology at the
University of Aberdeen before return¬
ing to the University of Glasgow,
where he received his M.D. degree
with honors in 1949. He served as a
major in the Royal Army Medical
Corps prior to appointment on the
Medical Research Council at the
National Institute for Medical Re¬
search in London.
Dr. Douglas first came to the
United States during a leave of
absence in 1952, when he was ap¬
pointed an associate professor of
pharmacology at the Albert Einstein
College of Medicine. He was appoin¬
ted professor of pharmacology in
1958. In addition to election to the
Royal Society, Dr. Douglas has been
honored with the John Gaddum
Memorial Award from the British
Pharmacological Society and the
H.B. Van Dyke Memorial Award
from Columbia University.

Colleagues and friends gathered at
the West Haven Veterans Adminis¬
tration Medical Center on November
4th for a symposium in honor of Dr.
Lewis Levy, clinical professor of
neurology. A member of the School
of Medicine faculty since 1954, Dr.
Levy was chief of Neurology Service
at the V.A. Medical Center from
1955 to 1976, and chief of the Cerebro¬
vascular Section from 1979 to 1983.
He was director of the Stroke Acute
Care Unit from 1971 to 1976.
Guests were welcomed to the sym¬
posium by Dr. Richard H. Mattson,

A “Global Disease Guide” has been
created and developed by Dr. Martin
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who succeeded Dr. Levy as chief of
the Neurology Service, and Dr. Philip
K.Bondy, chief of staff and associate
dean, introduced the speakers. Dr.
Gilbert H. Glaser, chairman of the
Department of Neurology, moderated
the morning session, while the after¬
noon session was led by Dr. Harold
E. Booker, director of Neurology
Service, V.A.Central Office.
During the day-long event, the
Veterans Administration awarded
Dr.Levy a special commendation
which read in part,“During the three
decades of his leadership. Neurology
grew from a single staff member to a
61-bed independent service that is
recognized as one of the outstanding
units within the V.A.system . . .He
initiated the development of a number
of specialized units including the first
Epilepsy Center and the Stroke Treat¬
ment Unit, that have served as proto¬
types for both the V.A. as well as for
non-federal hospitals.
“Dr. Levy was instrumental in start¬
ing the neurology residency training
at the Center which has been inte¬
grated with the program at the Yale
School of Medicine. Over the years
more than 60 resident physicians
have trained under his expert guidance
.. .Concurrently, (he) has been exten¬
sively involved in both clinical and
basic research, particularly in cerebral
vascular disease. He has encouraged
and fostered similar participation of
his staff. Most importantly, his devo¬
tion to the human aspects of medical
care has won him the respect and
warm admiration of all who are
fortunate enough to know him.”

FOR

E. Gordon, associate clinical professor
of medicine. This desk-top, record¬
sized informational disc permits in¬
stant finger-tip dialing of disease pre¬
valence in 170 countries. The many
voluminous and often obscure data
references have been culled and
brought together as a physicians’
world scanner to aid in post-travel
diagnosis as well as an immediate
guide to pre-travel immunizations.
Color codes direct the physician to
prevalence rates of viruses, helminths,
protozoa, bacteria, rickettsia and
even venomous bites and stings. The
diverse types of arboviruses, dengue,
schistosoma and the resistant malarial
strains are readily spotted, height¬
ening the physicians’ ability to rec¬
ognize diseases that are no longer
tropical or exotic in this jet age.
Dr. Gordon’s continuing interest
in parasitology, the paucity of readily
available references, and the need to
increase physicians’awareness of dis¬
eases of the traveler led him to develop
the Global Disease Guide as an aid in
disease prevention and post-travel
diagnosis. National distribution of
the Guides to medical schools, hos¬
pitals and physicians has just been
initiated. Inquiries can be directed to
Dr. Gordon at 111 Sherman Avenue,
New Haven, Connecticut 06511.

THE CASE OF
THREE MISSING HAMSTERS
Three infected hamsters reported
missing from their cage in the animal
containment facility on the ninth
floor of the Laboratory of Epidemiol¬
ogy and Public Health became over¬
night celebrities — of a sort. “Infected
Yale Hamsters Escape” was headline
news for the wire services, major
television and radio networks and
newspapers across the nation, includ¬
ing the New York Times, which de¬
voted almost half a page to the story.
The hamsters have not been found,
and are presumed dead. Although
their disappearance caused consider¬
able stir in the media and concern in
the University, the three rodents and
others like them in the LEPH-9 facility
are of little threat to human health
and the likelihood that they escaped
from the facility is practically nil. The
incident, however, called attention
to several potential areas which are
vulnerable to error.
The hamsters were among several
hundred research animals in a major
study of Alzheimer’s disease being
conducted by Dr. Elias Manuelidis,
professor of neuropathology and neu¬
rology. They were infected with Creutzfeld-Jacob virus, a so-called “slow
virus”, which is invariably fatal, and
causes symptoms of senility similar
to those of Alzheimer’s disease. Be¬
cause of its extremely low transmissibility in animals - only by injection
into brain tissue — the C-J virus has
been classified as Level 2 by the
Center for Disease Control. Classifica¬
tion is according to risk level from
Level 1, minimal risk, to Level 4, high
risk.
Dr. Manuelidis and his colleagues
had been working with C-J infected
rodents for more than a decade in
their laboratory in Brady Memorial
Laboratory, but to further assure
safety and security, the animals were
moved last year to the recently com¬
pleted Level 3 animal containment
facility on the ninth floor of the
Laboratory of Epidemiology and Pub¬
lic Health. Research procedures and
equipment there were reviewed by
leading experts from the National
Institutes of Health and the Center
for Disease Control, who found the
facility met, and indeed, exceeded, all
of the requirements for biological
safety for this research. Safety pre¬
cautions are supervised and enforced

by the Division of Animal Care and
by the Department of Biological Safe¬
ty, University Health Services.
An associate in research for the
C-J virus study first discovered that
the hamsters were missing on October
third. She later reported that the lid
appeared to have been pushed off
their cage, which was quite warped
due to repeated autoclaving (high
pressure steaming for decontaminating
infectious material). Health and safety
officers, however, were unaware of
the missing hamsters until a week
later, when Robyn Gershon, acting
director of the Department of Biolog¬
ical Safety, made a periodic, unan¬
nounced inspection.
A series of meetings has since been
held to ascertain facts of the escape,
and to plan remedial actions. Two
problems addressed are the need for
the establishment of a more definitive
line of responsibility for maintenance
of the containment facility, and a
more accurate method for keeping a
census of the animals. The high cost
of maintaining the LEPH-9 animal
containment facility is another factor.
Cages have to be replaced repeatedly
due to damage from autoclaving.
The Division of Animal Care recently
invested $ 14,000 on new cages report¬
edly more durable than ones previ¬
ously used, and because of persistent
problems, the autoclave itself will be
replaced at an estimated cost of
$125,000, according to Dr. Stephen
Barthold, the acting director.
Although most are confident that
their health and safety is not endan¬
gered, faculty, staff and students in
the Laboratory of Epidemiology and
Public Health have expressed concern
over the incident. In discussing it
with them. Dr. Edward Adelberg,
deputy provost for the biomedical
sciences, told them that the delay in
notifying University officials about
the missing hamsters was certainly an
error, but he assured them that precau¬
tions will be taken to ensure that no
“accidents of this nature will occur in
the future.” Dr. Jan Stolwijk, chair¬
man of the Department of Epidemiol¬
ogy and Public Health was firm in
agreeing that the problems must be
remedied. “It would be difficult to
maintain a viable working atmosphere
if this sort of thing keeps happening,”
he said.
— MBN

W. H.O.
WORKSHOP ON
TRYPANOSOMES HELD HERE
A workshop on African trypano¬
somes, sponsored by the World Health
Organization, was held at the School
of Medicine in November. Dr. Frank
F. Richards, professor of medicine,
was host to the three-day meeting of
scientists from Africa, Europe and
the United States.
African trypanosomes are the para¬
sites responsible for trypanosomiasis
(sleeping sickness) and N’gana, a
disease affecting domestic livestock
which has had severe implications for
the economy of African nations. Accord¬
ing to Dr. Richards, who is wellknown for his research in tropical
medicine, the incidence of sleeping
sickness in Uganda and Sudan has
risen sharply in recent years following
war and unrest in those countries.
Drugs used for treatment of trypano¬
somiasis are effective in the early
stages of the disease, but many of
them have considerable toxicity and
can be given only for short periods.
In addition, they are of little use in
regions where re-infection is an ever¬
present risk.
For these reasons, efforts to find a
vaccine for trypanosomes have been
accelerated in recent years. So far,
the trypanosomes have outwitted the
biologists studying the disease, accord¬
ing to Dr. Richards. “The disease is
remittent, giving rise to many succes¬
sive waves of fever and trypanosome
parasitemia in the host. In each wave,
the parasites are covered by a different
protein overcoat - Variant Specific
Glycoprotein (VSG). The host does
make antibodies to one VSG and
destroy the parasites. This destruction
is, however, rapidly followed by the
emergence of a second population of
the parasites, carrying a different
VSG,” he explained.
The progeny of a single parasite
has been shown to produce 100 or
more different VSG surface proteins,
and it seems likely that as many as
1000 different genes coding for the
proteins are present.
In addition to Dr. Richards, partici¬
pants from Yale included Dr. Curtis
Patton, associate professor of epi¬
demiology, Dr. Larry Ruben, post¬
doctoral fellow in epidemiology, and
Dr. Thomas Lalor, postdoctoral fellow
in medicine.
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THE FIRST INTERNATIONAL
SYMPOSIUM ON LYME DISEASE
IS HELD AT YALE
“The Lyme disease story begins with
two mothers in Lyme, Connecticut,”
Dr. Allen Steere said in introducing
the First International Symposium
on Lyme disease, held here on Novem¬
ber 16-18. The mothers, skeptical of
the diagnosis of juvenile rheumatoid
arthritis in their children and several
others in their neighborhood in 1974,
called Dr. Andrew Spielman at the
Connecticut State Department of
Health, who in turn conferred with
the Yale Section of Rheumatology.
Thus began an intensive investigation
into the cause and treatment of a
mysterious and serious new disease
which ultimately would involve col¬
laboration with scores of scientific
investigators in the United States and
Europe.
One of the mothers, Mrs. Polly
Murray, and Dr. Spielman were
among the more than 100 participants
at the symposium, which was spon¬
sored by the Yale Journal of Biology
and Medicine and the Section of
Rheumatology. The Journal will pub¬
lish a limited edition of a book based
on the symposium in mid-1984.
The theme of the symposium was
established in the first session with a

report of the clinical spectrum and
treatment of Lyme disease by Dr.
Steere, who is associate professor of
medicine and principal investigator
of the Lyme disease research at Yale.
His report was followed by a history
and comparison to Lyme disease of
European erythema migrans disease
disorders seen in Europe, by Dr.
Klaus Weber, a dermatologist and
allergist from Munich, West GerGermany. Dr. Stephen Malawista,
professor of medicine and chief of the
Section of Rheumatology, spoke on
the implications of the Lyme disease
study for research on other rheumatic
diseases in a talk entitled “Lyme
disease: a unique human model for
an infectious etiology of rheumatic
disease.”
For the next two days, talks by
leading investigators from throughout
the United States, Germany and Scan¬
dinavia dealt with other related tickborne disorders in Germany and Scan¬
dinavia; a description of Ixodes dammani, the tick vector of the disease;
and an indepth study of the spirochete
discovered last year to be the causative
agent, and the host response to it.
The final two sessions were devoted
to epidemiologic studies of Lyme
disease. Each talk was followed by
lively discussion.

PHOTOS BY SVI \ MAR ISON

Top left. Dr. Steere with Mrs. Polls Murray
and Wilson Nolen. Mr. Nolen w as the major
sponsor of the symposium.
Left.

Dr

Willy Burgdorfer, Acting Chief.

Epidemiology Branch of the National Institute
of Allergy and Infectious Disease, center, first
isolated the Lyme disease spirochete from Ixodes
dammini ticks.
Below, Dr. Klaus Weber with Dr. Gustav J.
Dammin, professor emeritus. Harvard School
of Public Health, for whom the lick. Ixodes
dammini. is named.

16

PROFILE

THE CLASS OF 1987
The 102 members of the Class of 1987
arrived on Cedar Street early in Sep¬
tember looking slightly bewildered,
but nevertheless ready to meet the
challenges of the coming four years
with the competence, humor and
perseverance expected of students
admitted to the Yale School of Medi¬
cine. The average age of the class is
23; and their cumulative GPA scores
average 3.63; twenty of the 68 men
and 34 women represent minority
populations.
Almost a third of the students
spent their undergraduate years in
Ivy League colleges. Interestingly,
more Harvard undergraduates applied
(181) and were accepted (37), than
Yale students (118 and 22), although
11 from Yale and 10 from Harvard
actually matriculated. Sixteen of the
first year class have advanced degrees,
including five Ph.D. degrees.
Statistics aside, this class, as others
before it, is impressive not only for
the outstanding scholastic achieve
ents of its members, but also for the
wide diversity of academic back¬
grounds and extracurricular interests
they represent. This is in keeping
with an established trend in the School’s
admissions policy, according to Dr.
Thomas Lentz, assistant dean for
admissions.
Although the majority of students
were science majors, there is variety
even within their ranks, including
those who concentrated in biology,
engineering, chemistry, biochemistry,
physics, or mathematics. Twenty-one
members of the class majored in the
humanities, while thirteen others stud¬
ied social sciences. Not without honor
students, the class includes a Fulbright
scholar, as well as those who received
All-American Academic Awards and
magna cum laude.summa cum laude,
and Phi Beta Kappa honors.
And there is talent — musicians
who sing in choirs and glee clubs, and
others who play the violin, cello,
trumpet, guitar or flute in marching
bands, symphony orchestras, and jazz
and rock groups. Some are writers,
including two published poets, a sci¬
ence writer and a medical editor; and
members of the radio-television world,
including a disc jockey, radio announ¬
cer, television producer and a director.

Every year in September, the Office of Student
Affairs sponsors a picnic for first year students.
A Iways a success, the picnic provides an oppor¬
tunity for new students, faculty and adminis¬
tration to meet informally.

Some are dancers — modern, ballet
and folk, while others have taken
part in theatrical productions.
Athletes in tne class have partici¬
pated in varsity track, swimming,
soccer, tennis, crew and football
including two students who are former
stars of Yale teams in more victorious
times. Others play baseball, squash
and volleyball just for the fun of it.
And there is one magician among the
ranks, whose skills, in the final analy¬
sis, may be the envy of all from time
to time during the next four years.

LOME
ACCREDITATION RENEWED
The Yale University School of Medi¬
cine was visited for three days in
March 1983 by a survey team repre¬
senting the Liaison Committee on
Medical Education, which is jointly
sponsored by the Association of
American Medical Colleges and the
American Medical Association
Council on Medical Education. The
purpose of the visit was to evaluate
and accredit the program in medical
education leading to the M.D.degree.
As a result of this survey, the Liaison
Committee on Medical Education
voted to confer continuing full accredi¬
tation for ten years, the maximum
length of time under the current
rules.

STUDENTS PRESENT LECTURE
SERIES ON NUCLEAR ARMS
The key to successful arms control
talks lies in maintaining a continuity
in the negotiations which thus far
have been disrupted with each new
presidential administration “trying
to reinvent the wheel”, Paul Warnke
told the large audience attending the
final lecture in a series on the “Age of
Nuclear Arms — a Medical Perspec¬
tive.” Warnke, the director of the
U.S. Arms Control and Disarmament
Agency during the Carter Administra¬
tion and chief negotiator for SALT
talks in 1977 - 78, was received enthusi¬
astically by the audience which over¬
flowed Mary S. Harkness Auditorium.
The series of twelve weekly lectures
sponsored by the Office of the Dean
and the Department of Internal Medi¬
cine, was organized by students to
present future physicians with an
understanding of the consequences
of nuclear war, as well as the political
and historical forces that underlie the
current standoff. The course did not
espouse any particular solution to
the problem.
“We believe this course embodies a
progressive movement in Yale medical
education — as future leaders of the
medical profession, Yale medical stu¬
dents should be experts on issues that
most threaten human health and well¬
being,” said Joshua Freedman, the
second year student primarily respon¬

sible for organizing the series.
“Further, because of their high stand¬
ing in the public image, physicians
are empowered to help form a con¬
sensus on how best to prevent nuclear
Armageddon.”
Speakers included well-known lead¬
ers in the historical, technological,
political and medical aspects of nuclear
warfare. Gaddis Smith, Larned Pro¬
fessor of History, presented the first
lecture, followed the next week by a
highly informative two-hour talk on
nuclear technology by Kosta Tsipis,
co-director of the Program in Science
and Technology at M.l.T. Dr. Jan
Stolwijk, chairman of the Department
of Epidemiology and Public Health;
Dr. Robert Jay Litton, professor oi
psychiatry; Dr. Richard Stahl, assis¬
tant professor of surgery, and Dr.
Stuart Finch, a former member of
the Yale faculty, who is now professor
and chief of the Department of Medi¬
cine at Rutgers Medical School at
Camden, were among the speakers.
In addition to Mr. Warnke, the final
lecture was to have included Eugene
Rostow. The former director of the
U.S. Arms Control Agency in the
Reagan Administration was unable
to participate due to illness.
Students Joshua Freedman, Laura
Kuckes and Jeremy Holtzman are to
be commended for the superb organi¬
zation of this important lecture series
and the recruitment of the outstanding
speakers.
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crew from the School’s

Physical Plant

installed the gift oj Dr. Felix Marti-thane: in
the Hope Building.

GIFT OF DR. FELIX MARTIIBANEZ IS DISPLAYED

Leonard G. Wilson, professor and
head of the Department of History of
Medicine at the University of Minne¬
sota, and former editor of The Journal
of the History of Medicine and Allied
Sciences, was named the John F.
Fulton Fellow in the History of Medi¬
cine for 1983. During his visit to Yale
in November, Dr. Wilson delivered a
series of lectures and met with students
and faculty for informal discussions.
On November 4th, he delivered the
Sixth Annual John F. Fulton Memo¬
rial Lecture entitled, “Internal Secre¬
tions in Disease; the Historical Rela¬
tions of Clinical Medicine and
Scihysiology. ” The lecture,
which was held in the Medical Histor¬
ical Library, was sponosored by the
Beaumont Medical Club.
The fellowship, named for the late
Dr. Fulton, who was Sterling Pro¬
fessor of the History of Medicine and
one of the founders of the Yale
Medical Library, was endowed in
1978 by Dr. Bern Dibner, director of
the Burndy Library, Norwalk, Con¬
necticut. The Fellow is selected an¬
nually by a committee of the Beau¬
mont Medical Club.

The impressive silk-screen of the title
page of Andreas Vesalius’ De Humani
Corporis Fabrica, recently installed
in the Hope Building, is part of a gift
of books and manuscripts from the
estate of the late Dr. Felix MartiIbanez, founder and publisher of
MD Magazine. Published in 1543,
the Fabrica is one of the most impor¬
tant medical works of the Renaissance,
blending perfectly anatomical skill,
artistic design, and format. The tur¬
bulent scene represents a public ana¬
tomy conducted by Vesalius, who is
surrounded by students, members of
the church, representatives of nobility,
and rectors of the University and
City of Padua. Vesalius dissects and
demonstrates from the body, dispens¬
ing with the demonstrators seen quar¬
reling among themselves under the
table in the foreground. Other sym¬
bols and characters are depicted on
the title page, which may be seen in
its original edition in the Historical
Library.

Illustration from the American Medicine Show
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CUSHING ROTUNDA FEATURES
THE “AMERICAN MEDICINE
SHOW”
“The American Medicine Show”, cur¬
rently on view in the Cushing Rotunda
of the Yale Medical Library, provides
a history of this unique American
institution, from its European roots
through its heyday, to current research,
to document the phenomenon.
The travelling patent medicine show
pioneered the idea of sponsored enter¬
tainment in the United States and
Canada by providing free concerts,
vaudeville and Wild West shows as
an inducement to buy Hamlin’s
Wizard Oil, Kickapoo Indian Sagwa,
and a host of other cure-alls. The
shows declined in the 1930’s and 40’s,
but not before spawning such famous
entertainers as Red Skelton.
Materials in the exhibition are lent
from the collection of Wiliam H.
Helfand, eminent collector and au¬
thority on the history of pharma¬
ceutical advertising and senior vice
president of Merck Sharp and Dohme
International. The exhibit was pre¬
pared by Mr. Helfand and Brooks
McNamara, professor of performance
studies at New York University and
author of Step Right Up,a history of
American Medicine Shows. The exhi¬
bition was designed by Donald Vlack,
curator of the Museum of Performing
Arts, Lincoln Center. Catalogues of
the exhibit are available, tree of
charge, in the Historical Library.
The exhibit coincided with the 250th
meeting of the Beaumont Medical
Club, held on January 20, when Mr.
Helfand and Professor McNamara
presented two lectures on the subject.

FACULTY NOTES
Members of the faculty have taken
an active role in the growing field of
organ transplantation. Dr. Gary Friedlaender, associate professor of surgery,
was named interim president of the
American Council on transplantation,
a new national group formed by the
U.S. Department of Health and
Human Services to coordinate the
efforts of private groups that now
seek to match organ donors with
recipients, as well as to educate the
medical profession and the public
about the need for more donors. In
May, Dr. Friedlaender was elected
president of the American Association
of Tissue Banks. Both organizations
are dedicated to the expansion and
improvement of the present voluntary,
non-profit system of procuring organs
and tissues for transplantation. They
strongly oppose their purchase or
sale, citing the potential for jeopar¬
dizing recipient safety and creating
an inequitable and inefficient distri¬
bution of transplants.
As a Robert Wood Johnson Health
Policy Fellow of the Institute of
Medicine last year. Dr. Myron Genel
was assigned to the Investigations
and Oversight Subcommittee of the
House of Representatives Committee
on Science and Technology, and was
largely responsible for organizing that
committee’s Congressional hearings
on organ transplantation. Subse¬
quently, he was extensively involved
in the drafting of corrective legislation
which culminated in the introduction
of a National Organ Transplant Act.
Dr. Genel, who is professor of pedia¬
trics, is director of the Children’s
Clinical Research Center at Yale.
In October, Yale-New Haven Hos¬
pital became the sixth hospital in the
United States to perform liver trans¬
plants, when Dr. M. Wayne Flye and
a team of physicians and nurses per¬
formed the surgery on a six-year old
New Haven girl with life threatening
liver disease. Dr. Flye, who is associate
professor of surgery, and the support
team Hew to Florida at 2:30 am to
retrieve the liver from the body of a
20-month old drowning victim, and
completed the operation in New
Haven by 11 am the same day. The liver
began to function immediately and
the little girl is making a satisfactory
recovery.

The National Kidney Foundation
presented Dean Robert W. Berliner
the 1983 David M. Hume Memorial
Award. This award is the Founda¬
tion’s highest tribute to an individual
in the field of nephrology. “Dr.
Berliner has made a number of major
contributions to the basic understand¬
ing of the kidney, including demon¬
stration of potassium secretion by
the renal tubule, the fundamental
concept that illustrates the way in
which the kidney handles potassium.
His accomplishments and dedication
have established him as a spokesman
for the scientific community at large
regarding health issues,” said Dr.
David Ogden, president of the Na¬
tional Kidney Foundation in presenting
the award to Dean Berliner at the
Foundation’s annual meeting on
December 3rd.
The Lawrence Berkeley Laboratory
of the University of California, Berke¬
ley, invited Dr.Jan Stolwijk, chairman
of the Department of Epidemiology
and Public Health, to deliver the first
Craig D. Hollowed Memorial Lecture
on Indoor Air Pollution. Dr. Hollowell, who was a senior scientist at the
Laboratory, was internationally
known for his research in indoor air
quality, a field in which Dr. Stolwijk
is also a leading authority.
For its Bicentennial Meeting, the
Society of the Cincinnati in the State
of Virginia invited Dr. David Musto
to participate in a symposium on
historic peacemaking and peacekeep¬
ing in celebration of the bicentennial
of the Treaty of Paris. At the meeting,
which was co-sponsored by the Smith¬
sonian Institution and The American
University, Dr. Musto spoke on “The
Internalization of British Traits After
the Peace.” Dr. Musto is professor in
the Child Study Center (psychiatry)
and the history of medicine.
For his pioneering contributions to
the understanding of erythrocyte mem¬
brane proteins, Dr. Vincent T.Marchesi was presented the 1983 Karl
Landsteiner Memorial Award of the
American Association of Blood
Banks. In a ceremony held at their
annual meeting in New York on
November 1, the A ABB cited Dr.
Marchesi’s studies which have
“allowed new insights into the organi¬
zation of normal and abnormal mem¬
branes, and have provided a practical

and powerful approach to assessing
molecular abnormalities in certain
inherited hemolytic diseases.” Dr.
Marchesi is Anthony N. Brady Pro¬
fessor and chairman of the Depart¬
ment of Pathology, and professor of
cell biology and biology.
The Board of Directors of the Univer¬
sity of Puerto Rico has appointed
Dr. Caleb Gonzalez visiting professor
of ophthalmology; and in ceremonies
held on November 18, he was honored
as “Distinguished Alumnus” of the
In ter-American University-Poly
Alumni Association. In addition. Dr.
Gonzalez, who is professor of ophthal¬
mology and visual science, was selec¬
ted as Special Guest at the annual
convention of the Section of Opthalmology of the Puerto Rico Medical
Association.
Dr. John McL.Morris was recently
named the Verstandig Distinguished
Visiting Professor of Tennessee Center
for the Health Sciences. Dr. Morris,
who is John Slade Ely Professor of
Obstetrics and Gynecology, is wellknown in the fields of women’s health,
birth control and gynecological
cancer.
The Embryology section of Dr Frank
Netter’s new book, “Nervous System,
Part I Anatomy and Physiology”,
was prepared in collaboration with
Dr. Edmund S. Crelin, professor of
anatomy. The volume is a part of The
Ciba Collection of Medical Illus¬
trations.
Three members of the Department of
Surgery have been elected to offices
in professional organizations. The
Society of Neurological Surgeons
(Senior Society) appointed Dr.
William CoIlins,Harvey and Kate
Cushing Professor of Surgery (neuro¬
surgery), president-elect. Dr. Irshad
Chaudry, senior research scientist,
was elected to the Executive Council
of the Shock Society; and Dr. Wayne
Southwick, professor of surgery (ortho¬
pedics), was recently appointed vicepresident of the American Ortho¬
paedic Association.
Dr. Charles M. Raddingand Dr. Uta
Francke attended the International
Congress of Genetics held in New
Delhi, India in December. Dr.
Radding, who is professor of human
genetics and molecular biophysics
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and biochemistry, spoke on “The
recombination mechanism of rec A
protein.” Dr. Francke’s talk was on
gene mapping on human and mouse
chromosomes. She is associate pro¬
fessor of human genetics and
pediatrics.

Dr. Sidney Blatt, professor of psychol¬
ogy and psychiatry, was elected a
Distinguished Practitioner of the
National Academies of Practice. Dr.
Blatt was cited for his contributions
to the study of depression and
schizophrenia.

NEW BOOKS BY FACULTY
“Osteochondral Allocrafts: Biology,
Banking, and Clinical Applications.”
By Gary E.Frieddlaender,M.D.,<mociate professsor of surgery (ortho¬
pedic); Henry .(.Mankind, M.D.,and
Kenneth W.Sell, M.D. Little, Brown
and Company (Boston) 1983. 403 pp.
illus.
“Laboratory Medicine in Clinical
Practice.” Edited by Harvey N. Mandell, M.D..associate clinical professor
of medicine; and Margaret Johnson
Bia, M.D. .associate professor of medi¬
cine. John Wright - PSG Inc. (Little¬
ton, MA)1983. 432 pp, illus.

“The Origins of Anesthesia” by Dr.
Sherwin B.Nuland,associate clinical
professor of surgery, has been pub¬
lished for the members of The Classics
of Medicine Library, Division of
Gryphon Editions, Ltd., Birmingham,
Alabama. Dr. Nuland has prepared
an introduction to this volume, com¬
mentary which precedes the presenta¬
tion of each historical paper, and an
extensive bibliography. The excerpts
and illustrations contained in this
volume were furnished to the publisher
courtesy of the Yale Medical Library.
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On October 16, Harry Zimmerman
was a guest of honor at a dinner
which initiated the celebration of
Montefiore's Centennial Year to com¬
memorate the hospital’s founding in
1884. Dr. Zimmerman, who is a
member of Montefiore Medical Cen¬
ter Staff and Alumni Association
executive committee and principal
scientific advisor to the Centennial
Committee is a consultant in path¬
ology at Montefiore and professor of
pathology emeritus at the Albert Ein¬
stein College of Medicine.
1932
Conrad Lam and his wife, Marian,
were honored recently at a farewell
reception on the occasion of Dr.
Lam's retirement after 50 years of
service at Henry Ford Hospital in
Detroit, Michigan. Among the letters
of recognition which were presented
to Dr. Lam at the reception were
those from President and Mrs. Ronald
Reagan, Michigan’s Governor James
Blanchard, U.S. Congressman Carl
Levin, Senator Don Riegle, Mayor
Coleman Young, Henry Ford II, and
Stan Nelson, Hospital executive vicepresident.
The reception was attended by
colleagues from the Division of
Cardiac and Thoracic Surgery, other
physicians and HFHers, according
to an account published in the Henry
Ford Hospital Weekly Newsletter. In
addressing his remarks to Dr. Lam,
Dr. Donald Magilligan. Jr..head of
Cardiac and Thoracic Surgery said,
“Dr. Lam, you will be remembered
by your accomplishments at HFH —
8,500 operations and 207 articles
in addition to being one of 10 world
pioneers in cardiac and thoracic sur¬
gery ... T his gathering is a very small
way to say 'thank you' for what
you’ve contributed to HFH. You
make us all feel very proud.”
He also announced a special tribute
to Dr. Lam that will continue year
after year. The Annual Conrad R.
Lam Lectureship of Cardio Thoracic
Surgery, a new yearly lecture series,
is to be sponsored by the Division of
Cardiac and Thoracic Surgery and is
scheduled to begin in 1984. The inau¬
gural speaker will be Dr. Denton
Cooley of the Texas Heart Institute.
In expressing his appreciation. Dr.
Lam said .“This has been great. I owe

much to everybody here. 1 only wish
that all of you could have been with
me in medical school at Yale Univer¬
sity in 1931. Right before 1 came to
HFH, I was told 'Conrad, you're
wasting your time taking the exams
to work at H FL - you’ll never make
it.' That was a long time ago. Now',
maybe I rate a place on the wall”, he
said, pointing to the portraits of
noted Henry Ford Hospital physicians
which hang on the walls of the Staff
Dining Room.
1933
The first of the Annual Robert W.
Huntington, Jr. Lecture Series was
presented by Dr. George Lundberg,
editor of the JAMA, at Kern Medical
Center in California on November 4
and 5. The lecture series was named
in honor of Robert W. Huntington
who, for twenty-five years in the
Kern County Service pursued his
interests in coccidioidomysis, neo¬
plasms and forensic pathology.
1949
In July it was announced that the
616-bed patient care towers and cen¬
tral core of the North Division of
Duke University Hospital have been
named the Anlyan Tower in honor of
William Anlyan, chancellor for health
affairs and senior administrative offi¬
cial Duke University Medical Center
since 1964. In his announcement,
Duke University President Terry San¬
ford noted that “naming the tower
for Dr. Anlyan honors a man who is
a national leader in medicine and in
medical administration. He has kept
Duke on the cutting edge of medical
research and practice. He inspired
the extraordinary Duke North Hospi¬
tal and led the University through the
challenge of its construction. He is
the principal figure in Duke Hospital’s
greatest expansion, which this build¬
ing represents.”
1951
Daniel Freedman is now Judson
Braun Professor of Psychiatry and
Pharmacology and director of the
Division of Adult Psychiatry and
vice chairman. Department of Psy¬
chiatry at the University of Califor¬
nia at Los Angeles.

1952
Harvey Young wrote recently of his
two new responsibilities: “1 have
started my first of three years as a
member of the Board of Trustees of
the Pacific School of Religion in
Berkeley, California. It is the oldest
seminary in the West, having been
founded in 1866. 1 have attended the
first meeting of the Board and am
sure 1 shall enjoy the challenge and
the responsibilities of membership. 1
have also started back into organized
medicine. 1 was elected as vice speaker
of the House of Delegates of the
Washington State Medical Associa¬
tion in September. 1 am committed
to four years, the last three as speaker
of the House of Delegates. So 1 am
not suffering from an excess of free
time.”
1955
William Edward of Albuquerque,
New Mexico, has been elected to the
Board of Governors of the Associa¬
tion of Yale Alumni for a three-year
term
1956
In a recent message, Hawaii’s Gover¬
nor George Ariyoshi extended “on
behalf of the people of Hawaii, our
deepest appreciation to Dr. William
H. Kindle f or his dedicated service
and leadership as a member and
chairman of the Commission on Pop¬
ulation and the Hawaiian Future.”
Dr. Hindle was a member of the
Temporary Commission on Popula¬
tion Stabilization in 1971 whose work
led to the establishment in 1973 of the
Commission on Population and the
Hawaiian Future; in 1974, he began
serving as a member on that commis¬
sion and in 1975 was appointed by
Governor Ariyoshi to the chairman¬
ship, a position he has held for the
past eight years.
The citation further states: “Dr.
Hindle’s eminently sound guidance
of the commission’s work has helped
to increase community understanding
of, and concern for, the serious im¬
pacts of population pressures and the
vital need for population planning
and growth management to protect
the limited resources and fragile envi¬
ronment of our island state.”
With the fulfillment of its mandate
and on its own request, legislation
was passed terminating the commis¬
sion as of July 1,1983; its functions of
population planningand management

will be absorbed by the Department
of Planningand Economic Develop¬
ment.
A note received from Dr. Hindle in
October stated that he has been elected
president-elect of the Hawaii Medical
Association and that he has served
for six years as treasurer of the
H.M.A.
1959
Ronald DeConti wrote recently that
he became professor of medicine at
Albany Medical College and chief of
oncology at the Albany Veterans
Administration Medical Center Hos¬
pital as of September 1. Dr. DeConti
left Yale in 1974 to become director
of oncology at Springfield (Massa¬
chusetts) Medical Center, now known
as Bay State Medical Center, and
from 1980 served there as acting chief
of the combined Hematology/Oncol¬
ogy Section until he left for his new
position in Albany.
1962
David Gelfand was named a fellow
of the American College of Radiology
in recognition of his outstanding per¬
formance in medicine. He was so
honored at the annual meeting of the
College in Denver in September. He
is affiliated with North Carolina
Baptist Hospital in Winston-Salem.
1964
Diane Shrier has been awarded the
Exceptional Merit Award for 1982-83
by the University of Medicine and
Dentistry of New Jersey. This award,
which recognizes those members of
the faculty who achieve a level of
productivity and excellence which
substantially exceeds accepted stan¬
dards, was also awarded to Dr. Shrier
for 1980-81. Dr. Shrier is clinical
associate professor of psychiatry and
pediatrics and director of child and
adolescent psychiatry at New Jersey
Medical School (Newark) of the Uni¬
versity of Medicine and Dentistry of
New Jersey.
1965
Robert Cohn wrote in August that
since 1978, he has been associate
director of the Clinical Laboratories
at the Children’s Hospital of Phila¬
delphia and is a member of the
Division of Metabolism of the Depart¬
ment of Pediatrics.
His second book,“Metabolic Dis¬
ease: A Guide to Early Recognition”,

co-authored with Karl Roth of the
Medical College of Virginia was pub¬
lished by Saunders in May, 1983. A
previous book, “Principles of Meta¬
bolic Control in Mammalian Sys¬
tems”, co-edited by R.Herman, R.
Cohn and P. McNamara, was pub¬
lished by Plenum in 1980.
He also wrote that since graduating
in 1965, he has taken great pride in
the continued progress at Yale Medical
School and especially looks forward
to interacting with graduates who
come to Children's from Yale to
continue their training.
Mohandas Kini has been elected presi¬
dent of the Massachusetts Society of
Eye Physicians and Surgeons and
chairman of the Section on Ophthal¬
mology of the Massachusetts Medical
Society. Dr. Kini, who resides in
Wakefield with his wife, Joanne and
theirfourchildren, practices ophthal¬
mology in Boston. He is director of
Retina Services and a consulting sur¬
geon in ophthalmology at University
Hospital, which is a teaching affiliate
of the Boston University School of
Medicine.
David Kupfer, professor of psychiatry
at the U niversity of Pittsburgh School
of Medicine since 1975 and director
of the Mental Health Clinical Re¬
search Center for Affective Disorders
at Western Psychiatric Institute and
Clinic since 1977, has been appointed
chairman of the Department of Psy¬
chiatry at the University of Pittsburgh
School of Medicine. Dr. Kupfer has
received a number of honors during
his career including the 1975 A.E.
Bennett Research Award in Clinical
Science, the 1977 Anna Monika Foun¬
dation Award for Research in De¬
pression, and the 1979 Daniel H.Efron
Award. He is on the editorial boards
of several publications and has written
more than 150 articles on affective
states, sleep, and psychopharmacology.
1966
Reynold Spector has been elected to
membership in the Association of
American Physicians. He is professor
of medicine and pharmacology at the
University of Iowa College of Med¬
icine where he serves as director of
the Divisions of General Medicine
and Clinical Pharmacology. During
the current academic year. Dr. Spector
is a visiting professor of biochemistry
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at Stanford University.
Richard Yules is the author of a new
book, “The Pilot’s Complete Medical
Guide”, an authoritative and up-todate guide which discusses medical
problems that affect Hying capability,
physical and mental fitness, common
sensory misperceptions and physical
reactions to altitude and flight pheno¬
mena.
Dr. Yules is a colonel and senior
flight surgeon in the Air National
Guard, USAF, and a senior FAA
medical examiner and crash investi¬
gator. In 1976, he was named U.S.
Flight Surgeon of the Year. He has
written, in addition to four medical
books, more than forty articles on
aerospace medicine. Dr. Yules prac¬
tices otolaryngology and facial plastic
surgery in Worcester, Massachusetts.
1967
Stephen Schimpff has been appointed
director of the University of Maryland
Cancer Center at the University of
Maryland School of Medicine and
Hospital in Baltimore.
1968
Ralph Greco, chief of the Section of
General Surgery and the Division of
Surgical Oncology at Rutgers Medical
School, has been promoted to pro¬
fessor of surgery. He is also chief of
General Surgery and Surgical Onco¬
logy at Middlesex General-University
Hospital in New Brunswick. Dr. Greco
completed his residency at Yale in
1973. After two years of military
service, he joined the Rutgers faculty
as an assistant professor in 1975, and
in 1979 was promoted to associate
professor.
Dr. Greco has published widely in
the area of surgical immunology. He
is doing research on the biochemical
bonding of antibiotics to surgically
implantable devices and is also a
participating principal investigator
in the National Surgical Adjuvant
Project for Breast and Bowel Cancer.
On September 1st, Elizabeth Short
joined the staff of the Association of
American Medical Colleges as director
of the Division of Biomedical Re¬
search and Faculty Development and
deputy director of the Department of
Academic Affairs.She will be respon¬
sible for monitoring biomedical re¬
search policy issues and working with
the AAMC’s Council of Academic
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Societies member societies to advance
biomedical research and faculty
development.
Gordon Sasaki, who is assistant pro¬
fessor of surgery (Division of Plastic
Surgery) at University of Southern
California School of Medicine was
awarded The Robert H. Ivy Award
of the American Society of Plastic
and Reconstructive Surgeons at their
November meeting in Dallas.
The Award, made annually for the
outstanding scientific presentation of
the year, is for his presentation at the
Society’s 1982 meeting in Honolulu,
Hawaii. His paper, “Pathogenesis
and Treatment of Infant Skin Straw¬
berry Hemangiomas: Clinical and in
vitro Studies of Hormonal Effects”,
is to be published in the March 1984
issue of Plastic anti Reconstructive
Surgical Journal.
1969
David Upton wrote recently that he
has written a new book, “Mental
Health Care and National Health
Insurance - A Philosophy of and an
Approach to Mental Health Care for
the Future” and that he is currently
engaged in writing a textbook on
psychotherapy and a book on the
psychological aspects of hospital care.
Dr. Upton, who resides in Alexandria,
Virginia, formerly served as consultant
to the United States Senate Veterans
Affairs Committee; was consultant
to the Los Angeles County Commun¬
ity Mental Health Center Systems;
and has held the position of chief of
psychiatry at the United States Army
Mental Health Clinic at Fort Belvoir,
Virginia.
1970
A novel by Robert Litman entitled
“Wynnefield and Limer” has recently
been published by the Ivy League
Press, Inc. Of Arlington, Virginia.
This story about a young doctor and
his fight to overcome great adversity
should have wide appeal. The author,
a family physician in Ogdensburg,
New York, is a member of the medical
staff of the A. Barton Hepburn
Hospital and is currently president of
the Northern New York Chapter of
the American Heart Association.

1971
On October 5, Ralph Kirmser received
the 1983 Magida Award presented by
the Richard and Hilda Rosenthal
Foundation of Stamford, Connecti¬
cut. Dr. Kirmser, an internist in
Norwalk, was cited for demonstrated,
notable capability in patient treatment
and care. The Magida Award was
established in 1979 by the Rosenthal
Foundation to honor the late Dr.
Melville Magida of Stamford and his
qualities as a concerned and outstand¬
ing physician.
Dr. and Mrs. Kirmser and their
three children reside in Wilton.
HOUSE STAFF
1946
John McGovern was recently honored
by the American School Health Associ¬
ation by being awarded the William
A.Howe Award, the Association’s
highest tribute, at its annual conven¬
tion in Louisville, Kentucky. Dr.
McGovern was cited for his enduring
advocacy of, and meritorious contri¬
butions to, the health of the nation’s
children and youth.
1948
David Hamburg is president-elect of
the American Association for the
Advancement of Science (AAAS)
and is scheduled to assume office as
president at the annual meeting in
May 1984. Dr. Hamburg served as
president of the Institute of Medicine
of the National Academy of Sciences
for a five-year term beginning in
1975. In 1980, he moved to Harvard,
where he founded a new Division of
Health Policy Research and Educa¬
tion. He assumed his present position
as president of the Carnegie Corpora¬
tion in January 1983. Since moving
to the Carnegie Corporation, he has
given considerable attention to the
problems of conflict between groups
and nuclear war.
1957
Herman Kamenetz, chief of Rehabili¬
tation Medicine at the Veterans Ad¬
ministration Medical Center in Wash¬
ington, D.C., wrote at the end of July
that he would be retiring “in a few
days and it is a particular joy for me
that Nessan McCann (HS 66), will
take over my position at this Medical
Center.”

1961
Chase Peterson took office as presi¬
dent of the University of Utah on
August 1, 1983. He was formerly vice
president for health sciences and be¬
came nationally known last winter as
spokesman for the University of Utah
medical team when Barney Clark
struggled to live with an artificial
heart.
1962
Samuel Heilman is now physicianin-chief at the Memorial Sloan-Kettering Cancer Center in New York
City.
1966
“Your Aching Back: A Doctor’s Guide
to Relief” by Augustus A.White III,
has been published by Bantam Books
of New York City. Dr. White is professor
of orthopedic surgery at the Harvard
Medical School and chief orthopedic
surgeon at the Beth Israel Hospital in
Boston. In this well illustrated paper¬
back volume written for backache
sufferers. Dr. White provides a great
deal of valuable information and also
gives answers to questions frequently
asked by his patients. As he notes in
the introduction, “I'm writing this
book to tell those of you with back
problems what scientific and clinical
research has substantiated to be true
about backache.” It is a book which
should be helpful to physicians and
patients alike.
Nessan McCann has been named the
new chief of Rehabilitation Medicine
at the Washington, D.C. Veterans
Administration Medical Center, ac¬
cording to a letter received from
Herman Kamenetz (HS 57), his pre¬
decessor.

1979

Have we heard from you recently?

Robert Shoen has joined Dr. James
Kenney and Dr. Charles DiSabatino,
Jr. in the private practice of internal
medicine and rheumatology in New
Haven.
PUBLIC HEALTH
1974
Gregory Belok and his wife, Diane,
are the proud parents of a son Arie
Chaim Belok, born on June 25, 1983.
Dr. Belok wrote in July, but his news
was received too late to appear in the
summer issue of Yale Medicine.

Have you received a special honor or
award? Have you been elected to office
in a professional society? Have you
travelled in a foreign country and/or
participated in an international semi¬
nar? Are you working in a particularly
interesting, unusual area?
If you have news about yourself or
about your classmates, please send
items to the Editor, Yale Medicine, 333
Cedar Street, New Haven, Connecticut
06510. The Alumni News section wel¬
comes news from medical alumni, pub¬
lic health alumni and former house
staff.

IN MEMORIAM
Robert F. Zimmerman, M.D

ex med’31

June 30, 1983

Donald R. Mills

M D.’34

August 2, 1983

Frederic E. Houghton

ex med’37

November 23, 1979

Hugh H. Butler

M.D.’41

July 4, 1983

Edwin I). Murphy
September 20, 1983

Richard K Gershon

M.D.’43
(March)

M.D.’59

July II, 1983

Stuart J. Brill

M.D.’68

August 15,1983

1970
Robert Resnik has been named chair¬
man of the Department of Reproduc¬
tive Medicine at University of Califor¬
nia at San Diego.

1976
Leon Speroff, professor and chairman
of the Department of Obstetrics and
Gynecology at Oregon Health Sci¬
ences University School of Medicine,
has been appointed professor and
chairman. Department of Repro¬
ductive Biology, Case Western Re¬
serve University School of Medicine

1984 ALUMNI WEEKEND
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1982 -1983 ALUMNI FUND REPORT

Message from the Medical School Alumni Fund
Chairman

FUND OFFICERS 1982-83
MEDICAL SCHOOL ALUMNI FUND
Lowell 1. Goodman '51, Chairman
Malvin F. White '39, Vice Chairman
William K. McClelland '47, Vice Chairman
John L. Cieply 71, Vice Chairman
J. Roswell Gallagher '30,
Bequest $ Endowment Co-Chairman
Samuel D. Kushlan '35
Bequest & Endowment Co-Chairman
Samuel D. Kushlan '35
Chairman, Former House Staff
EPIDEMIOLOGY AND PUBLIC HEALTH ALUMNI FUND
Kathleen H. Howe '56, Co-Chairman
Samuel B. Webb, Jr. '63, Co-Chairman

The Medical School Alumni Fund again broke all
previous records and I thank each and every one of you
who helped to make the 1982-83 such an outstanding
success. Final receipts were $449,065 an increase of 51%
over the amount received in 1981-82. This total includes
dollars earned from the Baumgartner Challenge awards,
earned income and two large gifts to the endowment
program. J he number of contributions from alumni,
former house staff, parents and friends rose to 1,889;
alumni participation increased to 50%.
In January after the Medical School Alumni Fund and
the Public Health Alumni Fund earned the entire $75,000
Baumgartner Challenge, Leona Baumgartner '32 Ph.D.,
'34 M.D., generously provided an additional challenge of
$50,000 for new and increased gifts for the School's
student loan program.
The challenge awards, and the interest and efforts of the
vice chairmen, the class agents, reunion phonathon
volunteers, and student telephoners all provided the
momentum that made our campaign so successful.
I appreciate everyone’s support and I am confident our
program will continue its upward swung.
Lowell 1 Goodman '51

A Message from the Dean

Message to Public Health Graduates and Friends

Once again the Medical School Alumni Fund has set a
phenomenal new record with contributions totalling
$449,065. Chairman Lowell Goodman and the many
volunteers who have worked with him deserve
congratulations and our sincere appreciation for this
remarkable achievement.
This past year our loyal alumna, Leona Baumgartner,
established a second challenge gift for new and increased
contributions; this undoubtedly provided incentive for the
growth in annual giving. The Fund also received two large
gifts to the Endowment. In addition to these three major
gifts, I was greatly encouraged to learn that 28 of our
graduates made contributions of $1000 or more. Medical
alumni participation this year was 50 percent. 1 want to
thank each of you who contributed to the 1982-83
campaign and urge you to continue your support during
the years ahead.
As I have noted previously, money for student financial
aid continues to be a high priority of this School. As in
previous years, your Medical School Alumni Fund
contributions will be added to the Student Revolving
Loan Fund and thus enable us to provide additional
loans.
I he students and faculty of the School of Medicine join
me in thanking you for your interest and support.

Money raised by the Public Health Alumni Fund is used
for the Department’s student financial aid program. Each
year the support received from EPH alumni and friends is
an indication not only of their loyalty, but also shows
their awareness of the financial crisis facing today’s Public
Health students.
We want to thank everyone who helped us to achieve
our goal with a grand total of $36,572. A very special
acknowledgment goes to Dr. Leona Baumgartner w ho
provided us with two generous challenge awards. These
incentives continue to have a great impact on the level of
giving and the number of contributors. We look forward
to another, even more, successful year.

Robert W. Berliner
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Jan A. S. Stolwijk
Kathleen H. Howe
Samuel B. Webb, Jr.

MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION
YEAR (S)

AGENT

1908-21

1981-1982
TOTAL

1981-82
% PART.

$7,758

1982-83
TOTAL

1982-83
% PART.

$843

1922

Edward T. Wakeman

286

56

561

56

1923

William Cohen

760

71

634

57

1924

Myron A. Sallick

2,195

63

2,400

63

( 118,000)
1925

Alice A. S. Whittier

945

73

805

67

1926

Maxwell Bogin

522

58

671

50

1927

Henry Irwin Fineberg

1,105

53

1,229

47

1928

Max Alpert

2,297

68

2,795

79

1929

Paul F. McAlenney

1,829

79

1,572

71

1930

J. Edward Flynn

5,343

58

3,800

65

1931

Michael D’Amico

1,687

68

1,373

44

1932

Henry Brill

4,384*

64

1,045

43

1933

Franklin M. Foote

2,133

57

5,399*

76

Dewitt Dominick

2,333

72

-

—

2,703

50

1934

John B. Ogilvie
1935

James Q. Haralambie

2,978

52

2,276

52

1936

George A. Hahn

2,672

44

3,275

35

1937

David Dolowitz

1,623*

50

1.590

53

1938

Nelson Ordway

1,095

52

2,630*

60

1939

Rebecca Z. Solomon

1,795

53

3,020

53

1940

James F. Ferguson

2,555

64

4,369

69

1941

Charles B. Cheney

2,260

100

3,331

59

1942

Walter J. Burdette

16,672*

55

1,789

55

1943 A

Jonathan Lanman

2,070

54

10,107*

1943B

S. Brownlee Brinkley

2,028

52

4,419*

64
57

1944

Nicholas P. R. Spinelli

4,615

65

7,086

67

1945

Richard W. Breck

3,360

64

3,590

58

1946
1946A

Julian A. Sachs

6,542

49

Charles S. Judd, Jr.

—

—

1946B

Thomas J. Whelan, Jr.

—

1947

William Roy Breg

1948

_

_
59

—

4,702
2,388

6,143*

68

4,320

61

Paul Koehler

3,905

62

8,141*

66

1949

Daniel Elliott

5,516

56

4,169

58

1950

David Frucht

2,814

56

3,688

62

1951

Lowell I. Goodman

5,276

52

5,515

50

1952

Harvey L, Young

4,873*

49

3,845

43

1953

Vincent Lynn Gott

3,908

47

4,950*

59

1954

John K. Rose

5,267

68

6,172

80
53
53

1955

Robert A. Kramer

4,443

52

5,748

1956

John H. Gardner III

4,070

33

4,925

73
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MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION
YEAR (S)

AGENT

1981-1982
TOTAL

1981-82
% PART.

9,291*

79

—

—

—

—

1982-83
TOTAL

1982-83
% PART.

_

_

3,320
3,160

63
67

1957
I957A
I957B

William J. Waskowitz
Ronald H. Fishbein
Howard Minners

1958
I958A
I958B

Charles A. Hall, Jr.
Charles A. Hall, Jr.
Paul A. Rudnick

5,370

59

—

—

—

—

1959
I959A
I959B

Asa Barnes, Jr.
Asa Barnes, Jr.
Muriel D. Wolf

6,665

62

—

—

—

—

I960
I960A
I960B

Thomas P. Kugelman
Roland H. Ingram
Thomas P. Kugelman

3,495

40

_

_

—

4,555
3,995

48
53

1961
1961A
1961B

Jon D. Dorman
Earl L. Baker
John R.Woodward

2,580

35

—

—

—

1962
I962A
I962B

A. Richard Pschirrer
A. Richard Pschirrer
Frank R. Hartman

$11.849*

1963

—

-

_
4,525*
6,025*

71
71

_

_

3,210
3,825

58
66

_

_

—

2,815
1,830

72
39

_

_

—

65
—
—

3,600
1,190

63
31

Craig H. Llewellyn

4,990

52

5,770*

49

1964
1964A
I964B

William J. Houghton
William J. Houghton
William B. Pratt

4,390

_

_

—

60
—
—

2,440
3,350

55
74

1965

David A. Hill

4,425

49

5,710

54

1966
1966A
I966B

Mary Alice Houghton
Mary Alice Houghton
Henry B. Mann

2,923

52

—

—

—

—

_
2,270
1,410

79
46

1967
1967 A
I967B

James Dowaliby
James Dowaliby
John A. Drews

I968A
I968B

—

—

—

_

_

1,940
3,025

67
60

46

3,130*
3,233*
( 20,000)

67
66

6,888

67

7,436

61

James R. Missett

2,001

36

2,795

42

1971
1971A
1971 B

John L. Cieply
John L. Cieply
Barbara K. Kinder

4,046
—

47
—
—

—
3,117
3,145

59
57

1972

Paul A. Lucky

3,709*

54

3,208

53

1973
1973 A
I973B

David N. Bailey
David N. Bailey
Lynne M. Liptay

2,273
—
—

44
—

—
2,029*
1,680*

—
54
53

1974

Peter J Buchin

710

26

2,155

32

1975
I975A
I975B

Daniel Passeri
Daniel Passeri
Mary Jane Minkin

701

24

—

—

—
488
445

—
28
22

1976

Robert F. Taylor

873

27

1.325

26

1977
1977A
I977B

David Kreis
David Kreis
Ronald J. Vender

1.575*

30

—

—

—
620
731

1978
I978A
I978B

Duke Cameron
Duke Cameron
Kendrick E. Lee

1.467

23

—

—

9,170*

70

—

—

—

—

Frank E. Lucente
Donald Lyman

2,760

1969

Lee Merrill Jampol

1970

—

—

—

•Reunion

26

—

—
775*
140*

—

22
36
—

31
10

AGENT

YEAR (S)

1981-1982
TOTAL

1981-82
% PART.

1979
1979 A
I979B

Barbara Peters
Michael R. Hausman
Laurie Smaldon

640

20

—

—

—

1980 A
1980B

Eduardo Alfonso
Mark Bernhardt

1981

Anthony Urbano

1982A
1982B
1982C

Muriel Cyrus
Jed B. Gorlin
Lynn T. Tanoue

1982-83
TOTAL

1982-83
% PART.

—

—

—

275
495

21
17

225
317

15
18

453
395

23
18

365

15

665

13

_

_

10

—

—

—

—

50
45

4
15
7

224,432

48

377,120

50

Former House Staff

6,863

21

8,053

18

Parents and Friends

9,858

13,589

Interest and Miscellaneous Gifts

13,393

10,492

Baumgartner Match

42,183

39,811

Alumni

$296,729

42%

$449,065

42%

PUBLIC HEALTH ALUMNI FUND CLASS PARTICIPATION
1923-41

Kathleen Howe

$4,258

56

$2,844

53

1942

Eric W. Mood

430

50

550

50

1943

Eric W. Mood

450

50

390

36

1944

Eric W. Mood

345

44

295

33

1945

—

180

38

120

31

1946

—

25

1 1

35

22

1947

250

39

290

39

1948

3,085

44
720

33

490

33

Elizabeth D. Robinton
1949

495

26

Elizabeth L) Robinton
1950

Eric W. Mood

905

61

723

52

1951

Leonard F. Menczer

455

35

635

48

1952

Yolande F. Lyon

700

39

730

39

1953

Milton H. Sisselman

615

40

735

40

1954

Ruth M. Taber

1 10

24

120

29

1955

Frances R. Ogasawara

305

33

390

43

710

21
352

32

422

52

1956
David D. Boyd
1957

Edward R DeLouise

602

43

27

PUBLIC HEALTH ALUMNI FUND CLASS PARTICIPATION
AGENT

YEAH (S)

1981-1982
TOTAL

1981-82
% PART.

1982-83
TOTAL

1982-83
% PART.

1958

Thomas T. Flynn

300

14

825

21

1959

Dorothy M. Wilson

915

39

535

33

1960

Hannah Clark Russell

400

33

565

33

1961

Gordon R. Beem

665

59

410

45

1962

A. Kay Keiser

105

31

70

23

1963

David Dolins

550

43

650

38

1964

Estelle Siker

1.310

54

1,025

50

1965

Michael E. Kove
H. Patterson Harris

430

38
540

31

1966

Allen Cohen

470

34

200

10

1967

James M. Malloy

790

26

1,260

28

1968

Arnold Saslow

1,300

32

1,420

46

1969

Samuel P. Korper

940

26

820

28

1970

Susan W. Balter

1,125

31

1,330

27

1971

John Bihldorff

1,360

49

1,500

42

1972

Daphne DeJ Gemmill

715

36

650

27

1973

Judith G. Beatrice

600

19

965

22

1974

Elizabeth Helming

290

32

345

36

1974B

Abigail L. Smith

315

39

395

48

1975

Linda K. Broker

1,321

41

1,666

39

1976

Elaine P. Anderson

1,297

43

890

36

1977

Carroll Shilling

1,223

33

960

30

1978

Richard C. Poole

1.074

33

1,400

35

1979

Ralph Tartaglione, Jr.

1,315

39

1,315

40

1980

Christina P. Quinn

880

34

665

25

1981A
B

Diane E. Goren
Jill Goldwater

435
105

31
15

390
255

17
27

I982A
B

Michelle Visconti
Amy B. Wilson

_

_

—

—

121
199

12
23

$34,149

37%

$31,532

33%

Alumni
Interest and Miscellaneous Gifts
Baumgartner Match

Public Health Alumni Fund Total

28

3,984

1,262

10,667

3,778

$48,800

37%

$36,572

33%

Yale School of Medicine
1982-1983 Contributors
1903
Robert L. Rowley*
1906
Charles R. Mitchell*
1908
Michael A. Parlato*
1912
Walter C. Tilden*

1928
Max Alpert

Storer P. Humphreys

Albert D. Spicer

Robert F. Dine

Clement F. Batelli

Conrad R Lam

John M. Thomas

John Burke
Berthold R. Comeau

Arthur J. Present

Jean Wells
Lucille R Wiepert

I loyd I). Flint
John Franklin

Sheldon A. Jacobson
Raymond A. Johnson

Elizabeth M. Ramsey
Benjamin N. Tager

Sidney L. Lasell
Bjorn Lih

1938
Roy N. Barnett

F. Eugene Martine

Myron E. Wegman

Edward P.J. Kearney

Robert L. Gilbert

Lorande M. Woodruff

Willys M. Monroe

Ralph E. Knutti
Ferdinand G. Kojis

1933
Myron J. Adams*

Agnes V. Bartlett

Malcolm C. Murfitt

R.Harold Lockhart
Edward W. Ludwig*

Fred W Buse

Henry L. Carideo

Edward B O'Connell

Warren P. Cordes

John A. Dillon

Robert W Ollayos

Nathan E. Ross
Robert I Rubinstein

Lee E. Farr

S. Charles Kasdon
Benjamin E. Lyons

Gioacchino S. Parrella

John J. McGillicuddy

Leslie Simmonds
Janet H Van Orden

John M. Russell*

Franklin M. Foote
Jack Greenberg
Daniel F. Harvey

Edward Nichols
Nelson K. Ordway

Edwin D. Rogers

1913
Ralph E. Taylor*

Lewis A. Scheuer
George C. Wilson

1919

1929
James R Arneilljr.

John G. Martin

Charles Petrillo
Edward W. Pinkham, Jr

1942
James M. Bunce

Joseph Mignone

James Radcliffe, Jr.

Walter J. Burdette

Frank H. D'Andrea

Raymond E. Miller

George E. Roberge

Robert E. Carroll

Charles J. Epstein

Ashley Pond 111

Lester J. Wallman

Robert A. Frisch

Paul L. Saffo
Lester Q. Stewart

J. Richard Zahn

Donald S. Childs, Jr
Vincent J. Collins

Willys M. Monroe*
1920
Oscar Brenner*
1921
Ella W. Calhoun
1922
Benedict R

Harris

Chester E. Hurwitz*

George K. Hirst
Robert W. Huntington, Jr.

Eugene M. DeHostos

Olive Gates
George S. Goldman
Alexander O Hoff*

Sidney Stringer*

1939

Hendrik DeKruif

John J. Wolfe

Norman L. Cressy

John A. Hangen

Francis M. Woods

William H. Druckemiller

Davitt Felder
William Fleeson

Harold J Harris
George P. Jackson

Robert G. Ernst*

Elihu Friedmann

1934

Allan V. Goodyer

Vernon W. Lippard
Paul F. McAlenney

Leona Baumgartner
James F. Blades

John l1. Ferguson, Jr.
Joseph B. Forman

Charles R. Harms
William Harrison, Jr.

Helen P. Langner
Reginald T. Lombard

Tony L. Rakieten

Knowles B. Lawrence

S. Jerome Greenfield
Paul E. Huston

Maurice F. O'Connell

William F. Roth,Jr

Theodore P. Merrick

Nathaniel Kenigsberg

John R. Lincoln

Edward T. Wakeman

Russell B. Scobie

Herbert C. Miller

James P. Murphy

Robert Tennant
Newell R. Washburn*

Edward T. O’Donnell
John B. Ogilvie

Russell Nahigian

Patrick S. Mullins
Dean Nichols*

Douglas S. Riggs

Julius G. Weiner*

Lucien M. Pascucci

Ernest L. Sarason

Mabel Wilson

Harry Sherman
William R Willard

Bradford Simmons
Rebecca Z. Solomon

Edgar B Taft

Herman Yannet

George Zalkan*

Stuart S. Stevenson

Irving N. Wolfson

1923
William Cohen
Joseph Epstein
Jacob Mellion
Julius A. Olean
Hyman W.Weinstein*
1924
John J. Batchelor

Frederick F. Boyce

D.Anthony D’Esopo

Charles A. Breck*

David M. Raskind

Frank H.Couch
Robert D. M. Cunningham

Harold T. Vogel

Vincent A. Doroszka
Knox H. Finley

1925
Dorence S. Cowles

J Edward Flynn
J. Roswell Gallagher

Waldo F. Desmond
Henry W. Ferris

James C. Hart
Edmund L. Kitzmeyer

William E. Hall

Paul H. Lavietes
Jack Lehner

Myron A. Sallick

Stanton K. Livingston
Samuel Reback
Welles A. Standish
Alice A.S. Whittier
Gonsalvo C. Williams,Jr.
Howard A. Wood

Moses D. Lischner
James M. Lynch*
John C. Mendillo

Arthur S. Tucker

George A. Carden, Jr.

Darrell G. Voorhees

1943 (March)
Ralph D. Alley

Edward F. Falsey
Sawnie R. Gaston

John H

John R. Brobeck
Lycurgus M, Davey

James Q. Haralambie

1940

C. Thomas Flynn, Jr.
Gerard Fountain

Samuel D. Kushlan
Norman E, Peatfield

Theodore E. Allen
Joseph V. Baldwin

Stuart L. Joslin

Norman P. Rindge

Ronald S. Beckett

Jonathan T. Lanman

Clark P. Searle

Jack S. Blaisdell

Jack C. Sleath

Philip S. Brezina

Douglas L.indsey
Henry E. Markley

Walter A. L. Thompson
Samuel Zelman

Thaddeus S. Danowski
Wynant Dean

Walter J. J. Nero

Richard E. Dormont

Edward F. Rabe
Earl J. Rhoades

H. Hoffman Groskloss

1936
George H. Brown
Lester W. Burket

Dunlap

Dorothea R. Peck

James F. Ferguson, Jr.

Henry A. Riedel
Bernard R. Rowen
Marcus E. Sanford

Amy H. Wilson

Franklin F. Ferguson

Charles L. Wood

Margaret C. L. Gildea
George D. Gross

H. Stuart Irons, Jr.

Edward H Soule

Donald G. Johnson

Hilliard Spitz
Sophie T. Stevens

Henry H. Briggs, Jr.

Maxwell Bogin
William H.Hahn*
Joseph L.Hetzel

Benjamin Castleman*
Michael D’Amico
Helen R. Gilmore

Louise G. Hutchins
Philip M. Lecompte

Morris Hinenburg

Paul A. Harper

Ben Klotz

Harold E. Harrison
Morris F. Heller*
Thomas C. Jaleski
A. Philip La France

1927

Rhoda M. Mickey

Milton B. Berman
Wallace R. Bostwick*
Henry 1. Fineberg

Nelson Newmark
Sheldon Payne
Abraham J. Schechter

John M. Freiheit*
Meyer Friedenson
Herman H. Goldstein

1932
Louis K. Alpert

Alfred F. Seibert

Robert M

R. Leonard Kemler

Eugene J. Fitzpatick, Jr.
Henry D. Humphrey

George A. Hahn

William C. Meredith
Moses Rothberg

Wentworth

Malvin F. White

1931

Albert Jablonsky
Nathan Levy

Maurice Tulin

1935

1926
Stanton T.Allison

Milton Malev
Alexander E. Rosenberg

Samuel Ritvo
Richmond W. Smith, Jr.

John D. Tobin

1930
Samuel Alpert
Daniel N.Beers*

Leo Kellerman

Henry Brill
Frank Carroll
Clement C. Clarke
Joseph P. Donnelly
Lewis F. Foster

Donald F. Marshall
Frederick A. Post

Ira D. LeFevre, Jr.
Paul D. MacLean
Edward Martin
William R. Oakes
Maurice Ross

Oliver G. Stonington
Robert L. Taylor
Robert G. Turner

Morris Tager
Edgar W. Warren

Lee S. Sannella
W. Norman Sears

Frederick A. Waldron
John J. Weber
Robert II Wyatt

1937

Joseph E. Sokal
J. Champneys Taylor
Patricia E. Wanning

Richard N. Abbott

Edmund R. Blower
David A. Dolowitz
D. Crosby Greene
Joseph B. Hollinshead
Benjamin F. Hoopes
Wilbur D. Johnston
Alfred E. King
Dunham Kirkham
Julia Mehlman
James P. Morrell
Charles W. Neuhardt
T. Dennie Pratt
Edward J. Shaw

John B. Wells
Helen H Woods
1941
Robert H. Alway

1943 (December)
John R. Almklov
David G. Borden
James L. Bradley

Robert H Areson

Robert F. Bradley, Jr.
S. Brownlee Brinkley
Henry B. Bruyn, Jr.

W. Randal Bell
Knute E. Berger
William A. Carey

Thomas L. Bucky
Jane B. Cadbury
Philip B. Chase

Joseph P. Carson, Jr.
Charles B. Cheney

Hunter H Comly
Norman I Condit

Herbert W Diefendorf
Deceased
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Jean P. Davis

1946

1948

Joseph I Epstein
Robert H Eurnian

Margaret J. Albrink
William G. Banfield. Jr.

Russell J Barrnett
Edith M. Beck

Chesterfield G. Gunn. Jr.

Donnell D. Etzwiler

Victor C. Hackney
Frank R Hurlbutt. Jr.

Aaron T. Beck
Franklin C. Behrle

Allyn G

Wallace M. Kemp. Jr.

Thomas O. Gentsch
Vincent L. Gott

Henry H Jones
Joseph F. Kell

Sanfurd G. Bluestein

Ruth E. Cortell

Linus W. Cave

G

Hoyt B. Miles. Jr.

James F. Cooney
Robert R. Cooper. Jr.

Victor A. Drill

Ira A Rashkoff
Donald W. Seldin
Francis A. Spellman
C. Wesley Watson
1944
Carl E. Andrews

David A. Frucht
Archie J. Golden

Bridge

Arthur L. Coleman. Jr.
Robert Downie

Marilyn M. Kritchman
Sidney S. Lee

George L. Hoffman

Harold March

David P. Holman

Harry 1

Emil Frei 111

John H

Peter B Hukill
Alvin J. Keroack

Martin E. Gordon

Julian Frieden

Orlando J. Miller

Robert F. Kiley, Jr.

Charles S Judd. Jr.

Allan Green
B Harold Griffith

Robert T. Sceery
Cy nia B. Shimm

Richard R. Knowles III
Hildegard M Leslie
Preston L. Leslie
Robert N Melnick

Thomas A. Doe
Gregory F. Flynn

Harold King
Benjamin F Kitchen. Jr

McClelland
Meyers

Sylvia P Griffiths

Jane B Shumway

Beatrix A. Hamburg

Martin Smith*

Vincent J. Longo

Frank W, Countryman
Charles H Crothers

Richard II. Mann

Richard Hannah
Ross R Harcus

Thomas J. Mathieu

Law rence G. Crowley

Hugh J. McLane

John H

Dunphy

Carol Goldenthal

Warwick Potter. Jr.

Paul B Koehler
Robert E Lempke

W. Robert Adams

Jose Ramirez-Rivera

Joe D. Morris

John P Morris

Thomas T. Amatruda. Jr.

John H

John B Morrison

Muriel H

Barbara F. Rosenberg
lrw in K Rosenberg

Morton

John F. Neville. Jr.
I aura W. Neville

Howard B. Hamilton
W. Raymond James

Francis Reilly
David H Riege

Edith M. Jurka

Phillips E. Roth
Julian A. Sachs

Ronald E. Losee
Ellen P. Mackenzie

Harvey M. Peck
1951
Karel B Absolon

Charles A. Hall

Frederick F. Krauskopl

A. Daniel Hauser

Marie C. Duncan
Boy Frame

James A. Kleeman

Doherty

Robert E. Hamlisch

Janus C. Lindner
Margaret S. Lyman

Edward J. Conway
John C. Coolidge

Donal 1

Louis R. DelGuercio
James P Dunn

Donald P Shedd
Richard G. Sisson

Bagshaw

Paul G. Quie

David E. Morton

Eleanor C. Bigley

Virginia C. Saft

Cierald R. Nowlis

Allan A. Brandt

James M. Post, Jr.

John J. Egan

Richard A. Sinnott. Jr.
Ora K. Smith

George P. Rostel
Lew is P. Row land

Sidney S. Furst

Ly nn C. Stoker
Matthew A. Tandysh

Gabriel A. Saviano*

Ralph M. Gofstein
Lowell I Goodman

William J. Vandervort
William A. Whalen. Jr.
William A. W'ilson

Daniel X. Freedman

Benjamin F. Rush. Jr.
Jerome H. Shapiro

John T. Groel

Colby S. Stearns
R Bruce Thayer

Jessie P Spear

Robert N. Hamburger

Anne G. St. Goar
Paul Talalay
Wallace W. Turner

Carrold K. Iverson
Paul D. Millikin

Joseph Massaro

Robert R W'agner
William J. Wedemeyer, Jr.

Walter S. Morgan

W. Dean Ashworth
Frank P Berg

A. Reese Matteson

J homas J. Whelan. Jr.

Paul W. Weld

Albert R. Mowlem

George W. Bostwick

Paul E. Molumphy

Hugh R. Williams

Lawrence K. Pickett

F.lihu S. W'ing. Jr.

1949

Richard S. Munford
Charles A. Nugent. Jr.

George N. Bowers. Jr.

1947
George R Barnes, Jr.

Alfred E. Bacon. Jr

Jose F. Patino
Arthur A. Pava

John R Cole

Henry W. Baird, 111

Majic S. Potsaid

William D. Bevis
Jonathan S Bishop

William F. Stephenson

Priscilla I) Taft

Henry N Blansfield
Albert W. Bostrom. Jr.

Anthony Varjabedian
Cabin W. Woodruff

John E. Bowers
William R Breg. Jr.

Thomas L. Chiffele

John S. Sullivan

Arthur C. Crovatto
Donald D. Davis

Mary P. Couchman

William Tay lor*

Frederick J. Fiederlein

Reuben Zucker

John L. Cannon

Phillip G. Couchman
Peter R Cunningham

Andrew S. Wong

N. Joel Ehrenkranz

1952
John W. Arnold

Elias J. Marsh
Katharine H. Martin
Nora H

Mason

Laurence G. Roth
Haynes W. Sheppard
Sarah P Sherwood
Nicholas P. R. Spinelli

William G. Anlyan

M. Richard Carlin
1945
George H. Allison
A. John Anlyan
Albert S. Atwood

Betty Carlin
Charles R. Cavanagh. Jr.
Robert A. Chase
Amo? I. Chernoff

Harold M. Sterling

Daniel W. Elliot
Gunnar O. Eng

Frederic M. Blodgett
Richard W Brcck

William F. Collins,Jr.

Albert A. Fisk
Paul S. Goldstein

Robert P Darrow

Louise H. Burr
Alice S. Cary

1954

Richard J. Bouchard
Ralph K. Campbell
William D. Cone
Alan H. Covey

Walter J. Freeman
Orlando F. Gabriele

Frank A. Carone
Frank R. Coughlin. Jr

John A. Gariepy
Edward J. Gerety
Frank L. Gruskay
Nicholas A. Halasz

Philip G. Deane

Robert P. Hatch

Eleanora C. Gordon

Raymond S. Duff

Archie L. Dean, Jr.

Frederic W'. Gray

Jean 11 Dougherty
Owen W. Doyle

Jackson Harris

James R. Durham
William J. Johnson

Walker R Heap. Jr.
Eva H Henriksen
Samuel J. Hunter

James K. Luce

Franklin H. Epstein

Robert C. Howard
Benjamin A. Johnson

N. Karle Mottet

Herbert S. Hurwitz
Robert F. Hustead

Thomas P Cotter
Edward M. Daniels

Edward D. Foord
Frank H Horton

Frank D. l aw
Orval 1. McKay

Robert F. Owen
Robert G Petersdorf

Donald S. Kornfeld

Richard R Dyer
Robert S. Easton

Don F. Kimmerling

Richard D. Otis
Julian I Pichel

Leon A. Phillips
John M. Roberts

Edmund L. Piper

Elizabeth M. Rush

Charles 1

Leonard Rush

Sanford I Cockerell
Jay B. Cohn

Sidney S. Feuerstein
Alice I). Friedman
Raymond A. Gagliardi
Philip S. Good

Robert J. Kerin
Richard P. Levy
Brock Lynch
Victor A. Macheinski
William K. McClelland

Rennell. Jr.

Murray Z. Rosenberg
Daniel Rudman
Carl M. Russell
William IL Sewell

Mary W. Schley
Donald 11 Schultz

Robert J. T. Joy
Lowell A. Kristensen
Richard Lamb
Harry C. Miller. Jr.
Paul V Neufeld
James J. Nora
Lowell E. Olson
William S. Palmer

Herbert S Harned. Jr.
Paul W Hoflert

Robert F. Newton

O. Roger Hollan
Hans R. Huessy

Lawrence C. Perry
Edgar B Phillips 11

Raymond D Sudarsky

Virginia L. Swanson
John H Wagner. Jr.

William I

Olive E. Pitkin

1950

Doris 1 Wethers
John L. Wolff

Irving Rudman
Alvin Somberg

Russell N. Anderson
l yaI D. Asay
John E Borowy

Harvey L. Young
Robert Zeppa

William II Bucher
Alvin Davis

1955
Claude Bloch
Harold D. Bornstein

John K. Rose
Elihu M. Schimmel
Leonard M. Silverman

William R. Chaffee
Allen Chetrick
Rex B. Conn

Robert L. Stein
John W. Vosskuhler

Jenney

Raymond E. Lesser
Mark M. Lindsey
Charles E McLean
George W Naumburg. Jr
Richard M Peters
Charles I Sherwood
Joseph R. Stanton
Kenneth C. Steele

Myron K. Nobil

Igor Tamm
Patricia B. ludbury
Ellis .1. Van Slyck
M. Henrv Williams. Jr.

Robert B. Schultz

Claude W. Delia
Kent Ellis
Thomas J. Ferraro. Jr.
Daniel Fine

30

Deceased

William J. Paule
Anthony V Piccirillo
Richard D. Pullen
Jacques M. Quen
Edwin R

Ranzenhofer

Earl D. Rees
David M. Robinson

1955
John B. Atwater
John C' Bailar 111
George E

Benjamin A. Shaver, Jr.
Donald W Sherrick

James Greenwald

1960

Charles A. Hall, Jr

Daniel R. Silbert

Stanley Harris
Michael Kashgarian

Victor Altshul
Alan W. Ames

Becker. Jr

Donald P Buebendorf

1962
Jon M. Aase
Paul H. Ackerman
Michael H. Alderman
Charles B Anderson
Frederic P. Anderson

E. Edward Bittar

1957

Haskins K. Kashima

Stanley M. K. Chung

Douglas G. Boyden

Donald Agostinelli
Jack N, Blechner

Jay W. Kislak
Theodore W. Lieberman

Jon E. Courtney
Louis A. D’Avanzo

Harry C. Briggs
John P. Carey

Myron Lotz
Jack W. Love

Caldwell B. Esselstyn, Jr

Ann B Barnes
Spencer J. Brody

Warren H. Fisher

Dean E. Burget, Jr.

Albert K. Chun-Hoon

Thomas J. Mauro, Jr.

Louis Z. Cooper

Michael J. McCabe

Paul J. Friedman
Alvin E. Friedman-Kien

Fredric K. Cantor
Richard N. Collins

Irwin M. Braverman
Edward N. Brennan
Padraic Burns
Leo R Cardillo
Nicholas A. Coassin
Edward D. Coppola*

Harold D. Cross

Leo T. McCallum

Eugene C. Gaenslen, Jr.

Arnold J. Eisenfeld

Milton Corn
Pasquale J. Costa
Fred W. Doyle

Brian Crowley

Gary E. Gathman

Joseph D. Ferrone, Jr

John D’Agostino, Jr
Thomas H Danaher

Andrew J. McGowan, Jr.
F Patrick McKegney, Jr.

James I. Gilman
Roland H. Ingram, Jr.

John W. Foreman

John A. Merritt, Jr.

William O. Edward

James R Dorr

Albert Muggia

Daniel M. Jones

Leroy A. Forstrom
Stephen J. Fricker

Leroy Engel

Edward L. Eyerman, Jr.
Salvatore Falbo

Robert S. Neuwirth
Carol F. Phillips

William S. Kaden

John N. German

F. Robert Fekety, Jr.

Eric P. Kindwall

Mahlon V. R

Harold J. Fallon, Jr.

David M. Pugh

Frank .1

Roderick C. Half
John T. Harrington

Barbara W. Gibson
Rudolph J. Goerke III

Robert E. Fishbein
Ronald II Fishbein

William E. Radcliffe

Susan T. Kleeman

Patricia C. Hassakis

Paul A. Rudnick

Thomas P. Kugelman

Walter W Karney

William W. Schlaepfer
Bruce H. Sklarew

Edward R Lang
Thomas 1 Lincoln

Glenn L. Kelly

Richard E. Sledden
Edward L. Socolow

Edward Longo
Eugene G. McCarthy, Jr.

Malcolm A. Martin

Arlene Sweedler
Raymond W. Turner

Donald L. Miller

Stanley E. Matyszewski

Freeman

Kleeman

Paul Gonick

James R. Fitzgerald

Dicran Goulian, Jr.
Ion Gresser

Anthony I . Fons, 111

John H. Hodge

Gary A. Fry

D. Franklin Johnson, Jr.
Harry O. Kendall

Robert H Glass
Anne H. Good

Richard G. Morrill

William G. Meffert

David R. Kessler
Gilbert M. P. Leib

Jack P. Green
Joyce D. Gryboski

Margaret S. Wenzel

Allan W. Newcomb

John P. Wood

Buford L. Nichols, Jr.

Malcolm S. Mitchell
David D. Nicholas

James l.um

Malcolm Hill

Pauline B. Wood

J. Thomas Okin

A. Richard Pschirrer

Joseph S. McGuire. Jr.

Gilbert F. Flogan

Fred Palace

Joseph Ross

Robert C. Nod me
Sherwin B. Nuland

Warren R Johnson
William L. Kissick

Gloria C. Onque

Edgar H

John C. Pace, Jr.
Robert II

Elizabeth H

Forsyth

Bernard Kosto
John P. Lynch

1959

Jerrold M. Post

James A. E. Spencer

Scott I Allen
Carol J. Amick

Charles H. Robinson, Jr.

Nancy A. Staley

Fred Stargardter

Jack Levin

Robert M. Amick

II Oliver Stoutland
Seth I haler

I .evin

Peters, .1 r

Bennett F. Markel

Asa Barnes, Jr.

Robert C Wallach
May Y. Wang

Gregory Peterson, Jr

Mark I). Marshall

Francis A. Beer

Ronald A. Yankee

Stewart R. Wright

Robert A Reich
E. Brantley Scott, Jr.

David E. Martin 111
Howard A. Minners

Jack F. Bowers
William C. Butterfield

1961

Phillip W. Smith
Alan A. Stone

Robert K

Edward Call, Jr.

Kenneth A. Arndt

1963
Arthur H. Ackerman

Sidney M. Cohen

Earl L. Baker
Frank II. Baker

Modlm

Sherwood Waldron, Jr.

Alexander Zuckerbraun

Hugh L. Moffet
George A. Nelson, Jr.
Herbert A. New'tnan

Ronald C. DeConti
William I Donegan

Albert A. Bechtoldt, Jr.

V. Richard Back
Gordon S. Cohen

1956

Thomas F. O’Brien, Jr.

Gerald Fenichel

Robert S Briggs

John E. Conte, Jr.

Alan E. Aplel

Jopseph S. Pagano
Raymond E. Phillips

Robert L. Fisher

David W. Brook
Orson R. Dee

Peter Bios, Jr.
Levon Z. Boyajian

Miguel R. Alonso

David F. Cross

Clifford B. Reifler

Robert J. Gonyea
Gerald B. Gordon

Paul D. Deiter

Andrew Edin
John P. Eliopoulos

Thcmas M. Brown

Arnold A. Schoolman

W. Keith Hadley

Ralph J. Deponte

B. Allen Flaxman

Rosalie A. Burns

Kenneth A. Simon
Gilbert B. Solitare

William II. Heydorn

Ronald A. Dierwechter

David II

C. Richard Hinckley

Jon D. Dorman
T. Wayne Downey

William T. Friedewald
David H. Fulmer

Joseph C. Cerny
Chandler Dawson

Fram

Robert W Southworth

Leonard Inker

Donald C. Stahl

John J. Jasaitis

Philip Felig

Alexander R. Gaudio

Edvardas Kaminskas
David W. Kingsbury

John E. Fenn

F, John Gennari

Gilbert M. Eisner

Arthur Taub
Romeo Vidone

Norbert Fleisig

Thomas F. Ferris

William J. Waskowitz

Myron S. S. Lee

Lee D. Goldberg
Peter B. Gregory

John FI. Gardner 111

Robert E. Youngen
James G. Zimmer

Kathryn H. Lewis
Daniel L. Macken

James M. Giffin
Edward C. Gilbert

Raymond Mark

Robert S. Gillcash
David D. Griffith

Armen C. Haig

1958

John C. Marsh

Louis D. Hunt

.loan M. Hardenbergh
John II Hart

George K. Aghajanian
Don P. Amren

Robert L. Hill

Joseph E. Angelo
John P. Arnot

S. Evans Downing
Mitchell Edson

Sumner Gochberg
George E. Green

William H. Hindle
Marie-Louise T. Johnson
Jerome O. Klein
William V. Lewit

Peter A. Benson
Gerard N. Burrow
Benjamin Bursten

Leo Lutwak
Jacob Mainzer, Jr.
Preston C. Manning
Dwight F. Miller

David A. Carlson
John A. Carlston
John A. Creatura
Lawrence Dubin

Norman F. Moon
Donald .1. NalebufT
David A. Page

Donald A. Duncan
Joel C. Eberlin
Philip R. Fazzone

George W. Paulson

Michael E. Fishman

Stewart E. Pursel
Robert L. Scheig

Raymond A. Gaito
John C. Gallagher

James Scheuer
Edward C. Senay

Marcia K. Goin
William M. Gould
* Deceased

D. Kent Morest

Richard L. Keefe

James A. O’Neil. Jr.
Robert H. Ostberg

Robert I Levy
Joseph R. Lusby

Nicholas M. Passarelli
Charles A. Phillips

David B Matloff

Lincoln T. Potter

Anoush Miridjanian
Richard A. Moore
Norman I. Moss

James D. Prokop
James R. Ralph

John C. Parker

David P Reed
Joseph D. Robinson, Jr.

Roy E. Ronke, Jr.
Thomas H. Sakoda

Joseph D. Saccio

Stanley G. Schade

Constantine J. Sakles
Marvin 1 Schulman

Robert N. Taub
Hugh C. Thompson 111
Franklin IF Top, Jr.

Marc D. Schwartz
David B Skinner
Sanford P. Solomon
James J. Stagnone
Lisa A. Steiner
Leo H Von Euler
Muriel D. Wolf

George H

HOlsten 111

Constantine D. Kyropoulos
William B. Lehmann
Craig H. Llewellyn
Edward G. Lund, Jr.
Robert H. Margulis
Herbert Meltzer
Robert E. Mueller
Jay M. Pomerantz
Gene R. Profant
Joseph B. Stevens
Lee B. Talner
Peter V. Tishler
Lawrence Tremonti
Helen N. Walsh
Peter G. Weiner
Seth M. Weingarten
Alfred J. Wise

David E. Weaver
Warren D. Widmann
John R Woodward
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1964
William A. Alonso
Millard J. Amdur
Sidney M. Baker
Leland S. Berger
Philip Blume
Anthony J. Bravo
Thomas A. Cardella
Joseph F. J. Curi
Alfonso Esguerra
Remo Fabbri, Jr.
Anthony Ferrante
Norman C. Fost
Peter A. Gross
John F B. Haney
Gene 1 Higashi
William J. Houghton
William E. Knight
I ewis Landsberg
Richard V. Lee
Thomas L. Lent/
James S. Levine
Paul R Lightfoot, Jr.
Richard M. Linburg
Robert W. Lyons
Andrew E. MacMahon
William F. Matchett
Thomas O. McCann
Robert L. Mitchell
Alan H. Morris
James J. Murphy
Donald A. O’Kieffe. Jr
William B. Pratt
Stanley J. Rosenberg
Jonathan J Russ
Richard P Saik
Robert L. Shelton
Diane K Shrier
A. T homas Snoke
I yall C. Snip II
Sigrid T. Tishler
Charles Vogel
Stephen Waltman
1965
Susan A. Aoki
ITomas T. Aoki
John H M. Austin
Paul Balter
Victor J Burner
David G. Campbell
Dewey A. Christmas, Jr.
Robert M. Cohn
Michael J. Cummings
David S. Fedson
Robert I. Finkel
T rank J. Grady
Gary L. Gross
Robert A Gryboski
James K. Gude
Reid R Heffner, Jr.
David A. Hill
Carl E. Hunt
Ronald J Karpick
Mohandas M. Kim
Robert II Kochi
Richard J. Ko/.era
David J. Kupfer
Sandra C. Levine
Mark W. I.isehner
Philip I). Manfredi
Walter W. Noll
A. Lawrence Ossias
John A. Parrish
Robert I . Pickens
Robert II Prall
Alan V Rachleff
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William A. Renert
Gene A. Robinson
John H. Seashore
Margretta A. Seashore
Charles J. Semonsky
David M. Shames
David P. Simmons
Harlan Spit/
E. James Stanley
Alan W. Stone
Bert Y. Wong
1966
Benjamin F. Balme
John D. Baxter
Patricia Ba/emore
Robert P. Ba/emore
Frank C Boll
Philip Bernstein
James E. Brown
Eugene P Cassidy
Donald J. Cohen
Joseph A. Donadio
Robert E. Dragon
Marvin A. Eisengart
Jared M. Emery
Peter M. Fitzer
Robert N. Frank
Peter D. Gibbons
Jeffrey B. Gluckman
Stanley I. Greenspan
J McLeod Griffiss
Robert A. Gunn
Stuart T. Hauser
Jay G. Hayden
Mary Alice Houghton
Richard J Howard
Bruce W. Jackson
Gordon R Kelly
Neal Koss
Stuart M Kotler
David C. Law
Lynne L. Levitsky
Henry B. Mann
Harold Mellin
Eli IT Newberger
Neil J Peterson
William D. Peterson
Joel Singer
James D. Slavin, Jr.
Parker J. Staples
Gary L. Townsend
Lee Van Lenten
Joan T. Wayland
John W. Wickenden
William B Yeagley
Arne S. Youngberg
1967
Daniel L. Arons
Edward W. Bartlett
Arthur L. Beaudet
Arthur W. Boddie
Daniel J. Booser
Gary C Burget
William T. Cave
David M. Conkle
Cynthia R. Curry
Marian C. Davidson
James L. Davis 111
James J. Dineen
Timothy J. Dondero, Jr.
James M. Dowaliby II
John A. Drews
Peter R. Egbert
Melvin V. Goldblat
Richard J. Hart

Richard L. Heppner
George P Herr
J. Robert Kirkwood
Melvyn Korobkin
Anthony P. Lovell
Laura K Manuelidis
Halbert B Miller
Stephen W. Miller
William J. Mitchell
Joseph L. Morris
Jennifer R. Niebyl
John O. Pastore
William E. Perkins
Robert I Roy
Alfred Q. Scheuer
Stephen C. Schimpff
Sidney C. Smith, Jr.
Helen L. Smits
Lewis S. Solomon
Robert S. Steinberg
M David Tilson 111
Karen H. Toker
Robert A. Vollero
Joseph F. Walter
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DR. ROSENBERG — DEAN DESIGNATE
Dr. Leon E. Rosenberg, one of the nation’s leading
geneticists and a distinguished teacher and clinician,
has been appointed the next dean of the School of
Medicine. On July 1, he will succeed Dr. Robert W.
Berliner, who has been dean since 1973. Dean Berliner
plans to take a sabbatical year before retiring as
professor emeritus of physiology and medicine.
Dr. Rosenberg, who is C.N.H.Long Professor of
Human Genetics, Medicine and Pediatrics, helped
organize the Department of Human Genetics and has
been the chairman since it was established in 1972.
Under his direction, the department has pursued a
vigorous and comprehensive program, ranging from
basic research into the molecular structure and function
of the gene to caring for and counseling patients with
genetic problems at Yale-New Haven Hospital.
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In announcing Dr. Rosenberg’s appointment. Presi¬
dent A. Bartlett Giamatti said, “The University and its
School of Medicine are immensely fortunate that Dr.
Rosenberg has accepted this important position. He is
a distinguished physician-scientist and 1 know he will
provide the school with superb leadership in the
coming years. I wish to affirm again the University’s
commitment to the life and work of the school, and to
say how fortunate we all are to have in our next dean
what we have had in Dean Berliner, an outstanding
leader for the School and citizen of the University.”
“Dr. Rosenberg is a highly respected member of the
medical center community who has brought great skill
and effective leadership as chairman of the Department
Human Genetics,’’said C. Thomas Smith, president of
Yale-New Haven Hospital. “I applaud President
Giamatti’s choice and look forward to working with
Dr. Rosenberg as we both seek to serve the joint
interests of the hospital and the School of Medicine.”
Born in Madison, Wisconsin, Dr. Rosenberg received
his B.A. and M.D. degrees, both summa cum laude
from the University of Wisconsin. Following internship
and residency at the Columbia-Presbyterian Medical
Center, he was a clinical associate and senior investi¬
gator with the National Cancer Institute’s Metabolism
Service from 1959 to 1962, when he first came to Yale
as a senior assistant resident in medicine. He returned
to the National Cancer Institute before he was appointed
assistant professor of medicine at Yale in 1965. He was
named professor of human genetics, medicine and
pediatrics in 1972, and was appointed to the C.N.H.
Long professorship in 1980.
Dr. Rosenberg has emphasized that he will remain
committed to the clinical program of the School as well
as to its teaching and research activities. “I look
forward to the challenge that this appointment
presents,” he said. “The excellence of this place is a
tribute to a fine faculty which has been recruited by
successive Yale presidents and deans, to the high
standard of the students we are able to enroll, and to
the effective partnership between Yale’s medical school
and Yale-New Haven Hospital. This is a unique school
which proudly demonstrates that succesful cooperation
can exist among the teaching, research and clinical
sides of medicine.”

In 1980, when he was elected president of The
American Society of Human Genetics, Dr. Rosenberg
told his colleagues, “When your experiments don’t
work, or your grant deadline is approaching, or your
patients appear ungrateful, don’t unburden yourself to
your undergraduates, your graduate students or your
postdoctoral fellows. Lock yourself in the closet, jog,
complain to your spouse, have a beer, but don’t
frighten the kids. They might just take you seriously. If
you must tell it like it is, please be sure to give equal
time to the privileges and pleasures of academic life, to
the dazzling sense of well-being that follows scientific
discovery, and to the excitement that each of us knows
lies beyond our current horizons.”

Dr. Rosenberg is a fellow of the American Academy
of Arts and Sciences, the American Association for the
Advancement of Science, and past-president of the
American Society of Human Genetics. He received a
Guggenheim Foundation Fellowship in 1972, and the
following year, the Borden Award from the American
Academy of Pediatrics for outstanding achievement in
research relating to infant nutrition and development
of children. In 1982, the University of Wisconsin
School of Medicine presented him with its Distin¬
guished Alumni Citation, and that same year, he was
elected to the Institute of Medicine of the National
Academy of Science. Dr. Rosenberg is a member of
numerous professional societies including the Associa¬
tion of American Physicians, the American Pediatric
Society, the American Society of Biological Chemists,
and the American Society of Human Genetics.
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WHO PAYS?
WHO CARES?
by C. Thomas Smith
The following article was excerpted front a talk by Mr.
Smith, entitled “The Health Needs of the Disenfran¬
chised: The Impact on Connecticut Hospitals’’,
presented at the Fifth Annual Leadership Program for
Trustees, Physicians, Nurses, and Administrators in
September 1983. The program was sponsored by The
University of Connecticut, The Capital Area Health
Consortium, and The Connecticut Hospital
Association.
Hospitals and the poor are not new acquaintances.
Students of hospital history know that the first hospitals
were primarily places for the poor to die. People of
means did not go to hospitals, since there was little that
could be done for patients except to provide basic
sustenance and comfort. The charitable origins of
hospitals reflected the concern, especially of religious
groups, to provide a shelter for the disadvantaged of
our society. The development of medical knowledge
and technology which changed hospitals to places of
healing also changed their clientele to all members of a
community.
Since most hospitals began for charitable purposes,
they maintained that format as they changed from
social agency to technical institute to complex corpor¬
ation. Throughout this evolution, non-profit hospitals
have continued to provide services to people with little
or no resources. Unfortunately, the pressure on financial
performance may have caused some institutions to
forget these charitable origins and to focus on doing
well financially versus doing good for the community.
Although too often not understood, it is necessary to
be financially strong in order to be able to provide free
services. While charity care is free to the recipient, it
obviously costs something to provide it. That cost
must be supported by resources; good will is insufficient.
Forgetting our charitable origins, however, ignores
one of our reasons for being and invites treatment as
any other commercial enterprise. Preservation ot our
non-profit status requires attention to the reason it was
conferred.
Non-profit hospitals have always attempted, to
varying degrees, to make services available to the
disadvantaged. Prior to the passage of Medicare and
Medicaid, government payment for “charity” or
“welfare” patients was often a token amount that was a

Mr. Smith is president of Yale-New Haven Hospital
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fraction of the costs. Hospitals made up the difference.
However, since the development of cost-based payment,
there has been a myth that hospitals were paid by
certain buyers of care, especially governments, on a
full cost basis. The public, and even some hospital
staff, believe that all costs are paid by third-parties.
Unfortunately, such is not the case. Even after the
implementation of Medicare and Medicaid, hospitals
have continued to be paid on a cost-minus basis for
government-sponsored patients, although payment
levels have been significantly better than prior to these
programs. Certain expenses, such as free care, bad
debts, fund-raising costs and a provision for capital
requirements (except for for-profits), were all excluded
from the so-called cost-reimbursement equation.
We have allowed, indeed required, the non-profit
hospitals of our nation to function as quasi-tax
authorities with income redistribution functions. Govern¬
ment underfunding has forced hospitals to levy a tax
on non-government patients to make up for the short¬
fall on patients paid for by governments. Hospitals
with large numbers of low-income, government-spon¬
sored patients are especially vulnerable to such
underpayment.
The extent to which a hospital serves such patients
determines the degree of increase in charges to other
patients to cover this short fall. This cost-shifting
technique, while useful in the past, will become a

historical relic in the near future.
If the achievements of the health sector were applied
to another area, it would be judged a raging success.
Goals were achieved regarding increased access,
comprehensiveness of care, diffusion of technology,
expansion of knowledge, increased capacity, high
utilization, recession-proof employment and constantly
increasing sales. Since 40 percent of resources for this
sector come from governments, who have other prior¬
ities, such success interferes with other obligations.
Therefore, instead of being applauded for our achieve¬
ments, we are being scrutinized for our excesses.
We seem to have passed through an era of societal
concern that everyone have access to all health services.
While we fell short of that goal, we came close. A
Robert Wood Johnson Foundation report showed
that the number of visits to physicians per person per
year changed between 1964 and 1978 in favor of the
poor. Specifically, in 1964 the poor averaged 24
percent less visits than the non-poor, whereas in 1978
the poor averaged 19 percent more visits. In terms of
expense, the same study showed average Medicaid cost
equal to the population average, suggesting equivalent
utilization of services by the poor.
Limited government resources have called attention
to the need to place limits on growing government
obligations. Perhaps no other area of social service
support has had the somewhat open-ended funding as
has health. As governments have attempted to augment
or provide support for other essential services, i.e.,
housing, food, general assistance, even education, they
have been far more restrictive in goals and practice
than in health. Some of us believe that health deserves
such special treatment due to its essentiality for
sustaining life and enhancing its quality. However,
other essential needs have never been supported at the
same qualitative level as have health services. Unfortu¬
nately, for both the recipients and the providers, main¬
stream health care seems destined for the lowest
common denominator which is applied to other essential
social services.
Sadly, poverty breeds health problems. While attend¬
ing to disabling disease or injury is a priority across all
segments of society, maintenance of health does not
merit priority attention from people who are unem¬
ployed, hungry and worried about the next rental
payment. In addition, given the high proportion of
secondary school drop-outs in this category, little
opportunity has been available to instill the importance
of prophylactic care and the impact of life style choices
on health status. Consequently, problems develop that
might be avoidable and medical services are often
sought late in the disease process.
The over-used slogan, “Health Care is a Right”, has
perhaps deluded us into believing that such an assertion
made it true. While much legislation has been passed to
improve access to services, there has not been statutory
and funding support to undergird the slogan. Absent

any legal right, therefore, we must continue to depend
upon a sense of moral obligation to support the
assertion.
“Rights” imply that someone or some agency (usually
government) has responsibility to assure that they are
fulfilled. Without an assured government commitment
to guarantee delivery of needed services, health
providers are left to try, as they have historically, to
play a quasi-governmental role without funding to
support it or taxing authority to finance it. This places
providers in the position of deciding how to allocate
their scarce resources between individual needs which
may be compelling, e.g., liver transplants, versus
attempting to do the greatest good for the greatest
number of people. Such profound decisions are never
easy, and they are impossible in the face of individual
need. No one is comfortable in deciding to withhold
available care for financial reasons. Broad public
policy guidelines should be developed through the
political process in consultation with providers, rather
than leaving such judgements to ad hoc, emotional
circumstances.
While health services are essential to all segments of
society, medical treatment of diseases which grow out
of poverty conditions is analogous to treating symp¬
toms, not underlying causes. Episodic conditions may
be ameliorated, but they are just as likely to reappear.
Acute health services barely touch the fundamental
problems which produce some of the disconcerting
health statistics.
In the recent important book, “The Social Transfor¬
mation of American Medicine”, author Paul Starr
commented on the doubt that developed in the late
1970’s regarding the ability of the health system to
solve all health problems. Several pertinent quotes
portray the cynicism which developed in concert with
concern about rising costs:
“Instead of merely questioning whether hospitalization and
surgery were excessive, critics began to ask whether medical care
made any difference in the overall health of society.”
“It had long been known that medical care, especially when
compared with the environment or social behavior, has relatively
modest effects on mortality rates... It suddenly struck intellectuals
and policy makers of diverse persuasions that this was the answer
to those who constantly wished to expand access to health care.”
“If the first revelation of the seventies had been that a 'health care
crisis’ existed, the second revelation was that health care hardly
affects health . . . the generalization of doubt undermined the
generalization of rights. Distributive justice is a morally compelling
concern, after all, only when what there is to distribute, or
redistribute, is truly valuable. If it is irrelevant or harmful to
human welfare, the poor would be better off without it.”

Such skepticism has forced health providers to
carefully evaluate the efficacy of treatment programs.
Closer scrutiny is being applied to new technology to
be sure that it will make a difference for patients, either
therapeutically, economically, or in terms of comfort
or human dignity. Too often, new medical technology
is additive, rather than substituting for existing modal5

ities. Changed financial incentives will have a marked
impact on past practices of each hospital having all
alternative services, to having only those which are
most therapeutically beneficial and cost effective.
Despite a healthy doubt about health services solving
problems which are best addressed by other social
interventions, there remains a significant demand for
necessary services by the poor. Even though medical
interventions may be episodic of broader underlying
social problems, the episode must still be managed.
Medical care will still have to be provided and
hospitals will be the major providers. What alternatives
are available to hospital leadership to cope with the
probable continued inadequate funding for care for
the permanent and temporarily poor, as well as other
financial pressures on our institutions? One simplistic
solution, articulated by a former Secretary of the
Department of Health and Human Services, is that
hospitals are so obese that the loss of fat is not only
achievable by hard-nosed management, but it will also
result in a healthier hospital with little untoward
impact on patients. Presumably, this would solve our
financial problems and assure the poor of needed care.
To be sure, honest appraisal requires acknowledgement
that such steps can be achieved in some hospitals.
Similarly, many governmental programs can be
managed more effectively, as can many businesses. No
sector of our society (including HHS) has a corner on
management wisdom and skills, nor is any perfect. We
can all utilize resources more effectively.
Rather than be defensive, we should be sure we
understand and convey to our communities the conse¬
quences of financially-oriented decision-making to
health services. Certainly, steps should be taken to
eliminate inefficient practices. If that means merger
between institutional programs which will assure the
community access to effective services, it should be
done, regardless of bruised institutional egos. However,
if program closure means patients will not have access
to needed services, the community must decide what
price it is willing to pay to have them available.
Some communities have decided that the most
attractive solution is to turn their hospital (sometimes
a government-owned facility, sometimes owned by a
non-profit entity, even religious institutions) over to a
national for-profit hospital chain. No doubt, such
steps are attractive in the short-run, because of the
financial relief provided. In addition, the management
responsibilities are assumed by an organization that
may be better able to handle them. However, the long¬
term impact of such a step on the less fortunate of the
community may be disastrous. A recent series in the St.
Petersburg, Florida, newspaper. The St. Petersburg
Times, described the impact of for-profit institutions
on those without the ability to fully pay for their care.
Denials of service and shifting of patients to non-profit
hospitals is common in this environment.
Other newspapers and magazines have recently had
6

numerous articles on changes occurring in the health
care industry. Several have featured the increasing role
of large corporations which control health services.
This reasonably recent phenomenon was noted in Paul
Starr’s book, as he expressed his views of one impact
from this trend:
“A corporate sector in health care is also likely to aggravate
inequalities in access to health care. Profit-making enterprises are
not interested in treating those who cannot pay. The voluntary
hospital may not treat the person the same as the rich, but they do
treat them and often treat them well. A system in which corporate
enterprises play a large part is likely to be more segmented and
more stratified. With cutbacks in public financing coming at the
same time, the two-class system in medical care is likely to become
only more conspicuous.”

Perhaps in our perceived role as guardians of the
community’s health, fulfilling a quasi-governmental
function, we have assumed that we are best able to
make decisions as to how the community expends its
health care dollars. We have been allowed to function
relatively freely in the past, but concern about costs is
changing the locus for decision-making away from
providers. Buyers of care will now' be calling the shots.
Our burden will be to assure that the consequences of
decisions are fully understood, including any untoward
impact on a segment of patients. This will require that
we understand what difference health service makes
and that we function as advocates for those least able
to speak up for their needs.
Our institutional missions proclaim our commitment
to everyone’s needs, but the price may become too
high. Our past income redistribution practices seem
short-lived. Furthermore, with the demise of costbased payment, we w ill no longer be paid for what we
do. Now we must learn to do that for which we get
paid. The distinction between these patterns is signifi¬
cant and far-reaching. If those who buy our services
are willing to pay only for the services provided and
nothing else
including subsidizing care of the poor
then we will either comply w ith such strictures or go
out of business. Perhaps some hospitals or programs
should close. However, the poor are likely to be most
affected by such terminations, as the non-poor can
seek service elsew here. Therefore, our only option is to
devise ways to reduce costs to levels wdiich buyers are
willing to pay.
In the short-run, we may see several actions by
hospitals:
1. Product-line evaluations will, inevitably,
result in the termination of programs
which are not financially viable. The poor
are especially vulnerable to such changes.
2. Some patient shifting may occur as providers
seek to minimize their free care and bad
debts. The absence of public hospitals in
Connecticut may limit patient transfers
between hospitals, but it will not mitigate
the existing pattern of ambulatory care.
While hospitals and non-hospital providers

directly (perhaps via capitation) with buy¬
ers for a full range of services. Incentives
will be developed to contain buyer expense
and to place risk on providers, as well as
patients.
3. Contracted services will be limited to those
deemed essential or with a demonstrable
payoff. This will include support for socalled wellness or prevention programs.
4. Hospitals will aggregate resources among
themselves and with other providers to
gain advantage of scale, to spread risk, to
share expertise and to enhance competitive
positions.

may compete for remunerative ambulatory
services, there is little competition with
hospitals to serve those with few or no
resources. Means need to be developed to
share this community responsibility, or
certain institutions will eventually collapse
from this unevenly distributed burden.
Physicians, particularly, should consider
the long-term consequences of this pattern
and their responsibilities to share some of
the load.
3. Health services to the poor will be scaled
down to essential services. Basic care will
be provided, absent amenities which may
be considered desirable, but not critical.
4. More careful financial screening will occur
to assure that those receiving subsidized
services are those who most need them.
Those eligible for governmental support
will be required to show evidence of
approval for it prior to receiving service.
5. Emergency care will continue to be provided
by hospitals, but the closure of high-cost,
low usage services will result in shifting of
patients requiring specialized care which
will be available at fewer institutions.
Non-emergent care will be limited or
deferred.
The longer view is always cloudier. However, a
number of forces already in motion suggest probable
nationwide trends that will ultimately affect all
hospitals:
1. Prudent buyer efforts by government and
business will force institutions to pare
costs to levels purchasers are willing to
pay. Hospitals will seek governmentfinanced patients, even at reduced payment
levels, to the extent that marginal costs
are covered.
2. Multi-institutional development will enable
vertically integrated providers to contract

Despite our dreams, we never eliminated two-tier
care. In fact, there are several tiers and, in health as in
other areas, personal resources determine which tier
we are on. Perhaps limited resources make the “equal
access, equal care” goal unattainable. Even if we
cannot achieve equal care, just as we have not achieved
equality in education, nutrition, housing or in other
important areas, we must not relent on equal access.
Hospitals have long been the guardian of the disadvan¬
taged in our communities, never doubting people’s
right to be served. What is at issue is to what extent,
and how, the financial burden will be handled.
My preferred definition of management is trusteeship
for other people’s interests. This suggests that those
who are responsible for our institutions
trustees,
management, medical and nursing leadership
must
have a clear understanding of who such “other people”
are, as well as what their “interests”are. The history of
Connecticut’s hospitals suggest that they do have such
understanding: they exist to serve their community
with responsive and responsible health services. This
constituency has included all of the community, both
the poor and the non-poor. However, in an environment
of increasingly scarce resources, decisions will have to
be made which may negatively affect the poor in the
short-term. The ultimate strategy has to be to prevent
institutional financial failure, in which case no one
benefits. Such survival strategy will undoubtedly create
hardships for those with perhaps the greatest need and
the least resources, financial and political, to press
their cause. In the give and take of an individual’s
needs versus those of a community, the democratic
process is prone to decide on the greatest good for the
greatest number. One person’s loss may be several
other’s gain. While that may make good political and
financial sense, we must vigilantly defend the presence
of compassion and respect for human dignity as a
necessary counterbalance to data-derived decisions.
Our survival requires tough-minded management of
the resources entrusted to us. Our missions, history,
and, indeed, our conscience demand that all decisions
take into account their human impact on those we seek
to serve.
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GERALD KLATSKIN, M.D.
By James L. Boyer, M.D.
In May 1983, Dr. Gerald Klatskin, David Paige Smith
Professor Emeritus of Medicine, received the Julius
Friedenwald Medal, the highest honor of The American
Gastroenterological Association. On this occasion. Dr.
James L. Bover delivered the following tribute to Dr.
Klatskin. It is reprinted here with permission of the Elsevier
Publishing Company. Inc.,from Gastroenterology; 85:
1235-8. copyright 1983 by The American Gastroenterology
Association. Dr. Boyer, professor of medicine, succeeded
Dr. Klatskin as director of the Yale Liver Study Unit.

Today, the American Gastroenterological Association
presents its highest honor to a legendary figure in
American medicine, a man who has made an indelible
impression on generations of students and physicians
by his single-minded dedication and devotion to the
study of the liver and his compulsive, yet articulate,
analysis of hepatic pathology and clinical liver disease.
In the few minutes that we have this morning, I will
attempt to capture something of the essence of Gerald
Klatskin, and to trace a few historical events that have
influenced and highlighted the career of this distin¬
guished clinician-scholar.
Let me begin with my own impressions as I entered
his office for the first time in the fall of 1965, seeking a
fellowship appointment, my anxiety having been height¬
ened by repeated stories of his imposing intellect and
personality. But hardly had I explained the purpose of
my visit when he spied, tucked under my arm, a box of
liver biopsy slides I had brought from Calcutta, where
1 was in the Public Health Service. He immediately
examined them under the microscope in great detail
without so much as a word, then launched into a full
discussion of the subject, including background litera¬
ture, as if he had just prepared a most comprehensive
review. From this extraordinary encounter, which I
later learned was his daily routine, began a long
association as his student, colleague, and most impor¬
tantly, as with many of you here today, his devoted and
admiring friend. What are the characteristics of this
man we honor today?
Dr. Gerald Klatskin, known affectionately as “G.K.”
or the “Klat,” or simply “Gerry,” is unmistakable
whether one encounters him in the hospital corridors,
in the hotel lobby at an annual meeting, or, as is most
likely, in his office, as the photograph so characteristi¬
cally depicts. The broad forehead, the bushy eyebrows,
the gruffness of his voice, these outward physical
manifestations of a “Great Bear,”as he has been called,
belie the personality beneath. He is, in fact, a kindly.
8

unpretentious man, whose entire career has been
focused, with nearly absolute determination, on the
pursuit of medicine and his specialty. Gifted with
extraordinary intelligence and qualities of complete
honesty and integrity, his scholarship encompasses the
entire range of clinical liver disease, including disorders
as diverse as sarcoidosis, porphyria, chronic hepatitis,
alcoholic liver injury, hepatic adenomas, and bifur¬
cation tumors (the latter bearing his name). He is a
pioneer in the development of liver biopsy techniques
and their histologic interpretation, a supreme performer
of the clinical consultation, the ultimate visiting pro¬
fessor and biopsy consultant, and mentor to many
leaders in medicine today.
How did all this begin? 1 must confess that despite
my long association with Gerry, I decided to hold a
series of interviews with him in preparation for this
occasion. Quite frankly, 1 did not want to miss the
opportunity to hear the story right from the beginning.
It will come as no surprise to those of you who know
him well that I spent many hours at this activity — all
delightful
nor will you be surprised to hear me say
that he has not forgotten a single name, nor anecdote,
nor episode. Indeed, the only fact that he cannot recall
is why he decided to study medicine in the first place!
Let me highlight just a few of these events.
Dr. Klatskin was born in 1910 in New York of
parents of Russian origin. He graduated from high
school at the young age of 16, already interested in
medicine, and completed college at Cornell in only
three years, graduating Phi Beta Kappa in 1929 at the
onset of the Depression. During his freshman year at
college, he wandered into the embryology and histology
labs and discovered to his surprise and delight that
tissues could be imbedded, stained, and examined
under the microscope. He was enthralled by the
process, and visited so often that the chairman of the
department offered him a part-time job. Here began
his fascination with histology. He worried about
entrance into medical school, but was easily admitted
to Cornell Medical School in New York, where he
graduated first in his class in 1933.
One spring weekend, a medical student friend drove
him to New Haven. Elm trees spanned Cedar Street in
those days, and the friendliness of a small town and the
relaxed atmosphere of the students and housestaff all
appealed to this young man from Brooklyn. He
applied for an internship in medicine and was accepted.
Eugene DuBois, Chief of Medicine at Cornell, preferred
that he apply to Johns Hopkins, telling Gerry that Yale
was “just a little village hospitaL’and “you can do a lot
better.” But Gerry was already enamored with Yale,
and in July of 1933, he began the first of two lifelong
obsessions; July 1983 marked the 50th anniversary of
this extraordinary association. His second obsession
was, of course, with the liver. Like many hepatologists
of his era, Gerry’s World War II army experience was
central to this development. Posted in Calcutta, India,

because of his curiosity to learn more about rare and
exotic diseases, he became interested in hepatitis and
amoebic abscess. Later, when transferred to Schick
Army Hospital in Iowa, he met Cecil Watson, who had
a profound influence on him. Watson emphasized a
careful, systematic approach to the study of the liver,
and introduced Gerry to the concept of a battery of
liver function tests called hepatograms. This approach
was entirely new and it appealed to Gerry, for back at
Yale only serum lipids and proteins were thought to be
useful. In 1946, he returned to New Haven intent on
establishing a proper liver laboratory. With the
support of his Chairman, Francis Blake, but with the
outspoken opposition of his Laboratory Chief, John
Peters (then, Mr. Metabolism), Gerry set about to
gather equipment, having been expelled from Peters’
laboratory. Soon consults and requests for tests came
pouring in, and even Peters, who didn’t speak to Gerry
for two years, became impressed.
Gerry performed the first liver biopsy at Yale in
1947. The Pathology Department laughed at the
miserable size of the specimen and deemed this approach
a failure. After a few false attempts and inadequate
preparations. Hazel Hubbel, the Chairman’s technician,
took over the project. She introduced Gerry to Carnoy’s
fixative and the Massontrichrome stain. Later, Hazel
joined the Liver Unit, and no tribute to Gerry would be
complete without recognizing this unusual and dedi¬
cated woman. A “born scientist,” she was his equal for
perfection. Because she abhorred automatic equipment,
she handled the processing, including knife-sharpening
by hand, for many years. Visitors to the Liver Unit
from around the world came to pay her homage and to
praise her work, but she never admitted to being
pleased. Countless fellows became her staunch ad¬
mirers. With Hazel’s handiwork, Gerry combined his
own keen interest in photography with the evolving art
of liver biopsy preparation. The result, over a 35-year
period, has been the accumulation of more than 50,000
Kodachromes from nearly 10,000 liver biopsy speci¬
mens. The Kodachromes, which are all correlated with
detailed clinical data from each case, represent the
largest personal collection of clinical pathologic cor¬
relations of liver disease in the world. A permanent
library in Dr. Klatskin’s honor is currently being
established for this collection.
This “pathologist’s pathologist” also earned the
accolade of “the clinician’s clinician.” Early in his
career he was given the title of DRD, “Doctor of Rare
Diseases,” by Dr. Peters for the depth of his knowledge
of esoteric as well as the more common clinical entities.
His compulsive attention to detail is legendary. What
one of his fellows does not recall Gerry uncovering a
critical fact in a patient’s history or physical examina¬
tion that had been missed by countless examiners
before him, arriving at an entirely different and
inevitably correct diagnosis, and then recounting from
memory an encyclopedic background literature on the

subject? An undiagnosed patient or a difficult manage¬
ment problem was presented and usually resolved by
the “Klat” at his weekly consulting rounds. Gerry
taught by example and demonstrated time and again
the rewards of careful, critical attention to detail by the
bedside.
Undoubtedly, the greatest beneficiaries of Gerry’s
skills were the 47 postdoctoral fellows who came to
train with him during the years between 1951 and 1978,
and over the years, their accomplishments have been
his pride and joy. He is fond of pointing out the values
of an unstructured, broadly based training program.
As the first recipient of a training grant in liver disease
in 1959, he maintained this grant for 17 years. Despite
the unstructured nature of his program, which often
cast fellows adrift in the laboratory to sink or swim, 34
are employed in academic medicine, 19 are currently
full professors, seven have become chairmen of depart¬
ments, and one is a dean. Most are members of the
American Gastroenterology Association and the
American Association for the Study of Liver Disease.
Three have been AG A councillors, and four are former
presidents of the AASLD.
Throughout his career, Gerry has been relatively
unaffected by the national and international recognition
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that has come to him. He refused offers to move from
New Haven, and successfully avoided additional
administrative positions. Although he served as Acting
Chairman of the Department of Medicine at Yale on
four different occasions, he never wished to accept this
responsibility permanently, preferring instead to pursue
the interests that he loved the best.
Nationally he has served on several important
committees, including the Gastrointestinal Nutrition
and Liver Disease Training Committees of the National
Institutes of Health between 1959 and 1964, and the
Surgeon General’s U.S. Army Medical Research and
Development Command from 1965 to 1975. He is a
member of the American College of Physicians, the
American Association of Physicians, the American
Association for the Study of Liver Disease, and the
Interurban Clinical Club, serving as president of the
latter two organizations in 1958 and 1966, respectively.
Many honors have come his way, including (at Yale)
the David Paige Smith Professorship, the Francis
Blake Award for Outstanding Student Teaching (he
was the first recipient), and the Mastership and
Distinguished Teacher Award from the American
College of Physicians in 1974 and 1979.
He has a daughter, Jane, who is a lawyer in
Copenhagen, and three grandchildren, all Danes; a
daughter, Ann, a graduate student in computer sciences;
and a son, Robert, an electrical engineer in Los
Angeles at the Howard Hughes Aircraft Space Program.
His wife, Lynn, who is here today, has recently retired
from her own distinguished 37-year career at the Yale
Child Study Center, where she was Professor of
Psychology.
Gerry’s many scientific and scholarly accomplish¬
ments are well known and include the first demonstra¬
tion that viral hepatitis and the Australian antigen
were associated with chronic hepatitis (1); the identifi¬
cation of birefringence of protoporphyrins in liver
biopsy specimens (2); the beneficial effects of alcohol
withdrawal on the natural history of alcoholic liver
disease (3); the prognostic significance of acute liver
cell injury in hepatitis (4,5); definitive evidence for an
association between halothane and hepatitis (6); the
clinical significance of granuloma in liver biopsies (50
percent of the world’s published literature on this
subject come from his own material) (7,8); recognition
that cholangiocarcinoma presents as a bile duct bifur¬
cation tumor (so-called Klatskin’s tumor) (9); recogni¬
tion of the common association of fever with Laennec’s
cirrhosis (10); recognition that alcoholic hyperlipemia
precedes and may precipitate episodes of pancreatitis;
the design of an effective liver biopsy needle (the
Klatskin needle, although he never received royalties);
and many other clinical and scientific observations
that he and his fellows pursued.
It has been said that the essence of a great man is the
lasting impressions of his students. Dr. L. Frederick
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Fenster, Clinical Professor at the University of Wash¬
ington, summarized his impressions four years ago on
the occasion of a festschrift where his fellows honored
Gerry, and I quote some of these:
“The Klat is warm, unassuming, and totally unpre¬
tentious. Affable, garrulous, and good-humored, his
story-swapping (more accurately described as story¬
telling) abilities are almost legendary. He combines
complete intellectual honesty and scientific skepticism
with a voracious curiosity and almost unbelievable
thoroughness. Who else, when titillated by anew
problem or question, would write or call every known
source of pertinent information, read every relevant
paper in whatever language, review every pathology
specimen (and take photos of each), and end up by
being one of the world’s experts on the subject, simply
because his curiosity would allow no other course of
action? In the (50) years he has been at Yale, Gerry
Klatskin has become an institution within an institution,
an internationally famous physician. But at Yale, he
has remained comfortable, intrinsic, and truly at
home. At Yale he is, like jaundice itself, a natural
phenomenon requiring no apology. He is unchangingly
an essential structural and functional element of the
institution.
“Gerry Klatskin has been a tremendous positive
influence on all of us. Just as he has always taken
satisfaction in our accomplishments, we have been
proud to have studied under his direction. He has been,
in this academic world of verbiage, a unique example
of how to educate by example. He is the best in his
field, still unspoiled and unchanged by his international
stature.”( 11) *
In conclusion, let me add my own personal reflections,
which I know to be shared by many others. For myself,
he has provided, above all else, an unparalleled model
of excellence. No matter what activity he is involved in,
he has demonstrated time and time again the rewards
of meticulous attention to detail and the importance of
pursuing scientific truth for its own sake and for the joy
that comes from new discoveries, whether these be
made from a careful history or physical examination,
or by analyzing specimens under a microscope, or
basic work at the laboratory bench
knowledge and
truth for their own sake and for no other. It is perhaps
for this reason, most of all, that the American Gastro¬
enterological Association honors Dr. Gerald Klatskin
today, on the 50th anniversary of his distinguished
medical career. Gerry, will you please come forward to
accept the Julius Friedenwald Medal?

* References on request from Yale Medicine
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With this issue, the editors introduce a new section to
acquaint our readers with a few of the very many research,
teaching, and clinical projects throughout the School. These
brief reviews of some of the work in progress in medicine
and public health are intended to illustrate the excellence
and broad scope of programs which have given the School
its reputation as one of the leading medical institutions in
the country.
One of the frustrations in medicine is the long wait, often up
to two weeks, for results of diagnostic tests for certain
illnesses. This is especially discouraging in very ill patients,
when rapid treatment can make a significant difference in
the outcome. Dr. David Ward, professor of human genetics
and molecular biophysics and biochemistry, has developed
a modified nucleotide technology to provide more rapid and
accurate diagnosis of viral, bacterial and fungal infections,
as well as for the detection of certain genetic disorders.
The invention involves modified nucleotides or “tagging”
molecules, called biotins, which mimic the natural nucleotides
of DNA or RNA. They are incorporated enzymatically into
portions of genetic material taken from blood, urine or
tissue samples from the patient and then detected by
interaction with proteins that bind specifically to such
modified nucleotides. If that material is matched with other
genetic material known to be associated with a specific
disease, a diagnosis can be made. Alternately, the “known”
DNA could be tagged with biotin and a match could be
attempted with a patient’s sample.
For practical application of this technique. Dr. Ward and
his colleagues are developing small cards lined with spots of
DNA from a number of specific viral, bacterial or fungal
strains. A specimen of biotin-tagged blood, urine or tissue
from a patient will be applied to the cards. If the specimen
hybridizes to one of the spots, the spot will change color,
indicating the presence of the disease strain, and diagnosis
can then be made within hours, or at the most a day.
In addition to significantly reducing the amount of time
necessary for accurate diagnosis, it is anticipated that this
new methodology will replace procedures currently in use in
biomedical research that rely heavily on the use of radioactive
material. Although it can be applied to DNA methods for
the isolation of genes, the new technique is not based on
recombinant DNA technology, and cannot be characterized
as genetic engineering, according to Dr. Ward.

Research which may open an entirely new approach to
treatment of multiple sclerosis is in progress in the laboratory
of Dr. J. Murdoch Ritchie, Eugene Higgins Professor of
Pharmacology. He has recently been awarded a grant by the
National Multiple Sclerosis Society to study the biophysical
basis of nervous dysfunction in demyelinating disease.
Dr. Ritchie has developed techniques for measuring ion
channels in the surface membrane of nerve fibers. Each ion
channel is specialized to permit the passage of only one type
of ion, either sodium or potassium. As a message moves
along a nerve fiber to a muscle, it is activated by a movement
of sodium, which enters the nerve fiber through a sodium
channel, and by a movement of potassium as it goes out
through a potassium channel. These channels open and
close at strategic moments. In order to prepare nerve fiber
for the next message, another structure in the fiber mem¬
brane, the sodium-potassium pump, carries the sodium out
and the potassium in, between messages. This three-way
cycle appears to operate for every message transmitted in the
nervous system.
In multiple sclerosis, patches of inflammation form in the
brain and spinal cord, eventually causing the protective
myelin sheath surrounding nerve fibers to break down, thus
interrupting nerve transmission. In previous work. Dr.
Ritchie demonstrated that when the myelin is damaged or
lost, the number of potassium channels increases, spreading
into other parts of the nerve fiber surface membrane. His
current research involves new methods to ascertain the exact
changes in the numbers of these channels when myelination
begins in the course of nervous system development; when
demyelination occurs under various experimental conditions;
and when myelin regenerates, as it sometimes does. He will
then relate these changes to changes in the function of the
nerve fibers.
According to the National Multiple Sclerosis Society, this
research may provide the key to one approach to multiple
sclerosis therapy — that of generating conduction of nerve
impulses in the permanent absence of myelin.
A team of Yale specialists are performing cochlear implant
surgery followed by extensive rehabilitative therapy to
enable profoundly deaf persons to hear. The collaborative
program of the Section of Otolaryngology at Yale and the
Rehabilitation Medicine at the V. A. Medical Center in West
Haven is funded by a grant from the Veterans Administration.
Candidates for cochlear implantation are persons who
have become deaf in both ears after they have learned
language, and for whom the use of a conventional hearing
aid is of little or no benefit. Cochlear implantation followed
by extensive audiologic and speech therapy enables them to
distinguish male and female voices, certain environmental
sounds such as sirens and bells, and some simple words.
Although it does not enable them to understand speech,
there is evidence that the device improves the patients’
ability to read lips, and enables them to monitor their own
voices. According to persons w ho have received implantation

therapy, among the most positive aspects are an increased
sense of security and independence.
The cochlear implant system is comprised of a microphone,
signal or voice processor and transmitter, external and
internal coils, and active and ground electrodes. The
microphone, placed at ear level, picks up sound and carries
it to the signal processor which is worn on the body. The
sound is processed and transmitted to an external coil which
is held in place behind the ear by magnetic attraction to an
internal coil which is implanted under it in the mastoid
cavity. The signal is magnetically induced across the coils
and carried down the electrodes from the internal coil into
the inner ear. The procedure to implant the internal coil in
the inner ear is similar to other techniques of ear surgery
which present relatively little risk.
Approximately 18 million people in the United States
have some degree of hearing loss; and nearly one out of
every 100 has severe to profound deafness. In 1969, the
estimated cost to the nation for the education, care and
compensation for the deaf was $100 million. This amount
may have doubled since then.
There are two types of deafness: conductive or middle ear
deafness, and sensorineural or nerve deafness. During the
past 30 years, the development of microsurgical techniques
has enabled otologic surgeons to treat all forms of conductive
deafness. However, the majority of hearing impaired Ameri¬
cans have nerve or sensory deafness, and until recently there
has been no treatment for this type of hearing loss.
The cochlear implant procedure and therapy is carried
out at the V. A. Medical Center. The team includes Dr.Jaclyn
B.R. Spitzer, assistant clinical professor of surgery (oto¬
laryngology); Dr. Frederick Richardson, associate professor
of medicine, neurology and pediatrics, and chief of Rehabili¬
tation Medicine Services at the V.A. Medical Center; Dr.
Linda J. Gardiner, assistant professor of surgery (otolaryn¬
gology); Dr. J. Cameron Kirchner, assistant professor of
surgery (otolaryngology), and Dr. Clarence T. Sasaki,
professor of surgery (otolaryngology), and chief of the
Section of Otolaryngology. The cochlear implant device was
developed by the House Ear Institute in collaboration with
the 3-M Company.
The U.S. Public Health Service has termed Acquired
Immune Deficiency Syndrome (AIDS) a “public health
problem that merits the highest level of concern” and has
made it a top priority. East year, recognizing a need for
specialized attention for patients with AIDS, a group of
health professionals at the Yale-New Haven Medical Center
representing physicians, nurses, social workers, religious
ministries, infection control and public health administrators,
began meeting as a multidisciplinary team to coordinate the
care provided to these patients.
An outpatient clinic was opened in early June to evaluate
the vast numbers of “worried-but-well” persons with early
signs and symptoms of A IDS, and persons with well-defined
cases of AIDS. In the past six months, the clinic has had
approximately 170 patient visits, most of whom have signs
and symptoms of the disease. The clinic also provides
follow-up care for patients who have been hospitalized. In
September, the Hospital employed Jeannee M. Parker,
R.N., M.P.H.,as an AIDS program coordinator to serve as
liaison to all hospital departments caring for AIDS patients,
and to be a consultant to community organizations with
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concerns about the illness.
Despite the number of patients affected by AIDS there
are tew clues to indicate the etiology of this complex illness,
or what treatment modalities may be the most successful. As
a result, investigators are pursuing a number of approaches.
Dr. John Dwyer, associate professor of medicine and
pediatrics and chief ot the Section of Clinical Immunology
has implanted thymic tissue, removed from infants under¬
going open heart surgery, into the muscle tissue of the
forearm of AIDS patients. It is hoped that this new tissue
will stimulate the production of T-lymphocytes in these
immunodeficient patients. Although the procedure is new to
patients with AIDS, it has been successful in patients with
other immunodeficiency syndromes.
Using a variety of laboratory techniques. Dr. George
Miller, John F. Enders Professor of Pediatric Infectious
Disease, is conducting research to identify and characterize
viral agents associated with AIDS and Kaposi’s sarcoma,
which occurs in its highly malignant form in 30 to 40 percent
of AIDS patients. With his colleagues. Dr. Warren Andiman
and Dr. James Robinson, he will conduct thorough diag¬
nostic virology studies on AIDS patients, especially children,
in an attempt to isolate viruses from hematopoietic elements
and other affected tissues. Further, they will attempt to
establish cell lines from tissues of AIDS patients and to
examine them for cell of origin, presence of viruses, viral
nucleic acids, or viral-specific antigens; also to transmit
AIDS agents in vitro to primary and continuous hemato¬
poietic cell lines of man and subhuman primates.They will
also attempt to determine whether cytomegalovirus alone,
or in combination with other viruses isolated from AIDS
patients, will transform morpologically human endothelial
cells or monocyte cultures in vitro.
In another study. Dr. Peter Tattersall, research scientist in
the Department of Human Genetics, will develop a mouse
model to study parvoviruses as a possible cause of AIDS. It
has been suggested that the severe T-lymphocyte depletion
which underlies Acquired Immune Deficiency Syndrome
may be the result of infection with a human T-cell-tropic
parvovirus, acting in synergy with a state of lymphoproliferative stress. To test this hypothesis, a mouse analog
of AIDS will be sought, using infection with MVM(i) in
conjunction with T-cell activators such as mitogens, viruses
or allogenic cells, to produce a profound T-cell depletion.
The research team working with Dr. Tattersall will also test
the implications and predictions derived from this model
system for human AIDS.
The recent development of endoscopic, non-surgical tech¬
niques such as extracorporeal shock wave lithotripsy,
percutaneous ultrasonic nephrolithotripsy, and transurethral
ureterorenoscopy, have greatly improved treatment of renal
and ureteral stones. For the past two years. Dr. Bernard
Lytton, professor of surgery (urology) and chief of the
Section of Urology, and his colleagues have been treating
patients with tw o of these relatively new techniques, percu¬
taneous nephrolithotripsy and transurethral ureteroreno¬
scopy, with promising results.
Percutaneous nephrolithotripsy is performed in collabora¬
tion with Dr. Morton Glickman, professor of diagnostic
radiology, who first cannulates the renal collecting system
with a long fine needle under radiographic control, using
fluoroscopy. A guidewire is inserted through the needle into

the renal pelvis and over this, a small catheter is placed into
the renal pelvis. The following day, this tract is dilated up to
about 10 millimeters in diameter and a small cannula is
inserted into the renal pelvis. A specially designed nephroscope and other instruments can then be passed easily into
the kidney so that calculi can be visualized and removed.
Small stones are removed with grasping forceps or a basket,
while larger calculi are disintegrated with a special ultrasonically powered probe which incorporates a suction
device to remove the fragments. Harder stones may require
electrohydraulic disintegration. Staghorn calculi occupying
the entire collecting system have also been successfully
removed.
In the second technique, the ureteroscope is passed
through the urethra and then directly into the ureter to
visualize stones. Small stones are extracted with instruments
under direct vision; larger stones have been disintegrated by
an electrohydraulic shock wave generated by an electrical
discharge at the tip of a special small electrode passed
through the instrument. These procedures are generally
performed under spinal or epidural anesthesia.
To date, 80 of the 100 patients with renal or ureteral
stones at Yale have been successfully treated with one or the
other of these techniques. In addition to the success rate, the
pain and discomfort of stone removal is significantly
decreased as there is no incision, and hospital stay and
convalescence time are markedly reduced. It is probable that
approximately 70 to 80 percent of all kidney and ureteral
stones requiring removal will be treated by these nonsurgical techniques.
A new surgical approach to the treatment of malignant
ventricular arrhythmias was introduced at Yale last summer
by Dr. Alexander Geha, professor of surgery and chief of the
Section of Cardiothoracic Surgery, and his colleagues. It
has already benefitted a number of patients suffering from
recurrent sustained and medical refractory ischemic ventri¬
cular tachyarrhythmias.
Each year, approximately one million Americans die of
cardiovascular disease. About two-thirds of these deaths are
due to cardiac disease, and half of this group die suddenly.
Presumably, a major portion of the victims of “sudden
death” have suffered abrupt ventricular tachyarrhythmias.
With increasing sophistication in emergency medical care
and the rise in the use of cardiopulmonary resuscitation
programs, the lives of many more heart patients are being
saved.
Ventricular tachyarrhythmias are the result of either
enhanced automaticity or re-entrant arrhythmia or both.
Automatic arrhythmias are common following cardiac
surgical operations and in the early period after myocardial
infarction. They arise from cells in the specialized conduction
system in the ventricle in response to factors such as hypoxia
and ischemia, electrolyte imbalance, increased catecho¬
lamines and drugs. Automatic arrhythmias characteristically
resolve when the enhancing stimulus is removed. Re-entrant
ventricular tachycardia is most frequently associated with
chronic ischemic heart disease and is encountered in those
patients with previous infarction who present with syncope
or “sudden death”since it may lead to ventricular fibrillation.
It is referred to as malignant arrhythmia and can be induced
in the electrophysiological laboratory by programmed
ventricular stimulation. Surgery has proven feasible only for

re-entrant ventricular tachycardia.
In patients with re-entrant ventricular tachyarrhythmias,
programmed ventricular electrical stimulation provides a
tool for diagnosis and evaluation of treatment. The inducibility of a ventricular arrhythmia by programmed stimulation
is considered as evidence supporting re-entry as a mechanism
for the arrhythmia. This is determined in the electrophysio¬
logical laboratory which, at Yale, is directed by Dr. William
Batsford, associate professor of medicine. Based on electrophysiologic studies, the patient is started on the antiarrhythmic agent which seems to be most effective; if pacing
is indicated, an appropriate pacemaker is implanted.
In 10 to 30 percent of patients with malignant ventricular
arrhythmias, however, an antiarrhythmic regimen and/or
pacing prove ineffective. These patients become candidates
for surgical therapy, prior to which they undergo more
detailed electrophysiologic evaluation including endocardial
mapping of both ventricles during induced ventricular
tachycardia to locate the site of origin of the arrhythmia.
This is done by catheter mapping of various sites in both
ventricles to find the earliest site of electical activation
during ventricular tachycardia or to locate a site of contin¬
uous electrical activity close to the area of old infarction.
The origin of the refractory tachycardia in the majority of
the patients is in the left ventricle. This preoperative
mapping provides an indication of the approximate location
of the short-circuit responsible for the re-entrant mechanism.
The surgical approach in these selected patients was
developed three years ago at the University of Pennsylvania
and Duke University and was brought to Yale by Dr. Geha.
The operation requires cooperation of the electrophysiologic
and surgical teams in the operating room to achieve accurate
direct epicardial and endocardial mapping during induced
ventricular tachycardia in the open chest. By slipping a ring
electrode on the index finger, the surgeon makes an
electrical map of the outside of the heart as it beats, looking
for the area of short circuit. With the use of the heart-lung
machine, the heart is then opened through the scar of the old
myocardial infarct and a detailed map of the inside of the
heart is made, far more detailed than Dr. Batsford and his
associates are able to make with an electrode catheter
preoperatively.
The area identified by surgical mapping as responsible for
the short circuit is often located on the inside of the left
ventricle, adjacent to the grossly scarred heart muscle, and
often appears normal to the naked eye. Once identified, it is
removed, and other mechanical defects in the heart wall,
such as an aneurysm, and/or valvular dysfunction are
corrected. When necessary, a coronary bypass operation is
also performed to improve the blood flow to the heart
muscle itself.
The results of the elctrophysiologically directed endo¬
cardial excision in the patients treated at Yale have been
very gratifying. No patients have had spontaneous sustained
ventricular arrhythmias after the operation. The Yale
surgical team had previously studied and reported their
experience w ith patients hav ing refractory ventricular arrhyth¬
mias and previous documented infarction, who were treated
by coronary bypass grafting and/or aneurysmectomy, as
well as correction of other mechanical defects when present.
In that group of patients, 19 of 26 long-term survivors
continued to have spontaneous recurrent ectopy after the
operation; the introduction of mapping-guided endocardial
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excision marks the only change in the surgical procedures
and has accounted for the aboliton of spontaneous recurrent
ventricular tachycardia in the recent group of patients.
Again, the operation is an intricate one and depends upon
close cooperation between the surgical and electrophysiological teams. The electrophysiologists record the map
obtained by the surgeons and interpret it on the spot, in
order to localize and remove the small mark in the heart wall
which is causing the runaway beats.
Within the last several years, critical but previously unrecog¬
nized metabolic functions of the pulmonary circulation have
been described. Dr. C.N. Gillis, professor of anesthesiology
and pharmacology, and his colleagues are studying the
physiological and pathophysiological roles of these processes.
The metabolic functions referred to are the uptake and
catabolism of vasoactive hormones and drugs by the
pulmonary microvasculature. In particular, we have studied
the fate of circulating vasoconstrictor hormones, including
catecholamines, 5-hydroxytryptamine and prostaglandins.
During their passage through the pulmonary microvascu¬
lature, many of these substances are removed to such an
extent that very little survives to reach the systemic circula¬
tion. Thus, it seems one function of the lung is to prevent
these potent vasoconstrictor hormones, which may be
released on the venous side of the circulation, from reaching
the systemic arteriolar bed, where they may have deleterious
effects.
Much of this metabolic activity is now known to occur in
endothelial cells of the pulmonary microvessels. Since these
cells are also know n to be injured early in disease processes
leading to acute respiratory failure, a current interest of Dr.
Gillis ’ laboratory is the measurement of these processes in
the intact animal, or in the patients, to determine whether
such processes are altered in advance of clinically detectable
Acute Respiratory Distress Syndrome (ARDS).
They have established that in experimental lung injury,
caused by high inspired oxygen tensions, endotoxin admini¬
stration or embolization, there is a diminished metabolic
capacity of pulmonary endothelial cells; furthermore, this is
evident at a time when no discernible morphologic change,
indicating injury, can be seen. At the clinical level, they have
also established that there is a significant decrease in the
ability of the pulmonary circulation to take up and metabolize
prostaglandins in patients suffering from acute respiratory
failure.
From this and related work, it may be possible to develop
methods for the early detection of the endothelial injury. If
successful, the latter effort may yield a method to predict
impending ARDS at a time when treatment of this very
serious and life-threatening situation may be initiated earlier
and therefore, be more effective.
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Research in the laboratories of Dr. Joan Steitz, professor of
molecular biophysics and biochemistry, and Dr. John
Hardin, associate professor of medicine (rheumatology) is
aimed at understanding the cause of systemic lupus erythe¬
matosus (SLE). A highly complex inflammatory disease
that strikes mainly young women, SLE often causes a skin
rash and arthritis, but may affect any organ.
Despite its clinical variability, the occurrence of anti¬
nuclear antibodies (ANA) has been recognized as a nearly
universal feature in virtually all affected patients. Although
there are many different types of ANA, they can each be
identified from the particular structures (antigens) to which
they bind. In recent years it has become increasingly
important to understand which types of ANA are present in
individual patients. Some of these antibodies, such as the
one known as anti-Sm, have extremely good correlations
with the diagnosis of SLE. Others, such as anti-native DNA,
have special roles in causing tissue injury. Since ANAs are
such a characteristic feature of SLE, it is reasonable to
believe that whatever mechanism leads to their production
has a great deal to do with the cause of lupus.
The work at Yale concentrates on understanding the
structural and biochemical features of the molecules that
become the targets for ANA. Their studies have demonstrated
that some of these antigens are located on the polypeptide
components of ribonucleoprotein particles that have roles in
gene expression. Others are located on segments of histones,
that are exposed within the structure of chromatin. Presently,
the investigators are looking for common denominators
among all of the many different components of the cell
nucleus that could explain why a relatively select group of
these structures begin to act as autoimmunogens in patients
with lupus. If these factors can be identified, they hope to
understand the cause of lupus. For similar reasons they are
also interested in understanding how the ANA found in SLE
compare with those found in patients with other rheumatic
diseases such as rheumatoid arthritis, drug induced lupus,
scleroderma, or inflammatory muscle diseases. Presently
each of these latter diseases appears to have its own
characteristic set of ANA.

THE SCIENCE OF CLINICAL EPIDEMIOLOGY

A new kind of medical scientist has been emerging over
the past decade, and they are already making their
mark on the quality of medical care service in this
country. At the mid-century, it had become evident
that health care delivery was becoming increasingly
complex and physicians were needed who were skilled
not only as clinicians but also had the analytical
capabilities to examine a broad range of health care
problems. In 1973, to meet this challenge, the Robert
Wood .Johnson Foundation established its Clinical
Scholars program.
Based on programs started in several medical schools
during the late 1960’s, it offers twenty young physicians
each year the opportunity for two years of graduatelevel study and research in non-biological disciplines
such as clinical epidemiology, law, economics or
behavioral sciences, which influence medicine and
health affairs. The Foundation currently funds six
such programs in medical institutions throughout the
United States. Some graduates of the program have
become involved in developing and managing a variety
of health care institutions and delivery systems; others
are contributing to the formulation, conduct and
evaluation of public policy issues in the health field.
Yale was one of the first schools to receive a grant to
establish a Robert Wood Johnson Clinical Scholars
Program, and it soon became recognized as one of the
leaders. As stated in the recruitment brochure, its
purpose is to “develop a new breed of investigative
scholarly clinicians concerned with challenges in the
strategies, delivery systems, and policies associated
with patient care.”
The four scholars enrolled each year come from a
variety of backgrounds and are either Board eligible or
Board certified physicians. Although they are encour¬
aged to maintain their clinical and patient-care interests,
it is expected that during the two-year program, their
primary interest will be the educational and research
activities of the program.
Dr. Alvan Feinstein, professor of medicine and
epidemiology, has been the program’s director since
the beginning. Regarded by colleagues and scholars
alike as a superb, provocative and demanding teacher,
he organized and formulated its basic philosophy, and
does a large share of its teaching.
The original goals for the Yale program included
plans for recruiting talented scholars; assembling
capable faculty; developing an effective core curriculum
in the methodology of research; providing suitable
attention to medically related issues of social science;
and supplying supervision, stimulation and assistance

to the scholars during the research portion of the
program. The basic mechanisms for accomplishing
these goals were set in place when the program began
in 1974, and most of them have been maintained with
relatively few substantial changes, according to Dr.
Feinstein.
The curriculum for the program includes a core
course in quantitative clinical epidemiology for the
first year scholars, and seminars in health policy and
delivery conducted by invited lecturers as well as by the
faculty, for both first and second year scholars. These
seminars cover a wide range of subjects such as health
manpower legislation, various facets of medical ethics,
malpractice, and the economics of medicine. Scholars
are also encouraged to take selected elective courses
offered in the Department of Epidemiology and Public
Health, the Child Study Center, the Institution for
Social and Policy Studies and the Law School. The
second year is devoted almost entirely to the design
and completion of an original independent research
project, using skills developed in the program.
Clearly the clinical epidemiology course is the
keystone of the Yale Clinical Scholars Program.
Developed by Dr. Feinstein specifically for the scholars
to provide them with the skills necessary for managerial
decisions of patient care and other activities in the
delivery of health care and in health policy, it has since
served as a model for programs in other medical
schools, and a Clinical Epidemiology Section was
established at the annual joint meeting of the American
Federation for Clinical Research, American Society
for Clinical Investigation and the Association of
American Physicians.
The principle of clinical epidemiology is the applica¬
tion of basic science and epidemiologic research tech¬
niques, and when appropriate, economic and sociologic
data skills, to areas that are of primary concern to
clinicians. The course consists of four main components:
data processing, computer orientation, research design,
and biostatistics. It has proven to be a highly effective
way to provide clinical scholars with critical exposure
to the general methods of epidemiology, biostatistics
and computers, while at the same time, developing new
methods of evaluating and advancing specific aspects
of the conventional methods that are pertinent to their
clinical concerns.
“To my knowledge, the Yale program is the one that
focuses most clearly on the original purposes of the
Robert Wood Johnson Foundation, which is to train
academicians and investigators in the techniques of
clinical research,” said Dr. James F. Jekel, C.E.-A.
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Winslow Professor of Public Health, who has been on
the Clinical Scholars Program faculty since 1975.
“There had been no clear track for people who wanted
to do clinical research. For the most part, they
stumbled into it either by working in a research
laboratory, or by taking part in an epidemiologic study
in a school of public health, and then making the
transition to clinically oriented techniques.”
Traditionally, it had been thought that clinical data
couldn’t be used for science unless they were quantita¬
tive. “One of Dr. Feinstein’s most significant contribu¬
tions to medical science has been to insist that clinical
phenomena and clinical data are scientifically very
important, and he has demonstrated this in a number
of studies, such as those he conducted on the prognosis
of cancer patients and patients with a history of
rheumatic fever,” according to Dr. Jekel.
Dr. John Leventhal, associate professor of pediatrics
and the Child Study Center, recently received a grant
from the Robert Wood Johnson Foundation to study
the effects of home glucose monitoring on diabetic
children and their families. A graduate of Tufts School
of Medicine, he trained in pediatrics at Yale for three
years before entering the Clinical Scholars Program in
16

1976 to further his interest in doing research in
childhood behavioral problems, child abuse and chronic
childhood illness. He has received several grants for
research projects in these areas since completing the
program. The disciplines and skills he acquired as a
scholar have enabled him to design more effective
protocols for these studies, he said, especially in areas
such as choosing patient populations and formulating
research strategies.
But the program isn’t only tailored to those interested
in clinical research. Dr. Lolita M. McDavid is a second
year scholar interested in health policy and planning
administration. “It was made very clear to me when I
was interviewed for admission that the strength of this
program is in clinical epidemiology,” she said, “but 1
decided that the kind of skills 1 would learn here would
serve me in better stead than would programs in other
schools that were strong in health policy.”
The w ife of a bank vice-president and mother of a
three-year-old daughter, she describes herself as a
“bent arrow” who received a B.A. degree in political
science and history, an M.A. degree in public admini¬
stration, and who worked as an administrator for
several years before entering Case Western Reserve
University School of Medicine in 1975. She was a
resident pediatrician at The Cleveland Clinic Founda¬
tion when she applied to the Robert Wood Johnson
Clinical Scholars Program.
“This program gives you a very solid background in
making your point,” she explained. “For instance,
most people in health policy and planning have
backgrounds in sociology, or psychology, or public
health. They often have difficulty in firming up their
plans because they don't have the tools. You get those
tools in this program.”
Although the scholars come from a variety of
backgrounds and have interests as diverse as religion
and ethics, and health policy and planning, most have
had experience in the real world of medicine. Returning
to an academic environment has rewards and a few
frustrations.
“It’s a radical change from residency, where one
tends to work 100 hours a week and is entirely
immersed in patient care,”admitted Dr. Dale Matthews,
a first-year scholar whose interests are rooted in
medical ethics and physician-patient relationships. A
cum laucle graduate of Princeton University where he
majored in romance languages, he received his M.D.
degree from Duke University and did his internship
and residency in medicine at the University of Connect¬
icut Health Center. “The balance here is completely
different. I see patients one or two half-days a week,
and do some teaching of nursing and medical students,
but its quite a change from my previous medical
experiences. In many ways, the first year is like going
back to college, in that course are structured, there are
assignments, and then there is time for reading and
reflection.”

Dr. Leventhal mentioned it, and others have con¬
firmed that designing and completing the research
project is perhaps the most difficult part of the two
years. “It’s a curious paradox. The program is very
structured during the first year, yet at the same time,
we are expected to develop a research project primarily
on our own.” Dr. Matthews explained. “I have found
that among our own group, each of us is his own worst
enemy
pushing himself harder than our instructors
are pushing us. To decide what we want to investigate,
and then do it without anyone telling us we have to do
it, or how we must do it, or whento do it, is an
important step in our careers that is unlike anything in
medical school or residency training.”
Through the ten years of the Yale Clinical Scholars
Program a camaraderie has been established not only
between scholars in the same year, but between all
graduates of the program. Underlying this is a sense of
gratitude for the opportunities the course offers, as
well as a sense of respect for the faculty and their
values. Often mentioned are Dr. Ralph Horwitz, co¬
director of the program, who was one of its first
graduates, and is now head of the Section of General
Medicine, Dr. Jekel, the assistant director, and Dr.
George Silver and Carolyn Wells, who have been with
the program since it began. Dr. Feinstein, though, merits
their special admiration.
“I compare this program to the Harvard Business
School,” said Dr. McDavid. “They recruit people who
are good, and then give them skills that others in their
field don’t have. They also give them the imprint of
being Harvard Business School graduates, and for the
most part, they excel,” she explained. “In the same
way, the Yale Clinical Scholars leave here with the
skills and the tools, as well as with a built-in support
system of having Yale and the Robert Wood Johnson
Foundation behind them.”

Dr.

Jekel,

center,

leads

a

discussion

in

quantitative

clinical epidemiology. Dr. Matthews is seated at the far right. Because
classes are small, there is opportunity for indepth discussion of topics
introduced in this first-year Clinical Scholars course.
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HERE AND ABOUT

NEW DIRECTOR APPOINTED
FOR CANCER CENTER
Dr. Alan C. Sartorelli, chairman of
the Department of Pharmacology,
and a leading cancer investigator, has
been appointed director of the Yale
Comprehensive Cancer Center. Dr.
Sartorelli, who is head of the Develop¬
mental Therapeutics Program of the
Center, has been its deputy director
since 1982. He succeeds Dr. Jack W.
Cole, Ensign Professor of Surgery,
who has been director since 1978.
“We are looking forward to continu¬
ing our work in areas of cancer
research and patient care as well as
serving the needs of the people of
Connecticut,’’said Dr. Sartorelli. “The
Yale Comprehensive Cancer Center
is one of 20 Comprehensive Cancer
Centers in the country, as designated
by the National Cancer Institute.
One of Yale's unique strengths is the
Department of Pharmacology, which
develops new drugs or drug combina¬
tions to be used in treating cancer.
These new therapies are rapidly moved
into clinical practice through sections
such as Medical Oncology, where
patients are being treated with some
of the most advanced drugs,” he
explained. “Another important pro¬
gram of the Cancer Center is the
Department of Therapeutic Radio¬
logy, headed by Dr. James J. Fischer,
which combines basic research in
radiobiology and radiologic physics
with radiotherapy in one of the best
and most advanced treatment pro¬
grams in the nation. The Center also
serves as the focal point for cancer
information and education through¬
out the State by interacting with
community organizations, such as
the American Cancer Society, hospi¬
tals, physicians, nurses, social workers,
dieticians, and the general public.”
Dr. Sartorelli, who received his
Ph.D. in biochemical oncology from
the University of Wisconsin, has been
a member of the Department of
Pharmacology at Yale since 1961; he
was promoted to professor in 1967,
and named chairman of the Depart¬
ment in 1977. The author of over 400
publications, he isexecutive editor of
Pharmacology and Therapeutics and
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regional editor for the American
continent of Biochemical Pharma¬
cology. He has been a director of the
American Association for Cancer
Research, a member of the Board of
Scientific Counselors of the Division
of Cancer Treatment of the National
Cancer Institute, and a member of
the Council for Analysis and Pro¬
jection of the American Cancer
Society.
In addition to Dr. Sartorelli’s
appointment, Marion E. Morra,
communications manager, has been
named to the new position of assistant
director of the Cancer Center. Dr.
Joseph R. Bertino, chief of the Section
of Medical Oncology, and Dr.
Sherman M. Weissman, professor of
human genetics, medicine and molecu¬
lar biophysics and biochemistry, and
head of the Molecular Virology Pro¬
gram at the Center, will continue in
their present positions as the Center’s
associate director for clinical science
and associate director for basic
science, respectively.

Dr. Manuelidis

TWO ON FACULTY RECEIVE
AWARDS FOR RESEARCH IN
THE NEUROSCIENCES
Dr. Pasko Rakic and Dr. Elias
Manuelidis are among the first re¬
search scientists to receive the Javits
Neuroscience Investigator Awards of
the National Institute of Neurological
and Communicative Disorders and
Stroke (NINCDS). The award,
passsed by a 1984 Act of Congress to
honor Senator Jacob K. Javits of
New York, recognizes NINCDS grant¬
ees who have achieved a distinguished
record of contributions in the field of
neurological and communicative
sciences, and who can be expected to
be highly productive over the next
seven years.
Dr. Rakic, who is the Dorys
McConnell Duberg Professor of
Neuroscience and chairman of the
Section of Neuroanatomy, received a
grant of $1,500,000 for seven years
for research on the neurogenetic pro¬
cesses in the fetal brain. A leading
scientist in brain research, he is best
known for his investigation of neuro¬
nal maturation, as well as for research
on the development of the visual
system and cerebellum in primates.
His work has important implications
for investigation of the interaction of
genetic and environmental factors
governing human behavior and intelli¬
gence, as well as for understanding
neurological diseases. A native of

DR. BARRON TO BE HONORED

Dr. Rakic

Yugoslavia, he came to Yale in 1978
from the Harvard Medical School,
where he had been on the faculty
since 1972.
N1NCDS awarded Dr. Manuelidis,
professor of neuropathology and
neurology, almost $ 1,200,000 for seven
years to continue his well-known
research on Alzheimer’s disease. Inter¬
nationally recognized for his studies
of dementias. Dr. Manuelidis and his
colleagues are among a small group
of scientists working on the hypothesis
that Alzheimer’s disease is caused by
a slow-virus of the type recovered
from brain tissues of victims of the
fatal but rare form of dementia,
Creutzfeldt-Jakob disease. Their work
involves comparison of the mecha¬
nisms and progress of CreutzfeldtJakob disease in laboratory animals
with changes seen in patients with
Alzheimer’s disease and other forms
of senile dementias, in an attempt to
understand the course, and eventually,
the cause of the disorders. A native of
Greece, Dr. Manuelidis was director
of the Pathological Anatomical Labo¬
ratory of the German Research Insti¬
tute of Psychiatry, Section of Brain
Pathology at the Kaiser Wilhelm
Institute before coming to the United
States and to Yale in 1951.

A symposium in obstetrical physi¬
ology will honor Dr. Donald H.
Barron, professor emeritus of physi¬
ology. Sponsored by the University
of Florida College of Medicine De¬
partments of Obstetrics and Gyne¬
cology and Continuing Medical Edu¬
cation, it will be held on April 1 I to
13 in Kissimmee, Florida.
Dr. Barron was one of the first to
recognize that an understanding of
the principles of physiology as they
apply to the process of human repro¬
duction is the foundation of the clinical
practice of obstetrics. He devoted his
professional career to the study of the
basic aspects of reproductive physi¬
ology, and his scientific contributions
to the field are widely recognized.
Through his teaching and his research,
he has been responsible for many of
the important basic contributions to
the field during the past 25 years.
Dr. Barron started his career at
Yale as a teaching fellow from 1929
to 1932. He returned in 1939 as a
Sterling Fellow and in 1943, he was
appointed associate professor of
physiology. He was a professor of
physiology from 1947 until his retire¬
ment in 1969.

EDUCATIONAL FUND
ESTABLISHED
IN
THERAPEUTIC RADIOLOGY
The Daniel S. Kapp Educational
Fund for Therapeutic Radiology has
been established by a gift from Mr.
and Mrs. Gordon B. Tweedy of Brew¬
ster, New York. Mr. Tweedy is a
member of the Class of 1929 at Yale
College and received his law degree
from the Yale Law School in 1932.
The Fund which honors Dr. Daniel
S. Kapp, associate professor of thera¬
peutic radiology, will establish a per¬
manent endowment, the income from
which will be used to bring distin¬
guished scientists and clinicians to
Yale as visiting lecturers in the field
of therapeutic radiology. It is antici¬
pated that there will be several visiting
lectureships each year.
“We are extremely grateful to Mr.
and Mrs. Tweedy for establishing
The Daniel S. Kapp Educational
Fund at Yale,’’said Dr. James Fischer,
professor and chairman of the Depart¬

ment of Therapeutic Radiology. “One
of the major needs of our department
has been a source of funds to bring
outstanding individuals to Yale to
lecture in the field of therapeutic
radiology. The need has been met by
this generous gift which honors our
colleague, Dr. Kapp.
The Yale Department of Thera¬
peutic Radiology has established a
reputation worldwide for leadership
in research, patient care and teaching.
One of the first departments in the
United States to be designated in
1960 by the National Cancer Institute
as a radiation therapy-radiobiology
research center, it has continued to
make major contributions to improved
treatment methods used in radiation
therapy centers throughout the coun¬
try, including the Hunter Radiation
Therapy Center at Yale, which is one
of the largest and most up-to-date in
the U.S.
Dr. Kapp received his B.S. and
M.S. degrees in physics from Poly¬
technic Institute in New York, and
his Ph.D. and M.D. degres from
Stanford University. He was a resident
in therapeutic radiology at the Stan¬
ford University Medical Center from
1973 to 1976, when he was appointed
assistant professor of therapeutic
radiology at Yale. In 1980, he was
appointed chief of Gynecologic Radi¬
ation Therapy, and in 1982, he was
promoted to associate professor. Dr.
Kapp returned to Stanford University
School of Medicine in January as
associate professor in the Division of
Radiation Therapy.
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NEW HAVEN COUNTY MEDICAL
ASSOCIATION CELEBRATES
ITS BICENTENNIAL
By David Musto, M.D.
The New Haven County Medical
Association came into being just
months after the Definitive Treaty of
Peace was signed with Great Britain
in September 1783. Called together
at the historic coffee house on the
east side of the Green in New Haven
(where the post office now stands),
the Association was formally oganized
on January 5, 1784 and chose as its
first president. Dr. Eeverett Hubbard,
a man destined in 1792 to become the
first president of the Connecticut
State Medical Society.
Dr. Hubbard spoke to the Associa¬
tion on February 2, 1784 in a brief
statement which encompassed much
of medical philosophy and the practice
of medicine. He pointed out that
although we are all the same as
regards the parts of our bodies, we
differ greatly in temperament, and
this difference in personality must be
taken into account by the physician.
This sensitivity to the patient’s needs
is the theme which was emphasized at
the bicentennial convocation on
March 22. Dr. Hubbard concluded
his observations by expressing the
hope: “May the blessings of heaven
ever attend this society, that peace,
brotherly love and knowledge in the
art of healing may flourish so as to

exceed any of the renowned societies
of the same denomination in Europe.”
Whether the New Haven County
Medical Association has exceeded all
the renowned societies of medicine in
Europe may be open to dispute, but
that later members of the society did
indeed distinguish themselves in the
development of medicine, there is no
disagreement. One of the members.
Dr. Jonathan Knight (1789-1864) was
a leader in the formation of the
American Medical Association in the
middle of the last century, and Dr.
Worthington Hooker (1806-1867) is
now recognized as a major pioneer in
the field of medical ethics with his
sensitive analyses of the mutual rights
of patient and physician. Dr. Hooker
was also a prolific author of children’s
textbooks on science and nature, and
one of New Haven's elementary
schools is named after him.
Furthermore, members of the
County Society were among the
founders in 1810 of The Medical
Institution of Yale College, and exer¬
cised authority over the School jointly
with Yale College until 1884.The
distinguished history of the County
Association is preserved in records
which exist without a break back to
the first meeting in 1784. An extensive
exhibit on its history, displaying many
of the Association’s and Yale’s
treasures in the history of medicine is
on view in the Yale Medical Library
until June.

Dean Robert Berliner held a reception on February 2 in honor of the New
Haven County Medical Association's centennial celebration. Dr. Theodore
/.anker, right, is president of the Association.
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PROGRAM FOR HUMANITIES
IN MEDICINE
The School of Medicine recently
received a grant from the Connecticut
Council for the Humanities in support
of a new program for humanities in
medicine. Directed by Dr. Howard
M. Spiro, professor of medicine, the
program is presenting a series of
twelve semi-monthly lectures through¬
out the spring and fall to bring to¬
gether scholars in the humanities and
members of the medical profession in
discussions about the influence of the
arts and letters on medicine and
health.
Speakers include Dr. Robert Coles,
professor of psychiatry and medical
humanities at Harvard University;
Arnold Rampersad, professor of
English at Rutgers University; Arthur
Caplan, associate for the humanities
at the Hastings Center; and Dr. Martin
Carey, associate professor of medi¬
cine, physiology and biophysics at
Harvard University. They will discuss
topics as diverse as the physician as a
writer; the effects of health and well¬
being on art and visa versa; ethical
issues in organ transplantation, and
creativity and illness.
The purpose of the series, according
to Dr. Spiro, is to encourage medical
students and professionals to expand
their definitions of health and disease
through a better understanding of
the cultural and intellectual influences
on health and well-being, as well as to
stimulate scholars in the humanities
to take a greater interest in health
related issues. The lectures are open
to the public without charge.

FACULTY NOTES
Dr. Luke Kitahata received a fellow¬
ship from the German Academic
Exchange Service for collaborative
research with Professor Manfred
Zimmerman of the University of
Heidelberg. They have conducted a
study of the effects of microinjection
of morphine sulfate in the brainstem
on dorsal horn neurons of the lumbar
spinal cord, and clarified some of the
important mechanisms of morphine
analgesia. Dr. Kitahata, professor of
anesthesiology, was chairman of the
Department from 1973 to 1982.
The American College of Physicians
has awarded the Willard O. Thompson
Memorial Traveling Fellowship to
Dr. Caroline Riely, associate professor
of medicine and pediatrics, for re¬
search on liver disease in children.
She will spend six months at l’Hopital
d’Enfants in Bicetre, France studying
biliary artresia, a liver disease attri¬
buted to arrested fetal development,
which has an unusually High incidence
in the Bicetre area.
The Japan Society for the Promotion
of Science has awarded a research
fellowship to Dr. Ethan Nadel, asso¬
ciate professor of epidemiology (envi¬
ronmental health) and physiology.
As a fellow. Dr. Nadel will spend a
month in Japan for discussion and
observation, as well as to deliver
lectures and participate in seminars.
Dr. Nadel, who is an associate fellow
of the John B. Pierce Foundation
Laboratory, is known for his studies
on factors contributing to the regula¬
tion of the circulatory system in
humans under stressful conditions
such as heat or exercise.
Dr. John Hobbins, professor of ob¬
stetrics and gynecology, has been
elected vice-president of the American
Institute of Ultrasound in Medicine.
The chief of the Section of Peri¬
natology at Yale-New Haven Hospi¬
tal, he has played an important role
in the devlopment of ultrasound as a
tool for perinatal diagnosis and for
the monitoring of fetal growth and
development. Dr. Frederick Kremkau,
associate professor of diagnostic
radiology has been elected to the
board of the American Institute of
Ultrasound in Medicine.

Dr. Alan Gurwitt has been appointed
to the editorial b,oard of the Inter¬
national Journal of Psychoanalytic
Psychotherapy. Co-editor of “Father
and Child: Developmental and Clinical
Perspectives”(Little,Brown), he is an
associate clinical professor of psychi¬
atry (Child Study Center.
The National Academy of Practice in
Social Work has elected Audrey
Naylor, a Distinguished Practitioner.
An assistant clinical professor in the
Child Study Center, Ms. Naylor is
the author of two books and numerous
articles on social work. One of nine
academies representing various as¬
pects of health care, the National
Academy of Practice in Social Work
was founded recently by leaders in
that field.
At the 93rd meeting of the Horace
Wells Society, honoring the discovery
of anesthesia in the United States,
Dr. Paul Barash was presented the
Award of Merit for outstanding con¬
tributions to the field. Dr. Howard
Smith, ‘53, clinical professor of sur¬
gery and president of the society,
presented the award, following
opening remarks by the chairman of
the board of trustees. Dr. Wilbur
Johnston, ‘37. Dr. Barash, who is
professor and chairman of the Depart¬
ment of Anesthesiology, delivered a
talk on “Cocaine in America: 1984.”
Dr. Leonard Kaplow has been elected
president of The Histochemical
Society and will assume office in
April. He is professor of pathology
and laboratory medicine, and chief
of Laboratory Service at the Veterans
Administration Medical Center in
West Haven.
Dr. Paul H. Duray, instructor in
pathology, presented a talk on “Pa¬
thology of Synovitis in Lyme Disease”
at the meeting of the International
Academy of Pathology, held in San
Francisco in February.

NEW BOOKS BY FACULTY
“Hypothesis and Evidence in Psycho¬
analysis.” Marshall Edelson, M.D.,
Ph.D., professor of psychiatry. Uni¬
versity of Chicago Press (Chicago)
1984.179 pp.
“Perinatal Epidemiology.” Michael
B. Bracken, associate professor ad¬
junct of research in epidemiology
and obstetrics and gynecology. Oxford
University Press (Oxford) 1984. 500
pp, illus.
Surgery of the Skull Base.” Clarence
T. Sasaki, M .D., professor of surgery ;
(otolaryngology); Brian F. McCabe,
M.D.; and John A. Kirchner, M.D.,
professor of surgery (otolaryngology).
J.B. Lippincott Company (Phila¬
delphia) 1983.
“Divorce and Your Child.” Sonja
Goldstein, LL.B., Lecturer, Child
Study Center, and Albert J. Solnit,
M.D., Sterling Professor in the Child
Study Center, Pediatrics and Psychi¬
atry. Yale University Press (New
Haven)1983. 160 pp.
“Comprehensive Surgical Atlases in
Otolaryngology and Head and Neck
Surgery.” K.J. Lee, M.D., editor-inchief, assistant clinical professor of
surgery (otolaryngology). Gruneand
Stratton (New York) 1983. 5 volumes,
including: “The Atlas of Head and
Neck Surgery.”Bruce W. Jafek, M.D.,
and Clarence T. Sasaki,
pro¬
fessor of surgery (otolaryngology);
“The Atlas of Cleft Lip and Cleft
Palate Surgery.” Howard W. Smith,
M.D., D.M.D., clinical professor of
surgery; and “The Surgical Atlas of
Otology and Neuro-otology.” Eiji
Yanagasawa, M.D., clinical professor
of otolaryngology.
The fourth edition of “Principles of
Surgery”, published by McGraw-Hill
Book Company (New York) is dedi¬
cated to Dr. Edward H. Storer, one
of the associate editors, “Whose con¬
tributions to surgical physiology and
education constitute a lasting legacy.
Whose efforts related to ‘Principles
of Surgery’ contributed significantly
and eased the editorial process
throughout the production of four
editions.” Dr. Storer, professor of
surgery and associate dean, died in
February 1983.
21

ALFRED GILMAN, Ph D.
Dr. Alfred Gilman, an internationally
recognized medical scientist, author
and authority in the field of pharma¬
cology, died suddenly at his home in
New Haven on Friday, January 13,
1984.
He was born in Bridgeport, Con¬
necticut on February 8,1908 and in
his 75th year was actively engaged in
writing and in lecturing at Yale and
in numerous advisory capacities. After
graduating from Yale College in 1928
and being awarded a Ph. D. degree in
biochemistry from Yale University in
1931, he served as a research fellow
and, from 1935, as assistant professor
of pharmacology and toxicology at
Yale until he left for Army service in
1943. He served as chief of the Pharma¬
cology Section of the Medical Division
with the rank of major.
In 1946, he was appointed to an
associate professorship in pharma¬
cology in the Columbia University
College of Physicians and Surgeons
in New York City, and became a full
professor there in 1948. He held this
position until 1956, when he accepted
the chairmanship of the Department
of Pharmacology at the newly estab¬
lished Albert Einstein College of
Medicine in New York City. There he
also served as associate dean for
graduate studies. On his retirement
from this position in 1973, Dr. Gilman
and his wife returned to New Haven,
where as a professor emeritus from
Albert Einstein College of Medicine,
he volunteered his services to teach in
the Yale School of Medicine.
With the title of lecturer in pharma¬
cology, he taught with singular effec¬
tiveness until his death. Indeed, on
the very day he died he was to have
delivered the concluding lecture in
the pharmacology course, a lecture
devoted to an overview of drug
therapy, past-present-and future,
which he was uniquely qualified to
deliver and which had become some¬
thing of an annual event — awaited
eagerly by students and faculty alike.
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All recognized his great stature in the
field and his ability to captivate his
audience by wisdom, force of argu¬
ment, and obvious dedication to the
discipline of modern pharmacology
which he had done so much to develop.
His ability to fire the enthusiasm of
the medical students and young
doctors for the rational use of thera¬
peutic drugs was remarkable. But
this was only one facet of his many
contributions to medicine.
Dr. Gilman's most influential con¬
tribution to medical science was his
authorship in collaboration with Dr.
Louis S. Goodman, of a landmark
textbook, first published in 1941,
that was to revolutionize the teaching
of pharmacology and the perspective
of generations of physicians. This
text. The Pharmacological Basis of
Therapeutics, was at once recognized
as an astonishing tour de force. It not
only presented a treasury of pharmaco¬
logical facts, but it organized these
within a novel framework where they
were interwoven, in a unique manner,
with current biochemical and physio¬
logical knowledge and with patho¬
physiological and clinical concerns
so that the whole provided a refresh¬
ingly rational basis for drug therapy.
One reviewer, in 1941, surely echoed
the general view when he wrote that
the text was “the kind of work that
might have been the fruit of the
collaboration of a team of authors,
and it is difficult to think how two
men did it.” From today’s perspective,
with this now classic textbook soon
to enter preparation for the seventh
edition
and long since “multiauthored”
the accomplishment is
even more remarkable and the great
impact of the work on the field of
pharmacology and on clinical medi¬
cine is universally acknowledged.
In addition. Dr. Gilman contributed
importantly in several fields of bio¬
logical experiment. His early studies
illuminated the osmotic relation be¬
tween blood and body fluids and led
him, eventually, to a series of out¬
standing works on renal pharmacol¬
ogy. In the interim, in the I940’s, he
published extensively and authori¬
tatively on the newly developed organo¬
phosphorous anticholinesterases, and
with his colleague, Louis Goodman,
was responsible for the clinical intro¬
duction, in 1946, of the first effective
cancer chemotherapeutic agent, nitro¬
gen mustard.

He also served at the national level
as a valued consultant and advisorto
various governmental agencies and
committees, as well as to industry
and many private foundations. Thus
he played a key role in governmental
review of drug efficacy, serving
notably on the Drug Research Board
of the National Academy of Sciences,
of the National Research Council,
from 1963 to 1972, latterly as
chairman.
Dr. Gilman received many honors
as a result of his remarkable profes¬
sional achievements and contribu¬
tions. He was elected to the presidency
of the Society for Pharmacology and
Experimental Therapeutics (1960) and
to membership in both the American
Academy of Arts and Sciences and
the National Academy of Sciences,
and he was awarded the degree of
D.Sc. from Dartmouth in 1979.
Alfred Gilman’s great stature and
authority in the field of pharamcologv
never eroded his modest character
nor the gentleness, patience and under¬
standing with which he advised and
encouraged the many who sought his
help. A revered teacher, colleague
and friend has been lost, but the
splendid influences of the man on so
many aspects of medicine will persist.
Dr. Gilman is survived by his wife,
the former Mabel J. Schmidt of
Bridgeport, whom he married in 1934,
by two children. Dr. Alfred G. Gilman,
chairman of the Department of Pharmacology. University of Texas Health
Science Center at Dallas, and Joanna
Gilman Feins of Hingham. Massa¬
chusetts, and by five grandchildren.
W.W.D.
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The Alumni in Medicine Column
Notes from the President
Nicholas PR. Spinelli, M.D.
It’s cool and comfortable in Howard
Levitin’s office on this suffocatingly
hot August day. The Office of Student
Affairs, 1983, is quiet and free of the
usual noise and bustle during this
holiday period. I glimpse Dean Betsy
Winters at her desk,her door always
open, as I cross the foyer into Dr.
Levitin’s office.
I try to recall the administrative
wing of 1943 when I was a student.
Was it “suffocatingly hot” in those
days before air-conditioning? My
memory fails at recollection; it rejects
the recall of discomfort and distress,
a guileful trick of senescence. 1 have
passed the door which belonged to
Miss Dasey who, unappointed, was
the student-advocate-confidante of
my day. Was she indeed unappointed,
serendipitous in this role? 1 do not
know. She was the Registrar in an
immensely simpler administrative
structure, in an immensely simpler
time. Her eyes twinkled. It felt good
to talk with her. Dean Winter’s role
is, indeed, more structured and de¬
fined. But like Miss Dasey, her per¬
formance has become a legend among
medical students of her time. “She
can do anything. Bring her the most
incredible idea or problem. She comes
up with a solution.” “She’s the most
compassionate, sensitive person you
could know. She listens.”
Dr. Levitin’s office is unpretentious
and functional, as pragmatic as the
dozens of daily dialogues with students
must be. The pictures of the student
body are prominent on his office
wall. It reveals this man’s concern for
each student for whom the Yale
School of Medicine bears educational
responsibility. Howard is the common
pathway through which flows informa¬
tion concerning the needs, the prob¬
lems, the progress of every medical
student at Yale. The story of him and
his team, of the multifaceted mission
of the Office of Student Affairs was
reported in Yale Medicine in the
winter of 1980.
Hiscommentsare punctuated with
the names of his colleagues as we
speak of the students of this and the

last decade, each touched by the
unique stresses of their time: Betsy
Winters, Jim Comer, Pam Nyiri, Lil
Dalton, Tom Lentz, and Alan Mermann. Each of them interfaces with
the entire student body, and as filters
they offer assistance to the academi¬
cally or otherwise troubled student.
The appropriate team member is
available to Dean Levitin should a
problem require consultation. Curricu¬
lum, clerkships, the thesis, electives,
student evaluations, residency, and
financial aid
all grist for the mill of
communication, the final denominator
which brings a student to the Office
of Student Affairs, the department
that Dr. Levitin heads.
He is thoughtful and ruminative as
he reviews his experience since the
late 60’s when he assumed the role
from Dr. Thomas Forbes, himself
beloved of students of the decade
before, the communicator of the fifties.
“Perhaps the most challenging
and rewarding part of my job is
helping students ad just to the intellec¬
tual challenge of the “Yale System”
and the psychological stresses of
medicine. Anxiety, the companion of
medical students from time immemo¬
rial, is a constant presence. For today’s
students, medicine is more complex
than it was in the past. The knowledge
explosion, the changing image of the
physician, major financial problems
and many new and different career
opportunities are ever present. They
come to school with the highest ideals
and slowly realize that they will have
to make adjustments. All students
tend to go through this matamorphosis, but the additional change from
layman to physician is an additional
burden for our students.”
Howard Levitin came to Yale as a
fellow in metabolism in 1956 (one of
the salt/water boys of the post-Peters
era). I remember him coming to give
CME lectures on “salt and water”at
my community hospital 20 miles away,
our Yale faculty consultant. His
student affairs role emerged a decade
later and has grown to its present
status. “I was from New York but

went to Southwestern Medical School
in Dallas,” he recalls. “It was tradi¬
tional, not as emotionally binding as
Yale. We had a Miriam Dasey .... a
Betsy Winters .... her name was Ann
Rucker.” One readily perceives New
Haven, not Dallas, dominates the
commitment of this man today. What
1 hear as I talk to him is a description
of student development in this modern
time of vastly increased knowledge
and technology, a more stressful
reality than we older alumni knew.
“We ask that they be mature in their
crises, but they are as scared as we
were,” notes Dr. Levitin. “What did
we do, how did we cope in our less
stressful time?” 1 ask myself. And my
answer seems valid; that during World
War II the forced communality of life
of the 40's (Company C, Yale Unit,
Howard Avenue) forced us to be our
own support system. We turned the
absurd pressure of that time, the war,
into a form of catharsis, sharing,
interpersonal challenging which
helped disperse anxiety. Our emo¬
tional needs and conflicts were dealt
with in an ad hoc fashion, with no
structured system. Today’s support
system must be thoughtfully struc¬
tured to meet this essential need. It is
one of many megabudget medical
school items.
My nagging notion that somehow
as alumni, we might be of help to the
students with this same process of
emotional support, through commun¬
ication as alumni, continues to fail to
materialize. Neither students nor
alumni, in the end, have the time
which can be structured socially to
achieve this end. Yet I am continually
amazed by how extraordinarily grati¬
fied those students would be to share
the fact that there is a universality
about student anxiety, no matter
what the time setting, that the pain of
today’s suffering to acquire personal
achievement dissipates with the heal¬
ing touch of time.
“Those of you who have been
there, who are there, can describe the
directions which we are still not able
to see. Direction is what we need.”
He is an eager, earnest, third year
student who is interested in plastic
surgery. 1 can easily arrange an appoint¬
ment with an experienced, practiced
plastic surgeon I know. As alumni,
we can be of help in many such ways.
We must continue to pursue the
means to do so.
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CLASS NOTES

1925
Our appreciation to Paul Saffo (’33)
for sending us news about Howard
Wood who resides in Torrance, Cali¬
fornia. Dr. Wood left private practice
12 years ago, but retired just last
September when he resigned his posi¬
tion as physician for the Torrance
Unified School District. He became
90 in January, and in addition to a
birthday celebration by the students
of the Howard A. Wood Elementary
School, he was honored by the Tor¬
rance Kiwanis Club for four decades
of community service. As noted in an
article in the local newspaper, “Daily
Breeze”, he is probably best remem¬
bered as the motivating force behind
the creation of an independent city
school district for Torrance almost
40 years ago.”
1932
“Health Care in China”, an AMSA
study tour of the People’s Republic
of China, June 19 - July 7, will be led
by Myron Wegman. The American
Medical Student Association is spon¬
soring this as a part of its medical
education program. Dr. Wegman,
dean-emeritus of the University of
Michigan School of Public Health, is
president of the American Association
for World Health. His connections
with China began in 1972, when he
chaired a Conference on Public Health
in the People’s Republic of China,
co-sponsored with the Center for
Chinese studies and the Josiah Macy
Foundation, and was co-editor of the
book that resulted from the confer¬
ence. As a member of the National
Academy of Sciences-sponsored
Committee on Scholarly Exchange
with the People’s Republic of China,
he was a member of the first medical
delegation to the People’s Republic
of China, in 1973. Dr. Wegman was
appointed to the Committee on Advaned Study of China in 1978 and
visited China again with the CASC
subcommittee in 1979 to arrange
long-term placement for the first
group of Americans to do advanced
study and research in China since the
establishment of the People’s
Republic.
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1933
Robert Huntington spoke at the
Fourth International Conference on
Coccidioidomycosis held in San Diego
in March. His address entitled “A
Modern View of Coccidioidomycosis
From a Personal Historic Perspective”
was one of the highlights of the
scientific program. The conference
was organized under the auspices of
the American College of Chest
Physicians.
1938
Announcement was received in Febru¬
ary that Charles Petrillo has moved
from New Haven to new offices in
Guilford, Connecticut for the practice
of ear, nose and throat diseases.
1953
William Whalen is president of the
newly organized Connecticut Peer
Review Organization (CPRO). Unlike
most physician review programs,
CPRO includes representatives of
both the providers (physicians and
facilities) and the payors (business,
industry and insurance carriers). Dr.
Whalen is also president-elect of the
Connecticut State Medical Society
and is currently chief of the medical
staff at Windham Community Memo¬
rial Hospital in Windham, where he
practices surgery.
1954
In October Robert Joy gave the
eighth annual Joseph Garland Memo¬
rial Lecture of the Boston Medical
Library. Dr. Joy, professorand chair¬
man of medical history at the Uni¬
formed Services University of the
Health Sciences, spoke on “Health
Reform in Nelson’s Royal Navy.”
The lecture honors the memory of
Dr. Joseph Garland, who was editor
of The New England Journal of
Medicine from 1947 to 1967.

1958
Michael Kashgarian is currently
serving as president of the Yale-New
Haven Hospital Medical staff.
1960
Festus Adebonojo, professor of pedia¬
trics at Cornell University Medical
College, has been named professor
and chairman of the Department of
Pediatrics at Meharry Medical College
School of Medicine in Nashville,
Tennessee.
1968
John Ogden, who has been on the
faculty at Yale since 1972, has been
appointed professor of orthopedic
surgery at the University of South
Florida College of Medicine in
Tampa.
1969
Lee Jampol, professor of ophthalmol¬
ogy at University of Illinois College
of Medicine, has been named profes¬
sor and chairman of the Department
of Ophthalmology at Northwestern
University Medical School in Chicago.

1971
H. Steven Moffic and his wife, Rusti,
were among 23 American academiians awarded fellowships by the Amer¬
ican Jewish Committee to attend the
annual Academician’s Seminar in
Israel in December. Dr. Moffic’s re¬
search interest is ethnic identity, and
on his return, he wrote two short
pieces for the seminar’s journal on
“Singing for the Scholars: the Yiskor
Service at Yad Vashem”, and “From
the Ivory Tower to the Dead Sea: the
Genesis of a Seminar”. Dr. Moffic is
associate professor of psychiatry at
Baylor College of Medicine.
1974
In a note received in November Isaac
Hoch and Jane Snyder Hoch said
that they “will be moving to Israel
this December to participate in the
development of family medicine in
Israel and will be affilliated with the
Department of Primary Care at BenGurion University of the Negev.”
They also wrote that they have been
in private practice in Northampton,
Massachusetts since 1978, have three
children and are expecting their fourth
in April.

1977
Harvey Berger has been named direc¬
tor of the Nuclear Medicine Division
and Magnetic Resonance Research
at Emory University School of Medi¬
cine in Atlanta, Georgia.
1978
The American Academy of Pediatrics
announced last fall that Elizabeth
Hodgson has been elected to fellow¬
ship in the Society. Dr. Hodgson is
on the staff at Athens General Hospi¬
tal and at St. Mary’s Hospital in
Athens, Georgia. The Academy, an
association of physicians certified in
the care of infants, children and
young adults, has 25,000 members in
the United States, Canada and Uatin
America.
1980
Holiday greetings from Steven and
Lisa Rosenfeld (PH‘79) included the
additional news that they became the
proud parents of a baby boy, M ichael,
last July. They are residing in St.
Louis, Missouri.

PUBLIC HEALTH

In Memo riant

1965
Viola Spinelli, formerly vice president
for operations at Bridgeport (Conn.)
Hospital, has been named senior vice
president, with responsibility for over¬
seeing and supervising all the institu¬
tion’s major operations. Miss Spinelli
held the position of associate adminis¬
trator of the Tufts New England
Medical Center in Boston before
joining Bridgeport Hospital in 1977.

J. Craig Potter, M.D.
August 22,1983

1969
Susan Addiss became president of
the American Public Health Associa¬
tion in November of 1983. As a
member of the APHA, Ms. Addiss
has served as Action Board chair¬
person, as a Governing Councilor, as
a member of nominating and awards
committees, and has testified before
the U.S. Congress on important
health-related matters.
She is chief of the Connecticut
Department of Health Services
Bureau of Health Planningand Re¬
source Allocation; her responsibilities
include conducting Connecticut’s
health planning activities and imple¬
menting the state health plan. Ms.
Addiss also holds teaching appoint¬
ments in Epidemiology and Public
Health at Yale, and in Community
Medicine and Health Care at the
University of Connecticut Medical
Center.

W. Norman Sears
February 14,1984

M.D.‘40

Robert F. Dine
July 1, 1983

M.D.’41

INFORMATION
REGARDING CHANGES
CLASS AFFILIATION

ex med ‘21

A.Glenn Evans M.P.H.‘34, M.D.‘39
(Date unknown)
Dan Tucker
September I 1, 1983

H.S.‘39

Milton Rose
M.D.‘35, D.P.H.‘41
August 10,1983

Richard E. Bodkin
November 11, 1983
Ann Brace Barnes
January 10, 1984
John T. Adams
April, 1980

ex med ‘41

M.D.‘62

ex med ‘83

IN

Medical graduates and Public Health
graduates are assigned to a Class
based on the year in which the degree
is earned, or would have been earned
in those cases where the work is not
completed. Under special circum¬
stances, and by written request, alumni
may affiliate with another Class for
reunion and fund-raising purposes.
Such affiliations will be made only
when an alumnus has interrupted or
extended the program of study and
graduates in a year other than the
year of graduation expected at the
beginning of studies.
Requests by alumni/ae for changes
in Class affiliation may be submitted
to: Alumni Records Office, P.O. Box
1950 Yale Station, New H aven,
Connecticut 06520.
25

JAPANESE THEATER ON MEDICAL ALUMNI WEEKEND
An exciting program has been planned
for the Medical Alumni Weekend to
be held this year on June 7, 8, and 9.
In addition to the outstanding aca¬
demic seminars and traditional, and
always popular social events, this
year’s program will include a presenta¬
tion by Dr. Howard Hamilton, Class
of 1944, of Japanese Noh Theater.
The oldest continually extant thea¬
ter in the world, Japanese Noh was
perfected in its present form about
500 years ago. It is a symbolic, nonrealistic, poetic monodrama with
origins in ancient Japanese and
Chinese dance and religious ceremony.
Noh is performed by elegantly cos¬
tumed actors, often masked, on a
unique stage devoid of realistic scenery
or properties. The highlight of the
drama is a stylized dance section of
minimum movement and spare
gestures. The poetic imagery of Noh
ranks with the best of Japanese liter¬
ature. Strictly maintained performing
traditions are passed down through
succeeding generations by hereditary
Noh Schools.
In the mid-18th century, five Noh
Schools were officially recognized by
the Tokugawa regime. The Kita
School was established around 1618.
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Dr. Hamilton began studying Noh
on his arrival in Japan in 1956, under
the tutelage of Izumo Tsunekazu, a
certified Master of the Kita School in
Hiroshima. He has also received in¬
struction from several masters of the
Kita School in Tokyo, as well as
instruction in musical aspects of Noh
from the former head of the Morita
Noh Flute School.
Playing leading roles. Dr. Hamilton
has performed in 30 full-length Noh
dramas in Hiroshima and Tokyo, as
well as in the annual three-day Noh
Festival at the Shrine on Miyajima
Island. He is the only non-Japanese
actor to appear in Noh Drama on the
450-year old stage of the Shrine. In
addition, he appears in six to eight
Kita recitals annually, and has
appeared in several television perfor¬
mances in Japan. In this country, he
has given a series of lectures and
demonstrations in art galleries and
on college campuses.
Dr. Hamilton's performance on
Alumni Weekend will be presented
by the Class of 1944 at 4 p.m. on
Saturday, June 9, in Fitkin Amphi¬
theater. All alumni and their guests
are invited to attend, but advance
registration is required.

HIGHLIGHTS OF

MEDICAL ALUMNI WEEKEND

Friday, June 8

10:00-4:00

Medical School Student Affairs Office Open House

1:30

Class of 1944 Reunion Seminar

2:30-3:45

Yale Alumni in Surgery Seminar

4:00-5:00

Edward Storer Memorial Lecture

8:30-4:30

Yale Alumni in Ophthalmology 1984 Annual Meeting

8:00

Yale School of Nursing Annual Alumnae/i College

9:00-4:45

School of Nursing Alumnae/i Seminars

8:30-9:30

AYAPH and YUHAAA Annual Workshops**

9:45-11:30

AYAPH and YUHAAA Joint Session

5:00

Alumni Reception to Honor Dean and Mrs. Robert W. Berliner
**Association of Yale Alumni/ae in Public Health (AYAPH)
Yale University Hospital Administration Alumni Association (YUHAAA)

Saturday, June 9

9:15-9:45

Remarks by A. Bartlett Giamatti, president of Yale University

9:45-4:00

Yale Alumni in Otolaryngology Reunion

10:00-11:45

Alumni Seminars

11:45-12:30

Annual Meeting of the Association of Yale Alumni in Medicine

12:30-2:00

Sherry and Buffet Luncheon

2:00

Seminar “Health Care Marketing”

4:00

Japanese NOH Drama Theater Performance and Lecture*

5:00

Reception Honoring Dean Donna Diers, School of Nursing

* Advanced registration required
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COMMENCEMENT 1984

F

PHILIP SIMON

By George Palade, M.D.

Smiling in the rain that drenched commence¬
ment are Dean Berliner (left) and Banner
Bearer Robert Havlik.

Umbrellas, not balloons, stole the
scene this year, as graduates and
their families and friends gathered
in the relentless downpour for
traditional graduation ceremonies
on the Old Campus. Later, in the
Mary S. Harkness Auditorium,
108 damp but jubilant medical
students received diplomas from
Dr. Robert W. Berliner,
officiating at his last
commencement as Dean of the
School. Among the graduates
there were 100 M.D. candidates;
five M. D. / Ph. D. candidates; one
M. D. / M. P. H. candidate; one
M. D. / J. D. candidate and one
M.D./J.D./M.P.H. candidate.
Dr. George Palade, Sterling
Professor Emeritus of Cel!
Biology and Special Advisor to
the Dean, delivered the
commencement address, which
follows.
Dr. Jan Stolwijk, Susan Dwight
Bliss Professor and chairman of
the Department of Epidemiology
and Public Health officiated at
the E. P. H. ceremonies, held once
again under their traditional blue
and white striped tent. Eighty-two
men and women received M. P. H.
degrees; 11 Ph. D. degrees were
awarded, and one Doctor of
Public Health. Dr. Colin White,
who retired in June as Ira
Vaughan Hiscock Professor of
Public Health, delivered the EPH
commencement address.

orty-five months ago, 1 had the pleasure of being the first member
of the faculty of this medical school to give you a formal lecture in
the first course of your curriculum. It was an introductory lecture to
Cell Biology. And now, 1 am, at your request, the last faculty
member to address you the day you are leaving your medical school to begin
stepwise progression through the second half of your training, through
internship, residency and laboratory work towards your final positions
within the medical community of this country.
Of course, this day is not the end of your efforts to learn whatever is needed
for your demanding profession. But it marks the end of a significant phase,
the one in which a foundation was laid (in reasonably logical fashion) to
allow you to understand the reasons behind specific disease cases that you’ll
have to diagnose and manage, as well as the knowledge of the day will make
it possible. More importantly, it is also the foundation over which new layers
of knowledge should be added through the years of your career, as work in
biomedical sciences will continue to progress.
Since advances in this field have proceeded at a spectacular rate over the
last few years, the foundation was intended to be broad and solid, relevant
not only for the medicine of today, but also - if possible — for that of a
number of years to come. While that foundation was under construction,
you may have had questions about the relevance of some of its building
blocks. But you may have second thoughts about this issue a few years from
now. In any case, you should realize that your alma mater might suffer severe
mental pains if, in the future, your patients may know more than you do
about some basic aspect of their condition, because they read about it that
day in the New York Times, or even their local newspaper, - because your
foundation was not broad enough, or because you didn't have a chance to
read about that specific issue in The New England Journal of Medicine.
Remember that the publication lag in the New York Times is much shorter
than in any properly edited medical or scientific journal. So, relevance in the
past, the present and especially the future should be considered on a safely
broad basis.
But now, leaving this question aside, let’s consider first your past
experience and then your future:
you handled bravely the mountains of information of the first year and a
half of your curriculum. Even if predigested and neatly packaged, those
mountains generated rushing torrents of letters and words that could have
flooded your minds, and scrambled them forever, but they didn’t;
you survived the acid test of the fourth semester of the curriculum, when
weaker souls would have collapsed under the weight of the triple demands of
the Pathophysiology course, the first round of board examinations, and
especially the second year show;
you went successfully through your clerkships;
you made smoothly that critical transition from well-worn casuals to ties
nice ties — and jackets
impeccable jackets (or their feminine
equivalents);
you looked carefully at your image as reflected in the eyes of your patients,
your residents and your faculty, and adjusted the source of the image in the
right direction, whenever adjustment was needed.
And now, 45 months later, and, I would say, 40,000 read pages later, you are
ready to face the world as medical doctors. However you look at it, and
notwithstanding any touch of slight irony, it has been a great performance.
You are fully entitled to be proud of it. You deserve the unreserved
congratulations of your faculty, your younger and older colleagues, and
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especially of your families.
But what about the future?
re you entering your
profession under the fog of
stagnation, or the clouds of
doubt and uncertainty? Or are you
becoming medical doctors at a time
when promise of progress and, w ith
it, promise of great professional
rewards, are to be found right
around the corner, past your entry
into the field?
The answer to this question is
undoubtedly the brightest part of
the entire picture. You should con¬
sider yourselves unusually fortunate.
In fact, you should congratulate
yourselves for the excellent timing
of your graduation.
If the primary objective and the
major source of satisfaction of a
physician, practicing at whatever
level fate places her or him, is to
cure or prevent diseases, especially
incapacitating, painful, destructive
diseases, you are entering the ranks
of your profession when there is
finally hope that we’ll be able to
control at least some of these dis¬
eases in your life-time, perhaps
even during the first ten to twenty
years of your professional activities.
Over the last century, especially
over the last fifty years, your pre¬
decessors were able to solve the
awesome problem of infectious dis¬
eases with such success that Homo
sapiens moved all the way from the
position of an endangered species,
endangered by the major epidemics
of the past, to that of a species that
has overpopulation problems, and
thereby damages in part the environ¬
ment and threatens most of the rest
of the biosphere. The problem of
infectious diseases is, generally
speaking, solved, although some
remaining pockets are still awaiting
practical solutions.

T

oday, however, we are finally
closer than ever before to a
precise understanding of neo¬
plastic diseases in molecular terms.
And this is a major achievement.
We are finally seeing the morbidity
and mortality curves for cardiovas¬
cular diseases coming down at an
unexpectedly rapid rate, primarily
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because of improved management;
we can detect many inherited metabolic
diseases in time to avoid many
unnecessary familial tragedies; and
given time and a better organization
of our society, we could eliminate
at least part of these inborn metabolic
diseases.
Moreover, our rapidly advancing
understanding of the organization
and control of expression of eukary¬
otic genes, including our own, and
the biotechnology developed during
these advances, makes possible the
development of new, highly refined
diagnostic and prognostic tools that
will greatly improve the manage¬
ment of many diseases and the
prevention of many genetic disor¬
ders. Similar tools may also help us
in controlling whatever problems
we still have with infectious diseases.
Biotechnology may even make
possible gene therapy, that dream
of the over-optimistic and most
venturesome among us. But you
should realize that cell therapy may
also become a valid alternative,
provided that in the meantime, we
learn more about the complex and
remarkably resourceful system that
governs our immune reactions.

S

o, with all these facts and
promises in mind, I believe
that you should raise a toast
today to the timing of your gradua¬
tion
two glasses of good cham¬
pagne are definitely warranted. But
before having the third glass, how¬
ever, you should pause and consider
that, in fact, not all the dragons and
nightmares of human pathology
are on the verge of being tamed,
conjured or dissipated. Between
what we know' and w hat we would
like to know in medicine there is
still a gap. In some cases, that gap is
as big, wide and dark as the Grand
Canyon early in the morning when
most of its depth is shrouded in
darkness. In that black abyss we
can place schizophrenia and the
degenerative diseases of central ner¬
vous systems of all ages, especially
the old.
At this junction, I would like to
turn for a few minutes autobio¬
graphical because 1 need a part of
my story to make a point. As you

probably know, my formal training
was in medicine, but as you probably
do not realize, I went through the
equivalent of a complete internship
and residency program before going
back to the laboratory.
At the beginning, I liked the
heroics of medical care in major
emergency cases, and the challenge
of great responsibility put on my
rather young shoulders. I had no
problems duringa year in infectious
diseases, primarily because I realized
that there w as hope of improvement.
I did reasonably well through two
years of internal medicine, but to¬
wards the end, I started having
doubts about the future. And I
didn't like at all a year in neurology
because I saw too much despair
and too little hope.
So. I went back to internal medi¬
cine, in which I functioned for a
year or so as an assistant professor,
and during that period I became
progressively uncomfortable about
the gap between what I knew and
w hat I had to know to live up to the
expectations of my patients. They
expected me to speak with the
authority of an oracle, but not
withstanding my efforts and my
many books, my authority rested
on a very modest bank of significant
information. So, in the late 1930's,
when sulfonamides had already
emerged as the new miracle drugs,
but before antibiotics entered the
scene, I left internal medicine and
moved back to a laboratory.
No mouse, rat, guinea pig or
rabbit w as going to ask me, “Doctor,
are you sure of your diagnosis?”
-or
“Is this treatment of yours
the best there is for my condition?”
And no mouse or guinea pig was
going to embarrass me more serious¬
ly by telling me, "Doctor. I am so
happy to be in your hands, because
you know so much about my
condition.”
It was not really giving up medi¬
cine, it was going back to the
scientific foundation of medicine
and trying to do something about
that disturbing gap. By a series of
unusually happy circumstances (for
which I was not directly responsible),
I was able to contribute reasonably
well to the new field of cellular

biology, which soon turned cellular
and molecular biology, and rapidly
became the common ground or the
starting line for many other fields
of biomedical interest. You may
know that neurobiology in our
school is now cellular and molecular,
that many other institutions
have cellular and molecular immuno¬
logy, and that pathology and even
medicine are becoming cellular and
molecular. There is even a Journal
of Molecular Cardiology on the
market!

H

owever, were 1 a member of
your graduating class, my
decision would not be so
easy. I would consider very seriously
medical practice, academic medicine,
and especially clinical research
because:
we know today so much more
than 40 or 45 years ago;
at present, our knowledge in bio¬
medical sciences is so much deeper
and coherent than it was in the late
1930's;
our diagnostic and therapeutic
arsenal is so much more powerful
and extensive - it covers, in fact, a
very large sector, if not the whole
front, of clinical sciences;
and especially because basic re¬
search, directly relevant to human
diseases, can be carried out success¬
fully on cells taken directly from
human patients afflicted by hemato¬
logic, immunologic, and neoplastic
disorders. This kind of work may
soon become possible in other fields
of clinical interest.
We can come back now to the
excellent timing of your graduation
and examine more critically some
relevant issues.
The timing is so much better
than that of many of your prede¬
cessors, because they brought the
biomedical sciences up to the level
from which you are starting. They
provided you with a high and firm
base line, which is the way it is
because under it are buried the
shoulders of Hippocrates, Galen,
Maimonides, Pasteur, Erlich, Osier
and those of legions of more recent
doctors and surgeons, even the
shoulders of most of the members
of your faculty.

You are the benficiaries of a long
ascending road that brought us all
the way from prehistoric witchcraft
to the medical sciences of today. As
any other beneficiaries, you should
consider yourself in duty bound to
sink, in time, your shoulders under
the same baseline to raise it even
higher and make it even firmer for
the classes of the late 1990’s or the
early 2,000’s.
But, before sinking your shoulders
under the feet of future generations,
make sure that they are as hard as
possible. No innocent youngster
should sink while stepping on soft
or mushy shoulders. Remember
that we have narrowed the gap
between what we know and what
we should know, but we have not
succeeded in closing it yet. Re¬
member that there is still a wide gap
in cardiovascular diseases, and a
dark, huge chasm in many mental
diseases. It may take many shoulders
to fill that abyss, but there is no
other way. 1 hope some of you will
work on these gaps and, if you do, I
wish you the best of luck.

N

Dr. Palade

ow, disregarding for the
moment those gaps and those
chasms, did I paint too opti¬
mistic a picture of the immediate
future of your profession?
I really don’t think 1 did.
Yet, 1 have to in ject a few correc¬
tions because I feel they are needed.
There are admittedly a few clouds
on the horizon that deserve to be
considered.
THE FIRST CLOUD: We find
ourselves, at present, in a situation
in which our inventiveness moves faster
than the increase of our material
resources. This is obvious in the
case of the so-called half-way tech¬
nologies. Renal failure requires sus¬
tained dialysis. Obstructive coronary
arteriosclerosis is bypassed by vascu¬
lar autografts, and organ transplan¬
tation is the object of considerable
and general attention.
Yet most, if not all, of these
procedures are palliatives, not cures.
And none of them is inexpensive
enough to be applicable or afford¬
able in all cases, even if the society
as a whole pays the expenses we are
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moving toward different ways of
management for the rich and the
poor and the move is clearly undesir¬
able. The problem is how to direct
our attention away from mechanistic
inventiveness toward basic research
aimed at preventing such afflictions
as kidney failure or arteriosclerosis
in general. This becomes, of course,
one more reason to concentrate on
those gaps already mentioned.
THE SECOND CLOUD: We
hear more and more often that
patients are unhappy, although they
receive in most cases good or excel¬
lent treatment, and although they
live today longer than at any time
in history.
Patients like to be treated as
persons, to be the object of the
visible attention of their physicians.
They believe their doctors concen¬
trate too much - sometimes exclu¬
sively
on the charts, numbers
and molecules of the sick, rather
than on their patients’ emotional
whole. Not even the most intractably
molecular biologist likes to be
treated like a collection of molecules
out of order when she or he is sick.
And the same applies clearly for the
most scientifically minded physi¬
cians when they become patients.
edicine is often referred
to as an art. And indeed,
it shares with the real arts
two major properties. Medicine can
generate rewarding, even engross¬
ing, results by skillfully handling
ordinary, often uncertain, poorly
defined elements, just like the arts.
And, in the past at least, like all the
arts, medicine kept man in the
center field of its attention. But
now, medicine seems to be pushing
man as a whole, out of the limelight;
it appears bent on replacing him/ her
by derivatives which are scientifi¬
cally valid, but are perceived as
cold, inaccessible abstractions by
the sick, ordinary mortal. This de¬
humanizing trend is general and
afflicts most severely the plastic
arts.
The roots of this second fall from
grace — this time on earth — can
be traced to a misinterpretation of
science.
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Slowly, over the years, we became
aware that perhaps (and let me
emphasize this perhaps, because I
would not like to hurt the feelings
of any believers among you) perhaps
we are not the daughters and sons
of Deity, or, in any case, the object
of Its special attention. We are, it
seems, the last primate species pro¬
duced by evolution, big clever
monkeys, but monkeys nonetheless.
Artists usually follow the major
trends in the thinking of their times,
but doctors should have their own,
more lasting set of values. The
theological record indicates quite
clearly that as a species Homo
sapiens is a specialist in recurrent
failure. His record as the Son of
God, which means the immediate
product of absolute perfection, has
always been questionable, often
miserable.
But his prehistorical and historical
record as a later times primate has
been, and still is, unique and splen¬
did,
unsurpassed and probably
unsurpassable. For this reason alone
he deserves to remain in the center
of our field of attention
artistic,
medical, scientific and otherw ise.
Besides, this creature definitely
needs constant attention. Moreover,
through history, this kind of treat¬
ment has been the most powerful
instrument in the betterment of the
species.
So, as medicine becomes more
and more of a science, it must
retain this element of its art-like
past. We have to find the means
that will allow the physician to
communicate with the patient as a
person, dealing with another person
badly in need of attention. Under
this level of intense, unmitigated
personal attention, the sick mole¬
cules of the patient must, ofcourse,
be treated with other appropriate
molecules prescribed by the physi¬
cian, but the patient as a person
cannot be left out of the limelight.
THE THIRD CLOUD: The medi¬

cal profession is acquiring a questionable reputation: it is becoming, on
the average, an affluent profession
and often likes the overt expression
of its affluence
obtained, natur¬
ally, from professional fees.
In the Christian calendar, there
are only two doctor-saints — Cosme
and Damien. And they are there
because they were taking care of
their patients without requesting
any fees. 1 am not suggesting any¬
thing as radical as that. But, after
paying those huge debts (incurred
while in medical school), could you
think twice before buying a Mer¬
cedes Benz, a Jaguar or even a
Cadillac, instead of, say, a Ford
Escort or a Nissan Stanza? In our
times, such means of ego gratifica¬
tion work only during the lifetime
of the owner of the ego. Sometime
ago they were admittedly supposed
to work forever. But even if we
would go back to those times, and
even if we would be buried in our
Mercedes Benzes, the archeologists
of the next millennium may say,
“What a clumsy, rudimentary ma¬
chine we found in the tomb of that
great doctor!” The long ships in
which Viking queens and kings
were buried a millennium before,
or the chariots in which Sythian
chieftains were put to rest even
more millennia before, have at least
the advantage of being highly
esthetic objects.

A

nd now we come to the end.
You are leaving, taking w ith
you the emotional equivalent
of a few fibers from the heart ol
your alma mater, and, from your
faculty, the emotional equivalents
of such precious objects as sodium
channels, signal recognition parti¬
cles, snRNP, scRNP, TATA boxes
or the latest membrane receptor.
Each one of you is a special
person among all men and women.
Each one of you is a precious
daughter or son of your alma mater.
Each one of you deserves a bright
future.
Farewell, and out there remember
to treat your patients as persons
remember the gaps and the chasms
still to be filled.
and harden your
shoulders for the sake of the future.

The brain — three pounds of tissue — more than 10 billion neurons — is
ceaselessly active whether we are awake or asleep. Neurons, no one of which
is exactly like another, are so intricate that each is connected to thousands of
others by complex chemical processes and electrical circuitry. To function,
these circuits depend on myriad channels — protein molecules that act as
tiny valves to control the flow of electric current.
The task of studying and understanding such an enormously sophisticated
organ is so staggering that it has long defied detailed analysis. But this basic
machinery of human behavior is finally yielding its secrets.
New techniques and instrumentation developed in the past decade provide
researchers with tools hardly even imagined when today’s freshly minted
neurologists entered medical school
At Yale, these tools are being applied by teams of researchers employing
the collaborative efforts of experts in neurophysiology, neurochemistry,
neuroanatomy, immunology and molecular biology. Contemporary neuro¬
science evolved into a multidisciplinary approach because the pursuit of
these separate disciplines proved constraining to research.
All neuroscientists share the same general question: How does the brain
work? But this one major question can be approached at many different
levels.
Four researchers at Yale are looking for the answer in strikingly different
ways. They are PatriciaGoldman-Rakic, professor of neuroscience; Pasko
Rakic, chairman of neuroanatomy and Dorys McConell Duberg Professor of
Neuroscience; Charles Stevens, chairman and professor of molecular neuro¬
biology, and George Aghajanian, professor of psychiatry and pharmacology.
The questions they ask and the techniques and methods adopted in pursuit of
their answers may seem esoteric at first glance, but come together to have
important therapeutic implications.

HOW DOES THE BRAIN WORK?
HOW DOES IT DEVELOP?
HOW DO THESE QUESTIONS
RELATE TO BRAIN DISORDERS?
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PATRICIA GOLDMAN-RAKIC

by Nissa Simon

Nissa Simon, an award-winning freelance
medical writer, is the author of "Don't
Worry You 're Normal: a Teenager’s Guide
to Medical Self-Help", published by Thomas
Y. Crowell.
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“People have been interested in the subject I'm studying
the cortex - for
centuries. Scientists have been asking questions, but the answers have been
unsatisfactory,” said Dr. Goldman-Rakic. “Progress was slow because we
didn’t have good methods. But in the last decade, methods developed rapidly
and as the methods get better, the questions get better and the answers get
better. There’s been an enormous revolution in techniques: computers,
sophisticated biochemical assays, sophisticated methods for analyzing
connections in the brain.”
In very early stages of brain science, scientists thought the brain was one
intermeshed network without breaks — that one cell and its process couldn’t
be separated from another. In fact, the brain is made up of discrete units
connected to one another. “This is the neuron doctrine, which is now 100
years old,” said Dr. Goldman-Rakic. “What is new is that now you can see
each unit and actually trace the connections.
“The brain is the most complex structure in the universe,” she continued.
“Every cell in the brain - and there are so many you can’t even imagine the
staggering number
is connected to other cells by a most complex wiring
system. Billions of individual elements communicate with each other in a
complicated manner, but one that can be unravelled.
“When you use a microscope and biochemical methods and physiological
techniques, you can dissect the brain into these elements. And these elements
are the subject of our study.
“One step in unravelling it is finding out how the individual neurons are
assembled and what kind of circuitry they form. This can be done now. It
sounds a bit like science fiction, but it can be done in a way that was
impossible even ten years ago.”
Dr. Goldman-Rakic is interested in the cerebral cortex, the region of the
brain that controls thought and language, where information from our
senses is analyzed, and where our body’s responses are determined. “You
almost have to be a metascientist to be interested in the cortex because you
can't understand it without know ing its connection to other structures in the
brain and other organs in the body, such as the circulatory system, endocrine
glands and even the viscera. So you end up learning about these other
structures, too.” she said.
One of Dr. Goldman-Rakic’s interests is studying the development of
connections in the cortex.
“We want to know' what happens to the brain from its earliest stages to old
age,” she explained. “In both monkeys and humans, most of the brain’s
developmental events take place before birth.” Dr. Goldman-Rakic studies
the development of cortical connections in monkeys by injecting radioactive
tracers into fetuses and then returning them to the womb where their
development continues uninterrupted until delivery.
Her studies showed that cortical connections are surprisingly welldeveloped at birth.“I was surprised to see that. However, the connections
aren’t fully developed because they continue to add outgrowths in the form
of dendrites and axons. First a cell comes to be located in a specific place;
then it sends out extensions to make contact with other cells in other places.
And that process continues after birth. “But the basic blueprint is there. We
can liken it to having a narrow footpath from A to B. Then, as the path is
more travelled, it gets wider. Finally it becomes a road,” Dr. Goldman-Rakic
continued.
Neuroscientists now believe that this process of maturing contacts is the
neurological basis for learning and the development of skills. When a child
speaks for the first time or w alks for the first time, some of these connections
have matured. “You’re born with all the neurons you’ll ever have,” said Dr.
Goldman-Rakic. “Those cells then do a lot of growing up and getting
educated. That’s what experience does; experience trains those cells.”
According to Dr. Goldman-Rakic, the critical event in the brain’s development
is the establishment of a synapse, the point of connection between one cell

T. CHARLES ERIK.SON

All scientists know that the
process of discovery, the
Eureka! factor, is built from
days and years and decades
of painstaking research,
assembled bit by bit, equation
by equation. But even the
daily and weekly routine has
its own appeal and
excitement.
What’s the most exciting
part of your work?
Nissa Simon

and another. The development of these fine contacts allows communication
between neurons to take place.
“At a synapse, the neurotransmitter of one cell is released and stimulates
the receptors on the next cell, and that will fire the cell. We believe that
development involves the fine tuning of the system as these synaptic
connections are formed. We look for correlations between when synapses
are formed in a structure in the brain and the maturation of a function that
depends on that structure,” Dr. Goldman-Rakic stated.
The brain is highly differentiated. There are brain centers concerned with
hunger, for example, and those are of great interest to researchers concerned
with obesity, weight control and all disorders that affect feeding. Then there
are centers that are important for fine control of motor skills, like the
cerebellum. There are centers for the mediation of vision, hearing and
speech.
These centers develop in parallel. In language and speaking, for instance, a
child must use both audition and vision to associate sounds with an object.
‘Book’ must have both a sound and an image. “That involves at least two
types of information,” continued Dr. Goldman-Rakic, “and those must be
synthesized at the level of the cortex where the two systems are integrated.
The cerebral cortex exerts the highest level of control of all of these
functions. And that’s the area I’m interested in and trying to understand.
“Most of my work and my life in research will be spent gathering more
neurobiological information about the systems that mediate these functions.
I believe they will be explicable in neural terms. Just as we can now explain
the patellar reflex, just as we can now approach an explanation of sensory
processes, we will be able to explain higher cortical processes physiologically,
because they’re organized the same way. One function doesn’t have a
separate set of rules. The relationship between structure and function is the
same. For example, we discovered that cortical cells are arranged in
modules. These modules, presumably information-processing units, are not
unlike modules of the visual cortex that organize visual information. If we
can understand how they’re organized, we can begin to study them. And
their function will emerge,” Dr. Goldman-Rakic said.
“Neuroscientists have been reluctant to think integratively about how to
apply knowledge of the elements of neuroscience to how we might think of
human behavior,” she continued. “If you understand the brain’s wiring and
you understand the biochemical constituents, then you can also think about
a rational means of drug therapy to apply when cells are lost through injury
or through disease. We hope that eventually this will enable us to treat
diseases that involve the loss of cortical cells. Many of the neurological
diseases that are coming to our attention, like Alzheimer’s, senile dementia,
and even Huntington’s chorea and Parkinson’s disease, all have symptoms of
dementia — and the cortex is probably involved.”

The most exciting part of
my research is gaining
insight into a complex
problem that Eve been
working on for a long time.
You begin to think you ’ll
never really understand it,
then one day you get an
additional bit of information
that attaches to some other
information that you have
—and suddenly a new view
opens up.
This is an intensely private
experience. You can share it
with other people afterwards.
When you take them through
that process vicariously, they
may or may not realize how
your knowledge developed.
You, however, know how you
started with nothing and
came to something. Then
when you have a new insight
you realize how pitiful your
previous understanding was.
It’s exciting to see that your
understanding which was at
first primitive, can be
enriched and realize how your
own efforts brought you to
that understanding.
Dr Goldman-Rakic
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PASKO RAKIC
“There are three questions worth asking in neuroscience today,” said Dr.
Rakic. “How does the brain work? How does it develop? How do both of
these questions relate to various brain diseases.?
“My research is concerned with finding answers to the second question:
How does the brain develop?
“The questions we’re asking have been around a long time,” he said, “but
answers are possible now because of the explosion in new methodology.
These new methods actually make it possible to trace the migration of
neurons as the brain develops during gestation.
“Using DNA labeling, we determined the sequence of genesis of various
cell classes in selected brain centers. We showed that all neurons in primates
are generated only during limited periods,” Dr. Rakic explained. “Unlike
cells in other organs in our body, most brain cells are generated before birth.
A few' are added during the neonatal period
but not a single neuron can be
added during adult life. Basically, we’re stuck with what we’re born with.
“In fact, we postulate that new neurons could interfere w ith the retention
of previous experiences. Therefore, we think that a final set of neurons, a
stable population of neurons, is essential for the primate brain to retain
previous experience encoded in a synaptic pattern,” continued Dr. Rakic.
“We found that cells in primates, including humans, migrate long
distances after they’re generated in utero,”he said. “While still in utero, they
move from place of their last division to their final destination. That’s a
delicate process that must be precise in terms of time and space. In monkeys
this occurs about mid-gestation. But the brain is not formed, because during
that period they must migrate to their final position. Then the process of
formation of connections continues through the second half of pregnancy,
after birth and during infancy. These migrating cells will later function as
local circuit neurons in the neocortex.” When the cells arrive, their
morphological, cytological, biochemical and physiological maturation
continues; they still must develop connections and appropriate neuro¬
transmitters.
In order to mediate behavior, cells must connect with each other in some
way. “Our main problem is to define the rules that govern the formation of
these synaptic connections in the brain,” said Dr. Rakic. “To what extent are
they determined genetically? To what extent can they be modified by
environmental factors such as training and experience?”
In the past, these connections were thought to be ‘hard-wired’, a phrase
borrowed from computer science to describe structures that are genetically
determined. “Now we know that the final synaptic pattern
at least in
higher organisms, including primates — is highly variable and depends on
many factors, including sensory experience,” said Dr. Rakic. Genetic
information encoded in the DNA of individual neurons does play an
essential role, but the innate blueprint can be modified by non-genetic
factors. This interaction allows an immense structural variability in synaptic
organization that may be the biological basis of our individuality and the
single most significant reason for the evolutionary success of the primate
brain.
“We had long suspected that the environment plays a role in the formation
of neuronal connections. But it was actually demonstrated less than ten years
ago,” continued Dr. Rakic.
“The way connections are made in the brain can be likened to sculpting a
figure from a piece of stone,” he explained. Most neurons are overproduced
during fetal life. Optic nerves, for instance, contain about three times as
many fibers during mid-gestation as we will have as adults. 1 his was initially
discovered in the monkey and later found true of humans as well. Similarly,
primates have 150 million fibers connecting the two halves of the brain at
birth. During infancy, this number is reduced to the adult level of fewer than
50 million.
“There is an excess of material and the only way to refine it is by
eliminating what is not needed,” said Dr. Rakic. He calls this process
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‘selective elimination’. “The brain is not formed by every neuron being
programmed precisely to make contact with another neuron. Rather, there is
an excess of neurons and their axons make the best connections by trial and
error. Those connections that are functional and serve the individual best are
reinforced and survive. Those that don’t serve a purpose will disappear. It’s
rather like Darwin’s theory of survival of the fittest: in this case, survival of
the best connections in the brain.”
Dr. Rakic believes that early training can play a sigmticant role. “When
you recognize that your child has three times as many axons as you have on
the corpus callosum connecting the two halves of the brain, you realize that
during those infantile years the environment determines which of these
axons will survive and which will not. The environment includes education
and training as well as the chemical environment, which includes drugs and
nutrition,” he said.
The implications of this research are great, because once we understand
the development of the normal brain, we can also understand abnormal
development — which occurs more frequently than suspected. “There are
many subtle abnormalities that can’t be detected by routine pathological
examination. In our technological world, we are just beginning to assess the
problems associated with external chemical and environmental influences
on the brain,” commented Dr. Rakic, “problems that our predecessors did
not have.”
Dr. Rakic recently received a telephone call from a member of the United
Nations commission assessing physical consequences of the atomic blasts at
Hiroshima and Nagasaki, almost 40 years ago. They were examining
individuals who were fetuses when their mothers were exposed to the blast,
yet were born and survived. He told Dr. Rakic that most of the survivors who
suffered from mental problems were between ten and 17 weeks of gestational
age at the time of the blast, and the commission wondered why.
“1 said that coincides well with the time that the major wave of neuronal
migration to the neocortex occurs. This wave contains the neurons that later
form the local circuits that are responsible for higher cortical function,” said
Dr. Rakic. “Therefore, 1 could predict that they have problems of higher
cortical function rather than sensory-motor problems. And that’s exactly
what happened to this group of survivors. Some cannot work, many of them
don’t have jobs, some of them are institutionalized. They don't have any
problems with social adjustment.”
Dr. Rakic suggested that perhaps their local circuit neurons didn’t
complete their migration to the cortex because of the radiation. They may
have been stopped below the cortex. The United Nations scientists answered
that they thought radiation could kill cells, but they didn't know whether it
could stop cell migration once it was initiated.
“We have experimental data showing that this precise neuronal migration
depends on the interaction between postmitotic cells and special path¬
finding elongated fibers that exist transiently in the brain,” said Dr. Rakic.

It's difficult to say just which
part of my work excites me
most. That’s like asking
which of your children you
like most. It s not a fair
question.
W hen / came to this
country, l was a resident in
neurosurgery. I thought that
the most exciting thing to do
was to perform surgery on
the brain — say to remove a
tumor. But I soon realized
that studying how the brain
is put together may advance
the field more than
removing tumors. Science is
like art or music: you have
an opportunity to create and
discover something new for
yourself— and for others.
The fact that you have the
privilege of looking at the
organ which governs all
human activity, the fact that
you try to understand this
organ by using your own
brain, that’s very exciting.
Dr. Rakic

“This interaction, which depends on molecules in the cell membrane
surfaces, is highly sensitive to temperature, chemistry and irradiation. So I
predicted that even far from the epicenter of the blast, radiation might also
affect neuronal migration.”
Six months later Dr. Rakic received another telephone call. A Japanese
neuropathologist found the protocol of one patient who was a fetus at the
time of the blast and died 12 years later. After her death, pathological
examination showed clearly that a lot of neurons were dispersed below the
cortex. Because the neurons didn’t reach their normal position, they couldn’t
make appropriate contacts and therefore couldn’t function properly.
Thus, although Dr. Rakic’s laboratory is devoted to experimental work
with animals, the work has direct implications for neurology and psychiatry.
“1 have always been fascinated with how the human brain develops and
how it works,” he said. “There’s not necessarily a direct line from the simplest
creatures to human beings. Our work is designed to provide a bridge between
the two.”
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CHARLES STEVENS
T. CHARLES ERIKSON

There are different levels of
excitement. Science as a
social endeavor is exciting.
To work with young people
and have them learning and
contributing; all the human
interactions of the people
who work together on these
projects
I find all that
exciting.
—
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The human brain contains more than ten billion neurons
give or take ten
million. “That’s about the same number as there are stars in our galaxy,” said
Dr. Charles Stevens. Each of these neurons communicates with thousands of
others by a method of such daunting complexity that a single three-pound
human brain has more "computing components’ than all the world’s
computers taken together.
It’s easy to think of the brain as an electrical system, especially in this age
of computers. That invites us to think of neurons, the elements of the brain,
as like computer components. And in some ways, the comparison is apt.
Until recently, it was thought that neurons received signals through the
dendrites, fibrous branches sprouting from the cell body, integrated them
and emitted outgoing signals through the axon, the stem of the neuron. The
reality, however, turns out to be more complex. Axon transport is no longer
thought to be one-way. There is also reverse flow where substances needed
by the cell are brought back along the axon. And dendrites, thought in the
past to only receive signals, may also leak substances in the other direction.
The signalling system between neurons is both electrical and chemical.
The signal generated by a neuron is an electrical impulse, but the signal is
transmitted along the axon and across the synapses chemically. These signaltransmitting chemicals, neurotransmitters, carry the message from one
neuron to another.
Specific molecules on the membrane of the neuron are responsible for
nerve impulses and for synaptic transmission. "'These protein molecules that
are embedded in the cell membrane are called "integral membrane proteins’.
They are the key to understanding neuron function and therefore, brain
function,” explained Dr. Stevens.
A special class of these proteins, called channels, are the molecules
responsible for the electrical activity of the brain. “All cells have pumps to
keep calcium and sodium ions on the outside and potassium ions on the
inside,” continued Dr. Stevens, “and they also have channels that spend the
energy stored by the pumps by opening and closing to let ions pass through
the membrane. The flow of ions causes voltage changes that give rise to nerve
impulses and electrical activity.
“When one of these channels opens, sodium ions, for instance, will move
from the outside of the cell to the inside. An electrical current results from
this movement, and the amount of that current is minute,’’said Dr. Stevens.
“Amps are a measure of how much current flows through a light bulb.
Milliamps flow through transistors. Picoamps flow through these pores. A
picoamp is a thousandth of a milliamp, so it’s a millionth of an amp. Usually
a pore stays open for a thousandth of a second and then it closes. We measure
the picoamps that flow through during that instant.”
There are hundreds or thousands of different kinds of channels, but they
all belong to two major categories. One category is responsible for nerve
impulses and the other category is responsible for synaptic transmission. The
first category opens and closes in response to voltage differences, and is
called "voltage-gated’. The second type opens when a particular molecule, a
neurotransmitter, binds to a receptor on the channel protein. I hese
chemically-gated channels are called "ligand-gated’.
According to Dr. Stevens, the fact that specific molecular properties are at
the core of brain function has been known for a long time. But the exact
molecular operation is now becoming available because of new techniques.
“The methods we use now to study individual channel molecules didn't

exist a decade ago,” Dr. Stevens said.
At the turn of the century, many people believed that molecules were
mathematical fictions, not real entities. “And now we study them one at a
time,” said Dr. Stevens. “We take pictures of individual molecules through
electron microscopes so that things no one had even seen when 1 was in
college we not only see, but we study.”
Even as recently as ten years ago, no one had ever recorded the current that
flowed through a single channel. In fact, the notion of the structure of a
channel was vague. Inferences about how channels behaved were made
indirectly by very complicated mathematical techniques.
“Not only did people not quite believe that channels existed, they didn't
know how many there were and how to tell them apart. But now that we can
record from a single channel, we can recognize them because each one
behaves differently,” stated Dr. Stevens. “So the kinds of things that were
inconceivable less than a decade ago are now our bread and butter.”
The immediate goal of the work is to make a physical theory for the nerve
impulse. “We should be able to predict the outcome of any experiment on
nerves that you could pose from the equations we devise. These equations
shouldn’t be arbitrary, but should express the essential physical mechanisms
that underlie nerve impulses. That’s been a goal of neurobiology for a long
time,” he explained.
Although researchers can take photographs of an individual neuron, they
still cannot count the exact number of channels on a cell. “In the
photographs, they don’t come with a label that says, ‘1 am a channel’, so we
have to know that the channel exists by some other method before we can
take the picture,” said Dr. Stevens. “The new molecular and cloning
techniques and the methods of recording the electrical How through a single
channel now allow us to count the number of molecules for the first time.
“The precise implications aren’t clear yet because we’ve been studying
individual molecules for such a short time, but we have a fair idea of what to
expect. One area researchers are investigating is learning, seeking the
methods of information storage,” Dr. Stevens continued. “Learning also
involves channels. At one level, learning is thought to depend upon a
particular connection — say between cell A and cell B. By virtue of
experience and the arrangement of nerve impulses, cell A becomes either
more or less potent in relation to cell B. That happens because the properties
of some of the channels are modified. This is called neuromodulation.”
Dr. Stevens made the comparison to what happens when a technician
wants to change the characteristics of an electronic circuit in a computer. “If
you want the computer to go faster, for example, you unplug one set of chips
and plug in another,” he said. “The nervous system has the interesting ability
to change its own behavior. It’s as though it were using the same chips instead
of changing chips, but modifying their characteristics so that they behave
differently. People in our group are studying how this happens — how
neurotransmitters modify the behavior of channels.”
Presumably, all diseases of the nervous system that are not associated with
trauma or viruses are going to be ultimately related to these molecular
mechanisms. “The fate of the basic scientist is to work out all the mechanisms
as far as you can go,” concluded Dr. Stevens. “Once you’ve done that, you
know what to do for diseases. But you can’t know which diseases are related
to which mechanisms until you know what the mechanisms are. I'm at the
level of working out the basic mechanisms.”

To set a problem for
yourself and get a solution is
exciting. It's like climbing
mountains, I suppose,
because you tell yourself
you 'cl be happy if you could
do this one thing
and
then you achieve it.
Science is an esthetic
discipline. Whenever you
finally understand
something, there’s a great
simplicity implied by your
understanding. You can
suddenly see many things
explained by one simple
idea.
It’s also exciting to realize
that you 're doing something
that people have dreamed
about, something that was
inconceivable before. To
make a contribution is an
exciting thing. That s true of
all science.
All of these things are true
of any part of science, of
course, and this is no
different from any other
kind of science
but it’s
more intensified in
neuroscience today because
the field is moving so rapidly
and everything is so new. It's
as if you’ve come into a new
world where nothing is like
anything you've ever seen
before.
—

—

Dr. Stevens
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“Because psychoactive drugs are chemical substances, they act on chemical
systems in the brain,” said Dr. George Aghajanian, professor of psychiatry
and psychopharmacology. “In the mammalian brain, 99 percent of all
communication between neurons is chemically mediated. One neuron
secretes a chemical substance that will cross a synapse and affect the firing of
the next neuron. There are dozens of these chemical transmitter systems in
the brain.”
According to Dr. Aghajanian, most of the drugs that affect behavior
antipsychotic drugs, antidepressant drugs, antianxiety drugs and antimanic
drugs — affect some specific aspect of the process of chemical
neurotransmission.
“An antipsychotic drug, for example, blocks the transmission of dopamine
at the synapse. Antianxiety drugs affect the transmission of impulses carried
by another neurotransmitter, gamma-amino-butyric acid (GABA).”
As a working hypothesis, investigators assume that specific brain
chemicals affect specific patterns of neuronal behavior. They concentrate on
one neurotransmitter and try to relate the effects of a drug to that substance.
Because the drug might have certain behavioral effects, an association is
established between that particular neurotransmitter and a behavioral or
psychiatric state.
“That’s oversimplified, of course, because for one thing, we know that all
of these neurochemical systems are connected to each other. There’s a
growing recognition that we have to understand how these different systems
interact,” said Dr. Aghajanian. “The research moves back and forth,
between trying to isolate effects and trying to understand interactions. We
first focus on one substance and one synapse. We try to understand the
process of transmission mediated by that substance and how drugs affect
that process. Then we must step back and see how that fits into the general
process.”
The group within which Dr. Aghajanian works is interdisciplinary. He
himself does cellular electrophysiology as well as electromicroscopy to look
at the functional and morphological aspects of transmission on single
neurons or synapses. Others in the group take a neurochemical approach
and look at the chemical nature of receptors on nerve cells.
“Much of our work has to do with characterizing precisely the nature of
each receptor. We can look at this electrophysiologically by seeing how the
application of a chemical transmitter will act at one of these receptors. We
can look at it biochemically. And we can look at it behaviorally,” explained
Dr. Aghajanian. “We have people in the group who study the behavioral
consequences of stimulating certain kinds of receptors. One of the real
advances in neurophsychopharmacologv in recent years has been to define
more precisely the subtypes of receptors through which the chemical
transmitters act.”
This opens the way to developing drugs that are more selective for the
specific receptor subtypes in order to minimize untoward side effects. More
precise definitions of the receptor subtypes should make it possible to
promote the therapeutic action of a drug and reduce unpleasant side effects.
At one time, receptors were only conceptual constructs. It was assumed
that when a cell responded in a particular way to a specific substance, a
chemical substance on its surface acted as a recognition site to detect the
presence of the chemical messenger. When this happened, a cascade of
biochemical and electrophysiological events would result, leading to the
final response of that cell to the transmission of the chemical message.

Recently developed biochemical methods allow identification and isolation
of those receptor substances, which are embedded in the cell membrane.
Only a few receptors have been fully characterized so far, and researchers are
trying to isolate virtually every known receptor to determine its primary
structure, that is, its sequence of amino acids.
Most cells have receptors fora large number of chemical transmitters, but
not all cells have the same complement of receptors. A specific type of
neuron can also be characterized by its receptivity to the known types of
chemical transmitters. This is done electrophysiologically, by recording the
activity of a single neuron.
“You can place a micropipette into an individual neuron,” said Dr.
Aghajanian. “Then you inject a detectable dye into the neuron, and later
analyze the brain histochemically for the presence of a specific neurochemical.
You can show the chemical is in a given cell because the dye causes it to
fluoresce. Then one knows with absolute certainty that a given cell belongs to
a certain neurochemical type.”
In some cases, this research has obvious therapeutic implications. One
dramatic example from recent research led to a treatment for opiate
withdrawal. The treatment is the result of research on the locus caeruleus,
which is the primary source of norepinephrine enervation in the brain. When
these neurons are activated excessively in primates, an anxiety-like state
results.
“In the laboratory here, we’ve shown that these cells become activated
during opiate withdrawal,” said Dr. Aghajanian. “T his led to a connection
being made between the symptoms of opiate withdrawal and the activation
of these neurons.
“Normally, the release of norepinephrine from these neurons maintains a
state of alertness or attention. When they become overactivated, this might
become anxiety. We know that these cells are heavily laden with receptors
for opiates, including morphine,” he continued. “However, repeated adminis¬
tration makes these cells tolerant to morphine, which has an inhibitory effect
and suppresses their firing activity. If you then remove the morphine, the
cells become overactive, which causes withdrawal symptoms.
“Basic laboratory researchers and clinical researchers subsequently
collaborated to develop a treatment for opiate withdrawal that suppresses
the activity of neurons by affecting a different receptor. Clonidine, an
anti-hypertensive drug, suppresses many of the unpleasant symptoms of
opiate withdrawal by suppressing a non-opiate receptor, the alpha-2adrenalceptor. Because the continued administration of opiates doesn’t
affect that receptor, the cell is amenable to the inhibitory effect of clonidine.
We normalize the cell’s activity by, so to speak, making an end run around
the opiate receptor.
“Although the receptors for opiates and the alpha-2-adrenaceptors are
distinct, we’ve shown that their final action is mediated through common
mechanisms, which is why one can substitute for the other. Both receptors
act through suppressing the cyclic AMP system, which ultimately regulates
the opening and closing of the potassium channel.
“In a way, we start where the basic laboratories like those of Drs.
Goldman-Rakic, Rakic, and Stevens leave off. We try to integrate the
various basic approaches into an overall picture of how drugs affect the
brain’s functioning and particular systems in the brain. By this kind of
approach, we expect to relate basic research to clinical research,” concluded
Dr. Aghajanian.

What I find most exciting is
that we can get down to an
elementary level of analysis,
we can look at ion channels
and molecular receptors.
This is the sort of thing that
could only be done in simple
systems in the past because
the mammalian brain
seemed to be too complex to
attempt that kind of
analysis.
Now we can do that kind
of fundamental analysis in
the mammalian brain. And
it’s through this work that
we will be able to recognize
the real advances. Then, at
the same time we re doing
fundamental research, we
can work at the clinical
level. That’s what I find
exciting.
Neuroscience is advancing
rapidly, but the cooperation
of neuroscience and
psychiatry is coming more
slowly. Yale is one of the
few places where basic
research in neuroscience
takes place side by side with
clinical research. I find that
most exciting.
Dr. Aghajanian
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perfecting organ transplantation
—

and beyond
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Dr. M. Wayne Flye’s goal is to transform Yale-New Haven Hospital into a
multi-organ transplant center. In the process, he is also helping to transform
his branch of medicine.
This protean organ transplant surgeon manages to juggle two separate
spheres of research together with his clinical work and his hectic schedule of
operations. “It is important for a clinician and even more important for a
surgeon, to bridge the gap continually between what’s happening in the
laboratory and what’s happening clinically,” Dr. Flye believes. “As a
physician, I can appreciate some of the problems and applications of current
research better because I see the day-to-day laboratory results. At the same
time, some of my clinical problems arouse questions that wouldn’t occur to
or be appreciated by someone working only in the laboratory.” This
balanced perspective enables Dr. Flye to carry out both immunosuppressive
research, which is directly applicable to daily practice, and regenerative
research, which is ambitiously aimed at the future.
After four years with the University of Texas Medical Branch in
Galveston, Dr. Flye joined the Yale faculty in February 1983 as associate
professor of surgery and the director of organ transplantation and immunol¬
ogy. He is also a consultant for the National Cancer Institute.
Although a pioneer in his field. Dr. Flye is unusually experienced. He had,
in fact already performed over 300 porcine liver transplant operations before
performing the operation in October last year on a six-year old girl, and
earning Yale-New Haven the rank of sixth center in the United States to
perform a liver transplant.
To date. Dr. Flye has performed eleven liver transplants at Yale-New
Haven, and has three patients waiting. “It’s just a matter of getting the
necessary organs,”he said. He has lost count by now of how many pigs have
passed successfully under his scalpel.
“Dr. Flye is a supersurgeon,” declared his research associate, George
Rodgers. “He’s capable of doing things other surgeons wouldn’t attempt,
because his research and his technique go hand in hand.” An assistant in
research in surgery, Mr. Rodgers has been workingwith Dr. Flyesince 1979,
taking care of the myriad details of their immunosuppressive research
investigating the potential of the new wonder drug cyclosporine (CyA).
Scientists discovered cyclosporine almost by accident in 1970, while they
were looking for a new antibiotic. At first, few researchers appreciated the
drug’s specific immunosuppressive qualities; then in 1977, Professor Caine
of Cambridge University demonstrated CyA’s ability to prolong organ graft
survival in laboratory animals. That news, according to Mr. Rodgers, “really
woke up the transplantation world.”
Cyclosporine forces the immune system to accept a transplanted organ
instead of perceiving the grafted tissue as a foreign antigen or “enemy”
substance, and mistakenly defending the body by fighting and rejecting the
transplant.

Although there are hundreds of subsets of lymphocytes, or white blood
cells, that can be directed against one antigen or another, there are two main
categories: B cells and T cells. While B cells make antibodies, T cells regulate
B cells and the immune response.
When the body is stimulated by an antigen, the T cells divide so that a
clone of cells expands. CyA suppresses the immune system hy preventing this
rapid multiplication of T cells, but, unlike other immunosuppressive drugs,
CyA operates without actually killing cells; it simply blocks the T cells from
dividing.
“With cyclosporine we can inhibit one particular clone of cells to an
organ,” explained Dr. Flye. No one yet knows exactly how CyA works on
the molecular level, but investigators soon hope to find out.
Still another important feature of Dr. Flye’s work is his special pig farm
presided over by Mr. Rodgers. Since most farm pigs are so inbred for meat
qualities, they often accept organ grafts without treatment. Mr. Rodgers
specially breeds genetically defined miniature pigs in order to examine the
response to grafts across genetic barriers and modification of rejection.
The two most important criteria in choosing a donor liver to transplant are
compatibility of blood type and compatibility of size. Normally, if the host
pig A is given pig B’s liver, it rejects the liver immediately, perceiving it as
antigenic. However, when Dr. Flye puts B’s liver into A and proceeds to give
A a short course of cyclosporine (for as brief a time as 25 days) to protect the
liver, he circumvents the rejection process and pig A accepts the graft.
When a kidney of the same B genetic makeup is grafted, the host pig A
rejects this additional organ, although the liver remains healthy. A second
attempt at “B” kidney transplantation provokes a hyperacute rejection while
the original B liver in pig A continues to be well tolerated. This indicates that
the kidney has a different antigenic structure from that of the liver. In
general, livers aren’t as antigenic as kidneys.
“Whenever you have tissue transplanting you have to worry about tissue
typing, and make sure the tissue matches,” Mr. Rodgers said. He is in charge
of maintaining the genetic integrity of the herd, at present about 15 breeders
and their offspring. Two more pig patients, placidly awaiting the outcome of
Dr. Flye’s latest liver-and-kidney grafts, live in the medical school animal
care facility.
The FDA did not approve general release of CyA until December 1983,
which meant Dr. Flye had to obtain special permission to use the drug to
ensure graft acceptance when he performed his first three liver transplant
operations.
Dr. Flye’s first clinical transplant operation was on a six-year old girl, who
had been given only a few weeks to live. After alerting the New England
Organ Bank to search intensively for a donor organ of compatible size and
blood type, a 20-month old drowning victim was reported in Florida. Dr.
Flye and his support team flew there at 2:30 am to retrieve the liver. Since

Ultimately, we would like
to reach the stage where a
failed organ would not need
to be replaced at all, but
could be supported while it
regenerated its capabilities. ”
“

DR FLYE
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How can a rat’s liver
completely regenerate within
three to four clays when 70
percent of it is removed?
And why, once the organ
has reattained normal size,
does the regenerative process
then stop? Why does the
liver not keep on growing
uncontrolledly as a tumor
would? If harnessed, this
process might be
transferable to human
beings.

George Rodgers, an assistant in research in
surgery, works with Dr. Five in research
that may ultimately lead to human organ
regeneration.
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livers are so delicate that they cannot be stored outside of the body for more
than six to eight hours, the child was called away from her brother’s birthday
party later that same morning, and the transplant was completed by 11 am.
Protected by CyA, the liver began to function at once.
The liver’s complexity has earned it a reputation as perhaps the most
difficult organ to transplant. It should not take, proportionately, anything
like the same amount of time and effort for Dr. Flye and his colleagues to
master transplantation of the heart, lung, or pancreas.
Approaching his goal of treatment of liver disease from another direction.
Dr. Flye is also conducting research to try to define the molecular stimulus of
regenerative growth, and to characterize whatever protein or other factor is
modulating the regenerative behavior which is almost unique to the liver.
In an aside. Dr. Flye provided backround: “If you take an amphibian — a
salamander or a starfish
and cut its leg off, it will regenerate the whole leg.
As you go higher up the phylogenetic scale, you lose that ability. There have
been studies with rats, though, in which the forearm was removed and an
electrical stimulus applied, with some regeneration resulting.
“This electrical stimulation may release a chemical that promotes
regeneration,” explained Dr. Flye.“ For some reason as we’ve evolved most
of our organs have lost that regenerative ability, except for the liver, and to a
lesser extent the kidney.”
How can a rat’s liver completely regenerate within three to four days when
70 percent of it is removed? And why, once the organ has reattained normal
size, does the regenerative process then stop? Why does the liver not keep on
growing uncontrolledly, as a tumor would? If harnessed, this process might
be transferable to human beings.
To study the precise mechanism of regeneration it is necessary to isolate
the responsible molecules. This is obtained by first performing a rat
hepatectomy; making an emulsion out of the organ; and extracting from the
supernatant the molecule that stimulates other cells to grow in culture.
Knowing already that “there’s something in there,” Dr. Flye and his staff
pass the preparation through a series of biochemical purifications to try to
characterize this “something”.
Presumably the same molecules are instrumental in repairing and
regenerating the injured liver in a patient. “If we could properly characterize
this process, we’d be a step closer to providing help for a patient’s liver to
regenerate to support a transplanted liver during rejection,” speculated Dr.
Flye. “It must be a fairly basic mechanism of control for the liver that
regenerates since other major organs like the heart do not have this capacity.
“Ultimately, we would like to reach the stage where a failed organ would
not need to be replaced at all, but could be supported while it regenerated its
capabilities.”
At present, there are still very few multiple organ transplant centers in the
United States. The various interests represented at Yale-New Haven Medical
Center are directed by Dr. Ali Khodadoust for ophthalmology; Dr. Gary
Friedlaender for orthopedics; Dr. Charles Cuono for skin grafts; and Dr.
Flye, Dr. Alexander Geha, and colleagues in general and cardiothoracic
surgery for kidney, liver, heart, lung and pancreas.
Dr. Flye is now working out the details of pancreas transplants in his
laboratory. Further studies will examine lung transplants. “The lung is tricky
because it has so many enzymes that begin to digest it as soon as you try to
preserve it,” he observed. “Improvements in organ preservation are of
concern to all areas of transplantation; however each organ has its special
requirements.”

... IN PROGRESS
... a brief report on some of the
many research projects ongoing in
the School of Medicine.

In the early 1970’s, Dr. Luke Kitahata,
professor of anesthesiology, was among
the first to discover that opioid anal¬
gesics are effective in blocking pain
signals to the spinal cord. It was the
first indication that a drug such as
morphine acts on sites other than the
brain to alleviate pain. This initial
work by Dr. Kitahata has led to an
expanding field of research in the phar¬
macology of pain transmission in the
spinal cord, and possible ways of selec¬
tively targeting specific drugs that would
be more effective in alleviating pain.
Administering opioid analgesia to
the spine has several advantages for
surgical patients as well as for nonsurgical patients with acute and chronic
pain syndrome. Requiring a minimum
of drugs for a very powerful effect, it
acts on only those parts of the body
involved pain. Unlike conventional
spinal anesthesia with local anesthetics,
the patient does not lose touch sensation
or motor function.
As with any new technique, however,
there are complications. One infrequent
but serious problem is respiratory de¬
pression following injection of opioid
drugs. Dr. Kitahata and his colleagues
are studying the basic mechanisms of
this condition in order to increase the
therapeutic value of this newly devel¬
oped method of pain control.
In related research. Dr. John G.
Collins, assistant professor of anes¬
thesiology and pharmacology, has de¬
monstrated that injection of epinephrine
near the spinal cord is effective in
blocking neurons that signal pain. This
action provides an alternative explana¬
tion for epinephrine enhancement of a
spinal block.
Of more significance. Dr. Collins has
demonstrated that when applied to the
spinal cord in combination with an
opioid, epinephrine requires only very
low doses to block pain signaling
neurons. In fact, the dosage is so low
that neither drug used independently in
that amount would be effective.
These findings have led to an ongoing
study of the interaction of known pain
inhibiting neurotransmitters in the
spinal cord. The ultimate goal is to
develop a multidrug combination that,
when applied near the spinal cord, will

block pain signals without producing
undesired side effects.
The neurophysiological basis for pain
accompanying disease or injury is fre¬
quently obscure. Although it is possible
for pain to originate solely within the
central nervous system, the usual cause
is the activation of certain sensory
peripheral nerve fibers in muscle, joint,
bone or visceral organs. The sensory
receptors at the ends of these fibers
specialize in responding to noxious
stimulation.
Dr. Robert LaMotte, associate pro¬
fessor of anesthesiology and neuroanat¬
omy, has developed an experimental
neurophysiological model of clinical
pain in which pain produced in humans
by localized heating of the skin to
precisely controlled temperatures is
measured by quantitative sensory test¬
ing. The responses of heat sensitive
“pain receptors” are recorded electrophysiologically in anesthetized monkeys
as well as in awake humans. The recep¬
tor responses are then correlated with
the sensory measurements of pain in
humans.
In other experiments. Dr. LaMotte
and his colleagues have altered the
local chemical environment of these
heat-sensitive pain receptors, either by
mild burn to the skin or by local
injection of a minute amount of inflam¬
matory chemical substance. This radi¬
cally increased pain sensitivity: normally
non-painful stimuli such as gently warm¬
ing or rubbing of the skin, became
painful; and normally painful stimuli
became much more so. In neurophysio¬
logical experiments in Dr. LaMotte’s
laboratory this clinical state, known as
hyperalgesia, was shown to result from
the local sensitization of the heat-sensi¬
tive pain receptors — particularly those
with non-myelinated nerve fibers.
These experimental models of pain
and hyperalgesia will be useful in deter¬
mining how changes in the local chemi¬
cal environment of pain receptors can
alter their sensitivity. Such alterations
could be responsible for clinical condi¬
tions such as causalgia — a chronic
burning pain, sensation and hypersensi¬
tivity to innocuous stimulation, such as
the rubbing of clothing against the
skin. The model will also be useful in
the development of drugs to block
functions in pain receptors without
affecting other types of sensory
receptors.

ICANCERI
The National Cancer Institute recently
awarded a grant of $421,000 for support
for three years of research being con¬

ducted by Dr. Sara Rockwell on the
use of perfluorochemical emulsions as
adjuncts to radiotherapy. The target
for this research is improved treatment
of those solid tumors which are resis¬
tant even to the best of current treat¬
ment.
Because of their oxygen transport
properties, perfluorochemicals have
been studied at a number of institutions
for use in perfusing organs for transplant
and for use after trauma or during
surgery when blood transfusions are
impossible, or are refused on religious
grounds. Dr. Rockwell, professor
(adjunct) of research in therapeutic
radiology, is investigating the effects
on solid tumors of one such perfluoro¬
chemical, Fluosol-DA 20%, to deter¬
mine whether this agent may be useful
as an adjunct to radiotherapy.
“Laboratory studies on animals with
solid tumors, and studies of cancer
patients treated with radiotherapy and
combined modalities suggest that the
resistance of some tumors to treatment
may be the result of oxygen deficient
(hypoxic) regions in the tumors,” Dr.
Rockwell explained. “Solid tumors of¬
ten have abnormal, inadequate and
poorly functional vascular beds, which
render many tumor cells chronically or
transiently hypoxic. Because oxygen
sensitizes cells to the effects of x-rays,
these radiation-resistant hypoxic cells
may survive treatment with radiother¬
apy and allow tumors to recur.
Fluosol is composed of a balanced
salt solution with properties similar to
plasma, containing a very fine stabilized
emulsion of droplets of liquid perfluoro¬
chemicals (PFCs). These PFCs have
the unusual property of being able to
dissolve very large amounts of oxygen
up to 40 percent of their weight.
When Fluosol is infused intravenously,
the PFC droplets will circulate in the
blood and carry oxygen
and because
they are much smaller than red blood
cells, they may reach and deliver oxygen
to areas inaccessible to red cells, such
as the hypoxic regions of tumors.
In preliminary studies. Dr. Rockwell
and her colleagues have found that
infusing laboratory animals that have
breast cancer or sarcomas, with Fluosol
and having them breathe oxygen before
and during radiotherapy increases the
number of tumor cells killed by radia¬
tion, but does not increase the toxicity
of the radiation to the blood-forming
cells of bone marrow. Further studies
will examine the effect of Fluosol treat¬
ment on other tumors and other normal
tissues, to evaluate whether this agent
in combination with radiotherapy has
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Dr. Charles Stevens was appointed
professor and chairman of the Section of
Neurobiology when it was established a
year ago for teaching and conducting
research on the molecular basis of brain
function, structure and development.
Since then, he has brought together a
faculty of outstanding young scientists
with interests in molecular biology and
neurobiology.
Two have recently been recognized with
important awards. Dr. Richard W.
Aldrich, above, assistant professor, has
been named a 1984 Searle Scholar with a
grant for three years in support of his
studies of the properties of voltage-gated
sodium channels. This research is aimed
at increasing the understanding of the
basic mechanisms of brain function.
Dr. Michael Lerner, below, also an
assistant professor, has been awarded a
Me Knight Foundation Scholars Award
for three years. He is investigating the
genetic basis of olfactory receptor cells —
research that has significant implications
for understanding the mechanisms of
memory and for treating conditions of the
central nervous system such as spinal cord
injury and Parkinson's disease.
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the potential for effective treatment of
solid tumors in humans.
Another project, in collaboration
with Dr. Alan Sartorelli, acting chair¬
man of the Department of Pharma¬
cology and director of the Comprehen¬
sive Cancer Center, has examined the
effects of drugs w hich might selectively
kill hypoxic cells because of their
unusual physiologic characteristics or
environment. These drugs — bioreductive alkylating agents — are not active
in their original forms, but are enzy¬
matically activated within cells, to give
reactive drugs. Some bioreductive alkyl¬
ating agents are activated more readily
in hypoxic cells than in aerobic cells,
and therefore, selectively kill hypoxic
cells. Members of Dr. Rockwell’s labora¬
tory, as well as of other laboratories in
the Department of Therapeutic Radi¬
ology, have been working with Dr.
Sartorelli and his colleagues to assess
whether the combination of these drugs
and radiotherapy would be especially
effective in the treatment of solid
tumors.
In another study. Dr. Ravinder Nath,
associate professor of therapeutic radio¬
logy, in collaboration with Dr. Richard
Peschel, assistant professor. Dr. Robert
.1. Schulz, professor, and Laurence
Gray, a radiation physicist, is developing
the use of Americium-241 radioactive
resources for treatment of uterine cancer
in anticipation of achieving two impor¬
tant benefits: the ability to protect
critical normal organs; and the substan¬
tial reduction of radiation exposure to
medical personnel.
Radium was first used in the treat¬
ment of cancer of the uterine cervix in
1903. Today, therapy typically combines
the use of intracavitary radium or cesium
radioactive sources and external beam
therapy. Intracavitary radiation
a
form of brachytherapv - is performed
by placing radioactive sources at very
short distances from the tumor in a
body cavity to deliver a highly localized,
lethal dose to the tumor while sparing
the sensitive normal tissues nearby.
Because the lower energy gamma
rays of americium can be effectively
shielded w ith thin layers of lead or gold
placed on the outside of the applicator.
Dr. Nath and his colleagues are develop¬
ing Americium-241 sources for brachytherapy. A thickness of 0.4 mm of lead
can reduce the intensity of americium
gamma rays by half, in contrast to 12
mm of lead required to shield radium
gamma rays.In addition, it should be
possible to custom modify the applicator
for each patient’s anatomy and tumor
distribution, according to Dr. Nath.

Further, Dr. Nath has predicted that,
with americium, it would be possible to
place effective shielding material within
body cavities. For example, a patient’s
bladder could be filled with hypaque
and the rectum with barium sulfate to
shield the distal portions of these organs,
while still treating the more proximal
areas where tumor infiltration might
occur.
In addition to therapeutic considera¬
tion, the exposure to radiation of medi¬
cal personnel is another consideration
in the use of brachytherapy techniques.
Nurses w ho care for patients undergoing
conventional brachytherapy receive
a higher rate of exposure to radiation
than most members of a hospital staff,
because the high energy of gamma rays
of radium and cesium make it imprac¬
tical to reduce exposure by shielding.
Devices developed to remove the radio¬
active sources from a patient during
routine nursing care have not been
entirely satisfactory because they com¬
promise the positioning of radioactive
sources and are uncomfortable and
inconvenient to the patient.
The use of americium would be
strikingly different, according to Dr.
Nath, because a lead shield of only 1.4
mm thick would reduce radiation levels
by a factor of 1000. Effective shielding
of operating room personnel could
easily be achieved, and exposure to
medical personnel and visitors w'ould
be negligible.
Most anticancer drugs do not cross
the blood-brain barrier, and are there¬
fore ineffective as brain tumor therapy.
In research to find a more effective
treatment of brain tumors and other
cancers of the central nervous system.
Dr. William N. Hait, assistant professor
of medicine, is studying the interaction
of drugs with calmodulin, a calcium¬
binding protein which plays an impor¬
tant role in cell proliferation and cell
differentiation.
He will isolate calmodulin from nor¬
mal brain tissue and compare its char¬
acteristics with calmodulin isolated from
brain tumors. “We have been able to
demonstrate that drugs which inhibit
the activity of calmodulin will inhibit
the growth of brain tumor cells grown
in culture," he said. “Our goal in this
project is to find more potent inhibitors,
and ones that may potentially be selec¬
tive for the calmodulin of the tumor
cells. Since many of the inhibitors
previously identified are known to ac¬
cumulate in the brain, it should be
possible to achieve higher concentra¬
tions of the drugs in tumors grow n in
animal tissue,” he explained. This re-

search is supported by a grant from the
American Cancer Society.
A major concern in anticancer drug
therapy is the damage these drugs
cause to surrounding normal tissue. In
an effort to learn more about the
interactions of normal cells and cancer
cells during chemotherapy, Dr. Evangelo Canellakis, professor of pharma¬
cology, has developed a method tor
growing cancer cells in co-culture with
normal cells. Because the method is
extremely sensitive, he is able to follow
the outgrowth of five to ten tumor cells
seeded on a bed of normal cells. The
tumor cells then form new individual
colonies. At this point. Dr. Canellakis
is able to estimate the growth of indi¬
vidual cancer cells that grow in contact
with normal cells.
Using this method, he will study the
response of cancer cells to drug toxicity,
to determine whether, as it is thought,
normal cells protect cancer cells from
the killing action of the drug. Prelim¬
inary studies have indicated that the
effect of an anti-cancer drug on cancer
cells is influenced by the length of time
the cancer cells have been in contact
with the normal cells, on the growth
rate of the normal cells and on com¬
munication between cancer cells.

HYPERTENSION
The School of Medicine received $2.1
million from the National Institutes of
Health to participate with 16 other
institutions in a collaborative clinical
trial to determine whether long-term
administration of antihypertensive
therapy to elderly persons with isolated
systolic hypertension (ISH) reduces the
incidence of stroke and other complica¬
tions of high blood pressure. Dr. Henry
R. Black, associate professor of internal
medicine, is principal investigator of
the program at Yale.
More than three million Americans
have ISH. In fact, the condition is more
prevalent than diastolic hypertension
in the age group over 70, and affects as
much as twenty percent of that popula¬
tion. Previous studies have indicated
that these persons face a two-to-three
fold increased risk of stroke, as well as
other cardiovascular diseases and death.
Whether or not ISH should be treated
is an important health issue, not yet
resolved because of a lack of sufficient
scientific evidence. “This study will
provide the necessary facts about this
important problem,” said Dr. Black.
“If the study shows that treatment
reduces strokes and other complica¬
tions, we will be able to prevent serious
disabling disease with inexpensive and

easily applied techniques.”
In addition to assessing the effects of
long-term antihypertensive therapy on
stroke, the objectives of the study in¬
clude assessing the effects of this therapy
on cardiovascular mortality and mortal¬
ity from all other causes, as well as the
prevention of dementia and depression.
The clinical centers will also study
possible adverse effects of chronic use
of antihypertensive drug treatment in
the elderly.
The Systolic Hypertension in the
Elderly Program (S H EP) will last approxi¬
mately six years. Each of the 17 partici¬
pating institutions will serve as a Clinical
Center fortheSHEP program and will
identify and enroll 300 relatively healthy
individuals over sixty years old who
have ISH. Half of this group will
receive standard antihypertensive ther¬
apy for from four to six years; the
others will receive a placebo. All of the
participants will be seen at regular
intervals by the medical personnel of
the SHEP clinical centers.
Dr. Charles Francis, associate pro¬
fessor of medicine, and Jan Davey,
M.S.N., clinical studies researcher in
medicine, will work with Dr. Black in
the Yale SHEP program. Yale-New
Haven Hospital, Park City Hospital in
Bridgeport, and the Meriden-Wallingford Hospital will participate in patient
evaluation and follow-up.

PEDIATRICS
The School has received a grant of
$800,000 from the Robert Wood John¬
son Foundation to participate in the
Foundation’s Infant Health and Devel¬
opment Program to test the effectiveness
of combining early childhood develop¬
ment services with pediatric care in
reducing the incidence of health and
developmental problems in low birthweight infants. There are indications
that programs designed to provide pedia¬
tric social and educational support to
low birthweight infants and their fami¬
lies promote enhancement of develop¬
ment in these infants in preschool years,
but as yet there has been no definitive
study on a national level.
In the program, 135 low birthweight
infants will be enrolled and randomly
assigned to one of two treatment levels.
Infants will receive full continuing pedia¬
tric and developmental services to assess
their progress after discharge from the
hospital, according to Dr. David T.
Scott, assistant professor of pediatrics,
director of the Yale study. Infants in
one of the groups will receive additional
services, including parental education
and day-care provided by the Quinni-

piac College Day Care Facility.
Pediatric and developmental assess¬
ment services will take place in the
Department of Pediatrics, co-directed
by Dr. Scott and Dr. Laura R. Ment,
associate professor of pediatrics and
neurology, in collaboration with Dr.
Richard A. Ehrenkranz, associate pro¬
fessor of pediatrics.
Most traditional pediatric programs
prepare residents to deal with acute
illness and well child care, but fail to
provide comprehensive educational ex¬
periences in three critical areas: develop¬
mental and psychosocial problems,
chronic illness, and adolescent medicine.
Dr. Paul McCarthy, professor of pedia¬
trics, is director of the Integrated Con¬
tinuity Group Program in the Depart¬
ment of Pediatrics, which has been
developed to improve residents’training
in these areas.The program is supported
by a grant of $618,000 from the Health
and Human Resources Division of the
Public Health Service.
Twelve residents will participate in
the Integrated Continuity Group (ICG)
throughout the three years of training.
T hey will see on a regular basis a panel
of continuity patients including well
children as well as children with develop¬
mental and psychosocial problems,
chronically ill children, and adolescents.
Faculty with special interest and exper¬
tise in the three critical areas, will teach
and supervise the program. A nurse
practitioner, social worker and child
psychiatrist will be an integral part of
the supervisory team.
It is anticipated that on completion
of the program, residents will be com¬
petent to (1) identify and evaluate
psychosocial and behavioral problems
of children in their practice;(2) provide
appropriate counseling for psychosocial
and behavioral problems and make
appropriate referrals to mental health
clinicians; (3) collaborate with other
health and educational professionals in
the care of chronically ill children; (4)
understand the impact of chronic disease
on families; (5) recognize and manage
psychosocial problems of adolescents.
If evaluation of the program clearly
demonstrates its effectiveness, the ICS
program will become a model for teach¬
ing general pediatrics at Yale. It could
also serve as a model for other teaching
programs in pediatrics throughout the
country.
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“ . . . it, as a whole, has competed
so successfully for NIH research
and training funds as to rank
among the top three medical
schools nationally in each of the
last five years. ”
President Giamatti to the Alumni, June 9,1984

JAVITS AWARDS
RECOGNIZE OUTSTANDING
RESEARCH IN
NEUROSCIENCES BY FOUR
YALE SCIENTISTS
In its 1984 fiscal appropriations,
the Congress of the United States
asked that special awards be made
for outstanding research in the neuro¬
sciences in honor of Jacob K. Javits,
the former senator from New' York.
Since then, four Yale scientists have
received Javits Neuroscience Investi¬
gator Awards designated by the
National Institute of Neurological
and Communicative Disorders and
Stroke (N1NCDS) for investigators
who have a distinguished record of
substantial contribution in a field
of neurological or communicative
science, and who can be expected
to be highly productive over the
next seven years.
In February, Dr. Elias Manuelidis, professor of neuropathology
and neurology, received $1.2 million
for his research on Alzheimer’s
disease, and Dr. Pasko Rakic, Dorys
McConnell Duberg Professor and
chairman of the Section ol Neuro¬
anatomy, received $1.5 million for
research on the neurogenic processes
in the fetal brain.( Yale Medicine,
Spring 1984).
More recently, NINCDS awarded
$1.2 million to Dr. Robert K. Yu
for basic research to understand
degenerative diseases of the central
nervous system, and $1 million to
Dr. Robert H. EaMotte for his
studies on the mechanisms ol pain.
The awards are for a period of
seven years.
Dr. Yu, professor (adjunct) of
research in neurology, is regarded
as an outstanding scientist in the
fields of neurochemistrv and devel¬
opmental neurobiology. In on-going
basic research to better understand
the processes of motorneural degen¬
eration seen in amyotropic lateral
sclerosis (AES), multiple sclerosis
(MS) and other disorders of the
central nervous system, he is study20

mg normal and abnormal glycosphingolipids, sugar containing sub¬
stances which are located in cells of
nerve fibers. In particular, he is
investigating the properties of glycosphingolipids called gangliosides,
to better understand the relation¬
ships of ganglioside metabolism
and the physiological dysfunction
associated with a variety of neuro¬
logical diseases.
“There is evidence that ganglio¬
sides play an important role in the
degenerative process of the central
nervous system seen in these dis¬
eases,” Dr. Yu said. “Through our
research, we hope to be able to
develop methods to interfere with
this process.”
Dr. EaMotte’s research is directed
at determining the neurophysical
origins of cutaneous pain, itch and
hyperalgesia. Specifically, the stud¬
ies will attempt to determine the
chemical origin of hyperalgesia.
“The results of these studies will
be useful in identifying those central
neurons at the level of the thalamus,
that process sensory information
about pain, itch and hyperalgesia,”
he explained. This information, in
turn may lead to the development
of specific pharmacological agents
that act peripherally to block the
pain-causing chemical or to act
centrally to block sensory processing
in neurons that transmit pain.
Dr. EaMotte is an associate pro¬
fessor of anesthesiology and neuro¬
anatomy.
YALE SCIENTISTS
RECOGNIZED FOR AN
IMPORTANT
BREAKTHROUGH IN
RESEARCH ON LUPUS
A team of Yale medical scientists
has been awarded the first Lee
Howley Sr. Prize for outstanding
research which represents a major
advance in the understanding of
rheumatic diseases. The Arthritis
Foundation presented the prize to
Drs. Joan A. Steitz, John A.Hardin
and Michael Lernerforthe identifi¬
cation of prominent autoantigens
in systemic lupus erythematosus.
Yale is considered one ol the
leading institutions in the world for
systemic lupus erythematosus (SLE)

research. Scientists have come here
from Japan and Europe to learn
new techniques developed by Drs.
Steitz, Hardin and Lerner for clinical
and basic science research in SEE
and other rheumatic diseases.
Dr. Steitz, professor of molecular
biophysics and biochemistry, is in¬
ternationally recognized for her re¬
search in deciphering molecular
mechanisms of gene expression in
bacterial cells. Dr. Hardin, who has
made significant contributions to
the understanding of the patho¬
physiology of SLE with his earlier
studies of immune regulation, is
associate professor of medicine in
the Section of Rheumatology. Al¬
though Dr. Lerner’s career began
only a few years ago, he has received
several important awards for his
research. A 1981 graduate of the
School of Medicine, he was ap¬
pointed assistant professor of mole¬
cular neurobiology last fall.
By providing a clear concept of
the nucleoprotein autoantigens that
seem to trigger diseases such as
SLE, this team has made a major
contribution to both basic molecular
biology and to clinical medicine. In
addition, their studies have demon¬
strated the usefulness of human
antibodies as tools for basic
research.
The work began in 1979, when,
as a student working with Dr. Steitz,
Dr. Lerner began to dissect the
structure and function of small
RNA-protein complexes that are
found in all cells, but which pre¬
viously had been poorly understood.
Using the autoantibodies which are
found in practically all patients
with SLE as a tool, he was able to
define three distinct classes of small
nuclear and cytoplasmic ribonucleoproteins.
Using this approach, Drs. Steitz,
Lerner, and Hardin have character¬
ized the structures within cells that
trigger autoimmune responses to
give rise to antinuclear antibodies,
the characteristic immune system
abnormality in SLE. At the same
time, they have developed a group
of defined patient sera and mono¬
clonal antibodies for clinical and
basic science research.

In recognition of his
achievements as a scholar, in
honor of that commitment to
the highest standards of
quality, and for his many
contributions in many wavs
to science, to Yale and to this
country, I am privileged to
announce the creation of the
Robert W. Berliner
Professorship of Internal
Medicine in the Yale School
of Medicine.
President A. Bartlett Giamatti

T

he occasion was a reception honoring Dean and Mrs. Berliner on
June 23rd in the courtyard of the Beinecke Rare Book and Manuscript
Library. Almost 600 guests gathered to join President Giamatti in
raising a “glass to Lea and Bob Berliner in affectionate thanks for all they
have done to enrich our lives and in the highest and delighted anticipation of
the many, many years to come and all the ways they will sustain us.”
Earlier in his remarks, the President cited Dr. Berliner’s accomplishments
during the eleven years of his deanship. “Under Bob Berliner’s leadership,
the School has become one of the top two or three institutions in America in
terms of hosting research supported by peer reviewed grants. He has
overseen the creation of outstanding teaching facilities in the Hope Building,
the renewal of in-patient teaching facilities at the Yale-New Haven Hospital,
the development of the Faculty Practice Plan, and the establishment of the
first major fund-raising campaign in the history of the School.”

Dean and Mrs. Berliner
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A NEW CHAIRMAN
IS APPOINTED FOR
HUMAN GENETICS

HERE & ABOUT

Dr. Carolyn W. Slayman, a leading
research scientist and educator, has
been named chairman of the Depart¬
ment of Human Genetics. She suc¬
ceeds Dr. Leon E. Rosenberg, who
assumed the office of dean of the
School on July 1.
In announcing the appointment.
President A. Bartlett Giamatti said,
“I am enormously grateful to Pro¬
fessor Slayman for taking on this
important responsibility, and I am
confident that under her leadership
the department will continue to
flourish.”
Dr. Slayman, who is professor of
human genetics and physiology,
has been a member of the Depart¬
ment of Human Genetics since it
was established in 1972. Herspecial
research interest is in the proteins
that transport nutrients across cell
membranes, and in the genes that
code for those proteins. In addition,
she is recognized as an outstanding
teacher, as exemplified by her ap¬
pointment as the first director of
graduate studies for the Department
of Human Genetics, a post she has
held almost continuously since 1972.
In 1981, she was appointed chairman
of the Genetic Basis of Disease
Review Committee of the National
Institutes of Health. This committee
reviews applications for predoctoral
and postdoctoral training grants in
genetics.
Dr. Slayman graduated from
Swarthmore College in 1958 with
highest honors in biology and chem¬
istry. She received her Ph.D. degree
in biochemical genetics from Rocke¬
feller University in 1963, and spent
the following year as a National
Science Foundation Postdoctoral
Fellow at Cambridge University.
Her first academic appointment
was as an instructor in biology at
Western Reserve University, Cleve¬
land. She came to Yale in 1967 as
an assistant professor of microbiol¬
ogy and physiology. In 1972, she
was appointed associate professor
of human genetics and physiology,
and in 1979, she was promoted to
professor.
A Research Career Development
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Awardee of the NIH from 1968 to
1973, Dr. Slayman served on the
NSF Advisory Panel on Genetic
Biology from 1974 to 1977, and was
associate editor and a member of
the editorial board of Genetics from
1977 to 1982. She is a member of
the Board of Overseers of Bowdoin
College, Brunswick, Maine, and of
the Board of Trustees of Foote
School in New Haven.
NEW CHAIRMAN
APPOINTED FOR
DEPARTMENT OF MB&B
Dr. William H. Konigsberg has
been appointed chairman of the
Department of Molecular Biophys¬
ics and Biochemistry, effective July
1. He succeeds Dr. Dieter G. Soil.
Dr. Konigsberg’s research inter¬
ests include protein chemistry, the
molecular biology of DNA replica¬
tion in bacteriaphage, and initiation
of blood clotting. He joined the
Yale faculty in 1964 as an associate
professor of biochemistry, and was
promoted to professor in 1976.
A graduate of Rensselaer Poly¬
technic Institutes, he received a
Ph.D. degree in organic chemistry
from Columbia University. The fol¬
lowing year, he was a National
Science Foundation Fellow at The
Rockefeller Institute, where he sub¬
sequently became a research associ¬
ate, and in 1959, assistant professor.

A DIRECTOR IS
APPOINTED FOR THE
MEDICAL LIBRARY
Bella Z. Berson, acting medical
librarian since January, has been
appointed director of the Yale Med¬
ical Library, effective August 1.
She will also retain her title of
associate librarian of the University
Library, a post she has held since
1982.
Mrs. Berson has been associated
with the Yale University Library
since 1969. A graduate of New
York University, where she was
elected to Phi Beta Kappa, she
received her masters degree in
library science from the University
of Wisconsin Library School.

DR. FRIEDLAENDER
APPOINTED CHIEF
OF THE SECTION OF
ORTHOPAEDIC SURGERY
Dr. Gary E. Friedlaender has been
appointed chief of the Section of
Orthopaedic Surgery. Dr. Fried¬
laender, who is associate professor
of surgery, is well known for his
research in orthopaedic transplanta¬
tion. He is interim president of the
American Council on Transplanta¬
tion, a group formed by the U.S.
Department of Health and Human
Services, and president of the Ameri¬
can Association of Tissue Banks.
Dr. Friedlaender’s major roles
will be to facilitate the review of
current structure and function of
orthopaedics in the Yale-New Haven
Medical Center and to make recom¬
mendations concerning long range
goals for the orthopaedics program
at Yale, according to the announce¬
ment of his appointment by C.
Thomas Smith, president of the
Hospital and Dean Leon E. Rosen¬
berg. “The term of this appointment
will be short, reflecting a mutual
desire to complete expeditiously an
orderly review process while sustain¬
ing clinical, research and teaching
function.
SEARCH COMMITTEES
APPOINTED FOR
CHAIRMEN OF THREE
DEPARTMENTS
Dr. Samuel O. Thier, chairman of
the Department of Internal Medi¬
cine, has been appointed chairman
of the search committee for a chair¬
man of the Department of Psychia¬
try to succeed Dr. Morton Reiser,
who has held that post since 1969.
Members of the committee include
Dr. David Clement, clinical pro¬
fessor of pediatrics; Dr. William
Collins, Jr.,Harvey and Kate Cush¬
ing Professor of Neurological Sur¬
gery; Mr. Vincent Conti, vice-presi¬
dent, Y-NHH; Dr. John Fenn, clini¬
cal professor of surgery; Dr. Sidney
Klaus, professor of dermatology;
Judith B. Krauss, associate dean.
School of Nursing; Dr. James W.
Prichard, professor of neurology;
Dr. Sally Provence, professor of

pediatrics. Child Study Center; Dr.
Pasko Rakic, chairman. Section of
Neuroanatomy; and William
Kessen, Eugene Higgins Professor
of Psychology and Pediatrics.
Dr. Aaron Lerner has announced
his intention to retire as chairman
of the Department of Dermatology.
Dr. Lerner, who was appointed head
of the Section of Dermatology in
1958, has been chairman since it
became a department in 1971. A
search committee for his successor
is being chaired by Dr. Richard
Greenspan, chairman of the Depart¬
ment of Diagnostic Radiology. Mem¬
bers of that committee include Vin¬
cent Conti, vice-president of
Y-NHH; Dr. Paul Errera, professsor
of psychiatry; Dr. Marilyn Farquhar, professor of cell biology;
Dr. Paul McCarthy, professor of
pediatrics; Dr. Stephen Malawista,
professor of medicine; Dr. John
Moench, associate clinical professor
of neurology; Dr. Jon Morrow
assistant professor of pathology;
Dr. Frederick Naftolin, chairman
of the Department of Obstetrics
and Gynecology; Dr. Richard Stahl,
assistant professor of surgery; and
Dr. Joseph Weissberg, associate
professor of therapeutic radiology.
A third search committee has
been appointed for a chairman of
the Department of Surgery to suc¬
ceed Dr. Arthur E. Baue. Chaired
by Dr. Paul Barash, chairman of
the Department of Anesthesiology,
the committee includes Dr. Joseph
Bove, professor of laboratory medi¬
cine; Dr. James Boyer, professor of
medicine; Dr. Joyce Gryboski, pro¬
fessor of pediatrics; Dr. Robert
Handschumacher, professor of phar¬
macology; Dr. John Hobbins, pro¬
fessor of obstetrics and gynecology;
Dr. Vincent Marchesi, chairman of
the Department of Pathology; Dr.
Richard Mattson, professor of
neurology; Dr. Frederick Sachs,
associate clinical professor of medi¬
cine; Dr. Marvin Sears, chairman
of the Department of Ophthalmol¬
ogy and Visual Science; and Joseph
Zaccagnino, executive vice presi¬
dent, Y-NHH.

FOURTH YEAR STUDENT
AWARDED FELLOWSHIP
Reginald Sanders, a member of the
class of 1985, has been named the
1984 recipient of a Commonwealth
Fund Fellowship with an award of
$5000 for the fellowship stipend
and research support. This program,
sponsored by The Commonwealth
Fund and National Medical Fellow¬
ships, Inc., is specifically designed
to encourage academically gifted
minority medical students to prepare
for careers in academic medicine
and biomedical research.
Mr. Sanders will be working
with Dr. Ali Khodadoust, professor
of ophthalmology, on the role of
hypoxia in neovascularization using
the cornea as a model.

“We all have to remember to tell
our students, when they get
discouraged by another tong week
in the lab when nothing's worked,
that the thrill when something
does work is worth it all. ”
Carolyn Slayman quoted ini ogue

FIRST YJB&M RESEARCH
PAPER AWARD
The Yale Journal of Biology and
Medicine presented its first Yale
Journal Student Research Paper
Award to Bruce K. Jacobson of the
class of 1986. He was presented
with a check for $1000 for the best
paper based on research carried out
at the School of Medicine by a
candidate for an M.D. or Ph.D.
degree and submitted to The
Journal.

Mr. Jacobson’s paper, “Immuno¬
suppression Following Escision of
Burn Eschar and Synergeneic Graft¬
ing in Major Thermal Trauma”,
was based on research carried out
in the Department of Surgery in
collaboration with Dr. Christopher
C. Baker. The paper will be pub¬
lished in a forthcoming issue of The
Journal. A similar contest will be
conducted annually.
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TWO ON FACULTY ELECTED
TO N A S
. . it contains one Nobel
laureate, George Palade, and no
fewer than 17 members of the
National Academy of Sciences, 11
members of the A merican
A cademy of A rts and Sciences,
and 9 members of the National
Institute of Medicine...”
President Giamatti to the Alumni, June 9, 1984

Dr. Giebisch

Dr. Hoffman

Dr. Marilyn G. Farquhar and Dr.
Gerhard H. Giebisch are among
five Yale professors to be elected to
the National Academy of Sciences
at its 121 st annual meeting in Wash¬
ington, D.C. on May 1. Election to
the NAS, one of the highest honors
for an American scientist, is in
recognition of distinguished achieve¬
ment in original research.
Dr. Farquhar, professor of cell
biology, is recognized for her out¬
standing research on secretion and
membrane recycling in anterior pitu¬
itary and other cells. Prior to her
appointment to the Yale medical
faculty in 1973, she was professor
of pathology at the University of
California, San Francisco until 1971,
when she was appointed professor
at Rockefeller University. Dr. Far¬
quhar received a B.A. degree in
zoology and M.A.and Ph.D. degrees
in experimental pathology from
the University of California at
Berkeley.
An authority on renal function.
Dr. Giebisch, who is Sterling Pro¬
fessor of Physiology, has received
numerous honors and awards for
his research. Born in Vienna, Aus¬
tria, he received his M.D. degree in
1951 from the University of Vienna
Medical School. Prior to his ap¬
pointment in 1968 as professor and
chairman of the Department of
Physiology at Yale, Dr. Giebisch
had been professor of physiology at
Cornell University Medical School.

AND TWO TO THE
AMERICAN ACADEMY OF
ARTS AND SCIENCES

Dr. Stevens
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Dr. Joseph F. Hoffman and Dr.
Charles F. Stevens were among six
Yale professors and 73 leading
scholars, scientists, public figures
and artists recently honored by
election to the American Academy
of Arts and Sciences. Dr. Hoffman
is Eugene Higgins Professor of
Physiology, and Dr. Stevens is chair¬
man and professor of molecular
neurobiology. Both are members
of the National Academy of Sciences
as well.

FACULTY NOTES
Dr. Samuel O. Thier has been
elected chairman of the American
Board of Internal Medicine for the
year 1984-85. Dr. Thier is Sterling
Professor of Medicine and chairman
of the Department of Internal Medi¬
cine. I he ABIM is the certifying
body for physicians who specialize
in internal medicine and in nine of
its subspecialties.
The University of Rochester award¬
ed an honorary Doctor of Science
degree to Dr. Joan A. Steitz, profes¬
sor of molecular biophysics and
biochemistry. One of three bio¬
medical scientists to receive the
honorduringthe University’s Schoolof Medicine and Dentistry com¬
mencement, she was cited for her
“record of continuously outstanding
research” that has provided “new
insights into the translation of
genetic information into proteins
and ultimately into cellular
function.”
Dr. Richard H. Greenspan, professorand chairman of the Department
of Diagnostic Radiology, received
the Gold Medal of the Association
of University Radiologists for his
basic research in pulmonary embo¬
lism and the application of a variety
of imaging techniques. The Gold
Medal is the highest honor of the
AUR, presented to individuals
whose contributions to the field of
radiology, academics and the AU R
merit special recognition.
The Class of 1983 at the University
of Arizona College of Medicine
invited Dr. Harold O. Conn to be
keynote speaker at their convocation
in May. Convocation is a special
program for the College of Medicine
graduates, held prior to the gradua¬
tion ceremony for the entire univer¬
sity. Dr. Conn is professor of medi¬
cine and chief of the Hepatic Disease
Unit at the Veterans Adminstration
Medical Center in West Haven.
The American College of Physicians
recognized Dr. Philip K. Bondy
with an ACP Mastership for his
outstanding contributions to medi¬
cine. Dr. Bondy, professor of medi-

cine and associate dean at the Veterans
Administration Medical Center, West
Haven, was honored for his contribu¬
tions to internal medicine as an educa¬
tor, author, administrator and ex¬
pert investigator. The editor of The
Yale Journal of Biology and Medi¬
cine, he is known for his studies on

internal secretory glands and for
research in cancer. Dr. Bondy is
one of about 150 of the 60,000
members of ACP to be honored
with the rank of ACP master.
The American Orthopaedic Associa¬
tion has elected Dr. Wayne O.
Southwick, professor of surgery
(orthopedic) its vice president. Dr.
Southwick is well known as a teacher
of medical students and residents
and as a research scientist. His
studies on surgery of the cervical
spine and the slipped capital femoral
epiphysis are recognized throughout
the world.
The American Heart Association,
South Central Connecticut Chapter
honored Dr. Ruth Whittemore as
its Woman of the Year at the
annual meeting in May. Dr. Whitte¬
more, who is clinical professor of
pediatrics, was cited for her outstand¬
ing contributions to the American
Heart Association in the field of
pediatric cardiology.
For their research paper entitled
“Air Quality in Buildings During
Smoking and Nonsmoking Occu¬
pancy”, Drs. Brian P. Leaderer and
William S. Cain received the Crosby
Field Award of the American So¬
ciety of Heating, Refrigerating and
Air Conditioning Engineers. Dr.
Leaderer is associate professor of
epidemiology and public health and
Dr. Cain is associate professor of
epidemiology and psychology. Both
are associate fellows of the John B.
Pierce Foundation Laboratory as
well. I heir work was reported in
the Spring 1982 issue of Yale
Medicine.

Dr. Robert Shulman, professor of

molecular biophysics and biochem¬
istry and chemistry was presented
the Gold Medal Award of the

Society of Magnetic Resonance for
his creative research in the applica¬
tion of nuclear magnetic resonance
spectroscopy to biomedical and clin¬
ical research. He was corecipient of
the award with Dr. George Radda
of Oxford University, during the
annual meeting of the Society of
Magnetic Resonance in New York
on August 14.
Dr. Kyle Grazier.assistant professor
of epidemiology and public health,
is one of five Fellows selected for
the first class of the Robert Wood
Johnson’s Program for Faculty
Fellowships in Health Care Finance.
The purpose of the program is to
develop outstanding university
faculty with the skills needed to
teach and conduct research in the
rapidly changing field of health
care finance, such as DRG’s. PPO’s,
ratesettingand others. Fellowships
begin at The Johns Hopkins Medical
Institutions with an intensive threemonth study of the latest innovaions in health care finance. During
the following nine months. Fellows
will have a structured field and
research experience in a public or
private health care financing organ¬
ization.

The 20th Annual Meeting of the
New England Public Health Associ¬
ation held this past spring was
dedicated to Dr. Ira V. Hiscoek,
Anna M R.Lauder Professor Emer¬
itus of Public Health.

JOSEPH M1GNONE, M.D.
Dr. Joseph Mignone, assistant clini¬
cal professor of medicine, died on
July 5 in Yale-New Haven Hospital.
He was 75 years of age and had
practiced medicine in New Haven
for 45 years prior to his retirement
in 1981.
Born in New Haven in 1909, he
attended Yale where he received his
bachelor’s degree in 1930 and his
M.D. degree in 1933. Following

house staff trainingat Duke Univer¬
sity Hospital and the New Haven
Hospital, he entered practice in
1936. During World War II, he
served as a medical officer in the
U.S. Navy and saw active duty in
the South Pacific and Philippines.
Dr. Mignone was first appointed
to the Yale School of Medicine
faculty in 1941 as a clinical assistant
in medicine. On his return from
military service in 1946, he became
a clinical instructor, and in 1956 he
was promoted to assistant clinical
professor of medicine. He was a
member of the attending staffs at
the Yale-New Haven Hospital and
at the Hospital of St. Raphael,
where he was chief of medicine
from 1943 to 1977 and served as
president of the staff from 1967 to
1968 and director of ambulatory
services from 1971 to 1976. He was
president of the New Haven Heart
Association from 1952 to 1954.
He is survived by his wife, Louise,
and by his son and daughter and
four grandchildren.

MARY ELIZABETH
McGARRY, M.D.
Dr. Mary Elizabeth McGarry, assis¬
tant clinical professor in the Child
Study Center and pediatrics, died
in the Yale-New Haven Hospital
on July 5 at the age of 63. She was a
native of New Haven and a graduate
of Albertus Magnus College and
the Tufts University School of Medi¬
cine. She did her internship at
Children’s Hospital in Boston.
Dr. McGarry held appointments
in the Yale Department of Pediatrics
from 1957 to 1961. She was then
appointed as an instructor in the
Child Study Center and subse¬
quently as a research associate.
Since 1969 she has been as assistant
clinical professor.
In addition to her pediatric activi¬
ties, she was a member of the New
Haven Symphony Associates and
the New Haven Council of Catholic
Women. She was the widow of Dr.
John C. McLaughlin and is survived
by their two sons.
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PRESIDENT
GIAMATTI
ANNOUNCES
$125 MILLION
FUND RAISING
CAMPAIGN FOR
THE SCHOOL

The following is President
Gianwtti's address to the alumni
on Saturday, June 9th.
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Universities do not only promote change; they also maintain continuity. To
maintain the interplay between continuity and change provides the challenge
in this unique environment. Although we generally regard the faculty as the
stable component of the university enterprise, it too is remarkable for
change. Every year numerous members of the faculty are recruited, and
numerous others leave - some for other universities or careers, others by
dint of retirement. But this changing faculty scene involves much more than
the names or ranks of people on the roster. The research questions this
faculty ask, and the means they employ to answer the questions they raise
about the mysteries of health and disease are continually being modified.
Tikew'ise, the body of information w'hich the faculty must transmit to
students is anything but static. This is particularly true today as the dramatic
advances in cellular and molecular biology, in genetics, in immunobiology,
and in neurobiology affect not only the basic fountains of biomedical
thought, but also the means bv which disease is detected, treated and
prevented.
But this year the Yale School of Medicine changes in a way (fortunately
for me as President) which occurs quite infrequently. As you all know, 1984
marks the end of Bob Berliner’s term as Dean of the School of Medicine and
the beginning of Dean-Designate Tee Rosenberg’s elevation (in my view at
least) to this most important post. As these two good friends accomplish this
transition upon which we all depend, it is fitting for me to mention some
things about them.
Bob Berliner came back to Yale as Dean in 1973 after an illustrious
scientific and administrative career at the National Institutes of Health. His
1 1 years as steward at Yale’s School of Medicine have been outstanding ones.
Let me remind you of Bob Berliner’s notable accomplishments as Dean:
He has recruited more than half of all the men and the first woman serving
(or soon to serve) as chairs of the School’s 22 departments and sections.;
He has helped secure the funds for the Nathan Smith Bridge building
which joins the old New Haven Hospital unit w ith Sterling Hall, and which
houses key components of the Department of Human Genetics and the
Comprehensive Cancer Center;
He has resisted the temptation to demolish this old. proud and beautiful
Hope Building, choosing instead to turn it into a much needed (and now
much enjoyed) teaching center;
He has helped bring major private support to the School through such
programs as the Howard Hughes Medical Institute in Immunology and the
Bristol-Myers affiliation with Pharmacology;
He has sustained and strengthened a strong working relationship with
Yale-New Haven Hospital
a bond critical to the success of the entire
venture;
He has managed the School’s finances such that student tuition here now
ranks 45th in the country, while at the same time mounting the already
mentioned new programs.
For these accomplishments and much, much more, the University, the
School, and indeed the country owe Bob a great but unpayable debt.
But what of the man to whom the University now entrusts the leadership
of this strong, complex school? Having chaired the committee responsible
for selecting Lee Rosenberg, and having had the good sense to recruit him
successfully, I am pleased to describe him to those of you unfamiliar with this
man. He is theC.N.H. Long Professor; he built one of the finest departments
of human genetics from the ground up; he is nationally recognized as a
national spokesman on matters of medical science and has the trust and
admiration of colleagues throughout our School and the country.
And, so. in a few weeks, and in the unobtrusive way institutions of learning
change their helmsmen (or perhaps more appropriately, their orchestra
conductors), the venerable Yale School of Medicine w ill have a new Dean. I
know he does not need to be reminded of the strength of the place or its

problems, but 1 believe it is right
that 1 take the remaining moments
to reflect with you
to whom,
after all, this School also belongs in
trust - in the state of the place.
Very often (perhaps too often),
university Presidents are pictured
as waking up in nightly cold sweats
thinking about the insoluble prob¬
lems of their massive, cacophonus
Medical Schools. I cannot tell you
that the Yale School of Medicine
never provokes such restlessness
for me, but 1 must remind you of
the other side of that coin —- the
enormous strength of the place
which derives first and foremost,
from the remarkably intelligent,
devoted, and entrepreneurial faculty
by whatever objective criteria one
can employ:
it contains one Nobel laureate,
George Palade, and no fewer than
17 members of the National Aca¬
demy of Sciences, 1 1 members of
the American Academy of Arts and
Sciences, and 9 members of the
National Institute of Medicine;
it, as a whole, has competed so
successfully for N1H research and
training funds as to rank among the
top three medical schools nationally
in each of the past five years;
it has responded to the challenge
of providing exemplary clinical care
by adding new programs in trans¬
plant surgery, in fetal medicine, in
clinical epidemiology, and in geron¬
tology;
it has added new courses to the
medical curriculum in immunology,
genetics, and neurosciences and has
continually strived to modify the
curriculum so as to reflect the ever
changing nature of medical thought
and practice;
and it has reached out to house
officers, postdoctoral fellows, com¬
munity physicians, foundations,
governments and businesses to share
its experience and educate practi¬
tioners, scientists, and legislators
alike.

But it has done all this with
insufficient resources. That problem,
members of the alumni, you and 1
must help solve. Two years ago, I
appointed a special development
advisory committee for the School
of Medicine chaired by George
Palade and including among its
members Bob Berliner, Lee Rosen¬
berg, Sam Thier, Arthur Baue, Jan
Stolwijk, Alan Sartorelli, and Art
Ebbert. A year ago, I reported to
you that this committee recom¬
mended that the University mount
a major fund raising campaign for
the School of Medicine — the first
such campaign in the School’s his¬
tory. 1 endorsed that recommenda¬
tion and 1 expect my recommenda¬
tion for the campaign to be approved
by the Corporation next week.
1 am most pleased, one year later
to have the opportunity to bring
you up-to-date on this issue, which,
1 think is central to the future of the
medical school. First, the campaign
target has been set at $125 million
and the campaign duration projected
at five years. Second, we have re¬
cruited a dean, Lee Rosenberg,
who has an appetite for this en¬
deavor, and a director of develop¬
ment, Sue Dorn, who is recognized
as among the most outstanding
institutional development officers
in the country. Third, we have
commissioned a New York firm to
prepare and deliver the case state¬
ment for the campaign by September
1, 1984. Fourth, the goals of the
campaign have been honed. The
principal needs include: some $40
million in endowment funds to but¬
tress the School’s foundations; funds
totalling $30 - $40 million to erect a
Magnetic Resonance Center, a
Faculty Practice Plan building, and
a new 50,000 square foot research
building aimed at blending funda¬
mental and applied research interests
toward the molecular basis of medi¬
cine; several millions of dollars
toward student financial aid ex¬
pected to take the form of scholar¬
ships, fellowships, and low interest
loans; and the remainder to accom¬
plish such tasks as library renova¬
tion, new faculty seed funds, and
senior faculty equipment replace-

“This is an effort for all
of us. And / expect the
campaign to succeed. . . ”
President Giamatti

ment funds. I expect this campaign
to be launched officially during the
next academic year. 1 expect to
work diligently towards its goals
and ask each of you —in your own
ways — to do the same. This is an
effort for all of us by all of us. And,
1 expect the campaign to succeed.
Yale University has many jewels
in its crown. The School of Medicine
is one of these. Like any jewel, its
apparent brilliance depends on the
nature of the light and its state of
care. These parameters change but
the intrinsic worth of the jewel does
not. Thank you, for coming back to
Yale, to the Medical School, and to
New Haven.
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distinguished senior alumni were recognized

Dr. Arthur Griswold, left, and Dr. Helen
iMngner of the Class of 22.

Dr. Myron Sallick, left and Dr. David
Raskind, both members of the Class of

. . .

Dr. Harry Zimmerman 27, center, with
Mrs. Zimmerman and a friend.

1924, which celebrated its 60th reunion.

ASSOCIATION OF YALE ALUMNI IN MEDICINE

annual business meeting

The meeting held in the Jane Ellen
Hope Building was chaired by Dr.
Nicholas Spinelli, president. After
recognition of distinguished senior
alumni in the audience, special recog¬
nition awards were presented to
those members present of the 50th
year class of 1934.
Dr. Robert Berliner was intro¬
duced and expressed his sincere
appreciation to the alumni for their
support during his eleven years as
dean. Later in the meeting. Dean
Berliner gave a brief historical
account of the Hope Building and
announced the dedication of the
restored amphitheater to the alumni.
He said, “Henceforth, this room
will be known as the John B. Ogilvie
Alumni Amphitheater, named alter
a distinguished alumnus, who is a
member of the great class of 1934.
It gives me great pleasure to an¬
nounce this at this final meeting
with you in my role as dean of this
great school.”
Dr. Spinelli then surprised the
dean. On behalf of the Association
of Alumni in Medicine, he presented
Dr. and Mrs. Berliner with lifetime
membership and the privilege ol
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participating in all future activities.
In presenting this warm, sincere
expression of appreciation. Dr. Spi¬
nelli noted, “Our gratitude for your
service to our school, its students,
and its alumni cannot be adequately
conveyed.”
Distinguished Alumni Awards
in the form of Yale chairs with
suitably inscribed plaques were then
presented by Dr. Spinelli to Dr.
Leona Baumgartner and Dr. Ogil¬
vie. They in turn each made a brief
but moving statement of appreci¬
ation to the School of Medicine
noting, in each case, what a Yale
medical education had done to
further their careers.
At the conclusion of the business
meeting. Dr. Lowell Goodman gave
a report on the Medical School
Alumni Fund 1983-84 annual giving

campaign,and Mrs. Kathleen Howe
presented an optimistic report for
the Public Health Alumni Fund.
Elections were an earlier part of
the business meeting. On recom¬
mendation of the Nominating Com¬
mittee chaired by Dr. Thomas
Kugelman, the following were
elected to serve on the Association’s
Executive Committee, each for a
term of two years: Gilbert Hogan
(’57), John Pastore (’67), Rebecca
Solomon (’39), Ora K. Smith (’53),
and Lynn T. Tanoue(’82). In addi¬
tion, Alexander Gaudio (’63), was
elected as a representative to the
Association of Yale Alumni (AYA)
Assembly.
Following the elections. Dr. Spi¬
nelli congratulated the newly elected
and expressed appreciation to those
going off the Executive Committee,
Leonard Kemler (’43), Richard
Norton (’60 HS), and O’Dell Owens
(’76), and to Carol Goldenthal (’44)
who had served as a representative
to the AYA. He also noted that he
hoped these dedicated alumni would
participate in Association activities
in the future.

. . .

as were members of the great Class of 1934
Citations and Yale Chairs were bestowed
on Dr. Leona Baumgartner and Dr. John
B. Ogilvie, by the Dean and Faculty and
The Association of Yale Alumni in Medicine.

Cordial greetings were sent to the members
of The Class of 1934 by the Dean and
Faculty of the Yale School of Medicine:
“ You left Yale in the turmoil of the great
Depression. As you completed your training,
the country became embroiled in war. Your
country and the world have survived these
and lesser crises and conflicts. In the fifty
years since your graduation, these vagaries

To Leona Baumgartner, M.D., Ph.D.

To John B. Ogilvie, M.D.

of life have not deterred you from your

“... your continued and regular support of

great contributions as clinicians, scholars,

annual giving has been a model for many to

academicians, scientists and public servants.

follow. The students who have profited by

“ Like you, your University and its School

your generous support of the Student Loan

. . For many years, you have contributed

of Medicine have weathered the storms,

Fund are many, and their gratitude is

much needed support for student financial

and have continued to gather on its Faculty

unmeasured. Most recently, you became

aid. Most recently, you have added to your

outstanding individuals in research, educa¬

aware of funds needed to complete restora¬

many and regular generosities by estab¬

tion, and clinical medicine.

tion of the Hope Building, specifically the

lishing a challenge fund, which has resulted

“ Yours was the privilege to learn from

old amphitheatre so etched into the memory

in the Medical School Alumni Fund reaching

and follow in the footsteps of the great

of medical students of the long past. Your

record heights in annual giving. This will

leaders on the Faculty a half-century ago.

generosity was responsible for the comple¬

provide additional revolving loan funds for
grateful students.

“ Today, new leaders are gathered together
to constitute the Faculty of the University

tion of that project, now a teaching center
of beauty and utility, as well as nostalgia.

"Now celebrating your fiftieth reunion

and the School of Medicine. They note with

"By these deeds, you have demonstrated

with your Medical School Class, the Associa¬

great pride the honor and esteem your

a loyalty unmatched and without bounds.

tion of Yale Alumni in Medicine with great

illustrious lives have brought to Yale. Though

The fruits of your wisdom and the fruits of

pride expresses its appreciation for the

your ranks have thinned from 33 to 22, your

your fiscal generosity have helped in main¬

reflected glory in which we bask, and for

light shines bright at this half century mark.

your many generosities."

“ We salute you. "

taining exemplary programs appropriate
for Yale. ”
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REUNIONS
1929
55th
The ranks of the class of 1929 are
depleted but those who turned up for
the 55th reunion seemed to be remark¬
ably fit. Those in attendance were
Frank D'Andrea, George Goldman
Vernon I.ippard, Russ Scobie and Bob
Tennant.
Although the temperature hovered
around 90 degrees, the meetings were
comfortable in the recently renovated
and air-conditioned Hope Building.
(Remember when that was the New
Haven Dispensary?) Features of the
meetings were an interesting address by
President Giamatti and seminars on
topics such as the immunological
mechanisms in desensitization and re¬
combinant DNA, which were never
heard of when we were students.
We assembled for dinner at the Gradu¬
ates Club where the unplanned entertain¬
ment turned out to be the portraits of
the entering class taken in September
1925. Of the 55 in the group, 38 gradu¬
ated on schedule in 1929. Seventeen of
that number survive. We were saddened
to hear of the recent death of Tony
Fiebman.
Vernon Lippard

1934
50th
On June 8 and 9, the class of 1934
(Yale’s best class!) reunioned in New
Haven. Those attending were Leona
and Alex Baumgartner, Joseph and
Rose Budnitz, Herbert and Polly Mil¬
ler, John and Donna Ogilvie, Harry
and Ida Sherman, Wedgewood and
Ann Webber and Knowles Lawrence.
An elaborate, interesting program
was prepared by the Medical School
and Alumni Association.
Three seminars of general interest
were presented; a Yale Alumni-in
Surgery seminar was presented by the
class of 1959, and the class ol 1944
contributed significantly to the program
under the guidance of Nicholas Spinelli
The business meeting was featured
by the awarding of the new' Alumni in
Medicine Distinguished Service Awards
to Leona Baumgartner and John Ogil¬
vie. Dr. Berliner announced that the
restored amphitheater in the Hope Build¬
ing would be called the John B. Ogilvie
Alumni Amphitheater. Proper acknow¬
ledgement was made to Leona Baum¬
gartner for her generous matching fund
gift to the Alumni Fund, which has
stimulated contributions to record
levels.
A gourmet luncheon of lobster and
roast beef on Saturday w as followed by
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a performance and lecture on Japanese
Noh drama theater by Howard Hamil¬
ton (’44).
In the course of the weekend a
reception was held for Dr. and Mrs.
Berliner. The new dean. Dr. Leon
Rosenberg, was introduced. All de¬
cided that the Medical School has
been, and will remain, under excellent
guidance.
Alter dinner at the Graduates Club,
the Class of 1934 dispersed and will
reunion again in 1989.
It is impossible to thank all the
individuals who made this reunion as
successful as it was. But great apprecia¬
tion exists for the thought, effort and
expense of producing an excellent
Alumni Weekend.
John Ogilvie

1939
45th
The distinguished class of 1939 enjoyed
their 45th reunion on June 8 and 9. The
members present were Harold and
Estelle Coopersmith, Joseph and Livia
Forman, Jerome and Phoebe Green¬
field, Nathaniel and Esther Kenigsberg,
Ernest and Dene Sarason, Darrell and
Catherine Voorhees, Stuart Stevenson,
and J. Wheeler MacDonald, the Arthur
Tuckers, and Paul Huston.
The peak day of activity, Saturday,
had all of us enjoying varied, truly
exciting seminars in the morning, fol¬
lowed by the school reunion meeting
with delightful speakers. We then re¬
paired to a sherry hour followed by a
bountiful repast. Thereafter, some
toured the new, impressive facilities at
the Medical School, while others toured
the Yale Center for British Art. Stu
Stevenson, however, had to return to
New York at this point.
Following a brief respite, we gathered
at the Woodbridge Country Club for
cocktails and candlelight dinner, w here
we were free to swap tall tales and short
fabrications. We all recalled anecdotes
of many individual members of the
class who did not attend, and read
letters from Norm Cressy, John Fergu¬
son, Pete Murphy, and Doug Walker,
regretting their absences.
The assembled group, in turn, regret¬
ted not having more of our members
present. But we plan an even larger
turnout, in what seems like a short time
these years, for our next togetherness.
Joseph B. Forman

1944
40th
Twenty-three members of the class of
1944 attended our 40th reunion in New
Haven last June 8th and 9th, and we
felt it was the best ever of many memor¬
able reunions. There was a feeling of a
comfortable family group even more
than ever before. Five years ago Reese
Matteson attended for the first time
and enjoyed it so much that he regretted
all the previous reunions he had missed.
This year Jerry Kaye and Reuben
Zucker had the same reaction. An
additional factor that made this reunion
even more our own is that Nick Spinelli
is the President of the Association of
Yale Alumni in Medicine. He was
chairingjust about everything, and in a
very masterly w ay, especially noticeable
when unforseen circumstances arose.
Nick had done a very sensitive job in
preparing the reunions for the whole
school, but particularly ours. As at our
last reunion, we were the only class
with a Reunion Seminar on Friday,
open to and attended by many others
besides our class members. We also
have a star performer in How ie Hamil¬
ton. who gave a Noh demonstration
and lecture w ith slides in the Harkness
Auditorium Saturday afternoon, open
to everyone. Our class’ reunion gift to
the School of Medicine amounted to
S20,000, also a record. It seems that our
class is, and is recognized as, outstand¬
ing in every w'ay. Who would have
foreseen this, seeing a bunch of young
Army recruits back in 1943!
Most of us were domiciled together
at Silliman College, which for me was
full of atmosphere, and very like the
College at Oxford w here 1 spent a week
last summer. Many arrived on Thursday
evening, and on Friday morning we got
together, about 15 of us, to hear what
we all were doing. Bob Frelick. who is
now at the National Cancer Institute,
and the inimitable Ronnie Losee, gave
presentations with slides. The others
who were there reported extemporane¬
ously. That afternoon in our Seminar,
Larrys Crow ley and Pickett, both deans
at medical schools (Stanford and Yale)
spoke about problems of medicine in
the U.S., now and in the future, with
Larry Pickett specifically explaining
the Yale picture. Then Russ Monroe
spoke about “Genius and Madness”, a
subject he has been researching and
w riting about, and then 1 (Edith) spoke
about the use of mental imagery in the
treatment of physical and mental illness.
A reception was held on the top floor
of the new Hope Building in honor of

Dean Berliner, who is retiring this July.
Even in a job which requires one to
refuse a lot of requests. Dean Berliner
has endeared himself to all who have
had the privilege of working with him.
Nick had invited the whole class to be
his guests at Leon’s for dinner Friday
evening, but there was a strike of their
employees. So instead, we went to a
restaurant on the shore for an extensive
seafood dinner.
Saturday morning there was a choice
of three seminars. I attended the one
where Howie Hamilton and Stu Finch
described their work in Hiroshima
researching the long-term effects of the
atom bomb. That afternoon, Howie
got dressed up in a georgeous costume
made of silk so heavy it can stand by
itself, and illustrated the various cate¬
gories of the Noh drama. The masks
used to depict the characters are real
works of art, and one thought there
was a real Japanese actor behind them.
Howie had the typical growling sound
of some of the Japanese language, the
unique, slightly bent forward stance,
and the leg work down perfectly.
Our class dinner was at the Gradu¬
ates Club, and it was a very warm,
congenial affair. We had an extemporan¬
eous performance by Corky which had
us all in uproarious laughter for half an
hour. Nick was asked to fill in informa¬
tion about those who were not present,
but had written. He stood in front of
the big fireplace with a lot of papers in
his hands, but one side of the room said
they could not hear. So, Corky got up
and interpreted for that side. A profes¬
sional comedian could not have done
nearly as well. As the evening wore on,
someone asked me “What are we going
to do tomorrow?” We dispersed on
Sunday, but if you all wish, I will plan
to have a Sunday program at my house
in five years.
Those who attended the reunion,
almost all accompanied by spice, were
Conway, Coolidge, Corcoran, Country¬
man, Crowley, Doherty, Frelick, Goldenthal, Hamilton, James, Jurka, Kaye,
Losee, MacKenzie, Martin, Matteson,
Monroe, Pickett, Roth, Spinelli, Taft,
Zucker. Special guests were Donald
Dock and his wife.
Edith Jurka

1949
35th
The class of ’49 reunion activites were
mainly dinner at the Graduates Club.
Present were Bill Anlyan with his
aunt; Harry Baird with wife Nora;
Peter Cunningham with wife Jan;
Gunnar Eng with wife Connie; Paul
Goldstein with wife Betty; Nora Gordon
with husband Harry; Dan Halvorsen
with wife Maxine; Dick Otis with wife
Mary, and Martha Vaughan with hus¬
band Jack.
Majority present have children and
grandchildren in various configurations.
A lew have retired; most still working.
All locally or nationally famous. Pro¬
posal to have a class convocation to
report on our unique contribution to
American medicine is in review, and
you may hear more from this.
Peter Cunningham
William Anlyan, chancellor for health
affairs at Duke, has been named to the
Council of the University-GovernmentIndustry Research Roundtable, a 13member committee newly created by
the National Academy of Sciences for
the purpose of looking after science’s
interests in Washington. Funds for the
Roundtable have been provided by the
Alfred B. Sloan Foundation and The
Andrew W. Mellon Foundation. Frank
Press, president of the Academy, has
said that the Roundtable “offers an
opportunity to address questions bear¬
ing on the health of American science
in a manner not previously available.”
DeWitt Baldwin is now president of
Earlham College, a four-year Quaker
liberal arts institution in Richmond,
Indiana. Previous to his appointment
in the spring of 1983. he had served as
professor of psychiatry and behavioral
science and assistant dean for rural and
community health at the University of
Nevada School of Medicine, as well as
director of the Center for Geriatric
Education and Research. He added
that he is also serving as chairman of
the Behavioral Sciences Test Committee
tor the Part I Examination of the
National Board of Medical Examiners
and serves on that Board.

1954
30th
After several days of attending Alumni
Weekend seminars and receptions, com¬
paring present day New Haven with the
New Haven of 30 years ago, attending
the Japanese Noh drama performance,
etc., nine members of the class of 1954
met for dinner on Saturday evening,
June 9, at the Graduates Club.
T hose attending were Alan and Sylvia
Covey, Jack and Elaine Gariepy, Frank
and Bette Gruskay, Low'd! and Barbara
Olson, Anthony and Jeanne Piccirillo,
Robert and Anita Stein, and Herb
Hurwitz.who escorted a lovely daughter,
Diana.
We enjoyed an excellent dinner, had
an opportunity to visit, read letters
from Edward Gerety, Jacques Quen,
and John Rose, and 1 am certain
everyone made a firm resolution to
return for our 50th in 2004.
Lowell E. Olson

1959
25th
1 he story of the silver anniversary of
the Yale Med Class of ’59 really began
in a dimly lit room at the rear of Mory’s
Tavern around the first of the year.
There a small group met for supper and
wine (selected from Mory’s “private”
stock) to organize and implement a
plan for the greatest reunion that a
class known for its superlatives ever
had. Nick Passarelli, Kris Keggi, Herb
Kaufman, Joe Saccio, John Marsh,
and Marc Schwartz planned (and drank)
well. Then, in the ensuing months, they
took a lot of time to make arrangements
and personally phone every member of
the class to urge them to come back to
New Haven. The response was tremen¬
dous! We recorded the best attendance
ever for a 25th reunion class: 50 of our
members gathered from the four corners
of the U nited States to enjoy a wonderful
two days of fun and fellowship; Mai
and Audrey Ing from Hawaii, Lyall
and Phyllis Crary from Washington,
Rae Larsen and Line Potter from Flor¬
ida and a cast of thousands from the
northeast.
The official functions began Friday.
That afternoon all the talent for a
seminar entitled “Yale Alumni in Sur¬
gery” was supplied by the Class of ’59.
In turn, the attendees were enthralled
by moderator Passarelli, Keggi on
“Non-Cemented Ceramic Hip Replace¬
ment' ”, O'Neill on “Surgical Manage¬
ment of Hypertension in Children with
Vascular Abnormalities”, Butterfield
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on “Caricatures of the 18th Century
Anatomists and Surgeons” and Heydorn on “Beta-Endorphins. Naloxane
and Shock”. This was followed by the
Edward El. Storer Lecture given by
Dave Skinner entitled 'The Pathophysi¬
ology of GastroEsophageal Reflux”.
Thereafter the meeting ad journed to an
alumni reception honoring retiring Dean
and Mrs. Robert Berliner.
About 6 pm we boarded a bus in
front of 333 Cedar and departed for the
Villa Keggi near Middlebury. Conversa¬
tions which had begun on the bus
continued as we strolled the broad
green lawn surrounding Julie and Kris’
country home. Libations and hors
d’oeuvres, especially the unique Maui
potato chips supplied for the occasion
bv ex-officio member of the Class of'59
(King) George LeBouvier, enhanced
the convivial assemblage. Lobsters and
clams steamed in seaweed, sweet corn
and onions, new potatoes, chicken and
fish followed by watermelon, made a
repast perfect for the evening in its
informality. Afterwards, we gathered
on the back porch to view slides made
around Grace-New Haven Hospital 25
years before. Many were the comments
about subsequent changes in girth and
thatch.
Saturday morning, most of us arose
early for seminars, meetings or tours of
the new Yale-New Haven Hospital or
the new Yale Center for British Art.
Prior to noon we posed for reunion
pictures in front of Sterling Hall of
Medicine and then meandered to Harkness for sherry and lunch. Remember,
we were the first class to inhabit it all
four years.
During the afternoon some toured,
some attended the Japanese Noh drama
theater performance, and a few mad
dogs braved the scorching 100 degree
heat for the class tennis tournament.
There were no winners, only survivors.
The New Haven Lawn Club hosted
us for what deserves to be remembered
as one of the most unique dinner
dances ever. It was a formal party in a
sauna, there being no air conditioning
and the monster east coast heat wave at
its worst. Before our eyes the dignity of
the pillars of American medicine crum¬
bled as coats were shed, then ties, and
in the case of DeConti, even pants. As
the remaining garments became soggy,
fluid and electrolyte balance suffered
and the ladies experienced problems
restretching their pantyhose. Susie
Fisher did her thing in the club pool
and others thought seriously about
joining her.
Dinner began with shrimp cocktails.
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progressed through prime rib and as¬
paragus and finished with Bananas
Foster while Pat Dorn’s band, without
an amplified guitar in sight, serenaded
us with favorites from the the '50’s.
After supper, while the band took a
break, we gathered around the dance
floor. Nick began with a moment of
silence as we remembered our deceased
classmates: Dick Gershon, Bill Edwards,
Rog Atwood, Bob Davis, Phil Griffin,
Arl Pond and Tony Warner. Then
Marc Schwartz settled himself at the
piano to lead a singalong of old favorites
from the Senior Show of the Class of
’59, "Day-O, Spend All Nite on OB
Ward” and “That's All There Is, We
Hope You've Had a Ball or Even Two”.
Between numbers various members of
the original cast recreated their roles
using a musty, yellow, old script sup¬
plied by Marc. Perhaps the most hilar¬
ious routine of the evening was per¬
formed by Pogo, Nick and Kauf as they
slid their glasses up and down their
noses simultaneously while attempting
to read the faded print. John Marsh,
Bob Fisher, and Bob Amick harmonized
their V A number again as we all realized
that time doesn’t change some things
such as our appreciation of the
special experience we had at Yale.
The attendees were: Bob and Carol
Amick, Ace and Jean Barnes, Frank
and Gwen Beer, Jack and Edie Bowers,
Bill and Ellie Butterfield, Sid and Phyl¬
lis Cohen, Lyall and Phyllis C’rary, Ed
and Franny Clayton, Marty Colodzin,
Ron and Louise DeConti, Bob and
Suzie Fisher, Paul Friedman, Bob and
Lorraine Gonyea, Gerry and Lois Gor¬
don, V era Glocklin, Rod and Nancy
Hartmann, Bill and Joan Heydorn,
Fen and Judy Inker, Mai and Audrey
Ing, Bill and Ann Jablonski, John and
Mary Ann Jasaitis, Ed Kaminskas,
Herb and Nancy Kaufmann, Kris and
Julie Keggi, Daveand Ginny Kingsbury,
Rae Larsen, Ray and Sally Mark, Dan
and Maritze Macken, John and Carol
Marsh, Brian and Judy McGrath, Kent
and Rosemary Morest, Pete and Joy
Molloy, Ron and Pat Morris, Jim and
Sue O'Neill, Bob and Freda Ostberg,
Nick and Mary Lou Passarelli, Fine
Potter, Jim and Bunny Prokop, Jack
and Lou Poglinco, Dave and Joan
Reed, Joe and Carol Robinson, Joe
Saccio, Marc and Anne Schwartz, Dick
and Clare Senfield, Dave and Ellie
Skinner, Sandy and Naomi Solomon,
Jim Stagnone, I.isa Steiner, and Mimi
and Dick Wolf.
Asa Barnes

Malcolm Ing wrote from Honolulu in
March that this year has been very busy
for him in that he has been recently
appointed chief of ophthalmology at
the John A. Burns School of Medicine,
University of Hawaii, and also elected
president of the Hawaii Ophthalmological Society (State society of ophthal¬
mologists).

1964
20th
Despite the torrid New Haven climate,
the ever-present overtures for contribu¬
tions, and the war-zone atmosphere
around Leon’s Restaurant, the class of
1964 20th reunion w'as an unqualified
success.
Alumni “traveling the farthest”
awards went to Al Morris (Salt Lake
City), Tony Alonso (Tampa), and Skip
Stilp (Neenah, Wisconsin).
The “best preserved” (without the
use of artificial substances) accolade
went to Dick Hockman, who on several
occasions during the evening was mis¬
taken for a busboy.
Class scribe, Joe “Nautilus” Curi,
w on the physical fitness prize for weigh¬
ing less than in his original application
photograph.
The “where is your kid in college?”
medals were swamped by Diane Shrier
(daughter at Yale), Tony Bravo (son at
Harvard), and Bob Briggs (daughter at
Princeton).
The Bacchanalian feasting was only
interrupted by the academic “turks”
who insisted on checking periodic blood
alcohol (Few Landsberg), cholesterol
(Virgil Brown), and colony count (Bob
Lyons), levels.
Later. John Hanev and Mary DiGangi led a soul searching, nostalgic
group therapy session. Fortunately,
Fee Berger misplaced his interesting
collection of class radiographs of the
early 1960’s.
At the close of the festivities, Sid
Baker supposedly returned to the Gesell
Institute to redefine the effect of a Yale
Medical education on early childhood
behavior patterns.
Joseph F.J. Curi

1969
15th
The class of 1969 gathered at Mory’s
for their 15th reunion and we were
amazed at how little any of us had
really changed and how much we all
felt for each other. For those of us
present it was a time of reminiscing,
rhapsodizing, and renewing and in retro¬
spect, perhaps the closest Yale ever
made us come to the three R’s. But we
did learn to cut the meat, so here goes.
Charles Angell and Sandy and their
children, Leah and Jordan, live in
Baltimore where Chuck practices cardio¬
logy and internal medicine. Seth Charney came in from San Francisco where
he practices psychiatry and has become
a real estate maven. Leo Cooney and
Kathleen live in New Haven with their
boys, Timothy and Joshua. Leo does
rheumatology and geriatrics as well as
is father manager of the Yale Youth
Hockey team. Lee Jampol with Carol
lives in Chicago with their children,
Melissa Lyn and Scott. Lee was named
chairman of the Department of Oph¬
thalmology of Northwestern. At the
dinner, Lee was also given special thanks
for his work for the Alumni Fund.
Stephen Krant is a plastic surgeon in
La Jolla, California, and if things ever
get slow could moonlight as an emcee,
based on his performance in that role at
our dinner. He was pinch-hitting for
David Upton who orchestrated the
reunion from the side lines but was
unable to attend in person because of
his bad back. Ellen Milstone and her
husband, Leonard, and their children,
Jenya, and Aaron, live in New Haven.
Ellen practices dermatology with an
interest in dermatopathology. Robert
Marier and Joanne and their children,
Alicia and Joanne, live in New Orleans.
Bob is professor of medicine at LSU in
infectious disease. Arnold Mazur and
wife Nancy, live in Boston. Arnie attri¬
butes his youthfulness to his children,
Scott and Sarah, as well as his specialty
of college health and running. Lionel
Nelson and wife, Elaine, and children,
Amanda, Hilary and Alex, live in San
Jose, California. Lionel specializes in
ENT and head and neck surgery and is
involved in medical politics as president
of his local PSRO and VP of County
Medical Society. Richard Pollis and
wife, Victoria, live in Los Angeles.
Richard practices orthopedic surgery
with special interest in the spine. Dave
Schulak lives in Tampa, Florida with
his wife, Paula and daughter, Hilary.
He is in partnership with Lutz Schlicke
who, Dave tells us, mainly fishes, boats
and occasionally practices. Gerald

Smallberg practices neurology in Man¬
hattan and has his eye on Off Broad¬
way for the plays that he has written.
Steve Webb and his wife, Dottie live in
Rochester, New York with their child¬
ren, Becky, Mike, Katie, and Tommy.
Steve practices pediatrics and was presi¬
dent of the Rochester Pediatric Society.
Sandy Genser is a psychiatrist in D.C.
and Ralph Falkenstein is an ophthal¬
mologist in Danbury. Both were present
but we have no other information
because they couldn’t manage to com¬
plete the questionnaire, although they
could get it together to share the record
for the longest marriages.
Unfortunately, Elliot and Carol Livstone, who helped plan the dinner, were
unable to attend. Elliot had undergone
surgery but was doing well. He is
leaving Yale to enter private practice in
Florida. Mike Liebowitz and Rowena
Korobkin did not attend but sent letters.
Both are married. Rowena is in practice
in San Francisco in pediatric neurology
and Mike is in New York doing re¬
search in psychopharmacology.
Those of you not here were remem¬
bered and talked about. The class net¬
work surprisingly was able to keep
track of everyone one way or another.
Although all present were happy with
what we were doing in medicine, we
were all concerned about the future of
our profession. Several strategies for
coping were suggested. Richard Pollis
was still touting gold as he did at its
high at our 10th reunion. Seth Charney
from his experience in the Bay area was
cautiously advising real estate. Dave
Schulak analyzing the new hip prostheses suggested that we consider
rhodium. In the end we figured we
would still mainly practice medicine as
best we could and would return for our
20th reunion happy but still pessimistic
about the future of medicine as most
likely all of our predecessors have done
at these same reunions.
G.J. Smallberg

1974
10th
Our tenth reunion was held in New
Haven during Medical Alumni Week¬
end on June 8 and 9. Despite the 100
degree heat and 100 percent humidity,
those of us able to attend enjoyed
renewing old acquaintances.Several
members of our class were fortunate to
attend a reunion dinner at Casa Marra
on Saturday. Kudos to Lenny Banco
who made all the arrangements and
even managed to come in under budget.
Lenny is director of Pediatric Ambu¬

latory Services at Hartford Hospital
(U.Conn.faculty). He and Liz have an
8-year-old daughter, Ellie, and a 5year-old son, Jonathan. Roger Emerson
is an orthopedist at Mass. General and
Cambridge Hospitals. He and Patricia
have an 8-year-old daughter Caroline,
and a 3-year-old son Christopher. Dan¬
iel Rosenthal is a radiologist at Mass.
General. He and Ins wife Jacqueline
have a 13-month-old daughter, Lillian.
Irl Extein will soon (September I) be
medical director of Psychiatric Institute
of Del Ray (Fla.). He and Barbara have
two or three children (depending on
when you read this).
Doug Berv is a psychiatrist in New
Haven. He and his wife Cheryl have a
young son. Ed Janosko. who has be¬
come an avid pilot, is a urologist in
Greenville, North Carolina. Ron Neu¬
mann is associate professor of radiology
and pathology at Yale. His wife, Maria,
is also on Yale’s pathology faculty. 1
am a geneticist based at San Francisco
Kaiser. Carol and 1 have a 2 and a
half-year-old son, Scott, and a 9
month-old daughter, Catherine.
Neil Blumberg is Blood Bank director
at University of Rochester and Peter
Buchin is a gastroenterologist in Man¬
hattan. Also up from New York for the
day was Harry Shamoon with his wife
and two sons. Bob Milstein is a psychi¬
atry resident at Yale.
Many members of our class were
unable to attend our reunion, but the
following rumors were circulated; I apolo¬
gize for any inaccuracies. Jason Zielonka is in nuclear medicine in Mil¬
waukee. Boston is home to Dick Paster¬
nak, cardiologist; Jim Strom.nephrolo¬
gist; and Maisie Tam,dermatologist.
Amy Schechter, pediatrician ; Bob
Schecter, ophthalmologist; and Ross
Tonkens are in the L A. area. Bob
Hempton is a hand surgeon in San
Diego. Fred Shessel is a urologist in
Atlanta.
The Pacific Northwest is home to
Dick Howe (Oregon) and Carol Teitz,
an orthopedist in Seattle. The San
Francisco area finds Steve Arnold;
Tom Munyer, Dani Goldwater, Rich
Cazen, gastroenterologist; John
Schrumpf, radiologist; David Ritvo,
psychiatrist; and Marge Oda, ortho¬
pedist. Mike Gerber is a pediatrician in
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Connecticut. Infectious Disease is the
specialty of George Talbot in Philadel¬
phia and Andy Mayrer, who will soon
be moving from New Haven to
Baltimore.
Information about other classmates
is sketchy; some of you seem to be lost
to follow-up. I hope to see or hear from
more of you at future reunions or
sooner.
Bruce Blumberg

1979
5th
No report received

1950
Sidney Lee has resigned as president of
Michael Reese Hospital and professor
of medicine at the University of Chicago
to accept the appointment as president¬
elect of The Milbank Memorial Fund
in New York City, effective in the fall of
1984. He claims that this will be his last
move. Sid’s two sons, Jonathan and
Michael, will both be entering medical
school this fall, at Georgetown and
McGill respectively.
Classmate Russell Anderson recently
visited Sid at Michael Reese as the
head of an Accreditation team for the
Joint Commission on Accreditation of
Hospitals.

OTHER CLASS NOTES

1943

1951

Ralph Alley received the degree Doctor
of Science Honoris Causa from the
Albany Medical College at commence¬
ment exercises in May. A member of
the faculty since 1952, he is a clinical
professor of surgery and former head
of the Division of Thoracic Surgery at
the Albany Medical Center. He was
cited for his exemplary career in thor¬
acic surgery and for his many contri¬
butions to the field, both in scholarly
publications and in innovative surgical
techniques.

The 1983 American Journal of Ophthal¬
mology Lecture was delivered by Brad¬
ley Straatsma at the XIV Pan-American
Congress in Lima, Peru. He spoke on
“Cataracts — Clinical and Biochemical
Correlations”and provided new insight
to the biochemical nature of cataracts
as it is related to the clinical appearance
of the lens opacities.
Dr. Straatsma is director of the Jules
Stein Eye Institute, and professor and
chairman of the Department of Oph¬
thalmology at the University of Califor¬
nia at Los Angeles School of Medicine.

1946
Ruth Kempe and her husband, C.
Henry Kempe (’48 HS) have written a
book, “The Common Secret”, which
deals with sexual abuse of children and
adolescents. It considers the difficulties
in coping with one’s personal feelings
about the occurence of sexual child
abuse which face all who have to deal
with it: social workers, physicians,
nurses, police, psychologists, teachers,
the clergy, and the public. The frank
but positive discussion of a subject
once considered taboo helps explain
the 200 percent increase in reported
cases of sexual child abuse since 1976
and sheds new light on the role pro¬
fessionals can play in this frightening
dilemma.
Robert Wagner has recently been ap¬
pointed director of the Cancer Center
at the University of Virginia Medical
Center in Charlottesville. He also will
continue to serve as chairman of the
Department of Microbiology.
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1953
Thomas O. Gentsch.now clinical pro¬
fessor of surgery at the University of
Miami School of Medicine and attend¬
ing surgeon at Miami Heart Institute,
has been elected to Fellowship in the
American College of Cardiology.

1955
Milton Corn was appointed medical
director and chief of staff at the Georgeown University Hospital in Washing¬
ton, D.C.,effective July 1984. He will
continue to serve as professor of medi¬
cine at the School of Medicine.
James Nolan has been appointed gover¬
nor-elect of the American College of
Physicians, U pstate New York Region.
He is professor and chairman of the
Department of Medicine at State Uni¬
versity of New York at Buffalo, w here
he has been a member of the School of
Medicine faculty for 21 years.
Dr. Nolan is also director of the Erie
County Medical Center’s Department
of Medicine and chairman of the board
and president of Research lor Health in

Erie County, Inc. A Buffalo native. Dr.
Nolan his wife and four children live on
Burbank Drive in Snyder, New York.

1957
Joseph Pagano, director of the Line berger Cancer Research Center at The
U niversity of North Carolina School of
Medicine, Chapel Hill, participated in
the dedication of the Cancer Research
Center’s new $9.4 million building in
May.
Clifford Reifler, medical director of
Strong Memorial Hospital of the Uni¬
versity of Rochester Medical Center
and director of the University Health
Service, has been elected to membership
in the American College of Physician
Executives. Dr. Reifler’s selection was
based on his “clinical excellence, formal
management education preparation,
and leadership excellence.”
A member of the Rochester faculty
since 1970. Dr. Reifler is professor of
psychiatry, of health services, and of
preventive, family and rehabilitation
medicine.

1961
Kenneth Arndt has been appointed
new chief editor of Archives of Derma¬
tology. In the announcement of his new
position. Dr. Arndt was cited for his
achievements, and it was noted that he
is widely regarded throughout the pro¬
fession as one of the premier academic
clinicians in dermatology in the country.
“Dr. Arndt brings to his new position
impressive credentials in medicine,
medical journalism, and teaching. Al¬
though he is best know n for his pioneer¬
ing research in laser technology and for
his authorship of the Manual of Derma tologv Therapeutics — considered by
physicians the world over to be the
‘standard work'in dermatology — he is
also a generalist with experience and
expertise in a variety of areas . . .
Archives of Dermatology recently ob¬
served its centennial year. The appoint¬
ment of Kenneth Arndt ensures the
continued excellence of this prominent
journal into its second century of publi¬
cation and marks a new era of vigorous
leadership.”
Earl Baker was elected to a two-year
term as president-elect of the American
Heart Association South Central
Connecticut Chapter at the Associa¬
tion’s annual meeting in May.

This past March, Philip Felig was
appointed president of the Sandoz Re search Institute in East Hanover, New
Jersey. This institute has been organized
to facilitate closer interaction with aca¬
demic research centers throughout the
country and broaden the base for future
preclinical and clinical research at
Sandoz. Dr. Felig, who has been a
member of the Yale faculty for the last
14 years, will continue his association
with the School as a clinical professor
of medicine.

1965
John Barchilon, now living in Califor¬
nia, wrote in April updating his most
recent activities. He noted that: “I’ve
always wanted a chance to see the
country before moving out west, so I
joined a practice management/locum
tenens group based in North Carolina,
and they sent me all over. It was a
terrific experience, practicing in small
towns in South Carolina, Georgia,
northern Connecticut, Illinois, and Mon¬
tana — especially coming from Man¬
hattan," Now settled in Los Angeles, he
divides his time between practicing
sports medicine and writing.
Between assignments last year, he
was able to finish a novel, “The Crown
Prince”, a story of love, war, and music
based on the life of the legendary
concert pianist Paul Wittgenstein. The
novel set in Europe from the nineties
through the twenties portrays kings,
courtesans, soldiers, scoundrels, artists,
and rabble rousers during these turbu¬
lent years.

1966
Henry Hanley, currently professorand
head of the Section of Cardiology in
the Department of Medicine at Louisi¬
ana State University, and chief of the
Cardiology Section of the Medical Ser¬
vice at the Veterans Administration
Medical Center in Shreveport has been
elected to Fellowship in the American
College of Cardiology.

1967
John Pastore is currently serving as
secretary of the International Physicians
for Prevention of Nuclear War and
attended the organization’s Fourth
Congress held in Helsinki, Finland this
past spring. He is director of the St.
Elizabeth’s Hospital of Boston and an
associate professor of medicine at Tufts
University School of Medicine.

1969
Elliot Livstone resigned from the Yale
medical faculty in June and has opened
his office for practice of gastroenterol¬
ogy in Riverview Professional Center,
Sarasota, Florida.

1971
H. Steven Moffic, who is associate
professor of psychiatry at Baylor
College of Medicine, was awarded a
fellowship by the American Jewish
Committee to attend the annual Aca¬
demician’s Seminar in Israel, December
20 to January 3, 1984. He was joined by
his wife Rusti, who isa learningdisabilities specialist. The trip included 23
American academicians and one other
phsycian. Dr. Moffic’s particular area
of research is in ethnic identity. After
returning, he wrote two short pieces for
the journal devoted to the seminar:
“Singing for the Scholars: The Yiskor
Service at Yad Vashem”and “From the
Ivory Tower to the Dead Sea: The
Genesis of a Seminar.”

1972
In response to Yale Medicine's request
in our last issue for news about current
activities of alumni, Roy Kaplan sent
in the following: “I have been appointed
chief. Division of Rheumatology at
Mercy Hospital and Medical Center in
San Diego; clinical assistant professor
in the Department of Medicine at Uni¬
versity of California at San Diego
Medical Center. I have also been reap¬
pointed chairman of the Medical and
Scientific Committee of the San Diego
Chapter of Arthritis Foundation for
1984 and re-elected to the Board of
Governors, San Diego Chapter, Arthri¬
tis Foundation.”

1978
Arthur Gershkoff, who is a member of
the attending staff of Magee Rehabilita¬
tion Hospital in Philadephia and direc¬
tor of its Chronic Pain Program, has
been elected president of Magee’s medi¬
cal staff. In addition to his position at
Magee, which is a regional lifetime
resource center dedicated to improving
the quality of life for the physically
disabled. Dr. Gershkoff is an instructor
and a consulting staff physician at
Thomas Jefferson University’s Depart¬
ment of Rehabilitation Medicine. He
has been the author and co-author of
numerous presentations in the areas of
pain, the chronically ill and spinal cord
injury.
Michael Owens has joined the Watts
Health Foundation, Inc. as medical
director of the Watts Health Center in
Los Angeles.

1980
Jay Barahan is one of five winners of
the Pfizer postdoctoral fellowships in
the first annual Pfizer Fellowship com¬
petition. After interning at Hospital of
St. Raphael in New Haven, he com¬
pleted his psychiatric residency training
at Columbia College of Physicians and
Surgeons and the New York State
Psychiatric Institute. Since July of last
year. Dr. Baraban has spent the elective
period of his psychiatry residency in
the laboratory of Dr. Solomon Snyder
at Johns Hopkins and will conduct his
postdoctoral research under Dr. Snyder.
Pursuing his interests in novel mech¬
anisms whereby chemotherapies may
relieve schizophrenic symptoms, he will
study the allosteric modulation of dopa¬
mine receptors and its implications for
the development of improved antipsy¬
chotic chemotherapies.

1976
Jerome Zeldis is one of five who were
recently awarded Pfizer postdoctoral
fellowships in the first annual Pfizer
Fellowship competition. Following his
internship and residency training in
internal medicine at UCLA Medical
Center, Dr. Zeldis, since 1981, has been
a research fellow in medicine at Harvard
and also a clinical research fellow in
medicine at Massachusetts General Hos¬
pital. His postdoctoral research will
examine, through molecular biological
and recombinant DNA technologies,
the induction of chronic hepatitis by
hepatitis- B virus (HBV) and the associa¬
tion of H BV and H BV-related hepatitis
with hepatocellular carcinoma.

1982
Lynn Tanoue, serving her residency in
medicine at Yale-New Haven Hospital,
has been selected as the recipient of The
Samuel D. Kushlan Award, which was
inaugurated in 1969 and which is given
annually to thejuniorassistant resident
who has contributed the most to patient
care during rotations through the Com¬
munity Medical Service.

1983
Eric Winer, a member of the house
staff at Yale-New Haven Hospital in
the Department of Medicine, has been
selected as the recipient of The Samuel
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D. Kushlan Award, annually given to
the intern who has contributed the
most to patient care during rotation
through the community Medical Ser¬
vice.

HOUSE STAFF
1946
John McGovern received an honorary
degree from Florida State University at
its commencement in April. Dr.
McGovern was also the main speaker
for the University’s commencement pro¬
gram. In May hedelivered the principal
address and was awarded an honorary
Doctorate of Laws degree at the spring
commencement of Lamar University in
Beaumont, Texas.

PUBFIC HEAFTH
1969

IN MEMOR1AM

Samuel Korper has been appointed
director of the National Institutes of
Health Division of Legislative Analysis.
In his new position. Dr. Korper will be
responsible for advising the N1H direc¬
tor and other senior NIH executive
staff on legislative developments rele¬
vant to NIH programs and activities,
the need for proposed changes in the
statutory base of NIH activities, and
development of new legislative pro¬
posals. Previously, Dr. Korper served
as associate director for Legislation,
Epidemiology, and the Environment in
the Office of the Deputy Assistant
Secretary for Health Research, Statis¬
tics, and Technology, OASH.

Max H. Ruby
July 16,1983

1967

1980

Thomas Hansen has announced the
opening of his office at 2 Church Street
South in New Haven for the practice of
dermatology.

Robert Levine has been appointed assis¬
tant administrator, University Hospital
at New York University Medical Center.
He was formerly director of the Faculty
Practice Plan at Long Island Jewish
-Hillside Medical Center.

1971
Thomas Koontz has been elected chair¬
man. Board of Trustees of the Medical
Park Hospital in Winston-Salem, North
Carolina.

Arthur G. Boggs
January 20,1984

HS’21

Mariano Riccitelli
July 1,1984

M.D.’22

Alexander E. Rosenberg
September 28,1983

M.D.’26

John Burke
March 2,1984

M.D.’28

Tony Liebman Rakieten
April 22,1984

M.D.’29

George P.Jackson
June 30, 1984

ex med’29

Roland T.Wehger
June 1984

M.D.’32

Daniel F. Harvey
June 29,1984'

M.D.’33

Joseph Mignone
July 5,1984

M.D.’33

William R.Newman
November 7,1983

M.D.’38

John Prutting
March 16,1984

M.D.’38

Henry W.Ryder,M.D.
March 13,1984

Fid ward McGuire has left Yale as pro¬
fessor of urology to become chairman
of the Department of U rology at U niversity of Michigan Medical School.

Henry Merriman
July 17,1984

Warren F’agadau has been named by
the Pan-American Association of Oph¬
thalmology to become the coordinator
between North American and Latin
American activities. In addition to his
ideas for increasing membership, partici¬
pation and service in the PAAO, his
primary goal is to increase the exchange
of fellowships between the Americas.
Dr. Fagadau is in practice in Dallas.
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ex med’36

John A.Dillon
August 28,1983

1972

1982

ex med’21

ex med’38
HS ’42

Paul T. Bruvere.M.D.
October 1971

MPH’43

Egberto P.deAssis.M.D.
date unknown

MPH’43

Karel Van Syckel Toll
November 19,1983

HS’46

Stanley Harvey Schneider
February 28,1984

HS’54

Nicholas P.Kitrinos
January 1,1984

HS’59

Peter W. Ralph
October 1983

MPH’62

Millard Amdur
March 15.1984

M.D.’64

CLASS OF 1984
postgraduate appointments
ALABAMA
University of Alabama Medical Center,
Birmingham
John Gwin, Jr., General Surgery
ARIZONA
Tucson Hospitals, Tucson
David Fillmore. Transitional
CALIFORNIA
Cedars-Sinai Medical Center, Los Angeles
Steven Schick, Pathology
Pacific Medical Center, San Francisco
Charles Zacks, Ophthalmology
UCLA Hospital and Clinics
Abner Korn, Obstetrics and Gynecology
University of California San Diego Affiliated
Hospitals
Robert Bookstein, Pathology
Robert Winchell, General Surgery
University of California Hospitals,
San Francisco
William Cimino, Orthopedic Surgery
Linda Grais, Internal Medicine
COLORADO
University of Colorado Affiliated Hospitals,
Denver
John Babich, Internal Medicine
Terri Richardson, Internal Medicine
CONNECTICUT
Middlesex Memorial Hospital, Middletown
Roger Phillips, Family Practice
Waterbury Hospital
Paul Gagliardi, Medicine
Yale-New Haven Medical Center
David Astrachan, Surgery
Leonard Bell Internal Medicine
Mary Bogucki, Internal Medicine
Michael Brines, Internal Medicine
Sandra Castro, Pediatrics
Terence Chen, Neurosurgery
Arthur Duberg, Diagnostic Radiology
Edward Duda, Internal Medicine
Mariano Garcia Blanco, Postdoctoral
Fellow,

Molecular

ILLINOIS
University of Chicago Clinics
Jessica Berman, Surgery
Steven Gore, Internal Medicine
Carolyn Johnston, Obstetrics
and Gynecology

MAINE
Eastern Maine Medical Center, Bangor
Connie Kreiss, Family Practice
MARYLAND
University of Maryland Hospital, Baltimore
Deborah Arrindell, Pediatrics
MASSACHUSETTS
Beth Israel Hospital, Boston
Paula Fracasso, Internal Medicine
Dominic Pennachio, Jr., Internal Medicine
Janet Rucker, Internal Medicine
Robert Staszewski, Internal Medicine
Boston City Hospital
Douglas Webber, Internal Medicine
Boston University Affilated Hospitals
Geoffrey Ahern, Neurology
Brigham and Women’s Hospital, Boston
Scott Haig, General Surgery
Donald Ingber, Research Fellow, Pathology
Susan Tredwell. Obstetrics and Gynecology
Children’s Hospital Medical Center, Boston
Donald Ingber, Research Fellow, Surgery
Massachusetts General Hospital, Boston
Samuel Bern, General Surgery
Troyen Brennan, Internal Medicine
Juanita Merchant, Internal Medicine
Massachusetts Institute of Technology,
Cambridge
Martin Yarmush, Research Associate,
Chemical Engineering

New England Medical Center Hospital, Boston
Michael Simons, Internal Medicine
Tufts University School of Medicine, Boston
Theoharis Theoharides, Assistant Professor,
of Biochemistry and Pharmacology

MICHIGAN
University of Michigan Affiliated Hospitals,
Ann Arbor
John Lane, Orthopedic Surgery

Biophysics and

Biochemistry

Bruce Haffty, Therapeutic Radiology
Robert Havlik, General Surgery
Ellen Heyneman, Pediatrics
Sabra Jones, Orthopedic Surgery
Jeffrey Katz, Internal Medicine
Daniel Kolansky, Internal Medicine
John Krystal, Psychiatry
James Linakis, Pediatrics
Dan Oren, Psychiatry
Ronnie Rosenberg, Psychiatry
Ana Salazar, General Surgery
Stephen Sigal, Internal Medicine
Paul Snyder, Surgery
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THE STATE OF OUR SCHOOL

I

Ladies and Gentlemen of the Faculty of the School of Medicine:

On September 9th, Dean Leon E. Rosen¬
berg convened the faculty in Mary S.
Harkness Auditorium to deliver his
first formal presentation to them on
the “State of Our School”. The
audience which filled the auditorium
to capacity included two of his
predecessors, Dr. Vernon W.
Lippard, dean from 1952 to 1967, and
Dr. Robert W. Berliner, who retired
in June after serving eleven years as
dean. The text of Dean Rosenberg's
address and accompanying
illustrations are printed in full on the
following pages.

’m pleased to stand before you as your new dean. Not being
superstitious, my pleasure is not lessened by assuming this post in
“Orwell’s year” or by addressing you on the thirteenth of September, or
by being the thirteenth dean of this institution. If anything should have
daunted me about where I find myself today, it would have been the
written and oral messages 1 received during the months after my appointment
was announced. Of the nearly 300 letters 1 received (a volume which
reminded me somewhat anxiously, of the national visibility of this deanship),
more than 30 added words of concern, condolences, even grief to their
congratulations. Several letters contained whole pages of jokes reveling in
the foolishness of deans. A good friend said that the last good dean was
Gunga Din because “at least he brought water to the troops.” Yet another
advised me “not to let the bastards get me down,” but failed to tell me who
the bastards were. Finally, so many of you asked me if I was really certain I
wanted to be dean that 1 came to understand that many perceive this job as
one to be taken on only by someone confused, intoxicated, or otherwise
impaired.
Why then do I stand here? My reasons are many: first, because I desire a
new career challenge (and have a queasy feeling these days that I’ve found
one); second, because I wish to learn more about Yale University, a place
which has earned my enduring loyalty by understanding what phrases like
“the academy,” or “academic freedom,” or “collegiality,” truly mean; third,
because I have great admiration and respect for Bart Giamatti and Bill
Brainard and believe they and their administration are committed to the
good fortunes of their medical school; fourth, and foremost, because I
consider it an enormous honor and privilege to be your leader — to be the
dean of and for this distinguished faculty.
I wonder, in fact, how many of you know that you are a member of a truly
outstanding faculty, and that this school’s faculty has been distinguished for
more than half a century. Whereas I abhore stiff-necked boasting or hubris,
by individual or institution, I have long felt that this faculty has honed the
virtues of modesty and self effacement to the point that they approach being
vices. We have been so “low key” that our achievements have sometimes
been invisible to ourselves and to the public.
How many of you know that:
• penicillin was first administered to a patient in this country by a Yale
physician at the Yale-New Haven Hospital in 1942
• that another Yale physician brought chemistry and biochemistry to the
bedside in the 1940’s
• that the first highly purified preparations of ACTH were prepared here
in 1943
• that cancer chemotherapy began here in the 1940’s with the introduction
of nitrogen mustard for the treatment of Hodgkin’s disease
• that a Yale biochemist first elucidated the mechanism of action of pepsin

• that in 1951, a member of Yale’s
poliomyelitis research unit illuminated
the pathogenesis of polio by demonstrat¬
ing the virus in the blood stream early in
the disease
• that the discovery that fragments of
an enzyme can reassociate to restore
catalytic activity was made here
• that the first newborn intensive care
unit in this country was established here
slightly more than 20 years ago.
To those of you who say these things
took place before your time, 1 ask how
many of you are familiar with some of
the more recent major achievements of
this faculty:
• the development of methods for the
mapping of human genes to specific
chromosomes
• the discovery of suppressor T cells
• the first demonstration of the role of
cyclic nucleotides in neurotransmitter
action
•the initial description of Lyme disease,
followed by elucidation of its spirochetal
etiology and definition of effective antimirobial treatment
• the discovery of biotinated nucleo¬
tides as multi-purpose gene probes
•the development of one of the premier
fetal medicine/prenatal diagnosis pro¬
grams in the world
•the discovery that beta-blocking drugs
are effective in the treatment of glaucoma
This faculty has been recognized nation¬
ally and internationally for its research
achievements. It currently contains one
Nobel Laureate, 17 members of the
National Academy of Sciences, 11 mem¬
bers of the American Academy of Arts
and Sciences and nine members of the
National Institute of Medicine. Its depart¬
mental programs in Physiology, Pharma¬
cology, Cell and Molecular Biology, and
Biochemistry, each ranked among the
top four in a recent survey of graduate
departments. This is all part of our
institutional heritage. We have a right to
recall it in the hope that it will elevate our
sights when we aim too low, and lessen
our pain when we suffer institutional
wounds.
But being more comfortable with data
presentation than with exhortation, let
me tell you who make up this faculty and
a bit about what we do. As can be seen
from the bottom line on figure I, this
faculty currently numbers 2,112; twothirds are part-time and voluntary; and
one-third full time. Of this full-time
faculty, roughly one-third have tenure or
its equivalent. This faculty has nearly
doubled since 1972-73. Most of this
growth has occurred in the voluntary
faculty, reflecting expansion of ouraffilia-
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tion program with community hospitals.
The full-time faculty has increased by
only about 18 percent since 1972 — this
increase reflecting a gain in tenured
academic faculty and in senior research
faculty. Term faculty members have de¬
creased slightly. These numbers suggest
that our full-time faculty is a bit “greyer”
in 1984 than it was a decade ago, but not
dangerously so. 1 am concerned, however,
by the relatively slight increase in the
number of women on our full-time fac¬
ulty. In 1972-73 women accounted for 11
percent of the total full-time faculty. By
1983-84, this number has risen to only 17
percent. Clearly, the “gender gap” is
closing here, but we still have some
distance to go. The situation regarding
Black faculty members is quite discour¬
aging; there has been essentially no
growth since 1972 despite recruitment
efforts.
This large and diverse faculty does
many things, but I’ll address only the
traditional trio of activities — teaching,
research and patient care — in that
order.
As can be seen in figure 2, we teach a
diverse array of students, eight categories
to be precise. In 1983-84, M.D. candidates,
who numbered 417, accounted for only
about one-quarter of the 1726 total
students at this school, with about equal
fractions coming from house officers
and postdoctoral fellows. Over the past
decade, as noted on the bottom line,
total students here have increased by
about 350 or by 25 percent. Nearly half
of this increase has come in the postdoc¬
toral fellow category, and another third
among house officers and Ph.D. candi¬
dates. These figures serve as a reminder
that many ol us teach on a one-to-one

basis in the laboratory or at the bedside,
rather than in the more traditional class¬
room setting. In contrast, little growth
has occurred among M.D. or M.D./
Ph.D. students. If, as some have said, the
combined M.D./Ph.D. degree program
represents the best hope of attracting
M.D.’s to research careers, perhaps we
should address ways of increasing their
representation in our student body.
None of us can afford to forget that
teaching is a fundamental raison d’etre
of this institution and that our students
are our legacy. They are tomorrow’s
medical scientists and clinicians. To them
we entrust the proceeds of the research
and clinical experience which we accumu¬
late over a lifetime’s work. Having said
that, I have no precise way of knowing
how well we do collectively as teachers
or how much time we spend at it. Data of
that sort are almost impossible to as¬
semble. Some of you are gifted educators,
capable of inspiring vour students. Some
others of you. sadly, give little to and get
little from this endeavor. Most of us fall
in the middle; we take our teaching
responsibilities seriously and derive con¬
siderable reward therefrom. I am grateful
to all of you who teach, and salute
particularly the voluntary faculty who
make such major contributions to the
clinical teaching programs at Yale-New
Haven Hospital and at the other hospitals
with which we affiliate.
The other raison d'etre for this school
is to conduct research
fundamental
and applied — of the highest quality.
Earlier I mentioned some of the historical
highlights of this faculty’s research contri¬
butions and alluded to a few of the
accolades received for such contributions.
Let me emphasize now that the scientific

figure 1
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number of applicants at a much larger
number of medical schools. In 1973, this
school ranked tenth nationally among
medical schools as a recipient of total
NIH research grants. In 1976, it was
seventh, in 1980 third, and in each of the
past two years, second. In 1973, our
fractional share of NIH’s total grant
awards to medical schools was 2.8 per¬
cent; by 1984 that had risen to 3.4
percent. In the research training grant
category, perhaps the most keenly com¬
petitive area of NIH funding, we have
done even better
ranking first nation¬
ally in each of the past four years. This
impressive performance is not confined
to any one part of the School. In 1984,
339 of the 666 eligible full-time faculty
(that is 51 percent of the total) were
principle investigators on one or more
externally funded grants; 157 of these
PI ’s came from the basic science depart¬
ments where virtually all faculty were
Pi’s. The remaining 210 Pi’s came from
the clinical departments.
Before leaving these encouraging data,
let me show you one other piece. In
figure 4, the direct cost income from
research grants (dots on the graphs) is
shown corrected for inflation (lines). In
constant 1972 dollars, this school’s
research grant income increased by 4.5
million dollars or 27 percent over the
interval shown. The number of individual
Pi’s increased too — from 225 in 1973 to
339 in 1984. Such real financial growth
did not occur at most medical schools
during this interval. It bears strong wit¬
ness to the vitality of our research
capability.
The great strength shown by this
school’s research enterprise is matched
by its clinical fortunes, which have pros-
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contributions of this faculty do not derive
from stellar contributions of a few “stars”
though stars we have. It is the collective
effort I want to underscore.
On the graph in figure 3 is plotted the
research grant and contract income (in
millions of dollars of direct costs) gener¬
ated by this school’s faculty annually
since fiscal year 1973. Federal research
and training grants, more than 90 percent
of which are from the N1H, are shown in
lines; non-federal grants are shown in
dots. In 1973, our total income from
these sources was 26 million dollars, 21
million of which came from federal
sources. Over the ensuing decade, this
income more than doubled, reaching a
total of 57 million in 1984. During this
interval, federal and non-federal funds
increased comparably
the fractional
contribution from federal sources being
80 percent in 1973 and 79 percent in
1984. This increased income is made
more impressive by recognizing that it
has occurred during an interval marked
by a leveling off of the NIH budget and
by more competition from the increasing
figure 2
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pered and broadened in recent years.
The major hospital in which our parttime and full-time faculty practice, YaleNeu' Haven Hospital, is an institution
regularly ranked among the top hospitals
in the country. This hospital, our hospital,
is now housed in an excellent new facility,
and is led by a superb administrative
team headed by Tom Smith. The mutually
pivotal relationship between Yale-New
Haven Hospital and the Yale School of
Medicine cannot be overstated. Strength¬
ening this powerful, (if sometimes frus¬
trating and always complex) symbiotic
partnership will be a central issue of my
deanship.
Some of you may not be aware of the
array of other health care institutions
with which this medical school affiliates
(figure 5). We have major relationships
with such local institutions as the West
Haven Veteran’s Administration Medical
Center, and the Connecticut Mental
Health Center. We have important affili¬
ation agreements with no fewer than ten
community hospitals in Connecticut and
with an array of health maintenance
organizations in our locale, including
the Yale Health Plan, the Community
Health Care Program,and the Hill Health
Center. All of these are vital to the
teaching mission of this school. In turn,
our presence at these institutions enhances the quality of care provided there.
Previously, 1 used some financial data
to describe our faculty’s research program,
recognizing, of course, that evaluating
our research by counting dollars is as
spurious as appraising a lootball team
by seeing how much its players weigh.
Nonetheless, 1 think we learn something
from such measuring, and I’ve done a bit
more ot it concerning our full-time
taculty s clinical activity. In 1 igure 6, I’ve
plotted total income earned from medical
services (i.e. patient billings and laboratory charges) in millions of dollars as an
annual function. Between 1973 and 1984.
this income has increased in actual dollars
3
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St Vincent’s Medical Center
Waterbury Hospital

figure 5

from 6.8 million to 46.4 millions (shown
in dots), a nearly six-fold rise. When
corrected for inflation, considerable real
growth is seen as shown in lines on the
graph. In constant dollars, however, the
increase since 1973 is only three-fold.
When examined critically, this apparently
remarkable growth has many explana¬
tions. First, it reflects a completely over
hauled and more efficient billing and col¬
lection program of the School’s Office
of Professional Services. Second, nearly
40 percent of the growth reflects billings
by several hospital-based departments
(Anesthesiology, Diagnostic Radiology,
Therapeutic Radiology) which formerly
billed their services through Yale-New
Haven Hospital. Third, it reflects the
introduction of a number of new tertiary
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care services by the full-time faculty.
Fourth, it reflects a modest increase in
the number of full-time faculty engaged
in some medical service activity. It is
particularly worth noting that the 300
percent increase in real medical service
income between 1973 and 1984 was
achieved with no increase in inpatients
admitted to Yale-New Haven Hospital
by full-time faculty and with only a 48
percent increase in outpatients seen by
this practicing group.
In 1973, only 15 percent of the School’s
total income was derived from medical
services and no less than 67 percent from
grants and contracts — a ratio which
mortgaged our future far too much to
the federal economy and political whim.
In 1984, medical service income ac¬
counted for 31 percent of the total, and
grants and contracts for 51 percent.
Together, these two sources continue to
account for 82 percent of the school’s
income. This testimony to your collective,
entrepreneurial efforts, I should add, is
not unlike that found in many other
prominent, research-intensive, private
medical schools with large faculty-tostudent ratios.
Institutions like this one remember
their past and assess their present to
prepare for the future. We of the faculty
and administration of the Yale School of
Medicine have every reason to face the
future with excitement and confidence.
None of us can doubt the opportunities
afforded by the exuberant, sometimes
breathtaking, pace of advances in cell
and molecular biology, genetics, immun¬
ology, and neuroscience — both for an
enhanced understanding of human bio¬
logy and for new insights into the patho¬
genesis, diagnosis, treatment, or pre¬
vention of disease. None of us should
doubt either the commitment or the
capacity of this school to remain at the
very top of this country’s medical institu¬
tions. My restless spirit has caused me,
from time to time, to look hard at some
other fine medical schools — to the
northeast of us, and just to the south;
slightly to the west of us, and far to the
west. None, in my view, is as vital, as
decent, or as sound as this school is. But
if you join me in aspiring to be vibrant as
well as vital, and to soar as well as be
sound, then we must strive ever harder
for excellence and be prepared for change.
It is this challenge of change which I see
as the major agenda item of my deanship,
and it will take many forms.
First, we must find new leadership for
many of our academic units. As of July
I, we have new chairmen in MB and B
(Bill Konigsberg)and in Human Genetics
(Carolyn Slayman), and I am negotiating

actively with a candidate for the chair of
Pharmacology. Search committees have
recently been appointed to identify re¬
placements for chairmen in Dermatology,
Psychiatry, and Surgery and next year, a
new chairman in Neurology will be
sought. Administration leadership, too,
is changing. Sue Dorn has recently been
appointed Director of an expanded
Medical School Development Office,
Bella Berson has been named director of
our much used and much needed medical
library, and we are seeking a head for a
revamped and enlarged public infor¬
mation office.
Second, we must strengthen (and in
some cases) establish programs in critical
or particularly exciting areas in which
we have unusual potential or in which we
are under-represented — molecular im¬
munology; neuroendocrinology; cancer
biology with particular reference to the
structure and function of oncogenes;
clinical pharmacology; and the biomed¬
ical applications of computers and of
nuclear magnetic resonance spectroscopy
to mention a few.
Third, we must appraise and, where
necessary, modify our curriculum for
medical students particularly, but for
our many other student constituencies as
well. We should not accept a medical
school basic science curriculum which is
either too dense or too ossified. Course
hours should reflect where medicine is
going, not merely where it has been. I see
a core curriculum as essential, but that
core needn't be rigidly assigned to depart¬
ments nor should it deny the opportunity
for electives. I believe our students should,
as part of their educational core, be
exposed to information concerning the
place of medicine in our society via such
topics as: biomedical ethics; medico¬
legal issues; and the economics of health
care - from the vantage of provider as
well as patient. If three semesters is not
sufficient time to do this part of our
teaching well, then let us consider going
back to four. That would result in com¬
pression of the clinical curriculum. But
if, as many argue, the fourth year is being
wasted because students devote too much
time to finding a house staff position or
to proving themselves as subinterns,
such compression may not be a bad idea.
Our country is filled with voices urging
modification of and experi¬
mentation with medical education. We
are too visible and too able a school to
act as the control group.
Fourth, we must add to and modify
the physical facilities in which we carry
out our functions. In this regard, change
will be particularly dramatic: renovation
of space in the Boardman Building for a
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much expanded Yale Eye Center; erection
of a new Faculty Practice Plan build¬
ing on the corner of Howard and Daven¬
port Avenues to permit our clinical
faculty to see outpatients in an appro¬
priate setting; construction of a Magnetic
Resonance Center below the LC1 building
to permit expansion of programs in
metabolic research, diagnostic imaging,
and macromolecular characterization;
renovation of space in the Tompkins
stack for our newly established Section
of Molecular Neurobiology. The latter
project is nearing completion; the other
three are scheduled to begin within the
next few months. Other construction
plans are only a bit further into the
future. The Yale Psychiatric Institute
will bring its widely recognized facility
for inpatient management of patients
with severe emotional disturbances back
to the medical center. The medical library
will be enlarged and modified to become
a vanguard facility of its kind. Finally,
and crucially, we need to construct a new
laboratory research building on our
campus — probably where the tennis
court now stands — to provide an oppor¬
tunity for much needed growth in our
outstanding laboratory research enter¬
prise whose facilities have expanded
little in the past decade.
These changes, and many others un¬
mentioned or even unimagined, will re¬
quire time, energy, and resources. Please
do not equate the word “resources” with
money. The most important resource we
have to accomplish what is needed is you
the human resource that is this faculty.
You have always been responsive sometimes even heroic — in your contribu¬
tions to this school. All of you
full or
part time, paid or voluntary, M.D. or
Ph. D., clinician or basic scientist - must
be prepared to continue, even to increase,
those contributions — not just to your
own research programs, or your teaching
commitments, or your patient care activi¬
ties, or your sections, or your depart¬
ments, but to the institution as a whole.
The other critical resource needed to
move ahead boldly is monetary. For two
years, a development advisory committee
composed of senior faculty and appointed
by Dean Berliner, examined the Medical
School’s resources with a particular eye
to the future. It concluded that the
continued greatness of this institution
depends on a major infusion of funds.
That conclusion was accepted by Presi¬
dent Giamatti and the Yale Corporation
who have agreed that the University
mount a major capital campaign on
behalf of the School of Medicine
the
first such campaign in the School’s his¬
tory. Within a few months, that campaign

will be launched officially. Here is where
it stands as of now:
• the target has been set at 125 million
dollars and the campaign duration at
five years
• the major financial goals have been
set: 40 million dollars for endowment
funds; 40 million for erecting new facilities
or modifying existing ones; the remainder
for a variety of programmatic needs
including increased student aid, funds
for laboratory equipment replacement,
and seeding new academic ventures
• the campaign director. Sue Dorn,
has been appointed and has recruited her
campaign staff
•a New York firm has been com¬
missioned to prepare the case statement
for the campaign and initial drafts of the
words and layout have already been
received. Completion of the statement is
expected before Christmas
• two key advisory committess, one
composed of faculty members and an¬
other of major volunteers, have been
fashioned and their membership nearly
completed
• more than 12 million dollars in gifts
or pledges are already in hand and a
major gift for the library renovation is in
the offing
In announcing this campaign to the
alumni of the School of Medicine in
June 1984, President Giamatti said, “1
expect this campaign to be launched
during the next academic year. 1 expect
to work diligently toward its goals and
ask each of you
in your own ways to
do the same. This is an effort for all of us
by all of us. And, I expect the campaign
to succeed.” 1 share the President’s
feelings and will do all 1 can to help this
noble effort meet its goals and perhaps
even surpass them.
That, my friends and colleagues of the
faculty, is my initial assessment of the
state of our school. 1 have much to learn
about being a dean, but 1 already sense
that the most difficult aspect will be to
step back from a myriad of day to day
issues and think about the school as a
whole. As 1 attempt to lead this institu¬
tion, to conduct this fine orchestra
with its many-toned, multi-voiced sec¬
tions of bedside clinicians and bench
researchers, of surgeons and physicians,
of clerks and technicians, of students
and alumni, of deans and managers — 1
know what I’ll be listening for. It is a
sound rich and mellow enough for all to
appreciate, yet unique enough for even
the most discerning ear to recognize.
Achieving that sound will not only be
gratifying for us, it will enrich all
mankind.
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Dean Rosenberg

“. . . if you join me in aspiring
to be vibrant as well as vital,
and to soar as well as be
sound, then we must strive
ever harder for excellence and
be prepared for change. It is
this challenge of change
which I see as the major
agenda item of my deanship,
and it will take many forms. ”
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CONTINUING THE SEARCH
FOR SOLUTIONS TO
INHERITED DISEASES
AND DISORDERS
Under the direction of Dr. Leon E. Rosenberg, who was chairman since its founding
in 1972 until his appointment as Dean in July, the Department of Human Genetics
has assumed a leadership role in the application of basic genetic knowledge to the
probelms of human illness. With Dr. Carolyn Slayman as chairman, the Department
continues to focus on the identification and explanation of the basic biochemical and
genetic mechanisms responsible for specific diseases, as well as on the study of new
methods of disease detection and treatment of patients.

by Nissa Simon

M

ore than 1,600 different human disorders are caused by abnormalities
-coding errors - that occur in any one of tens of thousands of genes,
each of which carries the genetic blueprint for a single protein. These
seemingly minor departures from the normal chemistry of the gene result in mental
retardation, physical deformity, metabolic disorders and a host of other inherited
disorders, some insignificant, others disastrous.
In recent years, scientists have learned to diagnose some of these problems before
birth and to read the genetic code in an effort to avoid the tragic consequences of
these diseases. Members of Yale’s Human Genetics Department are among those
scientists working to assure that eventually as many infants as possible will be born
free of the burden of genetic diseases. Four of these scientists approach the problem
from different levels. Dr. Roy W. Breg, Jr., professor of human genetics and
pediatrics, and director of the diagnostic cytogenetic laboratory, is studying genetic
diseases at the level of chromosomes. Dr. Kenneth K. Kidd, associate professor of
human genetics and psychiatry, is involved in the relatively new science of human
gene mapping. Dr. Maurice J. Mahoney, professor of human genetics, pediatrics
and obstetrics and gynecology, is working on ways of identifying genetic problems
during fetal life. Dr. Margretta R. Seashore, associate professor of human genetics
and pediatrics, and director of the genetic consultation service, is attempting to
quantify the risk of genetic illness even before conception.
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n the late 1960’s, Dr. Breg and a
colleague were the first to demon¬
strate that cells from amniotic fluid
could be cultured and used to diagnose
genetic problems prenatally. By the
mid-1970’s, amniocentesis was a routine
procedure. It remains a major tool for
diagnosing genetic defects.
Dr. Breg now studies chromosomes
associated with a variety of health
problems. “One of the largest groups
we work with consists of couples where
the woman has had multiple spontan¬
eous abortions and couples where the
woman gave birth to an infant with a
birth defect or congenital malformation.
“When I speak of birth defects or
malformations, I include a spectrum of
abnormalities such as mental retarda¬
tion, multiple physical abnormalities
and problems of incomplete sex differen¬
tiation. Not all of these have a chromo¬
somal basis, but many do,” said Dr.
Breg. His laboratory is also developing
techniques to pinpoint chromosomal
imbalances that cause multiple abor¬
tions, which will permit more accurate
counseling.
Chromosomes must be studied using
cells that are alive and dividing because
only during mitosis do they contract so
that they can be stained and photo¬
graphed. One of the recent advances in
cytogenetics allows the study of cells
during earlier stages of mitosis.
“Before 1970. we could identify chromo¬
somes only by their length and by the
position of the centromere. In many
cases, we couldn’t distinguish between
chromosomes within a certain group
that were similar in length and the
position of their centromere. When
new banding techniques came along,
we could begin to see the patterns that
are specific for each type of chromo¬
some. This improved our method of
detecting various abnormalities. But
we knew at the time that we were still
not seeing some deletions and trans¬
locations.
“We realized that we would be able
to see more if the chromosomes were
longer, before they contracted for divi¬
sion. But these long chromosomes are
difficult to work with because there are
so many overlaps and bends. Gradually,
we’ve been learning to work with longer
and longer chromosomes,” said Dr.
Breg. “The trick is to get them to spread
enough so they're reasonably separate,
which makes them easier to work with.
But there’s a limit, because if you
spread them too much, the cell breaks
and loses chromosomes. If they’re not
spread enough, you can’t distinguish
them. So we try to strike a balance.

Dr. Breg

“I wish the chromosomes were as
neatly lined up in the cells as they are
after we stain them, photograph them,
cut them out of the photograph individu¬
ally and then line them up for their
portrait. In a textbook they look very
tidy, but in actuality, they look more
like a bowl of spaghetti,’’continued Dr.
Breg.
As its name implies, the diagnostic
cytogenetics laboratory is primarily respon¬
sible for providing clinical services.
Because the work is so painstaking, not
many other laboratories offer this tech¬
nique as a diagnostic service.
Dr. Breg foresees some kind of com¬
puter-assisted analysis to help locate
which cells are dividing. “We also hope
to get help from a computer-based
image analysis system to analyze the
800 to 1,000 different bands per set of
chromosomes,” he said. “There are so
many genes in chromosomes that no
one knows how many there are alto¬
gether, but even the smallest chromo¬
some surely must have more than 100
genes.”

T

he problem of identifying these
individual genes is the task of
gene mapping, the specialty of
Dr. Kidd. DNA molecules form a
continuous strand in each chromosome
and the only way to distinguish a gene
from a ‘spacer’ DNA between genes is
by identifying the information content.
“It’s like taking the 26 letters of the
English language, some spaces, a few
commas, some semicolons, colons and
periods and putting them all into a
random string. Insert a sonnet by Shake¬

speare into the stringand then continue
with the gibberish. Someone who didn’t
know English wouldn’t be able to recog¬
nize that there was something in there
that made sense. If you tried to analyze
it by any criterion other than informa¬
tion content, you couldn’t do it,” said
Dr. Kidd.
“If you know how to translate the
information into the meaning, that is,
the function of the gene, then you can
find the gene. But for many diseases we
only know the clinical signs, we don’t
know the controlling mechanism, there¬
fore we don’t know the responsible
gene. So we look for markers,” Dr.
Kidd continued.
Recently, researchers learned how to
use restriction enzymes to cut DNA
fragments. This new technique has al¬
ready permitted the discovery of a
marker for the Huntington’s disease
gene and will be used to locate markers
technically known as restriction
fragment length polymorphisms
(RFLPs) — for several thousand other
inherited disorders. These markers are
included in the spacer DNA and are
genetically determined.
Each of the more than 100 known
different restriction enzymes cuts at its
specific nucleotide sequence known as
a recognition site. All humans have
millions of these sites and some vary
from person to person. Any given site
that is sometimes present and sometimes
absent on a specific chromosome can
serve as a marker. In a given family, if
one parent has one chromosome with

the site and one without it, the inheri¬
tance pattern can be observed. “If the
disease gene is located in the part of the
DNA close to the marker, we can often
determine which child in the family has
inherited the disease gene by looking at
the inheritance pattern of this closely
linked marker,” said Dr. Kidd.
Because there is no way yet of predic¬
ting the form of the marker that goes
along with a specific disease gene in any
family, (that is, whether or not the site
is present) scientists now test several
generations of large families with inheri¬
ted diseases.
“I’m studying a family for a dominant¬
ly inherited genetic form of cancer. We
have DNA samples for the entire family.
We know who has the gene and who
inherited it from whom. We can now
test all of these genetic markers until we
find one that segregates with the cancer.
And that will tell us that we have found
a marker that is close by on the same
chromosome. It won’t give us the gene
for the cancer, but if we’re close enough,
we can use it for prenatal diagnosis,”
said Dr. Kidd.
“The most dramatic evidence of the
explosion of knowledge in this field is
the discovery of these DNA markers,”
continued Dr. Kidd. “The first genetic
polymorphism
a common, normal
variation — in humans was discovered
in 1900, and that was the ABO blood
group system. By the mid-1960s, bio¬
chemical stains and starch-gel electro¬
phoresis had been developed and quite
a few more polymorphisms were found.
Dr. Kidd

By 1978, perhaps 100 had been dis¬
covered, but only about 20 of them
were common enough to be good
markers. Most of the others happened
so infrequently that although they were
polymorphisms, they weren’t useful. In
1978, the first of the DNA polymor¬
phisms was discovered. By 1979, there
were three that were known, mostly
near the hemoglobin region. By 1981,
we knew about 26 of them. Last summer,
156 had been tabulated. No one has
done a tabulation in the last year, but
its probably close to 500 by now. The
number is tripling each year.”
All of these variants are inherited
and it may be that as many as one out
of every 100 base pairs in spacer DNA
shows such a variation. That’s on the
order of 3 X 107 potential markers.
“They’re everywhere, all over the chro¬
mosomes,” continued Dr. Kidd. “Any¬
where anyone has looked, they’ve found
polymorphisms. It's a whole new ball
game.”
Mapping the human genome is impor¬
tant because it is a necessary first step.
“It will enable us to learn a phenomenal
amount about human biology, what
makes us what we are and how we
function. We'll learn about human be¬
havioral disorders and psychiatric disor¬
ders. There are more genes active and
devoted to the function of the brain
than to any other part of the body.
There may be 30,000 to 50,000 different
genes required only for the functioning
of the brain. These are genes that aren’t
used in the fingernails or kidney or
heart or muscles or bone. They are
genes devoted only to the brain, geneti¬
cally the most complex part of the
human body. So genes offer an exciting
approach to finding out how the brain
functions and how it goes awry,” con¬
cluded Dr. Kidd.

R

esearch at the level of genes
and chromosomes done in lab¬
oratories like Dr. Breg’s and
Dr. Kidd’s provides the kind of informa¬
tion used in clinical settings such as
Drs. Mahoney and Seashore.
“I’m involved in diagnosing disease
during fetal life,” said Dr. Mahoney.
“Asking questions about an unborn
baby’s health has become such a com¬
mon elective procedure for pregnant
women that we have to screen large
groups of women to narrow the group
to a manageable one. Then we apply
more invasive or more expensive diag¬
nostic techniques where necessary.”
These techniques include amniocen¬
tesis or chorionic villus biopsy, a new
technique for obtaining fetal cells for
8

Dr. Mahoney

“We at Yale have a diverse
faculty that looks at many
aspects of human genetics and
works together in a cooperative
setting. The willingness to push
forward and to be innovative
have always been hallmarks of
this department. We’re now at a
period when we can see the
possibility of some exciting
therapies for genetic diseases,
and we have people working
actively in those directions. ”

prenatal diagnosis. Dr. Mahoney is
principal mvestiator at Yale in a fouryear collaborative clinical trial asses¬
sing the safety and accuracy of chorionic
villus biopsy. Six other medical centers
in the country are participating in the
study funded by the National Institute
of Child Health and Human Develop¬
ment (NICH HD).
Unlike amniocentesis, which relies
on culturing fetal cells found in the
amniotic fluid, chorionic villus biopsy
samples fetal tissue directly through
the cervix. The procedure provides a
larger tissue sample than amniocentesis,
can be done much earlier in pregnancy
and gives faster results.
Using a catheter and guided by ultra¬
sound, the physician suctions off a
small plug of tissue from one or more
villi, protrusions of the chorion. Where
the villi grow and attach to the inner
surface of the womb, the early chorion
matures to form the placenta. Other

villi grow into the membranous chorion,
which lies outside the amnion as part of
the fetal membranes. The tissue can be
analyzed for defects immediately be¬
cause it constitutes a dense sample of
rapidly dividing cells.
Chorionic villus biopsy permits test¬
ing during the first three months of
pregnancy and yields results within
days, whereas amniocentesis is not rou¬
tinely performed before the 15th week
of gestation and doesn't yield results
for another two weeks.
“To move prenatal diagnosis back
from the middle of the second trimester
to the eighth, ninth or tenth week of
pregnancy has major benefits,” said
Dr. Mahoney. “One of the major draw¬
backs of amniocentesis is that of having
to face a second-trimester abortion
decision if serious fetal disease is dis¬
covered. The possibility of obtaining
that same information earlier in preg¬
nancy shifts the decision to a firsttrimester abortion using suction aspira¬
tion.
“The dangers of chorionic villus
biopsy and the risks to both the unborn
baby and the woman still must be
established. It’s doubtful that the risks
will be as low as those in amniocentesis.
That will mean a significant decision. A
pregnant woman will have to ask herself
whether she wants an early diagnosis
with a somewhat higher risk of mis¬
carriage or a later diagnosis with a low
chance of losing the baby. At the
moment, the risk estimates of miscarriaae are in the ranee of two to five
percent. We expect it to drop, just as
the risks for amniocentesis dropped.
But most of us doubt that the risks will
soon be as low as those for amnio¬
centesis,” Dr. Mahoney said.

W

hereas Dr. Mahoney is con¬
cerned with early diagnosis
of genetic diseases. Dr. Sea¬
shore attempts to identify the prospects
of a genetic disease even before
conception.
“Most families come to see us because
of a child who is mentally retarded or
who has a birth defect,” she said. “The
family wants to know why it happened,
will it happen again with another child,
and what will happen with this child.
“We also have people come in who
know that a family member suffers
from what is believed to be a genetic
condition and would like to know
wheter it runs in the family. They may
tell us about a brother who has muscular
dystrophy, or an uncle who has hemo¬
philia, or a cousin who has epileptic
seizures and they want to know if they

themselves or their children might have
the disease.”
The first thing Dr. Seashore does is
attempt to confirm the diagnosis. “There
are many different kinds of genetic
problems and if we don't know the
exact problem, we’re sunk. We have to
corroborate the diagnosis ourselves, so
it’s important that we’re diagnosticians
as well as genetic counselors.
“That may sound distrustful, and I
certainly don’t mean to imply that we
don’t trust the rest of the medical
community, but we've all seen cases
that on first blush look like one thing
and then turn out to be something
different,” Dr. Seashore explained. “In
many cases scientific knowledge has
progressed since the diagnosis was first
made and there are now better tests and
better ways of ascertaining just what

Dr. Seashore

kind of genetic problem it is.
“Achondroplasia, for instance, is one
of a group of diseases that have to be
distinguished from one another. Hurler’s
syndrome is now recognized to be one
of at least ten different mucopolysac¬
charide storage diseases, some of which
are inherited in a recessive way and one
of which is inherited on the X chromo¬
some. Each has a different biochemical

defect, so it's important to distinguish
them for purposes of prenatal diagnosis.
There are many examples of that kind
of similarity and the more we learn, the
more there seem to be. In fact, it’s
almost become a rule that many things
that look similar may be biochemically
or genetically distinct,” she said.
When patients come in to the clinic,
the first person they see is the genetic
counselor who also serves as clinic
coordinator. She obtains the necessary
medical records that tell what tests
have been done. “We try not to do any
more tests or x-rays than are absolutely
necessary. It’s costly, sometimes uncom¬
fortable and perhaps, even risky for the
patient,” said Dr. Seashore.
During ensuing visits, the physician
responsible for the diagnosis and care
interprets the tests and explains the
results. Once the family receives the
needed information, they must then
decide what to do. “They may decide
this isn’t the time to have a child and
would like to think about it for a while.
Then they may come back in a couple
of years and ask whether anything has
changed or whether there's any new
information. Or, they may decide to go
ahead with a pregnancy,” said Dr.
Seashore. “Then we arrange for prenatal
diagnosis when that’s possible and the
family wants it.”
Another part of Dr. Seashore’s clini¬
cal service involves caring for children
with inborn errors of metabolism. For
instance, all infants in Connecticut are
screened for PKU after birth. There are
several different kinds of PKU, each of
which requires a different treatment.
One must be treated by dietary restric¬
tions; one doesn’t require treatment
beyond the first few years of life, and
yet another kind needs treatment with
neurotransmitters and vitamin cofac¬
tors. “Within the first few weeks we can
tell which kind of PKU it is,” said Dr.
Seashore, “and treat it accordingly.”
Dr. Seashore’s service is part of the
Connecticut Genetic Services Program,
a coordinated effort of Yale, the Univer¬
sity of Connecticut and the State Health
Department. The consultation clinics
are not all located at Yale. The Yale
School of Medicine is also responsible
for the supervision of three genetic
counseling clinics at community hos¬
pitals in Danbury, Norwalk and Bridge¬
port.
“Our center is also very active in the
New England regional genetics group.
Members from all over New England
meet regularly to discuss new develop¬
ments and coordinate services,” said
Dr. Seashore. “We can work together

to try to help a family with members
scattered throughout New England in¬
stead of having isolated groups trying
to solve the problem separately.”
Members of the Genetic Consultation
Service have faculty appointments in
the Department of Human Genetics.
“We take our places as full members of
the department in research and teaching,”said Dr. Seashore. “All of us feel a
scholarly commitment to the academic
part of the department. It’s exciting to
work with basic scientists on a daily
basis. And, having us around helps
them see problems from a different
perspective.
“Teaching is an important part of
our job. 1 feel a strong commitment to
teaching and to helping students
whether or not they eventually specialize
in genetics,” she continued. “Although
it doesn’t always seem obvious to pa¬
tients, we know that having people in
training asking questions and seeking
the latest information improves the
level of care for patients.”
What’s ahead?
“We’ll get better at diagnosis. We're
now able to identify finer chromosome
structures so that we’ll improve our
ability to locate genes, recognize them
and identify mutations that we cannot
now identify. We’ll get better at telling
people whether or not they carry a
specific gene that puts them at risk,”
predicted Dr. Seashore.
“What’s the next really big step?
Manipulating a defective gene to make
it work by fixing it or replacing it. We
talk a lot about replacing the protein
that’s missing because the gene is mal¬
functioning. But it’s clear that we have
a great deal more ot learn about how to
do that and we cannot go forward at all
without a lot of very careful basic
resarch,” Dr. Seashore concluded.
“This is an exciting time in the
history of medicine,”said Dr. Mahoney.
“Knowledge of genetic disease is ex¬
ploding. We at Yale have a diverse
faculty that looks at many different
aspects of human genetics and works
together in a cooperative setting. The
willingness to push forward and to be
innovative have always been hallmarks
of this department. We’re now at a
period where we can see the possibility
of some exciting therapies for genetic
diseases, and we have people working
actively in those directions.”
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NEW
KNOWLEDGE
TAKES THE
GUESSWORK
OUT OF
HIGH RISK
PREGNANCIES
by Marje Noyes
ome of the most remarkable
progress in medicine over the
past ten years has been made in
the relatively young field of perinatol¬
ogy. Disorders caused by chromosomal
abnormalities, as well as an increasing
number of genetically transmitted dis¬
eases and structural abnormalities can
be detected prenatally, and perinatolo¬
gists are beginning to be able to success¬
fully treat some of these disorders in
utero.
A number of advances in all aspects
of this new field are due in large part to
pioneering research by members of the
Comprehensive Maternal Care Unit at
Yale, which has been under the direction
of Dr. John C. Hobbins, professor of
obstetrics and gynecology and diagnos¬
tic radiology, since it was founded ten
years ago. One of the leading fetal
medicine/ perinatal diagnosis programs
in the world, the Unit’s reputation is
based on its contributions to the develop¬
ment of fetoscopy and other diagnostic
procedures involving ultrasound, as
well as for its superb care of mothers
whose pregnancy is at risk. Their accom¬
plishments are the result of truly close
collaboration with researchers in human
genetics, diagnostic radiology, obstetrics
and gynecology, pediatric cardiology
and surgery.
“Women come here literally from all
over the world to find out if an illness
or condition present in the family or a
previous pregnancy will recur,” said
Inge Venus, pointing to a large map of
the world marked with colored pins in
countries as far away as South Africa,
the Fiji Islands, India and Europe. A
clinical studies researcher in the Depart¬
ment of Obstetrics and Gynecology,
Ms. Venus has been a member of the
Unit’s staff since its beginning, and has
witnessed the rapid advances in prenatal
diagnosis which are giving parents op¬
tions unheard of as little as ten years
ago.
10
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wenty-seven in every thousand
babies in the United States are
born with some kind of defect,
according to Dr. Hobbins. The Unit
has the capability to accurately diag¬
nose, and in some cases, treat in utero
from ten to 15 of those problems.
Dr. Hobbins and Dr. Maurice J.
Mahoney were leaders in the develop¬
ment of fetoscopy, a method of intra¬
uterine visualization requiring neither
laparotomy nor general anesthesia, as
well as new techniques combining fetos¬
copy and ultrasound, for fetal blood
sampling and skin biopsy. These tech¬
niques have expanded the number of
fetal problems that can be diagnosed
by amniocentesis to include hemoglobin¬
opathies, deficiencies of certain clotting
proteins, and other errors of meta¬
bolism, as well as congenital abnormal¬
ities occurring in repeated pregnancies,
such as spina bifida cystica.
Yale-New Haven is one of only tour
or five medical centers in the U.S. to
offer fetoscopy. “Our purpose is to
avoid needless abortions,” explained
Ms. Venus, who is responsible for
reviewing the patients’genetic situation,
and for giving them and their families
necessary' information and support. “Be¬
fore fetoscopy, a couple at risk for a
sex-linked disease such as hemophilia
would have amniocentesis, and if they
found the fetus was a male, they would
automatically consider abortion,” she
explained. “Sometimes these were per¬
fectly healthy babies. Fetoscopy saves
these healthy fetuses.”
Drs. Mahoney and Hobbins think of
fetoscopy as more than a diagnostic
tool. “1 think it will be part of the path
to new therapeutics as well as diagnostic
techniques - access to the unborn
baby we never had before,” predicted
Dr. Mahoney.
Drs. Hobbins and Mahoney have
collaborated on a number of procedures
involving human genetic and diagnostic
radiology techniques. They are currently
participating in a nationwide study to
test the accuracy as well as the risk
factors of a new technique, chorionic
villus biopsy, for obtaining fetal cells
for prenatal diagnosis (See preceding
article on the Department of Human
Genetics —page 6).
Literally hundreds of women are
referred to the Unit from the New
Haven area, and from all over the U.S.
and abroad for testing for conditions
ranging from Down’s syndrome to limb
and structural abnormalities and ob¬
structive uropathy. The Unit is a major
referral center for women suspected of
bearing hydrocephalic fetuses, who

come here to learn whether or not the
condition can be treated prenatally;
and it conducts one of the most active
maternal serum alpha fetal protein
screening programs in the nation.
“We are able to definitely determine
whether the fetus has a spinal defect,
and if so, the size and precise location
of that defect,’’explained Dr. Hobbins.
“Indirectly, we are being asked what
the quality of life is going to be for
those babies. If the defect is low on the
spine, there is a chance for surgical
repair; if it is high, there is very consider¬
able risk for severe paralysis.”

I

n collaboration with Dr. Charles
Kleinman, associate professor of
pediatrics and diagnostic radiology,
the Unit has been at the forefront in
developments in fetal cardiology. Cap¬
able of diagnosing a large number of
fetal cardiac anomalies of the gross
structure of the heart, they are also
doing research in the diagnosis and
treatment of cardiac function.
Cardiac defects are a major problem
affecting fetuses, according to Dr. Hob¬
bins. About eight in every 1.000 fetuses
have a cardiac problem.
For instance, fetal immune ideopathic
hydrops has long been associated with
interuterine death, with the exact cause
unknown. “We found a cardiac reason
in 13 of the first 16 patients referred to
us with this diagnosis,” said Dr. Hob¬
bins. “The heart was structurally sound,
but the beat was irregular, causing
inadequate blood How, and eventually,
an excessive buildup of fluids.”
After typing the various fetal heart
arrhythmias. Dr. Kleinman began treat¬
ing the condition by giving the mothers
digitalis, or in more severe cases, similar
but more effective newer drugs. “In a
majority of cases, we were able to keep
the fetus alive until it was mature
enough to be delivered, and in some
cases, we reversed the hydrops,” said
Dr. Hobbins.
A large portion of current research is
directed toward monitoring fetal growth
and nourishment, in an effort to circum¬
vent problems caused by living in an
unsuitable or alien uterine environment.
“We think the key may be fetal blood
flow,”commented Dr. Hobbins. “There¬
fore, we are directing a large part of this
research into evaluating blood flow in
normal and in undergrown fetuses.”
Dr. Hobbins and his colleagues have
developed ways to measure the limbs,
abdomen and head of fetuses, and even
to determine their approximate weight,
based on formulas designed in the
Unit. These data, plus observations by

Dr. John Hobbins, left, and his
colleagues are developing new
procedures to obtain samples of
fetal liver and kidney tissue and
pure fetal blood. “The
excitement comes in what
geneticists like Dr. Mahoney can
do with these samples, using
new techniques to diagnose
problems, such as cystic fibrosis,
that have frustrated us, and
ultimately, using some of these
same tools to treat many more
problems prenatally. ”
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ultrasound of fetal behavior such as the
character of movement, the r.e.m.,
breathing and the like, give clues as to
whether or not the fetus is undernour¬
ished and suffering from relative as¬
phyxia or hypoxia.
The fetal diagnosis program is a non¬
stop operation, starting early in the
morning and going on well into the
evening. At least 20 women are seen
each day. The majority come only once
or twice for diagnostic procedures and
consultation, but others require further
care, either on an outpatient or in¬
patient basis.

T

he high-risk outpatient program
is extremely active. There are
special programs designed especi¬
ally for pregnant women who are dia¬
betics, as well as for those who are
hypertensive or who are Rh sensitive or
toxemic.
“In the diabetes program we monitor
both the fetal development and the
blood sugar of the mother. We have
spent a great deal of effort on developing
ways to control the blood sugar level of
the mothers in order to avert some of
the problems that infants of diabetics
are subject to,’’explained Dr. Hobbins.
The survival rate of infants of diabetics
has increased dramatically over the
past ten years, as a result. A few years
ago, perinatal mortality for infants of
diabetic mothers was almost 50 percent;
today, the survival rate for these babies

is almost the same as those of non¬
diabetic mothers, according to Dr. Hobbins. “Similarly, through research we
are able to identify a certain population
of women who are at risk for hypertension
in pregnancy and intervene by pre¬
scribing medication and bedrest.”
The new Maternal Special Care Unit
was created for patients with acute
complications of pregnancy - either a
fetus at risk, or a mother with a serious
illness such as pneumonia or liver dis¬
ease. Directed by Dr. Peter Grannum,
assistant professor of obstetrics and
gynecology, it is staffed 24 hours a day
by a team of specially trained nurses
who offer the kind of care that generates
a great deal of enthusiastic fan mail
from former patients.
Because many of the infants born to
high-risk mothers will spend some time
in the Newborn Special Care Unit, the
Maternal Special Care Unit is located
adjacent not only to the prenatal diag¬
nostic facilities, but also to the Newborn
Unit. Physicians of the Newborn staff
have joint appointments in obstetrics
and gynecology, and become involved
in the care of their prospective patients
several weeks prior to their delivery.
“We consult with parents to tell them
what to expect, and work closely with
the staff of the Maternal Special Care
Unit, as well as with others who may be
involved, to coordinate the delivery,”
said Dr. Richard Ehrenkranz, clinical
director of the Newborn Special Care
Unit.

esearch and advances in pre¬
natal diagnosis and care aren’t
limited to the third floor of the
Yale-New Haven Hospital. Physicians
come here from around the country to
attend training courses given bi-monthly
in ultrasonography. Every year, two or
three postdoctoral fellows from medical
institutions abroad come for a year or
two for training or research. “Having
visitors from other institutions creates
a stimulating environment here,” said
Dr. Hobbins. “This is a very exciting
field to be in right now. We’re making
progress — and we have a way to go.”
Looking to the future, he described
current research that seeks to find safe
and accurate ways to obtain samples of
fetal liver and kidney tissue, and a new
procedure he is working on to obtain
pure fetal blood. “The excitement comes
in what geneticists like Dr. Mahoney
can do with these samples, using new
enzyme and DNA techniques, and leukage techniques to diagnose problems
that have baffled us, such as cystic
fibrosis and muscular dystrophy,” he
said. “And, ultimately, using some of
these same tools to treat many more
problems prenatally.
“For instance, it may well be possible
to inject a clone of cells from a normal
fetus into the blood stream or directly
into the liver of a fetus who is dying
because it is missing an enzyme,” he
continued. “As a result, that fetus will
start producing these cells, which will
multiply and the tissue will regenerate.
In time, normal genes will produce
normal enzymes in that fetus.”
Thus, one of the foremost prenatal
diagnosis/fetal medicine programs in
the world looks to the future in its
research to improve not only the survival
rate , but also the quality of of life for
fetuses with severe problems.
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A VERY SPECIAL PLACE TO BE BORN

WIL LIAM CARTER
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After more than twenty years,
ongoing research and the
latest in technology combined
with professionalism and
dedication remain the heart
of the first and one of the
finest newborn intensive care

Despite the bright balloons floating above and the cuddly toys in every isolet,
it is obvious at once that the mission here is extremely serious. Against a
background of the insistent wails typical of newborns and the steady hum
and beep of hi-tech life support systems, teams of nurses maintain a constant
vigil over their tiny patients.
A mother, scrubbed and gowned, lovingly feeds her baby, so fragile it
hardly seems possible that he is able to take nourishment from the bottle. A
doctor quietly consults with parents as they peer anxiously at their infant
daughter, attached by many wires to monitoring equipment surrounding her
isolet. The phone rings — and within minutes after the message is relayed, a
crisis transport team is mobilized and on its way to bring in a critically ill
newborn from a hospital 25 miles away.
The first of its kind in the country, the 44-bed Newborn Special Care Unit
has earned a reputation of outstanding research in the cause and treatment of
critical problems affecting premature infants. It has served as a model for
similar units in hospitals throughout the world.
Almost 150 of the more than 1,000 infant patients last year were brought
to the Unit from hospitals throughout Connecticut and from nearby states.
Another 150 were born to high-risk mothers who were patients in Yale’s
Maternal Special Care Unit.
This prototype intensive and special care unit for prematures and
newborns was founded in 1960 by Dr. Louis Gluck, who is now professor of
pediatrics and reproductive medicine at the University of California, San
Diego. “Knowing what constituted intensive care was difficult, lacking as we
did, both guidance and precedent. Part of our work had to extend to the
delivery room,” he wrote in an article in Yale New Haven on the occasion of
the Unit’s twentieth anniversary.“We adapted existing adult and pediatric
intensive care techniques to prematures and newborns. We developed
transport procedures for patients from outlying hospitals and experimented
with different architectural schemes, learning that babies received better care
in large rooms rather than in the little cubicles prescribed by law. . .”
During those first few years, the basis for intensive care for newborns
slowly developed. “We knew little of electrical hazards or of sophisticated
techniques,” said Dr. Gluck.
In 1962, Dr. Edward Hon, one of the leaders in the development of
electronic fetal monitoring, returned to the Yale Department of Obstetrics,
and with Dr. Gluck, founded the first known perinatal unit with joint
training of residents and fellows.
“What incredible excitement there was in those days!” wrote Dr. Gluck.
“Every day we developed more confidence and sophistication. This was
infectious, and soon pediatric and obstetric residents began to appreciate the
great opportunites of this new frontier: perinatal medicine.”
Today, with Dr. Ian Gross, associate professor of pediatrics and obstetrics
and gynecology, as director, and Dr. Richard Ehrenkranz, associate
professor of pediatrics and obstetrics and gynecology, as clinical director,
the Unit has a staff of four full-time physicians, four postdoctoral fellows
and seven house officers. Ongoing nursing care is provided by a staff of
almost eighty nurses under the direction of Jeryl Gagliardi, assistant clinical
director of pediatrics.

WII.I.IAM CARTER

units in the world. . .

The largest tertiary neonatal center in
Connecticut, the Newborn Special
Care Unit is a referral center for
critically ill newborns from nearby
towns and cities in Rhode Island,
New York and Massachusetts. Within
a very short time, two members of a
specially trained and equipped
nursing team are mobilized to safely
transport these infants to the Unit.
The twelve-nurse transport team,
on call 24hours a day, 365 days a
year, is prepared to perform
important life-supporting procedures
including intubation, initiation of
ventilatory assistance, and
interpretation of x-rays, arterial
blood gases and other clinical and
laboratory data, under standing
protocols.
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The population of patients on the
Unit is quite different from that of
twenty years ago, when babies stayed
there until they were well enough to
go home.
“ We are much more of a critical
care nursery now, ”said Jeryl
Gagliardi, director of the nursing
staff, who has been on the Unit since
the beginning.
As soon as they pass the critical
phase, babies are transferred into a
less intensive area of the Newborn
Special Care Unit. Referral infants
are returned to the hospital they came
from once the level of care required is
compatible with the care provided in
the community hospital.
Today families are encouraged to
be active participants in their infant ’s
care. This family involvement really
has changed since 1962, when there
were many restrictions governing
what parents were allowed to do. “ We
have become more and more liberal
over the years, "commented Ms.
Gagliardi.
Parents are encouraged to visit
even the most critically ill infants as
often as they like, day and night. “ We
even suggest they bring in their other
children. If a mother and father are
worried about the baby here, it's
better for the siblings to see the sick
baby, "she explained. “It helps them
understand the source of their
parents ’ worry. ”
Nurturing, too, is encouraged. A
rocking chair is by every isolet.
Mothers can cuddle and feed their
babies, and in time, even bath them.
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“As our understanding of the
physiology of the very small
premature infant has increased, we
have become much more aware of the
nutritional needs of these babies, ”
observed Dr. Richard Ehrenkranz,
associate professor of pediatrics and
obstetrics and gynecology, and
clinical director of the Unit. In
collaboration with Barbara
Ackerman, R.N., he has conducted
research on human milk and on the
ability of premature infants to absorb
dietary nutrients.
Their research has demonstrated
that milk produced by mothers of
preterm infants contains as much as
20 percent more protein for four to
six weeks after birth than does the
milk of mothers of full term babies.
Although it is not known precisely
why this is, the extra protein may
have a decided advantage for the
growth of preterm babies who are fed
their own mother's milk. In addition,
this research has shown that preterm
human milk changes as the duration
of lactation increases, and that some
nutrients, such as calcium and
phosphorus, might not meet the
nutritional needs of the growing
premature infant.
Coincidental to these findings is an
increasing move toward feeding
mother’s milk to premature infants —
a trend some mothers feel is not only
important to the health of their baby,
but also important to the nurturing
process. Milk is expressed by the
mothers and stored in containers in
the Unit’s freezer until the baby is
able to be bottle fed. Then, it is given
in the sequence in which the mother
has expressed it.

“Are we going to reach a limit in
terms of the viability of very low
birthweight infants?"pondered Dr.
Ehrenkranz.
During the last 20 years physicians
and nurses in neonatology have
witnessed some of the most dramatic
changes in the recent history of
medicine. Less than a decade ago, the
survival rate of infants weighing two
pounds was less than ten percent.
Today, approximately 70 percent of
these babies survive with a prognosis
for a quality of life that is generally
very good.
“Now we care for infants who
weigh one to one-and -a half- pounds.
The survival rate for these infants is
not very high— and some who
survive have multiple problems.
Those without multiple problems do
very well, ” according to Dr.
Ehrenkranz. “ This is due not only to
refinements in technology, but also to
our increased knowledge of the
pathophysiology of the smaller and
smaller infant.
"The challenge today is how to
improve their care — to better
ventilate them, to nourish them, and
to deal with or prevent problems
technology sometimes cause, ”he
added. “ The greatest challenge,
ofcourse, is to prevent prematurity. ”

* *

Research has contributed important
new knowledge on a number of fronts
in the care of premature infants.
Much of the work at Yale has
focussed on fetal lung development.
Dr. Ian Gross, director of the Unit,
(at left in photo below) is widely
recognized for his research on
respiratory distress syndrome, (RDS)
a major problem of prematurity. The
mortality rate for RDS has decreased
dramatically in the last 20 years, due
in large part to advances in the ability
to ventilate premature infants until
their lungs are capable of taking on
the task. Nevertheless, prolonged
ventilation causes chronic lung
disease. RDS is also associated with
an increased incidence of brain
hemorrhage as well.
RDS of the newborn is believed to
be caused by immaturity of the fetal
lung, particularly the pulmonary
surfactant system. Research by Dr.
Gross and his colleagues suggests that
fetal lung development, including the
maturation of the pulmonary
surfactant system, is under multihormonal control.
Tissue culture and animal studies
have shown that some hormones act
synergistically to promote the
production of pulmonary surfactant
during fetal life. This observation will
soon be tested in a collaborative
clinical trial involving Yale and three
other major medical centers. It is
hoped that administering a
combination of hormones to women
in premature labor, one day prior to
delivery, will prevent the development
of RDS in their offspring.

I
“ You can V help getting involved when
you take care of these babies and
interact with their parents, ” observed
Dr. Ehrenkranz, (above). “But it’s
important to maintain a sense of
objectivity so that when an infant
doesn t do well or dies, one can ‘get
back on the horse’, doing the best for
other infants. ’’
“The rewards are the kids. Seeing
them when they come back for visits
one, two or three years later. They ’re
great, ” he said. “I still correspond
with twin boys I took care of ten
years ago. They live in the mid-west
now. ”

PHOTOS BY WILLIAM CARTER
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DR. PERKINS APPOINTED
CHAIRMAN OF
PHARMACOLOGY
The Yale Corporation has appointed
Dr. John P. Perkins professor and
chairman of the Department of Pharma¬
cology, effective January 1, 1985. Wide¬
ly recognized as a superior administra¬
tor, teacher and researcher. Dr. Perkins
has been professor and chairman of the
Department of Pharmacology at the
University of North Carolina School of
Medicine in Chapel Hill, since 1977.
“The appointment of John Perkins
to chair the Department of Pharma¬
cology is extremely important to the
School of Medicine," said Dean Leon
E. Rosenberg. “He has demonstrated
outstanding leadership during the past
seven years as chairman of Pharma¬
cology at the University of North Caro¬
lina, while remaining among the na¬
tional and international leaders in his
scientific field concerned with regulation
of the adenylate cyclase system by
hormones and neurotransmitters.”
Dr. Perkins’ research is of broad
pharmacological significance, particu¬
larly to studies of the neuronal and
hormonal regulation of cardiac function
and blood pressure, as well as for
research on cancer cell growth. A gradu¬
ate of Arizona State University, where
he received a B.S. degree in chemistry
in 1960, and an M.S. degree in biochem¬
istry in 1962, he received his Ph.D.
degree in pharmacology from Yale
Univeristy in 1966.
Following a postdoctoral fellowship
in the Department of Biochemistry at
the University of Washington in Seattle,
he was appointed assistant professor of
pharmacology at the U niversity of Color¬
ado Medical Center in Denver in 1968,
and was promoted to associate professor
in 1974. In addition to a Merck Faculty
Development Award, he held a Re¬
search Career Development Award of
the U.S. Public Health Service and the
National Cancer Institute from 1972
until 1977, when he was appointed
professor and chairman of pharmaco¬
logy at the University of North Carolina.
Dr. Perkins is co-founder of the
Journal of Cyclic Nucleotide Research,
and serves on the editorial boards of
Molecular Pharmacology and the Jour¬
nal of Nucleotide Research. He is a
member of the American Society for
Pharmacology and Experimental Thera¬
peutics, the American Society for Bio¬
logical Chemists and the Association
for Medical School Pharmacology.
Dr. Perkins succeeds Dr. Alan C.
Sartorelli, who has been chairman of
the Department since 1977. A leading
cancer investigator. Dr. Sartorelli was
appointed director of the Yale Compre¬
hensive Cancer Center a year ago.

FIRST ROBERT W. BERLINER
PROFESSOR NAMED
Dr. Barry L. Zaret, professor of medi¬
cine and diagnostic radiology, has been
appointed the first Robert W. Berliner
Professor of Internal Medicine. The
Chair was created in honor of the
former Dean of the School of Medicine
on his retirement last June, in recogni¬
tion of his many contributions to sci¬
ence, to Yale and to this country.
Internationally recognized for his
pioneer research in nuclear cardiology
and cardiac imaging and for his studies
of heart function. Dr. Zaret is also chief
of the Section of Cardiology at the
School of Medicine and director of one
of three NIH-sponsored core labora¬
tories in the U.S. for collaborative
clinical trials of a new treatment of
acute heart attack. The National Insti¬
tutes of Health awarded Yale $ 1.5 mil¬
lion for its participation in the trials.
Dr. Zaret received his B.S. degree
cum laude from Queens College in
1962, and his M.D. degree from New
York University School of Medicine in
1966. Following internship and residen¬
cy at Bellevue Hospital, he was ap¬
pointed National Heart, Lung, Blood
Institute Special Research Fellow in
the Department of Medicine at The
Johns Hopkins University School of
Medicine from 1969 to 1971. Hejoined
the Yale medical faculty as assistant
professor of medicine in 1973, following
two years of military duty as a major in
the USAF Medical Corp. He was ap¬
pointed assistant professor of diagnostic
radiology the next year, and was pro¬
moted to associate professor of medicine
and diagnostic radiology in 1976. He
was named professor in 1982.
An associate editor of the Yearbook
of Nuclear Medicine, Dr. Zaret serves
on the editorial boards of several other
professional journals, and is a fellow of
the American College of Cardiology,
the Council on Clinical Cardiology and
the Council on Circulation of the Ameri¬
can Health Association.
DR. JANERICH APPOINTED
Dr. Dwight T. Janerich has been ap¬
pointed professor of epidemiology and
cology), as well as associate director for
cancer control and prevention at the
Yale Comprehensive Cancer Center. In
addition, he has been named director
of the Connecticut State Tumor Regis¬
try, the oldest such registry in the
United States.
Widely recognized for his contribu¬
tions to knowledge of the epidemiology
of cancer and birth defects. Dr. Janerich
will be program director for training in

cancer epidemiology in the Department
of Epidemiology and Public Health,
and will coordinate the development of
a cancer control research program of
the Department and the Cancer Center.
Prior to his appointment, he was adjunct
professor of preventive and community
medicine at Albany Medical College,
Union University, and acting chairman
of the Department of Epidemiology,
School of Health Sciences, SUNY at
Albany.
A graduate of King’s College, Dr.
Janerich received a D.D.S. degree from
Temple University in 1963, and an
M.P.H. degree from Harvard University
in 1967. Most of his career to date has
been as an epidemiologist with the New
York State Health Department where
he was appointed resident in 1965;
director of epidemiology and population
genetics of the Birth Defects Insitute in
1968; director of the Bureau of Cancer
Control in 1978; and acting director of
the Division of Epidemiology, prior to
his appointment in 1982 as Director of
the Division of Community Health and
Epidemioogy.
Dr. Janerich is president of the Amer¬
ican College of Epidemiology and was
president of the Society for Epidemio¬
logic Research in 1976-77. He is a
member as well of the American Epi¬
demiology Society and of the American
Public Health Association.
Among numerous professional ap¬
pointments, Dr. Janerich is a member
of the Breast Cancer Task Force of the
National Cancer Institute, a charter
board member of the American College
of Epidemioogy, and an advisor to the
National Institute of Child Health and
Human Development. He is past presi¬
dent of the Society for Epidemiologic
Research and of the American College
of Epidemiology.

PLANS ARE UNDERWAY FOR
THE SCHOOL’S $125 MILLION
FUND RAISING CAMPAIGN
With the appointment last spring of
Sue B. Dorn as Associate Vice-President
and Director of Medical School Develop¬
ment, plans were initiated for the
School’s major fund raising campaign.
Three staff members have been ap¬
pointed
Daniel W. Vecchitto, Carole
L. Corbett, and Ann Pecora Diamond
— and a distinguished volunteer leader¬
ship committee chaired by Dr. James
G. Hirsh, ‘43S, has been formed.
In announcing the $ 125 million cam¬
paign to the alumni last spring. Presi¬
dent A. Bartlett Giamatti noted that
Mrs. Dorn is recognized as among the
most outstanding institutional develop¬

ment officers in the country. Prior to
her appointment as Vice-President and
Director of Medical School Develop¬
ment, she served as Senior Development
Officer for Yale University, and as
Associate Director for Major Gifts during
The Campaign for Yale. She has been a
Vice-President for Resource Planning
and Development at the Aspen Institute
for Humanistic Studies and Vice-Presi¬
dent for Resource Development and
Public Information at the Bank Street
College of Education, as well as Director
for Promotion, Executive Compensa¬
tion Service, the American Management
Association.
A graduate of Stanford University,
Mrs. Dorn received an M.S. degree in
special education from the Bank Street
College of Education. She is a member
of the National Resource Committee
and Chairman of the Greater New
York Special Gift Committee of Stan¬
ford University. In 1976, she was the
first woman and the first eastern member
of the Stanford alumni to receive the
Gold Spike Award, the University’s
highest award for outstanding volunteer
service to the Alumni Fund.
Prior to his appointment as Deputy
Director of the Campaign for the School
of Medicine, Daniel W. Vecchitto was
Associate Director of Development for
the School. A graduate, cum laude.oi
Saint Michael’s College in Winooski,
Vermont, he has been a coordinator of
grants and planned giving for Saint
Michael’s, as well as Director of Devel¬
opment at Merrimack College, North
Andover, Massachusetts, and Associate
Development Director of the Woods
Hole Oceanographic Institution.
Carole L. Corbett was Director of
Development for the Illinois Masonic
Medical Center, Chicago, from 1977
until her appointment in June as Associ¬
ate Director for Medical School Devel¬
opment. In addition to development,
she has been involved in broadcasting
as Producer/ Director of Public Affairs
Programming for Station WBBMFM / CBS Radio and as Producer/ Direc¬
tor for WGN Continental Broadcasting
Company, both in Chicago. Ms. Corbett
attended Vassar College and the Univer¬
sity of California at Berkeley.
Ann Pecora Diamond has been
named Assistant Director of Medical
School Development. A graduate of
Syracuse University, she attended Colum¬
bia University, and received a B.S.
degree in biology from the University

of California, Los Angeles. She did
graduate studies in cell biology at the
Yale School of Medicine, and was an
associate in research in the Department
of Internal Medicine from 1979 until
her appointment with the Development
Office.
The goal of the campaign is to raise
$125 million: $33 million for facilities
and equipment; $33 million for program
and research, and $59 million for endow¬
ment.

CHIEF NAMED FOR SECTION
OF IMMUNOLOGY
Dr. Philip Askenase has been appointed
chief of the Section of Immunology,
effective July 1, 1985. Well known for
his studies in clinical immunology and
in tropical medicine. Dr. Askenase has
been a member of the Yale medical
faculty since 1971. He succeeds Dr.
John Dwyer, who has retired from
Yale to return to his native Australia as
chairman of the Department of Medi¬
cine at the University of New South
Wales in Sidney.
A graduate of Brown University,
where he received a B. A. degree, magna
cum laude in physics in 1961, Dr.
Askenase received his M.D. degree
cum laude from Yale University in
1965. Following completion of intern¬
ship and residency in the Harvard
Medical Unit and Thorndike Labora¬
tories at Boston City Hospital, he was
appointed clinical associate in the Arth¬
ritis and Rheumatism Section, NIAMD,
NIH. He was a British American Heart
Fellow of the American Heart Associ¬
ation at London Hospital Medical Col¬
lege in London for a year prior to
returning to the Yale School of Medicine
in 1970 as a postdoctoral fellow in
inflammatory diseases in the Section of
Internal Medicine. He was appointed
assistant professor of medicine the fol¬
lowing year, and associate professor in
1975.
In 1978-79, Dr. Askenase was a
Visiting Scientist in the Immunoparisitology Division of the National Insti¬
tute of Medical Research. London. He
was appointed associate professor of
the Yale Department of Pathology in
1981, and the following year, he was
named associate professor of medicine
and pathology.
Dr. Askenase is a member of a
number of professional societies in¬
cluding the American Association of
Immunologists, the British Society for
Immunology, the Reticuloendothelial
Society, and the American Federation
for Clinical Research.
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A CHAIRMAN IS NAMED FOR
SECTION OF GROSS ANATOMY
Dr. William B. Stewart, assistant profes¬
sor of surgery in the Sections of Ana¬
tomy and Neurosurgery has been ap¬
pointed chairman of the Section of
Gross Anatomy. Recognized as an out¬
standing teacher. Dr. Stewart has been
director of medical studies in the Section
of Anatomy for the past two years.
A graduate of the University of Illi¬
nois, he received his M.A. degree from
Western Michigan University and his
Ph.D degree in anatomy from Emory
University. Dr. Stewart came to Yale in
1976 as a NIH Postdoctoral Research
Fellow in Physiology and Neurosurgery.
He became a member of the faculty in
1978 as a lecturer in gross anatomy.

TWO MORE FACULTY NAMED
JAVITS AWARD WINNERS
Dr. Linda M. Bartoshuk and Dr. Wil¬
liam S. Cain have received Javits Neuro¬
science Awards of the National Institute
of Neurological and Communicative
Disorders and Stroke (NINCDS). Mem¬
bers of the scientific staff of the John B.
Pierce Foundation and of the faculty of
Epidemiology and Public Health, they
are psychophysicists considered leaders
in studies of chemosensory response to
enviornmental stimuli. Dr. Bartoshuk’s
research interest is taste sensation; Dr.
Cain’s work focuses on olfactory per¬
ception.
Over two million Americans suffer
from a loss or impairment of the sense
of taste or smell, according to a
NINCDS report. Although the condi¬
tion is not generally considered lifethreatening, scientists now realize that
the chemical senses have considerable
medical significance, according to Dr.
Bartoshuk.
In previous studies, she demonstrated
that a subject’s ability to taste PTC
(phenylthiocarbamine), a bitter subs¬
tance, was linked to a recessive gene,
individuals with two recessive genes
are relatively insensitive to the bitterness
of PTC and are classified as “non¬
tasters”; those with one or more dom¬
inant genes are much more sensitive to
the PTC and are called “tasters”. Ac¬
cording to Dr. Bartoshuk, 70 percent
of all Americans are “tasters”.
The $683,000 Javits Award will sup¬
port Dr. Bartoshuk’s studies of addi¬
tional compounds to characterize the
differences between tasters and non¬
tasters She will also evaluate various
aster receptors and determine their
location on the tongue.
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Dr. Cam will apply his award ol
$835,000 to the development of proced¬
ures to compare the olfactory and
trigeminal sensitivity of individuals suf¬
fering from olfactory impairment or
loss with that of people with a normal
sense of smell. He will also work to
develop ways to diagnose different types
of olfactory impairment and loss.
In addition. Dr. Cain will study the
way in which individuals’perceptions
of odors vary. This in turn will provide
information about how to select items
for clinical test of odor identification
and offer a theoretical rationale for
such tests, according to Dr. Cain. (More
about Dr. Cain's work appears in the
Fall 1980 issue of Yale Medicine.)
Drs. Bartoshuk and Cain are the
fifth and sixth members of the School
of Medicine faculty to receive Javits
Awards. The award honors NINCDS
grantees who have achieved a distin¬
guished record of contributions in the
field of neurological and communicative
sciences and who are expected to be
highly productive over the next seven
years.

FACULTY PRACTICE PLAN
WILL HAVE A NEW BUILDING
OF ITS OWN
Plans are finalized and construction
will begin soon of an ambulatory care
facility that will consolidate clinics and
offices of the Faculty Practice Plan
which are currently scattered in 17
locations throughout the Medical
Center. “Such consolidation will en¬
hance patient convenience and provide
opportunities not currently available
for cost effectiveness,” according to
Arthur G. Isack, executive director of
the Plan.
The four-story glass, concrete and
brick building will be located on the
southeast corner of Howard and Daven¬
port Avenues. With adjacent parking
and a pedestrian bridge to the Hospital,
the new facility will include specialty
and consultative services, x-ray and
laboratory services, and a pharmacy. It
will not include hospital beds or oneday surgery facilities.
The Yale Faculty Practice Plan was
established in 1981 to bring together
administrative, management and billing
and collection activities of the existing
clinical practice of the full-time faculty.
Clinical practice, research and teaching
are essential activities of a medical
school, and the mission of the Plan is to
enhance the academic responsibilities

of the School by directly relating its
clinical activities to teaching and
research.
The building of about 90,000 square
feet will be constructed at an estimated
cost of $9 million on land presently
owned by the Hospital and used as part
of a parking lot.

A REGIONAL EYE CENTER AT
YALE SOON TO BECOME A
REALITY
Ground breaking ceremonies were held
on November 16 for the new Eye
Center at Yale, A regional, national
and international referral resource, the
Center will be the only facility of its
kind between Boston and New York
for persons requiring diagnosis and
treatment of eye disease.
The $2.5 million project is the cul¬
mination of 23 years of planning by Dr.
Marvin Sears, who has been chairman
of the Department of Ophthalmology
and Visual Science since it was founded
in 1971. Under his leadership, the de¬
partment has earned a world-wide repu¬
tation for its significant contributions
to the development of treatments for
blinding eye diseases.
The Eye Center will occupy the entire
Boardman Building, which is being
extensively renovated for the purpose.
Centrally located in the Medical Center,
and adjacent to the Department of
Ophthalmology’s research labs, it will
integrate patient care with basic research
and teaching activities.
With an entrance off Cedar Street,
the first floor will include admissions
and nurses offices and a general eye
clinic; retinal and corneal diseases will
be treated on the second Boor; and
glaucoma and strabismus treatment
centers will be located on the third
floor. The Center will include two
operating rooms for eye surgery, a 15bed inpatient recovery unit and research
laboratories.

AN MR CENTER WILL BE BUILT
UNDERGROUND ADJACENT TO
THE LCI BUILDING
Excavation is expected to start this
spring for an underground addition to
the LCI building to bring together
Yale’s research and clinical activities in
magnetic resonance technology, con¬
sidered one of the most important
developments in medicine in this decade.
The Magnetic Resonance Center, includ¬
ing offices, laboratories and patient
care rooms, will be equipped with two
whole body scanners, a small animal

instrument and a high field spectro¬
meter. The four magnets will have a
combined strength of almost 450,000
times that of the earth’s magnetic field,
and will require special construction
and shielding to contain their tremen¬
dous force.
The MR Center will bring together
distinguished scientists in the field in¬
cluding the directors, Dr. Robert Schulman, recognized as one of the world
leaders in MR studies of the brain,
liver, kidney and heart; and Dr. Richard
Greenspan, well known for his research
in clinical MR imaging. Dr. John Gore,
associate professor of diagnostic radio¬
logy, who helped develop the first
whole-body scanner, is another of the
group who will be exploring the great
potential of this new technology. They
will collaborate on basic and clinical
MR studies with colleagues including
Drs. Joseph Coleman and Ian Armitage
of the Department of Molecular Bio¬
physics and Biochemistry.

POSTDOCTORAL FELLOWS
RECEIVE AWARDS
Drs. Deborah Dyett and Gary Desir
have been awarded Robert Wood John¬
son Foundation Minority Medical Fa¬
culty Awards. Graduates of the Class
of 1980, Yale School of Medicine, Dr.
Dyett and Dr. Desir are postdoctoral
fellows in the Department of Internal
Medicine.
Dr. Dyett, who is a fellow in the
laboratory of Dr. Stephen Malawista,
chief of the Section of Rheumatology,
received a grant of $120,000 for two
years in support of her research to
study the way in which neutrophils
interpret messages and move, and how
they release mediators of inflammation.
Neutrophils are white blood cells impor¬
tant in protecting the body from infec¬
tion. They are also important in inflam¬
mation, and are responsible for much
of the pain and discomfort of diseases
such as rheumatoid arthritis and gout.
“A better understanding of the inflam¬
matory process may open new thera¬
peutic avenues in the treatment of these
and other inflammatory diseases,”said
Dr. Dyett. A graduate of Harvard
University, she received the John P.
Peters Prize for an outstanding thesis,
and the Henry J. Kaiser Family Founda¬
tion/National Medical Fellowship
Merit Graduation Award in 1980.
Dr. Desir is a fellow in nephrology in
the laboratory of Dr. Fred Wright,
professor of medicine and physiology.
The Robert Wood Johnson Foundation

awarded him $119,673 in support of his
research to determine the mechanisms
that account for potassium transport in
the proximal tubule. “A detailed know¬
ledge of the mechanisms that account
for ion transport could greatly enhance
our understanding, and thereby our
ability to treat many diseases,"said Dr.
Desir. “It is noteworthy that the pro¬
cesses described in the kidney might
pertain to other organs. Therefore our
studies might be of general interest.”
Dr. Desir received his B.A. degree
magna cum laude from New York
University, where he was elected to Phi
Beta Kappa, and received the Univer¬
sity’s Founder’s Day Award in 1976.
The Robert Wood Johnson Minority
Medical Faculty Development Program
seeks to increase the number of minority
faculty who can encourage and foster
the development of succeeding classes
of minority physicians. It offers postdoc¬
toral research fellowships to minority
physicians who have demonstrated
superior academic and clinical skills
and who are committed to careers in
academic medicine and biomedical
research.

Cheung Lam King, Ph.D., a postdoc¬
toral associate in the Department of
Pharmacology, has been awarded the
first Leslie Warner Postdoctoral Fellow¬
ship of the Yale Comprehensive Cancer
Center.
Dr. King, who received his Ph.D.
from the Graduate School of Biomedical
Sciences at the University of Texas, is
studying the induction of terminal differ¬
entiation on malignant keratinocytes
and determination of the differential
gene expression during cellular differen¬
tiation. His research is directed toward
a new approach for cancer treatment,
inducing malignant cells to differentiate
to mature cells with low proliferative
capacity, hopefully without major ef¬
fects on normal cells.
The Leslie Warner Postdoctoral Fellowship was established from gifts given in
memory of the former chairman of the
board of General Telephone and Elec¬
tronics of Stamford, Connecticut.

FACULTY NOTES
Dr. Allen C. Steere, associate professor
of medicine, received the Society
Citation of the Infectious Diseases Soci¬
ety of America at its annual meeting in
Washington, D.C. Dr. Steere was hon¬
ored for his recognition of Lyme disease
as a new entity and for defining its
epidemiology, clinical features, micro¬
biology, pathogenesis and treatment.
Dr. Richard K. Root, former professor
and vice president of the Department
of Internal Medicine, now at the Seattle
V.A. Medical Center, presented the
award to Dr. Steere.
“Besides defining this new infectious
disease and all of its important aspects.
Dr. Steere’s investigations have demon¬
strated the bright side of effective scienti¬
fic collaboration among investigators
in the same lab or between different
laboratories. In an age when competi¬
tion to get there first is the overriding
concern of many, the dramatic value of
this collaboration is a stirring reminder
of how the quest for scientific truth
should properly supersede personal no¬
toriety,’’said Dr. Root. “Appropriately,
Dr. Steere has requested that his associ¬
ate investigators at Yale University
also be named in this citation. These
are Dr. Stephen E. Malawista, chief of
the Section of Rheumatology in the
Department of Internal Medicine, Dr.
John A. Hardin and Dr. Joseph E.
Craft, both members of the Section of
Rheumatology, and Robert L. Grodzicki and Elice Taylor, research associ¬
ates in the Section.”
Dr. Arthur L. Horwich received a 1984
Life and Health Insurance Medical
Research Fund Award. One of six
medical scientists to receive the award
this year, he was recognized for his
studies of the Expression of cDNA
Encoding Human Ornithine Transcarbamylase. Dr. Horwich is assistant pro¬
fessor of human genetics.
The 1984 Heath Memorial Award was
presented to Dr. Raymond Yesner at
the Twenty-eighth Annual Clinical Con¬
ference of the University of Texas
System Cancer Center. The award
honors individuals who have made
outstanding contributions to the better
care of the cancer patient by the clinical
application of basic cancer knowledge.
Dr. Yesner, who is professor emeritus
of pathology and director of Pathologic
Anatomy, Laboratory Service at the
West Haven VA Medical Center, is
well known for his classification of
lung tumors, recently adopted by the
WHO.
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At its 80th annual meeting held in
Baltimore in December, the American
Society of Tropical Medicine and Hy¬
giene awarded the Walter Reed Medal
to Dr. Wilbur G. Downs in recognition
of his outstanding work in the field of
tropical medicine; and the Richard
Moreland Taylor Award to Dr. Thomas
H.G. Aitken for outstanding scientific
contribution to the field over a signifi¬
cant period of time.
Dr. Downs, clinical professor of epi¬
demiology, is recognized worldwide
for his research on malaria and other
diseases attributed to arthropod-borne
viruses. A consultant to the World
Health Organization for the East Afri¬
can Research Institute in Entebbe,
Uganda since 1970, Dr. Downs was
associate director of The Rockefeller
Foundation from 1963 until 1971, and
head of the Yale Arbovirus Research
Unit from 1965 until 1971. In 1977, he
was the recipient of the Richard More¬
land Taylor Award.
Dr. Aitken, who is senior research
scientist emeritus, has been a member
of the Yale Arbovirus Research Unit
since 1971. An entimologist and parisitologist, he is best known for his research
on mosquito-transmitted viruses.
Dr. Joseph F. Hoffman,Eugene Higgins
Professor of Physiology, has received
the Humboldt-Award in recognition of
his past accomplishments in research
and teaching. An authority on cellular
and comparative physiology, best
known for his investigations of the
membrane transport processes. Dr.
Hoffman, who is a member of the
National Academy of Sciences and the
American Academy of Arts and Sci¬
ences, is president-elect of the American
Biophysical Society. The HumboldtAward was established in Germany in
1860 to enable academically trained,
highly qualified persons of foreign na¬
tionality to carry out research in the
Federal Republic of Germany.
Dr. Edith Hsiung, professor of labora¬
tory medicine, has received an honorary
degree from Hubei Medical College in
the People's Republic of China. Dr.
Hsiung recently conducted a virology
workshop at the College, and was also
invited to lecture at the Institute of
Virology, Chinese National Center of
Preventative Medicine in Beijing, Tienjing Medical College, and at epidemic
prevention stations in various cities in
China.
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The New Jersey Chapter of the Ameri¬
can Diabetes Association has honored
Dr. Ralph A. DeFronzo, associate pro¬
fessor of medicine, for his contributions
over the past ten years to the advance¬
ment of diabetes research. Well known
for his studies of diabetes. Dr. DeFronzo
is co-author of “The Physician’s Guide
to Type II Diabetes (NIDDM): Diag¬
nosis and Treatment” and the editor of
a new journal. Diabetes/Metabolism
Reviews.
Dr.M.David Tilson, professor of sur¬
gery has been named a Surgical Traveler
of the James IV Association of Sur¬
geons, Inc. The purpose of the Associa¬
tion is to foster the exchange of know¬
ledge among the distinguished surgeons
of English-speaking countries through
an honorarium to Surgical Travelers
who have made outstanding contribu¬
tions to the art and science of surgery.

BOOKS BY FACULTY
“Continuity and Change in Art: The
Development of Modes of Representa¬
tion”, by Sidney J. Blatt,
profes¬
sor of psychiatry and psychology, in
collaboration with Ethel S. Blatt. Law¬
rence Erlbaum Associates (1984).
“Psychotherapeutic Management in the
Day Program — Practices in Day
Hospital Psychiatry”, by Jerzy E.
Henisz, M.D., associate professor of
psychiatry, with a foreward by Boris
M. Astrachan,professor of psychiatry.
Charles C. Thomas (Springfield, Ill.)
1984. 194 pp, illus.
“Psychotherapeutic Management on
the Short-term Unit — Glimpses at
Inpatient Psychiatry”, by Jerzy E.
Henisz, M.D., associate professor of
psychiatry, with a forward by Stephen
Fleck, M.D., professor of psychiatry
and public health.Charles C. Thomas
(Springfield, 111)1981. 182 pp.

VERNON WILLIAM LIPPARD.M.D.
Dr. Vernon W. Lippard, dean emeritus
and professor emeritus of pediatrics,
died of a heart attack on December 22
at his home in New Haven. He was 79
years old.
Few have had a more distinguished
career in the field of medical education
than Vernon Lippard, who served as
dean of the Yale School of Medicine
from 1952 to 1967. Before coming to
Yale as dean, he taught at the Cornell
Medical College, was associate dean at
the College of Physicians and Surgeons
of Columbia University, and was dean
and professor of pediatrics at Louisiana
State University and the University of
Virginia in Charlottesville.
Born in Marlborough, Massachu¬
setts, Dr. Lippard was a member of the
class of 1926 at Yale’s Sheffield Scienti¬
fic School, and graduated from the
School of Medicine in 1929. After
training as a resident at the New York
Nursery and Child’s Hospital and the
New York Hospital, he conducted re¬
search on the development of immunity
to infections in infancy and in 1939,
directed the Commission on the Care
of Crippled Children in New York
City, one of the first health projects
sponsored by the U.S. Children’s Bu¬
reau. Its report brought forcefully to
the attention of the public the inefficien¬
cy and lack of coordination in treatment
of children who had been paralyzed by
poliomyelitis.
In World War II, Dr. Lippard served
in the Army Medical Corps in New
Guinea, and the Phillipines. When the
war ended, he held the rank of colonel
and was stationed in Manilla as Chief
of Medical Personnel.
Dr. Lippard was active in national
and international health affairs. In 1949,
he conducted a study of health services
in Italy under the auspices of the World
Health Organization. As president of
the Association of American Medical
Colleges in 1954-55, and as a consultant
to the Surgeon General of the U.S.
Public Health Service, he led the move¬
ment for federal aid to medical educa¬
tion which resulted in increased produc¬
tion of physicians by American universi¬
ties and decreased dependence on gradu¬
ates of foreign medical schools. The
University of Maryland awarded him
the honorary degree of doctor of science
in 1955.
Under his leadership, the Yale School
of Medicine experienced a fifteen year
period of phenomenal growth. The
faculty more than doubled in size.
Three new academic departments were
established. The annual budget grew
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about five-fold, with a considerable
increase in support from the federal
government and foundations. The phys¬
ical plant underwent impressive expan¬
sion with the construction of new educa¬
tional and research facilities. Postgrad¬
uate educational programs and fellow¬
ships were greatly increased, as was the
program of continuing education for
practicing physicians. It was also at this
time that the Yale-New Haven Medical
Center was formally established.
After retiring as dean. Dr. Lippard
served as Assistant to the President for
Medical Development. Following his
retirement from the faculty in 1971, he
remained active in the field of medical
education in this country and abroad.
He was a consultant to the Josiah
Macy, Jr., Foundation on its programs
to aid medical education in developing
countries. He served on the boards of a
number of organizations, including the
National Fund for Medical Education
and the William T. Grant Foundation.
He also served on various advisory
committees here and throughout the
country.
Dr. Lippard is survived by his wife,
Margaret Isham Cross Lippard; a daugh¬
ter, Lucy Rowland Lippard; and a
grandson, Ethan Ryman.
It is suggested that memorial gifts,
payable to Yale University, be sent to
the Section of the History of Medicine,
Yale School of Medicine, 333 Cedar
Street, P.O.Box 3333, New Haven,
Connecticut 06510. A.E.

Dr. Courtney C. Bishop, clinical profes¬
sor emeritus of surgery, died on January
17 at his home in Wardsboro, Vermont.
He was 79 years old.
Dr. Bishop was born and raised in
New Haven. He graduated from Yale
College in 1926, and was awarded his
M.D. degree from the Yale School of
Medicine in 1930. He was a surgical
house officer with Dr. Harvey Cushing
at the Peter Bent Brigham Hospital in
Boston. When Dr. Cushing retired in
1932, Dr. Bishop moved to the New
York Hospital to complete his residency
under Dr. George Hoyer, then chairman
of surgery. In 1938, he returned to New
Haven and Yale, and was appointed to
the staff of the New Haven Hospital,
and a clinical instructor on the School
of Medicine faculty.
During World War II, Dr. Bishop
served in the Army Medical Corps with
the 39th General Hospital, the Yale
Unit stationed in New Zealand and on
Saipan. When the war ended, he was
chief of the surgical service with the
rank of lieutenant colonel, and in Novem¬
ber 1945, he returned to his practice
and to his assignments at the Hospital
and the School
In the succeeding years, Dr. Bishop
continued to serve both institutions in
various capacities. In 1949, he was
promoted to associate clinical professor
of surgery and in 1958, to clinical
professor. He had been appointed chief
of surgery at the Grace-New Haven
Community Hospital in 1953. When
the community and University physi¬
cians merged into a single staff in 1960,
Dr. Bishop was appointed chief of
staff, a position in which he served with
great distinction until his retirement in
1973.
For two decades he had worked
tirelessly to improve cooperation be¬
tween the Hospital and the School of
Medicine and between members of the
full-time faculty and their colleagues in
the community. In 1981, in honor of his
long years of service to the Hospital,
the Board of Directors dedicated the
newly renovated conference room- in
the Clinic Building in his honor.
Dr. Bishop is survived by his wife,
Eleanor Alcorn Bishop; two daughters,
and grandchildren. A.E.

ISIDORE SYDNEY FALK., PH.D.
Isidore Sydney Falk, Ph.D., professor
of public health (medical care) in the
Department of Epidemiology and Public
Health from 1960 to 1968, died in New
Haven on October 4, 1984, after a brief
illness.
Dr. Falk’s distinguished career began
when, after graduating from Yale in
1923, he was appointed to the faculty of
the University of Chicago. He left that
position in 1927 to become the director
of the first major analysis of the national
medical care system in the U.S., the
Committee on the Cost of Medical
Care. This committee’s final report in
1932, changed the history of health
care in this country. The ideas advanced
in this report of prepayment through
some form of health insurance and of
the advantages, in particular, of prepaid
group practice medicine were areas in
which Dr. Falk was to spend the rest of
his life.
He was active in the efforts to enact
Social Security and subsequently
served Presidents Roosevelt, Truman,
and Eisenhower as Director of Research
and Statistics for the Social Security
Administration from 1941 to 1954.
After his retirement from the Social
Security Administration, he was advisor
on Social and Health Services to the
World Bank and a consultant to the
Republic of Panama, the U.S. Canal
Zone, and various other countries on
health care and social security programs.
He was a health services and medical
care consultant to the United Steel
Workers of America, where he assisted
in the planning and development of a
number of prepaid group medical plans
in the United States and Canada. Yale
University was fortunate in recruiting
him in 1960 for the professorship in
medical care. During his eight years at
the school, this renowned man patiently
opened to faculty, students and commun¬
ity leaders, the principles of medical
care and health economics. Dr. Falk
did not permit his reputation to erect a
facade between him and his students,
nor did he use his expertise as a platform
for exhortation or polemics.
After his retirement from Yale, Dr.
Falk became the executive director of
the Community Health Care Center
Plan in New Haven, the first HMO in
Connecticut, and a flourishing example
of this new health care delivery system.
He was decorated with the Congres¬
sional Selective Service Medal and
received the 1973 Sedgwick Memorial
Medal of the American Public Health
Association. J.D.T.
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MERRILL ABNER BARATZ, M.D.

DONALD PETER GRANGER, M.D.

Merrill A. Baratz, M.D., associate clini¬
cal professor of pediatrics, died follow¬
ing an acute myocardial infarction on
December 26, 1984. He was 63 years
old at the time of his death.
Born in New London, Connecticut
in 1921, “Judge” Baratz received a
bachelor’s degree from Johns Hopkins
University, following which he enlisted
in the Army Air Corps, quickly rising
to the rank of major. He served in the
European Theater as a B-17 pilot,
participating in 35 missions. Upon his
return, he enrolled in the University of
Rochester School of Medicine from
which he later graduated.
Dr. Baratz came to Yale in 1950 to
study pediatrics under Dr. Grover
Powers, whose kindly, observant de¬
meanor was passed along to his trainee.
Following internship and residency at
the New Haven Hospital, he established
a private practice in New Haven and
spent the next 17 years at it. When the
Yale Health Plan was being developed,
he was recruited as its first pediatrician
and served as senior member of its
Department of Pediatrics from 1971
until his death.
A kind and gentle practitioner as
well as observant and careful clinician,
his philosophical approach to the art
and practice of medicine was, indeed,
as he expressed in an autobiographical
sketch published in a Yale Health Plan
consumer newsletter a year ago, “My
interests have been the care of a patient
as a person; a part of our general
society... it is important to understand
how the patient reacts to him or herself,
to his or her family, to the stresses of his
or her society. An illness is a mixture of
physiological forces and effects of psycho¬
social stress.”
Dr. Baratz was a fellow of the Ameri¬
can Academy of Pediatrics, a member
of the executive board of the New
Haven Pediatrics Society, and a former
president of the Connecticut and the
American Orchid Societies. He was
also a fellow of Yale’s Trumbull College
and long-time participant in study
groups at the Yale Child Study Center.
He is survived by his wife, Nancy
Shemitz Baratz, a reference librarian in
the Yale Medical Library, and by three
children, Steven Baratz of Los Angeles,
Susan Baratz of San Francisco, and
Thomas Baratz, of Hamden. J.V.F.

On January 19, 1985, Dr. Donald P.
Granger, associate clinical professor of
neurology, died at age 55, following a
lengthy illness.
Dr. Granger was born in New York
City on October 6, 1929. After graduat¬
ing from Antioch College, he attended
the University of Pennsylvania School
of Medicine, where he received his
M.D. degree in 1954. He interned at the
Cincinnati General Hospital and then
served for two years in the U.S. Army
in Korea.
Following military service, he began
his residency in neurology at the University of Pennsylvania Hospital. In 1959,
he came to Yale as a clinical fellow and
in 1961, was appointed an instructor.
He was engaged in private practice of
neurology for the past 20 years and
since 1964, was chief of neurology at
the Bridgeport Hospital and the director
of its electroencephalography labora¬
tory, which he had established.
During this time he continued to be
an active member of the part-time
faculty and in 1974, was promoted to
associate clinical professor. He was
highly regarded as a clinical teacher by
medical students and residents.
Dr. Granger was a fellow of the
American Academy of Neurology and
a member of the American Electroencephalographic Society and the Ameri¬
can Epilepsy Society. He had served as
chairman of the executive committee
of the Board of Trustees of Antioch
College.
He was the husband of Susan Simon
Granger, film and drama critic for
radio station WICC in Bridgeport. In
addition to his wife and mother, he
leaves a daughter, Janet Granger; a
son, Donald Granger, Jr.; and a brother.
Dr. Richard Granger of New Haven.
A.E.

SPECIAL NOTICE TO ALUMNI
Arrangements have been made for all
medical school alumni to receive the
Yale Alumni Magazine regularly. The
cost of the first year’s subscription is
being borne by the School of Medicine.
The magazine, published eight times
a year from October to June, previously
was distributed only to Yale College
alumni and others who subscribed.
In accord with the efforts of the
Association of Yale Alumni (AYA) to
involve graduate and professional
alumni more actively in Yale affairs,
the Yale Alumni Magazine has increased
coverage of events and people in the
graduate and professional schools. We
hope that you read the NMR article in
the November issue. Future issues will
contain additional news and article for
the School of Medicine.

ALUM%ws
The Alumni in Medicine Column
Notes front the President
Nicholas P.R.Spinelli, M.D.
TWO ALUMNI
One has seen these two veteran alumni
for decades: at medical school social
events in New Haven or New York, and
at scientific conferences to which alumni
are invited. They have always responded
when called. In younger days, they
have functioned as members of our
Association’s executive committee; been
officers of this body; have offered sage
counsel to members of our school’s
administration when consulted. Their
service has spanned the tenure of seven
deans. Regardless of the time frame,
theirs has been a youthful, thoughtful,
vigorous presence. Myron Sallick cele¬
brated the 60th year anniversary of his
graduation this past June; John Ogilvie
enjoyed his 50th reunion the same
weekend.
To share the pleasure of their com¬
pany at these events is always an inspira¬
tion. The leadership of our alumni
association struggles with the questions:
what is our organization’s purpose? Its
goals? How do we reach them? Pondering
the intense loyalty, the unflagging dedi¬
cation of these two men is a source of
wonder. What is the motivation, the
driving force of these two men’s feelings,
so vital to the accomplishment of any
organization’s goal?
Myron Sallick is a soft spoken, gentle
man of gallant bearing. His eyes twinkle
and he smiles often when he speaks,
recollecting the experiences of the early
years of his medical education. John
Ogilvie is a solidly built, gregarious
man with a full thatch of white hair
crowning what could still be an undergraduate-football-player-figure. He is
inquisitive; open; direct; eager.
Both men have been practicing gener¬
al surgeons; Dr. Sallick in New York
City, and Dr. Ogilvie still active in
Stamford, Connecticut. Both have had
successful careers, enjoying the accom¬
plishment and gratification of their
professional objectives in surgery.
Neither became outstandingly wealthy
in doing it. Myron and John came to
New Haven as poor students, dependent
on Yale financial aid and part-time
jobs for these goals to become possible.
It has been an unvarying fact of life for
six decades, it seems. Educational costs
are always a quantum beyond the stu¬

dent’s financial reach. The need to help
the qualified student find monetary
resources is always a high priority of
school administrations in every era.
Reminiscing about their school days
at Cedar Street many years ago comes
easily and with enthusiasm to both
men. It is remarkable how vivid and
immediately accessible all of the details
of these experiences are to them. The
admission to medical school of both by
an almost identical process, involving
interviews with Dean Milton Winternitz
in the presence of Miss Miriam Dasey,
then registrar, is intriguing. Both these
figures are now ledgends in the history
of the Yale School of Medicine. The
process of admission of these young
men was both similar and relatively
expeditiously decided. In both instances.
Dr. Winternitz delivered the favorable
judgement. The almost absurd simpli¬
city of administrative structure of this,
then small medical school, is affecting.
There were so many fewer students;
such a small faculty; and a curriculum
which was largely yet to come in the
breadth and its complexity of our more
modern time. The modern science and
technologies of medicine were then
about to unfold. Both men, with a kind
of reverence, describe the career counsel¬
ling by the “great men of medicine” of
the faculty, who thoughtfully guided
them into their choosing surgery as a
future direction. The names of Dr. Sam
Harvey, Dr. Grover Powers, Dr. George
Bloomer, among others, recur in their
commentary; the “great men of medi¬
cine” — the motive forces among stu¬
dents then as now, as faculty, as role
models.
Was it the simpler time, with com¬
munications and student identification
then an easier task, responsible for the
emergence of such devoted graduates?
One doubts that, because it was not a
universal phenomenon among their
peers. Also, one can find among gradu¬
ates in every decade since, behavior
which identifies the “grateful” alum¬
nus/a, the doctor seeking to repay with
service in many arenas for remembered
privileges. One indeed can identify the
Sallicks, the Ogilvies, among current
students in Yale medicine. Their names
differ and they are often the student
leaders. They are in a sense “alumni” in
transit.
In the truest spirit of generosity, our
old friends sought little in return after
leaving Yale. Myron Sallick has one
son who became a physician. “Not at
Yale, incidentally, but I didn’t expect
Yale had to accept him. He went to
Cornell and has done very well.” Rich¬

ard Sallick is now on the Yale faculty
and heads a department in a Yale
affiliated hospital. John Ogilvie has
four sons. “None wanted to become
doctors and two wanted to go to Yale
College. They did.”
Both men, in their later years, were
to add to the most generous of their
gifts to their alma mater, themselves,
material gifts as well. Dr. Sallick has
bequeathed, for eventual transfer to
Yale, the old homestead where his
children were born. Dr. Ogilvie recently
provided funds for the restoration of
the old amphitheater in the Hope Build¬
ing (Dr. Sallick has described attending
classes in the original as an undergradu¬
ate). When the dedication of this amphi¬
theater was commemorated with the
placing of a plaque bearing his name
last June, Dr. Ogilvie was overwhelmed
by the “generosity of the gesture”. In
both of them, modesty is not just an
attitude but a passion. Their feelings
perhaps are best paraphrased by the
statement almost identically articulated
by them both: “I can never repay Yale
for what was given to me. What I have
done, what I do for Yale now, is
nothing compared to the opportunity
the School gave me. I was exposed to
the finest teachers of my time. I owe
everything I did, or am, to Yale.”
This dialogue was to be repeated this
past June at reunion weekend. Fol¬
lowing the annual meeting of the Yale
Alumni in Medicine, Dr. Leona Baum¬
gartner and her classmate. Dr. John
Ogilvie, had just been awarded the
Association’s first Distinguished Ser¬
vices Awards for alumni. Dr. Baum¬
gartner was expressing perplexity, a
true sense of wonder, as though her
diploma had been freshly awarded her.
“I didn’t do anything. Yale did it all for
me. I was given a great opportunity.”
John Ogilvie nodded in energetic agree¬
ment.
The opportunity for alumni to contri¬
bute, in ways other than financial, to
the activities of the medical school in
the years after graduation has been
severely limited by the fragile organiza¬
tional structure of our alumni associa¬
tion. With the publication of our Direc¬
tory and with it, our ability to find
where our alumni colleagues are, new
opportunities for participation are tantalizingly possible. In the past, only those
graduates within commuting distance
of New Haven could be tapped for the
committee functions which formed the
larger part of non-reunion activities.
Only they could participate in the oc¬
casional social activity on campus. The
potential for development of regional
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groups, thereby enhancing the possibil¬
ities of more varied alumni functions, is
an imminent challenge. The reality of
continuity in the character of the alumnischool relationship looms more pos¬
sible. School speakers might address
regional graduates, thereby providing
a more palpable sense of the school’s
vitality, of where our school is now.
The massive burgeoning of medical
scientific knowledge is a present chal¬
lenge for the postgraduate to assimilate
and maintain. The present and future
physician is indeed becoming a docu¬
mented, life-long student. Can a given
student be linked to a given University
in this life-long quest? Will the word
“Alumni” become synonymous with
“on-going students”? How exciting if
alumni-as-students could become part
of such a creative process.
Such conjecture renders even more
seductive the portrait of our two alumni,
our students of a simpler time. Their
message to us, through the years, re¬
mains clear and lucid and germane:
there is joy in achieving a professional
goal in a learning institution of quality;
in maintaining the links of communica¬
tion with such a medical school; and in
working for the continued health of
that institution assuring the same experi¬
ence to the countless students to come.
Perhaps this “same experience” may
serve the possible alumni-student of
the future as well.

CLASS NOTES

1927
In honor of Harry Zimmerman, chairman
emeritus of the Department of Pathology
at Montefiore Medical Center and pro¬
fessor emeritus of pathology at Albert
Einstein College of Medicine, The Harry
Zimmerman Chair in the Neurosciences
has been established at Montefiore Med¬
ical Center in New York City.
The endowed chair will be the foun¬
dation upon which Montefiore will build
a S10 million Institute of Neurosciences,
to combine under one roof, all the dis¬
ciplines involved in the study of the brain
and the functioning of the central nervous
system, including neuropathology, neu¬
rology, neurosurgery, neurochemistry,
neuropharmacology, neurophysiology,
and psychiatry.
Dr. Zimmerman served on the faculties
of Yale and of Columbia College of
Physicians and Surgeons before going to
Montiefiore in 1946. Over the years, he
has trained hundreds of neuropatholo¬
gists, 137 of whom are now professors or
department chairmen in this country,
Japan, Israel and throughout many coun¬
tries of Europe.
Among the many honors bestowed on
Dr. Zimmerman is the Gold-Headed Cane
of the American Association of Patholo¬
gists which he received in 1982. Created
in 1919 to honor “a physician who repre¬
sents the highest ideals in medicine and
pathology”, this award is the highest
honor given to a pathologist, and has
been awarded only 30 times since it was
established.
Now at 83, Dr. Zimmerman carries a
full teaching-research-writing program
at the Montefiore Medical Center as
chairman emeritus of the Department of
Pathology and he also has just completed
a year as scientific adviser/coordinator
for the eight symposia held to celebrate
Montefiore's centennial.

1947
Robert Chase is the subject of an article
in the fall 1984 issue of Stanford Medicine.
It notes: “Dr. Robert Chase has nurtured
the specialty of reconstructive hand sur¬
gery from its infancy to a fine-tuned
microsurgical and biomechanics science.
Along the way, he’s molded an image for
himself among students, colleagues and
patients that can’t be beat.”
The article continues to describe Dr.
Chase’s work: “His latest research project
is bringing hand surgery into an era that
could easily be mistaken for the stuff
science fiction is made of. He is digitizing-assigning numerical values—to cross sec¬
tions of each part of the hand. He’s

entering all this information, obtained by
photographing millimeter-thick slivers
one at a time, into a computer. He is then
able to call up a three-dimensional, mov¬
able image of the hand parts on the
computer screen. He can move the parts
of the hand, isolate them, or make them
larger in order to study them in new ways.
“ ‘By animating the hand we can study
the relationship of one part to another,
and the biomechanics of its function,’ he
predicts. ‘Well be able to learn exactly
what parts can be substituted for others
for surgical repairs. We’ll also have the
data that will allow us to construct artifi¬
cial parts that are closer akin to human
parts. If we better understand how the
hand works, we’re better able to duplicate
it or substitute for it using robotic devices.’ ”

1956
At the 128th annual meeting of the
Hawaii Medical Association William
Hindle was installed as president. Dr.
Hindle has been actively involved with
Hawaii Medical Association affairs since
1965, has been a member of numerous
committees and has served as an Associ¬
ation officer since 1978. He is currently in
private practice at Straub Clinic &
Hospital, is an associate professor of
obstetrics and gynecology at the Univer¬
sity of Hawaii School of Medicine and is
very active with the American College of
Obstetrics and Gynecology both locally
and nationally.

1957
William Kissick was the keynote speaker
at the Annual Meeting of the American
Public Health Association in November.
Dr. Kissick is The George Seckel
Pepper Professor of Public Health and
Preventive Medicine at the University of
Pennsylvania School of Medicine. He is
also professor of health care systems in
The Wharton School as well as director
of the Health Policy and Planning
Program of the Leonard Davis Institute
of Health Economics.
Dr. Kissick has written on a wide range
of issues such as training of public health
professionals; planning and budgeting in
health; cost/benefit in health planning;
national health insurance; hospices and
home care and multi-institutional delivery
of services. He is currently completing a
book entitled, “Who Shall Live? Who
Shall Decide?: A Strategy for Health.”
A brief note from Thomas O'Brien, who
is living in Greenville, North Carolina,
stated that he has been elected chief of
staff for 1985 at the Pitt County Memorial
Hospital, the teaching facility for East
Carolina University School of Medicine.

1962
Michael Alderman was appointed as of
September 1, to the position of chairman

of the Department of Epidemiology and
Social Medicine at Montefiore Medical
Center and the Albert Einstein College of
Medicine. The Department, now renamed
and unified under Dr. Alderman’s leader¬
ship, was formerly known as the Depart¬
ment of Social Medicine at Montefiore
and the Department of Community
Health at Einstein.
Prior to accepting his new position at
Montefiore, Dr. Alderman was a pro¬
fessor in the Departments of Public
Health and Medicine at Cornell University
Medical College and an attending phy¬
sician at New York Hospital.
He has developed programs in Jamaica
and East Africa which reduced child
mortality in those areas by more than 50
percent; and in an urban setting, his
pioneering research on hypertension con¬
trol at the work site, has brought a new
understanding to the course of the
disease and workers’ responses to treat¬
ment. From 1979 to 1983, he adminis¬
tered a Robert Wood Johnson Founda¬
tion National Grants Program to design,
establish and evaluate community-based
systems for the improvement of care
for persons with chronic diseases.
Dr. Alderman presently is chairman of
the Board of Directors of the African
Medical and Research Foundation and a
consultant to the World Health Organiza¬
tion and the National Institutes of Health.

1965
Thomas Aoki is now at University of
California, Davis where he has been
appointed professor of internal medicine
and chief of the Division of Endocrin¬
ology. Until his move to Davis, he was at
the Joslin Diabetes Center in Boston
where he was head of the Metabolism
Section and associate professor of medi¬
cine at Harvard Medical School.
In the announcement of his appoint¬
ment it was noted that Dr. Aoki’s research
has focused on hormone-fuel interrela¬
tionships, especially the effects of the
pancreatic polypeptide hormones, insulin
and glucagon, on the transport and
metabolism of low molecular weight sub¬
stances in peripheral tissues. In his most
recent efforts with the artificial beta-cell
(Biostator), he has demonstrated the
inability of conventionally treated diabetic
patients to both oxidize and store carbo¬
hydrates; however, with his unique treat¬
ment, he has managed to restore both
functions in severely compromised type 1
diabetic patients.

1968
As of November 1, Frank Lucente became
chairman of the Department of Otolaryn¬
gology, Head and Neck Surgery at The
New York Eye and Ear Infirmary.
Dr. Tucente received his training in
otolaryngology at Barnes Hospital under
the late distinguished Dr. Joseph Ogura,

completing his residency in 1974. From
1974 to 1976 during military service, he
was chief of the Department of Otolaryn¬
gology at the U.S. Public Health Service
Hospital in Staten Island, New York.
Also in 1974 he was appointed to the
faculty of Mount Sinai School of Med¬
icine where he became professor this
year.
Dr. Lucente’s extensive teaching exper¬
ience has included several visiting lecture¬
ships, an annual course at the American
Academy of Otolaryngology, and the
Paige and William Black Post Graduate
School of Medicine at Mount Sinai. For
his contributions to the American Acad¬
emy of Otolaryngology’s educational
program, he won the 1980 Honor Award.
He has published numerous papers
and books including two medical text¬
books, “Essentials of Otolaryngology”
and “Diseases of the External Ear”, and
is on the editorial board or is a reviewer
for several major journals. In addition to
being a member of many professional
societies, he serves on a number of local
and national committees.

1973
Michael Kaufman was elected to fellow¬
ship in the American Academy of Pedia¬
trics at a recent fall meeting of its executive
board. To qualify as a fellow of the
Academy, a pediatrician must have been
certified as a fully-qualified specialist in
the field of child health. Dr. Kaufman
resides in Beverly Hills, California.

1974
Harry Shamoon has been elected to
fellowship in The American College of
Physicians and will be honored during
the convocation ceremony at the College’s
annual session in Washington, D.C.,
March 28-31, 1985. Dr. Shamoon, a
specialist in endocrinology, is on the
faculty of the Albert Einstein College of
Medicine. He and his wife, Rona, and
sons Evan, Mark and Michael, reside in
Scarsdale, New York.

In Memoriam

Joseph T. Eagan
September 7, 1984

M.D. ’21

Robert Kapsinow
June 18,1984

M.D. ’22

Edward T. Wakeman
June 17, 1984

M.D. ’22

Vernon W. Lippard
December 22, 1984

M.D. ’29

William F. Roth, Jr.
November 23, 1984

M.D. ’29

Morris L. Rakieten
November 7, 1984

M.D. ’31

Edmund A. Zybulewski
December 28, 1983

M.D. '32

Emin Kilidj Kale
May 29, 1984
Francis A. Read
June 27, 1984
Lester J. Sawyer, M.D.
July 7, 1984

ex med ’33

M.D. ’34

ex med ’34

John H. Peters
November 9, 1984

M.D. ’37

Allan Green
October 26, 1984

M.D. '48

Harry Auerbach
September, 1984

M.P.H. ’49

Shih-Shun Chao, M.D.
June 20, 1984

ex P.H. ’49

Gaetano R. Sandulli, M.D.
October 18, 1980

M.P.H. ’50

HOUSE STAFF

1946
John McGovern has been elected a fellow
of the Royal College of Physicians of
London, England. Under a special bylaw
of the Royal College of Physicians,
fellowship may be conferred on “men and
women of great distinction in medicine
worldwide.... and their number must not
exceed eight in any one year.” This year,
fellowship was conferred upon six distin¬
guished physicians—two from France,
one from Germany and three from the
United States. The other two Americans
honored are Dr. James Wyngaarden,
director of the NIH, and Dr. Baruch
Blumberg, 1976 Nobel Prize winner in
Medicine.
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1983 - 84 ALUMNI FUND REPORT
FUND OFFICERS 1983-84
Medical School Alumni Fund
Lowell I. Goodman, '51, Chairman
Malvin F. White,'39, Vice Chairman
William K.McClelland,'47, Vice Chairman
John L.Cieply,71, Vice Chairman
J. Roswell Gallagher,'30 Bequest
and Endowment Co-Chairman
Samuel D.Kushlan,’35, Bequest
and Endowment Co-Chairman,
and Chairman, Former House Staff
Public Health Alumni Fund
Kathleen H. Howe,'56, Chairman

MESSAGE FROM THE MEDICAL
SCHOOL ALUMNI FUND CHAIRMAN
The 1983-84 campaign ended with a grand total of $304,320
— not quite reaching the $325,000 goal. However, the average
gift from alumni of $152 compared to $143 the previous year,
indicates a heightened awareness of our program which is to
provide income for the Student Revolving Loan Fund.
During the midpoint of our campaign we succeeded in
earning the entire $50,000 Baumgartner Challenge award for
new and increased gifts for student loans. This incentive plus
over $77,000 from the reunion classes, gifts from non-reunion
alumni, former house staff, parents and friends, contributed to
our final total.
I appreciate the efforts of the Bequest and Endowment
chairmen, the chairman of the former house staff program, the
vice chairmen, the 85 class agents, the reunion phonathon
volunteers, and the student telephoners who contributed their
time and energy to this worthwhile program.
On behalf of the students and the school, I extend my sincere
thanks to all the Fund’s loyal supporters.
Lowell I. Goodman, '51

A MESSAGE FROM THE DEAN
During the eleven years I have been Dean, I have been
impressed by the generosity of the alumni of the School of
Medicine. Your prompt and enthusiastic response to Leona
Baumgartner’s magnificent challenge gift this year is yet
another example of your loyalty.
Funds raised this year, amounting to $304,320, will be added
to the Student Revolving Loan Fund. As you all know, helping
our students meet the tremendous cost of medical education
through scholarships and student loans is a high priority.
Monies acquired through the Alumni Fund Campaign continue
to be a mainstay in this effort. It is an important way for you to
assure the quality of medical practice, research and teaching in
the future.
1 join the faculty and students in sending congratulations and
appreciation to Lowell Goodman and the many volunteers who
"■ c worked so hard on the 1983-84 Alumni Fund campaign,
d to those of you who, through your continued interest and
port, have made their fund raising goals a reality.
Robert W. Berliner

MESSAGE TO THE PUBLIC HEALTH GRADUATES
AND FRIENDS
This past year the proceeds of the 1983-84 Public Health
Alumni Fund Campaign were designated the “Colin White
Scholarship Fund" in honor of our popular professor of public
health and statistics, who retired in June.
The final total — nearly $44,000 contributed by 646 graduates
represents 115 percent of the goal. This included funds
earned as a result of the Leona Baumgartner challenge gift and
over $5,000 raised by graduates in the New Haven area, who
generously participated in two phonathons.
Many thanks to the energetic agents and all of the Fund’s
loyal supporters who made our campaign for 1983-84 the
success it was.
Jan A.J.Stolwijk
Kathleen H. H owe

MEMORIALS
Deceased medical alumni (and friends) may be memorialized
by a gift at any time to the Medical School Alumni Fund
Endowment, in the name and class of the person so honored.
The next-of-kin of a deceased medical alumnus/a is advised
about this “In Memoriam Program” by mailing from New
Haven some weeks after the School of Medicine receives
notification of the death. The letter of information includes a
copy of “The Testament of Remembrance” in which the names
of all persons so memorialized are listed in the medical section
by class, thus establishing a lasting memorial. Donors receive a
personal penned note of appreciation from me. Your inquiries
and interest are welcome at any time.
In 1983-84, the Medical School Alumni Fund received
$2,123 from 18 donors of In Memoriam gifts. Deceased alumni
and friends so honored for the first time in 1983-84 were:
Maurice Grozin '22
Julius Weiner '29
Paul Watson '30
Roland T. Wehger '32
Daniel Harvey '33
Milton Rose '35
W. Norman Sears '40
Robert F. Dine’41
John Taylor Adams '83
James Wells
Richard G. Jordan, Director, In Memoriam Program

MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION
AGENT(S)

1982-3
PARTICIPATION

1982-3
AMOUNT

1983-4
PARTICIPATION

1983-4
AMOUNT

50%,
67%
86%

$ 385
608
3,652

77%
67%
—
56%
73%
90%,
52%
68%
50%
74%
61%

960
546

1922
1923
1924

Edward Wakeman
William Cohen
Myron Sallick

56%
57%
63%

1925
1926
1927

Alice Whittier
Maxwell Bogin
Henry Fineberg
Harry Zimmerman
Max Alpert
Paul McAlenney
J. Edward Flynn
Michael D’Amico
Henry Brill
Franklin Foote
John Ogilvie

67%
50%
47%

$ 561
634
2,400
(+ 118,000)*
805
671
1,229

""
79%
71%
65%
44%
43%
76%
50%,

2,795
1,572
3,800
1,373
1,045
5,399°
2,703

James Haralambie
George Hahn
David Dolowitz
Nelson Ordway
Rebecca Solomon
James Ferguson
Charles Cheney
Walter Burdette
Jonathan Lanman
Dorothea Peck
S. Brownlee Brinkley
Nicholas Spinelli

52%
35%
53%
60%,
53%
69%
59%
55%
64%

2,276
3,275
1,590
2,360°
3,020
4.369
3,331
1,789
10,107°

57%
67%

4,419°
7,086

58%
47%
48%
63%
57%
65%
64%
61%
—
66%
47%
74%

Richard Breck
Charles Judd
T homas Whelan
William Roy Breg
Paul Koehler
Daniel Elliott
David Frucht
Lowell Goodman
Harvey Young
Vincent Gott
John Rose
Robert Kramer
John Gardner
Ronald Fishbein
Howard Minners
Charles Hall
Paul Rudnick
Asa Barnes
Muriel Wolf
Roland Ingram
Thomas Kugelman
Earl Baker
John R. Woodward
Anoush Miridjanian
A. Richard Pschirrer
Frank Hartman
Craig Llewellyn
William Houghton
William Pratt
David Hill
Mary-Alice Houghton
Henry Mann
James Dowaliby
John Drews
Anthony Lovell
Frank Lucente

58%
66%

3,590
7,090

60%,
64%

—
2,915
2,686
14,394°
(+3,000)*
3,350
7,021

61%
66%
58%
62%
50%
43%)
59%
80%
53%
53%
68%

4,320
8,141°
4,169
3,688
5,515
3,845
4,950°
6,172
5,748
4,925
6,480

66%
51%
52%,
58%
45%
46%,
56%
65%
62%
49%
64%,

4,918
5,251
5.829°
5,230
5,075
5,035
3,865
6,248°
4,712
6,275
6,400

69%

10,550°

62%

5,065

64%

7,035

62%

10,115°

Wo

8,550

66%

8,280

54%

4,645

49%

5,836

47%

4,790

47%

4,047

49%,
64%,

5,770°
5,790

54%
67%

5,715
8,670°

54%,
62%,

5,710
3,680

38%
63%

3,905
4,125

62%

4,975

76%,

6,596

OV7o

6,363°
(+20,000)°

54%

4,666

1928
1929
1930
1931
1932
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943 A
I943B
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
I960
1961

1962
1963
1964
1965
1966
1967

1968

1969
1970
1971
1972
1973

Donald Lyman
Lee Lampol
James Missett
John Cieply
Barbara Kinder
Paul Lucky
David Baily
Lynne Liptay
Jerrold Rosenbaum
Peter Buchin
Daniel Passeri
Mary Jane Minkin
Robert Taylor
David Kreis
Ronald Vender
Duke Cameron
Seth Powsner
Thomas Smith

—

_

_

—
975
3,216
1,612
2,446
1,901
1,366
2,107
9,929°
(+5,000)*
3,736
4,333
1,671
1,100
3,231°
3,750
2,287
2,356

61%
42%
58%

7.436
2,795
6,262

62%
49%
51%

7,948°
3,909
6,031

53%
52%

3,208
3,709°

44%
47%

3,048
3,515

32%
24%

2,155
933

37%
21%

1,970°
1.420

26%,
25%

1,325
1,351

30%
36%

1,982
1,915

20%

915

26%

2,135

CLASS
1979
1980
1981
1982

1983

AGENT(S)

1982-3
PARTICIPATION

1982-3
AMOUNT

1983-4
PARTICIPATION

1983-4
AMOUNT

17%

$ 770

20%

$ 830

17%

848

26%

830

13%
7%

665
105

19%
14%

530
275

10%

255

Michael Hausman
Laurie Smaldon
Eduardo Alfonso
Mark Bernhardl
Anthony Urbano
Muriel Cyrus
Jed Gorlin
Lynn Tanoue
Michael Tom
David Schwartz

Alumni
Former House Staff
Parents & Friends
Interest & Miscellaneous
gifts
Baumgartner Match

50%
18%
19%,

$377,120(1)
8,053
13,589
10,492

TOTAL

42%

$449,065

48%
16%
18%

$254,711(2)
7,095
11,652
11,319

40%

304.319

39,811

19,542

1) includes $6,648 endowment income
2) includes $7,474 endowment income

RECORD REUNION GIFT BY CLASS OF 1944
The report of annual giving for 1983-84 published in this issue
of Yale Medicine lists the Class of 1944 as contributing $ 17,394
on the occasion of the 40th anniversary of its graduation.
Through errors in record keeping as class agent for 1944, this
total is in error, and should read $21,697. Either figure
represents a record for giving by a reunion class to the Yale
Medical School Alumni Fund. Funds pledged by my class
members for one reunion gift were in part given by some in ’82 '83 and some in the ’84 -’85 periods. Totals for those off years
will thereby be reported erroneously high, including as they do,
some reunion year pledges.
Pausing to analyze some aspects of this accomplishment is of
interest:
•This record was achieved by one of the smallest post WWII
classes (44 graduates/41 living) and possibly one of the least
affluent, then as now.
• It required no gigantic effort on my or anyone’s part. Many
economically stressed class members could contribute no¬
thing. Some contributions emerged from grateful patients of
class members, a gesture of gratitude to their doctor. •
•A major factor in the achievement was the planning of the gift
over time (a two-year period); and the setting of a goal (a
tentative $1,000 per alumnus/a -preposterous for some, far
short of the possibilities for others). Now that the unexpected
total is in, it is apparent that a more rational goal of $25,000
could easily have been achieved. No pressure or last minute
efforts were indulged.
•The process engendered no huckstering, no breach of confiden¬
tiality. It was followed by one of the warmest, most successful
reunion weekends we ever had. Sixty-five percent of the class
attended. No one ever knew of the individual contribution of
his classmates.
•Without mention in speech or print, we contributed to one of
the most vital causes our medical school — and every
American medical school
faces today; student financial
aid The Revolving Student Loan Fund, in the current
climate of medical education costs, has changed from a
welcome assist to a vital life-line for so many students. The
performance of my classmates, I believe, represents a mani¬
festation of the rising of consciousness of such need.
28

This October, Chairman Lowell Goodman convened an organi¬
zational meeting to structure an advisory board of the Yale
Medical School Alumni Fund, such as are now functioning in
other professional schools at Yale. It will assist him as chairman
to realize larger returns through such organizational effort, as
have been realized where such boards function. As part of this
organizational structure, I was appointed vice chairperson for
reunions on the advisory board.
I report this experience as class agent for my class because the
simplicity of the process and the response of my classmates was
so gratifying, and worthy of emulation by other classes. As vice
chairman for reunions, I am ready to assist all appropriate
agents for such a task.
Finally, — and with apologies for my long-windedness — my
salute to my extraordinary class!
N.P.R. Spinelli, M.D., class agent, 1944 Med.

PUBLIC HEALTH ALUMNI FUND CLASS PARTICIPATION

AGENT

LASS
1923-1941
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951

—
—
—

Elizabeth Robinton
Elizabeth Robinton
Eric W Mood
Leonard F. Menczer
Norton Chaucer
Yolande F. Lyon
Milton Sisselman
Ruth Taber
Frances Ogasawara
David Boyd
Edward DeLouise
Thomas Flynn
Dorothy Wilson
Hannah Russell
Else Schulze
Gordon R. Beem
William Slivka
A. Kay Keiser
David Dolins
Estelle Siker
H. Patterson Harris
Allen Cohen
James Malloy
Arnold Saslow
Samuel Korper
Susan Balter
John Bihldorff
Daphne Gemmill
Dorothy Lewis
Judith Beatrice
Elizabeth Helming
Karen Lindlors
Linda Broker
Elaine Anderson
Carroll Schilling
Dorothy Rice
Richard Poole
Ralph Tartaglione
Christina Quinn
Diane Goren
Jill Goldwater
Michele Visconti
Amy Wilson
Jeffrey Hughes
Mary Beth McNerney

1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983

Alumni
Baumgartner Match
Interest & Miscellaneous
gifts

1982-83
AMOUNT

1983-84
PARTICIPATION

1983-84
AMOUNT

50%
36%
33%
31%
22%
39%
33%
33%
52%
48%

$1,844
(+1,000)*
550
390
295
120
35
290
720
490
723
635

-

-

39%
40%
29%
43%
32%
52%
21%
33%
33%

730
735
120
390
352
422
825
535
565

-

-

45%

410

-

-

-

-

23%
38%
50%
31%
10%
28%
46%
28%
27%
42%
27%

70
650
1,025
540
200
1,260
1,420
820
1,330
1,500
650

43%
10%
33%
29%
29%
24%
36%
43%
27%
35%
53%

1,300
60
520
895
580
305
2,445
1,475
1.450
1,650
2,221

-

-

22%
40%

965
740

39%
36%
30%

53%
Eric W Mood
Eric W. Mood
Eric W. Mood

1952
1953
1954
1955
1956
1957
1958
1959
I960

1982-3
PARTICIPATION

58%

$1,791

33%
31%
56%
33%
22%
39%
39%
22%
50%

265
275
270
130
65
265
785
440
790

-

-

37%
39%
42%
13%
50%
36%
48%
29%
48%

565
840
860
70
535
555
470
765
945

-

-

54%

1,050

-

-

34%
20%
27%

830
820
695

1,666
890
960

35%
34%

1,391
1,560

-

-

-

-

35%
40%
25%
20%

1,400
1,315
665
645

29%
38%
51%
31%
33%

1,390
1,318
2,420
1,020
970

15%

320

26%

860

-

-

36%

805

33%

$31,532(1)
3,778
1,262

33%

$36,572

36%
$38,761(2)
3,162
1,755

TOTAL

1) includes $50 endowment income
2) includes $104 endowment income

36%

$43,678

Contributors to the
Medical School Alumni
Fund 1983-84
1906
Charles R. Mitchell *
1908
Michael A. Parlato *
1912
Walter C. Tilden *
1913
Ralph E. Taylor *
1919
Willys M. Monroe *
1920
Oscar Brenner *
1921
Ella W Calhoun
Joseph T. Eagan
1922
Maurice Grozin *
Benedict R Harris
Chester E. Hurwitz *
Helen P. Langner
1923
William Cohen
Joseph Epstein
Jacob Melhon
Julius Olean
Hyman Weinstein *
1924
John J. Batchelor
D Anthony D’Esopo
David M Raskind
Myron A. Sallick
Morris Slater
Harold T Vogel
1925
Dorence S. Cowles
Waldo F Desmond
Henry W. Ferris
William E. Hall
Stanton K. Livingston
Samuel Reback
Welles A. Standish
Alice A.S. Whittier
Gonsalvo C. Williams
Howard A Wood
1926
Stanton T Allison
Maxwell Bogin
William H Hahn *
Joseph L. Hetzel *
Morris Hinenburg
Ben Klotz
Milton Malev
Joseph T. Matteis
1927
Milton B Berman
Wallace R Bostwick *
Henry Irwin Fineberg
John M. Freiheit *
Meyer Friedenson
Edward E. Harkavy
Albert Jablonsky
Nathan Levy
William C. Meredith
Moses Rothberg
Harry M Zimmerman
1928
Max Alpert
Clement F. Batelli
Berthold R Comeau
Sheldon A Jacobson
Edward P J Kearney
Ralph E Knutti
R Harold Lockhart
Edward W. Ludwig *
Nathan E. Ross
Robert I Rubinstein
John M Russell *
Alvin A. Schaye *
Lewis A. Scheucr
• Deceased

1929
James Rae Arneill
Frank H D’Andrea
Charles J Epstein
Robert A. Frisch
Olive Gates
George S. Goldman
Alexander O Haff *
John A. Hangen
Harold J Harris
Vernon W. Lippard
Paul F. McAlenney
Tony L Rakieten *
William F Roth, Jr. *
Russell B Scobie
Benjamin Spock
Robert Tennant
Newell R. Washburn *
Julius Weiner *
Mabel Wilson
Fumiko Yamaguchi-Amano
Herman Yannet
1930
Samuel Alpert
Daniel N. Beers *
Courtney Craig Bishop
Charles A. Beck *
Frederick Fitzherbert Boyce
Vincent A. Doroszka
Knox H. Finley
J Edward Flynn
J Roswell Gallagher
Leonard Greenburg
James C Hart
Edmund L. Kitzmeyer
Paul H Lavietes
James M Lynch *
Paul Watson *
Amy Wilson
Charles L. Wood
1931
Henry H. Briggs
Benjamin Castleman *
Michael D'Amico
Richard L. Frank
Helen R Gilmore
Paul A. Harper
Harold E. Harrison
Morris Heller *
Thomas C. Jaleski
A Philip Lafrance
Rhoda M. Mickey
Nelson Newmark
Sheldon Payne
James W Reed
Abraham J. Schechter
1932
Louis K. Alpert
Henry Brill
Frank Carroll
Clement C. Clarke
Robert M. Cushing
Joseph P. Donnelly
Lewis F. Foster
Storer Plumer Humphreys
Conrad R. Lam
Arthur J. Present
Elizabeth M. Ramsey
Benjamin N. Tager
Rudolph E. Vandeveer
Myron E. Wegman
Roland J. Wehger*
1933
Myron J Adams *
Fred W Buse
Warren P. Cordes
Franklin M Foote
Jack Greenberg
George K Hirst
Robert W Huntington
Robert E. Kaufman

Raymond E. Miller
Ashley Pond 111
Paul L. Saffo
Sidney Stringer *
John J Wolfe
Francis M. Woods
1934
Leona Baumgartner
James F Blades
Joseph Budnitz
Derick A. January
Knowles B. Lawrence
Theodore P Merrick
Herbert C. Miller
Edward T. O’Donnell
John B Ogilvie
Lucien M. Pascucci
Harry Sherman
William R. Willard
George Zalkan *
1935
George A. Carden
Edward F. Falsey
Sawnie R Gaston
H Hoffman Groskloss
James Quintin Haralambie
W. Howard Horner
Samuel D Kushlan
Donald P. Morris
Graham C. Newbury
Norman E. Peatfield
Norman P Rindge
Milton Rose *
Clark P. Searle
Walter A.L, Thompson
Samuel Zelman
1936
George Henderson Brown
Lester W. Burket
Nicholas D. D’Esopo
Albert W. Diddle
Franklin F Ferguson
Margaret C.L. Gildea
George D. Gross
George A. Hahn
Louise G Hutchins
Philip M, Le Compte
Donald F. Marshall
Stephen F. Nagyfy
Frederick A. Post
Margaret Sommers
Morris Tager
Edgar W. Warren
1937
David A. Dolowitz
D. Crosby Greene
Wilbur D. Johnston
Alfred E King
Dunham Kirkham
Julia Mehlman
James P. Morrill
Charles W. Neuhardt
Alan A. Rozen
Morgan Sargent
Edward J. Shaw
Albert D. Spicer
John M. Thomas
Jean Wells
Lucille R Wiepert
1938
Roy N. Barnett
Henry L. Carideo
S. Charles Kasdon
Benjamin E. Lyons
John J McGillicuddy
Edward Nichols
Nelson K. Ordway
Edward W Pinkham
James Radcliffe
George E. Roberge
Lester J. Wallman
J. Richard Zahn
1939
Harold H Coppersmith

Norman L. Cressy
William H Druckemiller
Robert G. Ernst
John P. Ferguson
Joseph B Forman
S. Jerome Greenfield
Paul E. Huston
Nathaniel Kenigsberg
Margaret A. Lennox
James Peter Murphy
Russell Nahigian
Douglas S. Riggs
Ernest L. Sarason
Rebecca Z. Solomon
Stuart S. Stevenson
John D Tobin
Darrell G. Voorhees
Douglass W. Walker
John H. Wentworth
Malvin F. White
1940
Theodore E. Allen
Joseph V. Baldwin
Jack S. Blaisdell
Philip S Brezina
Thaddeus S. Danowski
Wynant Dean
Richard E Dormont
Robert M. Dunlap
James F. Ferguson
Eugene J. Fitzpatrick
Henry D Humphrey
H. Stuart Irons
Donald G. Johnson
Ira D LeFevre
Paul D. MacLean
Edward Martin
William R. Oakes
Maurice Ross
Lee S. Sannella
W. Norman Sears *
Joseph E. Sokal
J. Champneys Taylor
Patricia E. Wanning
John B. Wells
Helen H. Woods
1941
Sophia H. Alway
Robert H Areson
W. Randal Bell
Knute E. Berger
William A. Carey
Joseph P. Carson
Charles B Cheney
Herbert W. Diefendorf
Robert Dine *
Lloyd D. Flint
John Franklin
Robert L. Gilbert
Frederick P Glike
Sidney L. Lasell
William Lee
Bjorn Lih
F. Eugene Martin
Willys M. Monroe
Malcolm C. Murfitt
Edward B. O'Connell
Robert W. Ollayos
Gioacchino S. Parrella
Leslie Simmonds
Irving Waltman
1942
Eugene M. de Hostos
James M. Bunce
Walter J Burdette
Robert E. Carroll
Donald S. Childs
Vincent J. Collins
Hendrik DeKruif
Davitt Felder
Elihu Friedmann
Allan V.N. Goodyer
Charles R. Harms
William Harrison
Wilson E. Hughes

Leo Kellerman
John R. Lincoln
Patrick S. Mullins
Dean Nichols *
Samuel Ritvo
Lois Knight Rogers
Charles F. Scholhamer
Richard W. Smith
Edgar B Taft
Maurice Tulin
Irving Norman Wolfson
1943 (March)
Ralph D. Alley
John R Brobeck
Lycurgus M. Davey
C. Thomas Flynn
Gerard Fountain
Jessamine R. Goerner
R. Leonard Kemler
Joseph P. Kriss
Jonathan T. Lanman
Dorothea R Peck
Edward F. Rabe
Earl J Rhoades
Henry A. Reidel
Bernard R Rowen
Marcus E. Sanford
Edward Hersey Soule
Hilliard Spitz
Nicholas M. Stahl
Sophie Trent Stevens
Oliver G Stonington
Robert Lee Taylor
Robert G. Turner
Frederick A Waldron
John J Weber
Robert H Wyatt
1943 (December)
Richard N. Abbott
John R Almklov
David G Borden
S Brownlee Brinkley
Henry B Bruyn
Thomas L. Bucky
Jane B Cadbury
Philip B. Chase
Hunter H Comly
Ronald W. Cooke
Jean P Davis
Joseph I. Epstein
Fred M. Haddad
Henry H Jones
Joseph Keel
Sawyer E. Medbury
Ira A Rashkoff
Donald W. Seldin
Francis A. Spellman
C. Wesley Watson
1944
Carl Andrews
Edward J Conway
John C. Coolidge
George B Corcoran
Frank W. Countryman
Charles H. Crothers
Lawrence G. Crowley
John H Doherty
Robert W Frelick
Carol Goldenthal
Howard B Hamilton
Robert 1 Hinkley
W Raymond James
Ward S. Jenkins
Edith M. Jurka
Jerome J. Kaye
John Weaver King
Frederick F Krauskopf
Ellen P. Mackenzie
Elias J Marsh
Katherine Hawley Martin
Joseph Massaro
A Reese Matteson
Paul E. Molumphy
Russell R. Monroe
Lawrence K Pickett
Laurence G Roth

Haynes W. Sheppard
Sarah P. Sherwood
Nicholas P R. Spinelli
Anthony J. Stone
Priscilla Dienes Taft
Anthony Varjabedian
Calvin W. Woodruff
Rueben Zucker
1945

George Howard Allison
A. John Anlyan
Albert S. Atwood
Frederic M. Blodgett
Richard W Breck
Louise H. Burr
Alice Shepard Cary
Sanford F. Cockerell
Jay B Cohn
Thomas P. Cotter
Edward M. Daniels
Richard R Dyer
Robert S. Easton
Sidney S. Feuerstein
Alice Dershimer Friedman
Raymond A. Gagliardi
Philip S. Good
Herbert S. Harned
Paul W. Hoffert
O. Roger Hollan
Hans R Huessy
William L. Jenney
William E. Laupus
Raymond E. Lesser
Mark McD Lindsey
Charles E. McLean
George W. Naumburg
Fitzhugh C. Pannill
Richard M. Peters
Elliot R. Reiner
Charles E. Sherwood
1946

Margaret J. Albrink
Aaron T. Beck
Sanfurd G. Bluestein
Linus W. Cave
James F. Cooney
George C. Cusick
Thomas A. Doe
Edward F. Edinger
H. Lambert Filer
Gregory E. Flynn
Martin E. Gordon
Charles S. Judd
Harold King
Benjamin F. Kitchen
Vincent J Longo
Richard H. Mann
Thomas J. Mathieu
Hugh J. McLane
Joe D Morris
John H Morton
John F. Neville
Laura W. Neville
Francis Reilly *
David H. Riege
Julian A. Sachs
Donald P. Shedd
Richard G. Sisson
Colby S. Stearns
R. Bruce Thayer
Robert R. Wagner
William P. Walsh
William J. Wedemeyer
Thomas J. Whelan
Hugh R. Williams
Elihu S. Wing
1947

George R Barnes
Henry N. Blansfield
Albert W. Bostrom
John E. Bowers
William Roy Breg
John L. Cannon
M. Richard Carlin
John C. Carpenter
Charles R. Cavanaugh
Roland G. Chambers
Robert Chase
* Deceased

Amoz I. Chernoff
William F. Collins
Robert P. Darrow
Archie L. Dean
Jean H. Dougherty
Owen W. Doyle
Franklin Harold Epstein
Edward D. Foord
Richard K. Friedlander
Frank H. Horton
Robert J. Kerin
Don F. Kimmerhng
Richard P. Levy
Brock Lynch
Victor A. Machcinski
William K. McClelland
Robert F. Newton
Myron K. Nobil
Lawrence C Perry
Edgar B. Phillips
Olive E. Pitkin
Irving Rudman
Igor Tamm
Patricia B Tudbury
Ellis J. Van Slyck
Laura B. Weed
M. Henry Williams
1948

Russell J. Barrnett
Edith M. Beck
Allyn G. Bridge
Richard Steele Buker
Ruth E. Cortell
Victor A. Drill
Boy Frame
Emil Frei
Julian Frieden
Allan Green
B. Herold Griffith
Sylvia Preston Griffiths
Beatrix A. Hamburg
Richard M. Hannah
Ross R. Harcus
W. Rayner Johnson
Paul B. Koehler
Robert E. Lempke
Patrick J. McLaughlin
John B. Morrison
George P. Rostel
Lewis P. Rowland
Benjamin F. Rush
Gabriel A. Saviano *
Jerome H Shapiro
Jessie Parkinson Spear
Anne G. St. Goar
Paul Woodbury Weld
1949

William G. Anlyan
Alfred E. Bacon
Henry W. Baird
William D. Bevis
Jonathan S. Bishop
Thomas L. Chiffele
Mary Pucci Couchman
Phillip G. Couchman
Peter R. Cunningham
N. Joel Ehrenkranz
Daniel W. Elliott
Gunnar O. Eng
Albert A. Fisk
Paul S. Goldstein
Frederic W. Gray
Jackson Harris
Robert C. Howard
Orval 1 McKay
Richard D. Otis
Julian I Pichel
Edmund L. Piper
Charles L. Rennell
Murray Z. Rosenberg
Carl M. Russell
William H. Sewell
Raymond D. Sudarsky
Martha Vaughan
1950

Russell N. Anderson
Lyal D. Asay
John E. Borowy
William H Bucher
Alvin Davis

Claude W. Delia
Kent Ellis
Thomas J. Ferraro
Daniel Fine
Yvette F. Francis
Carl A. Gagliardi
Archie J. Golden
Sidney S. Lee
Janus C. Lindner
Margaret S. Lyman
Harry L McClelland
John H. Meyers
Orlando J. Miller
Robert T. Sceery
Cynia B. Shimm
Jane B Shumway
Martin Smith *
Myra D. Tyler
1951

W. Robert Adams
Frank R. Allen
Thomas T. Amatruda
Stanley D. Ardell
Eleanor Clay Bigley
John J. Egan
Daniel X. Freedman
Sidney S. Furst
Ralph M. Gofstein
Lowell 1. Goodman
John T. Groel
Robert N. Hamburger
Carrold K. Iverson
Jocelyn S. Malkin
Paul D. Millikin
Albert R. Mowlem
Richard S. Munford
Charles A. Nugent
Jose Felix Patino
Arthur A. Pava
Majic S. Potsaid
Robert G. Small
William F. Stephenson
William Taylor *
Andrew S. Wong
1952

John W. Arnold
Frank A. Carone
Frank R. Coughlin
Philip Gardner Deane
Raymond S. Duff
James R. Durham
Robert P. Gerety
William Joseph Johnson
Thomas S. Kelly
James Kent Luce
N. Karle Mottet
Sidney Nathan Paly
Robert G. Petersdorf
Leon A. Phillips
John Macklin Roberts
Leonard Rush
Mary Wheatland Schley
Donald H. Schultz
Robert B Schultz
Virginia Lee Swanson
John H. Wagner
Doris L. Wethers
John L. Wolff
Harvey L. Young
Robert Zeppa
1953

Claude Bloch
Harold D. Bornstein
Remi J. Cadoret
William R. Chaffee
Allen Chetrick
Rex B. Conn
Louis R.M. Del Guercio
James P. Dunn
Vincent Lynn Gott
Robert Emanuel Hamlisch
A. Daniel Hauser
George L. Hoffmann
David Purdy Holman
Peter Biggs Hukill
Richard Robert Knowles
Frederick Martin Lane
Hildegard Mueller Leslie
Preston Lee Leslie
John Dutch Lord

Robert N. Melnick
Harvey Martin Peck
Paul G. Quie
Jose Ramirez-Rivera
John C. Roberts
Barbara F. Rosenburg
Irwin K. Rosenburg
Virginia C. Saft
Howard Willis Smith
Ora K. Smith
Lynn Cortland Stoker
Matthew Andrew Tandysh
William Junior Vandervort
William August Wilson
1954

Frank P Berg
Richard J. Bouchard
George N. Bowers
John R. Cole
William D. Cone
Alan H. Covey
Arthur C. Crovatto
Donald D Davis
Walter J. Freeman
John A. Gariepy
Edward J. Gerety
Frank L. Gruskay
Nicholas A. Halasz
Katherine H. Halloran
Robert P Hatch
Walker R. Heap
Eva H. Henriksen
Herbert S. Hurwitz
Robert F. Hustead
Robert J.T. Joy
Robert M. Keith
Robert P. Knight
Donald S. Kornfeld
Harry C. Miller
Paul N. Neufield
William J. Paule
Anthony V. Piccirillo
Richard D Pullen
Jacques M. Quen
Edwin R. Ranzenhofer
Earl D Rees
John Keith Rose
Elihu M. Schimmel
Leonard M. Silverman
Robert L. Stein
John W. Vosskuhler
1955

John B Atwater
John C. Bailar
George E. Becker
Jerome Bobruff
Douglas G. Boyden
Irwin M. Braverman
Edward Noel Brennan
Padraic Burns
Leo R. Cardillo
Nicholas A. Coassin
Edward D. Coppola *
Milton Corn
Pasquale James Costa
John G. Daley
Fred Wendell Doyle
William O. Edward
Leroy Engel
F Robert Fekety
Mahlon V.R. Freeman
Barbara W. Gibson
Rudolph J. Goerke
Paul Gonick
Ion Gresser
John H. Hodge
D Franklin Johnson
Harry O. Kendall
David R. Kessler
Robert A. Kramer
William E. Lattanzi
Gilbert M.P. Leib
Roger Lester
Alexander Maitland
Joseph S. McGuire
Russel] Miller
Robert C. Nodine
James P. Nolan
Sherwin B. Nuland
Gloria C. Onque

John C. Pace
Robert H Peters
Gregory Peterson
Robert A. Reich
Paul J Robinson
F Brantley Scott
Phillip W. Smith
Alan A. Stone
Alexander Zuckerbraun
1956

Alan E. Apfel
Peter Bios
Levon Z. Boyajian
Thomas M Brown
Rosalie A. Burns
Joseph C. Cerny
Edwin L. Child
James C. Collias
Donald J. Dalessio
Chandler Dawson
S. Evans Downing
Mitchell Edson
Gilbert M. Eisner
Thomas F. Ferris
Sumner Gochberg
John Herd Hart
William H. Hindle
Marie-Louise T. Johnson
George T. Kammerer
Jerome O. Klein
William V. Lewit
Preston C. Manning
Dwight F. Miller
Norman F. Moon
Donald J. Nalebuff
A. Frederick North
David A. Page
George W. Paulson
Robert Lee Scheig
James Scheuer
Edward C. Senay
Benjamin A. Shaver
Donald William Sherrick
Daniel R Silbert
1957

Donald Agostinelli
Joseph S. Amenta
Jack Norman Blechner
Richard I Breuer
Harry C Briggs
John P Carey
Albert K. Chun-Hoon
Louis Z. Cooper
Harold Dick Cross
John D’Agostino
Thomas H. Danaher
James R. Dorr
Harold J Fallon
Robert E. Fishbein
Ronald H, Fishbein
Anthony L. Fons
Elizabeth H. Forsyth
Robert H. Glass
Anne H. Good
Jack Peter Green
Joyce D. Gryboski
Gilbert F. Hogan
Warren R. Johnson
Richard Lee Kahler
Stanley E. Kilty
William L. Kissick
George C. Knovick
Jack Levin
Bennett F. Markel
Mark D. Marshall
David E. Martin
Howard A. Minners
Robert K Modlin
Hugh Lamson Moffet
George Albert Nelson
Herbert A. Newman
Thomas Francis O'Brien
Joseph S. Pagano
Raymond E Phillips
Clifford B Reifler
Jesse G. Rubin
Kenneth A. Simon
Charles A. Slanetz
Gilbert B. Solitare
Robert W. Southworth
Donald C. Stahl

Arthur Taub
William J. Waskowitz
James G. Zimmer
1958

George K Aghajanian
Joseph E. Angelo
John P Arnot
Gerard N. Burrow
Benjamin Bursten
David A. Carlson
John A. Carlston
Lawrence Dubin
Donald A. Duncan
Joel C. Eberlin
Michael E. Fishman
Peter A. Flynn
Raymond A. Gaito
John C. Gallagher
Marcia Kraft Goin
James Greenwald
Charles A. Hall
Michael Kashgarian
Haskins K Kashima
Jay Ward Kislak
Theodore W Lieberman
Myron Lotz
Thomas J. Mauro
Michael J. McCabe
Leo T. McCallum
William S. McClanahan
Andrew Joseph McGowan
John A. Merritt
Albert Muggia
Robert S. Neuwirth
David W O’Keeffe
Carol F. Phillips
David M Pugh
William B Radcliffe
Paul A Rudnick
Bruce H Sklarew
Edward Lloyd Socolow
Arlene Sweedler
Raymond W Turner
Margaret Smith Wenzel
Joseph P. Wierzbinski
John Patrick Wood
Pauline B Wood
1959

Scott Ingram Allen
Carol J Amick
Robert M Amick
Asa Barnes
Francis A. Beer
Jack F. Bowers
William C. Butterfield
Edward Call
Sidney M Cohen
Martin Colodzin
Lyall S. Crary
William L. Donegan
Robert L. Fisher
Robert J. Gonyea
Gerald B. Gordon
W Keith Hadley
William H Heydorn Me
C. Richard Hinckley
Leonard Inker
John J. Jasaitis
Edvardas Kaminskas
David W. Kingsbury
Parry B. Larsen
Myron S.S. Lee
Kathryn Huxtable Lewis
Daniel L. Macken
James A. O'Neill
Robert H. Ostbcrg
Nicholas M Passarelli
Charles A. Phillips
John A. Poglinco
Lincoln T. Potter
James D. Prokop
James R Ralph
David Pardee Reed
Joseph Douglas Robinson
Joseph D. Saccio
Marvin L. Schulman
Marc D. Schwartz
David B Skinner
Sanford P. Solomon
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James J. Stagnone
Lisa A. Steiner
John S. Strauss
Leo H Von Euler
Robert B Whitney
Muriel D. Wolf
1960

Victor Altshul
Alan W. Ames
Jack D Barchas
Donald P Buebendorf
Thomas E. Carson
Stanley M.K. Chung
Jon E. Courtney
March Enders
Caldwell B. Esselstyn
Warren H Fisher
Paul Jay Friedman
Alvin E. Friedman-Kien
Eugene C. Gaenslen
Gary Earl Gathman
James 1 Gilman
Sylvia D Grant
Roland H Ingram
Daniel M. Jones
William S. Kaden
Eric P Kindwall
Frank J Kleeman
Susan T. Kleeman
Thomas P Kugelman
Edward R. Lang
Thomas L. Lincoln
Edward Longo
Eugene G McCarthy
Donald L. Miller
Richard G Morrill
Allan W. Newcomb
Buford l.. Nichols
J Thomas Okin
Fred Palace
Jerrold M. Post
Nancy Rolick Powell
Martin L. Reite
Albert Matthew Ross
Daniel J Rubin
John J. Schrogie
Ross L. Snyder
Fred Stargardter
Constantine M Voyagis
Robert C. Wallach
May Yung-Fun Woo Wang
1961

Kenneth A. Arndt
Earl L. Baker
Albert A. Bechtoldt
Robert S. Briggs
David William Brook
Orson R. Dee
Paul David Deiter
Ronald A. Dierwechter
Jon Dudley Dorman
Christopher Francis Durham
John E. Fenn
James M Giffin
Edward C. Gilbert
Robert Sterling Gillcash
Louis D. Hunt
Richard L. Keefe
Robert Isaac Levy
Hugh James Lurie
David B Matloff
Anoush Miridjanian
Richard Allen Moore
Norman 1 Moss
John Pearce
William M Rogoway
Roy E. Ronke
Stanley G. Schade
John J. St. Andre
Robert N. Taub
Hugh C. Thompson
Franklin H. Top
David E Weaver
Warren D. Widmann
1962

Michael H Alderman
Charles B Anderson
Frederic P. Anderson
Dean E. Burgct
Fredric K Cantor

Oliver Townsend Dann
Arnold Joel Eisenfeld
John W. Foreman
Leroy A. Forstrom
Stephen John Fricker
Anthony V. Furano
John N. German
John H Hageman
John T. Harrington
Patricia C. Hassakis
Victor W. Hurst
Walter Watson Karney
Glenn L. Kelly
David E. Knoop
Alan D. Lieberson
Manuel J. Lipson
John P Lynch
Malcolm A. Martin
Stanley E. Matyszewski
David J. McConnell
William G. Meffert
William A. Miller
Malcolm S. Mitchell
David D. Nicholas
A Richard Pschirrer
James A.E. Spencer
Larry Lee Stewart
H. Oliver Stoutland
Seth Thaler
Sherwood Waldron
William Farnsworth Weber
1963

Arthur Howard Acherman
Miguel R. Alonso
V Richard Back
Charles W. Carl
Theodore J Chu
Gordon S. Cohen
John E. Conte
David F. Cross
James S. Dalsimer
Dudley Seth Danoff
Andrew Edin
John P. Eliopoulos
B. Allen Flaxman
David H. Fram
William T. Friedewald
Alexander R Gaudio
Vincent F. Geremia
Lee D. Goldberg
Peter B Gregory
Harold P Kaplan
Constantine D. Kvropoulos
William B Lehmann
Craig H. Llewellyn
Robert H Margulis
Herbert Meltzer
Robert E. Mueller
Sheldon R Pinnell
Jay M Pomerantz
Gene R. Profant
Marvin R Skolnick
Lee Bland Talner
Thomas W. Tillack
Peter V. Tishler
Lawrence Tremonti
Peter G. Weiner
Seth M Weingarten
James G Wepsic
Jerome Allen Winer
Alfred J. Wise
1964

William A. Alonso
Leland S Berger
Philip Blume
Anthony J Bravo
Robert M Briggs
William Virgil Brown
Thomas A. Cardella
Joseph F.J Curi
Mary V. Digangi
Alfonso Esguerra
Remo Fabbri
Anthony Ferrante
Norman C. Fost
Peter A. Gross
John F.B. Haney
Gene I Higashi
Richard Hockman
Lawrence Horwitz

William J. Houghton
William E. Kmght
Lewis Landsberg
Richard V. Lee
Thomas L. Lentz
Paul R Lightfoot
Richard Murray Linburg
Robert W. Lyons
Andrew E. MacMahon
William F. Matchett
Thomas O. McCann
Robert L. Mitchell
Alan H. Morris
James J. Murphy
Donald A. O’Kieffe
William B Pratt
Stanley J. Rosenberg
Jonathan J. Russ
Norman Scher
Robert L. Shelton
Donald G. Skinner
A. Thomas Snoke
Lyall C. Stilp
Sigrid L. Tishler
Charles Vogel
Stephen Waltman
Oscar Wand
1965

Susan A. Aoki
Thomas T. Aoki
Paul Balter
Michael J. Cummings
Carl Ellenberger
David S. Fedson
Robert 1. Finkel
Frank J. Grady
James K. Gude
Reid R. Heffner
Carl E. Hunt
Virginia Burnham Johnson
Robert H. Koehl
Richard J Kozera
Mark W. Lischner
A. Lawrence Ossias
Robertson Parkman
John A. Parrish
Robert L. Pickens
Alan N. Rachleff
William A. Renert
Gene A. Robinson
George B Rowland
John H. Seashore
Margretta Ann Reed Seashore
Charles J. Semonsky
David M. Shames
Harlan Spitz
E. James Stanley
Bert Yuan-Shu Wong
1966

Benjamin F. Balme
John D Baxter
Patricia Bazemore
Robert P. Bazemore
Frank C. Bell
Philip Bernstein
James Edward Brown
Eugene Patrick Cassidy
Donald J. Cohen
Thoburn Aaron Dadisman
Joseph A. Donadio
Robert E. Dragon
Marvin A. Eisengart
Jared M. Emery
Robert N. Frank
Robert C. George
Jeffrey B Gluckman
Stanley I Greenspan
J McLeod Griffiss
Robert A Gunn
Stuart T. Hauser
Jay G Hayden
Mary Alice Houghton
John B Howard
Richard J Howard
Bruce W Jackson
Gordon R Kelly
Neal Koss
Stuart M Kotler
David C. Law
Lynne L. Levitsky
Henry B Mann

Robert L. McRoberts
Harold Mellin
John J. Mooney
Edward J O'Keefe
William D. Peterson
James D. Slavin
Parker J. Staples
Gary L. Townsend
Lee Van Lenten
Joan T. Wayland
Jon S. Wayland
John W. Wickenden
William B. Yeagley
Arne S. Youngberg
1967

Daniel L. Arons
Arthur L. Beaudet
Arthur Walker Boddie
Daniel J Booser
Gary C. Burget
William T. Cave
Mary Williams Clark
Cynthia Rapp Curry
Marian C. Davidson
James Lucius Davis
James J. Dineen
Alexander F. Dora
James M. Dowaliby
John A. Drews
Peter R. Egbert
Herbert W. Felsenfeld
Melvin Victor Goldblat
Richard J. Hart
Richard L. Heppner
Peter N. Herbert
George P Herr
David L. Ingram
J Robert Kirkwood
Melvyn Korobkin
Carl E. Lane
Anthony P. Lovell
Stephen W. Miller
William J. Mitchell
Joseph L. Morris
Jennifer Robinson Ntebyl
John O Pastore
William E. Perkins
Brian F Rigney
James J Robinson
Marvin J. Rosser
Robert 1 Roy
Jonathan L. Saveli
Alfred Q. Scheuer
Stephen C. Schimpff
Sidney C. Smith
Helen L. Smits
Robert S. Steinberg
Richard B. Swett
M. David Tilson
Karen H. Toker
George Tyler
Robert A. Vogel
Robert A. Vollero
Joseph F Walter
Martin Wand
Robert J Winer
Robert S.K Young
lhor George Zachary
Peter M. Zeman
1968

Julius H Anderson
Joseph F. Andrews
Philip L Barry
Daniel I. Becker
Donald R Coustan
Robert G. Dillard
Edward M. Druy
Barbara Mayer Egbert
Lamar Ekbladh
Alan G. Finesilver
William F. Flynn
Richard A. Getnick
Mark Gilbert Grand
Leonard Grauer
Kevin N Hennessey
John R Hill
Harry S. Holcomb
Peter A. Kirkpatrick
Jeffrey S. Lee
Marc E. Lippman
Peter A. Livingston

Frank E. Lucenle
Donald O. Lyman
Rodrigo Martinez
Harmon Michelson
David P. Millett
James B. Morris
Margot Onek
Jackson B E. Pickett
Charles T. Post
Joseph L. Renda
Gordon H. Sasaki
Jacob J. Schlesinger
Bruce Stuart Schoenberg
George F. Sheckleton
Frederick C. Sherman
Howard W. Siegel
Gerald L. Springer
Lee H. Strohl
James L. Weiss
Per Henrik Wickstrom
1969

Brian D. Altman
Charles S. Angell
David G. Ansel
David W. Barry
Robert E. Belliveau
N. Roger Cooke
Leo M. Cooney
Richard J. Daly
Charles A. Dinarello
Douglas T. Domoto
Ralph J. Falkenstein
Gary S. Larnham
Steven A. Frankel
William H. Frazier
Anna S. Gail
Royal J. Gay
David A. Geer
Sander G. Genser
Robert O. Gordon
Steven M. Herzberg
Thomas C. Howard
Lee M Jampol
Joel Mark Kaufman
Paul H. Kelker
John J. Kelly
Rowena Korobkin
Stephen Krant
Michael R. Liebowitz
Robert L. Marier
Arnold F. Mazur
Ellen B Milstone
Thomas F. Minehan
Bruce K. Nagel
Lionel M. Nelson
Deborah A. Putnam
N. Burgess Record
Joseph D. Robinson
Joseph M. Rochford
Dennis J. Rudzinski
David J. Sahn
Lutz H. Schlicke
Adrian M. Schnall
David J. Schulak
Gerald J. Smallberg
Michael S. Toren
Robert J. Walat
Stephen R Webb
Steven C. White
1970

Elissa B. Arons
Roger J Branson
Henry Chessin
Michael J. Chusid
C. Norman Coleman
Michael D Danzig
James E. De Lano
Margaret W. Delano
Jonathan Ecker
Bruce A. Fabric
B. Graeme Fincke
Thomas H. Gouge
Paul C. Hessler
Jay H. Hoofnagle
Robert L. Janco
Gerard T. Kennealy
Ely A. Kirschner
Mark A. Korsten
Thomas L. Lewis
Stephen Lipper

Robert B. Litman
Anne W. Lucky
Jay W. Marks
Leonard M. Milstone
James R Missett
William K. Mueller
Bruce A. Reitz
Robert M. Rosa
Joel F. Rubinstein
Dennis E. Shield
Stuart S. Shorr
Richard A. St. Onge
Philip E. Steeves
Ray W Tripp
Brian Weiss
C. Bruce Wenger
Joellen Werne
Daniel Wuensch
1971

Judith L. Bader
Gregory W Bartha
Laurie J. Bleicher
Willard Cates
Frederick L. Cohn
Andrew D. Cook
David Cossman
Edward C. Cottle
Michael Cynamon
John S. Ebersole
Leonard I. Eisenfeld
Daniel E. Feldman
Harvey Fernback
Fred Finkelman
Jared J. Gardner
Michael J. Hart
William W. Hay
Richard E. Kaufman
Robert M. Kessler
Barbara K. Kinder
William L. Krinsky
David H Lippman
Sten B. Lofgren
Samuel S. Masters
John C. Mills
Patrick T. Mimhan
Steven H. Moffic
Richard Albert Moggio
Martin Paris
John A. Patti
Barry Bruce Perlman
Michael C. Piercey
Anthony V. Proto
Barry S. Rand
Irving G. Raphael
David M. Rinzler
John Smiarowski
James P. Southwick
Jonathan W. Stewart
Daniel R. Synkowski
Richard D. Travers
Yvonne E. Vaucher
Paul A. Vignola
Albert Carl Weihl
Burns Woodward
1972

Robert D. Arbeit
Michael A. Catalano
Leonard H. Cohan
Philip L. Cohen
Gloria Cummings *
Norman M. Dinerman
William H. Druckemiller
M. Fleix Freshwater
John P Fulkerson
Robert D. Glassman
Dorothy M. Gohdes
Bruce B. Haak
Thomas L. Horn
Vernon H Humbert
Anthony H Jackson
Jesse B Jupiter
Frank M. Kahr
Roy A. Kaplan
David L. Kneapler
Philip W. Lebowitz
Theodore M. Levin
Paul A. Lucky
Harry L. Malech
Jeffery S. Menkes
Jerome H. Meyer

Jorge A. Motta
Edward J. Olinger
Peter J Panzarino
John N. Posch
William L. Risser
David H Romond
Philip M. Rothfeld
John S. Smolowe
Frederick D. Stockwell
Philip J. Weyman
John D. Wright
Michael W. Yogman
1973

David A. Adler
David Nelson Bailey
Mary Ann Brunstetter-Shafer
Robert W Bucholz
Marvin M. Chassin
Joseph M Connors
David L. Coulter
Christopher M. Doran
Joseph W. Eichenbaum
Jane H. Ferguson
Richard J. Fingeroth
Robert E. Galloway
Lee Goldman
Gary T. Grimes
Jorge L. Hernandez
Howard S. Honig
David C. Johnson
Andrew G. Kadar
Lynne M Liptay
George Lister
Mark G.F. McCormick
John F. McQuade
Jerry Nagler
Victor L. Pappoe
David E. Peach
David Pickar
Robert J. Polackwich
Charles F. Reynolds
James S. Robertson
Harry S. Romanowitz
Jerrold F. Rosenbaum
Joseph F. Simeone
Michael E. Solin
James F. Sullivan
Thomas F. Sweeney
Robert J. Ursano
Christine A. Walsh
Marc A. Weinberg
Richard S.K. Young
Randall M. Zusman
1974

Irving M. Asher
Leonard I. Banco
Douglas A. Berv
Bruce David Blumberg
Neil Blumberg
Peter J. Buchin
Paul David
Vincent A. Di Maria
Roger H. Emerson
Michael K. Eshelman
Irl L. Extein
Reginald K. Franklin
Allan B. Friedland
Michael A. Gerber
David Grant
Robert F. Hempton
Ancil A. Jones
Edward L. Marut
Marjorie A.S. Oda
Richard C Pasternak
Andrew L. Ries
David Z Ritvo
Amy S. Schechter
John D. Schrumpf
Frederick S. Shessel
Carol C. Teitz
John Jones Thompson
Jason S. Zielonka
1975

J. Edwin Atwood
Ralph E. Binder
Neil Blumberg
Stanley W. Gale
Isaac Hoch
Kevin Kane

Martin B Leon
Richard J Loewenstein
Hyman J. Milstein
Mary Jane Minkin
Robert G. Nankin
Edwin G. Olson
Vivia Reznik
Philip J Rich
Salvatore V. Romano
Fred P Rosenfelt
Robert S. Sandler
Steven A. Schwartz
Barbara J. Stoll
George H Talbot
Douglas R. Zusman
1976

Sarah S. Auchincloss
Alfredo L. Axtmayer
Peter B Bitterman
Alan B Block
Sharon L. Bonney
Roger A. Boshes
Randall D. Cebul
Richard S. Childs
John A. Elefteriades
Geoffery Etherington
Leonard Firestone
Dennis M. Fisher
Rose Hannah Goldman
Glenn A. Gorlitsky
Norman V. Kohn
William J. Lederer
William K. Levy
George W. Luedke
Douglas G. Mann
Larry Markowitz
Paul R Ramirez
James L. Rosenzweig
Mark C. Ruchman
John T. Sladky
Peter M. Ting
Frank B Watkins
John C. Wiles
Carol M. Ziminski
1977

Marcia Clark Arem
George Bolen
John J Boronow
Margery Buck Brenner
Richard D. Bucholz
Charles M. Bunke
Christopher S. Clark
John H. Cook
Stuart Brian Dubin
Marybeth Ezaki
Susan Firestone
James A. Fox
Julia B. Frank
Robert W. Hand
Jeffrey Neal Hausfeld
Bruce L. Innis
Karen G. Kelly
David J. Kreis
Robert J. Mitchell
Stephen N. Oesterle
Alan S. Penziner
Theodore M. Pitts
Ricky M Schneider
Simeon A. Schwartz
Mark S. Smith
Gail M. Sullivan
Ronald J Vender
Steven L. Warsof
J. Douglas White
Daniel Wohlgelernter
1978

Thomas T. Amatruda
Richard J. Baron
Joann N. Bodurtha
Booker T. Bush
Jesse M. Cedarbaum
Henry R. Desmarais
Eric B. Einstein
Emily A. Fine
Eugene Glenn Fong
Stuart M. Forman
Robert A. Gelfand
Jerald D. Hansing
Alexandra N Helper
Robert Hershfield

Cynthia S. Kretschmar
Robert P. Lamberton
Seth M Powsner
Steven M. Shoum
Donald C. Simonson
Thomas Joseph Smith
Rafael J. Tavares
Stanley J. Tillinghast
Marcia J. Wade
Sharon R Weinstein
David L. Wessel
Susan Wong
1979

Nancy Berliner
Daniel M Bethencourt
Richard D Bey
David A Brenner
Stuart L. Bursten
Michael M. Chang
Orlando Fernandez
John Jay Gargus
David E. Golan
Bruce Halperin
Jeffrey L. Kaine
Michael K. Lindsay
David E. Ness
Jean Rosenthal
Gary L. Schaer
Cynthia Anne Sherman
Jill A. Silverman
John T. Woo
Jeffrey Work
1980

David E. Adelberg
Eduardo Alfonso
Seth Leo Alper
Frederick R Aronson
David Allen August
Jay M. Baraban
Mark S. Bernhardt
Patricia Church Brown
Stuart L. Bursten
Forrest John Doud
David M. Gaba
Todd J Garvin
Marc F. Glickstein
David Jay Goldberg
Gary I. Greenwald
Barry M. Kacinski
Theodore W. Marcy
Suzanne M. Matsui
Cesar R Molina
Steven Ira Rosenfeld
Jane G. Schweitzer
Jeffrey N. Siegel
Leslie W. Sojka
Marcia R, Taylor
Maria L White Greenwald
1981

Cynthia B Aten
Alicia Barela
Sherri L. Brown
Patricia A. Burke
Colleen Bursten
Christine M. Duranceau
Louis Essandoh
Jonathan M. Fine
Judy E. Garber
Robert S. Goldman
Laurie J. Gordon
Neil D. Gross
Scott A. Hundahl
Elliot Lach
Barton N. Milestone
Robert M. Milstein
Robert B Portney
Barbara A. Roach
Susan C. Schachner
Anthony M. Urbano
John C. Wong
1982

Rise Maura Chait
Keith L. Gladstien
Liba E. Goldblum
David Goldstein
Jed B. Gorlin
Patricia Kellner
Kathleen Anne Nolan
Dan B Odenheimer
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Carrie A. Redlich
Paula C. Schlesinger
Henry J. Stern
Albert L. Ungricht
Stephanie Wolf-Rosenblum
1983

John T. Adams *
George Bartzokis
Elena Citkowitz
Nancy Kraemer Crocker
William Kadish
Augusta S Roth
Leonard B. Saltz
Michael Silverberg
Daniel M. Sosin
Michael B. Tom

Contributors to the
Public Health Alumni
Fund 1983-84
1923

Isidore S. Falk *
Leonard Greenburg
1927

Alice S. Baldwin
1929

Gertrude S Boyle
1930

Ruth E. Grout
Katherine Marden
1932

Leona Baumgartner
1933

Edward B Bosworth
Evelyn H Halpin
Elizabeth Murphy
Eunice Nickerson Tyler
1934

Ivai A Merchant
lwao M, Moriyama
Amy H. Wilson
1935

Franklin M. Foote
Almeda King
1936

Henry Packer
M Allen Pond
1937

Lidie V. Dyer
Howard West
William R. Willard
1938

Willard H. Boynton
Richard K.C. Lee
Katharine Hawley Martin
Lucy S. Morgan
Andrew S. Wong
1939

Carl T. Cohen
James C. Hart
Frances S. Miller
1940

Elizabeth H. Pitney
1941

Roslyn L. MacNish
Alexander Witkow

1945

Roslyn R Bilford
Naomi Barer Golden
Joe B Graber
Lois M. Jund
Naomi Helen Kalajan
1946

Edith M Blakeley
D. Patricia Nelson
1947

Sidney S. Chipman
Clara E. Councell
Anne E. Fulton
Lillian L. Konick
Raymond W. Leonard
JoAnn S. Lewis
Rosa Frances Montgomery
Jean M Pinder
Cecil G. Sheps
1948

Mary Margaret Fitzgerald
Samuel S. Herman
Barbara L. Holman
Sylvia Johnson
Beatrice H Kaasch
Dorothea S. LaBelle
Hiram Sibley
1949

Eleanor C. Connolly
Edgar L. Geibel
Hilda H. Kroeger
Christine R Owre
William B Parsons
Elizabeth D Robinton
1950

Henry G. Brickman
Ida M, Bucher
Helen P. Cleary
Jerome M. Glassman
Eugene K. Harris
Martha P Jayne
Everette D Reese
Frances K Reynolds
Elizabeth M. Scully
Nathan M. Simon
John D Thompson
1951

Clarissa E. Boyd
Norton G. Chaucer
John W Gerdes
Homer P. Hopkins
Robert L Johnson
George Kraus
Leonard F Menczer
Jessie Parkinson Spear
Angelica Z. Sysesky
Elizabeth Ulrich Throm
Walter Wenkert
1952

Cahit H. Corbacioglu
Howard Dunphy
Virgina M. Good
Joanna Adele Henry
Malcolm C Hope
Charles Holway Lawrence
Sidney S. Lee
Helen Kardys Loria
Yolande F. Lyon
Richard B. Ogrean
Anne Barlow Ramsay
Brena B. Wolff

1942

1953

Henry F. Canby
Charles D. Spangler

Jeanette Averill
Harold Robert Bernshock
Abraham Cutcher
Cecilia Frances DiCicco
Shirley L. Handler
William H. Hermann
Barbara J. Lee
Laurence K. Rainsford
Milton H Sissclman
Donald N. Zehl

1943

Carolyn S. Kofflcr
Eric W Mood
Miriam H. Rohde
Jane 1 White
1944

Massimo Calabrcsi
Paul E. Gagnon
Jean F. Heston
l ily Berman Moslyn
Jane Y. Parker

4

1956

David D Boyd
Marvin H Burton
John P Dowling
Kathleen H Howe
Paul C. Kaufman
Floyd D Parrish
Henry M. Parrish
Alice M. Wagner
1957

Janet Beach
Lee De Cady
Edward R Delouise
Sheldon Selig King
Edna May Klutas
William R Metzger
Jerome R. Sapolsky
Alice K. Smith
Shirley T. Steidel
Sylvia R Talbot
Patricia A. Viscosi
1958

Helen H Davenport
Thomas T. Flynn
Patricia P Grimaila
Fred M. Haddad
Philip B. Hallen
Chun-Lin Lai
Edward H. Noroian
Thomas P. Weil
1959

O. Wade Avant
Rita Dingman
Raymond S. Duff
Bennett 1 Enowitch
John T. Foster
Folly Hofer
William L. Kissick
Erica J. Koehler
Marvin A. Lavenhar
John F O’Connor
John S. Pullman
Ellwyn D Spiker
Kenneth J. Williams
Dorothy M. Wilson
1960

Bruce A. Barron
Gyla E. Brooks
Kathryn L D’Amico
Wouter Ekker
Armin F. Funke
Maxine Geeslin
Rose A Iannotta
Katherine Anna Keppel
Lowell Stern Levin
Salvatore Miano
R John C. Pearson
Hannah Clark Russell
Else Niebuhr Schulze
1961

Nicholas G Alexiou
Gordon R. Beem
Mary S. Blackburn
Martin Donabedian
Alfred E. Fletcher
Herbert Rubinstein
Angela M. Russo
William R. Slivka
K Berridge Sohler
1962

Richard B. Blakney
1963

1954

Calvin P Hatcher
Ruth M. Taber
1955

• Deceased

Lester M. Bornstein
Charline S. Buck
Amy L. Cawley
Isreal Gitlitz
Morris London
Mary Me C. Mogan
Frances R. Ogasawara
Ann Peverley
Gerald Rosenblatt
Daniel E. Ross

Constance T. Beemer

Dorothy Weichert Brockway
David Dolins
C. DuVe Florey
Frank M Isbell
Edward M Kenney

Jean M. Maynard
Samuel B Webb
1964

Elizabeth C. Beilis
James J. Culhane
Katherine Maria Detre
Neal L. Maslan
Theodore Rosenberg
Estelle Siker
Claudewell Sidney Thomas
1965

Robert M. Edwards
H Patterson Harris
James F. Jekel
Michael E. Kove
Peter J Levin
Charlotte Miller
Elliott A. Segal
David S Weiner
1966

Allen Cohen
Anne B Collart
[Dorothy Noyes Kane Evans
Diana B. Fischer
Norman M. Gervais
Jennifer L Kelsey
Robert C. Lowrie
1967

Peter T. Elliot-Wotton
Caroline Fong-Cheng
Ann Gomez
Alice Ipsen
Steven Jonas
Gustavo Justines
Joel Kavet
Joseph F. Kukla
Patricia D. Mail
James M. Malloy
Nancy Ruth Phillips
Brigitte Prusoff
Michael C. Quadland
Bruce J Steinhardt
Robert L. Woodward
1968

Glenda Davis Anderson
Philip D. Cobb
Sonia M. Colon
Joseph L. Dorsey
Robert R Everett
L. Carol Fernow
Carl R Fischer
Susan F Klein
Jean C. MacCorison
John M. Patton
Richard L. Petrelli
Arnold R. Saslow
Cornell Scott
Doreen P Sharabati
Elizabeth A. Small
Martha F. Steel
Sheila W. Wellington
Barbara L. Yetka-Eisenberg
1969

Susan S. Addiss
Vistor Crown
E. Belle Evans
Sharon A. Garcia
Gerald R Harpel
Sylvia N. Holtzberg
Charles C. Jelfrey
Samuel P. Korper
Samuel D. Rowley
Marva Serotkin
Wanda Vierthaler
Robert L Young
1970

Susan W. Balter
Robert T. Beeman
Arthur A. Berarducci
Michael B Bracken
Hamilton B Brown
Shan Cretin
Sabina M. Dunton
Walter M. Gawlak
Robert S. Gureasko
J. Kevin Kinsella
C.P. Noel McCarthy
Anthony M. Orlando
Peter Orris

David A Pearson
Nancy Norton Reitz
Charlotte F. Schwartz
Carol B. Von Stein
Joseph A. Zaccagnino
1971

Evarists Berzins
John Bihldorff
Evelyn J. Bromet
William F. Carey
Willard Cates
Katrina H. Clark
Karen S. Cohen
John A. Daeley
Harvey Fernbach
William P. Ferretti
Anne-Marie A. Foltz
Billie S. Hamblin
Sara P. Hartman
Wanda J. Hatmaker
Mohamed Ismail Johnson
William P. Koughan
Catherine S. Lindenberg
Mark J. Magenheim
Joan L. Martinez
Eugene S. Mayer
Joseph S. McManus
Nancy P. Mogielnicki
Lloyd F. Novick
Wan Hin Ooi
David A. Osgood
Carol L Paul
Jane Silver
Walter O. Spitzer
David L. Stockton
Judith Whitcomb
1972

Stephen B Baruch
C. Gene Cayten
Catherine A. Connolly
Paul Finlayson
Daphne Dej Gemmill
Susanne Harris
Jean T. Harrison
Selby Campbell Jacobs
Dorothy N. Lewis
Steven M. Lipsius
Sergio Ruschel
Jo Ann K. Silverstein
Raymond L. Sphar
Laurence A. Tanner
Joyce R. Waksman
Carol H. Simpson Yee
1973

Emily M. Barclay
Eva Danielsson Cohen
Schula Russell Hobbs
Chang S. Lao
George A. Million
Marjorie E. Nelson
Gary Dean Sax
Thomas J Stranova
Irene Trowell-Harris
Larry S. Webber
Bonnie C. Yankaskas
Carl J. Zack
1974

Gregory Belok
Thomas A Benoit
Carl A. Cappello
J. Breckenridge Eagle
Elizabeth M Helming
Stanley E. Kilty
Roberta Lawrence
Karen K Lindfors
Edward A. Martinez
Shirley M. Pripstein
Nils R Richardson
Abigail L. Smith
Myrna M. Weissman
Bienvenido G. Yangco
1975

Clayton A Ajello
Christine P. Antaya
Edith N. Baum
Ralph E. Binder
Gerald E Bisbee
Linda K. Broker
George R. Curry

Hillary Demby
Mary Frances Flynn
Susan T. Gershman
Elizabeth T. Hunter
Mary F. Johnson
Philip D. Kennedy
James E. Knoben
Kathy S. Kohn
Nancy J. Kreiger
Patrick W. Laskey
Stuart L. Lefkowich
Laurence F. McMahon
Edward J. O’Neill
Mary W. Palshaw
Dale P. Sandler
Edward V. Sargent
Nancy E. Stroup
Thomas J. Trudell
Franziska U. Ulrich
Audrey S. Weiner
Marion Lee Wu

Margaret Long Karis
Roslyn 1. Liss
Christopher M. Maylahn
Barbara J. Mieras
Marguerite Nelhgan
Elizabeth L. Pantelick
Trudee Parenteau
Ellen J. Reifler
Ellen D. Rothberg
Irene Schapiro
Robert E. Schwartz
Roberta Jo Shapiro
Gloria Shappy-Meickle
Karen Wolchuck Sher
Roberta Nancy Silbert
Alan J. Siniscalshi
Martyn R Smith
Marie Squattrito
Marie Stoeckel
Bernadette S. Vissani
Lucy Ellen Weiger

1976

1979

Peter B Aaronson
Elaine P. Anderson
William F. Appicelli
Catherine M. Boyle
Kathleen Keenan Bucholz
Frances L. De Peyster
Agueda N. Deans
Joanna M. Erikson
Tim M. Ettenheim
Gail lies Genvert
Linda J. Goodhart
Karen A. Gordon
Janet Heinrich
Frances Anne Kanach
Robert T. Kauer
Karen E. Me Clelland
Gino A. Nalli
Peter N. Peduzzi
Ruth Fitch Quah
James B Rokos
Robert Risdon Schwarz
Mary Jo Shepard
Gladys A. Williams
Thomas S. Wingardner

Rosemary C. Baggish
Virginia P. Bainbridge
Gertrud S. Berkowitz
Marianne Berwick
Rhonda S. Besunder
Marna P Borgstrom
Maria A. Bautti
Ralph J. Coburn
James F. Consedine
Richard T. D’Aquila
Susan De Renzo
Frances D. Dwyer
Terry Edelstein
Nurit Erger
Elizabeth Feuer
Lynn Fielden-Smith
Kathe P. Fox
Judith B. Gancher
Lucinda H. Gerson
Debra Haffner
Candice C. Haslegrave
Bruce H. Heckman
Karen G. Hellenbrand
Catherine Hobbins-Norton
Siu L. Hui
Karen Kmetzo
Paul Anthony Kowalski
Benjamin Krevsky
Renee S. Leary
Jean-Fern Lian
Bennett Myles Locke
Mary Elizabeth Lorenzi
Elizabeth Lee Luttgens
Osvaldo Marrero
William McCune
Patricia J. Moore-Pastides
Laure C. Nichols
Anna M Reager
Betty J. Reid
Marcia C. Richardson
Lisa K. Rosenfeld
George B. Rowland
William E. Schweizer
Ralph Tartaglione
Elizabeth Tedder
Mary Jane A. Teta
llene B. Wachs
Louise Wise
Jonas Zucker

1977

Patrick F. Carone
Steven R. Cohen
Marsha E. Dunn
Gerard J. Foley
Paula Yaney Gambill
Rhona Kantor Kershnar
Teri J. Klein
Ronald F. LaPensee
Wendy K. Lefkowich
Robert Walter Makuch
Polly W. Marvin
Kristin K. O’Connor
Harris Pastides
Linda Mendelsohn Pottern
Dorothy A. Rice
Lynne E. Rosenwald
Abby Rothschild
Anthony V. Sardinas
Carroll Schilling
Young S. Shin
Barbara G. Smith
Gail M. Sullivan
Thomas H. Ulfelder
Leon F. Vinci
Judy Walrath
1978

David S. Abernethy
Vijaya V. Bapat
Kathleen M. Berman
Alan B. Bloch
Maura Carley
Scott H. Flamm
Robert H. Frazier
Ann T. Freedman
Janice F. Gold
Cynthia R. Gross
Olympia Hadjimichael
Nancy G. Hildreth
Stephen W. Hildreth
David W. Houck
Jean Crum Jones
* Deceased

1980

Gary J. Aboff
Frederick R. Aronson
Curtis S. Breslin
Antoinette M. Brooke
Richard L. Buck
Sheila Conneen
Diane L, Denis
Phyllis F. Dower
Audrey L. Fetter
Beth M. Finkelstein
Richard J. Frankosky
Barbara H. Granger
Ellen B Greif
Samuel S. Hamilton
Virginia S. Humphrey
Helen E. Kelly
Yee-Lean Lee
Kathleen A. Lewis

Merle J. Lewis
Leroy F. Ludwig
Anne E. Morrison
Steven Morrow
Jane Ungate O’Connor
Susan L. Schwartz
Jane T. Siegal
Marsha L. Silverman
Richard Gerard Stracqualursi
Thomas A. Tobin
Rhona Weiss
Carolyn K. Wells
Philip A. Witman
Marie L. Zanotti
Barbara A. Zappas
1981

Jean Adnopoz
Nancy R. Angoff
Nancy M. Blankenship-Wheeler
Donna A. Brenn
Rollin C. Chew
Ann M. Dunbar
Julia Eisenstein
Kristen H. Forrest
Richard T. Forsley
Robert Fox
Judy E. Garber
Barbara A. Gaugler
Marie F. Gavula
Susan A. Hart
Susan E. Jennings
Jill L. Lapides
Katherine M. McCormack
Blackford Middleton
Howard J. Newman
Mary E. Papke
Gerald W Robinson
Marsha Thomas Rudov
Elizabeth N. Shapiro
Susan M. Stoecker
Karin Swanson
Keith D. Tait
Joan H. Urquhart
Kathy S. Vita
Nancy Schlesinger Weiss
Kathleen R. Yager
Nancy C. Yedlin
1982

Jamie L. Amaral
Jenny 1 Andrus
Lynn A. Baden
Francis L. Crowley
Mary Desmond-Tait
Kathleen K Devine
Meryl Beth Gold
James L. Hadler
Nancy Pitt Hopkins
Kim Fulmer Humphrey
Leonard Kalm
Christina H. Kohout
Linda F. Me Caig
William F. McKeon
Constance A- Morris
Jill A. Okrent
Carolyn Xavier Orcutt
Sally R. Rinaldi
Dale Allan Rublee
Lisa E. Stone
Elizabeth S. Valalik
Michele T. Visconti
Sandra Michaelson Warren
Daniel Wartenberg
Amy B. Wilson
1983

Barbara W Abraham
Gail Alexander
Joseph Amatruda
Dean S. Archibald
Jeffrey R. Botwinick
Patricia Charnas
Peter A. Charpentier
Benjamin Obi Chukwumah
Eileen Conlon
Mark L. Dembert
Robert A. Duncan
Susan Faris
James N. Gaito
Ellen M. Ginzler
Judith S. Goldstein

Halesteen Graham
Daniel A. Graybill
Nancy R Kellett
Linda S. Leo
Allen F. Levy
Cynthia M. Maglaque
Wendy L. McGill
Shinsuke Morio
Beverly Y. Nipper
Suzanne Nutt
Jeannee M. Parker
Lynn Saint Germain
Paul M Schur
Ina L. Silverman
James G. Uberti
Marilyn F. Vine
Vicki L. Wilson
Nancy K Wright

Contributors to the
Medical School Alumni
Fund 1983-84
Former House Staff
Frederick W. Ackroyd
N. Erick Albert
Ronald Angoff
Adel H Ayoub
Robert G. Bachand
Ronald J. Baily
Jane E. Barry
Arnold M. Baskin
Carl Bennett Bean
Gregory Kent Bergey
Kenneth R. Berv
Mary C. Bibro
Ralpph Daniel Bien
Jacques L. Bonnet-Eymard
Alan L. Breed
David Brigati
Marvin B. Brooks
Bruce Burnham
Thomas N. Byrne
Dennis J. Card
Victor Carpiniello
J Richard Casuccio
Whei C. Chang
Richard Allen Chase
Chang Song Choi
Michael Chun
James C. Cobey
David L. Copen
Alan R. Cote
Robert E. Crootof
F. Mitchell Cummins
Harvey Davis
Michael Martin Deren
Richard K. Donabedian
William R. Drucker
Marlene R. Eckstein
Stephen A. Edelstein
Daniel S. Egbert
Lawrence B. Eisenberg
Malcolm Mitchell Ellison
Alvan R. Feinstein
Richard Webster Finner
Morris A. Fiaum
Norman H. Gahm
George O Gelinas
David M. Gershenson
V Philip Glassman
Nelson H. Goldberg
Issac Goldrich
William H. Greene
Williard F. Greenwald
Gordon W. Grundy
Joseph Guaraldo
William R Haas
Seymour Haber
Hedda Ann Litowitz Haning
Stanley Hersh
Thomas P Higgins
Melvin Horowitz
David Smith Hubbell
Eric A. Hyson
Robert Orville Jensen
Robert M. Johnston
Jill P. Karpel
Bernard L. Kaye
Michael W. Keith

Stephen King
Samuel C. Klagsbrun
Lawerence E. Klein
Thomas J. Koontz
Eugene Kuchner
Joel C. Labow
Sheri J. Lagin
Paul Julius Laube
Douglas M. Levin
Stanley B Levine
Peter G. Levinson
Arthur L. Levy
John D. Lewis
Genevieve Losonsky
Roderick Macdonald
Steven Macht
Kim Margolin
Stephen Mariam
Frank Masino
Richard J. Maunder
John P. McGovern
William W. Merrill
Paul R. Meyer
Patrick E. Moriarty
Dominic J. Nardi
Seymour Cy Nash
Richard A. Norton
Ruth Eiko Oda
Joseph Manuel Ortiz
Raymond L. Osborne
Robert L. Paltzik
Gordon K. Phillips
Donald C. Rankin
Gilbert A. Ratcliff
Ranjit Rath
Stephen Rawe
Thomas Rock
Claude Roge
William T. Rowe
Mark Rubenstein
Michael Saruk
Ronald Scarpinato
Anton Schittek
Susan Lynn Schley
Louis N. Scotti
Richard Alan Selzer
Howard Senter
Thomas E. Shaffer
Daniel W. Shapiro
Ezra A. Sharp
Vernon H. Sharp
Joel Silidker
Frederick N. Silverman
Paul 1. Silverstein
Ethan A H. Sims
Leon G. Smith
Richard 1. Staiman
John G. Steciw
Sturla Stefansson
Elsa L. Stone
Fred Leslie Strieker
Herbert Tabor
lmad F. Tabry
Jared R. Tinklenberg
Theodore Tyberg
Daniel W. Van Heeckeren
Douglas Viets
Romulo L. Villar
E. Maurice Wakeman
Thomas A. Warthin
Herbert Allan Wenner
George Wharton
Robert R White
Robert J, Williamson
Eiji Yanagisawa
Michael Yaros
Robert C. Young
Andrew Zaruski
Marvin Paul Zimmerman
Richard Walter Zimmerman
Lawrence H. Zingesser
Louis Zinterhofer

35

Contributors to the
Medical School Alumni
Fund 1983-84
Parents and Friends
Kurt I. Altman
Dr & Mrs. Dorrance 1 Anderson
Stanley August
Drs. John & Marie Babich
Hritos Bartzokis
Edwin Beall
Suzanne Berman
Hormoz K Broumand
Mr. & Mrs. Ormonde L Brown
Hariet F Brown *
Mr & Mrs. Richard S. Childs
Chin S. Chung
Evis J. Coda
Mr. & Mrs. Sidney J. Cohen
Willibald H Conzen
Daniel W De Renzi
Mr. & Mrs. Kenneth T. Doran
William C Drennan
Max Finkelman
Jose M. Garcia-Madrid
William J. German *
Mrs. Harold Grant
Myron Greengold
Barbara J Guillette
Kenneth H Gutner
Murray Halperin
Frederick W Heilman
Carl Hirshfield
Gloria F Holmes
Jordan L Holtzman
Harold Katz
Kenneth P Kinney
Boris Kliot
Joseph Litchman
Amy G. Lloyd
Shizuo Matsui
Mr. & Mrs. Victor M. Newman
William G. O'Donnell
Mary M. Olson
Louis H. Orkin
Samuel Perlman
Dr & Mrs Levi V. Perry
R Donald Reich
Barry D Reznik
Yolanda Rivero
Mr. & Mrs. Irving Rosenberg
Joel G Roth
Robert L. Rowley *
Mr & Mrs. Jack Saltz
Harold & Frances Sampson
Joseph Schlesinger
Melvin L. Schwartz
Arthur A. Shachner
Antonio Siu
Mr. & Mrs. Philip Soskis
Mark L. Sternlicht
Mrs. Leo Teitz
Thomas M Tierney
Pable Vazquez-Calcerra
Mr. & Mrs. Milton Weinberg
Jack Weingold
James Wells *
Tony Y. Wong
Rosalyn Yarmush
Mr & Mrs. Herman H Zusman

Contributors to the
Public Health Alumni
Fund 1983-84
Friends
John C. Bailar
Robert E. Brubaker
Mr. & Mrs Norman W. Lindsey
Deceased

PLEASE MARK YOUR
CALENDAR: The 1985
Medical School Alumni
Weekend and the 5-year
Class Reunions will be
held Friday, June 7
through Saturday, June 8.

Dear Fellow Alumni/ae:

Dear Alumni/ae:

1 am extending an invitation to alumni/ae across the country to
open their homes as hosts to Yale medical students who may be
visiting your communities for residency interviews during their
junior and senior years. The travel, bed and board costs for all
students have become formidable at a time when education
costs are approaching the outrageous. The student’s pause in
any city is rarely more than 24 hours.
As important as the economic advantage to the students, is
the opportunity for alumni to meet the current medical student
and to receive present perspectives of medical education at
Yale. The value to the student of counselling by graduates in the
“real world” is incalculable. Insights into the region you
practice in, specialty needs there (or lack of same); the
academic, social and cultural character of the community you
have been a part of, are obvious data to be communicated.
Please complete and return the form below if you could and
would like to participate in this effort. Further details will be
forthcoming upon receipt of your response.
Sincerely yours,

As you know, there is more to a residency program than
working 100 hours per week in a hospital. As Yale alumni no
longer practicing within the Yale community, you are a
valuable resource to current students attempting to evaluate
postgraduate programs in different regions of the country. As
host to a Yale student overnight, you would provide the student
with a broader perspective on residency programs in your area
(both medical and geographic). In return, you can expect to
meet some interesting people while learning about the changes
at Yale since your graduation. I hope you will choose to
participate in this network — it could make a big difference to
one of us.
Sincerely,

Nicholas P.R.Spinelli, M.D.,’44
President, Association of Yale Alumni in Medicine

Barry Weinstock
President, Medical Student Council

If you would like to participate in this effort, or would like more
information about it, please complete and return the form
below and return it to the Office of Student Affairs, Yale
School of Medicine, 333 Cedar Street, New Haven, CT 06510,
or call Howard Levitin, M.D., Dean of Students, (203)
785-2644.

Yes, I am willing to participate, and would like additional information about the program.

Name

Type of practice

YALE MEDICINE
P. O. Box 3333
333 Cedar Street
New Haven, Connecticut 06510
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A NEW ERA IN MEDICINE

CAMPAIGN FOR THE SCHOOL OF MEDICINE
—so far, gifts and commitments for the $125 million capital campaign total $32 million
by D. Helaine Patterson

T. CHARLES ERICKSON

Yale President A. Bartlett Giamatti, Dean Leon E. Rosenberg and
Dr. James G. Hirsch, chairman of the Campaign National Volunteer
Committee, announced the $ 125 million capital campaign for the
School of Medicine at a gala reception on May 28. Two weeks later,
they held a press conference to announce a gift of $8 million from
Betsey Cushing Whitney for a major addition to the Yale Medical
Library.

Students, physicians and scholars who use the Yale
Medical Library daily may be aware that Dr. Harvey
Cushing, the Sterling Professor of Neurology at Yale; Dr.
Arnold C. Klebs, a bibliographer and incunabulist who
lived in Basel, Switzerland; and Dr. John F. Fulton,
Sterling Professor of Physiology at Yale, spearheaded
efforts to establish the library that opened in 1941.
Today, the physician-triumvirate, who referred to
themselves as the Trinitarians, would be proud and
happy to know about the exciting plans to expand and
renovate the library
plans that will move this already
fine medical resource well into the 21st century.
Betsey Cushing Whitney of Manhasset, New York,
and her family have given $8 million to Yale University to
construct a major addition to the Yale Medical Library.
It is the largest single gift ever received by the medical
school.
Yale President A. Bartlett Giamatti announced the
Whitney gift shortly after the University launched a $ 125
million capital campaign to increase endowment and
meet research and program needs for the School of
Medicine. It is anticipated that the campaign will last five
years. Gifts and commitments, including that of the
Whitney family, now total $32 million.
President Giamatti said that Yale will name the library
the Harvey Cushing/John Hay Whitney Medical Library
to recognize two great names in the history of Yale and
medicine. They are, respectively Mrs. Whitney’s late
father and husband.
Dr. Harvey Cushing, an 1891 Yale College graduate
and internationally known neurosurgeon who taught at
Yale, collected the works of early anatomists and surgeons.
His collection forms the cornerstone of the School’s
historical library.
Dr. Cushing possessed a keen interest in books and
even mended volumes himself. He advocated locating the
medical library near the hospital because medical students
and interns had little leisure time to walk across town to
the University Library. He was a prolific writer, and his
diaries, correspondence and papers now fill his study
recreated in the medical historical library. In 1926, his
biography of Sir William Osier, a British physician,
earned him a Pulitzer Prize.
Dr. Cushing was married to Kate Crowell for more
than 30 years. She took a great interest in her husband’s
students and hosted teas for them at the medical school.
John Hay Whitney, a 1926 graduate of Yale College,
served as United States Ambassador to Great Britain
from 1957 to 1961. On his return from England, Mr.
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T CHARLES ERICKSON

Betsey Cushing Whitney's gift — the largest single gift ever made to
the Yale School of Medicine, will make possible the first major
e xpansion and renovation of the Yale Medical Library in 44 years.
Yale will name the library the Harvey Cushing I John Hay Whitney
Medical Library to recognize two great names in the history of Yale
and medicine. They are, respectively, Mrs. Whitney’s late father and
husband.

Bella Z. Berson, director of the Yale Medical Library, right, is
explaining the model of the Medical Library addition to Dr.
William Summers, professor of therapeutic radiology, molecular
biophysics and biochemistry and human genetics. Plans call for an
additional 20,000 net square feet — a 50 percent increase in space.

1 ii > of the first tower level. This zone of light, is the seam between
new structure and the old. It will create attractive places to read
and study.

Die Library will retain its Y-shape; however, the stem of the Y will
be widened to gain additional space for staff and reader services.
Entrance to the curved addition in the foreground will be through
the Cushing Rotunda.

Whitney became publisher and editor-in-chief of the New
York Herald Tribune and Chairman of its Paris-based
newspaper. The International Herald Tribune.
His philanthropy helped shape higher education in the
United States. In addition to substantial gifts to Yale,
through the John Hay Whitney Foundation which he
established in 1949, Mr. Whitney focused on the field of
education and on supporting individuals from minority
groups who sought to make educational, social and
economic changes in their communities. Mr. Whitney
served as a Fellow of the Yale Corporation from 1955 to
1970, and as Senior Fellow of the Corporation from 1970
to 1973. In 1977, the John Hay Whitney Professorship in
the Humanities at Yale was established.
“The magnificent gift of the Whitney family will help
ensure that the medical library will continue to serve the
scholarly needs of students, scholars and health profes¬
sionals at Yale and from all parts of the world,” said Mr.
Giamatti, who expressed the University’s profound appre¬
ciation to the Whitney family.
“With the explosion in biomedical information, the
library is a primary resource used daily in sustaining the
school’s high standards of quality to train physicians,
conduct research and provide patient care,’’the president
said.
In planning the project — the library’s first major
modification in 44 years — a task force of researchers,
physicians, librarians, information specialists and a devel¬
opment officer prepared a comprehensive plan to address
the library’s long-standing needs for additional space and
ways to improve information access. Bella Z. Berson,
associate University librarian and director of the Yale
Medical Library, chaired the task force.
“By expanding the medical library, we will address the
critical requirements for more space, and the program
also will incorporate new, innovative technology for
meeting the information needs of students, faculty,
researchers and clinicians,” Mrs. Berson said. “The
library today has become a center for information access
rather than simply a repository for information. In
addition to gathering and maintaining information, the
library also is faced with synthesizing the information,
and automatic tools will help this process,” she explained.
Computers will enhance the library’s traditional pro¬
gram and extend the collection beyond its books and
materials to include broader reference resources. In
addition, new technologies will be used to automate the
traditional library functions of acquisitions, cataloguing
and circulation.
“The expansion and renovation will enable the library
to bring books and readers together,” Mrs. Berson said.
Plans call for adding to and rearranging book stacks,
creating a new periodicals room for all current issues,
doubling seats in the reserve book room and enlarging
the information room to bring more of the reference
materials together and to accommodate computer termi¬
nals. A room where scholars can use the internationally
acclaimed history of medicine collection also will be
added.
The addition and renovation will provide 20,000 net
square feet of space for books and readers, a 50 percent
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increase in space. The library will retain its characteristic
Y-shape; however, the stem of the Y will be widened to
gain additional space for staff and reader services. The
curved addition will be tucked between the arms of the Y,
and visitors will enter it through the Cushing Rotunda.
Tightwells and skylights will connect the existing library
and the new addition, allowing light and spaciousness.
The architects are Alexander Purves and Allan J.
Dehar, both of New Haven. According to architect
Purves, the design lor the library expansion has “a dual
responsibility. On the one hand it must create urgently
needed space for the growth and consolidation of the
library’s collections and look forward to the most innova¬
tive technology in information retrieval.
“At the same time, the design must look back to the
traditional role of the library as a quiet place for reading
and reflection . . .The new expansion maintains the
architectural integrity of the older building while in¬
creasing its capacity in a form that supports and amplifies
the original design.”
Construction is expected to begin in the spring of 1986,
and the project is scheduled to be completed in 1988.
At the campaign kick-off on May 28, Dr. Teon E.
Rosenberg, dean of the School of Medicine, told faculty
and friends gathered in Freshmen Commons, “Our
School of Medicine is among the best anywhere. By many
different measures, the accomplishments of our faculty,
staff and students place us in a preeminent position in the
medical world. But this is not a time w hen any of us can
feel secure that the future of our school is assured.
“Competition from other institutions for human and
financial resources is keener than ever. Confusion about
the future of federal programs for biomedical research,
training and health care is greater than ever,” said Dr.
Rosenberg, a human genetics researcher and former
department chairman who became dean in July 1984.
“We can meet this competition and be insulated from
this confusion only if this capital campaign is a success,”
the dean added. “Funds generated by the captial campaign
will enable the School to advance its strong biomedical
programs.”
The medical school has launched the capital campaign
after a tw'o-year study by a faculty committee on the
future of medicine at Yale. This committee, chaired by
Dr. George Palade, Nobel laureate cell biologist, defined
broad areas of needs for the Yale School of Medicine to
advance biological knowledge and translate that know¬
ledge into preventive, diagnostic and therapeutic applica¬
tions.
Dr. James G. Hirsch, president of the Josiah Macy, Jr.
Foundation and successor trustee of the Yale Corporation,
heads the 13-member volunteer committee that will guide
the campaign. To raise this huge sum increasing the
school's security and flexibility in the biomedical sciences
is “a daunting challenge, but the cause is just, the
ment is firm, the plans and timetable are well
drawn. We shall succeed,” he said.
Dean Rosenberg chairs the 10-member faculty cornmit■>n the capital campaign. Sue B. Dorn, associate vice
! tor development and director of the medical
>! development office, directs the campaign.

During the next five years, the school will seek gift
support for the follow ing areas:
— $59 million for endowment, including $29.5 million in
unrestricted funds for the school’s activities; $22.5 million
for endowed professorships, and $7 million for endowed
fellowships.
— $33 million for biomedical research programs in gene
structure, molecular neurobiology, molecular oncology,
neuroendocrinology, immunobiology, neuropsychophar¬
macology, clinical pharmacology, parasitology and tropi¬
cal medicine, pediatric medicine, neurologic diseases and
toxicology.
“Special efforts will be directed at obtaining start-up
funds for Yale’s rapid entry into activities that promise an
important return in new knowledge and technologies that
will benefit all humanity,” Dr. Rosenberg said.
— $33 million for facilities and equipment, including
funds to build a Center for Molecular Medicine; funds to
expand and renovate the medical library, and to modern¬
ize laboratories and support facilities.

THE COMPLEAT CAMPAIGN
What’s a campaign without a button?
It’s unheard of nowadays.
So the Yale School of Medicine’s
development staff, triggered by an
article on a female cartoonist in a
student magazine. The New Journal,
enlisted the talents of artist and
humorist Sandra Boynton, the 1974
Yale graduate who draws greeting
cards.
“With the button, we wanted
everyone to join in the spirit of the
campaign and support it to the fullest
extent possible,” said Sue B. Dorn,
associate vice president for
development and director of medical
school development. Faculty
members, friends and guests who
attended the University-wide
campaign kick-off May 28 in the
Freshman Commons, received the
two- and -a half-inch button.
“We hope that the medical school’s
Capital Campaign will be just as
successful as Sandra Boynton's
career,” Mrs. Dorn said. —H P.

a history of

CHILD DEVELOPMENT AT YALE

In evaluating a child, trainees in the Child Study Center are taught to look for healthy behavioral skills as well as
developmental deficits.

I

by David F. Musto, M.D.

n the fall of 1911, the Dean of the Yale School
of Medicine, Dr. George Blumer, assigned to a new
faculty member one room, a table, and a chair in the
Hope Building to start a Juvenile Psycho-Clinic.
Here Dr. Arnold Gesell inaugurated at Yale services
for emotionally disturbed children, as well as research
into the normal development of children. Dr. Gesell’s
contributions would grow in significance and reputation
until the Yale Clinic of Child Development would
become known worldwide and its publications translated
into many languages even today.
In 1930, a wing was added to the medical school’s
building to house the many activities which had become
established during the past two decades. The Clinic of
Child Development flourished there, and the group was
made a department in the School of Medicine, the first
program in child development to receive that recognition
by any medical school.
The Child Study Center succeeded the Clinic of Child
Development upon the retirement of Dr. Gesell in 1948.
Located in the same quarters, but taking a more environ¬
mental and psychoanalytic approach to child develop¬
er. Musto is professor in the Child Study Center, psychiatry and the
history of medicine.

ment, the Child Study Center was established by Dr.
Milton J.E. Senn. Dr. Senn was succeeded as director by
Dr. Albert J. Solnit in 1966. The current director, Dr.
Donald J. Cohen, followed Dr. Solnit in 1983. Thus, in
the fall of 1986, clinical child development at Yale will
celebrate its 75th anniversary.
Prior to the Psycho-Clinic, New Haven was the site of
active work to improve the lot of the mentally ill and to
understand better the nature of mental illness. Clifford
Beers, a recent Yale graduate who had published a
moving account of his own mental illness, A Mind that
Found Itself (1908), established with the aid of prominent
local individuals the Connecticut Society for Mental
Hygiene, a group which would grow eventually into the
National and World Mental Health Associations. In New
Haven, Beers catalyzed a great deal of latent interest in
normal and deviant mental development and functioning.
Within a year of the publication of Beers’ book, the
National Committee for Mental Hygiene had been
established.
Dean Blumer accepted the chairmanship of the National
Committee for Mental Hygiene’s Executive Committee.
The head of Yale’s Sheffield School, Russell H. Chitten¬
den, chaired the Finance Committee, and the president
and secretary of Yale served on the National Committee,
5

Dr. Arnold Gesell, 1951 (courtesy Yale University Archives)
Formal child study at Yale began in 1911 under the leadership of
Dr. Arnold Gesell, who founded the Yale Clinic for Child
Development. The Clinic soon became known throughout the world
for its detailed observation of children at different stages of
development as well as for the innovative techniques, including
photographs and films, it used to record them. At a time when the
notion prevailed that environmental factors were solely responsible
for the way a child developed, Dr. Gesell and his colleagues were
able to present compelling evidence with their detailed
documentation, that the way a child developed was in large measure
a result of the pattern established by his or her biological
constitution.

his primary task the accurate description of these stages
of development. He differed radically from the behaviorist position of J.B. Watson, who saw the child as being
molded by life’s experience and the psychoanalytic view,
which combined the biological and experimental norma¬
tive developmental pattern with the therapeutic effects of
group and individual intervention.
With Dr. Gesell’s retirement in 1948, Yale considered
how best to continue a leadership role in child develop¬
ment and concluded to establish the Child Study Center.
Dr. Milton J.E. Senn of Cornell University, a nationally
prominent pediatrician with a psychoanalytic approach
to child development, was chosen to be the first director.
Dr. Senn expanded the training of psychiatrists and
pediatricians in child development, inaugurated longi¬
tudinal studies of young families, and brought to Yale a
series of investigators and teachers who would attain
leadership in their fields. Dr. Sally Provence began her
pioneering study of institutionalized children, and Drs.
Ernst and Marianne Kris joined Dr. Senn in organizing a
psychoanalytically oriented longitudinal study. Drs.
Provence, Samuel Ritvo and Albert Solnit played a
prominent role in the Yale Longitudinal Study and its
10-year followup.

along with James B. Angell, of the University of Michigan,
whose son was later to become Yale’s president. Thus,
when Gesell moved to New Haven, he joined a fostering
environment.

G

esell, while an assistant professor in the Department
of Education, enrolled in the Yale School of
Medicine and obtained his M.D. degree in
1915. He did this to gain “familiarity with the
physical basis and the physiological processes
of life and growth.” His life’s work would be to achieve
the goal expressed just before coming to Yale: “to make a
thorough-going study of the developmental stages of
childhood.”To accomplish this monumental task, Gesell
introduced the use of the motion picture camera in the
1920s, as well as still photography. He was able to map
the developmental stages and publish the results in
atlases of human behavior and development. His studies
on the normative development of children gave parents a
welcome guide to their own children’s progress.
He saw a child's development proceeding from the
pattern established by his or her biological constitution,
'he environment might assist or retard this development,
but the general trend was there to begin with. He saw as

Dr. Grover Powers, left, former chairman of the Department of
Pediatrics, who was known for his sensitivity to child development,
was chairman of the search committee that selected Dr. Milton
Senn, right, to succeed Dr. Gesell on his retirement in 1948. Under
Dr. Senn's guidance, the new unit, called the Yale Child Study
Center, became a model clinical facility which offered unique
opportunities for the teaching and training of students and
professionals.

provided by Dr. Melvin Lewis as editor of the Journal of
the American Academy of Child Psychiatry and Dr.
Solnit as managing editor of The Psychoanalytic Study
of the Child.
Through the teaching and research of many of its
faculty, the Child Study Center has gained recognition as
a Center at which child psychoanalysis has flourished at
the same time as more socially and biologically based
studies have been carried out effectively.

U
Dr. Albert J. Solnit. director of the Center from 1966 to 1983. has
collaborated with the late Dr. Anna Freud, left and Professor
Joseph Goldstein of the Yale Law School to provide important
guidelines, based on psychoanalysis, to assist professionals who are
charged with making difficult decisions about child placement and
custody. The results of their studies, published in two volumes,
Beyond the Best Interests of the Child and Before the Best Interests
of the Child, have generated controversy and discussion which have
helped establish better means to understand and protect the child’s
best interest and the family's integrity. With Drs. Freud and Solnit is
Dr. Julian Ferholt, associate clinical professor in the Child Study
Center, pediatrics and psychiatry.

W

hen Dr. Albert J. Solnit became director in
1966, the Child Study Center had a broad
program of child therapy, training of child
psychiatrists, and action research in the
primary settings in which children grow up,
including the family, pediatric settings, schools and child
care programs and institutions. Professor Edward Zigler,
first director of the Federal Office of Child Development,
has played a vital role in the sustained teaching and
research collaboration of the Child Study Center and the
Department of Psychology. Dr. Zigler, as a leading
scholar and champion of mentally retarded childen and
adults and as an academic leader in contributing to the
definition and improvement of an effective national
social policy for children, has played a vital role as a
senior faculty member of the Child Study Center.
Dr. James P. Comer began what would be a remarkable
demonstration that inner-city schools can revive and
tlourish. Yale law professor Joseph Cioldstein accepted a
joint appointment at the Child Study Center, establishing
links with the Law School which have led to a better
understanding of the best interests of the child and the
implications of custody for the child’s mental health.
Child Study Center faculty have reflected its leadership
role in scholarship and the dissemination of state-of-theart knowledge through publications in scholarly journals
and books as well as through the editorial leadership

nder the current director. Dr. Donald J.
Cohen, biochemical studies of childhood autism
and other serious afflictions of children have
greatly expanded, and a long-term goal of the
Child Study Center, an inpatient unit within
the Yale-New Haven Hospital, has become a reality.
The Center approaches the 75th anniversary of child
development studies at Yale with a range and depth of
research and teaching about children unparalleled in it
history. Major support for research and delivery of
services has been provided by individuals and foundations
—as well as by the Federal government
which made
possible an expansion of Child Study Center programs
and space. It also made possible vital collaborative
activities with the Departments of Pediatrics, Psychiatry
and Psychology such as the Children’s Clinical Research
Center in Child Development and the Bush Center in
Child Development and Social Policy, directed by Dr.
Zigler. These centers have improved the resources of the
Child Study Center in maintaining multidisciplinary
training and research programs that have gained national
and international recognition.

The present director is Dr. Donald J. Cohen, whose clinical and
laboratory research into the biochemical origins of childhood autism
and other major psychiatric disorders of childhood are widely
recognized. Under his leadership, and in collaboration with the YaleNew Haven Hospital, a new Child Psychiatry In-Patient Service will
open this summer as a national resource for the clinical investigation
and treatment of children from pre-school years through adolescence
with serious psychological disorders.
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over the last decade there has been encouraging progress in

TREATING DISORDERS OF BONES

by Marje Noyes

Many thousands of Americans of all ages are victims of skeletal disorders
as a result of injury or disease. Until quite recently, they had to struggle
with the pain and crippling effects of these disorders with little hope for
relief.
Without much fanfare, researchers have made considerable progress
during the last decade in understanding how bone is formed, and in
applying this important new knowledge to developing treatments for a
number of serious bone disorders. Scientists at Yale have made important
contributions in several areas to these advances.

M

usculoskeletal disorders represent one of the leading causes of
health-related expenditures in the United States — an estimated
$59 billion each year — second only to diseases of the circulatory
system. They rank highest among all disease categories when almost any
indicator of the quality of life is concerned; and for people in their
working years — ages 18 to 65. musculoskeletal conditions are the leading
cause of disability.
While these disorders have an effect on people of all ages, the impact on
the elderly population is especially severe. By far the most common and
devastating affliction of the skeletal system is osteoporosis.
An estimated 20,000 women die each year of complications caused by
postmenopausal osteoporosis — a condition of progressive bone loss.
Many are unaware they have the problem until they fall, often for no
apparent reason, fracturing a hip or their spine. As the expected life span
of the population increases, the problem is bound to become even more
prevalent.
Until recently, it was thought that once the initial rapid phase of
postmenopausal bone loss occurred, the condition was irreversible.
Research at Yale over the past ten years offers considerable evidence to
the contrary.
A number of theories had been advanced and discarded about the cause
of osteoporosis, when in 1964, several investigators noted that bone is a
very dynamic, constantly regenerating tissue: bone turnover, or remod¬
eling, follows a set pattern of resorption first, and then, new bone
formation. This information led to a better understanding of the cause of
osteoporosis — that is, a failure in the normal progression of the cycle
from a resorption to a formation phase, which results in net bone loss. At
about the same time, researchers also found that calcitonin, a naturally
occurring hormone, is a powerful inhibitor of bone resorption.
With this information, it was logical to assume that calcitonin therapy
would increase net bone formation in osteoporosis patients. Studies in
1971 proved to the contrary, that while calcitonin inhibits bone resorption,
it also blocks bone formation.

I

n 1974, Dr. Howard Rasmussen, professor of medicine and chief of
the Section of Endocrinology, and the late Dr. Phillipe Bordier of the
Hopital Lariboisiere in Paris, conducted one of the first demonstrations
that suggested the possibility that progressive bone loss in elderly women

can be reversed with medical therapy. Their hypothesis was to stimulate
bone resorption, and at the same time, shorten the duration of resorption
and allow formation to continue. The idea of stimulating resorption was
considered heretical at the time, according to Dr. Rasmussen.
He and his colleagues reasoned that, if its secretion was stimulated, the
parathyroid hormone — the one agent known to increase the rate of bone
remodeling
could play an important role in the treatment of
osteoporosis. By combining phosphate, which activates parathyroid
hormone secretion, with calcitonin, they aimed their research towards
minimizing bone resorption while maximizing bone reformation.
The results were encouraging. In a double blind pilot study of 26
women with osteoporosis who had experienced at least two major bone
fractures. Dr. Rasmussen and his colleagues were able to demonstrate
that the bone of elderly women is hormonally responsive and can, in fact,
be stimulated to new formation.
A second study, with modified calcitonin and phosphate therapy, was
done at Yale by Dr. Robert Lang, a colleague of Dr. Rasmussen. This
study showed that while the dense outer cortical bone responded
positively to the combined therapy, there was little or no regeneration of
the trabecular, inner spongy bone.
Loss to the cortical bone can lead to hip fracture; loss to the inner bone
can result in fracture of the spine.
Clearly, the researchers were on the right track — only further
refinements to the therapy were necessary.

drawing of different bones from Osteographia or ihe Anatomy
of the Bones by William Cheselden, c. 1753, courtesy Yale
Medical Historical Library
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or the past fifteen years, first in Paris, and since 1977 at Yale,
Dr. Roland Baron has been doing basic research on the cellular
basis of bone remodeling. With his colleagues. Dr. Agnes Vignery
and Dr. Mark Horowitz, he is recognized for important clinical work with
bone biopsies, as well as for advanced basic research leading to a better
understanding of the mechanisms involved in bone diseases.
Their research, supported by four grants from the N1H totalling about
$ 1 million for the next three years, seeks answers to such basic questions
as how do bone cells differentiate? What exactly is their function at each
stage of bone remodeling and how do they communicate with each other?
How does a site that has been resorbed know that it has to be repaired and
how does the precursor of the cell that is going to resorb the tissue know
where to go and how much to resorb? Why does it stop when the exact
amount has been resorbed?
“All clinical problems involving the skeleton, whether they are
endocrine-related, congenital or local problems such as arthritis or
periodontal disease, or metastatic lesions, are mediated through these
cells,” explained Dr. Baron. “If we understand how they work, we will
have a more precise basis for designing effective therapies for major bone
disease.”
Drs. Baron, Horowitz and Vignery are studying the interface between
bone and bone marrow. The precursors of bone cells, blood cells and cells
of the immune system are located in bone marrow. “It has been known for
a long time that wherever and whenever there is local inflammation, there
is bone destruction,” Dr. Baron said. “One or more components of the
inflammatory immune response has a side effect, which becomes, in fact,
the main clinical problem — the activation of bone resorption. We
became interested in trying to understand one aspect of the local
regulation of bone cells by observing activities of cells in the immune
system.”
An important part of their research has zeroed in on the osteoclast
activating factor (OAF), a lymphokine only recently associated with bone
resorption. They have made significant progress in understanding the

Paleopathologic specimens reveal that bone
loss has been a problem for aging women since
earliest times. The condition went virtually
unnoticed in medical accounts until the mid19th century, when physicians attributed the
fact that more women over 50 fractured their
hips and legs than did men the same age to the
long skirts women wore, which caused them to
trip and frequently fall. In (he last decade, new
knowledge about bone formation has ted to
research that may soon bring about vastly
improved treatment of degenerative bone
diseases such as menopausal osteoporosis.
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cellular mechanisms involved in its local secretion. “We have been able to
identify the cell that is responsible for OAF production — a helper T
lymphocyte — and to demonstrate that OAF is secreted in the same
manner as other lymphokines such as gamma interferon, but operates
differently from the other activators at the bone level,” said Dr. Baron.
The laboratory is now working on the purification of these products.
“These findings have important implications for all diseases where
there is local destruction of bone, including metastatic cancer in bone,
arthritis and periodontal disease,” explained Dr. Baron. “In fact, they
contribute significantly to the understanding of bone resorption and even
to skeletal development and bone transplantation.”

B

Born in Tunis in 1944, Dr. Roland
Baron was educated at the University of
Paris where he received a Baccalaureate
in experimental Sciences; a DDS, and a
Ph.D. in oral biology. Following an
academic career in oral biology in
Paris, he came to the Yale School of
Medicine in 1977 as an assistant
professor of pathology. In 1979, he was
appointed assistant professor of internal
medicine and cell biology, and in 1982,
he was promoted to associate professor
of medicine and cell biology.
He is intensely involved in research
into bone cell biology and the
pathophysiology and treatment of
skeletal diseases. Current projects in
which he and his colleagues are
involved include studies of bone cell
function and differentiation, the role of
the immune system in bone remodeling;
and the pathophysiology and treatment
of osteoporosis, osteopetrosis and of
renal osteodystrophy in children.
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ased on these findings, Dr. Robert Lang is conducting a study to
test a new therapy to increase bone mass in women with postmeno¬
pausal osteoporosis who have had bone fracture. This study,
funded by a $100,000 grant from the NIH, will refine previous studies by
Dr. Rasmussen and Dr. Lang, with the goal of increasing the regeneration
of not only the cortical bone, but of the trabecular bone as well.
“Basically, in this study, which like the earlier studies, involves combine
calcitonin and phosphate therapy for 12 months, we will increase the
frequency and amount of calcitonin dosage. Recent research has shown
that more frequent dosages are necessary to turn off bone resorption,”
explained Dr. Lang.
This study will be further enhanced by interpretation of bone biopsies
in Dr. Baron’s laboratory, where bone resorption and formation can be
measured, and by a new procedure using CT scanning to measure bone
density. Developed by Dr. Pamela Jensen, associate professor of
diagnostic radiology, the system enables investigators to note even very
subtle changes in bone mass, and has been extremely useful in following
the progress of therapy in osteoporosis patients.
The pilot study will also include nutritional counseling and an exercise
program of weight-bearing activities. “Diet and exercise are extremely
important factors in osteoporosis therapy,"said Dr. Lang. “Although we
were unable to prevent trabecular bone loss in our previous study, most of
the patients felt much better because they had been put on a diet and
exercise program which was clearly helpful, not only for strengthening
their muscles and bones, but also for their general well being. This is very I
important.”
Estrogen replacement therapy reduces the rapid loss of bone that
occurs at the onset of menopause, but it is of little or no therapeutic value
once osteoporosis is established. On the other hand, there are indications
that good nutritional habits, including a diet high in calcium and low in
animal protein, and regular exercise such as walking or bicycling, may
slow down, and perhaps even reverse the degenerative process.
“Most of the women we have seen in our studies have had very poor
nutritional habits and do very little in the way of exercise,” commented
Dr. Lang.
If the present pilot study with calcitonin and phosphate proves
successful in increasing bone formation in osteoporosis patients, the
research will also benefit patients with other disorders resulting in bone
loss, including renal diseases, primary biliary cirrhosis and other gastro¬
intestinal disorders. “We are very confident that within this decade we will
have a treatment for increasing bone formation,” predicted Dr. Lang. “If
we can achieve it in menopausal osteoporosis, there is every likelihood
that we can do it for other conditions as well, perhaps with slight
variations in therapy.”

M

any thousands of Americans of all ages are victims of skeletal
disorders as a result of injury or of diseases such as rheumatoid
arthritis or bone cancer. Until quite recently, treatment alterna¬
tives for the crippling effects of these disorders were limited in scope, and
provided little hope for relief.
Recent advances in orthopedic research and practice holds promise for
many of these patients. One of the most encouraging developments has
been progress in the transplantation of human bone to replace injured or
diseased segments of arms and legs.
The Yale School of Medicine is at the forefront in developing
techniques for the preservation and transplantation of major bones. The
Yale-New Haven Medical Center is among few centers in the country
which routinely bank and implant whole bones or large bone segments, as
well as smaller, but equally important bone grafts. One or two such
operations are performed here each month. About one-third are to
replace bone segments compromised by tumors; the balance involve
accident victims who have severely damaged a limb, and for patients
undergoing reconstruction as a result of arthritis.
Much of the research and its clinical application has been done by Dr.
Gary Friedlaender. As his titles indicates, he is a leading expert on tissue
transplantation, who neatly balances his activities in many of its issues.
He is deeply involved in research, some of which is in collaboration with
Dr. Roland Baron, to improve understanding of the biologic and
immunological aspects of bone transplantation, and in studies of the
effects of chemotherapy and radiation therapy on the skeleton; he is
responsible for the clinical care of orthopedic patients; and he is totally
committed to providing national resources for information and program¬
ming support of organ and tissue donation and transplantation.
“About 100,000 Americans require bone transplants each year, yet less
than five percent of these patients were able to benefit from the use of
banked bone last year because there weren’t enough replacement bones
available,” noted Dr. Friedlaender. Banked bone works well and avoids
sacrifice of normal bone in patients to provide graft material for another
site. Also, some people can’t donate their own bone graft because the size,
shape or quantity required is not available or is too large to take from their
own body. “There is a great need to communicate these facts to potential
donors and their families,” continued Dr. Friedlaender.

A

dvances in transplantation of bones began in the 1950’s, when it
was observed that bone allograft immunogenicity was reduced by
freezing. Both the clinical science and banking methodologies
required for transplantation of large bones have been substantially
improved since then, reflecting to a large extent new knowledge of bone
graft biology, cryopreservation techniques, immunobiology and critical
analysis for factors contributing to clinical results.
While amputation of an arm or leg is devastating for persons of any age,
it is particularly tragic for young people. This is one reason why progress
in bone transplantation is so important.
Metallic and plastic implants to replace arthritic or fractured hips have
been used with some success for several years, but implants of these
materials to replace large segments of bones of the leg have proven less
than satisfactory because they are not stable and are increasingly prone to
loosening, as well as to failure of materials after a time. Furthermore, they
are especially vulnerable in the rough and tumble life typical of a
youngster.

Dr. Robert Lang, associate professor of
medicine, has been involved in
osteoporosis studies ever since he came
to Yale in 1976 as assistant professor of
medicine. A graduate of Rutgers
College, he received his M.D. degree
from Albany Medical College and
completed his internship and residency
in medicine at the Hospital of the
University of Pennsylvania. From 1971
to 1973, he was a NIAMDD trainee in
metabolism at Washington University
School of Medicine.
In addition to his work in
osteoporosis, he has done extensive
research on the diagnosis and treatment
of Paget’s disease — a disorder
characterized by abnormal increase in
bone resorption followed by rapid and
disordered bone formation. He is also
involved in metabolic studies of renal
stones, as well as in studies of the
effects of exercise on the endocrine and
skeletal systems of women athletes.

Dr. Gary E. Friedlaender, professor of
surgery (orthopedics), is chief of the
Section of Orthopedic Surgery, director
of the Orthopedic Oncology and
Transplantation Immunobiology
Laboratory and founder and director of
the Bone Bank at Yale. In addition, he
is a founder and immediate pastpresident of the American Council of
Transplantation (ACT)— a centralized
national resource for information and
programming support on organ and
tissue donation and transplantation. He
is also president of the American
Association of Tissue Banks.
A graduate of the University of
Michigan, he received an M.D. from
the University’s School of Medicine in
1969. He first came to Yale in 1971 as
an NIH postdoctoral research fellow in
surgery, oncology and immunology, as
well as a resident in orthopedic surgery.
It was here that he first became
interested in bone transplantation. In
1982, he received the Kappa Delta
Award for Outstanding Orthopaedic
Research from the American Academy
of Orthopaedic Surgeons and the
Orthopaedic Research Society.

When feasible, bone autografts — replacement with segments of the
patient’s own bone — make the most viable and successful transplants,
but the supply is necessarily limited. An alternative, under ongoing
investigation by Dr. Friedlaender and his colleagues is that of the
cadaveric allograft, which is replaced by host bone over a period of time.
Virtually any bone suited to clinical application can be removed from
cadavers, but generally, the long bones of the extremities, the pelvis, and
the ribs are the most useful for this procedure.
Effective bone banking is of the essence to the success of these
transplants. “In order to support the challenging and innovative contem¬
porary approaches to limb sparing reconstructive surgery, as well as the
need for bone grafts used to treat a wide variety of traumatic, degenerative
and benign neoplastic skeletal disorders, it is necessary to establish a safe
and effective source for allogeneic tissue,’’commented Dr. Friedlaender, a
crusader for a systematic approach to donor selection, tissue removal and
preservation methodology.
Unlike organs which must be removed and transplanted almost
immediately following death, bones and other tissues may be removed as
long as 24 hours later, and stored for five years. At Yale, they are removed
under sterile operating conditions, cleaned of muscle and dipped in
gylcerol of dimethyl sulfoxide for cryoprotection before being placed in a
plastic bag and wrapped in sterile cloth. They are stored in a freezer at -70
degrees Fahrenheit until required for transplantation. Each specimen is
x-rayed to record its size and anatomical shape.
When bone grafts are not reconnected to a blood supply immediately,
they are subjected to a complex process of revascularization and
replacement known as “creeping substitution” — a predictable sequence
of events including cell necrosis, revascularization, resorption and
eventually, replacement. In bone graft procedures, the replacement bone
segment is fitted in between undamaged existing bone. Once in place, the
graft is invaded by blood vessels from the host site. This new blood supply
carries the primitive mesenchyal cells of recipient site origin that
differentiate into bone resorption and bone remodelling cells.
Initially, the bone becomes weaker than the original, but within
months, it begins to strengthen and to build new bone from the old.
Within five to ten years, the body will replace most of the donated bone
with its own, a process identical to the replacement of bone which
normally occurs.

D

r. Friedlaender has trained with and collaborated for several years
with researchers in the Orthopedic Oncology Unit at Massachu¬
setts General Hospital in clinical studies of allograft transplanta¬
tions
mostly for malignant or aggressive tumors. That group now has
experience with 300 major transplants in patients who are from 11 to 69
years old.
The types of graft procedures included osteoarticular, in which an
articular joint was included with the bony replacement part (the majority
of transplantations); intercalary, in which the grait consisted only of a
portion of the shaft of a long bone; and allograft, in combination with a
joint prosthesis (most of these have been used for hip joint replacement).
All of the patients have been carefully followed and to date none has
shown what could be interpreted as a “rejection”. Furthermore, data
suggest that the graft is incorporated and slowly replaced by the host after
an initial period and that the prognosis for long retention and tunction of
the implanted segment is reasonable, providing there are not problems of

drawing of the six lowest ribs with 6th and 7th vertebra of back
from the Anatomy of the Bones by William Cheselden, c. 1753,
courtesy Yale Medical Historical Library

The idea of transplantation of bones may have
originated when, according to the Bible, a rib
was removed from Adam to create Eve. There
are numerous other references in literature and
art to allogeneic and xenogeneic hybrids,
including the canvasses of the 15th century
masters, Fra Angelico and Bellini, showing
Cosmos and Damian, the patron saints of
medicine replacing the diseased leg of a light¬
skinned patient with that of a Moor.
Today, through clinical and laboratory
research at institutions including Vale, bone
allografts are becoming an increasingly viable
treatment for a number of bone disorders.

infection or fracture early on.
“We aren’t there yet. The system needs further study — but clearly,
these early results suggest that continued research is definitely warranted,”
said Dr. Friedlaender, who is principal investigator of a national, multiinstitutional study of bone graft biology, banking immunology and
clinical results. A major portion of the project will be to correlate the
long-term follow-up clinical, x-ray and histological data with an assess¬
ment of humoral evidence of the immune response. It is hoped that these
data will provide a means of selection of the best graft for each patient.
“This may be the key to avoiding failures we now naively attribute to the
immune reaction,“ explained Dr. Friedlaender.
In summing up the work to date. Dr. Friedlaender emphasized the
tremendous need to educate both physicians and the public to the need for
donor tissue and organs. “With all of the advances in surgery, in drugs
that reduce rejection and in the biological understanding of transplanta¬
tion, we’re getting to be in an increasingly better position to do more and
more transplants. So, the current shortage of organ and tissues will
become severe in the future,” concluded Dr. Friedlaender.
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MORE THAN ONE MISSION
Dr. Curtis L. Patton, Professor of Epidemiology (Microbiology)

by Marje Noyes with Charles Eguagu
Sitting in his office, which is absolutely packed with
photographs and travel posters, and stacks of journals
and papers piled precariously high. Dr. Curtis Patton
discussed his career. It didn't take long for a visitor to
figure out that, early on, he had carefully charted his
course to accomodate a commitment to encourage
young minority students to enter careers in science, along
with his own strong attraction to research and teaching.
A man of many interests and talents. Dr. Patton is first
and foremost an established parasitologist who has
provided important new' insights into the biology of
African trypanosomes. He is as well, a distinguished
educator who, in the words of a former postdoctoral
student, is as committed to leading his students into
unique career opportunities as he is to the advancement
of tropical medicine. “It was a pleasure to study with
him,” said Dr. Larry Ruben.
Dr. Patton grew up in Birmingham, Alabama in a very
supportive environment. His father, the principal of a
local high school, and his mother, a music teacher,
encouraged his curiosity, and by so doing had a profound
influence on his educational and career decisions. He was
a good student, who admits to occasional minor mischief
along the way, and who graduated with honors from high
school.
At Fisk University, “the going was a lot rougher,” he
recalled. A small, private, predominantly Black liberal
arts school in Tennessee, Fisk provided extraordinary
opportunities for scholarship as well as for leadership. It
was later, though, as a graduate student at Michigan
State University (where he received an M.S. degree in
1961 and a Ph.D. degree in 1966), that Dr. Patton first
became interested in parasitology. This interest was
furthered at Rockefeller University, where as a guest
investigator and Fellow from 1967 to 1970. he was
exposed to the work of unusually talented scientists and
other resources in biomedical research.
“Yale offered an opportunity to continue some aspects
of this experience,” he said, “and 1 was excited about the
prospects of continuing my work here.”
Soon after his appointment as assistant professor of
microbiology in 1970, Dr. Patton received a U.S. Public
Health Service Career Development Award which offered
a tempting opportunity to be rid of administrative and
teaching responsibilities to devote full time to his research.
But, it didn't work out quite that way.
“At the time, I was one of a very few Black faculty in
the University. I felt an obligation and responsibility to
een as a teacher as well as a researcher,” he explained,
sides, I really enjoy teaching. Having bright, energetic
iplc around, who may be naive about some of the

As much of Dr. Patton’s teaching takes place in his
laboratory as it does in classrooms and lecture halls.
Above, he is conferring with, from left to right, Henry
Rice, a second year medical student; Rollin Johnson, a
doctoral student at Cambridge University, England;
Sharon Usip, a research assistant; Sarah Schleck, a
Ph. D. student; and Charles Eguagu, a Ph. D. student.

problems you are most concerned with, provides an
opportunity for looking at things in a very different way.”
By teaching, he could also advance the cause for
parasitology. “It is difficult to believe now
when so
much attention is being paid to tropical medicine at all
levels
but when I first came to Yale, the field was not
regarded as either important or very interesting to many
of the leading biomedical scientists,” explained Dr.
Patton. For several years, as the only parasitologist in the
entire University, he taught undergraduates as well as
medical and public health students. (There are now three
research groups studying parasitic organisms in the
Department of Epidemiology and Public Health, and
five others in the Departments of Medicine and Pharma¬
cology, as well as groups elsewhere in the University.)
Today, much of his teaching takes place in his labora¬
tory on the eighth floor of the Laboratory of Epidemiology
and Public Health, where studies on the cellular and
molecular biology of African trypanosomes are focused
on antigens that may be of importance in immune
responses as well as to regulatory problems.
“When an organism lives on or in another organism, it

been influential in attracting a large number of minorities
to the sciences.
In seeking a career in science, Dr. Patton believes one
has to be driven, but not necessarily obsessed with the
notion that it is important to make a contribution to
science and perhaps, indirectly, to the nation and the
world.
“Those of us who are driven probably find it most
satisfactory to be in a place like Yale, which is an exciting
environment for scientific pursuits,” he concluded.

WILLIAM CARTER

has to figure out how to get what it needs for its own
well-being without being destroyed by its host," explained
Dr. Patton. “We have the feeling that the interface
between the membrane of the parasite and its host is most
important in the host-parasite complex. To exist, the
parasite must remove its life sustaining substances across
the host membrane and across its own membrane into its
body or cell — and it has to do this very skillfully, because
the parasite membrane is also the site where host immune
responses are most effective."
In their research. Dr. Patton and his colleagues have
isolated and characterized a calcium-binding protein,
calmodulin, in trypanosomes. Similar to protein found in
the host, calmodulin is present in all eukaryotic cells and
is highly conserved throughout evolution. Although
trypanosome calmodulin exhibits a high degree of amino
acid sequence homology with the host protein, it is
sufficiently different to be termed “unique”. Current
evidence suggests that specific residues interact with
receptor proteins and drugs. Some of these may be
unique for trypanosomes, and thus useful in the develop¬
ment of novel, trypanosome-specific chemotherapies.
This research recently received major grant support from
the National Institutes of Health.
In addition to being able to contribute new knowledge
to the understanding of the immune responses and
regulatory problems, there is the very real satisfaction of
contributing basic knowledge which may eventually lead
to the control of diseases which have for years devastated
Third World populations. Trypanosomes, for instance,
cause African sleeping sickness in humans, and in
animals, they cause ngana, a disease which has all but
eradicated cattle farming in many parts of Africa.
“As important as these organisms are as research tools,
from a humanistic view, they are even more important as
agents of suffering, and they deserve intense study for this
reason as well,” said Dr. Patton.
Because of his reputation as an outstanding Yale
scientist and educator. Dr. Patton has been asked to
participate on perhaps more than his share of committees
and review boards — especially those involved with
minority students. Although time consuming, he regards
these activities as stimulating and necessary.
“There is a notion that Black students are not tradi¬
tionally interested in careers in science. The very first
Black to receive a Ph.D. in the United States, Eduard
Alexander Bouchet, received that degree in physics from
Yale, when no more than a dozen Ph.D.’s had been
awarded in the country — in the sciences or any other
field for that matter,” said Dr. Patton. “Unfortunately,
the percentage of Blacks in the sciences today is very
low.”
Taking a leadership role in trying to increase this
percentage, he serves on committees at Yale as well as of
the National Research Council and the National Institutes
of Health. One of the most important of these is the NIH
Committee for Minority Access for Research Careers, of
which he was chairman. This committee, which spent
considerable time visiting colleges and research institu¬
tions, reviewing curricula and the preparation necessary
for developing careers in the biomedical sciences, has

Although he claims he no longer is a “Champion on
the squash and racquet ball courts ”, a pair of racquets
are ready for action in a corner of Dr. Patton's office.
And, by all accounts, he is an accomplished musician
playing jazz as well as classical on the piano, clarinet
and recorder. “After all, ” he quipped, “the son of a
music teacher is simply not allowed not to play
something. ” He also confesses he pretends he is writing
the great American novel. “But 1 read the Book Review
Section of The New York Times more than I write. I
doubt very seriously that I'll ever appear on those
pages. "And, in a rare moment, he relaxes in the
garden of the Patton home with his daughter Lynne
and wife Barbara, whom he met when they both were
graduate students at Michigan State University.
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NOTED NEUROSCIENTIST
IS APPOINTED TO
RESEARCH CHAIR
Dr. George K. Aghajanian has been
appointed Foundations Fund for Re¬
search in Psychiatry Professor. A neuro¬
psychopharmacologist widely recog¬
nized for his studies on the effects of
psychoactive drugs on the mammalian
brain. Dr. Aghajanian has been profes¬
sor of psychiatry and pharmacology
since 1974.
Born in Beirut, Lebanon, Dr. Agha¬
janian has been at the Yale School of
Medicine almost continuously since his
graduation from Cornell University in
1954; first as a medical student in the
Class of 1958, then as an intern in the
Department of Internal Medicine, and
from 1959 to 1963, as a resident and
postdoctoral fellow in the Department
of Psychiatry. Following two years in
the U.S. Army Medical Corps, Dr.
Aghajanian returned to Yale as assis¬
tant professor in the Department of
Psychiatry. He was promoted to associ¬
ate professor in 1968, and named associ¬
ate professor of psychiatry and pharma¬
cology in 1970.
A recipient of the Efron Award of
the American College of Neuropsycho¬
pharmacology in 1975, Dr. Aghajanian
received the Scheele Medal and was
co-winner of the Foundations Fund
Research Prize, both in 1981. He is a
member of a number of professional
societies including the American Society
for Pharmacology and Experimental
Therapeutics, the Psychiatric Research
Society and the Neurochemistry So¬
ciety. A fellow of the American College
of Neuropsychopharmacology, he is
also a member of the International
Brain Research Organization.

DR. HOLMES APPOINTED
TO CHAIR
Dr. Frederic L. Holmes has been named
Avalon Foundation Professor of the
History of Medicine. Dr. Holmes is
internationally recognized as a leading
scholar in the history of medicine and
science, particularly in the fields of
physiology and chemistry. He has been
professor and chairman of the Section
of the History of Medicine since it was
established in 1977.
A graduate of the Massachusetts
Institute of Technology, Dr. Holmes
received an M.A. degree in history and
a Ph.D. degree in the history of science
from Harvard University. While at
Harvard, he received the Schumann

Prize of the History of Science Society,
which later also awarded him the Pfizer
Prize. In 1978, the American Associa¬
tion for the History of Medicine pre¬
sented Dr. Holmes the William H.
Welch Medal. He is the author of

Claude Bernard and Animal Chemistry
(Harvard University Press, 1974), and
numerous articles on the history of
medicine.
The Avalon Foundation Professor¬
ship was established in 1962. The late
Dr. Derek deSolla Price was the first
and only incumbent prior to Dr.
Holmes’ appointment.

DIRECTOR OF GRANTS
AND CONTRACTS
APPOINTED
Dr. Halvor G. Aaslestad has been
appointed director of the Office of
Grants and Contracts at the School of
Medicine. An accomplished administra¬
tor with academic and scientific experi¬
ence as well. Dr. Aaslestad had been
chief of the Biological Sciences Review
Section, Referral and Review Branch
of the Division of Research Grants at
the National Institutes of Health, prior
to his appointment.
A graduate of Louisiana State Univer¬
sity, Dr. Aaslestad received an M.S.
degree from Pennsylvania State Univer¬
sity and a Ph. D. degree from Louisiana
State University, both in microbiology.
He was a postdoctoral fellow at the
U.S. Army Biological Laboratories
from 1965 to 1968, when he was ap¬
pointed assistant professor of microbio¬
logy at the University of Georgia. From
1973 to 1976, he was senior scientist in
primate virology and special projects at
the Frederick Cancer Research Institute,
Frederick, Maryland.
In 1976, Dr. Aaslestad was appointed
executive secretary of a Special Study
Section of the National Institutes of
Health, and in 1981, he was named
chief of the Biological Sciences Review
Section of the Scientific
Review
Branch of NIH, a post he held until
1984.
Dr. Aaslestad, who received the NIH
Quality Increase Award in 1980, is a
member of the American Society for
Microbiology, Sigma Xi, and the Na¬
tional Council of University Research
Administrators. As director of Grants
and Contracts Administration at the
School of Medicine, he succeeds Francis
L. Crowley, who resigned in January
after twelve years to assume a position
in the private sector.

ASSOCIATE DEAN FOR
MEDICAL EDUCATION
AND STUDENT AFFAIRS
IS NAMED
Dr. Robert H. Gifford, professor of
medicine, has been appointed associate
dean for medical education and student
affairs, effective July 1, 1985. Chief of
Medical Service at the West Haven
Veterans Administration Medical Cen¬
ter, Dr. Gifford is well known as an
outstanding teacher.
A graduate of Ohio Wesleyan Univer¬
sity, Dr. Gifford received his M.D.
degree cum laudefrom Tufts University.
Prior to coming to Yale-New Haven
Medical Center in 1966 as a resident in
medicine, he was director of medical
programs in Bogota, Columbia for
three years for the Peace Corps. He was
appointed assistant professor of medi¬
cine in 1969, and promoted to associate
professor of clinical medicine in 1972,
and professor in 1976. Active on a
number of committees in the School,
including the Standing Committee on
the Status of Women, he organized the
Clinical Correlations course for firstand second-year students.
As associate dean for student affairs.
Dr. Gifford succeeds Dr. Howard Levi¬
tin, who has held that post since 1966.
Dr. Levitin, who is professor of medi¬
cine, plans to continue his research in
nephrology and teaching in medicine.

DR. GENEL TO DIRECT
OFFICE OF GOVERNMENT
AND COMMUNITY
AFFAIRS
Dean Leon E. Rosenberg has an¬
nounced the appointment of Dr. Myron
Genel as associate dean for govern
mentand community affairs, effective
July 1. Dr. Genel is professor of pedia¬
trics and program director of the Child¬
ren’s Clinical Research Center, as well
as an authority on pediatric endocrinol¬
ogy and metabolism.
In 1982, Dr. Genel was awarded a
Robert Wood Johnson Health Policy
Fellowship in the Institute of Medicine,
National Academy of Sciences. As¬
signed to the Investigations and Over¬
sight Subcommittee of the House of
Representatives Committee on Science
and Technology, he was largely respon¬
sible for organizing the committee’s
Congressional hearings on organ trans¬
plantation. As a result, he was involved
in the drafting of corrective legislation
which culminated in the introduction
of a National Organ Transplant Act.
A graduate of Moravian College,

Bethlehem, Pennsylvania, Dr. Genel
received his M.D. degree from the
University of Pennsylvania in 1961. He
had been a member of the faculty of the
University of Pennsylvania School of
Medicine prior to his appointment to
the Yale medical faculty in 1971 as
assistant professor of pediatrics, as well
as program director of the Childrens’
Research Center and director of pedia¬
tric endocrinology. He was promoted
to associate professor in 1976, and was
named professor of pediatrics in 1981.
A member of a number of profes¬
sional societies including the American
Association for the Advancement of
Science, the American Academy of
Pediatrics, and the American Diabetes
Association, Dr. Genel served as presi¬
dent of the Association of Program
Directors of the General Clinical Re¬
search Centers of the N1H in 1981-82.
In 1979, he was presented the Annual
Award of the Connecticut Campaign
Against Cooley’s Anemia, and was co¬
recipient of The Jonathan May Award
of the American Diabetes Association
— Connecticut Affiliate.
As associate dean for government
and community affairs. Dr. Genel suc¬
ceeds Louis J. Kaplan, who retired in
March after serving in that office for 18
years.

DIRECTOR IS APPOINTED
FOR ALUMNI AFFAIRS
Dean Leon E. Rosenberg has appointed
Dr. Nicholas P.R. Spinelli director of
Alumni Affairs for the School of Medi¬
cine. Well known to alumni for his
enthusiastic support of the school and
participation in many alumni activities.
Dr. Spinelli is an associate clinical
professor of medicine in the Department
of Internal Medicine, as well as pres¬
ident of the Executive Committee of
the Association of Yale Alumni in
Medicine.
A graduate of Yale University, where
he received a B.S. degree with high
honors in 1941, Dr. Spinelli received
his M.D. degree cum laude from the
School of Medicine in 1944. During his
academic career he was elected to Phi
Beta Kappa, Sigma Xi and Alpha
Omega Alpha honor societies.
Following internship at Bridgeport
Hospital, he served as a neuropsychi¬
atrist in the military service from 1945
to 1947. On completion of his residency
in internal medicine at the Veterans
Administration Hospital in Newington,
Connecticut, Dr. Spinelli entered pri¬
vate practice of internal medicine in

Miss Patterson

Dr. Spinelli

Stratford. He has been senior attending
physician since 1950, and director of
medical education since 1960 at Bridge¬
port Hospital. In 1950, he was appointed
clinical instructor in medicine in the
School of Medicine, and was promoted
to associate clinical professor in 1978.
As an alumnus of the School, Dr.
Spinelli has served on the Executive
Committee of the Association of Yale
Alumni in Medicine since 1970, and
was vice president from 1977 until his
election in 1981 as president. He has
also been involved in the Yale Medical
School Alumni Fund, as Class of 1944
agent since 1950.

DIRECTOR APPOINTED
FOR PUBLIC
INFORMATION
D. Helaine Patterson has been ap¬
pointed director of the Office of Public
Information of the School of Medicine,
effective March 18. As director. Miss
Patterson will coordinate and expand
the public information program of the
School involving the news media and
publications.
Prior to her appointment, she had
been director of Medical Center Infor¬
mation Services at the University of
Virginia Medical Center. From 1975 to
1979, she served as director of University
Information Services. She began her
career as a general assignment reporter,
then copy editor of the Free Lance Star in Fredericksburg, Virginia.
A graduate of Mary Washington
College of the University of Virginia,
Miss Patterson received an M.A. degree
in public affairs journalism from Ameri¬
can University in 1974. She is a member
of the Board of Directors for Camp
Holiday Trails, a national, non-profit
summer camp in Charlottesville, Vir¬
ginia for children with special medical
needs.
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DEAN AND CHAIRMAN
OF NEUROANATOMY
ELECTED TO NAS

Dr. Rosenberg

Dr. Malawista

Dr. Stevens

Dr. Sieere

Dr. Shepherd

Dr. Tsien

At its 122nd annual meeting in April
the National Academy of Sciences an¬
nounced the election of 60 new mem¬
bers, including Dr. Leon E. Rosenberg,
dean of the School and C.N.H.Long
Professor of Human Genetics, and Dr.
Pasko Rakic, Dorys McConnell Duberg
Professor and chairman of the Section
of Neuroanatomy. They were elected
to the nation’s most distinguished organ¬
ization of scientists and engineers in
recognition of their outstanding achieve¬
ments in original research.
One of the nation’s leading geneticists.
Dr. Rosenberg is known for his work in
clinical genetics as well as for his contri¬
butions to new knowledge in inherited
metabolic disorders. He helped establish
the Department of Human Genetics
and was its chairman from the time of
its founding in 1972 until his appoint¬
ment as dean of the School in 1984.
An alumnus of the University of
Wisconsin where he received both a
B.A. and an M.D. degree summa cum
laude, he was awarded a Guggenheim
Foundation Fellowship in 1972, and
the following year the American Aca¬
demy of Pediatrics presented him the
Borden Award for outstanding achieve¬
ments in research relating to infant
nutrition and development of children.
In 1982, the University of Wisconsin
School of Medicine awarded him its
Distinguished Alumni Citation, and
that same year, he was elected to the
Institute of Medicine of the NAS.
Dr. Rakic is an internationally recog¬
nized leader in research on brain develop¬
ment. Although his research covers a
broad range of developmental neuro¬
biology, he is best known for his investi¬
gation of the development of neuronal
maturation, as well as for research on
the development of the visual system
and cerebellum in primates. His work
has important implications for studies
of the interaction of genetic and environ¬
mental factors governing human behav¬
ior and intelligence, as well as for
understanding human disease.
Born and educated in Yugoslavia,
Dr. Rakic came to Yale in 1978 from
Harvard, where he had been on the
faculty since 1972. He was one of the
f irst scientists to receive a Javits Neuro¬
science Award for distinguished contri¬
butions in the field of neurological and
communicative disorders.
The election of Dean Rosenberg and
Dr. Rakic brings to 19 the number of
distiguished Yale medical faculty in the
1,453-member NAS.

TWO ON FACULTY
AWARDED PRESTIGIOUS
RHEUMATISM AWARD
The Ciba-Geigy-ILAR Rheumatism
Prize, considered one of the most pres¬
tigious awards given for arthritis re¬
search, has been presented to Dr. Allen
C. Steereand Dr. Stephen E. Malawista
for their research on Lyme disease. The
award, which is presented every four
years, was presented to Drs. Steere and
Malawista at the opening session of the
X Vlth International Congresss of Rheu¬
matology in Sidney, Australia.
Dr. Steere is associate professor of
medicine and Dr. Malawista is professor
of medicine and chief of the Section of
Rheumatology in the Department of
Internal Medicine. Theircontributions
are considered unique since they not
only identified Lyme disease as a specific
disorder, but also demonstrated the
organism responsible for it, and the
vector that carries it. In addition, they
alerted the medical community to ef¬
fective courses of treatment. Their inves¬
tigations may advance the understand¬
ing of other forms of rheumatic disease.
“Dr. Steere and Dr. Malawista must
be congratulated on a truly magnificent
piece of medical detective work,” noted
Dr. George E. Ehrlich, vice president
of development, Ciba-Geigy Pharmaceu¬
ticals. “There are few examples in
modern times of a single team accom¬
plishing so much in such an elegant
way.”
Lyme disease, a complex, multi-sys¬
tem infection, was first identified in
1975 in Lyme, Connecticut by a team
headed by Drs. Steere and Malawista.
In the past few years, thousands of
cases have been reported in 14 states,
particularly in the northeast, midwest
and California.
The award, sponsored by the CibaGeigy Pharmaceutical Corporation of
Summit, New Jersey, and the Interna¬
tional League Against Rheumatism,
includes a prize of $27,000.

DRS. STEVENS AND
SHEPHERD RECEIVE
JAVITS AWARDS

DR. TSIEN RECEIVES
AWARDS FOR HEART
RESEARCH

In recognition of their outstanding
research contributions to the neuro¬
sciences, Dr. Charles Stevens and Dr.
Gordon Shepherd have received 1985
davits Neuroscience Investigator
Awards of the Nl H.
Dr. Stevens, professor ol molecular
neurobiology and physiology and chair¬
man of the Section of Molecular Neuro¬
biology, is widely recognized as one of
the pioneers in the application of molecu¬
lar techniques to the study of the
human brain. He received a davits
Award of almost $ 1.3 million in support
of his studies aimed at discovering how
the brain's electrical activity
nerve
impulses and synaptic transmission
arises through the operation of special
proteins in nerve cells called “channels”.
This research should ultimately lead to
a better understanding of the actions of
drugs that affect the brain, such as
tranquillizers and antidepressants.
Dr. Shepherd is professor of neuro¬
science in the Section of Neuroanatomy.
The author of two acclaimed texts.
Neurobiology and The Synaptic Organi¬
zation of the Brain, both published by
Oxford University Press, he is well
known for his studies on the structure
and function of nervous tissue.
He received a davits Award of almost
$1.3 million in support of his research
on the synaptic organization of the
brain, using the vertebrate olfactory
system as a model. The long-term ob¬
jective of these studies is to elucidate
the structure and function of local
circuits within the cortical regions of
the vertebrate central nervous system.
The results should provide a much
clearer understanding of neuronal struc¬
ture-function relations within different
cortical regions of the nervous system
and provide insight into normal func¬
tions of microcircuits within the central
nervous system, and abnormal functions
related to epilepsy, schizophrenia and
Alzheimer’s dementia.
Drs. Stevens and Shepherd are the
seventh and eighth members of the
Yale faculty to receive these special
awards honoring Senator dacob K.
davits of New York. The N1H have
designated the awards for investigators
submitting regular research grant appli¬
cations for competitive review, who
have a distinguished record of substan¬
tial contributions in some field of neuro¬
logical or communicative science and
who can be expected to be highly
productive over the next seven years.

Research on calcium channels and their
role in the function of heart cells and
neurons by Dr. Richard Tsien, professor
of physiology, and his colleagues has
recently been recognized by two distin¬
guished professional societies. The Inter¬
national Society for Heart Research
has awarded Dr. Tsien its 1984/1985
dournal of Molecular and Cellular Car¬
diology Award for outstanding research,
and The Biophysical Society presented
him the 1985 Kenneth S. Cole Memorial
Award.
Dr. Tsien is well known for his
studies of calcium channels and their
response to drugs that have important
therapeutic effects on the cardiovascular
system. Calcium channels are molecular
pores in the cell membrane which in
general, have the important role of
linking electrical activity to other func¬
tions such as contraction or neuro¬
secretion. In the heart they are vital for
the generation of the normal heart beat
and can also be responsible for mal¬
function of the cardiovascular system,
such as angina and cardiac arrhythmias.
“Understanding the mechanisms of
action of calcium channels is essential
to the intelligent use of existing channel
blocking drugs as well as to the develop¬
ment of new drugs to stimulate the
heart,"explained Dr. Tsien. By singling
out the activity of a single calcium
channel among tens of thousands in the
cell membranes. Dr. Tsien and his
colleagues were able to study the mecha¬
nism of action of calcium channel
inhibitors and calcium channel stimula¬
tors such as epinephrine. They have
presented a new explanation for how
calcium channels manage to pass cal¬
cium ions rapidly, yet very selectively.
In both heart cells and nerve cells, they
have discovered novel types of calcium
channels, different from those previous¬
ly recognized.
Working with Dr. Tsien in this re¬
search were Drs. Peter Hess, Jeffry
Lansman, Aaron Fox and Martha
Nowycky.

FACULTY AND FELLOWS
RECEIVE GRANTS FOR
CANCER RESEARCH
The American Cancer Society has
awarded grants in support of cancer
research by two members of the faculty,
and six fellows and research associates
have received grants from the Leukemia
Society of America for their research.
Dr. William N. Hait, assistant profes¬

sor of medicine (medical oncology),
has received $162,500 from the ACS in
two-year support of his search for new
effective anticancer agents. Most effec¬
tive anticancer drugs act on DNA,
inhibiting the cancer cell's ability to
divide and grow by interfering with
DNA metabolism. Dr. Hait is adopting
a different approach. He has found
that an increased concentration of a
substance called cyclic AMP can inhibit
the growth of certain malignant tissues,
and is investigating drugs that will
inhibit the enzyme PDE (cyclic
nucleotide phosphdiesterase) which
degrades cyclic AMP. In his research,
PDE will be compared in leukemic
versus normal tissue and then potent
inhibitors to this enzyme will be investi¬
gated.
A grant of $149,572 from the ACS
will support research of Dr. John Lazo,
associate professor of pharmacology,
into improving the effectiveness of bleo¬
mycin, a potent antibiotic used clinically
in treating some cancers, including
squamous cell carcinoma and malignant
lymphomas. Dr. Lazo’s research will
involve testing the effectiveness of other
members of the naturally occurring
bleomycin family in an effort to find a
variation of the substance which might
improve the use of the drug.
The Leukemia Society of America
has awarded two-year fellowships to:
Dr. Malgorzata Jastreboff, postdoctoral
fellow in pharmacology, and Dr. Kimiko Ishiguro, associate research scientist
in pharmacology, for research in the
development of potent anti-leukemic
agents and techniques for administering
and enhancing chemicals that kill malig¬
nant cells; and to Dr. Jill Lacy, a
postdoctoral fellow in medical onco¬
logy, and Dr. Alan Waldman, postdoc¬
toral fellow in therapeutic radiology,
for research on the understanding of
normal cellular genetic mechanisms
and how changes in certain genes in a
cell can lead to malignancy.
Also, to Dr. Hal Jenson, postdoctoral
fellow in pediatrics and epidemiology,
for his research on the process by which
normal, healthy cells become malignant;
and to Dr. William Brown, a postdoc¬
toral fellow in cell biology, for his
investigation of the growth character¬
istics and requirements of both normal
and abnormal cells.
The six Yale researchers are among
45 investigators receiving the Society’s
awards this year.
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A CENTER FOR
RADIOLOGIC PHYSICS
ESTABLISHED AT YALE
The School of Medicine has received a
S1.03 million contract from the National
Cancer Institute to establish a Center
for Radiological Physics (CRP). It is
one of six such centers in the United
States created by the NCI to ensure
uniformly high quality of radiological
physics serv ices in diagnostic and thera¬
peutic radiology at hospitals partici¬
pating in projects supported by its
Division of Cancer Prevention and
Control.
The Yale CRP will serve as a resource
for review, consultation and education
to approximately 70 hospitals in the
northeast, according to Dr. Robert J.
Schulz, professor of radiology (radiologic
physics), who is the director. Dr. Ravinder Nath, associate professor of thera¬
peutic radiology (radiologic physics), is
the associate director.
“The purpose of the CRP at Yale is
to develop methods and equipment for
assessing the performance of radiation
equipment by on-site visits as well as by
mailed dosimetry kits,”said Dr. Schulz.
“The goal of these review processes is
to help the participating hospitals reach
and maintain a uniformly high level of
health care delivery that heretofore has
not been possible.”
About half of all cancer patients
receive radiotherapy at some point in
their treatment program. For 25 percent
almost 200,000 patients a year
radia¬
tion is the primary treatment, or is used
in conjunction with other modalities in
the primary treatment. Despite on¬
going improvement in treatment with
combined modality therapy, tumors
recur in some areas of the body in
approximately 100,000 patients each
year.
These statistics are the basis for the
NCI’s decision to establish the CRP
program. “Success or failure of topical
tumor control by radiotherapy can
depend on the accuracy with which a
prescription is fulfilled,” said Dr.
Schulz. “Accurate equipment calibration,
treatment planning and dosimetry are
essential for the delivery of quality
radiation therapy.”
Through a telecommunications net¬
work developed by Dr. Schulz and his
colleagues, the dosimetry service at
Yale provides radiation treatment plan¬

ning for cancer patients in six hospitals
in Connecticut and Massachusetts. The
dosimetry training program in the De¬
partment of Therapeutic Radiology is
the first, and one of only two such
programs in the country. Each year,
four trainees are instructed in the physics
of ionizing radiations, radioactivity,
radiation oncology and treatment plan¬
ning before taking positions in hospitals
throughout the United States.

BEAUMONT MEDICAL
CLUB AWARDS FULTON
PRIZE AND PRESENTS
FULTON LECTURE
At its final meeting of the year the
Beaumont Medical Club presented the
John F. Fulton Memorial Lecture and
awarded the John F. Fulton Memorial
Prize. Barbara Gutman Rosenkrantz,
the 1985 Fulton Fellow presented the
lecture, “MindingOther People’s Busi¬
ness: Claims for Public Health Between
the Wars.”
The Fulton Memorial Prize was pre¬
sented to William Gaillard, Class of
1985, the outgoing president of the
Nathan Smith Club, for his research
paper “The Great Plague of Athens:
Thucydides and the Bonds of Polity.”
The Prize is awarded to the member of
the Club whose research paper was
considered the most outstanding contri¬
bution of the academic year. It was
presented to Mr. Gaillard by Dr. Arthur
Viseltear, associate professor of the
history of medicine and public health,
on behalf of the Section of the History
of Medicine. “In presenting this prize,
we not only honor its recipient, but
perpetuate Dr. Fulton’s memory,’’said
Dr. Viseltear.
Barbara Gutman Rosenkrantz
is
professor and chairman of the Depart¬
ment of the History of Science at
Harvard University. As the seventh
Fulton Fellow of the Beaumont Medical
cal Club, the distinguished medical
historian was in residence at Yale Uni¬
versity from May 1-3, during which
time she presented three lectures, includ¬
ing “The Conquest of the Great White
Plague” presented at the last meeting of
the year of the Nathan Smith Club.
The Fulton Fellowship was founded
by Dr. Bern Dibner, director of the
Burndy Library, Norwalk, Connecticut
to honor and perpetuate the memory of
Dr. John F. Fulton. The Fellow is
selected annually by a committee of the
Beaumont Medical Club.

NATHAN SMITH CLUB
HONORS MRS. FULTON
At the final meeting this year of the
Nathan Smith Club, president William
Gaillard. Class of 1985, announced the
creation of the Lucia P. Fulton Fellow¬
ship to honor Mrs. Fulton “in appreci¬
ation for her ardent and enthusiastic
support and unsurpassed hospitality
over these many years.” Mrs. Fulton,
the widow' of the late Dr. John F.
Fulton, has traditionally invited mem¬
bers of the Nathan Smith Club to hold
their final meeting of the year at her
home, “Millrock.”
The Nathan Smith Club is comprised
of Yale medical students who meet
throughout the academic year in the
homes of faculty to discuss historical
medical topics. Dr. Fulton served as its
principal sponsor and advisor for many
years.
The outstanding student in the history
of science and medicine will be selected
by the club's officers to present his or
her paper at the last meeting of the year
as the Lucia P. Fulton Speaker, accord¬
ing to Mr. Gaillard.

BOOKS BY FACULTY
“T he Admirable Secrets of Physick &
Chyrurgery” by Thomas Palmer; edited
by Thomas R. Forbes, E. K. Hunt Profes¬
sor Emeritus of Anatomy, senior re¬
search scholar in the History of Medi¬
cine. Yale University Press (New Haven)
1984.
“Clinical Epidemiology”, by Alvan R.
Feinstein, M. Dprofessor of medicine
and epidemiology. W.B. Saunders, Co.
(Philadelphia)
“A Stranger in My House: Jews and
Arabs in the West Bank”, by Walter
Reich, M.D., lecturer in psychiatry.
Holt Rhinehart and Winston (New
York) 1984.
“Mind, Brain, Body: Toward a Conver¬
gence of Psychoanalysis and Neuro¬
biology”, by Morton F. Reiser, M.D.,
professor and chairman of the Depart¬
ment of Psychiatry. Basic Books (New
York) 1984- 228 pp„ illus.

FACULTY NEWS
Dr. Vincent A. Andriole, professor of
medicine, has been elected a member of
the Council of Infectious Disease Soci¬
ety. There are six elected councilors of
this distinguished society with a mem¬
bership of over 3,000.

At its annual meeting in April, the
Association of University Programs in
Health Administration awarded its
highest recognition to Professor John
D. Thompson for his contributions to
the improvement of health services
through management education. Profes¬
sor of public health (hospital administra¬
tion) and nursing administration, he is
widely recognized as the co-developer
of the diagnostic related group (DRG)
system. The AUPHA has established
the John D. Thompson Prize for health
services research to be awarded to a
young faculty member any where in the
world who has published the most
significant original research report dur¬
ing the past year.
The American Urological Association
presented its prestigious Hugh Hampton
Young Award to Dr. Bernard Lytton,
professor of surgery (urology). The
award, which is co-sponsored by Bristol
Laboratories and carries an honorarium
of $2,000, is presented for outstanding
contributions to the study of urinary
tract disease.
Dr. Robert M. Donaldson, David Paige
Smith Professor of Medicine, has been
named a Master of the American Col¬
lege of Physicians. A leading medical
educator and investigator in gastroenter¬
ology, Dr. Donaldson’s contributions
to internal medicine include research
on cobalamine transport and the blind
loop syndrome.

The New Haven Foundation presented
one of its eight 1984 Elm and Ivy
Awards to Dr. James P. Comer for
outstanding contributions toward im¬
proved relations between New Haven
and Yale University. Dr. Comer, who
is Maurice Falk Professor of Child
Psychiatry and associate dean for stu¬
dents at the School of Medicine, was
cited for his leadership in a major
collaboration between the Yale Child
Study Center and the New Haven
public school system to help solve the
problems of inner-city school education,
especially in the elementary schools.
In addition, the American Psychiatric
Association presented its Agnes Purcell
McGavin Award to Dr. Comer for his
outstanding work related to the preven¬
tive aspects of the emotional disorders
of childhood.
Dr. James F. Jekel, C.E.—A. Winslow

Professor of Public Health, has received
a 1985-86 Fulbright Fellowship to assist
the people of the Bahamas in the
development of an epidemiological sur¬

veillance system to monitor the island's
drug and teenage pregnancy problems.
Selected by the U.S. Information Agen¬
cy and the Board of Foreign Scholar¬
ships, Dr. Jekel will help promote
mutual understanding between the
people of the U.S. and the Bahamas.
In addition to receiving a Javits Award,
Dr. Charles Stevens was one of ten

recipients of the McKnight Awards for
Research Projects. The award for
$150,000 for a three-year period is in
support of his research on “Neuromodulatory Mechanisms of Information Stor¬
age.” The McKnight Awards support
outstanding investigative programs by
established neuroscientists and their
associates to encourage them to direct
more of their efforts toward developing
new approaches to the understanding
of memory and related diseases.
Dr. Arthur Horwich is one of twelve
physicians selected from a group of 86
highly qualified applicants to receive a
Hartford Fellowship from The John A.
Hartford Foundation, Inc. of New
York, which provides annual salary
support of $35,000 for three years. An
assistant professor of human genetics
and pediatrics who has focused his
research on inborn errors of metabo¬
lism, Dr. Horwich received the Life
and Health Insurance Medical Research
Fund Award last year for his studies of
the Expression of cDNA Encoding
Human Ornithine Transcarbamy lase.

The Alzheimer’s Disease and Related
Disorders Association, Inc. has pre¬
sented Dr. Amy F.T.Arnsten a 1985
Allied Corporation/ADRDA Faculty
Scholar Award. The award of $38,000
annually for three years is intended to
support faculty at the junior level who
have demonstrated an ability for inde¬
pendent and innovative research in the
causes or treatment of Alzheimer’s dis¬
ease and related disorders. Dr. Arnsten
is an associate research scientist in the
Section of Neuroanatomy.
The Japan Society of Anesthesiology
has made Dr. Nicholas M. Greene and
Dr. Luke M. Kitahata honorary mem¬
bers in recognition of their many contri¬
butions to research in the field. Drs.
Greene and Kitahata are professors
and former chairmen of the Department
of Anesthesiology. In addition. Dr.
Greene has been awarded an honorary
degree and appointed a Fellow of the
Faculty of Anesthesists, Royal College
of Surgeons, England.

Dr. William Cain, professor of epidemio¬
logy (environmental health)and psycho¬
logy, has been voted president-elect of
the New York Academy of Sciences.
Dr. Cain, who is also a fellow of the
John B. Pierce Foundation Laboratory,
is well known for his studies of the
olfactory system and for his research
on the eflects of indoor air pollution on
the sensory system. The New York
Academy ot Sciences is an international
membership organization of 50,000 sci¬
entists from the United States and 81
foreign nations, representing every
scientific discipline.
Dr. Sara Rockwell, professor of re¬
search in therapeutic radiology, has
been elected a Councilor-at-large of the
Rad iation Research Society. The society
is the major international society for
research in radiation and its effects.

On May 23, Dr. Myrna M.Weissman,
professor of psychiatry and epidemi¬
ology and director of the Depression
Research Unit, presented the Distin¬
guished Psychiatric Lecture at the Amer¬
ican Psychiatric Association’s annual
meeting in Dallas. The title of her
lecture was “Does Psychiatric Epidemi¬
ology Count for the Clinician?”
Dr. Paul G. Barash, professor and
chairman of the Department of Anesthe¬
siology, has been elected to a two-year
term as president of the Society of
Cardiovascular Anesthesiologists, a na¬
tional organization promoting research
and clinical development in cardiovascu¬
lar and thoracic anesthesiology.
Dr. Norman Talner, professor of pedia¬
trics and diagnostic radiology, served
on the organizing committee for the
2nd World Congress of Pediatric Cardi¬
ology, held in New York City, June 2-6.
Several other Yale medical faculty gave
invited presentations including Drs.
George Lister, associate professor of
pediatrics and anesthesiology; Charles
Kieinman, associate professor of pedia¬
trics (cardiology) and diagnostic radio¬
logy; William Hellenbrand, associate
professor of pediatrics; Ruth Whittemore, clinical professor of pediatrics;
William W.L. Glenn, Charles W. Ohse
Professor of Surgery (cardiothoracic);
and Gary Kopf, assistant professor of
surgery (cardiothoracic). In addition,
Drs. Michelle Moss and John Fahy,
postdoctoral fellows and instructors in
pediatrics, and Patricia A. Richard,
nurse clinical instructor in pediatric
cardiology, presented papers at the
session.
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alumVews
MR. KAPLAN IS HONORED
Over 100 friends and family gathered
on March 31 in the Hope Building to
honor Louis J. Kaplan on his retirement
as Associate Dean for Community and
Government Relations and Alumni
Affairs. Guests included not only mem¬
bers of the Yale and Medical Center
communities, but representatives of
the local and state governments as
well. Several who could not attend,
including former deans Fredrick Redlich and Lewis Thomas sent messages
of congratulations and best wishes.
Lou Kaplan came to Yale in 1967 as
assistant to Dean Redlich for commun¬
ity affairs and government relations. In
1974, he became Assistant Dean for
Community and Government Relations
and Alumni Affairs; and in 1979, he
was appointed Associate Dean. He was
also a lecturer in epidemiology and
public health and psychiatry..
During his 18 years at Yale, he
retained membership on boards of many
city, community and Yale affiliated
organizations. He was Communicator
Lobbyist for the State of Connecticut
as well as a key source and advisor for
local, state and federal officials.
Alumni of the School of Medicine
perhaps know Mr. Kaplan best for his
participation in many alumni activities
including the Yale Medical School
Alumni Fund, the Association of Yale
Alumni in Medicine, and the Associa¬
tion of Yale Alumni Graduate and
Professional School Committee.
One colleague expressed the opinion
of many when she said, “Lou’s talents
and expertise will be sorely missed by
his Yale family and friends.”

CLASS NOTES
1932
Conrad Lam wrote on February 1 that

he was leaving the following week to
participate in a World Congress on
Open Heart Surgery in Bombay, India.
The Congress was being held to com¬
memorate 25 years of open heart surgery
in that country.
1934
Edward T. O’Donnell was honored on

November 6, 1984 by the Medical
Society of Delaware on the 50th anniver¬
sary of his practice of pediatrics. In
addition, the Wilmington Friends
School honored Dr. O’Donnell with a
reception marking his retirement after
20 years as school physician.

well-being of his patients, his family,
his colleagues, and his community. He
is held in the highest esteem both as a
man and as a physician by all who have
been privileged to know him.”
A tribute to Dr. Franklin written by
Willys Monroe, entitled “Salute to a
Life of Excellence” was published in
the May 1985 issue of Virginia Medical
He reports as follows in the final para¬
graph of that article:
“A few weeks after the dedication
ceremony. Jack underwent a quadruple
coronary artery bypass. While he came
through the procedure with flying
colors, he tells me that the enforced rest
period postoperatively was so pleasant
that he decided to retire from the
practice of medicine on May 1. His
presence on the medical scene will be
sorely missed, but we wish him and
Frannie much happiness, contentment
and many more productive years among
their children, grandchildren and a
host of friends.”

1939
Douglass Walker has given Yale’s Trum¬

bull College a set of Wedgewood china
depicting various Yale scenes. The china
belonged to Dr. Stanhope Bayne-Jones,
who was master of the college from
1932to 1938 and who served as dean of
the School of Medicine from 1935 to
1940.
As a medical student and also a
proctor in one of the Howard Avenue
dormitories, Douglass Walker came to
know Dean Bayne-Jones quite well.
Subsequently, as an Army medical
officer in World War II, he worked
with B.J. (a colonel and latera brigadier
general) in the Surgeon General’s office.
While Dr. Walker was on the faculty at
the Johns Hopkins School of Medicine
(1963-1970), he renewed his friendship
with B.J., who had retired and was
living in Washington where he was
writinga history of preventive medicine
in World War II. In 1970, when B.J.
died, Mrs. Bayne-Jones gave the set of
china to the Walkers. Through their
thoughtful generosity, the china has
now returned to Trumbull College.
1941

A foundation to promote and support
medical research, education and patient
care has been named in honor of John
Franklin of Norfolk, Viriginia. The
John Franklin Medical Foundation
was dedicated on January 12. A plaque
installed in the lobby of the foundation
building reads in part, “Dr. Franklin
has devoted his professional life to
excellence in the practice of medicine
and his personal life to the care and

1949
Martha Vaughan, Chief of the Labora¬

tory of Cellular Metabolism at the
National Heart, Lung and Blood Insti¬
tute, has been elected a member of the
National Academy of Sciences, the
nation’s most distinguished organiza¬
tion of scientists. She was one of sixty
scientists to be so honored this year.
1953
William Whalen of Willimantic was

installed as the 148th president of the
Connecticut State Medical Society at
the annual meeting in May. Since 1959
he has been staff surgeon and from
1982 to 1984, chief of staff, at Windham
Community Memorial Hospital. In 1983
Dr. Whalen, an associate clinical pro¬
fessor of surgery at Yale, received the
Edward B. Storer Award for Excellence
in Surgical Teaching, which was pre¬
sented by the chief residents of Yale’s
Department of Surgery.

1955

1983

The American College of Physicians
(ACP) has announced that James P.
Nolan has assumed office as a Governor
of the 60,000-member national medical
specialty society. Elected locally. Dr.
Nolan will hold his post as the ACP
Governor of Upstate New York for
four years. A specialist in internal
medicine, he is professorand chairman
of the Department of Medicine at the
State University of New York at Buffalo.

The American Academy of Family
Physicians (AAFP) presented a $ 1,500
award to Patricia Kellner in support of
her graduate training in family practice.
Dr. Kellner, who is a family practice
resident at Case Western Reserve Uni¬
versity, Cleveland, is one of twenty
selected from 170 candidates on the
basis of scholastic achievement, leader¬
ship qualities and qualifications for,
and interest in family practice.

1962
Norman Bass, professor and chairman

Martin Yarmush is one of two biomedi¬

of the Department of Neurology at the
University of Kentucky College of Medi¬
cine, has been named dean of the
Medical College of Georgia School of
Medicine.
1973
Jerry Nagler, recently elected to fellow¬

ship in the American College of Physi¬
cians, was honored in March during
the convocation ceremony at the Col¬
lege’s Annual Session in Washington,
D.C. Dr. Nagler, who specializes in
internal medicine and gastroenterology,
has been a resident of New York City
for twelve years and is on the staff of
New York Hospital - Cornell Medical
Center and Cornell University Medical
College.
1977
John White of Bethesda, Maryland has

been elected to fellowship in the Ameri¬
can College of Physicians. He received
this honor in March, at the College’s
Convocation ceremony at its Annual
Session in Washington, D.C. Dr. White,
a specialist in internal medicine and
emergency medicine, is a resident of
Bethesda and is on the staff of the
Georgetown University Medical Center.
Christine K.Carrico has been appointed

director of the Pharmacological Sci¬
ences Program of the National Institute
of General Medical Sciences (N1GMS),
one of the National Institutes of Health.
As director, she will provide leadership
in the administration of a large program
of research and research training grants
in the pharmacological sciences, bio¬
related chemistry and anesthesiology.
Dr. Carrico will also direct the Pharma¬
cology Research Associate Program.

1984

cal scientists at Massachusetts Institute
of Technology who have been selected
as recipients of the first Markey Scholar
Awards by the Lucille P. Markey Chari¬
table Trust. The awards which have
been made to sixteen outstanding young
researchers, will provide from $500,000
to $700,000 support to each recipient
over six to eight years.
Dr. Yarmush, who received his Ph.D.
in immunology/ biochemistry from The
Rockefeller University in 1979, is a
principal research associate in the De¬
partment of Chemical Engineering at
MIT. His work involves experimental
and theoretical studies in applied immun¬
ology and biochemical and biomedical
engineering. Among his specific interests
are immunological approaches to treat¬
ment of cancer and other chronic dis¬
eases, immunoadsorption for large-scale
biomolecule purification, and develop¬
ment of an artificial pancreas and liver.

HOUSE STAFF
1975
Richard Uauy wrote recently that as of

March 1, he was to leave his position as
head of the Clinical Nutrition Unit at
the University of Chile to become associ¬
ate professor of pediatrics at the University of Texas in Dallas for a three-year
period. He noted that the chairman of
this department is Dr. Joseph Warshaw,
who he trained with in neonatology at
Yale.

IN MEMOR1AM

Joseph Epstein
February 3, 1985

M.DJ23

Henry W. Ferris
January 19,1985

M.D/25

Tzu Pei Chou
December 6, 1984

M.D.’25

Robert B. Love
November 19, 1984

M.DJ26

Herman H. Goldstein
September 30, 1983

M.D/27

Berthold R. Comeau
February 14, 1985

M.D728

Uno H. Helgesson
October 28, 1978

M.D728

Courtney C. Bishop
January 17, 1985

M.D730

Frank H. Couch
January 17, 1985

M.D730

Morris Y. Krosnick
February 24, 1985

M.DAJO

Gideon K. deForest
March 11, 1985

M.D732

Michael L. Furcolow
January 20, 1985

M.D/34

Leo P. Rosenthal
August 4, 1984
Richard J. Hinchey
April 1, 1978

exP.H.‘37
M.P.H740

Charles R. Harms
March 3, 1985

M.D'42

James L. Bradley
February 1, 1985

M.D‘43

Helen B. Ausley
November 13, 1982

M.P.H745

Lorraine C. Patterson
July 2, 1974

M.P.H/49

Albert L. Stone
October 20, 1984

M.D753

Merrill A. Baratz
December 26, 1984

HS’54

Edwin D. Harrington
September 20, 1973

M.P.H/54

William C. Edwards
October 28, 1983

M.D.'59

PHYSICIAN ASSOCIATE
PROGRAM
1976

Karlen L. Paulay
December 9, 1981

M.D762

Andrew Scala writes that he received
an appointment with the DartmouthHitchcock Clinic in New Hampshire,
as of December 1. He is associated with
the Department of Internal Medicine,
although he is concentrating on ortho¬
pedic problems.

William B. Yeagley
January 3, 1985

M.D766

Joseph H. Zelson
December 23, 1984

HS‘69

Thomas W. Jones
December 20. 1977

M.P.H.71

Stephen R. Shell
February 14, 1985

HS‘80
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CLASS OF 1985

RESIDENCY POSITIONS

CALIFORNIA
Harbor-UCLA Medical Center, Torrance
Lisa Nelson-Robinson, Transitional
Santa Monica Hospital
Michael Gilbert, Family Practice
UCLA Neuropsychiatric Institute
Thomas Newton, Psychiatry
University of California San Diego Affiliated
Hospitals
Jaime Arroyo, Internal Medicine
Peter Rubin, Surgery
Javier Vizosos, Obstetrics and Gynecology
University of California (Irvine) Affiliated

ILLINOIS
McGaw Medical Center-Northwestern
University, Chicago
Edward Tyau, General Surgery
University of Chicago Clinics
Greg Sachs, Internal Medicine

Hospitals
Alice Chi, Internal Medicine
University of California, San Francisco
Sandra Wolin, Postdoctoral Fellow,
Department of Biochemistry and Biophysics
University of California Hospitals
San Francisco
Brent Moelleken, General Surgery
Jon Nakamoto, Pediatrics
Eric Poeschla, Internal Medicine
Fong Wang, Pediatrics
COLORADO
University of Colorado Affiliated Hospitals,
Denver
Barry Bergquist, Internal Medicine
Michael Johnson, Psychiatry
Elizabeth Mason, Obstetrics and Gynecology
Leslye Pennypacker, Internal Medicine
CONNECTICUT
Hartford Hospital
Robert Smith, Transitional
Hospital of St. Raphael, New Haven
Ellen Rieur, Internal Medicine
Norwalk Hospital
Kimball Woodward, Internal Medicine
Yale-New Haven Hospital
David Birnkrant, Pediatrics
Vance Brown, Internal Medicine
JoAnne Burger, Pediatrics
Jane Carter, Internal Medicine
Jacqueline Gutmann, Obstetrics and
Gynecology
Susan Korrick, Internal Medicine
Jonathan Lewin, Pediatrics
Susan Moore, Internal Medicine
Jeffery Morton, Therapeutic Radiology
David Roberts, Internal Medicine
Richard Ruiz, Surgery
Reginald Sanders, Internal Medicine
Mark Topazian, Internal Medicine
Pablo Vazquez-Seoane, Surgery
DISTRICT OF COLUMBIA
Children’s Hospital
Fred Santoro, Pediatrics
George Washington University Hospital
Shirley Lee, Internal Medicine
Walter Reed Army Hospital
Jennifer Calagan, Internal Medicine

MARYLAND
Johns Hopkins Hospital, Baltimore
Peter Greene, General Surgery
John Roberts, General Surgery
MASSACHUSETTS
Beth Israel Hospital, Boston
Terri Cornelison, Obstetrics and Gynecology
Virginia Huang, General Surgery
Boston City Hospital
Carol Farver, Internal Medicine
Samuel Goos, Internal Medicine
Angela Grant, Internal Medicine
Robert Needlman, Pediatrics
Brigham and W omen's Hospital, Boston
Hingge Hsu, Internal Medicine
John Merendino, Internal Medicine
Collin Smikle, Obstetrics and Gvnecoogy
Steven Warren, Surgery
Cambridge Hospital
Janice Blustein, Primary Care Medicine
Joshua Sparrow, Transitional
Eye Research Institute Retina Foundation,
Boston
Tina Tillis, Research Fellow, Ophthalmology
Lemuel Shattuck Hospital, Boston
Marie Hobart, Transitional
Massachusetts General Hospital, Boston
Richard Garber, Pediatrics
Ted Love, Internal Medicine
Joshua Schor, Internal Medicine
McLean Hospital, Belmont
Alec Bodkin, Psychiatry
New England Deaconess Hospital, Boston
Jeffrey Lowell, General Surgery
New England Medical Center Hospital, Boston
Brian Annex, Internal Medicine
Anthony Marks, Internal Medicine
MICHIGAN
University of Michigan Affiliated Hospitals,
Ann Arbor
Janet Young, Diagnostic Radiology
MINNESOTA
University of Minnesota Hospital, Minneapolis
Calixto Dimas, Diagnostic Radiology
Richard Parker, Neurosurgery
NEW YORK
Maimonides Medical Center, Brooklyn
Paul Roberts, Internal Medicine
Millard Fillmore Hospital, Buffalo
Barbara Guillette, Surgery
Montefiore Hospital, Bronx
Daniel Greenwald, General Surgery
Mt. Sinai Hospital, New York
Stafford Broumand, General Surgery
Julie Danaher, Obstetrics and Gynecology
Darlyne Johnson, Surgery
Maria Rivera, Internal Medicine
New York University Medical Center, New York
Peter Chang Sing, Internal Medicine

Presbyterian Hospital, New York
Gail Mattson, General Surgery

Roosevelt Hospital, New York
Michael Behrman, General Surgery
Strong Memorial Hospital, Rochester
Lynn Mehlman, Internal Medicine
State University of New York-Erie County
Medical Center, Buffalo
Timothy Tanner, Internal Medicine/ Pediatr
The New York Hospital, New York
Sara Cartmell, Obstetrics and Gynecology
Robert Klitzman, Psychiatry
Marnin Merrick, Internal Medicine
Anne Regenstein, Obstetrics and Gynecolog
NORTH CAROLINA
Duke University Medical Center, Durham
Bryan DeSouza, Neurosurgery
Victor Hsu, Internal Medicine
OHIO
Case Western Reserve University-Cleveland
Metropolitan General Hospital, Cleveland
Guy Fish, Internal Medicine

PENNSYLVANIA
Children's Hospital, Philadelphia
Sara Schutzman, Pediatrics
Louis Tesoro, Pediatrics
Graduate Hospital, Philadelphia
Samuel Pesin, Internal Medicine
Hospital of the University of Pennsylvania,
Philadelphia
Edward Savage, General Surgery
Mark Shachner, General Surgery
Timothy Shapiro. Internal Medicine
Hospitals of the University Health Center of
Pittsburgh
William Gaillard, Pediatrics
Robert Higgins, General Surgery
Medical College of Pennsylvania, Philadelphia
Ronald Lisan, Internal Medicine
Pennsylvania Hospital, Philadelphia
Robert Aronowitz, Internal Medicine
Jane Mathisen, Obstetrics and Gvnecoogy
Temple University Hospital, Philadelphia
Stuart Isaacs, Internal Medicine
Thomas Jefferson University Hospital,
Philadelphia
Guy Fried. Internal Medicine
RHODE ISLAND
Women and Infants Hospital, Providence
Elizabeth Moy, Obstetrics and Gvnecoogy
TEXAS
Baylor University Medical Center, Dallas
Peter Shile, Internal Medicine
University of Texas Southwestern Affiliated
Hospitals, Dallas
Kathleen Maurer, Internal Medicine
CANADA
Royal Victoria Hospital, Montreal
David Alwin, Internal Medicine
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